PReS 2026 16 a 19 de Septiembre de 2026, Belgrado, Serbia,
Más información
Última actualización: 22 junio 2026
ABRIL 2026
-
Uğur Es Y, Özçelik E, Erdem Torun Ş, Öztürk D, Yoğun SN, Işıklar Ekici M, Çelikel E, Ekici Tekin Z, Karagöl C, Ertem Ş, Esen E, Çelikel Acar B.
Exertional leg pain in pediatric familial mediterranean fever: clinical associations and implications for treatment.
Eur J Pediatr. 2026 Apr 29;185(5):316. doi: 10.1007/s00431-026-06965-9.
https://pubmed.ncbi.nlm.nih.gov/42050020/ -
Kasap Cuceoglu M, Hinze T, Wittkowski H, Haslak F, Mamutova A, Oner N, Caorsi R, Bourguiba R, Elhani I, Delplanque M, El Moussaoui M, Pateras K, Sestan M, Kirijas M, Constantin T, Ducharme-Benard S, Lanchmann H, Butbul Aviel Y, Hentgen V.
Cross-national biologic treatment guidelines for familial Mediterranean fever: a comparative analysis.
Rheumatology (Oxford). 2026 Apr 26:keag230. doi: 10.1093/rheumatology/keag230. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/42036840/ -
Bayindir Y, Satirer Ö, Cam V, Turkmen S, Sozeri B, Kuemmerle-Deschner JB, Ozen S.
Genotype-phenotype correlations in pediatric CAPS with predominantly low-penetrance NLRP3 variants among Turkish patients in Germany and Turkey: beyond borders.
Pediatr Rheumatol Online J. 2026 Apr 11;24(1):21. doi: 10.1186/s12969-026-01214-7.
https://pubmed.ncbi.nlm.nih.gov/41965684/
MARZO 2026
-
Turner S, Roberts E, Hall N, Hedrich CM.
Treatment of pediatric chronic nonbacterial osteomyelitis - a systematic review.
Autoimmun Rev. 2026 Mar;25(3):104005. doi: 10.1016/j.autrev.2026.104005.
https://pubmed.ncbi.nlm.nih.gov/41654205/ -
Kong L, Zhou W, Wang X, Zhang H.
Chronic Recurrent Multifocal Osteomyelitis: A Review of 80 Cases in Chinese Children.
J Clin Rheumatol. 2026 Mar 1;32(2):54-58. doi: 10.1097/RHU.0000000000002292.
https://pubmed.ncbi.nlm.nih.gov/41481904/ -
Viana SL, Machado BB.
Atypical and less-common imaging presentations of chronic nonbacterial osteitis in children: a pictorial review
Pediatr Radiol. 2026 Mar;56(3):514-525. doi: 10.1007/s00247-026-06517-1.
https://pubmed.ncbi.nlm.nih.gov/41619012/ -
Michaud M, Jamilloux Y, Delmas C, Lairez O, Coulier H, Bruguière E, Pugnet G.
Idiopathic pericarditis in 2025: Advances in diagnosis and therapeutic strategies.
Autoimmun Rev. 2026 Mar;25(3):103991. doi: 10.1016/j.autrev.2026.103991.
https://pubmed.ncbi.nlm.nih.gov/41619958/ -
David C, Nathan N, Al-Abadi E, Arkwright PD, Bader-Meunier B, Becker S, et al.
Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome
Ann Rheum Dis. 2026 Mar;85(3):547-557. doi: 10.1016/j.ard.2025.09.013.
https://pubmed.ncbi.nlm.nih.gov/41395910/ -
Menentoğlu B, Arık SD, Prencuva Akyürek P, Akgün Ö, Aktay Ayaz N.
Comparative analysis of exon 10 and non-exon 10 variants in children with familial mediterranean fever: a retrospective cohort study.
Eur J Pediatr. 2026 Mar 9;185(3):169. doi: 10.1007/s00431-026-06835-4.
https://pubmed.ncbi.nlm.nih.gov/41801261/ -
Zhu Y, Zhang F, Li S, Tian Z, Jiang Z, Lv F, Zeng X, Zhou Z, Zhong B, Peng Q, Lu X.
Targeting CD177: A Novel Therapeutic Strategy for NLRP3-Associated Autoinflammatory Diseases
Int J Mol Sci. 2026 Mar 20;27(6):2841. doi: 10.3390/ijms27062841.
https://pubmed.ncbi.nlm.nih.gov/41898699/ -
Akgün Ö, Demirkan FG, Koné-Paut I, Coşkuner T, Çam V, Polat MC, et al.
Biological therapies in paediatric Behcet's disease: results of an international collaborative study by the PRES Vasculitis Working Party
Rheumatology (Oxford). 2026 Mar 5;65(3):keaf404. doi: 10.1093/rheumatology/keaf404.
https://pubmed.ncbi.nlm.nih.gov/40748718/ -
Bozkaya Yücel B, Doğantan Ş, Çelik ÖG, Elmas S, Öğreten Yadigaroğlu N, Eser Öztürk H, et al.
Clinical phenotype and long-term damage in paediatric Behcet's disease: comparative performance of ISG, ICBD and PEDBD classification criteria in a retrospective endemic cohort.
RMD Open. 2026 Mar 9;12(1):e006514. doi: 10.1136/rmdopen-2025-006514.
https://pubmed.ncbi.nlm.nih.gov/41802833/
FEBRERO 2026
-
Balay-Dustrude E, Marques MC, Appenzeller S, Bracaglia C, Dedeoglu F, Eloseily E, Jimenez PM, Ombrello MJ, Onel K, Twilt M, Zhao X, Minoia F, Shenoi S; CARRA Systemic JIA Work Group and the PReS MAS/sJIA Working Party.
Clinical Features and Outcome Measures Across Still Disease (Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still Disease) Cohorts Worldwide: A Systematic Literature Review.
J Rheumatol. 2026 Feb 1;53(2):134-143.
https://pubmed.ncbi.nlm.nih.gov/41033820/ -
Başaran Ö, Yıldız AE, Bilginer Y, Özen S.
Chronic nonbacterial osteomyelitis: current perspectives in pediatric practice.
Turk J Pediatr. 2026 Feb 27;68(1):1-17.
https://pubmed.ncbi.nlm.nih.gov/41871553/ -
Peng SM, Yu ZX, Song HM.
Undifferentiated autoinflammatory diseases: a systematic review.
World J Pediatr. 2026 Feb;22(2):194-211.
https://pubmed.ncbi.nlm.nih.gov/41350948/ -
Dupré L, Castanon I, Boztug K.
Immune-related actinopathies at the cross-road of immunodeficiency, autoimmunity and autoinflammation.
Nat Rev Immunol. 2026 Feb;26(2):89-111.
https://pubmed.ncbi.nlm.nih.gov/40931027/ -
Li Q, Wang Y, Liu F, Zheng P.
Chronic nonbacterial osteomyelitis: a typical case and review.
Front Pediatr. 2026 Feb 27;14:1747342.
https://pubmed.ncbi.nlm.nih.gov/41837191/ -
Bank I.
γδ T Cells in Autoinflammatory Diseases.
Cells. 2026 Feb 24;15(5):388.
https://pubmed.ncbi.nlm.nih.gov/41827822/ -
Wu D, Matsuda T, Xie D, Shen M, Dhar A, Davis JM 3rd, Shen B, Kambe N, Strober W, Yao Q.
NOD2-Related Multisystem Inflammatory Disorders and Recent Advances.
Curr Rheumatol Rep. 2026 Feb 12;28(1):5.
https://pubmed.ncbi.nlm.nih.gov/41678017/
ENERO 2026
- Kucuk E, Senpolat S, Kaya F, Koru L, Aydin Z, Dizman EN, et al.
Reported Triggers and Self-reported Management Strategies in Children With Familial Mediterranean Fever.
J Clin Rheumatol. 2026 Jan 1;32(1):1-7.
https://pubmed.ncbi.nlm.nih.gov/40694669/ - Kazanasmaz H, Gündoğmuş F, Eroğlu EC, Kalyoncu M.
Serum amyloid A as predictive factor in PFAPA syndrome attack. Med Clin (Barc). 2026 Jan;166(1):107244.
https://pubmed.ncbi.nlm.nih.gov/41505970/ - Lalaoui N, Masters SL.
Monogenic disorders of the TNF signalling pathway.
Nat Rev Rheumatol. 2026 Jan;22(1):8-25.
https://pubmed.ncbi.nlm.nih.gov/41381726/
DICIEMBRE 2025
- Papa R, Bovis F, Federici S, Palmeri S, Bustaffa M, Recchi G et al.
Decision tree analysis as a preliminary evidence-based tool for identifying the syndrome of undifferentiated recurrent fever in children compared with hereditary recurrent fevers and periodic fever, aphthosis, pharyngitis and adenitis syndrome
Arthritis Rheumatol. 2025 Dec 21
https://pubmed.ncbi.nlm.nih.gov/41423343/
OCTUBRE 2025
-
Unal D, Yigit YD, Basaran O, Yildiz AE, Bayindir Y, Cam V, et al.
Validation of the EULAR/ACR classification criteria for chronic nonbacterial osteomyelitis in a pediatric cohort
Clin Rheumatol. 2025 Oct;44(10):4229-4236. doi: 10.1007/s10067-025-07653-z.
https://pubmed.ncbi.nlm.nih.gov/40858879/ -
Pervane YD, Bağlan E.
Evaluation of biological treatment in pediatric patients with familial Mediterranean fever: a retrospective study of 832 patients.
Expert Opin Biol Ther. 2025 Oct 21:1-8
https://pubmed.ncbi.nlm.nih.gov/41091186/ -
Schulert GS.
Update on new autoinflammatory disorders from the 2024 Pediatric Rheumatology European Society Congress.
Pediatr Rheumatol Online J. 2025 Oct 28;23(1):107.
https://pubmed.ncbi.nlm.nih.gov/41152899/ -
Yue J, LeSon CE, Rimland CA, Brodeur K, Weng R, Hsu EE, et al.
Diagnostic implications and correlates of plasma ADA2 activity and ADA2 variants.
Arthritis Rheumatol. 2025 Oct 28.
https://pubmed.ncbi.nlm.nih.gov/41147740/ -
Wang S, Yu T, He X, Ding Y, Wu Y.
Clinical and genetic analysis of Majeed syndrome caused by LPIN2 complex heterozygous mutation and literature review.
Front Pediatr. 2025 Oct 2;13:1602509. doi: 10.3389/fped.2025.1602509.
https://pubmed.ncbi.nlm.nih.gov/41113563/
SEPTIEMBRE 2025
-
Zhao Y, Oliver MS, Schnabel A, Wu EY, Wang Z, Marino A, et al.
EULAR/ACR classification criteria for paediatric chronic nonbacterial osteomyelitis (CNO).
Ann Rheum Dis. 2025 Sep;84(9):1458-1468. doi: 10.1016/j.ard.2024.11.006.
https://pubmed.ncbi.nlm.nih.gov/39966038/ -
Matucci-Cerinic C, Bayindir Y, Longo C, Mori F, Alessi F, Vergani M, Rosina S, Consolaro A, Volpi S, Caorsi R, Arrigo S, Gattorno M, Ozen S, Malattia C.
Data from a multicentric international study unveils a neglected association between chronic non-bacterial osteomyelitis and inflammatory bowel diseases.
Clin Exp Rheumatol. 2025 Sep 25. doi: 10.55563/clinexprheumatol/2pobji. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/41004323/ -
Bonet N, Mascaro JM Jr, Hurtado-Navarro L, Angosto-Bazarra D, Callejas-Rubio JL, Clemente D, et al.
Novel Insights into the Clinical Features, Genetic Spectrum and Clonal Evolution of Patients Carrying NLRP3 Mosaicism.
J Clin Immunol. 2025 Sep 30;45(1):134. doi: 10.1007/s10875-025-01922-x.
https://pubmed.ncbi.nlm.nih.gov/41026232/ -
Bahaa A, Nour A, Hamza A, Mohammad G, Kenana A, Lama G, Fawzi A.
Scrotal Pain in Familial Mediterranean Fever: A Series of Three Case Reports and Literature Review.
Mediterr J Rheumatol. 2025 Sep 15;36(3):497-501. doi: 10.31138/mjr.180425.tar.
https://pubmed.ncbi.nlm.nih.gov/41122187/ -
Haslak F, Oner N, Elhani I, Hinze T, Mamutova A, Bourguiba R, et al.
Comparative analysis of global practices in the management of colchicine-resistant familial Mediterranean fever: a CliPS network analysis
RMD Open. 2025 Sep 26;11(3):e006097. doi: 10.1136/rmdopen-2025-006097.
https://pubmed.ncbi.nlm.nih.gov/41005976/ -
La Bella S, Corsello A, Bayraktar D, Di Ludovico A, Scorrano G, Rinaldi M, Bayindir Y, Ozen S, Milani GP, Gattorno M, Caorsi R.
Neurological involvement in children with familial Mediterranean fever: a systematic review.
Pediatr Rheumatol Online J. 2025 Sep 2;23(1):90. doi: 10.1186/s12969-025-01137-9.
https://pubmed.ncbi.nlm.nih.gov/40898210/ -
Bhattacharjee R, Das S, Das MK, Basu S.
KRAS-associated pediatric lupus: Expanding the genomic landscape of monogenic lupus.
Lupus. 2025 Sep 5:9612033251378398. doi: 10.1177/09612033251378398. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40911346/
JULIO 2025
-
Manthiram K, Ortega-Villa AM, Lapidus S, Bowes M, Romeo T, Garguilo K, Failla L, Srinivasalu H, Mudd P, Ombrello A, Barron K, Kastner DL, Edwards KM.
Features Associated with Response to Tonsillectomy in Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis Syndrome in Children.
J Pediatr. 2025 Jul;282:114559. doi: 10.1016/j.jpeds.2025.114559. Epub 2025 Mar 21.
https://pubmed.ncbi.nlm.nih.gov/40122279/ -
Reiser C, Klotsche J, Schnabel A, Hofmann C, Groesch N, Niewerth M, Minden K, Girschick H.
Assessing Disease Activity in Pediatric Chronic Nonbacterial Osteomyelitis: A Proposal for Composite Scoring, Including Inactivity Measures.
ACR Open Rheumatol. 2025 Jul;7(7):e70061.
https://pubmed.ncbi.nlm.nih.gov/40604344/ -
Alblooshi H, Mustafa N, Khalam AA, Bharathan A, Mohammed E, Baydoun I, et al.
A novel LACC1 variant c.658G>A (p. Asp220Asn) in familial juvenile arthritis: identification and functional analysis.
Hum Genomics. 2025 Jul 25;19(1):85. doi: 10.1186/s40246-025-00800-2.
https://pubmed.ncbi.nlm.nih.gov/40713900/ -
Al-Mayouf SM, Alenzi F, Khamaj Y, Aljazaeri S, Fouda L, AlSaleem A, Alhuthil R.
Effectiveness and safety of bisphosphonates in inflammatory bone disorders: a systematic review.
Clin Exp Rheumatol. 2025 Jul;43(7):1354-1362. doi: 10.55563/clinexprheumatol/y0ve3b.
https://pubmed.ncbi.nlm.nih.gov/40153323/
JUNIO 2025
-
Wang OJE, Jacob M, Crawford RI, Lam JM.
Blau Syndrome (Juvenile Systemic Granulomatosis): State-Of-The-Art Review.
Pediatr Dermatol. 2025 Jun 2. doi: 10.1111/pde.16001. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40456554/ -
Matucci-Cerinic C, Attico A, Malattia C, Consolaro A, Rosina S, Breda L et al.
Towards the definition of disease phenotypes in paediatric SAPHO syndrome: a national multicentric study.
Rheumatology (Oxford). 2025 Jun 1;64(6):3777-3786. doi: 10.1093/rheumatology/keaf065.
https://pubmed.ncbi.nlm.nih.gov/39909492/ -
Batu ED, Sener S, Rodrigues M, Vinit C, Hofer F, Laskari K et al.
Corticosteroid use in PFAPA syndrome: clinical practice data from the JIR-CliPS Survey Study and a comprehensive literature review.
Rheumatology (Oxford). 2025 Jun 1;64(6):3787-3796. doi: 10.1093/rheumatology/keaf036.
https://pubmed.ncbi.nlm.nih.gov/39924747/ -
Belot A, Boespflug-Tanguy O, Boursier G, Hully M, Neven B, Renaldo F et al.
French protocol for diagnosis and management of type 1 interferonopathies.
Rev Med Interne. 2025 Jun;46(6):320-340. doi: 10.1016/j.revmed.2025.04.027. Epub 2025 May 14.
https://pubmed.ncbi.nlm.nih.gov/40374386/ -
l-Hakim A, Goldberg S, Gaillard S, Heiblig M, Beck DB, Savic S.
Clinical Features in VEXAS syndrome: a systematic review.
Rheumatology (Oxford). 2025 Jun 16:keaf293. doi: 10.1093/rheumatology/keaf293. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40570089/ -
Vatandoost N, Biglari S, Ranjbarnejad T, Vahidnezhad H, Jafarpour S, Abdolvand M et al.
Association Between Pathogenic Variants in NLRP12 and Autoinflammatory Disease: A Comprehensive Systematic Review.
Int J Immunogenet. 2025 Jun 24:e70001. doi: 10.1111/iji.70001. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40556386/ -
Sag E, Otón T, Carmona L, Ozen S.
Efficacy and safety of treatments in familial Mediterranean fever and its complications: a systematic review informing the EULAR/PReS recommendations for familial Mediterranean fever.
Ann Rheum Dis. 2025 Jun 24:S0003-4967(25)01034-9. doi: 10.1016/j.ard.2025.05.020. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40562663/
ABRIL 2025
-
Ozen S, Sağ E, Oton T, Gül A, Sieiro Santos C, Bayraktar D, et al.
EULAR/PReS endorsed recommendations for the management of familial Mediterranean fever (FMF): 2024 update
Ann Rheum Dis. 2025 Apr 9:S0003-4967(25)00084-6. doi: 10.1016/j.ard.2025.01.028. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40234174/ -
Tunce E, Atamyıldız Uçar S, Polat MC, Gücenmez ÖA, Çakan M, Bozkaya Yücel B, et al.
Predicting homozygous M694V genotype in pediatric familial Mediterranean fever: multicenter analysis and scoring system proposal.
Rheumatology (Oxford). 2025 Apr 21:keaf221. doi: 10.1093/rheumatology/keaf221. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40257440/
MARZO 2025
-
Caterson H, Papadopoulou C, Peet C, Lachmann HJ.
Systemic autoinflammatory disease diagnoses in a single year from a UK national referral centre
Rheumatology (Oxford). 2025 Mar 24:keaf165. doi: 10.1093/rheumatology/keaf165. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40128169/ -
Maccora I, Wouters C, Rosè CD, Maniscalco V, de Masi S, Mastrolia MV, et al.
Treatment of uveitis in Blau syndrome: A systematic review and meta-analysis.
J Autoimmun. 2025 Mar 26;153:103401. doi: 10.1016/j.jaut.2025.103401. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40147219/ -
Natale MF, Celani C, Federici S, Passarelli C, Perrone C, Marasco E, De Benedetti F, Insalaco A.
Genotype-phenotype correlation in a cohort of pediatric patients with autoinflammatory diseases carrying NOD2 variants.
Front Immunol. 2025 Mar 24;16:1439333. doi: 10.3389/fimmu.2025.1439333.
https://pubmed.ncbi.nlm.nih.gov/40196132/ -
Almojali A, Alrasheed A, Alharbi B, Alharbi R, Alsuwairi W, Alroqi F, Alqanatish J.
Deficiency of Adenosine Deaminase 2 Masquerading as Behçet's Disease: Phenotypic Mimicry with HLA-B*51 Positivity.
J Clin Immunol. 2025 Mar 17;45(1):83. doi: 10.1007/s10875-025-01876-0.
https://pubmed.ncbi.nlm.nih.gov/40097865/ -
Becker SL, Badawi AH, Thornton C, Ortega-Loayza AG.
Clinical Mimickers Misdiagnosed as Pyoderma Gangrenosum.
Am J Clin Dermatol. 2025 Mar 28. doi: 10.1007/s40257-025-00941-z. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40155526/ -
Monfort JB, Zhu YY, El Moussaoui M, Grateau G, Soria A; French CAPS Study Group; Savey L, Georgin-Lavialle S.
Digital clubbing, an unfamiliar feature of cryopyrin-associated periodic syndrome: a cohort study.
J Am Acad Dermatol. 2025 Mar 25:S0190-9622(25)00526-2. doi: 10.1016/j.jaad.2025.03.057. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40147682/ -
Di Cola I, Bartoli A, Savey L, Bensalek F, Delplanque M, Bourguiba R, et al
The needed daily dose of colchicine in patients with Familial Mediterranean Fever may be higher in women: a study on behalf of the JIR cohort.
Arthritis Res Ther. 2025 Mar 19;27(1):59. doi: 10.1186/s13075-024-03440-4.
https://pubmed.ncbi.nlm.nih.gov/40108720/ -
Zhang J, Shen M.
The Role of IL-17 in Systemic Autoinflammatory Diseases: Mechanisms and Therapeutic Perspectives.
Clin Rev Allergy Immunol. 2025 Mar 12;68(1):27. doi: 10.1007/s12016-025-09042-5.
https://pubmed.ncbi.nlm.nih.gov/40074883/ -
Zhu G, Didry-Barca B, Seabra L, Rice GI, Uggenti C, Touimy M, et al
Autoinflammatory encephalopathy due to PTPN1 haploinsufficiency: a case series.
Lancet Neurol. 2025 Mar;24(3):218-229. doi: 10.1016/S1474-4422(24)00526-X.
https://pubmed.ncbi.nlm.nih.gov/39986310/ -
Shunyakova J, Reynolds M, Taylor A, Sieck EG, Walsh JT, Hassman LM.
Case Report: ROSAH syndrome presents diagnostic and therapeutic challenges.
Front Ophthalmol (Lausanne). 2025 Mar 25;5:1535805. doi: 10.3389/fopht.2025.1535805.
https://pubmed.ncbi.nlm.nih.gov/40201710/ -
Yamazaki S, Kaneko S, Shimbo A, Irabu H, Ogino R, Miyamoto T, et al.
Overlapping Aicardi-Goutieres and Singleton-Merten syndromes with a heterozygous gain-of-function mutation in IFIH1 mimicking juvenile idiopathic arthritis.
Immunol Med. 2025 Mar 21:1-5. doi: 10.1080/25785826.2025.2479148. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40116369/
FEBRERO 2025
-
Matucci-Cerinic C, Attico A, Malattia C, Consolaro A, Rosina S, Breda L, et al.
Towards the definition of disease phenotypes in pediatric SAPHO syndrome: a national multicentric study
Rheumatology (Oxford). 2025 Feb 5:keaf065. doi: 10.1093/rheumatology/keaf065. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39909492/ -
Alehashemi S, Buehring B, de Jesus AA, Gaurav S, Rastegar A, Baumgardner A, et al.
Sustained IFN Signature Suppression with Anifrolumab in a SAVI patient Refractory to JAK Inhibitor and Dazukibart Therapy.
Arthritis Rheumatol. 2025 Feb 25. doi: 10.1002/art.43145. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40007227/ -
Rigante D.
The Golden Card of Interleukin-1 Blockers in Systemic Inflammasomopathies of Childhood.
Int J Mol Sci. 2025 Feb 21;26(5):1872.
https://pubmed.ncbi.nlm.nih.gov/40076498/ -
Öksüz Aydın B, Aydın F, Taş Ö, Bahçeci O, Özçakar ZB.
Associated diseases and their effects on disease course in patients with chronic non-bacterial osteomyelitis: retrospective experience from a single center.
Clin Rheumatol. 2025 Feb;44(2):855-862.
https://pubmed.ncbi.nlm.nih.gov/39808231/ -
Ferraioli M, Levani J, De Luca R, Matucci-Cerinic C, Gattorno M, Guiducci S, et al.
What Is New and What Is Next for SAPHO Syndrome Management: A Narrative Review.
J Clin Med. 2025 Feb 18;14(4):1366. doi: 10.3390/jcm14041366.
https://pubmed.ncbi.nlm.nih.gov/40004896/
ENERO 2025
-
De Rose DU, Campi F, Maddaloni C, Ronci S, Caoci S, Savarese I, Bersani I, Ronchetti MP, Auriti C, Capolupo I, Merli P, Insalaco A, De Benedetti F, Dotta A.
Off-Label Use of Anakinra in Inflammatory Conditions in Neonates and Infants Up to 3 Months of Age: A Case Series and a Review of the Literature.
Paediatr Drugs. 2025 Jan 13. doi: 10.1007/s40272-024-00679-x. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39804459/ -
Öksüz Aydın B, Aydın F, Taş Ö, Bahçeci O, Özçakar ZB.
Associated diseases and their effects on disease course in patients with chronic non-bacterial osteomyelitis: retrospective experience from a single center.
Clin Rheumatol. 2025 Feb;44(2):855-862. doi: 10.1007/s10067-025-07306-1. Epub 2025 Jan 14.
https://pubmed.ncbi.nlm.nih.gov/39808231/ -
Nowicki KD, Rogers ND, Keeter CL, Donaldson NJ, Soep JB, Zhao Y.
Factors associated with treatment response in chronic nonbacterial osteomyelitis at a single center: a retrospective cohort study.
Pediatr Rheumatol Online J. 2025 Jan 3;23(1):2. doi: 10.1186/s12969-024-01051-6.
https://pubmed.ncbi.nlm.nih.gov/39754119/ -
Sonoda M, Kinoshita K, Harada N, Park S, Adachi S, Yada Y, Eguchi K, Fujiwara T, Kido-Nakahara M, Kinjo N, Ishimura M, Ohga S.
Monocyte STAT1 phosphorylation and treatment response of JAK inhibitors in chronic nonbacterial osteomyelitis.
Pediatr Rheumatol Online J. 2025 Jan 23;23(1):6. doi: 10.1186/s12969-025-01059-6.
https://pubmed.ncbi.nlm.nih.gov/39849463/
DICIEMBRE 2024
-
Haslak F, Kilic H, Sahin S, Hotaman B, Cebi NM, Yildiz M et al.
Children With Type I Interferonopathy: Commonalities and Diversities in a Large Patient Cohort.
J Rheumatol. 2024 Dec 1;51(12):1208-1217. doi: 10.3899/jrheum.2024-0294.
https://pubmed.ncbi.nlm.nih.gov/39089832/ -
Oommen PT, Kallinich T, Rech J, Blank N, Weber-Arden J, Kuemmerle-Deschner JB.
Long-Term Safety and Effectiveness of Canakinumab in Patients with MKD/HIDS: Interim Analysis of the RELIANCE Registry.
Rheumatol Ther. 2024 Dec 26. doi: 10.1007/s40744-024-00733-7. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39724475/ -
Politano D, Tonduti D, Battini R, Fazzi E, Orcesi S.
Exploring emerging JAK inhibitors in the treatment of Aicardi-Goutières syndrome.
Expert Opin Emerg Drugs. 2024 Dec 27:1-19. doi: 10.1080/14728214.2024.2445508. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39704072/ -
Elhani I, Calas L, Bejar F, Pieroni L, Kone-Paut I, Rossi-Semerano L et al.
Performance of serum interleukin-18 (IL-18) levels for the follow-up of patients with familial Mediterranean fever.
J Allergy Clin Immunol Pract. 2024 Dec 10:S2213-2198(24)01240-6. doi: 10.1016/j.jaip.2024.11.025. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39667435/ -
Yan L, Sun X, Lou B, Zhang Y, Zhuang D, Jia J et al.
Carrier frequency and incidence estimation of deficiency of adenosine deaminase 2 in the Chinese population based on massive exome sequencing data.
Clin Immunol. 2024 Dec;269:110394. doi: 10.1016/j.clim.2024.110394. Epub 2024 Oct 29.
https://pubmed.ncbi.nlm.nih.gov/39481740/ -
Hu M, Zeng W, Zhang J, Yan H, Huang F, Xiong H, Fang B, Li Y.
Chronic recurrent multifocal osteomyelitis in pediatric patients: A Chinese single center observational study and literature review.
Medicine (Baltimore). 2024 Dec 6;103(49):e40805. doi: 10.1097/MD.0000000000040805.
https://pubmed.ncbi.nlm.nih.gov/39654209/
NOVIEMBRE 2024
-
Winter EM, Dekkers OM, Andreasen CM, D'Angelo S, Appelman-Dijkstra NM, et al.
Expert consensus recommendations for the diagnosis and treatment of chronic non-bacterial osteitis (CNO) in adults.
Ann Rheum Dis. 2024 Nov 28:ard-2024-226446. doi: 10.1136/ard-2024-226446. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39608805/ -
Bregel LV, Matunova AE, Zhou Q, Kostik MM.
Case Report of Unusual Manifestation of Mevalonate Kinase Deficiency Syndrome Mimicking Juvenile Idiopathic Arthritis with Systemic Onset.
Int J Rheum Dis. 2024 Nov;27(11):e15416. doi: 10.1111/1756-185X.15416.
https://pubmed.ncbi.nlm.nih.gov/39555620/ -
Kisla Ekinci RM, Kilic Konte E, Akay N, Gul U.
Familial Mediterranean Fever in Childhood.
Turk Arch Pediatr. 2024 Nov 1;59(6):527-534. doi: 10.5152/TurkArchPediatr.2024.24188.
https://pubmed.ncbi.nlm.nih.gov/39540697/ -
Souali M, Sakhi A, Bousfiha AA, Bouayed K.
Phenotype-genotype correlation in children with familial Mediterranean fever in Morocco.
Qatar Med J. 2024 Nov 25;2024(3):41. doi: 10.5339/qmj.2024.41.
https://pubmed.ncbi.nlm.nih.gov/39588206/ -
Wang X, Zhang J, Wu J, Wang X, Yao X, Niu W, Li X, Li J.
Clinical characteristics of coronary artery involvement in children with Behcet's syndrome.
Clin Rheumatol. 2024 Nov 25. doi: 10.1007/s10067-024-07228-4. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39585573/
OCTUBRE 2024
-
La Bella S, Loconte R, Attanasi M, Muselli M, Di Donato G, Di Ludovico A, et al.
Familial Mediterranean fever in children from central-southern Italy: a multicentric retrospective cohort study.
Clin Rheumatol. 2024 Oct 29. doi: 10.1007/s10067-024-07207-9. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39470916/ -
Kretzschmar G, Páez LP, Tan Z, Wang J, Gonzalez L, Mugabo CH, et al.
Normalized Interferon Signatures and Clinical Improvements by IFNAR1 Blocking Antibody (Anifrolumab) in Patients with Type I Interferonopathies.
J Clin Immunol. 2024 Oct 23;45(1):31. doi: 10.1007/s10875-024-01826-2.
https://pubmed.ncbi.nlm.nih.gov/39441221/ -
Hofer MJ, Modesti N, Coufal NG, Wang Q, Sase S, Miner JJ, Vanderver A, Bennett ML.
The prototypical interferonopathy: Aicardi-Goutières syndrome from bedside to bench.
Immunol Rev. 2024 Oct 29. doi: 10.1111/imr.13413. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39473130/
SEPTIEMBRE 2024
-
Mallo-Miranda MV, Morales-Angulo C.
Otorhinolaryngological manifestations of autoinflammatory diseases. Systematic review.
Acta Otorrinolaringol Esp (Engl Ed). 2024 Sep 26:S2173-5735(24)00093-0. doi: 10.1016/j.otoeng.2024.09.005. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39341593/ -
Murphy R, Moots RJ, Brogan P, Çelik AF, Clement-Jones M, Coulson I, et al.
British Association of Dermatologists and British Society for Rheumatology living guideline for managing people with Behçets 2024.
Br J Dermatol. 2024 Sep 10:ljae263. doi: 10.1093/bjd/ljae263. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39253835/ -
Bourguiba R, Deshayes S, Amaryan G, Kone-Paut I, Belot A, Sarkisyan T, et al.
Diagnostic delays in familial Mediterranean fever: a Juvenile Inflammatory Rheumatism (JIR) cohort study.
Rheumatol Int. 2024 Sep 24. doi: 10.1007/s00296-024-05706-1. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39316109/ -
Hospach T, Blankenburg F, Heinkele A, von Kalle T, Uziel Y, Kallinich T, Rücklová K.
Protracted febrile myalgia syndrome in children with familial Mediterranean fever - systematic review and a case report
Pediatr Rheumatol Online J. 2024 Sep 10;22(1):85. doi: 10.1186/s12969-024-01019-6.
https://pubmed.ncbi.nlm.nih.gov/39256780/ -
Drago E, Bertoni A, Grossi A, Damasio MB, Anfigeno L, Miano M, Papa R, Volpi S, Ceccherini I, Gattorno M, Caorsi R.
Majeed syndrome: first description in a patient of central-European ancestry.
Rheumatology (Oxford). 2024 Sep 10:keae480. doi: 10.1093/rheumatology/keae480. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39255247/ -
Bulté D, Barzaghi F, Mesa-Nuñez C, Rigamonti C, Basso-Ricci L, Visconti C, et al.
Early bone marrow alterations in patients with adenosine deaminase 2 deficiency across diseasephenotypes and severities.
J Allergy Clin Immunol. 2024 Sep 14:S0091-6749(24)00945-X. doi: 10.1016/j.jaci.2024.09.007. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39284370/
AGOSTO 2024
-
Dirks J, Wölfl M, Speer CP, Härtel C, Morbach H.
Inborn Errors of Immunity in Early Childhood: Essential Insights for the Neonatologist.
Neonatology. 2024 Aug 23:1-10. doi: 10.1159/000540436. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39182489/ -
Chia DT, Toms A, Sanghrajka A, Ramanan A, Killeen OG, Ilea C, et al.
Incidence of chronic recurrent multifocal osteomyelitis in children and adolescents in the UK and Republic of Ireland.
Rheumatology (Oxford). 2024 Aug 21:keae447. doi: 10.1093/rheumatology/keae447. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39167099/ -
Roberts E, Charras A, Hahn G, Hedrich CM.
An improved understanding of paediatric chronic nonbacterial osteomyelitis (CNO) pathophysiology informs current and future treatment.
J Bone Miner Res. 2024 Aug 29:zjae141. doi: 10.1093/jbmr/zjae141.
https://pubmed.ncbi.nlm.nih.gov/39209330/ -
Aslan E, Akay N, Gul U, Konte EK, Gunalp A, Haslak F, et al.
The Impact of Different MEFV Genotypes on Clinical Phenotype of Patients with Familial Mediterranean Fever: Special Emphasis on Joint Involvement.
Eur J Pediatr. 2024 Aug 7. doi: 10.1007/s00431-024-05716-y.
https://pubmed.ncbi.nlm.nih.gov/39112805/ -
La Bella S, Attanasi M, Porreca A, Di Ludovico A, Maggio MC, Gallizzi R, La Torre F, Rigante D, Soscia F, Ardenti Morini F, Insalaco A, Natale MF, Chiarelli F, Simonini G, De Benedetti F, Gattorno M, Breda L.
Reliability of a generative artificial intelligence tool for pediatric familial Mediterranean fever: insights from a multicentre expert survey.
Pediatr Rheumatol Online J. 2024 Aug 23;22(1):78. doi: 10.1186/s12969-024-01011-0.
https://pubmed.ncbi.nlm.nih.gov/39180115/ -
Dingulu G, Berrebi D, Martinez-Vinson C, Dumaine C, Melki I, Viala J, et al.
Potential association between M694V homozygous mutation in familial Mediterranean fever and eosinophilic intestinal inflammation: a pediatric case series.
Front Pediatr. 2024 Aug 2;12:1419200. doi: 10.3389/fped.2024.1419200.
https://pubmed.ncbi.nlm.nih.gov/39156024/ -
Coşkun Ç, Ünal Ş.
Deficiency of Adenosine Deaminase 2.
Turk J Haematol. 2024 Aug 28;41(3):133-140. doi: 10.4274/tjh.galenos.2024.2024.0265.
https://pubmed.ncbi.nlm.nih.gov/39120005/ -
Al-Mayouf SM, Hadef D, Aljaberi N, Movahedi N, AlEed A, Almutairi A, et al.
A proposed clinical tool to identify high-risk patients for monogenic lupus: a pilot study.
Clin Exp Rheumatol. 2024 Aug 27. doi: 10.55563/clinexprheumatol/tjt58t.
https://pubmed.ncbi.nlm.nih.gov/39212133/ -
Triaille C, Rao NM, Rice GI, Seabra L, Sutherland FJH, Bondet V, et al.
Hereditary C1q Deficiency is Associated with Type 1 Interferon-Pathway Activation and a High Risk of Central Nervous System Inflammation.
J Clin Immunol. 2024 Aug 28;44(8):185. doi: 10.1007/s10875-024-01788-5.
https://pubmed.ncbi.nlm.nih.gov/39196411/ -
Mendonça LO, Frémond ML.
Interferonopathies: From concept to clinical practice.
Best Pract Res Clin Rheumatol. 2024 Aug 8:101975. doi: 10.1016/j.berh.2024.101975.
https://pubmed.ncbi.nlm.nih.gov/39122631/ -
Idiiatullina E, Al-Azab M, Lin M, Hrovat-Schaale K, Liu Z, Li X, et al.
Heterozygous de novo dominant negative mutation of REXO2 results in interferonopathy.
Nat Commun. 2024 Aug 6;15(1):6685. doi: 10.1038/s41467-024-50878-w.
https://pubmed.ncbi.nlm.nih.gov/39107301/
JULIO 2024
-
An J, Marwaha A, Laxer RM.
Autoinflammatory Diseases: A Review.
J Rheumatol. 2024 Jul 15:jrheum.2023-1209. doi: 10.3899/jrheum.2023-1209. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/38879186/ -
Mertz P, Hentgen V, Georgin-Lavialle S.
Could tocilizumab be used in familial Mediterranean Fever? A systematic review.
Rheumatology (Oxford). 2024 Jul 1:keae338. doi: 10.1093/rheumatology/keae338. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/38950176/ -
Özçelik E, Çelikel E, Tekin ZE, Güngörer V, Karagöl C, Kaplan MM, et al.
Sacroiliitis in familial Mediterranean fever: A rare joint involvement of the disease
J Paediatr Child Health. 2024 Jul 25. doi: 10.1111/jpc.16623. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39051573/
JUNIO 2024
-
Mastrolia MV, Matucci-Cerinic C, Ozen S, Kasapcopur O, Gaggiano C, Koné-Paut I, et al; EUROFEVER REGISTRY and Pediatric Rheumatology International trial organization (PRINTO).
Thrombotic manifestations in pediatric Behcet syndrome: A multicenter comparative study from the EUROFEVER registry.
Semin Arthritis Rheum. 2024 Jun;66:152454. doi: 10.1016/j.semarthrit.2024.152454.
https://pubmed.ncbi.nlm.nih.gov/38678817/ -
Mertz P, Costedoat-Chalumeau N, Ferrada MA, Moulis G, Mekinian A, Grayson PC, Arnaud L.
Relapsing polychondritis: clinical updates and new differential diagnoses.
Nat Rev Rheumatol. 2024 Jun;20(6):347-360. doi: 10.1038/s41584-024-01113-9.
https://pubmed.ncbi.nlm.nih.gov/38698240/ -
He T, Wang L, Huang X, Weng R, Yang J.
LACC1 deficiency leading to juvenile arthritis and anemia.
Clin Immunol. 2024 Jun 27. doi: 10.1016/j.clim.2024.110290. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/38944365/ -
Miyamoto T, Izawa K, Masui S, Yamazaki A, Yamasaki Y, Matsubayashi T, et al; Japan CAPS Working Group.
Clinical Characteristics of Cryopyrin-Associated Periodic Syndrome and Long-Term Real-World Efficacy and Tolerability of Canakinumab in Japan: Results of a Nationwide Survey.
Arthritis Rheumatol. 2024 Jun;76(6):949-962. doi: 10.1002/art.42808.
https://pubmed.ncbi.nlm.nih.gov/38268504/
-
Koné-Paut I, Georgin-Lavialle S, Belot A, Jover M, Pouriel M, Lacoin L, et al.
Canakinumab treatment real world evidence in 3 monogenic periodic fever syndromes in 2009-2022: an interim analysis using the French JIR cohort database.
Arthritis Res Ther. 2024 Apr 8;26(1):80. doi: 10.1186/s13075-024-03316-7.
https://pubmed.ncbi.nlm.nih.gov/38589954/
MARZO 2024
-
Yang J, Yuan C, Zhou S, Teng Z, Li M.
Successful Treatment of Refractory Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Syndrome with Baricitinib, a Janus Kinase Inhibitor.
Clin Cosmet Investig Der006Datol. 2024 Mar 4;17:529-537. doi: 10.2147/CCID.S446468.
https://pubmed.ncbi.nlm.nih.gov/38463557/ -
van der Made CI, Kersten S, Chorin O, Engelhardt KR, Ramakrishnan G, Griffin H,
Expanding the PRAAS spectrum: De novo mutations of immunoproteasome subunit β-type 10 in six infants with SCID-Omenn syndrome.
Am J Hum Genet. 2024 Mar 12:S0002-9297(24)00045-4. doi: 10.1016/j.ajhg.2024.02.013. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/38503300/ -
Zhong L, Wang W, Tang X, Zhang Y, Gou L, Wang L, et al.
Phenotype of Takayasu-like vasculitis and cardiopathy in patients with Blau syndrome.
Clin Rheumatol. 2024 Mar;43(3):1171-1181. doi: 10.1007/s10067-024-06876-w.
https://pubmed.ncbi.nlm.nih.gov/38253779/ -
Pernaa N, Vakkuri A, Arvonen M, Kuismin O, Santaniemi W, Glumoff V, et al
Germline HAVCR2/TIM-3 Checkpoint Inhibitor Receptor Deficiency in Recurrent Autoinflammatory Myocarditis.
J Clin Immunol. 2024 Mar 15;44(3):81. doi: 10.1007/s10875-024-01685-x.
https://pubmed.ncbi.nlm.nih.gov/38485795/ -
Shangguan Y, Ding X, Ma L, Cai YX, Xiang S, Huang XF, Shen Y, Yu HG, Zheng W.
Clinical and Genetic Spectrum of Nine Cases of NLRP3-Associated Autoinflammatory Disease (NLRP3-AID) and Identification of One Novel NLRP3 Mutation by Genetic Variation Analyses.
J Immunol Res. 2024 Mar 6;2024:5722548. doi: 10.1155/2024/5722548.
https://pubmed.ncbi.nlm.nih.gov/38481988/ -
Saad AJ, Patil MK, Cruz N, Lam CS, O'Brien C, Nambudiri VE.
VEXAS syndrome: A review of cutaneous findings and treatments in an emerging autoinflammatory disease.
Exp Dermatol. 2024 Mar;33(3):e15050. doi: 10.1111/exd.15050.
https://pubmed.ncbi.nlm.nih.gov/38469984/v
FEBRERO 2024
-
Yildirim D, Kardas RC, Gun M, Kaya B, Vasi I, Duran R, Karadeniz H, Avanoglu Guler A, Kucuk H, Erden A, Goker B, Ozturk MA, Tufan A.
Colchicine-intolerant familial mediterranean fever patients: A comparative study between different colchicine doses and IL-1 inhibitor monotherapy.
Int Immunopharmacol. 2024 Feb 15;128:111491. doi: 10.1016/j.intimp.2024.111491.
https://pubmed.ncbi.nlm.nih.gov/38241844/ -
Chen KR.
Cutaneous vasculitis in autoinflammatory diseases.
J Dermatol. 2024 Feb;51(2):150-159. doi: 10.1111/1346-8138.17030.
https://pubmed.ncbi.nlm.nih.gov/37955334/ -
İncesu Ç, Kayaalp GK, Demirkan FG, Köker O, Çakmak F, Akgün Ö, et al.
The assessment of fatigue and sleep quality among children and adolescents with familial Mediterranean fever: A case-control and correlation study.
Eur J Pediatr. 2024 Feb 23. doi: 10.1007/s00431-024-05442-5.
https://pubmed.ncbi.nlm.nih.gov/38393372/ -
Kuemmerle-Deschner JB, Kallinich T, Henes J, Kortus-Götze B, Oommen PT, Rech J, et al.
Long-term safety and effectiveness of canakinumab in patients with monogenic autoinflammatory diseases: results from the interim analysis of the RELIANCE registry.
RMD Open. 2024 Feb 15;10(1):e003890. doi: 10.1136/rmdopen-2023-003890.
https://pubmed.ncbi.nlm.nih.gov/38360038/ -
Charras A, Hofmann SR, Cox A, Schulze F, Russ S, Northey S, Liu X, Fang Y, Haldenby S, Hartmann H, Bassuk AG, Carvalho A, Sposito F, Grinstein L, Rösen-Wolff A, Meyer-Bahlburg A, Beresford MW, Lainka E, Föll D, Wittkowski H, Girschick HJ, Morbach H, Uebe S, Hüffmeier U, Ferguson PJ, Hedrich CM.
P2RX7 gene variants associate with altered inflammasome assembly and reduced pyroptosis in chronic nonbacterial osteomyelitis (CNO).
J Autoimmun. 2024 Feb 22;144:103183. doi: 10.1016/j.jaut.2024.103183.
https://pubmed.ncbi.nlm.nih.gov/38401466/ -
Niedźwiedź M, Narbutt J, Siekierko A, Skibińska M, Kwiek B, Sobolewska-Sztychny D, Ciążyńska M, Poznańska-Kurowska K, Gostyński A, Lesiak A.
Case report: Successful treatment with biologics in a pediatric patient with a severe inflammatory skin disease and novel CARD14 mutation.
Front Med (Lausanne). 2024 Feb 5;11:1360248. doi: 10.3389/fmed.2024.1360248.
https://pubmed.ncbi.nlm.nih.gov/38375322/
ENERO 2024
-
Miyamoto T, Izawa K, Masui S, Yamazaki A, Yamasaki Y, Matsubayashi T, et al; Japan CAPS working group.
Clinical characteristics of cryopyrin-associated periodic syndrome and long-term real-world efficacy and tolerability of canakinumab in Japan: results of a nationwide survey.
Arthritis Rheumatol. 2024 Jan 25. doi: 10.1002/art.42808. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/38268504/ -
Baysac K, Sun G, Nakano H, Schmitz EG, Cruz AC, Fisher C, Bailey AC; PLCG2-Immune Dysregulation Working Group; Mace E, Milner JD, Ombrello MJ.
PLCG2-associated immune dysregulation (PLAID) comprises broad and distinct clinical presentations related to functional classes of genetic variants.
J Allergy Clin Immunol. 2024 Jan;153(1):230-242. doi: 10.1016/j.jaci.2023.08.036.
https://pubmed.ncbi.nlm.nih.gov/37769878/
NOVIEMBRE 2023
-
Papa R, Gattorno M.
New genes, pathways and therapeutic targets in autoinflammatory diseases.
Nat Rev Rheumatol. 2023 Dec 14. doi: 10.1038/s41584-023-01063-8. Epub ahead of print. Erratum in: Nat Rev Rheumatol. 2024 Jan 8.
https://pubmed.ncbi.nlm.nih.gov/38097849/ -
Tzaneti A, Athanasopoulou E, Fessatou S, Fotis L.
Nonbacterial Osteomyelitis in Inflammatory Bowel Disease.
Life (Basel). 2023 Dec 15;13(12):2347. doi: 10.3390/life13122347.
https://pubmed.ncbi.nlm.nih.gov/38137947/ -
Wouters F, Bogie J, Wullaert A, van der Hilst J.
Recent Insights in Pyrin Inflammasome Activation: Identifying Potential Novel Therapeutic Approaches in Pyrin-Associated Autoinflammatory Syndromes.
J Clin Immunol. 2023 Dec 22;44(1):8. doi: 10.1007/s10875-023-01621-5.
https://pubmed.ncbi.nlm.nih.gov/38129719/ -
Maronese CA, Moltrasio C, Genovese G, Marzano AV.
Biologics for Hidradenitis suppurativa: evolution of the treatment paradigm.
Expert Rev Clin Immunol. 2023 Dec 22:1-21. doi: 10.1080/1744666X.2023.2298356. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/38130204/ -
Hall CHT, de Zoeten EF.
Understanding very early onset inflammatory bowel disease (VEOIBD) in relation to inborn errors of immunity.
Immunol Rev. 2023 Dec 19. doi: 10.1111/imr.13302. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/38115672/ -
Miao J, Zhang J, Huang X, Wu N, Wu D, Shen M.
NLRP12-associated autoinflammatory disease in Chinese adult patients: a single-centre study.
RMD Open. 2023 Dec 20;9(4):e003598. doi: 10.1136/rmdopen-2023-003598.
https://pubmed.ncbi.nlm.nih.gov/38123482/ -
Kouranloo K, Dey M, Almutawa J, Myall N, Nune A.
Clinical characteristics, disease trajectories and management of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome: a systematic review.
Rheumatol Int. 2023 Dec 21. doi: 10.1007/s00296-023-05513-0. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/38129348/ -
Ryckmans C, Donge M, Marchèse A, Mastouri M, Thomee C, Stouffs K, et al.
TREX-1 related Aicardi-Goutières syndrome improved by Janus kinase inhibitor.
Am J Med Genet A. 2023 Dec 22. doi: 10.1002/ajmg.a.63510. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/38135344/
NOVIEMBRE 2023
-
Zhong Z, Dai L, Ding J, Gao Y, Su G, Zhu Y, Deng Y, Li F, Gao Y, Yang P.
Molecular diagnostic yield for Blau syndrome in previously diagnosed juvenile idiopathic arthritis with uveitis or cutaneous lesions.
Rheumatology (Oxford). 2023 Nov 6:kead596. doi: 10.1093/rheumatology/kead596.
https://pubmed.ncbi.nlm.nih.gov/37941393/ -
Ozdel S, Coşkuner T, Demirkan F, Torun R, Aydın EA, Bağlan E, Yener GO, Öztürk K, Demir F, Karadağ ŞG, Çakan M, Sönmez HE, Makay BB, Ünsal ŞE, Bülbül M, Ayaz NA, Sözeri B.
Inflammatory comorbidities ın the largest pediatric Familial Mediterranean fever cohort: a multicenter retrospective study of Pediatric Rheumatology Academy (PeRA)-Research Group (RG).
Clin Rheumatol. 2023 Nov 6. doi: 10.1007/s10067-023-06802-6.
https://pubmed.ncbi.nlm.nih.gov/37926798/ -
Smajlović H, Prohić A.
PAPA Syndrome: Challenges in Achieving Long-Term Remission.
Acta Dermatovenerol Croat. 2023 Nov;31(2):106-109.
https://pubmed.ncbi.nlm.nih.gov/38006373/
OCTUBRE 2023
-
Demir F, Sözeri B.
NLRP12-associated autoinflammatory disease: much more than the FCAS phenotype.
Clin Exp Rheumatol. 2023 Oct;41(10):2115-2121. doi: 10.55563/clinexprheumatol/kzggp3. Epub 2023 Oct 9.
https://pubmed.ncbi.nlm.nih.gov/37877365/ -
Matucci-Cerinic C, Malattia C, Pistorio A, Rosina S, Consolaro A, Viola S, Volpi S, Caorsi R, Viglizzo G, Gattorno M.
Skin manifestations help identifying different phenotypes of paediatric SAPHO syndrome.
Semin Arthritis Rheum. 2023 Oct 5;63:152277. doi: 10.1016/j.semarthrit.2023.152277. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37839270/
SEPTIEMBRE 2023
-
Fonollosa A, Pelegrín L, García-Morillo S, Buján-Rivas S, Distefano L, Robles-Maruenda A, Fernández-Martín J, González-García A, Garcia-Aparicio Á, Ortego-Centeno N, Llorenç V, Sainz de la Maza M, Pinedo C, Sopeña B, Cocho L, Carreño E, Blanco R, Antón J, Pérez-Quintana M, Marques-Soares JR, Artaraz J, Ruiz-Arruza I, Soto-Peleteiro A, Gómez-Caverzaschi V, Araújo O, Espinosa G, Adan A, Fabiani C, Cantarini L, Hernández-Rodríguez J; Spanish Society of Ocular Inflammation (SEIOC) and the AutoInflammatory Diseases Alliance (AIDA) Network.
Ocular involvement in adult and paediatric patients with monogenic autoinflammatory diseases: a Spanish multicentre retrospective study.
Clin Exp Rheumatol. 2023 Sep 28. doi: 10.55563/clinexprheumatol/ukegcc. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37812477/ -
Lassoued Ferjani H, Kharrat L, Ben Nessib D, Kaffel D, Maatallah K, Hamdi W.
Management of Blau syndrome: review and proposal of a treatment algorithm.
Eur J Pediatr. 2023 Sep 22. doi: 10.1007/s00431-023-05204-9. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37735224/ -
Pastore S, De Martino E, Taddio A.
Variant STAT4 and Treatment of an Autoinflammatory Syndrome.
N Engl J Med. 2023 Sep 21;389(12):1151. doi: 10.1056/NEJMc2308588.
https://pubmed.ncbi.nlm.nih.gov/37733320/ -
Ben-Chetrit E.
Old paradigms and new concepts in familial Mediterranean fever (FMF) - an update 2023.
Rheumatology (Oxford). 2023 Sep 19:kead439. doi: 10.1093/rheumatology/kead439. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37725337/ -
Gattorno M, Obici L, Penadés IC, Kallinich T, Benseler S, Dekker E, Lévy J, De Benedetti F, Lachmann H.
Long-term efficacy/safety of canakinumab in patients with tumor necrosis factor receptor-associated periodic syndrome: results from a phase III trial.
Arthritis Rheumatol. 2023 Sep 5. doi: 10.1002/art.42695. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37668289/ -
Cooray S, Price-Kuehne F, Hong Y, Omoyinmi E, Burleigh A, Gilmour KC, Ahmad B, Choi S, Bahar MW, Torpiano P, Gagunashvili A, Jensen B, Bellos E, Sancho-Shimizu V, Herberg JA, Mankad K, Kumar A, Kaliakatsos M, Worth AJJ, Eleftheriou D, Whittaker E, Brogan PA.
Neuroinflammation, autoinflammation, splenomegaly and anemia caused by bi-allelic mutations in IRAK4.
Front Immunol. 2023 Sep 6;14:1231749. doi: 10.3389/fimmu.2023.1231749
https://pubmed.ncbi.nlm.nih.gov/37744344/ -
Birk-Bachar M, Cohen H, Sofrin-Drucker E, Kropach-Gilad N, Orenstein N, Lidzbarsky G, et al.
Discovery of a novel missense variant in NLRP3 causing atypical CAPS with hearing loss as the primary presentation, responsive to anti-IL-1 therapy.
Arthritis Rheumatol. 2023 Sep 22. doi: 10.1002/art.42721. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37738164/ -
Okorie CL, Nayudu K, Nambudiri VE.
Cutaneous findings and treatments in deficiency of interleukin-36 receptor antagonist (DITRA): A review of the literature.
Exp Dermatol. 2023 Sep 19. doi: 10.1111/exd.14934. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37726967/ -
Blank N, Kötter I, Schmalzing M, Rech J, Krause K, Köhler B, et al.
Clinical presentation and genetic variants in patients with autoinflammatory diseases: results from the German GARROD registry.
Rheumatol Int. 2023 Sep 25. doi: 10.1007/s00296-023-05443-x. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37747561/
AGOSTO 2023
-
Zhang J, Lee PY, Aksentijevich I, Zhou Q.
How to Build a Fire: The Genetics of Autoinflammatory Diseases.
Annu Rev Genet. 2023 Aug 10. doi: 10.1146/annurev-genet-030123-084224. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37562411/ -
Wei Q, Sun L.
Monogenic autoinflammatory disease-associated cardiac damage.
Inflamm Res. 2023 Aug;72(8):1689-1693. doi: 10.1007/s00011-023-01771-7. Epub 2023 Aug 10.
https://pubmed.ncbi.nlm.nih.gov/37563333/ - Dzhus M, Ehlers L, Wouters M, Jansen K, Schrijvers R, De Somer L, Vanderschueren S, Baggio M, Moens L, Verhaaren B, Lories R, Bucciol G, Meyts I.
- A Narrative Review of the Neurological Manifestations of Human Adenosine Deaminase 2 Deficiency.
- J Clin Immunol. 2023 Aug 7. doi: 10.1007/s10875-023-01555-y. Epub ahead of print.
- https://pubmed.ncbi.nlm.nih.gov/37548813/
- Priyanka P, Patra PK, Banday AZ, Reddy P, Sharma N, Jannarthanan J, Bhattarai D.
- Recurrent flare-associated urticaria in adenosine deaminase type 2 deficiency.
- Rheumatology (Oxford). 2023 Aug 25:kead443. doi: 10.1093/rheumatology/kead443. Epub ahead of print.
- https://pubmed.ncbi.nlm.nih.gov/37624921/
-
Gullu UU, Balaban İ, Kara SS, Yaralı O, Türkyılmaz A, İpek S, Güllü ŞD, Çalışkan OF.
Frequency of Familial Mediterranean Fever Gene Mutation in Patients Presenting With Joint Pain and Diagnosed With Acute Rheumatic Fever.
Cureus. 2023 Aug 5;15(8):e43001. doi: 10.7759/cureus.43001.
https://pubmed.ncbi.nlm.nih.gov/37671203/ -
Mejbri M, Renella R, Candotti F, Jaques C, Holzinger D, Hofer M, Theodoropoulou K.
PSTPIP1-Associated Myeloid-Related Proteinemia Inflammatory (PAMI) Syndrome: A Systematic Review.
Genes (Basel). 2023 Aug 19;14(8):1655. doi: 10.3390/genes14081655.
https://pubmed.ncbi.nlm.nih.gov/37628706/ -
Gagne S, Sivaraman V, Akoghlanian S.
Interferonopathies masquerading as non-Mendelian autoimmune diseases: pattern recognition for early diagnosis.
Front Pediatr. 2023 Aug 9;11:1169638. doi: 10.3389/fped.2023.1169638.
https://pubmed.ncbi.nlm.nih.gov/37622085/ -
Papendorf JJ, Ebstein F, Alehashemi S, Piotto DGP, Kozlova A, Terreri MT, Shcherbina A, Rastegar A, Rodrigues M, Pereira R, Park S, Lin B, Uss K, Möller S, da Silva Pina AF, Sztajnbok F, Torreggiani S, Niemela J, Stoddard J,
Rosenzweig SD, Oler AJ, McNinch C, de Guzman MM, Fonseca A, Micheloni N, Fraga MM, Perazzio SF, Goldbach-Mansky R, de Jesus AA, Krüger E.
Identification of eight novel proteasome variants in five unrelated cases of proteasome-associated autoinflammatory syndromes (PRAAS).
Front Immunol. 2023 Aug 4;14:1190104. doi: 10.3389/fimmu.2023.1190104.
https://pubmed.ncbi.nlm.nih.gov/37600812/ -
Ambrus-Aikelin G, Takeda K, Joetham A, Lazic M, Povero D, Santini AM, Pranadinata R, Johnson CD, McGeough MD, Beasley FC, Stansfield R, McBride C, Trzoss L, Hoffman HM, Feldstein AE, Stafford JA, Veal JM, Bain G, Gelfand EW.
JT002, a small molecule inhibitor of the NLRP3 inflammasome for the treatment of autoinflammatory disorders.
Sci Rep. 2023 Aug 19;13(1):13524. doi: 10.1038/s41598-023-39805-z.
https://pubmed.ncbi.nlm.nih.gov/37598239/ -
Ruffer N, Krusche M.
VEXAS syndrome: a diagnostic puzzle.
RMD Open. 2023 Aug;9(3):e003332. doi: 10.1136/rmdopen-2023-003332.
https://pubmed.ncbi.nlm.nih.gov/37532466/ -
Heiblig M, Patel B, Jamilloux Y.
VEXAS syndrome, a new kid on the block of auto-inflammatory diseases: A hematologist's point of view.
Best Pract Res Clin Rheumatol. 2023 Aug 29:101861. doi: 10.1016/j.berh.2023.101861. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37652853/
JULIO 2023
-
Öner N, Çelikel E, Güngörer V, Ekici Tekin Z, Coşkun S, Karagöl C et al.
The Effect of Clinical and Genetic Variables of Familial Mediterranean Fever Patients on Real-Life Data.
J Clin Rheumatol. 2023 Jul 27. doi: 10.1097/RHU.0000000000002002. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37496121/ - Mosad Mosa D, Shokry D, Ahmed DB, Sobh A.
Early predictors of colchicine resistance in familial Mediterranean fever.
Mod Rheumatol. 2023 Jul 4;33(4):830-835. doi: 10.1093/mr/roac068.
https://pubmed.ncbi.nlm.nih.gov/35789271/ - Hidradenitis suppurativa and psoriasis: the odd couple.
Front Med (Lausanne). 2023 Jul 7;10:1208817. doi: 10.3389/fmed.2023.1208817.
https://pubmed.ncbi.nlm.nih.gov/37484864/ -
La Bella S, Di Ludovico A, Di Donato G, Scorrano G, Chiarelli F, Vivarelli M, Breda L.
Renal involvement in monogenic autoinflammatory diseases: A narrative review.
Nephrology (Carlton). 2023 Jul;28(7):363-371. doi: 10.1111/nep.14166.
https://pubmed.ncbi.nlm.nih.gov/37142240/ -
Bulté D, Rigamonti C, Romano A, Mortellaro A.
Inflammasomes: Mechanisms of Action and Involvement in Human Diseases.
Cells. 2023 Jul 3;12(13):1766. doi: 10.3390/cells12131766.
https://pubmed.ncbi.nlm.nih.gov/37443800/ -
Borges T, Silva S.
RS3PE syndrome: Autoinflammatory features of a rare disorder.
Mod Rheumatol. 2023 Jul 4;33(4):640-646. doi: 10.1093/mr/roac071.
https://pubmed.ncbi.nlm.nih.gov/35904275/ -
Wei Z, Yang Z, Li D, Zhang X, Li B, Zhao X, Yan W, Wu B, Wu N, Wang X, Yu W, Shen M.
New retinal findings in NLRP3-associated autoinflammatory disease.
Orphanet J Rare Dis. 2023 Jul 21;18(1):202. doi: 10.1186/s13023-023-02815-1.
https://pubmed.ncbi.nlm.nih.gov/37480029/ -
Macca L, Li Pomi F, Ingrasciotta Y, Morrone P, Trifirò G, Guarneri C. Reygaerts T, Laohamonthonkul P, Hrovat-Schaale K, Moghaddas F, Baker PJ, Gray PE, Masters SL.
Pyrin variant E148Q potentiates inflammasome activation and the effect of pathogenic mutations in cis.
Rheumatology (Oxford). 2023 Jul 22:kead376. doi: 10.1093/rheumatology/kead376. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37481715/
MAYO 2023
-
Singhal S, Landes C, Shukla R, McCann LJ, Hedrich CM.
Classification and management strategies for paediatric chronic nonbacterial osteomyelitis and chronic recurrent multifocal osteomyelitis.
Expert Rev Clin Immunol. 2023 May 24. doi: 10.1080/1744666X.2023.2218088. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37224535/ -
Melo A, de Carvalho LM, Ferriani VPL, Cavalcanti A, Appenzeller S, Oliveira VR, et al.
A brazilian nationwide multicenter study on deficiency of deaminase-2 (DADA2).
Adv Rheumatol. 2023 May 22;63(1):23. doi: 10.1186/s42358-023-00303-5.
https://pubmed.ncbi.nlm.nih.gov/37217999/ -
Batu ED, Şener S, Arslanoglu Aydin E, Aliyev E, Bagrul İ, Türkmen Ş, et al.
A score for predicting colchicine resistance at the time of diagnosis in familial Mediterranean fever: data from the TURPAID registry.
Rheumatology (Oxford). 2023 May 25:kead242. doi: 10.1093/rheumatology/kead242. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37228026/ -
Levinsky Y, Azani L, Shkalim Zemer V, Chodick G, Tal R, Harel L, Amarilyo G.
Adherence to colchicine prophylaxis among patients with familial Mediterranean fever treated with interleukin-1 inhibitors.
Semin Arthritis Rheum. 2023 May 4;61:152211. doi: 10.1016/j.semarthrit.2023.152211. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37201215/ -
Haşlak F, Kılıç Könte E, Aslan E, Şahin S, Kasapçopur Ö.
Type I Interferonopathies in Childhood.
Balkan Med J. 2023 May 8;40(3):165-174. doi: 10.4274/balkanmedj.galenos.2023.2023-4-78.
https://pubmed.ncbi.nlm.nih.gov/37161741/ -
Chen L, Mamutova A, Kozlova A, Latysheva E, Evgeny F, Latysheva T, et al.
Comparison of disease phenotypes and mechanistic insight on causal variants in patients with DADA2.
J Allergy Clin Immunol. 2023 May 5:S0091-6749(23)00564-X. doi: 10.1016/j.jaci.2023.04.014. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37150360/
ABRIL 2023
-
Pisacreta AM, Mascolo R, Nivuori M, Dominioni CC, Gabiati C, Trotta L, Pancrazi M, Marco GD, Carollo C, Pedroli A, Casarin F, Tombetti E, Bizzi E, Imazio M, Brucato A.
Acute pericarditis with pleuropulmonary involvement, fever and elevated C-reactive protein: A systemic autoinflammatory disease? A cohort study.
Eur J Intern Med. 2023 Apr 15:S0953-6205(23)00112-7. doi: 10.1016/j.ejim.2023.03.034. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37069014/
MARZO 2023
-
Rodríguez-Carrio J, Burska A, Conaghan PG, Dik WA, Biesen R, Eloranta MLet al.
2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice.
Ann Rheum Dis. 2023 Mar 1:ard-2022-223628. doi: 10.1136/ard-2022-223628. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36858821/ -
Hegazy MT, Fayed A, Nuzzolese R, Sota J, Ragab G.
Autoinflammatory diseases and the kidney.
Immunol Res. 2023 Mar 29. doi: 10.1007/s12026-023-09375-3. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36991303/ -
Caldirola MS, Seminario AG, Luna PC, Curciarello R, Docena GH, Fernandez Escobar N, Drelichman G, Gattorno M, de Jesus AA, Goldbach-Mansky R, Gaillard MI, Bezrodnik L.
Case report: De novo SAMD9L truncation causes neonatal-onset autoinflammatory syndrome which was successfully treated with hematopoietic stem cell transplantation.
Front Pediatr. 2023 Mar 10;11:1108207. doi: 10.3389/fped.2023.1108207.
https://pubmed.ncbi.nlm.nih.gov/36969289/ -
Costi S, Germinario S, Pandolfi M, Pellico MR, Amati A, Gattinara M, Chighizola CB, Caporali R, Marino A.
Chronic Nonbacterial Osteomyelitis and Inflammatory Bowel Disease: A Literature Review-Based Cohort.
Children (Basel). 2023 Mar 3;10(3):502. doi: 10.3390/children10030502.
https://pubmed.ncbi.nlm.nih.gov/36980060/ -
Matsumoto Y, Rottapel R.
PARsylation-mediated ubiquitylation: lessons from rare hereditary disease Cherubism.
Trends Mol Med. 2023 Mar 20:S1471-4914(23)00032-1. doi: 10.1016/j.molmed.2023.02.001. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36948987/ -
Bruno A, Gurnari C, Alexander T, Snowden JA, Greco R; Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation.
Autoimmune manifestations in VEXAS: Opportunities for integration and pitfalls to interpretation.
J Allergy Clin Immunol. 2023 Mar 20:S0091-6749(23)00231-2. doi: 10.1016/j.jaci.2023.02.017. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36948992/ -
Hines AS, Mohandesi NA, Lehman JS, Koster MJ, Cantwell HM, Alavi A, et al.
Cutaneous involvement in VEXAS syndrome: clinical and histopathologic findings
Int J Dermatol. 2023 Mar 8. doi: 10.1111/ijd.16635. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36890121/
FEBRERO 2023
-
Gil-Lianes J, Gariup G, Iranzo-Fernández P, Mensa-Vilaró A, Peñín-Franch A, Hurtado-Navarro L, Pelegrin P, Aróstegui JI.
Early-onset recurrent panniculitis as a phenotype of NLRC4-associated autoinflammatory syndrome: Characterization of pathogenicity of the p.Ser445Pro NLRC4 variant.
Australas J Dermatol. 2023 Feb 16. doi: 10.1111/ajd.14005. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36797819/ -
Gallego E, Arias-Merino G, Sánchez-Díaz G, Villaverde-Hueso A, Posada de la Paz M, Alonso-Ferreira V.
Familial Mediterranean Fever in Spain: Time Trend and Spatial Distribution of the Hospitalizations.
Int J Environ Res Public Health. 2023 Feb 28;20(5):4374. doi: 10.3390/ijerph20054374.
https://pubmed.ncbi.nlm.nih.gov/36901385/ -
Çağlayan Ş, Mardinoğlu G, Yarar MH, Ulu K, Coşkuner T, Yiğit RE, Baykal GÖ, Türkmen Ş, Çakan M, Demir F, Sözeri B.
The assessment of autoinflammatory disease classification criteria (Eurofever/PRINTO) in a real-life cohort
Clin Rheumatol. 2023 Feb 24. doi: 10.1007/s10067-023-06557-0. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36826737/ -
La Torre F, Sota J, Insalaco A, Conti G, Del Giudice E, Lubrano R, et al.
Preliminary data revealing efficacy of Streptococcus salivarius K12 (SSK12) in Periodic Fever, Aphthous stomatitis, Pharyngitis, and cervical Adenitis (PFAPA) syndrome: A multicenter study from the AIDA Network PFAPA syndrome registry.
Front Med (Lausanne). 2023 Feb 16;10:1105605. doi: 10.3389/fmed.2023.1105605.
https://pubmed.ncbi.nlm.nih.gov/36873863/ -
Ru C, Qian T, Liu X, Wang C, Li W, Hou X, Li C.
SAPHO syndrome with Takayasu arteritis successfully treated with tofacitinib
Int J Rheum Dis. 2023 Feb 22. doi: 10.1111/1756-185X.14628. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36814398/ -
Li GM, Han X, Wu Y, Wang W, Tang HX, Lu MP, et al.
A Cohort Study on Deficiency of ADA2 from China
J Clin Immunol. 2023 Feb 18. doi: 10.1007/s10875-023-01432-8. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36807221/ -
Sacco KA, Gazzin A, Notarangelo LD, Delmonte OM.
Granulomatous inflammation in inborn errors of immunity
Front Pediatr. 2023 Feb 20;11:1110115. doi: 10.3389/fped.2023.1110115.
https://pubmed.ncbi.nlm.nih.gov/36891233/ -
An JW, Pimpale-Chavan P, Stone DL, Bandeira M, Dedeoglu F, Lo J, Bohnsack J, Rosenzweig S, Schnappauf O, Dissanayake D, Hiraki LT, Kastner DL, Pelajo C, Laxer RM, Aksentijevich I.
Case report: Novel variants in RELA associated with familial Behcet's-like disease
Front Immunol. 2023 Feb 28;14:1127085. doi: 10.3389/fimmu.2023.1127085.
https://pubmed.ncbi.nlm.nih.gov/36926348/ -
Hua Y, Wu N, Miao J, Shen M.
Single-cell transcriptomic analysis in two patients with rare systemic autoinflammatory diseases treated with anti-TNF therapy.
Front Immunol. 2023 Feb 24;14:1091336. doi: 10.3389/fimmu.2023.1091336.
https://pubmed.ncbi.nlm.nih.gov/36911721/ -
Aiello A, Mariano EE, Prada M, Cioni L, Teruzzi C, Manna R.
Budget impact analysis of anakinra in the treatment of familial Mediterranean fever in Italy.
J Mark Access Health Policy. 2023 Feb 9;11(1):2176091. doi: 10.1080/20016689.2023.2176091.
https://pubmed.ncbi.nlm.nih.gov/36819891/ -
Manole S, Rancea R, Vulturar R, Simon SP, Molnar A, Damian L.
Frail Silk: Is the Hughes-Stovin Syndrome a Behçet Syndrome Subtype with Aneurysm-Involved Gene Variants?
Int J Mol Sci. 2023 Feb 5;24(4):3160. doi: 10.3390/ijms24043160.
https://pubmed.ncbi.nlm.nih.gov/36834577/ -
Jorch SK, McNally A, Berger P, Wolf J, Kaiser K, Chetrusca Covash A, et al.
Complex regulation of alarmins S100A8/A9 and secretion via gasdermin D pores exacerbates autoinflammation in familial Mediterranean fever.
Allergy Clin Immunol. 2023 Feb 22:S0091-6749(23)00225-7. doi: 10.1016/j.jaci.2023.01.037. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36822481/
ENERO 2023
-
Cohen K, Spielman S, Semo-Oz R, Bitansky G, Gerstein M, Yacobi Y, Vivante A, Tirosh I.
Colchicine treatment can be discontinued in a selected group of pediatric FMF patients.
Pediatr Rheumatol Online J. 2023 Jan 4;21(1):2. doi: 10.1186/s12969-022-00780-w.
https://pubmed.ncbi.nlm.nih.gov/36600239/ -
Du Y, Liu M, Nigrovic PA, Dedeoglu F, Lee PY.
Biologics and JAK inhibitors for the treatment of monogenic systemic autoinflammatory diseases in children.
J Allergy Clin Immunol. 2023 Jan 25:S0091-6749(22)02589-1. doi: 10.1016/j.jaci.2022.12.816. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36707349/ -
Poker Y, von Hardenberg S, Hofmann W, Tang M, Baumann U, Schwerk N, Wetzke M, Lindenthal V, Auber B, Schlegelberger B, Ott H, von Bismarck P, Viemann D, Dressler F, Klemann C, Bergmann AK.
Systematic genetic analysis of pediatric patients with autoinflammatory diseases.
Front Genet. 2023 Jan 27;14:1065907. doi: 10.3389/fgene.2023.1065907.
https://pubmed.ncbi.nlm.nih.gov/36777733/ -
Pinchevski-Kadir S, Gerstein M, Pleniceanu O, Yacobi Y, Vivante A, Granat OE, Spielman S, Oz RS, Tirosh I.
Effect of interleukin-1 antagonist on growth of children with colchicine resistant or intolerant FMF.
Pediatr Rheumatol Online J. 2023 Jan 9;21(1):4. doi: 10.1186/s12969-022-00784-6.
https://pubmed.ncbi.nlm.nih.gov/36624531/ -
Özkılınç Önen M, Onat UI, Uğurlu S, Timuçin AC, Öz Arslan D, Everest E, Özdoğan H, Tahir Turanlı E.
Detection of a rare variant in PSTPIP1 through three generations in a family with an initial diagnosis of FMF/MKD-overlapping phenotype.
Rheumatology (Oxford). 2023 Jan 24:kead044. doi: 10.1093/rheumatology/kead044. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36692132/
DICIEMBRE 2022
-
Sarika GM, Shreberk-Hassidim R, Maly A, Molho-Pessach V.
Acrofacial necrotic ulcers in an infant: An undiagnosed presentation
Front Pediatr. 2022 Dec 22;10:1069242. doi: 10.3389/fped.2022.1069242. eCollection 2022.
https://pubmed.ncbi.nlm.nih.gov/36619501/ -
Caldiran FY, Deveci K, Cacan E.
NLRP13 inflammasome complex is hypermethylated in familial Mediterranean fever and global methylation correlates with the disease severity
Ann Hum Genet. 2022 Dec 30. doi: 10.1111/ahg.12493. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36583259/ -
Caorsi R, Insalaco A, Bovis F, Martini G, Cattalini M, Chinali M, Rimini A, Longo C, Federici S, Celani C, Filocamo G, Consolini R, Maggio MC, Fadanelli G, Licciardi F, Romano M, Teruzzi BL, Taddio A, Miniaci A, La Torre F, De Fanti A,
Cavalli G, Bigucci B, Gallizzi R, Chinello M, Imazio M, Brucato A, Cimaz R, De Benedetti F, Gattorno M.
Paediatric recurrent pericarditis: Appropriateness of the standard of care and response to IL1-blockade
J Pediatr. 2022 Dec 2:S0022-3476(22)01095-2. doi: 10.1016/j.jpeds.2022.11.034. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36470465/ -
Cebecauerová D, Malcová H, Koukolská V, Kvíčalová Z, Souček O, Wagenknecht L, Bronský J, Šumník Z, Kynčl M, Cebecauer M, Horváth R.
Two phenotypes of chronic recurrent multifocal osteomyelitis with different patterns of bone involvement
Pediatr Rheumatol Online J. 2022 Dec 1;20(1):108. doi: 10.1186/s12969-022-00772-w.
https://pubmed.ncbi.nlm.nih.gov/36456962/
NOVIEMBRE 2022
-
Legger GE, Dermer CWE, Brunger AF, van Daele PLA, Nienhuis HLA.
The relation between C-reactive protein and serum amyloid A in patients with autoinflammatory diseases.
Pediatr Rheumatol Online J. 2022 Nov 24;20(1):106. doi: 10.1186/s12969-022-00757-9.
https://pubmed.ncbi.nlm.nih.gov/36434581/ -
Saulescu I, Ionescu R, Opris-Belinski D.
Interferon in systemic lupus erythematosus-A halfway between monogenic autoinflammatory and autoimmune disease.
Heliyon. 2022 Nov 24;8(11):e11741. doi: 10.1016/j.heliyon.2022.e11741.
https://pubmed.ncbi.nlm.nih.gov/36468094/ -
Raftopoulou S, Rapti A, Karathanasis D, Evangelopoulos ME, Mavragani CP.
The role of type I IFN in autoimmune and autoinflammatory diseases with CNS involvement.
Front Neurol. 2022 Nov 10;13:1026449. doi: 10.3389/fneur.2022.1026449.
https://pubmed.ncbi.nlm.nih.gov/36438941/ -
Zanatta L, Biscaro F, Bresolin S, Marzaro M, Sarcognato S, Cataldo I, Marzollo A, Martelossi S.Front Pediatr. 2022 Nov 18;10:1044007. doi: 10.3389/fped.2022.1044007.
Case Report: An early-onset inflammatory colitis due to a variant in TNFAIP3 causing A20 haploinsufficiency.
Front Pediatr. 2022 Nov 18;10:1044007. doi: 10.3389/fped.2022.1044007.
https://pubmed.ncbi.nlm.nih.gov/36467491/ -
Yıldız Ç, Gezgin Yıldırım D, Inci A, Tümer L, Cengiz Ergin FB, et al.
A possibly new autoinflammatory disease due to compound heterozygous phosphomevalonate kinase gene mutation.
Joint Bone Spine. 2022 Nov 18;90(1):105490. doi: 10.1016/j.jbspin.2022.105490. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36410683/
OCTUBRE 2022
-
Guilpain P.
JAK inhibitors in autoinflammatory syndromes? The long road from drug development to daily clinical use.
Rheumatology (Oxford). 2022 Oct 11:keac592. doi: 10.1093/rheumatology/keac592. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36218416/ -
Wan R, Fänder J, Zakaraia I, Lee-Kirsch MA, Wolf C, Lucas N, et al.
Phenotypic spectrum in recessive STING-associated vasculopathy with onset in infancy: Four novel cases and analysis of previously reported cases.
Front Immunol. 2022 Oct 6;13:1029423. doi: 10.3389/fimmu.2022.1029423. eCollection 2022.
https://pubmed.ncbi.nlm.nih.gov/36275728/ -
Li Y, Yu M, Lu M.
Pathophysiology, clinical manifestations and current management of IL-1 mediated monogenic systemic autoinflammatory diseases, a literature review.
Pediatr Rheumatol Online J. 2022 Oct 17;20(1):90. doi: 10.1186/s12969-022-00728-0.
https://pubmed.ncbi.nlm.nih.gov/36253853/ -
Andreasen CM, Klicman RF, Herlin T, Hauge EM, Jurik AG.
Standardized reporting and quantification of whole-body MRI findings in children with chronic non-bacterial osteomyelitis treated with pamidronate.
Pediatr Rheumatol Online J. 2022 Oct 1;20(1):85. doi: 10.1186/s12969-022-00746-y.
https://pubmed.ncbi.nlm.nih.gov/36183086/ -
Nayır Buyuksahin H, Basaran O, Balık Z, Bilginer Y, Ozen S, Dogru D.
Interstitial lung disease in autoinflammatory disease in childhood: a systematic review of the literature.
Pediatr Pulmonol. 2022 Oct 31. doi: 10.1002/ppul.26220. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36314652/ -
Betrains A, Wright WF, Moreel L, Staels F, Blockmans D, Vanderschueren S
Etiological spectrum and outcome of fever and inflammation of unknown origin. Does symptom duration matter?
Eur J Intern Med. 2022 Oct 16:S0953-6205(22)00354-5. doi: 10.1016/j.ejim.2022.10.002. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36261311/
AGOSTO 2022
-
Lazea C, Damian L, Vulturar R, Lazar C.
PFAPA Syndrome: Clinical, Laboratory and Therapeutic Features in a Single-Centre Cohort
Int J Gen Med. 2022 Aug 29;15:6871-6880. doi: 10.2147/IJGM.S373942.
https://pubmed.ncbi.nlm.nih.gov/36061962/ -
Lanis A, Van Den Bogaerde S, Zhao Y.
Chronic recurrent multifocal osteomyelitis and tofacitinib: a case series
Rheumatology (Oxford). 2022 Aug 17:keac461. doi: 10.1093/rheumatology/keac461.
https://pubmed.ncbi.nlm.nih.gov/35976104/ -
Monfort JB, Deshayes S, Dusser P, Bourguiba R, Savey L, Vinit C, Koné-Paut I, Amaryan G, Theodoropoulou K, Guedri R, Pachlopnik J, Belot A, Melki I, Maldar NP; JIR cohort investigators, Hentgen V, Georgin-Lavialle S.
Cutaneous manifestations of monogenic auto-inflammatory diseases: an international cohort study from the JIR cohort.
J Am Acad Dermatol. 2022 Aug 12:S0190-9622(22)02527-0. doi: 10.1016/j.jaad.2022.08.015.
https://pubmed.ncbi.nlm.nih.gov/35970384/ -
Welzel T, Oefelein L, Twilt M, Pfister M, Kuemmerle-Deschner JB, Benseler SM.
Tapering of biological treatment in autoinflammatory diseases: a scoping review.
Pediatr Rheumatol Online J. 2022 Aug 13;20(1):67. doi: 10.1186/s12969-022-00725-3.
https://pubmed.ncbi.nlm.nih.gov/35964053/ -
Renson T, Hamiwka L, Benseler S.
Central nervous system manifestations of monogenic autoinflammatory disorders and the neurotropic features of SARS-CoV-2: Drawing the parallels
Front Pediatr. 2022 Aug 10;10:931179. doi: 10.3389/fped.2022.931179.
https://pubmed.ncbi.nlm.nih.gov/36034552/ -
Jafarpour S, Banerjee A, Boyd NK, Vogel BN, Paulsen KC, Ahsan N, Mitchell WG, Jeste SS, Santoro JD.
Association of rare variants in genes of immune regulation with pediatric autoimmune CNS diseases.
J Neurol. 2022 Aug 12:1-18. doi: 10.1007/s00415-022-11325-2.
https://pubmed.ncbi.nlm.nih.gov/35960392/ -
Koné-Paut I, Piram M, Benseler S, Kuemmerle-Deschner JB, Jansson A, Rosner I, Tommasini A, Murias S, Karadag O, Levy J, McCreddin S, Migliaccio M, De Benedetti F.
Use of the Auto-inflammatory Disease Activity Index to monitor disease activity in patients with colchicine-resistant Familial Mediterranean Fever, Mevalonate Kinase Deficiency, and TRAPS treated with
anakinumab.
Joint Bone Spine. 2022 Aug 6;89(6):105448. doi: 10.1016/j.jbspin.2022.105448.
https://pubmed.ncbi.nlm.nih.gov/35944600/
JULIO 2022
-
Romano M, Arici ZS, Piskin D, Alehashemi S, Aletaha D, Barron K, et al.
The 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Interleukin-1 Mediated Autoinflammatory Diseases: Cryopyrin-Associated Periodic Syndromes, Tumour Necrosis Factor Receptor-Associated Periodic Syndrome, Mevalonate Kinase Deficiency, and Deficiency of the Interleukin-1 Receptor Antagonist.
Arthritis Rheumatol. 2022 Jul;74(7):1102-1121. doi: 10.1002/art.42139.
https://pubmed.ncbi.nlm.nih.gov/35621220/ -
Levinsky Y, Butbul Aviel Y, Ahmad SA, Broide M, Gendler Y, Dagan N, Gafner M, Gavra H, Kagan S, Kedar K, Natour HM, Tal R, Veres T, Amarilyo G, Harel L.
PFAPA flares observed during COVID outbreak: can emotional stress trigger PFAPA attacks? A multicenter cohort study.
Pediatr Rheumatol Online J. 2022 Jul 8;20(1):46. doi: 10.1186/s12969-022-00705-7.
https://pubmed.ncbi.nlm.nih.gov/35804374/ -
Jeyaratnam J, Faraci M, Gennery AR, Drabko K, Algeri M, Morimoto A, Sirait T, Lankester AC, Albert M, Neven B, Frenkel J; EBMT Inborn Errors Working Party.
The efficacy and safety of allogeneic stem cell transplantation in Mevalonate Kinase Deficiency.
Pediatr Rheumatol Online J. 2022 Jul 29;20(1):56. doi: 10.1186/s12969-022-00716-4.
https://pubmed.ncbi.nlm.nih.gov/35906690/ -
Miyazawa H, Wada T.
Immune-mediated inflammatory diseases with chronic excess of serum interleukin-18.
Front Immunol. 2022 Jul 25;13:930141. doi: 10.3389/fimmu.2022.930141. PMID: 35958573.
https://pubmed.ncbi.nlm.nih.gov/35958573/ -
Batu ED, Kaya Akca U, Basaran O, Bilginer Y, Özen S.
Probiotic use in the prophylaxis of periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome: a retrospective cohort study.
Rheumatol Int. 2022 Jul;42(7):1207-1211. doi: 10.1007/s00296-021-05084-y.
https://pubmed.ncbi.nlm.nih.gov/34994815/
JUNIO 2022
-
Broderick L, Hoffman HM.
IL-1 and autoinflammatory disease: biology, pathogenesis and therapeutic targeting.
Nat Rev Rheumatol. 2022 Jun 21;1-16. doi: 10.1038/s41584-022-00797-1. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35729334/ -
Boyadzhieva Z, Ruffer N, Burmester G, Pankow A, Krusche M.
Effectiveness and Safety of JAK Inhibitors in Autoinflammatory Diseases: A Systematic Review
Front Med (Lausanne). 2022 Jun 27;9:930071. doi: 10.3389/fmed.2022.930071. -
Penco F, Petretto A, Lavarello C, Papa R, Bertoni A, Omenetti A, Gueli I, Finetti M, Caorsi R, Volpi S, Gattorno M.
Proteomic Signatures of Monocytes in Hereditary Recurrent Fevers.
Front Immunol. 2022 Jun 23;13:921253. doi: 10.3389/fimmu.2022.921253.
https://pubmed.ncbi.nlm.nih.gov/35812440/ -
Papakonstantinou O, Prountzos S, Karavasilis E, Atsali E, Bizimi V, Alexopoulou E, Fotis L.
Whole-body magnetic resonance imaging findings and patterns of chronic nonbacterial osteomyelitis in a series of Greek pediatric patients.
Acta Radiol Open. 2022 Jun 22;11(6):20584601221106701. doi: 10.1177/20584601221106701. eCollection 2022 Jun.
https://pubmed.ncbi.nlm.nih.gov/35757189/ -
Karamanakos A, Tektonidou M, Vougiouka O, Gerodimos C, Katsiari C et al.
Autoinflammatory syndromes with coexisting variants in Mediterranean FeVer and other genes: Utility of multiple gene screening and the possible impact of gene dosaje.
Semin Arthritis Rheum. 2022 Jun 23;56:152055. doi: 10.1016/j.semarthrit.2022.152055. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35780723/ -
Tapiz I Reula AJ, Cochino AV, Martins AL, Angosto-Bazarra D, Ortiz de Landazuri I, Mensa-Vilaró A et al.
Characterization of Novel Pathogenic Variants Leading to Caspase-8 Cleavage-Resistant RIPK1-Induced Autoinflammatory Syndrome.
J Clin Immunol. 2022 Jun 18. doi: 10.1007/s10875-022-01298-2. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35716229/ -
Gezgin Y, Kırnaz B, Berdeli A.
Screening of OTULIN gene mutation with targeted next generation sequencing in Turkish populations and in silico analysis of these mutations.
Mol Biol Rep. 2022 Jun;49(6):4643-4652. doi: 10.1007/s11033-022-07312-5. Epub 2022 Mar 16.
https://pubmed.ncbi.nlm.nih.gov/35294702/ -
Romano M, Garcia-Bournissen F, Piskin D, Rodoplu U, Piskin L, Elzagallaai AA et al.
Anti-Inflammatory, Antioxidant, and Anti-Atherosclerotic Effects of Natural Supplements on Patients with FMF-Related AA Amyloidosis: A Non-Randomized 24-Week Open-Label Interventional Study.
Life (Basel). 2022 Jun 15;12(6):896. doi: 10.3390/life12060896.
https://pubmed.ncbi.nlm.nih.gov/35743929/
MAYO 2022
-
Jeyaratnam J, Simon A, Calvo I, Constantin T, Shcherbina A, Hofer M, Gattorno M, et al.
The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology Points to Consider for Diagnosis and Management of Autoinflammatory Type I Interferonopathies: CANDLE/PRAAS, SAVI, and AGS.
Arthritis Rheumatol. 2022 May;74(5):735-751. doi: 10.1002/art.42087. Epub 2022 Mar 21. PMID: 35315249.
https://pubmed.ncbi.nlm.nih.gov/35315249/ -
Al-Mayouf SM, Akbar L, Abdwani R, Ginesi G, Volpi S, Gattorno M, et al.
Performance of the EULAR/ACR 2019 classification criteria for systemic lupus erythematous in monogenic lupus.
Clin Rheumatol. 2022 May 19. doi: 10.1007/s10067-022-06209-9. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35590114/ -
Bourguiba R, Kyheng M, Koné-Paut I, Rouzaud D, Avouac J, Devaux M, et al; FAI2R/SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors.
COVID-19 infection among patients with autoinflammatory diseases: a study on 117 French patients compared with 1545 from the French RMD COVID-19 cohort: COVIMAI-the French cohort study of SARS-CoV-2 infection in patient with systemic autoinflammatory diseases.
RMD Open. 2022 May;8(1):e002063. doi: 10.1136/rmdopen-2021-002063.
https://pubmed.ncbi.nlm.nih.gov/35537796/ -
Schnabel A, Nashawi M, Anderson C, Felsenstein S, Lamoudi M, Poole-Cowley J, et al.
TNF-inhibitors or bisphosphonates in chronic nonbacterial osteomyelitis? - Results of an international retrospective multicenter study.
Clin Immunol. 2022 May;238:109018. doi: 10.1016/j.clim.2022.109018.
https://pubmed.ncbi.nlm.nih.gov/35460903/Martini A, Bader-Meunier B, Vastert B, Levy J, Dekker E, de Benedetti F, Frenkel J.
Long-term efficacy and safety of canakinumab in patients with mevalonate kinase deficiency: results from the randomised Phase 3 CLUSTER trial.
Rheumatology (Oxford). 2022 May 5;61(5):2088-2094. doi: 10.1093/rheumatology/keab696. PMID: 34554243. -
Aktaş B, Gümüş D, Tunalı A, Kunter Z, Adrovic A.
Mevalonate kinase deficiency/Hyperimmunoglobulin D syndrome (MVK/HIDS) in a Differential Diagnosis of Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome and Familial Mediterranean Fever (FMF): A Case Report.
Turk Arch Pediatr. 2022 May;57(3):365-367. doi: 10.5152/TurkArchPediatr.2022.21321. PMID: 35781244; PMCID: PMC9131824.
https://pubmed.ncbi.nlm.nih.gov/35781244/ -
Assrawi E, Louvrier C, El-Khouri E, Delaleu J, Copin B, Dastot-Le Moal F,
Mosaic variants in TNFRSF1A: An emerging cause of tumor necrosis factor receptor-associated periodic syndrome.
Rheumatology (Oxford). 2022 May 28:keac274. doi: 10.1093/rheumatology/keac274. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35640127/ -
Alamlih L, Al-Karaja L, Alayaseh M, Abunejma F, Al-Zeer Z, Sultan B.
Familial Mediterranean Fever with Pseudo-Septic Arthritis: A Case Report and Review of the Literature.
Mod Rheumatol Case Rep. 2022 May 10:rxac040. doi: 10.1093/mrcr/rxac040. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35534442/
ABRIL 2022
-
Kul Cinar O, Putland A, Wynne K, Eleftheriou D, Brogan PA.
Hereditary Systemic Autoinflammatory Diseases: Therapeutic Stratification
Front Pediatr. 2022 Apr 28;10:867679. doi: 10.3389/fped.2022.867679. eCollection 2022.
https://pubmed.ncbi.nlm.nih.gov/35573950/ -
Schnabel A, Nashawi M, Anderson C, Felsenstein S, Lamoudi M, Poole-Cowley J, Lindell E, Oates B, Fowlie P, Walsh J, Ellis T, Hahn G, Goldspink A, Martin N, Mahmood K, Hospach T, Lj M, Hedrich CM.
TNF-inhibitors or bisphosphonates in chronic nonbacterial osteomyelitis? - Results of an international retrospective multicenter study.
Clin Immunol. 2022 May;238:109018. doi: 10.1016/j.clim.2022.109018. Epub 2022 Apr 20.
https://pubmed.ncbi.nlm.nih.gov/35460903/ -
Hong Y, Casimir M, Houghton BC, Zhang F, Jensen B, Omoyinmi E, Torrance R, Papadopoulou C, Cummins M, Roderick M, Thrasher AJ, Brogan PA, Eleftheriou D.
Lentiviral Mediated ADA2 Gene Transfer Corrects the Defects Associated With Deficiency of Adenosine Deaminase Type 2.
Front Immunol. 2022 Apr 22;13:852830. doi: 10.3389/fimmu.2022.852830. eCollection 2022.
https://pubmed.ncbi.nlm.nih.gov/35529868/ -
Batu ED, Basaran O, Bilginer Y, Ozen S.
Familial Mediterranean Fever: How to Interpret Genetic Results? How to Treat? A Quarter of a Century After the Association with the Mefv Gene.
Curr Rheumatol Rep. 2022 Apr 18. doi: 10.1007/s11926-022-01073-7. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35435612/
MARZO 2022
-
Cetin Gedik K, Lamot L, Romano M, Demirkaya E, Piskin D, Torreggiani S, Adang LA, Armangue T, Barchus K, Cordova DR, Crow YJ, Dale RC, Durrant KL, Eleftheriou D, Fazzi EM, Gattorno M, Gavazzi F, Hanson EP, Lee-Kirsch MA, Montealegre Sanchez GA, Neven B, Orcesi S, Ozen S, Poli MC, Schumacher E, Tonduti D, Uss K, Aletaha D, Feldman BM, Vanderver A, Brogan PA, Goldbach-Mansky R.
The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology Points to Consider for Diagnosis and Management of Autoinflammatory Type I Interferonopathies: CANDLE/PRAAS, SAVI, and AGS.
Arthritis Rheumatol. 2022 Mar 21. doi: 10.1002/art.42087. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35315249/ -
Lee Y, Wessel AW, Xu J, Reinke JG, Lee E, Kim SM, Hsu AP, Zilberman-Rudenko J, Cao S, Enos C, Brooks SR, Deng Z, Lin B, de Jesus AA, Hupalo DN, Piotto DG, Terreri MT, Dimitriades VR, Dalgard CL, Holland SM, Goldbach-Mansky R, Siegel RM, Hanson EP
Genetically programmed alternative splicing of NEMO mediates an autoinflammatory disease phenotype.
J Clin Invest. 2022 Mar 15;132(6):e128808. doi: 10.1172/JCI128808.
https://pubmed.ncbi.nlm.nih.gov/35289316/ -
Sun G, Qiu L, Yu L, An Y, Ding Y, Zhou L, Wu J, Yang X, Zhang Z, Tang X, Xia H, Cao L, You F, Zhao X, Du H.
Loss of Function Mutation in ELF4 Causes Autoinflammatory and Immunodeficiency Disease in Human.
J Clin Immunol. 2022 Mar 9. doi: 10.1007/s10875-022-01243-3. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35266071/ -
Kırnaz B, Gezgin Y, Berdeli A.
MEFV gene allele frequency and genotype distribution in 3230 patients' analyses by next generation sequencing methods.
Gene. 2022 Mar 28:146447. doi: 10.1016/j.gene.2022.146447. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35358658/ -
Zhong Z, Ding J, Su G, Liao W, Gao Y, Zhu Y, Deng Y, Li F, Du L, Gao Y, Yang P.
Genetic and Clinical Features of Blau Syndrome among Chinese Patients with Uveitis.
Ophthalmology. 2022 Mar 18:S0161-6420(22)00209-3. doi: 10.1016/j.ophtha.2022.03.014. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35314268/ -
Aden S, Wong S, Yang C, Bui T, Higa T, Scheck J, Iyer RS, Egbert M, Lindberg A, Zhao Y.
Increasing Cases of Chronic Nonbacterial Osteomyelitis in Children: a series of 215 cases from a single tertiary referral center.
J Rheumatol. 2022 Mar 15:jrheum.210991. doi: 10.3899/jrheum.210991. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35293328/ -
Gezgin Yıldırım D, Bakkaloğlu SA.
Monogenic lupus caused by mutations in DNASE1L3: A rare cause of systemic lupus erythematosus in children
Scand J Immunol. 2022 Mar 18:e13162. doi: 10.1111/sji.13162. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35302646/ -
Rodrigues F, Cuisset L, Cador-Rousseau B, Giurgea I, Neven B, Buob D, Quartier P, Hachulla E, Lequerré T, Cam G, Boursier G, Hervieu V, Grateau G, Georgin-Lavialle S.
AA Amyloidosis complicating cryopyrin-associated periodic syndrome: a study on 86 cases including 23 French patients and systematic review.
Rheumatology (Oxford). 2022 Mar 9:keac145. doi: 10.1093/rheumatology/keac145. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35262642/ -
Yamada SM, Pontillo A.
The genetics behind inflammasome regulation.
Mol Immunol. 2022 Mar 9;145:27-42. doi: 10.1016/j.molimm.2022.03.005. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35278849/
FEBRERO 2022
-
Mathieu AL, Omarjee O, Walzer T, Belot A.
Macrophage involvement in juvenile arthritis onset: LACC1 bridges the gap?.
Med Sci (Paris). 2022 Feb;38(2):133-135. doi: 10.1051/medsci/2021253. Epub 2022 Feb 18.
https://pubmed.ncbi.nlm.nih.gov/35179464/ -
Semo-Oz R, Biton B, Tesher MS.
The Role of Anti-IL-1 Medications in Autoinflammatory Disease.
Pediatr Ann. 2022 Feb;51(2):e72-e76. doi: 10.3928/19382359-20220115-01. Epub 2022 Feb 1.
https://pubmed.ncbi.nlm.nih.gov/35156883/ -
Abbasi A, Batllori M, Gil-Sáez FJ, Rodríguez-Pintó I, Antón López J, Iglesias Jímenez E.
Importance of the determination of enzymatic activity in the diagnosis of deficiency of adenosine deaminase 2 (DADA2).
Med Clin (Barc). 2022 Feb 28:S0025-7753(22)00044-6. doi: 10.1016/j.medcli.2021.12.020.
https://pubmed.ncbi.nlm.nih.gov/35241284/
ENERO 2022
-
Cetin Gedik K, Lamot L, Romano M, Demirkaya E, Piskin D, Torreggiani S, Adang LA, Armangue T, Barchus K, Cordova DR, Crow YJ, Dale RC, Durrant KL, Eleftheriou D, Fazzi EM, Gattorno M, Gavazzi F, Hanson EP, Lee-Kirsch MA, Montealegre Sanchez GA, Neven B, Orcesi S, Ozen S, Poli MC, Schumacher E, Tonduti D, Uss K, Aletaha D, Feldman BM, Vanderver A, Brogan PA, Goldbach-Mansky R.
The 2021 EULAR and ACR points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS, SAVI and AGS.
Ann Rheum Dis. 2022 Jan 27:annrheumdis-2021-221814. doi: 10.1136/annrheumdis-2021-221814.
https://pubmed.ncbi.nlm.nih.gov/35086813/ -
Borst C, Symmank D, Drach M, Weninger W.
Cutaneous signs and mechanisms of inflammasomopathies.
Ann Rheum Dis. 2022 Jan 17:annrheumdis-2021-220977. doi: 10.1136/annrheumdis-2021-220977.
https://pubmed.ncbi.nlm.nih.gov/35039323/ -
Beshlawy AE, Zekri AER, Ramadan MS, Selim YMM, Abdel-Salam A, Hegazy MT, Ragab L, Gaggiano C, Cantarini L, Ragab G.
Genotype-phenotype associations in familial Mediterranean fever: a study of 500 Egyptian pediatric patients.
Clin Rheumatol. 2022 Jan 6. doi: 10.1007/s10067-021-06006-w.
https://pubmed.ncbi.nlm.nih.gov/34988684/ -
Avar-Aydın PO, Ozcakar ZB, Aydın F, Karakas HD, Cakar N, Yalcınkaya F.
The expanded spectrum of arthritis in children with familial Mediterranean fever.
Clin Rheumatol. 2022 Jan 28. doi: 10.1007/s10067-022-06082-6.
https://pubmed.ncbi.nlm.nih.gov/35091781/ -
Yan K, Zhang J, Lee PY, Tao P, Wang J, Wang S, Zhou Q, Dong M.
Haploinsufficiency of PSMD12 causes proteasome dysfunction and subclinical autoinflammation.
Arthritis Rheumatol. 2022 Jan 26. doi: 10.1002/art.42070.
https://pubmed.ncbi.nlm.nih.gov/35080150/ -
David C, Frémond ML.
Lung Inflammation in STING-Associated Vasculopathy with Onset in Infancy (SAVI).
Cells. 2022 Jan 18;11(3):318. doi: 10.3390/cells11030318.
https://pubmed.ncbi.nlm.nih.gov/35159128/ -
Delplanque M, Ducharme-Bénard S, Moguelet P, Chasset F, Grateau G, Georgin-Lavialle S, Bachmeyer C.
Is neutrophilic dermatosis a manifestation of familial Mediterranean fever?
Scand J Rheumatol. 2022 Jan;51(1):42-49. doi: 10.1080/03009742.2021.1904588.
https://pubmed.ncbi.nlm.nih.gov/34159892/
DICIEMBRE 2021
-
Lin B, Goldbach-Mansky R.
Pathogenic insights from genetic causes of autoinflammatory inflammasomopathies and interferonopathies.
J Allergy Clin Immunol. 2021 Dec 7;S0091-6749(21)01685-7. doi: 10.1016/j.jaci.2021.10.027. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34893352/ -
Savic S, Coe J, Laws P.
Autoinflammation: Interferonopathies and Other Autoinflammatory Diseases.
J Invest Dermatol. 2021 Dec 7;S0022-202X(21)02406-4. doi: 10.1016/j.jid.2021.07.189. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34887082/ -
Sota J, Rigante D, Cimaz R, Cattalini M, Frassi M et al.
Drug survival of anakinra and canakinumab in monogenic autoinflammatory diseases: observational study from the International AIDA Registry.
Rheumatology (Oxford). 2021 Dec 1;60(12):5705-5712. doi: 10.1093/rheumatology/keab419.
https://pubmed.ncbi.nlm.nih.gov/33961014/ -
Çiçek SO, Şahin N, Karaman ZF, Taşkın SN, Kısaarslan AP et al.
The Possible Relationship Between Familial Mediterranean Fever and Chronic Nonbacterial Osteomyelitis: Coincidence or Coexistence?
J Clin Rheumatol. 2021 Dec 1;27(8):e342-e348. doi: 10.1097/RHU.0000000000001431.
https://pubmed.ncbi.nlm.nih.gov/32541616/ -
Chavan PP, Aksentijevich I, Daftary A, Panwala H, Khemani C et al.
Majeed Syndrome: Five Cases With Novel Mutations From Unrelated Families in India With a Review of Literature.
J Rheumatol. 2021 Dec;48(12):1850-1855. doi: 10.3899/jrheum.201663. Epub 2021 May 15.
https://pubmed.ncbi.nlm.nih.gov/33993107/ -
Vahidnezhad H, Youssefian L, Saeidian AH, Ziaee V et al.
Homozygous MEFV Gene Variant and Pyrin-Associated Autoinflammation With Neutrophilic Dermatosis: A Family With a Novel Autosomal Recessive Mode of Inheritance.
JAMA Dermatol. 2021 Dec 1;157(12):1466-1471. doi: 10.1001/jamadermatol.2021.3899.
https://pubmed.ncbi.nlm.nih.gov/34643647/ -
Delaleu J, Deshayes S, Rodrigues F, Savey L, Rivière E et al.
Tumour necrosis factor receptor-1 associated periodic syndrome (TRAPS)-related AA amyloidosis: a national case series and systematic review.
Rheumatology (Oxford). 2021 Dec 1;60(12):5775-5784. doi: 10.1093/rheumatology/keab252.
https://pubmed.ncbi.nlm.nih.gov/33715002/ -
Hautala T, Vähäsalo P, Kuismin O, Keskitalo S, Rajamäki K et al.
A Family With A20 Haploinsufficiency Presenting With Novel Clinical Manifestations and Challenges for Treatment.
J Clin Rheumatol. 2021 Dec 1;27(8):e583-e587. doi: 10.1097/RHU.0000000000001268.
https://pubmed.ncbi.nlm.nih.gov/31977656/ -
Rodrigues FG, Petrushkin H, Webster AR, Bickerstaff M et al.
A Novel Pathogenic NOD2 Variant in a Mother and Daughter with Blau Syndrome.
Ophthalmic Genet. 2021 Dec;42(6):753-764. doi: 10.1080/13816810.2021.1946701. Epub 2021 Jul 12.
https://pubmed.ncbi.nlm.nih.gov/34251956/ -
Sikora KA, Wells K, Bolek EC, Jones AI, Grayson PC.
Somatic Mutations in Rheumatologic Diseases: VEXAS Syndrome and Beyond.
Rheumatology (Oxford). 2021 Dec 9;keab868. doi: 10.1093/rheumatology/keab868. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34888629/
NOVIEMBRE 2021
-
Vinit C, Georgin-Lavialle S, Theodoropoulou A, Barbier C, Belot A, Mejbri M, Pillet P, Pachlopnik J, Poignant S, Rebelle C, Woerner A, Koné-Paut I, Hentgen V.
Real-life indications of Interleukin-1 blocking agents in hereditary recurrent fevers: Data from the JIRcohort and a Literature Review.
Front Immunol. 2021 Nov 11;12:744780. doi: 10.3389/fimmu.2021.744780.
https://pubmed.ncbi.nlm.nih.gov/34858402/ -
Welzel T, Ellinghaus M, Wildermuth AL, Deschner N, Benseler SM, Kuemmerle-Deschner JB.
Colchicine Effectiveness and Safety in Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenitis.
Front Pediatr. 2021 Nov 25;9:759664. doi: 10.3389/fped.2021.759664.
https://pubmed.ncbi.nlm.nih.gov/34900867/ -
Maccora I, Marrani E, Mastrolia MV, Abu-Rumeileh S, Maniscalco V, Fusco E, Barbati F, Pagnini I, Simonini G.
Ocular involvement in monogenic autoinflammatory disease.
Autoimmun Rev. 2021 Nov;20(11):102944. doi: 10.1016/j.autrev.2021.102944.
https://pubmed.ncbi.nlm.nih.gov/34509650/ -
Zhang S, Cai Z, Mo X, Zeng H.
Tofacitinib effectiveness in Blau syndrome: a case series of Chinese paediatric patients.
Pediatr Rheumatol Online J. 2021 Nov 15;19(1):160. doi: 10.1186/s12969-021-00634-x.
https://pubmed.ncbi.nlm.nih.gov/34781959/ -
Wang W, Wang W, Zhong LQ, Li WD, Wu SJ, Song HM.
Thalidomide may be an effective drug for Blau syndrome: a case report
Ann Palliat Med. 2021 Nov 9:apm-21-2216. doi: 10.21037/apm-21-2216. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34775778/ -
Casas-Alba D, Darling A, Caballero E, Mensa-Vilaró A, Bartrons J, Antón J, García-Cazorla À, Vanderver A, Armangué T.
Efficacy of baricitinib on chronic pericardial effusion in a patient with Aicardi-Goutières syndrome.
Rheumatology (Oxford). 2021 Nov 30:keab860. doi: 10.1093/rheumatology/keab860. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34850826/ -
Iyengar VV, Chougule A, Gowri V, Taur P, Prabhu S, Bodhanwala M, Desai MM.
DADA2 presenting as nonimmune hemolytic anemia with recurrent macrophage activation syndrome.
Pediatr Blood Cancer. 2021 Nov 22:e29461. doi: 10.1002/pbc.29461. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34811889/ -
Omoyinmi E, Rowczenio D, Sebire N, Brogan PA, Eleftheriou D.
Vasculitis in a patient with mevalonate kinase deficiency (MKD): a case report.
Pediatr Rheumatol Online J. 2021 Nov 22;19(1):161. doi: 10.1186/s12969-021-00645-8.
https://pubmed.ncbi.nlm.nih.gov/34809655/ -
Jiang W, Deng M, Gan C, Wang L, Mao H, Li Q.
A novel missense mutation in TNFAIP3 causes haploinsufficiency of A20.
Cell Immunol. 2021 Nov 10;371:104453. doi: 10.1016/j.cellimm.2021.104453. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34808442/ -
Zeng J, Hao J, Zhou W, Zhou Z, Miao H.
A Novel Mutation c.841C>T in COPA Syndrome of an 11-Year-Old Boy: A Case Report and Short Literature Review.
Front Pediatr. 2021 Nov 24;9:773112. doi: 10.3389/fped.2021.773112.
https://pubmed.ncbi.nlm.nih.gov/34900872/
OCTUBRE 2021
-
Rood JE, Behrens EM.
Inherited Autoinflammatory Syndromes.
Annu Rev Pathol. 2021 Oct 26. doi: 10.1146/annurev-pathmechdis-030121-041528. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34699263/ -
Marcuzzi A, Melloni E, Zauli G, Romani A, Secchiero P, Maximova N, Rimondi E.
Autoinflammatory Diseases and Cytokine Storms-Imbalances of Innate and Adaptative Immunity.
Int J Mol Sci. 2021 Oct 18;22(20):11241. doi: 10.3390/ijms222011241.
https://pubmed.ncbi.nlm.nih.gov/34681901/
SEPTIEMBRE 2021
-
Fayand A, Chasset F, Boutboul D, Queyrel V, Tieulié N, Guichard I, Dupin N, Franck N, Cohen P, Bessis D, Guenno GL, Koné-Paut I, Belot A, Bonhomme A, Ducharme-Bénard S, Grateau G, Sarrabay G, Touitou I, Boursier G, Georgin-Lavialle S.
DADA2 diagnosed in adulthood versus childhood: A comparative study on 306 patients including a systematic literature review and 12 French cases.
Semin Arthritis Rheum. 2021 Sep 16;51(6):1170-1179. doi: 10.1016/j.semarthrit.2021.09.001. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34571400/ -
Welzel T, Wildermuth AL, Deschner N, Benseler SM, Kuemmerle-Deschner JB.
Colchicine - an effective treatment for children with a clinical diagnosis of autoinflammatory diseases without pathogenic gene variants.
Pediatr Rheumatol Online J. 2021 Sep 14;19(1):142. doi: 10.1186/s12969-021-00588-0.
https://pubmed.ncbi.nlm.nih.gov/34521435/ -
Hadjadj J, Frémond ML, Neven B.
Emerging Place of JAK Inhibitors in the Treatment of Inborn Errors of Immunity.
Front Immunol. 2021 Sep 17;12:717388. doi: 10.3389/fimmu.2021.717388. eCollection 2021.
https://pubmed.ncbi.nlm.nih.gov/34603291/ -
Maccora I, Marrani E, Mastrolia MV, Abu-Rumeileh S, Maniscalco V, Fusco E, Barbati F, Pagnini I, Simonini G.
Ocular involvement in monogenic autoinflammatory disease: A systematic literature review.
Autoimmun Rev. 2021 Sep 9:102944. doi: 10.1016/j.autrev.2021.102944. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34509650/ -
Tucker LB, Niemietz I, Mangat P, Belen M, Tekano J, Cabral DA, Guzman J, Houghton KM, Morishita KA, Chan MO, Human A, Sundqvist M, Brown KL.
Children with systemic autoinflammatory diseases have multiple, mixed ethnicities that reflect regional ethnic diversity.
Clin Exp Rheumatol. 2021 Sep-Oct;39 Suppl 132(5):124-128. Epub 2021 Sep 29.
https://pubmed.ncbi.nlm.nih.gov/34596025/ -
Lachmann HJ, Lauwerys B, Miettunen P, Kallinich T, Jansson A, Rosner I, Manna R, Murias S, Savic S, Smeets S, De Benedetti F, Simon A.
Canakinumab improves patient-reported outcomes in children and adults with autoinflammatory recurrent fever syndromes: results from the CLUSTER trial.
Clin Exp Rheumatol. 2021 Sep-Oct;39 Suppl 132(5):51-58. Epub 2021 Oct 6.
https://pubmed.ncbi.nlm.nih.gov/34622762/ -
Bader-Meunier B, Martins AL, Charbit-Henrion F, Meinzer U, Belot A, Cuisset L, et al.
Mevalonate Kinase Deficiency: A Cause of Severe Very-Early-Onset Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2021 Sep 15:izab139. doi: 10.1093/ibd/izab139. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34525209/ -
Jeyaratnam J, Simon A, Calvo I, Constantin T, Shcherbina A, Hofer M, Gattorno M, Martini A, Bader-Meunier B, Vastert B, Levy J, Dekker E, de Benedetti F, Frenkel.
Long-term efficacy and safety of canakinumab in patients with mevalonate kinase deficiency: results from the randomised Phase 3 CLUSTER trial.
J.Rheumatology (Oxford). 2021 Sep 23:keab696. doi: 10.1093/rheumatology/keab696. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34554243/ -
Gaggiano C, Rigante D, Hernández-Rodríguez J, Vitale A, Tarsia M, Soriano A, et al.
Anakinra and canakinumab for patients with R92Q-associated autoinflammatory syndrome: a multicenter observational study from the AIDA Network.
Ther Adv Musculoskelet Dis. 2021 Sep 9;13:1759720X211037178. doi: 10.1177/1759720X211037178. eCollection 2021.
https://pubmed.ncbi.nlm.nih.gov/34527082/ -
Otar Yener G, Paç Kısaarslan A, Ulu K, Atalay E, Haşlak F, Özdel S, et al.
Differences and similarities of multisystem inflammatory syndrome in children, Kawasaki disease and macrophage activating syndrome due to systemic juvenile idiopathic arthritis: a comparative study.
Rheumatol Int. 2021 Sep 7:1-11. doi: 10.1007/s00296-021-04980-7. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34491393/ -
Yücel BB, Aydog O, Nalcacioglu H, Yılmaz A
Effectiveness of Canakinumab Treatment in Colchicine Resistant Familial Mediterranean Fever Cases
Front Pediatr. 2021 Sep 10;9:710501. doi: 10.3389/fped.2021.710501. eCollection 2021.
https://pubmed.ncbi.nlm.nih.gov/34568239/ -
Karabulut Y, Gezer HH, Duruöz MT
Canakinumab is effective in patients with familial Mediterranean fever resistant and intolerant to the colchicine and/or anakinra treatment.
Rheumatol Int. 2021 Sep 22. doi: 10.1007/s00296-021-04997-y. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34550430/ -
Kopeć M, Brąszewska M, Jarosz M, Dylewska K, Kurylak A.
Role of Diagnostic Imaging in Chronic Recurrent Multifocal Osteomyelitis (CRMO) in Children: An Observational Study.
Children (Basel). 2021 Sep 10;8(9):792. doi: 10.3390/children8090792.
https://pubmed.ncbi.nlm.nih.gov/34572224/ -
Cafaro A, Pigliasco F, Barco S, Penco F, Schena F, Caorsi R, Volpi S, Tripodi G, Gattorno M, Cangemi G
A Novel LC-MS/MS-Based Method for the Diagnosis of ADA2 Deficiency from Dried Plasma Spot.
Molecules. 2021 Sep 21;26(18):5707. doi: 10.3390/molecules26185707.
https://pubmed.ncbi.nlm.nih.gov/34577178/
AGOSTO 2021
-
Szekanecz Z, McInnes IB, Schett G, Szamosi S, Benkő S, Szűcs G
Autoinflammation and autoimmunity across rheumatic and musculoskeletal diseases.
Nat Rev Rheumatol. 2021 Aug 2. doi: 10.1038/s41584-021-00652-9. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34341562/ -
Schaal MC, Gendler L, Ammann B, Eberhardt N, Janda A, Morbach H, Darge K, Girschick H, Beer M.
Imaging in non-bacterial osteomyelitis in children and adolescents: diagnosis, differential diagnosis and follow-up-an educational review based on a literature survey and own clinical experiences.
Insights Imaging. 2021 Aug 9;12(1):113. doi: 10.1186/s13244-021-01059-6.
https://pubmed.ncbi.nlm.nih.gov/34370119/ -
Peet CJ, Papadopoulou C, Sombrito BRM, Wood MR, Lachmann HJ.
COVID-19 and autoinflammatory diseases: prevalence and outcomes of infection and early experience of vaccination in patients on biologics.
Rheumatol Adv Pract. 2021 Aug 23;5(2):rkab043. doi: 10.1093/rap/rkab043
https://pubmed.ncbi.nlm.nih.gov/34466775/ -
Aarts P, Dudink K, Vossen ARJV, van Straalen KR, Ardon CB, Prens EP, van der Zee HH.
Clinical Implementation of Biologics and Small Molecules in the Treatment of Hidradenitis Suppurativa.
Drugs. 2021 Aug;81(12):1397-1410. doi: 10.1007/s40265-021-01566-2.
https://pubmed.ncbi.nlm.nih.gov/34283386/ -
Sharma A, Naidu G, Deo P, Beck DB.
VEXAS syndrome with systemic lupus erythematosus- expanding the spectrum of associated conditions.
Arthritis Rheumatol. 2021 Aug 30. doi: 10.1002/art.41957. Online ahead of print
https://pubmed.ncbi.nlm.nih.gov/34463053/ -
Obiorah IE, Patel BA, Groarke EM, Wang W, Trick M, Ombrello AK, et al.
Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1.
Blood Adv. 2021 Aug 24;5(16):3203-3215. doi: 10.1182/bloodadvances.2021004976.
https://pubmed.ncbi.nlm.nih.gov/34427584/ -
Papa R, Rusmini M, Schena F, Traggiai E, Coccia MC, Caorsi R, Arrigo S, Pasetti F, Signa S, Barone P, Santamaria G, Spirito G, Sanges R, Vozzi D, Cavalli A, Gustincich S, Ravelli A, Gattorno M, Ceccherini I, Volpi S.
Type I interferon activation in RAS-associated autoimmune leukoproliferative disease (RALD).
Clin Immunol. 2021 Aug 26:108837. doi: 10.1016/j.clim.2021.108837. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34455097/ -
Vahedi M, Parvaneh N, Vahedi S, Shahrooei M, Ziaee V.
Identification of a New Variant in NLRP3 Gene by Whole Exome Sequencing in a Patient with Cryopyrin-Associated Periodic Syndrome.
Case Reports Immunol. 2021 Aug 16;2021:2023119. doi: 10.1155/2021/2023119
https://pubmed.ncbi.nlm.nih.gov/34447596/ -
Vai S, Marin E, Cosso R, Saettini F, Bonanomi S, Cattoni A, Chiodini I, Persani L, Falchetti A.
A Novel Germline Mutation of ADA2 Gene in Two "Discordant" Homozygous Female Twins Affected by Adenosine Deaminase 2 Deficiency: Description of the Bone-Related Phenotype
Int J Mol Sci. 2021 Aug 3;22(15):8331. doi: 10.3390/ijms22158331.
https://pubmed.ncbi.nlm.nih.gov/34361096 -
Verhoeven D, Schonenberg-Meinema D, Ebstein F, Papendorf JJ, Baars PA, van Leeuwen EMM, et al.
Hematopoietic stem cell transplantation in a patient with proteasome-associated auto-inflammatory syndrome (PRAAS).
J Allergy Clin Immunol. 2021 Aug 17:S0091-6749(21)01244-6. doi: 10.1016/j.jaci.2021.07.039. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34416217/
JULIO 2021
-
Ozen S, Lutz HL, Rivera VM, Reiff A, Batu ED, Anderson E, Salas Garcia M, Aldrovandi G, Akbaba TH, Pazarbasi İ, Bilginer Y, Balat A, Balci-Peynircioglu B, Gilbert JA, Dedeoglu F, Hausmann JS.
Microbiome is not linked to clinical disease severity of familial Mediterranean fever in an international cohort of children.
Clin Exp Rheumatol. 2021 Jul 5. Epub ahead of print. PMID: 34251310.
https://pubmed.ncbi.nlm.nih.gov/34251310/
JUNIO 2021
-
Ozen S, Lutz HL, Rivera VM, Reiff A, Batu ED, Anderson E, Salas Garcia M, Aldrovandi G, Akbaba TH, Pazarbasi İ, Bilginer Y, Balat A, Balci-Peynircioglu B, Gilbert JA, Dedeoglu F, Hausmann JS.
Microbiome is not linked to clinical disease severity of familial Mediterranean fever in an international cohort of children.
Clin Exp Rheumatol. 2021 Jul 5. Epub ahead of print. PMID: 34251310.
https://pubmed.ncbi.nlm.nih.gov/34251310/ - Atas N, Eroglu GA, Sodan HN, Ozturk BO, Babaoglu H, Satis H, et al.
Long-term safety and efficacy of anakinra and canakinumab in patients with familial Mediterranean fever: a single-centre real-life study with 101 patients
Clin Exp Rheumatol. 2021 Jun 21. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34251317/ - Liu J, Yu X, Li C, Wang Y, Yu W, Shen M, Zheng W.
Behcet's Syndrome in a Chinese Pedigree of NLRP3-Associated Autoinflammatory Disease: A Coexistence or Novel Presentation?
Front Med (Lausanne). 2021 Jun 24;8:695197. doi: 10.3389/fmed.2021.695197.
https://pubmed.ncbi.nlm.nih.gov/34249981/ - Athanassios Kolivras, Isabelle Meiers, Ursula Sass, Curtis T Thompson.
Histologic Patterns and Clues to Autoinflammatory Diseases in Children: What a Cutaneous Biopsy Can Tell Us.
Dermatopathology (Basel). 2021 Jun 8;8(2):202-220. doi: 10.3390/dermatopathology8020026.
https://pubmed.ncbi.nlm.nih.gov/34201078/ - Wang L, Wen W, Deng M, Li Y, Sun G, Zhao X, Tang X, Mao H.
A Novel Mutation in the NBD Domain of NLRC4 Causes Mild Autoinflammation With Recurrent Urticaria.
Front Immunol. 2021 Jun 23;12:674808. doi: 10.3389/fimmu.2021.674808.
https://pubmed.ncbi.nlm.nih.gov/34248956/
MAYO 2021
-
Walker UA, Tilson HH, Hawkins PN, Poll TV, Noviello S, Levy J, Vritzali E, Hoffman HM, Kuemmerle-Deschner JB; CACZ885D2401 Study Investigators.
Long-term safety and effectiveness of canakinumab therapy in patients with cryopyrin-associated periodic syndrome: results from the β-Confident Registry.
RMD Open. 2021 May;7(2):e001663. doi:10.1136/rmdopen-2021-001663
https://pubmed.ncbi.nlm.nih.gov/34001647/ -
Sota J, Rigante D, Cimaz R, Cattalini M, Frassi M, Manna R, Sicignano LL, Verrecchia E, Aragona E, Maggio MC, Lopalco G, Emmi G, Parronchi P, Cauli A, Wiesik-Szewczyk E, Hernández-Rodríguez J, Gaggiano C, Tarsia M, Mourabi M, Ragab G, Vitale A, Fabiani C, Frediani B, Lamacchia V, Renieri A, Luca C; Autoinflammatory Diseases Alliance (AIDA) and the Autoinflammatory Diseases Working Group of the Italian Society of Rheumatology (SIR).
Drug survival of anakinra and canakinumab in monogenic autoinflammatory diseases: observational study from the International AIDA Registry.
Rheumatology (Oxford). 2021 May 7:keab419. doi:10.1093/rheumatology/keab419
https://pubmed.ncbi.nlm.nih.gov/33961014/ -
Zhang D, Su G, Zhou Z, Lai J.
Clinical characteristics and genetic analysis of A20 haploinsufficiency.
Pediatr Rheumatol Online J. 2021 May 24;19(1):75. doi10.1186/s12969-021-00558-6
https://pubmed.ncbi.nlm.nih.gov/34030699/ -
Butbul Aviel Y, Rawan S, Fahouma S, Wexler I, Berkund Y.
Discontinuation of colchicine therapy in children with Familial Mediterranean Fever.
J Rheumatol. 2021 May 15:jrheum.201158. doi:10.3899/jrheum.201158
https://pubmed.ncbi.nlm.nih.gov/33993110/ -
Girardelli M, Valencic E, Moressa V, Margagliotta R, Tesser A, Pastore S, Spadola O, Athanasakis E, Severini GM, Taddio A, Tommasini A.
Genetic and immunologic findings in children with recurrent aphthous stomatitis with systemic inflammation.
Pediatr Rheumatol Online J. 2021 May 10;19(1):70. doi:10.1186/s12969-021-00552-y
https://pubmed.ncbi.nlm.nih.gov/33971891/
ABRIL 2021
-
Manna R, Rigante D.
The everchanging framework of autoinflammation.
Intern Emerg Med. 2021 May 17. doi: 10.1007/s11739-021-02751-7.
https://pubmed.ncbi.nlm.nih.gov/33999387/ -
Gómez-Arias PJ, Gómez-García F, Hernández-Parada J, Montilla-López AM, Ruano J, Parra-Peralbo E
Efficacy and Safety of Janus Kinase Inhibitors in Type I Interferon-Mediated monogenic Autoinflammatory Disorders: A Scoping Review.
Dermatol Ther (Heidelb). 2021 Apr 15. doi: 10.1007/s13555-021-00517-9.
https://pubmed.ncbi.nlm.nih.gov/33856640/
MARZO 2021
-
Kataoka S, Kawashima N, Okuno Y, Muramatsu H, Miwata S, Narita K, et al.
Successful treatment of a novel type I interferonopathy due to a de novo PSMB9 gene mutation with a Janus kinase inhibitor.
J Allergy Clin Immunol. 2021 Mar 13:S0091-6749(21)00378-X. doi: 10.1016/j.jaci.2021.03.010. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/33727065/ -
Yasudo H, Ando T, Maehara A, Ando T, Izawa K, Tanabe A, et al.
A possible association between a novel NLRP1 mutation and an autoinflammatory disease involving liver cirrhosis.
Hepatology. 2021 Mar 19. doi: 10.1002/hep.31818. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/33738798/ -
Del Borrello G, Guardo D, Micalizzi C, Ceccherini I, Miano M, Gattorno M, Dufour C.
Hemolysis and Neurologic Impairment in PAMI Syndrome: Novel Characteristics of an Elusive Disease.
Pediatrics. 2021 Mar;147(3):e20200784. doi: 10.1542/peds.2020-0784.
https://pubmed.ncbi.nlm.nih.gov/33597285/ -
O'Leary D, Wilson AG, MacDermott EJ, Lowry C, Killeen OG.
Variability in phenotype and response to treatment in chronic nonbacterial osteomyelitis; the Irish experience of a national cohort.
Pediatr Rheumatol Online J. 2021 Mar 25;19(1):45. doi: 10.1186/s12969-021-00530-4.
https://pubmed.ncbi.nlm.nih.gov/33766071/ -
Zou J, Luo JF, Shen Y, Guan JL.
Distinct clinical characteristics of pediatric Behcet's syndrome: A study from a referral center in China.
Mod Rheumatol. 2021 Mar 16:1-6. doi: 10.1080/14397595.2021.1891670. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/33627024/ -
Delaleu J, Deshayes S, Rodrigues F, Savey L, Rivière E, Martin Silva N, A
Tumor necrosis factor receptor-1 associated periodic syndrome (TRAPS) related AA amyloidosis: a national case series and systematic review.
Rheumatology (Oxford). 2021 Mar 14:keab252. doi: 10.1093/rheumatology/keab252. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/33715002/ -
Pinto B, Deo P, Sharma S, Syal A, Sharma A.
Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment.
Clin Rheumatol. 2021 Mar 31. doi: 10.1007/s10067-021-05711-w. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/33791889/ -
Al-Mayouf SM, Yateem M, Al-Dusery H, Monies D, Wakil S, AlShiakh M, AlEnazi A, Aladaileh B, Alzyoud R, Meyer B.
New or vanishing frontiers: LACC1-associated juvenile arthritis.
Int J Pediatr Adolesc Med. 2021 Mar;8(1):44-47. doi: 10.1016/j.ijpam.2020.11.005.
https://pubmed.ncbi.nlm.nih.gov/33718577/ -
Omarjee O, Mathieu AL, Quiniou G, Moreews M, Ainouze M, Frachette C, et al
LACC1 deficiency links juvenile arthritis with autophagy and metabolism in macrophages.
J Exp Med. 2021 Mar 1;218(3):e20201006. doi: 10.1084/jem.20201006.
https://pubmed.ncbi.nlm.nih.gov/33606008/ -
Michev A, Borghesi A, Tretti C, Martella M, Di Comite A, Biffi A, Marzollo A, Bresolin S.
Neonatal-Onset Familial Mediterranean Fever in an Infant with Human Parainfluenza Virus-4 Infection.
Neonatology. 2021 Mar 31:1-5. doi: 10.1159/000514694. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/33789313/ -
Sari A, Bodakçi E, Armagan B, Satis H, Atas N, Yasar Bİlge NŞ, et al.
Phenotypic characterisation of Familial Mediterranean Fever patients harboring variants of uncertain significance.
Turk J Med Sci. 2021 Mar 17. doi: 10.3906/sag-2011-273. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/33726481/ -
Korkmaz C, Üsküdar Cansu D, Kabay SC.
Familial coexistence of demyelinating diseases and familial Mediterranean fever.
Rheumatol Int. 2021 Mar 13. doi: 10.1007/s00296-021-04821-7. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/33715072/ -
Van Nieuwenhove E, De Langhe E, Dooley J, Van Den Oord J, Shahrooei M, Parvaneh N, et al.
Phenotypic analysis of Pyrin-Associated Autoinflammation with Neutrophilic Dermatosis patients during treatment.
Rheumatology (Oxford). 2021 Mar 8:keab221. doi: 10.1093/rheumatology/keab221. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/33693560/ -
Orlando F, Naddei R, Stellacci E, Gallinoro CM, Melis D, Tartaglia M, Alessio M.
Etanercept as a successful therapy in autoinflammatory syndrome related to TRNT1 mutations: a case-based review.
Clin Rheumatol. 2021 Mar 1. doi: 10.1007/s10067-021-05653-3. Online ahead of print.
ttps://pubmed.ncbi.nlm.nih.gov/33646446/ -
Huang H, Zhang W, Cai W, Liu J, Wang H, Qin T, et al.
VEXAS syndrome in myelodysplastic syndrome with autoimmune disorder.
Exp Hematol Oncol. 2021 Mar 19;10(1):23. doi: 10.1186/s40164-021-00217-2.
https://pubmed.ncbi.nlm.nih.gov/33741056/
FEBRERO 2021
-
Kadowaki S, Hashimoto K, Nishimura T, Kashimada K, Kadowaki T, Kawamoto N, Imai K, Okada S, Kanegane H, Ohnishi H.
Functional analysis of novel A20 variants in patients with atypical inflammatory diseases.
Arthritis Res Ther. 2021 Feb 6;23(1):52. doi: 10.1186/s13075-021-02434-w.
https://pubmed.ncbi.nlm.nih.gov/33549127/ -
Tirosh I, Yacobi Y, Vivante A, Barel O, Ben-Moshe Y, Erez Granat O, Spielman S, Semo Oz R, Shinar Y, Gerstein M.
Clinical significance of E148Q heterozygous variant in paediatric Familial Mediterranean Fever.
Rheumatology (Oxford). 2021 Feb 9:keab128. doi: 10.1093/rheumatology/keab128.
https://pubmed.ncbi.nlm.nih.gov/33560333/ -
Pain CE, Beresford MW, Fortune F, Lai ETC, Murphy R, Taylor-Robinson D, Brogan PA, Moots RJ.
Behcet's syndrome in children and young people in the United Kingdom & Republic of Ireland: a prospective epidemiological study.
Rheumatology (Oxford). 2021 Feb 2:keab084. doi: 10.1093/rheumatology/keab084.
https://pubmed.ncbi.nlm.nih.gov/33527995/ -
Yildiz M, Haslak F, Adrovic A, Sahin S, Koker O, Barut K, Kasapcopur O.
Pediatric Behcet's Disease.
Front Med (Lausanne). 2021 Feb 3;8:627192. doi: 10.3389/fmed.2021.627192. eCollection 2021.
https://pubmed.ncbi.nlm.nih.gov/33614684/ -
Zou J, Luo JF, Shen Y, Guan JL
Distinct clinical characteristics of pediatric Behcet's syndrome: A study from a referral center in China.
Mod Rheumatol. 2021 Feb 24:1-16. doi: 10.1080/14397595.2021.1891670.
https://pubmed.ncbi.nlm.nih.gov/33627024/ -
Malcova H, Strizova Z, Milota T, Striz I, Sediva A, Cebecauerova D, Horvath R.Front
IL-1 Inhibitors in the Treatment of Monogenic Periodic Fever Syndromes: From the Past to the Future Perspectives.
Immunol. 2021 Feb 1;11:619257. doi: 10.3389/fimmu.2020.619257.
https://pubmed.ncbi.nlm.nih.gov/33603750/ -
Okazaki F, Wakiguchi H, Korenaga Y, Nakamura T, Yasudo H, Uchi S, Yanai R, Asano N, Hoshii Y, Tanabe T, Izawa K, Honda Y, Nishikomori R, Uchida K, Eishi Y, Ohga S, Hasegawa S.
A novel mutation in early-onset sarcoidosis/Blau syndrome: an association with Propionibacterium acnes.
Pediatr Rheumatol Online J. 2021 Feb 18;19(1):18. doi: 10.1186/s12969-021-00505-5.
https://pubmed.ncbi.nlm.nih.gov/33602264/ -
Kaufman KP, Becker ML.
Distinguishing Blau Syndrome from Systemic Sarcoidosis.
Curr Allergy Asthma Rep. 2021 Feb 9;21(2):10. doi: 10.1007/s11882-021-00991-3.
https://pubmed.ncbi.nlm.nih.gov/33560445/ -
Luu I, Nation J, Page N, Carvalho D, Magit A, Jiang W, Leuin S, Bliss M, Bothwell M, Brigger M, Kearns D, Pransky S, Broderick L.
Undifferentiated recurrent fevers in pediatrics are clinically distinct from PFAPA syndrome but retain an IL-1 signature.
Clin Immunol. 2021 Feb 24;226:108697. doi: 10.1016/j.clim.2021.108697.
https://pubmed.ncbi.nlm.nih.gov/33636366/ -
Lantto U, Koivunen P, Tapiainen T, Renko M.
Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis Syndrome: Relapse and Tonsillar Regrowth After Childhood Tonsillectomy.
Laryngoscope. 2021 Feb 25. doi: 10.1002/lary.29474.
https://pubmed.ncbi.nlm.nih.gov/33630321/ -
Sicignano LL, Rigante D, Moccaldi B, Massaro MG, Delli Noci S, Patisso I, Capozio G, Verrecchia E, Manna R
Children and Adults with PFAPA Syndrome: Similarities and Divergences in a Real-Life Clinical Setting.
Adv Ther. 2021 Feb;38(2):1078-1093. doi: 10.1007/s12325-020-01576-8. Epub 2020 Dec 14.
https://pubmed.ncbi.nlm.nih.gov/33315168/ -
Geraldo AF, Caorsi R, Tortora D, Gandolfo C, Ammendola R, Alessio M, Conti G, Insalaco A, Pastore S, Martino S, Ceccherini I, Signa S, Gattorno M, Rossi A, Severino M.
Widening the Neuroimaging features of Adenosine Deaminase 2 Deficiency
AJNR Am J Neuroradiol. 2021 Feb 25. doi: 10.3174/ajnr.A7019.
https://pubmed.ncbi.nlm.nih.gov/33632736/ -
Mahajan R, Bishnoi A, Manjunath S, Vignesh P, Suri D, Gopal M, Chatterjee D, Jamwal M, De D, Das R, Handa S, Kubba A, Batrani M, Radotra BD.
Severe epidermolysis bullosa/Kindler syndrome-like phenotype of an autoinflammatory syndrome in a child.
Clin Exp Dermatol. 2021 Feb 24. doi: 10.1111/ced.14557.
https://pubmed.ncbi.nlm.nih.gov/33625737/ -
Schwartz DM, Kitakule MM, Dizon BL, Gutierrez-Huerta C, Blackstone SA, Burma AM, Son A, Deuitch N, Rosenzweig S, Komarow H, Stone DL, Jones A, Nehrebecky M, Hoffmann P, Romeo T, de Jesus AA, Alehashemi S, Garg M, Torreggiani S, Montealegre Sanchez GA, Honer K, Souto Adeva G, Barron KS, Aksentijevich I, Ombrello AK, Goldbach-Mansky R, Kastner DL, Milner JD, Frischmeyer-Guerrerio P.
Systematic evaluation of nine monogenic autoinflammatory diseases reveals common and disease-specific correlations with allergy-associated features.
Ann Rheum Dis. 2021 Feb 22:annrheumdis-2020-219137. doi: 10.1136/annrheumdis-2020-219137.
https://pubmed.ncbi.nlm.nih.gov/33619160/
- Ayaz NA, Tanatar A, Karadağ ŞG, Çakan M, Keskindemirci G, Sönmez HE.
Comorbidities and phenotype-genotype correlation in children with familial Mediterranean fever.
Rheumatol Int. 2021 Jan;41(1):113-120. doi: 10.1007/s00296-020-04592-7. Epub 2020 Apr 28. PMID: 32347339.
https://pubmed.ncbi.nlm.nih.gov/32347339/ - Karpuzoglu EM, Kisla Ekinci RM, Balci S, Bisgin A, Yilmaz M.
Altered expression of apoptosis-related, circulating cell-free miRNAs in children with familial Mediterranean fever: a cross-sectional study.
Rheumatol Int. 2021 Jan;41(1):103-111. doi: 10.1007/s00296-020-04541-4. Epub 2020 Mar 5. PMID: 32140884.
https://pubmed.ncbi.nlm.nih.gov/32140884/ - Aviel YB, Ofir A, Ben-Izhak O, Vlodavsky E, Karbian N, Brik R, Mevorach D, Magen D.
A novel loss-of-function mutation in LACC1 underlies hereditary juvenile arthritis with extended intra-familial phenotypic heterogeneity.
Rheumatology (Oxford). 2021 Jan 25:keab017. doi: 10.1093/rheumatology/keab017. Epub ahead of print. PMID: 33493343.
https://pubmed.ncbi.nlm.nih.gov/33493343/
DICIEMBRE 2020
- Bardou MLD, Rivitti-Machado MC, Michalany NS, de Jesus AA, Goldbach-Mansky R, Barros JCR, Terreri MTSELRA, Grumach AS.
Neutrophilic dermatosis: a new skin manifestation and novel pathogenic variant in a rare autoinflammatory disease.
Australas J Dermatol. 2020 Dec 17. doi: 10.1111/ajd.13527
https://pubmed.ncbi.nlm.nih.gov/33332575/ -
Özen S, Sag E, Ben-Chetrit E, Gattorno M, Gül A, Hashkes PJ, Kone-Paut I, Lachmann HJ, Tsitsami E, Twilt M, de Benedetti F, Kuemmerle-Deschner JB.
Defining colchicine resistance/intolerance in patients with familial Mediterranean fever: a modified-Delphi consensus approach.
Rheumatology (Oxford). 2020 Dec 17:keaa863
https://pubmed.ncbi.nlm.nih.gov/33331943/ -
Boleto G, El Chamieh C, Biard L, Koné-Paut I, Hentgen V, Boursier G, Sarrabay G, Cacoub P, Touitou I, Saadoun D.
Correspondance on 'Clinical characteristics and genetic analyses of 187 patients with undefined autoinflammatory diseases'.
Ann Rheum Dis. 2020 Dec 9:annrheumdis-2020-219566
https://pubmed.ncbi.nlm.nih.gov/33298408/ -
Ugurlu S, Ergezen B, Egeli BH, Selvi O, Ozdogan H.
Anakinra treatment in patients with familial Mediterranean fever: a single-centre experience.
Rheumatology (Oxford). 2020 Dec 9:keaa596
https://pubmed.ncbi.nlm.nih.gov/33295622/ -
Oldham J, Lachmann HJ.
The systemic autoinflammatory disorders for dermatologists. Part 1: overview.
Clin Exp Dermatol. 2020 Dec;45(8):962-966
https://pubmed.ncbi.nlm.nih.gov/32901977/ -
Oldham J, Lachmann HJ.
The systemic autoinflammatory disorders for dermatologists. Part 2: disease examples.
Clin Exp Dermatol. 2020 Dec;45(8):967-973
https://pubmed.ncbi.nlm.nih.gov/32882069/ -
Ziegeler K, Eshed I, Diekhoff T, Hermann KG.
Imaging of Joints and Bones in Autoinflammation.
J Clin Med. 2020 Dec 17;9(12):4074
https://pubmed.ncbi.nlm.nih.gov/33348664/ -
Mulazzani E, Zolyniak N, Noe E, Mulazzani M, Azad SC, Kümpfel T, Kraft E.
Clinical and psychological phenomenology of pain in autoinflammatory diseases.
BMC Rheumatol. 2020 Dec 18;4(1):71
https://pubmed.ncbi.nlm.nih.gov/33334368/ -
Bhatt H, Cascella M.
Familial Mediterranean Fever.
2020 Dec 1. In: StatPearls [Internet]https://pubmed.ncbi.nlm.nih.gov/32809589/ -
Ben-David Y, Gur M, Ilivitzki A, Khoury A, Bentur L, Butbul Aviel Y.
Atypical cardiopulmonary manifestations in pediatric Behçet's disease.
Pediatr Pulmonol. 2020 Dec;55(12):3407-3413
https://pubmed.ncbi.nlm.nih.gov/32915509/ -
Amarilyo G, Harel L, Abu Ahmad S, Abu Rumi M, Brik R, Hezkelo N, Bar-Yoseph R, Mei-Zahav M, Ohana O, Levinsky Y, Chodick G, Butbul-Aviel Y.
Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenitis Syndrome - Is It Related to Ethnicity? An Israeli Multicenter Cohort Study.
J Pediatr. 2020 Dec;227:268-273
https://pubmed.ncbi.nlm.nih.gov/32805260/
NOVIEMBRE 2020
-
Sözeri B, Demir F, Sönmez HE, Karadağ ŞG, Demirkol YK, Doğan ÖA, Doğanay HL, Ayaz NA.
Comparison of the clinical diagnostic criteria and the results of the next-generation sequence gene panel in patients with monogenic systemic autoinflammatory diseases.
Clin Rheumatol. 2020 Nov 9. doi: 10.1007/s10067-020-05492-8.
https://pubmed.ncbi.nlm.nih.gov/33165748/ - Papa R, Lane T, Minden K, Touitou I, Cantarini L, Cattalini M, Obici L, Jansson AF, Belot A, Frenkel J, Anton J, Wolska-Kusnierz B, Berendes R, Remesal A, Jelusic M, Hoppenreijs E, Espada G, Nikishina I, Maggio MC, Bovis F, Masini M, Youngstein T, Rezk T, Papadopoulou C, Brogan PA, Hawkins PN, Woo P, Ruperto N, Gattorno M, Lachmann HJ; Pediatric Rheumatology International Trials Organization (PRINTO), the EUROTRAPS and the Eurofever Project.
INSAID variant classification and Eurofever criteria guide optimal treatment strategy in patients with TRAPS: data from the Eurofever registry.
J Allergy Clin Immunol Pract. 2020 Nov 9:S2213-2198(20)31208-3. doi: 10.1016/j.jaip.2020.10.053
https://pubmed.ncbi.nlm.nih.gov/33181346/ - Fayand A, Savey L, Ducharme-Bénard S, Grateau G, Georgin-Lavialle S.
Prescription of interleukin-1 inhibitors in a French adult cohort of familial Mediterranean fever.
Eur J Intern Med. 2020 Nov 19:S0953-6205(20)30411-8. doi: 10.1016/j.ejim.2020.11.001
https://pubmed.ncbi.nlm.nih.gov/33223329/ - Pham F, Schissler C, Schaeffer M, Lachmann HJ, Lipsker D.
Diagnostic value of skin biopsy in autoinflammatory diseases for patients with recurrent fever and urticarial eruption.
Clin Exp Dermatol. 2020 Nov 13. doi: 10.1111/ced.14508
https://pubmed.ncbi.nlm.nih.gov/33185903/ - Boursier G, Piram M, Rittore C, Sarrabay G, Touitou I.
Phenotypic Associations of PSTPIP1 Sequence Variants in PSTPIP1-Associated Autoinflammatory Diseases.
J Invest Dermatol. 2020 Nov 17:S0022-202X(20)32168-0. doi:10.1016/j.jid.2020.08.028
https://pubmed.ncbi.nlm.nih.gov/33218716/ - Bourguiba R, Delplanque M, Vinit C, Ackermann F, Savey L, Grateau G, Hentgen V, Georgin-Lavialle S.
Clinical course of COVID-19 in a cohort of 342 familial Mediterranean fever patients with a long-term treatment by colchicine in a French endemic area.
Ann Rheum Dis. 2020 Nov 2:annrheumdis-2020-218707. doi: 10.1136/annrheumdis-2020-218707
https://pubmed.ncbi.nlm.nih.gov/33139307/ - Nigrovic PA, Lee PY, Hoffman HM.
Monogenic autoinflammatory disorders: Conceptual overview, phenotype, and clinical approach.
J Allergy Clin Immunol. 2020 Nov;146(5):925-937.
https://pubmed.ncbi.nlm.nih.gov/33160483/
OCTUBRE 2020
-
Beck DB, Ferrada MA, Sikora KA, Ombrello AK, Collins JC, Pei W, Balanda N, Ross DL, Ospina Cardona D, Wu Z, Patel B, Manthiram K, Groarke EM, Gutierrez-Rodrigues F, Hoffmann P, Rosenzweig S, Nakabo S, Dillon LW, Hourigan CS, Tsai WL, Gupta S, Carmona-Rivera C, Asmar AJ, Xu L, Oda H, Goodspeed W, Barron KS, Nehrebecky M, Jones A, Laird RS, Deuitch N, Rowczenio D, Rominger E, Wells KV, Lee CR, Wang W, Trick M, Mullikin J, Wigerblad G, Brooks S, Dell'Orso S, Deng Z, Chae JJ, Dulau-Florea A, Malicdan MCV, Novacic D, Colbert RA, Kaplan MJ, Gadina M, Savic S, Lachmann HJ, Abu-Asab M, Solomon BD, Retterer K, Gahl WA, Burgess SM, Aksentijevich I, Young NS, Calvo KR, Werner A, Kastner DL, Grayson PC.
Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease
N Engl J Med. 2020 Oct 27. doi: 10.1056/NEJMoa2026834. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/33108101/ -
Maniscalco V, Abu-Rumeileh S, Mastrolia MV, Marrani E, Maccora I, Pagnini I, Simonini G.
The off-label use of anakinra in pediatric systemic autoinflammatory diseases.
Ther Adv Musculoskelet Dis. 2020 Oct 16;12:1759720X20959575.
https://pubmed.ncbi.nlm.nih.gov/33149772/ -
Yildiz M, Haslak F, Adrovic A, Gucuyener N, Ulkersoy I, Koker O, Sahin S, Unlu G, Barut K, Kasapcopur O.
Independent risk factors for resolution of periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome within 4 years after the disease onset
Clin Rheumatol. 2020 Oct 16. doi: 10.1007/s10067-020-05466-w. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/33067771/ -
d'Angelo P, de Horatio LT, Toma P, Ording Müller LS, Avenarius D, von Brandis E, Zadig P, Casazza I, Pardeo M, Pires-Marafon D, Capponi M, Insalaco A, Fabrizio B, Rosendahl K.
Chronic nonbacterial osteomyelitis - clinical and magnetic resonance imaging features.
Pediatr Radiol. 2020 Oct 9. doi: 10.1007/s00247-020-04827-6. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/33033917/
SEPTIEMBRE 2020
-
Rama M, Mura T, Kone-Paut I, Boursier G, Aouinti S, Touitou I, Sarrabay G.
Is gene panel sequencing more efficient than clinical-based gene sequencing to diagnose autoinflammatory diseases? A randomized study.
Clin Exp Immunol. 2020 Sep 9. doi: 10.1111/cei.13511. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32909274/ -
Paç Kısaarslan A, Şahin N, Özdemir Çiçek S, Gündüz Z, Poyrazoğlu H, Düşünsel R.
Evaluation of familial Mediterranean fever patients concomitant with juvenile spondyloarthropathy.
Mod Rheumatol. 2020 Sep 7:1-7. doi: 10.1080/14397595.2020.1812809. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32815445/ -
Sen N, Yilmaz M, Mercan R, Volkan O, Yilmaz-Oner S, Tukel E, Tezcan ME.
Enthesitis may be one of the signs of severe disease in familial Mediterranean fever.
Clin Rheumatol. 2020 Sep 12. doi: 10.1007/s10067-020-05392-x. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32920724/ -
Ben-David Y, Gur M, Ilivitzki A, Khoury A, Bentur L, Butbul Aviel Y.
Atypical cardiopulmonary manifestations in pediatric Behçet's disease.
Pediatr Pulmonol. 2020 Sep 11. doi: 10.1002/ppul.25068. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32915509/ -
Lopalco G, Rigante D, Lopalco A, Emmi G, Venerito V, Vitale A, Capozio G, Denora N, Cantarini L, Iannone F.
Safety of systemic treatments for Behçet's syndrome.
Expert Opin Drug Saf. 2020 Sep 15:1-33. doi: 10.1080/14740338.2020.1817379. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32883123/ -
Frémond ML, Nathan N.
COPA syndrome, 5 years after: where are we?
Joint Bone Spine. 2020 Sep 9:S1297-319X(20)30155-X. doi: 10.1016/j.jbspin.2020.09.002. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32919065/ -
Nikolakis G, Kaleta KP, Vaiopoulos AG, Wolter K, Baroud S, Wojas-Pelc A, Zouboulis CC.
Phenotypes and Pathophysiology of Syndromic Hidradenitis Suppurativa: Different Faces of the Same Disease? A Systematic Review.
Dermatology. 2020 Sep 17:1-25. doi: 10.1159/000509873. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32942279/ -
Broderick L, Hoffman HM.
Pediatric Recurrent Fever and Autoinflammation from the Perspective of an Allergist/Immunologist.
J Allergy Clin Immunol. 2020 Sep 28:S0091-6749(20)31330-0. doi: 10.1016/j.jaci.2020.09.019. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/33002514/ -
Turan H, Yildiz M, Civan O, Cakir AD, Tarcin G, Ozer Y, Bayramli Z, Kucur M, Adaletli I, Adrovic A, Barut K, Ercan O, Kasapcopur O, Evliyaoglu SO.
Evaluation of the thyroid disorders in children with familial Mediterranean fever
Clin Rheumatol. 2020 Sep 30. doi: 10.1007/s10067-020-05430-8. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32996072/ -
Wu N, Shao Y, Huo J, Zhang Y, Cao Y, Jing H, Zhang F, Yu C, Yu Y, Li C, Song H, Zhang W.
Clinical characteristics of pediatric synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome: the first Chinese case series from a single center.
Clin Rheumatol. 2020 Sep 15. doi: 10.1007/s10067-020-05393-w. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32929648/ -
Maitrepierre F, Marzano AV, Lipsker D.
A Unified Concept of Acne in the PAPA Spectrum Disorders.
Dermatology. 2020 Sep 16:1-8. doi: 10.1159/000509874. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32937626/ -
Klein A, Cremer P, Kontzias A, Furqan M, Forsythe A, Crotty C, Lim-Watson M, Magestro M.
Clinical Burden and Unmet Need in Recurrent Pericarditis: A Systematic Literature Review.
Cardiol Rev. 2020 Sep 18. doi: 10.1097/CRD.0000000000000356. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32956167/
AGOSTO 2020
-
Tsoukas P, Laxer RM.
Follow the complex bread crumbs: A review of autoinflammation for the general paediatrician.
Paediatr Child Health. 2020 Aug;25(5):279-285. doi: 10.1093/pch/pxz072. Epub 2019 Jul 18.
https://pubmed.ncbi.nlm.nih.gov/32765163/ - Gaggiano C, Vitale A, Obici L, Merlini G, Soriano A, Viapiana O, et al.
Clinical Features at Onset and Genetic Characterization of Pediatric and Adult Patients with TNF-α Receptor-Associated Periodic Syndrome (TRAPS): A Series of 80 Cases from the AIDA.
Mediators Inflamm. 2020 Aug 7;2020:8562485. doi: 10.1155/2020/8562485.
https://pubmed.ncbi.nlm.nih.gov/32831641/ - Menashe SJ, Aboughalia H, Zhao Y, Ngo AV, Otjen JP, Thapa MM, Iyer RS.
The Many Faces of Pediatric Chronic Recurrent Multifocal Osteomyelitis (CRMO): A Practical Location- and Case-Based Approach to Differentiate CRMO From Its Mimics.
J Magn Reson Imaging. 2020 Aug 25;e27299. doi: 10.1002/jmri.27299.
https://pubmed.ncbi.nlm.nih.gov/32841445/ - Perazzio SF, Allenspach EJ, Eklund KK, Varjosalo M, Shinohara MM, Torgerson TR, Seppänen MRJ.
Behçet disease (BD) and BD-like clinical phenotypes: NF-kB pathway in mucosal ulcerating diseases
Scand J Immunol. 2020 Sep 5;e12973. doi: 10.1111/sji.12973.
https://pubmed.ncbi.nlm.nih.gov/32889730/ - Lopalco G, Rigante D, Lopalco A, Emmi G, Venerito V, Vitale A, Capozio G, Denora N, Cantarini L, Iannone F.
Safety of systemic treatments for Behçet's syndrome
Expert Opin Drug Saf. 2020 Sep 4. doi: 10.1080/14740338.2020.1817379.
https://pubmed.ncbi.nlm.nih.gov/32883123/ - Umar M, Megarbane A, Shan J, Syed N, Chouery E, Aliyev E, Jithesh P, Temanni R, Mansour I, Chouchane L, Ismail Chouchane A.
Genome sequencing unveils mutational landscape of the familial Mediterranean fever: Potential implications of IL33/ST2 signalling
J Cell Mol Med. 2020 Aug 27.doi: 10.1111/jcmm.15701.
https://pubmed.ncbi.nlm.nih.gov/32853466/ -
El Roz A, Ghssein G, Khalaf B, Fardoun T, Ibrahim JN.
Spectrum of MEFV Variants and Genotypes among Clinically Diagnosed FMF Patients from Southern Lebanon.
Med Sci (Basel). 2020 Aug 17;8(3):E35. doi: 10.3390/medsci8030035.
https://pubmed.ncbi.nlm.nih.gov/32824452/ - Tufan A, Lachmann H.
Familial mediterranean fever, from pathogenesis to treatment: a contemporary review
Turk J Med Sci. 2020 Aug 18. doi: 10.3906/sag-2008-11.
https://pubmed.ncbi.nlm.nih.gov/32806879/ - Durcan G, Yildiz M, Kadak MT, Barut K, Kavruk Erdim N, Sahin S, Adrovic A, Haslak F, Dogangun B, Kasapcopur O.
Increased frequency of sleep problems in children and adolescents with familial Mediterranean fever: The role of anxiety and depression.
Int J Rheum Dis. 2020 Aug 10.doi: 10.1111/1756-185X.13941.
https://pubmed.ncbi.nlm.nih.gov/32776695/ - Paim-Marques LB, Cavalcante A, Castro C, Muskardin TLW, de Oliveira JB, Niewold TB, Appenzeller S.
Novel mutation in the NRLP3 manifesting as an intermediate phenotype of cryopyrinopathies.
Rheumatol Int.2020 Aug 19. doi: 10.1007/s00296-020-04683-5.
https://pubmed.ncbi.nlm.nih.gov/32813153/ - Kendall JL, Springer JM.
The Many Faces of a Monogenic Autoinflammatory Disease: Adenosine Deaminase 2 Deficiency.
Curr Rheumatol Rep. 2020 Aug 26;22(10):64. doi: 10.1007/s11926-020-00944-1.
https://pubmed.ncbi.nlm.nih.gov/32845415/ - Khubchandani R, Aksentijevich I.
Deficiency of Adenosine Deaminase 2 (DADA2) - A New Autoinflammatory Disease with Multisystem Features.
Indian Pediatr. 2020 Aug 14;S097475591600231.
https://pubmed.ncbi.nlm.nih.gov/32796151/ - Luo Y, Wu D, Shen M.
Recurrent fever of unknown origin: An overlooked symptom of Fabry disease
Mol Genet Genomic Med.2020 Aug 14;e1454. doi: 10.1002/mgg3.1454.
https://pubmed.ncbi.nlm.nih.gov/32797665/ - Kim HY, Song JY, Kim WI, Ko HC, Park SE, Jang JH, Kim SH.
The First Case of an Infant with Familial A20 Haploinsufficiency in Korea
J Korean Med Sci.2020 Aug 3;35(30):e252. doi: 10.3346/jkms.2020.35.e252.
https://pubmed.ncbi.nlm.nih.gov/32743991/ - Okada S, Asano T, Moriya K, Boisson-Dupuis S, Kobayashi M , Casanova JL, Puel A.
Human STAT1 Gain-of-Function Heterozygous Mutations: Chronic Mucocutaneous Candidiasis and Type I Interferonopathy
J Clin Immunol. 2020 Aug 27.doi: 10.1007/s10875-020-00847-x.
https://pubmed.ncbi.nlm.nih.gov/32852681/ - Mendonça LO, Grossi A, Caroli F, de Oliveira RA, Kalil J, Castro FFM, Pontillo A, Ceccherini I, Barros MAMT, Gattorno M.
A case report of a novel compound heterozygous mutation in a Brazilian patient with deficiency of Interleukin-1 receptor antagonist (DIRA)
Pediatr Rheumatol Online J. 2020 Aug 20;18(1):67. doi: 10.1186/s12969-020-00454-5.
https://pubmed.ncbi.nlm.nih.gov/32819369/ - Speir M, Lawlor KE.
RIP-roaring inflammation: RIPK1 and RIPK3 driven NLRP3 inflammasome activation and autoinflammatory disease.
Semin Cell Dev Biol. 2020 Aug 5;S1084-9521(19)30233-2. doi:
10.1016/j.semcdb.2020.07.011.
https://pubmed.ncbi.nlm.nih.gov/32771377/
JULIO 2020
-
Hedrich CM, Morbach H, Reiser C, Girschick HJ.
New Insights into Adult and Paediatric Chronic Non-bacterial Osteomyelitis CNO.
Curr Rheumatol Rep. 2020 Jul 23;22(9):52. doi: 10.1007/s11926-020-00928-1.
https://pubmed.ncbi.nlm.nih.gov/32705386/ -
Ter Haar NM, Jansen MHA, Frenkel JF, Vastert SJ.
How autoinflammation may turn into autoimmune inflammation: Insights from monogenetic and complex IL-1 mediated auto-inflammatory diseases.
Clin Immunol. 2020 Jul 15:108538. doi: 10.1016/j.clim.2020.108538. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32681980/ -
Lin B, Berard R, Al Rasheed A, Aladba B, Kranzusch PJ, Henderlight M, Grom A, Kahle D, Torreggiani S, Aue AG, Mitchell J, de Jesus AA, Schulert GS, Goldbach-Mansky R.
A novel STING1 variant causes a recessive form of STING-associated vasculopathy with onset in infancy (SAVI).
J Allergy Clin Immunol. 2020 Jul 13:S0091-6749(20)30963-5. doi: 10.1016/j.jaci.2020.06.032. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32673614/ -
d'Adamo AP, Bianco AM, Ferrara G, La Bianca M, Insalaco A, Tommasini A, Pardeo M, Cattalini M, La Torre F, Finetti M, Alizzi C, Simonini G, Messia V, Pastore S, Cimaz R, Gattorno M, Taddio A; Italian Pediatric Rheumatology Study Group.
High prevalence of rare FBLIM1 gene variants in an Italian cohort of patients with Chronic Non-bacterial Osteomyelitis (CNO).
Pediatr Rheumatol Online J. 2020 Jul 10;18(1):55. doi: 10.1186/s12969-020-00447-4.
https://pubmed.ncbi.nlm.nih.gov/32650789/ -
Matsuda T, Kambe N, Ueki Y, Kanazawa N, Izawa K, Honda Y, Kawakami A, Takei S, Tonomura K, Inoue M, Kobayashi H, Okafuji I, Sakurai Y, Kato N, Maruyama Y, Inoue Y, Otsubo Y, Makino T, Okada S, Kobayashi I, Yashiro M, Ito S, Fujii H, Kondo Y, Okamoto N, Ito S, Iwata N, Kaneko U, Doi M, Hosokawa J, Ohara O, Saito MK, Nishikomori R; PIDJ members in the JSIAD; PIDJ (Primary Immunodeficiency and Autoinflammatory Diseases Database Project) members in the JSIAD (Japanese Society for Immunodeficiency and Autoinflammatory Diseases).
Clinical characteristics and treatment of 50 cases of Blau syndrome in Japan confirmed by genetic analysis of the NOD2 mutation.
Ann Rheum Dis. 2020 Jul 9:annrheumdis-2020-217320. doi: 10.1136/annrheumdis-2020-217320. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32647028/ -
Martín-Nalda A, Fortuny C, Rey L, Bunney TD, Alsina L, Esteve-Solé A, Bull D, Anton MC, Basagaña M, Casals F, Deyá A, García-Prat M, Gimeno R, Juan M, Martinez-Banaclocha H, Martinez-Garcia JJ, Mensa-Vilaró A, Rabionet R, Martin-Begue N, Rudilla F, Yagüe J, Estivill X, García-Patos V, Pujol RM, Soler-Palacín P, Katan M, Pelegrín P, Colobran R, Vicente A, Arostegui JI.
Severe Autoinflammatory Manifestations and Antibody Deficiency Due to Novel Hypermorphic PLCG2 Mutations.
J Clin Immunol. 2020 Jul 15. doi: 10.1007/s10875-020-00794-7. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32671674/ -
Andronikou S, Kraft JK, Offiah AC, Jones J, Douis H, Thyagarajan M, Barrera CA, Zouvani A, Ramanan AV.
Whole-body MRI in the diagnosis of paediatric CNO/CRMO.
Rheumatology (Oxford). 2020 Jul 10:keaa303. doi: 10.1093/rheumatology/keaa303. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32648576/
JUNIO 2020
-
Çiçek SÖ, Şahin N, Karaman ZF, Taşkın SN, Kısaarslan AP, Gündüz Z, Poyrazoğlu MH, Düşünsel R.
The Possible Relationship Between Familial Mediterranean Fever and Chronic Nonbacterial Osteomyelitis: Coincidence or Coexistence?
J Clin Rheumatol. 2020 Jun 12. doi: 10.1097/RHU.0000000000001431.
https://pubmed.ncbi.nlm.nih.gov/32541616/ -
Balcı-Peynircioğlu B, Kaya-Akça Ü, Arıcı ZS, Avcı E, Akkaya-Ulum ZY, Karadağ Ö, Kalyoncu U, Bilginer Y, Yılmaz E, Özen S.
Comorbidities in familial Mediterranean fever: analysis of 2000 genetically confirmed patients.
Rheumatology (Oxford). 2020 Jun 1;59(6):1372-1380. doi: 10.1093/rheumatology/kez410.
https://pubmed.ncbi.nlm.nih.gov/31598713/ -
Aksentijevich I, Soriano A, Hernández-Rodríguez J.
Editorial: Autoinflammatory Diseases: From Genes to Bedside.
Front Immunol. 2020 Jun 19;11:1177. doi: 10.3389/fimmu.2020.01177
https://pubmed.ncbi.nlm.nih.gov/32636839/
MAYO 2020
- Clarke SLN, Robertson L, Rice GI, Seabra L, Hilliard TN, Crow YJ, Ramanan AV.
Type 1 interferonopathy presenting as juvenile idiopathic arthritis with interstitial lung disease: report of a new phenotype.
Pediatr Rheumatol Online J. 2020 May 12;18(1):37
https://doi.org/10.1186/s12969-020-00425-w - Batlle-Masó L, Mensa-Vilaró A, Solís-Moruno M, Marquès-Bonet T, Arostegui JI, Casals F.
Genetic diagnosis of autoinflammatory disease patients using clinical exome sequencing.
Eur J Med Genet. 2020 May;63(5):103920.
https://doi.org/10.1016/j.ejmg.2020.103920 - Hirsch MC, Ronicke S, Krusche M, Wagner AD.
Rare diseases 2030: how augmented AI will support diagnosis and treatment of rare diseases in the future.
Ann Rheum Dis. 2020 Jun;79(6):740-743.
https://doi.org/10.1136/annrheumdis-2020-217125 - Amarilyo G, Rothman D, Manthiram K, Edwards KM, Li SC, Marshall GS, Yildirim-Toruner C, Haines K, Ferguson PJ, Lionetti G, Cherian J, Zhao Y, DeLaMora P, Syverson G, Nativ S, Twilt M, Michelow IC, Stepanovskiy Y, Thatayatikom A, Harel L, Akoghlanian S, Tucker L, Marques MC, Srinivasalu H, Propst EJ, Licameli GR, Dedeoglu F, Lapidus S; CARRA PFAPA Consensus Treatment Plan Workgroup
Consensus treatment plans for periodic fever, aphthous stomatitis, pharyngitis and adenitis syndrome (PFAPA): a framework to evaluate treatment responses from the childhood arthritis and rheumatology research alliance (CARRA) PFAPA work group.
Pediatr Rheumatol Online J. 2020 Apr 15;18(1):31. doi: 10.1186/s12969-020-00424-x.
https://pubmed.ncbi.nlm.nih.gov/32293478 - Ayaz NA, Tanatar A, Karadağ ŞG, Çakan M, Keskindemirci G, Sönmez HE
Comorbidities and phenotype-genotype correlation in children with familial Mediterranean fever.
Rheumatol Int. 2020 Apr 28. doi: 10.1007/s00296-020-04592-7. Online ahead of print
https://pubmed.ncbi.nlm.nih.gov/32347339 - Van der Houwen T, Van Laar J.
Behҫet's Disease, and the Role of TNF-α and TNF-α Blockers.
Int J Mol Sci. 2020 Apr 27;21(9):E3072. doi: 10.3390/ijms21093072.
https://pubmed.ncbi.nlm.nih.gov/32349254 - Yıldız M, Haşlak F, Adrovic A, Barut K, Kasapçopur Ö.
Autoinflammatory Diseases in Childhood.
Balkan Med J. 2020 Apr 27. doi: 10.4274/balkanmedj.galenos.2020.2020.4.82. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32338845 - Conte M, Pastore S, Berti I, Taddio A, Tommasini A.
Cutaneous manifestations in mevalonate kinase deficient patients treated with canakinumab.
Clin Exp Rheumatol. 2020 Apr 23. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32324125 - Kuemmerle-Deschner JB, Welzel T, Hoertnagel K, Tsiflikas I, Hospach A, Liu X, Schlipf S, Hansmann S, Samba SD, Griesinger A, Benseler SM, Weber AN.
New variant in the IL1RN-gene (DIRA) associated with late-onset, CRMO-like presentation.
Rheumatology (Oxford). 2020 Apr 7:keaa119. doi: 10.1093/rheumatology/keaa119. Online ahead of print
https://pubmed.ncbi.nlm.nih.gov/32259833 - Meinzer U, See H, Bader-Meunier B, Juillard C, Duquesne A, Melki I, Faye A, Bourrat E; Groupe de recherche de la Société Française de Dermatologie Pédiatrique; Société Francophone pour la rhumatologie et les Maladies Inflammatoires en Pédiatrie (SOFREMIP).
Clinical characteristics of pediatric patients with acne fulminans associated to chronic non-bacterial osteomyelitis.
J Rheumatol. 2020 Apr 1:jrheum.191232. doi: 10.3899/jrheum.191232. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32238518 - Kadowaki T, Ohnishi H, Kawamoto N, Kadowaki S, Hori T, Nishimura K, Kobayashi C, Shigemura T, Ogata S, Inoue Y, Hiejima E, Izawa K, Matsubayashi T, Matsumoto K, Imai K, Nishikomori R, Ito S, Kanegane H, Fukao T.
Immunophenotyping of A20 haploinsufficiency by multicolor flow cytometry
Clin Immunol. 2020 Apr 23;216:108441. doi: 10.1016/j.clim.2020.108441. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32335289 - Schulert GS, Cron RQ.
The genetics of macrophage activation syndrome.
Genes Immun. 2020 Apr 15. doi: 10.1038/s41435-020-0098-4. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32291394
MARZO 2020
- Bonnekoh H, Butze M, Kallinich T, Kambe N, Kokolakis G, Krause K
Spectrum of Genetic Autoinflammatory Diseases Presenting with Cutaneous Symptoms.
Acta Derm Venereol. 2020 Mar 9. doi: 10.2340/00015555-3427. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/32147748 - Shinar Y, Ceccherini I, Rowczenio D, Aksentijevich I, Arostegui J, Ben-Chétrit E, Boursier G, Gattorno M, Hayrapetyan H, Ida H, Kanazawa N, Lachmann HJ, Mensa-Vilaro A, Nishikomori R, Oberkanins C, Obici L, Ohara O, Ozen S, Sarkisian T, Sheils K, Wolstenholme N, Zonneveld-Huijssoon E, van Gijn ME, Touitou I.
ISSAID/EMQN Best Practice Guidelines for the Genetic Diagnosis of Monogenic Autoinflammatory Diseases in the Next-Generation Sequencing Era.
Clin Chem. 2020 Mar 16. pii: hvaa024. doi: 10.1093/clinchem/hvaa024. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32176780 - Kacar M, Savic S, van der Hilst JCH.
The Efficacy, Safety and Tolerability of Canakinumab in the Treatment of Familial Mediterranean Fever: A Systematic Review of the Literature.
J Inflamm Res. 2020 Mar 9;13:141-149.
https://www.ncbi.nlm.nih.gov/pubmed/32210604 - Fraisse T, Savey L, Hentgen V, Rossi-Semerano L, Koné-Paut I, Grateau G, Georgin-Lavialle S, Ducharme-Bénard S.
Non-amyloid liver involvement in familial Mediterranean fever: a systematic literature review.
Liver Int. 2020 Mar 20. doi: 10.1111/liv.14445. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32196885 - Miyamae T, Hanaya A, Kawamoto M, Tani Y, Kawaguchi Y, Yamanaka H.
Diagnostic Rate of Autoinflammatory Diseases Evaluated by Fever Patterns in Pediatric- and Adult-Onset Patients.
J Clin Rheumatol. 2020 Mar;26(2):60-62.
https://www.ncbi.nlm.nih.gov/pubmed/32073516 - Schwob E, Bessis D, Boursier G, Kottler D, Guillot B, Lerisson M, Girard C.
PASS: A rare syndrome within the autoinflammatory diseases that still lacks a genetic marker.
J Eur Acad Dermatol Venereol. 2020 Mar 25. doi: 10.1111/jdv.16385. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32215958 - Navallas M, Inarejos Clemente EJ, Iglesias E, Rebollo-Polo M, Zaki FM, Navarro OM.
Autoinflammatory diseases in childhood, part 1: monogenic syndromes.
Pediatr Radiol. 2020 Mar;50(3):415-430.
https://www.ncbi.nlm.nih.gov/pubmed/32065272 - Navallas M, Inarejos Clemente EJ, Iglesias E, Rebollo-Polo M, Hernández JC, Navarro OM.
Autoinflammatory diseases in childhood, part 2: polygenic syndromes.
Pediatr Radiol. 2020 Mar;50(3):431-444.
https://www.ncbi.nlm.nih.gov/pubmed/32065273 - Asan G, Derin ME, Doğan HO, Bayram M, Şahin M, Şahin A.
Can Calprotectin Show Subclinical Inflammation in Familial Mediterranean Fever Patients?J Korean Med Sci. 2020 Mar 16;35(10):e63.
https://www.ncbi.nlm.nih.gov/pubmed/32174062Timme M, Bohner L, Huss S, Kleinheinz J, Hanisch M.
Response of Different Treatment Protocols to Treat Chronic Non-Bacterial Osteomyelitis (CNO) of the Mandible in Adult Patients: A Systematic Review.Int J Environ Res Public Health. 2020 Mar 6;17(5). pii: E1737. doi: 10.3390/ijerph17051737.
https://www.ncbi.nlm.nih.gov/pubmed/32155902 - Shinkarevsky Fleitman I, Nevo Y, Harel L, Amarilyo G, Dori A, Agmon-Levin N, Kachko L, Zaks Hoffer G, Dabby R, Rabie M, Aharoni S.
Small-fiber neuropathy associated with autoinflammatory syndromes in children and adolescents.
Muscle Nerve. 2020 Mar 4. doi: 10.1002/mus.26857. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32133669 - Bonnekoh H, Butze M, Kallinich T, Kambe N, Kokolakis G, Krause K
Spectrum of Genetic Autoinflammatory Diseases Presenting with Cutaneous Symptoms.
Acta Derm Venereol. 2020 Mar 9. doi: 10.2340/00015555-3427. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32147748 - Shinar Y, Ceccherini I, Rowczenio D, Aksentijevich I, Arostegui J, Ben-Chétrit E, Boursier G, Gattorno M, Hayrapetyan H, Ida H, Kanazawa N, Lachmann HJ, Mensa-Vilaro A, Nishikomori R, Oberkanins C, Obici L, Ohara O, Ozen S, Sarkisian T, Sheils K, Wolstenholme N, Zonneveld-Huijssoon E, van Gijn ME, Touitou I.
ISSAID/EMQN Best Practice Guidelines for the Genetic Diagnosis of Monogenic Autoinflammatory Diseases in the Next-Generation Sequencing Era.
Clin Chem. 2020 Mar 16. pii: hvaa024. doi: 10.1093/clinchem/hvaa024. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32176780 - Kacar M, Savic S, van der Hilst JCH.
The Efficacy, Safety and Tolerability of Canakinumab in the Treatment of Familial Mediterranean Fever: A Systematic Review of the Literature.
J Inflamm Res. 2020 Mar 9;13:141-149.
https://www.ncbi.nlm.nih.gov/pubmed/32210604 - Fraisse T, Savey L, Hentgen V, Rossi-Semerano L, Koné-Paut I, Grateau G, Georgin-Lavialle S, Ducharme-Bénard S.
Non-amyloid liver involvement in familial Mediterranean fever: a systematic literature review.
Liver Int. 2020 Mar 20. doi: 10.1111/liv.14445. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32196885 - Miyamae T, Hanaya A, Kawamoto M, Tani Y, Kawaguchi Y, Yamanaka H.
Diagnostic Rate of Autoinflammatory Diseases Evaluated by Fever Patterns in Pediatric- and Adult-Onset Patients.
J Clin Rheumatol. 2020 Mar;26(2):60-62.
https://www.ncbi.nlm.nih.gov/pubmed/32073516 - Schwob E, Bessis D, Boursier G, Kottler D, Guillot B, Lerisson M, Girard C.
PASS: A rare syndrome within the autoinflammatory diseases that still lacks a genetic marker.
J Eur Acad Dermatol Venereol. 2020 Mar 25. doi: 10.1111/jdv.16385. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32215958 - Navallas M, Inarejos Clemente EJ, Iglesias E, Rebollo-Polo M, Zaki FM, Navarro OM.
Autoinflammatory diseases in childhood, part 1: monogenic syndromes.
Pediatr Radiol. 2020 Mar;50(3):415-430.
https://www.ncbi.nlm.nih.gov/pubmed/32065272 - Navallas M, Inarejos Clemente EJ, Iglesias E, Rebollo-Polo M, Hernández JC, Navarro OM.
Autoinflammatory diseases in childhood, part 2: polygenic syndromes.
Pediatr Radiol. 2020 Mar;50(3):431-444.
https://www.ncbi.nlm.nih.gov/pubmed/32065273 - Asan G, Derin ME, Doğan HO, Bayram M, Şahin M, Şahin A.
Can Calprotectin Show Subclinical Inflammation in Familial Mediterranean Fever Patients?J
Korean Med Sci. 2020 Mar 16;35(10):e63.
https://www.ncbi.nlm.nih.gov/pubmed/32174062 - Timme M, Bohner L, Huss S, Kleinheinz J, Hanisch M.
Response of Different Treatment Protocols to Treat Chronic Non-Bacterial Osteomyelitis (CNO) of the Mandible in Adult Patients: A Systematic Review.
Int J Environ Res Public Health. 2020 Mar 6;17(5). pii: E1737. doi: 10.3390/ijerph17051737.
https://www.ncbi.nlm.nih.gov/pubmed/32155902 - Shinkarevsky Fleitman I, Nevo Y, Harel L, Amarilyo G, Dori A, Agmon-Levin N, Kachko L, Zaks Hoffer G, Dabby R, Rabie M, Aharoni S.
Small-fiber neuropathy associated with autoinflammatory syndromes in children and adolescents.
Muscle Nerve. 2020 Mar 4. doi: 10.1002/mus.26857. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32133669 - Navallas M, Inarejos Clemente EJ, Iglesias E, Rebollo-Polo M, Zaki FM, Navarro OM.
Autoinflammatory diseases in childhood, part 1: monogenic syndromes.
Pediatr Radiol. 2020 Mar;50(3):415-430. doi: 10.1007/s00247-019-04536-9. Epub 2020 Feb 17.
https://www.ncbi.nlm.nih.gov/pubmed/32065272 - Navallas M, Inarejos Clemente EJ, Iglesias E, Rebollo-Polo M, Hernández JC, Navarro OM.
Autoinflammatory diseases in childhood, part 2: polygenic syndromes.
Pediatr Radiol. 2020 Mar;50(3):431-444. doi: 10.1007/s00247-019-04544-9. Epub 2020 Feb 17.
https://www.ncbi.nlm.nih.gov/pubmed/32065273 - Miyamae T, Hanaya A, Kawamoto M, Tani Y, Kawaguchi Y, Yamanaka H.
Diagnostic Rate of Autoinflammatory Diseases Evaluated by Fever Patterns in Pediatric- and Adult-Onset Patients.
J Clin Rheumatol. 2020 Mar;26(2):60-62. doi: 10.1097/RHU.0000000000000929.
https://www.ncbi.nlm.nih.gov/pubmed/32073516 - Hansmann S, Lainka E, Horneff G, Holzinger D, Rieber N, Jansson AF, Rösen-Wolff A, Erbis G, Prelog M, Brunner J, Benseler SM, Kuemmerle-Deschner JB.
Consensus protocols for the diagnosis and management of the hereditary autoinflammatory syndromes CAPS, TRAPS and MKD/HIDS: a German PRO-KIND initiative.
Pediatr Rheumatol Online J. 2020 Feb 17;18(1):17. doi: 10.1186/s12969-020-0409-3.
https://www.ncbi.nlm.nih.gov/pubmed/32066461 - Stolberg NG, Verbsky JW.
Autoinflammatory Disorders with Perinatal Onset.
Clin Perinatol. 2020 Mar;47(1):41-52. doi: 10.1016/j.clp.2019.10.007. Epub 2019 Oct 21.
https://www.ncbi.nlm.nih.gov/pubmed/32000928
FEBRERO 2020
- Krainer J, Siebenhandl S, Weinhäusel A.
Systemic autoinflammatory diseases.
J Autoimmun. 2020 Feb 1:102421. doi: 10.1016/j.jaut.2020.102421.
https://www.ncbi.nlm.nih.gov/pubmed/32019685 - Sota J, Rigante D, Emmi G, Lopalco G, Orlando I, Tosi GM, Frediani B, Vitale A, Guerriero S, Iannone F, Vannozzi L, Fabiani C, Cantarini L.
Behçet's syndrome in Italy: a detailed retrospective analysis of 396 cases seen in 3 tertiary referral clinics.
Intern Emerg Med. 2020 Feb 1. doi: 10.1007/s11739-019-02248-4.
https://www.ncbi.nlm.nih.gov/pubmed/32006221
ENERO 2020
- Özen S, Batu ED, Taşkıran EZ, Özkara HA, Ünal Ş, Güleray N, Erden A, Karadağ Ö, Gümrük F, Çetin M, Sönmez HE, Bilginer Y, Ayvaz DÇ, Tezcan I.
A Monogenic Disease with a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2.
J Rheumatol. 2020 Jan;47(1):117-125. doi: 10.3899/jrheum.181384. Epub 2019 May 1.
https://www.ncbi.nlm.nih.gov/pubmed/31043544 - Hautala T, Vähäsalo P, Kuismin O, Keskitalo S, Rajamäki K, Väänänen A, Simojoki M, Säily M, Pelkonen I, Tokola H, Mäkinen M, Kaarteenaho R, Jartti A, Hautala N, Kantola S, Jackson P, Glumoff V, Saarela J, Varjosalo M, Eklund KK, Seppänen MRJ.
A Family With A20 Haploinsufficiency Presenting With Novel Clinical Manifestations and Challenges for Treatment.
J Clin Rheumatol. 2020 Jan 21. doi: 10.1097/RHU.0000000000001268. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/31977656 - Sato TS, Watal P, Ferguson PJ.
Imaging mimics of chronic recurrent multifocal osteomyelitis: avoiding pitfalls in a diagnosis of exclusion.
Pediatr Radiol. 2020 Jan;50(1):124-136. doi: 10.1007/s00247-019-04510-5. Epub 2020 Jan 4.
https://www.ncbi.nlm.nih.gov/pubmed/31901992 - Gaal A, Basiaga ML, Zhao Y, Egbert M.
Pediatric chronic nonbacterial osteomyelitis of the mandible: Seattle Children's hospital 22-patient experience.
Pediatr Rheumatol Online J. 2020 Jan 15;18(1):4. doi: 10.1186/s12969-019-0384-8.
https://www.ncbi.nlm.nih.gov/pubmed/31941491 - Ferrara G, Insalaco A, Pardeo M, Cattalini M, La Torre F, Finetti M, Ricci F, Alizzi C, Teruzzi B, Simonini G, Messia V, Pastore S, Morra L, Cimaz R, Gattorno M, Taddio A; Italian Paediatric Rheumatology Study Group.
Prevalence of cranial involvement in a cohort of Italian patients with chronic non-bacterial osteomyelitis.
Clin Exp Rheumatol. 2020 Jan 29. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/31994478 - Kostik MM, Kopchak OL, Maletin AS, Mushkin AY.
The peculiarities and treatment outcomes of the spinal form of chronic non-bacterial osteomyelitisin children: a retrospective cohort study.
Rheumatol Int. 2020 Jan;40(1):97-105. doi: 10.1007/s00296-019-04479-2. Epub 2019 Nov 21.
https://www.ncbi.nlm.nih.gov/pubmed/31754777 - Vampertzi O, Papadopoulou-Legbelou K, Triantafyllou A, Douma S, Papadopoulou-Alataki E.
Familial Mediterranean fever and atherosclerosis in childhood and adolescence.
Rheumatol Int. 2020 Jan;40(1):1-8. doi: 10.1007/s00296-019-04457-8. Epub 2019 Nov 8.
https://www.ncbi.nlm.nih.gov/pubmed/31705200 - Tao P, Sun J, Wu Z, Wang S, Wang J, Li W, Pan H, Bai R, Zhang J, Wang Y, Lee PY, Ying W, Zhou Q, Hou J, Wang W, Sun B, Yang M, Liu D, Fang R, Han H, Yang Z, Huang X, Li H, Deuitch N, Zhang Y, Dissanayake D, Haude K, McWalter K, Roadhouse C, MacKenzie JJ, Laxer RM, Aksentijevich I, Yu X, Wang X, Yuan J, Zhou Q.
A dominant autoinflammatory disease caused by non-cleavable variants of RIPK1.
Nature. 2020 Jan;577(7788):109-114. doi: 10.1038/s41586-019-1830-y. Epub 2019 Dec 11.
https://www.ncbi.nlm.nih.gov/pubmed/31827280
DICIEMBRE 2019
- de Jesus AA, Hou Y, Brooks S, Malle L, Biancotto A, Huang Y, Calvo KR, Marrero B, Moir S, Oler AJ, Deng Z, Montealegre Sanchez GA, Ahmed A, Allenspach E, Arabshahi B, Behrens E, Benseler S, Bezrodnik L, Bout-Tabaku S, Brescia AC, Brown D, Burnham JM, Caldirola MS, Carrasco R, Chan AY, Cimaz R, Dancey P, Dare J, DeGuzman M, Dimitriades V, Ferguson I, Ferguson P, Finn L, Gattorno M, Grom AA, Hanson EP, Hashkes PJ, Hedrich CM, Herzog R, Horneff G, Jerath R, Kessler E, Kim H, Kingsbury DJ, Laxer RM, Lee PY, Lee-Kirsch MA, Lewandowski L, Li S, Lilleby V, Mammadova V, Moorthy LN, Nasrullayeva G, O'Neil KM, Onel K, Ozen S, Pan N, Pillet P, Piotto DG, Punaro MG, Reiff A, Reinhardt A, Rider LG, Rivas-Chacon R, Ronis T, Rösen-Wolff A, Roth J, Ruth NM, Rygg M, Schmeling H, Schulert G, Scott C, Seminario G, Shulman A, Sivaraman V, Son MB, Stepanovskyy Y, Stringer E, Taber S, Terreri MT, Tifft C, Torgerson T, Tosi L, Van Royen-Kerkhof A, Wampler Muskardin T, Canna SW, Goldbach-Mansky R.
Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases.
J Clin Invest. 2019 Dec 24. pii: 129301. doi: 10.1172/JCI129301 https://www.ncbi.nlm.nih.gov/pubmed/31874111 - Standing AS, Hong Y, Paisan-Ruiz C, Omoyinmi E, Medlar A, Stanescu H, Kleta R, Rowcenzio D, Hawkins P, Lachmann H, McDermott MF, Eleftheriou D, Klein N, Brogan PA.
TRAP1 chaperone protein mutations and autoinflammation.
Life Sci Alliance. 2019 Dec 27;3(2). pii: e201900376. doi: 10.26508/lsa.201900376. https://www.ncbi.nlm.nih.gov/pubmed/31882397 - Gupta A, Tripathy SK, Phulware RH, Arava S, Bagri NK.
Cryopyrin-associated periodic fever syndrome in children: A case-based review.
Int J Rheum Dis. 2019 Dec 19. doi: 10.1111/1756-185X.13772 https://www.ncbi.nlm.nih.gov/pubmed/31858722 - Wang W, Zhou Y, Zhong LQ, Li Z, Jian S, Tang XY, Song HM.
The clinical phenotype and genotype of NLRP12-autoinflammatory disease: a Chinese case series with literature review.
World J Pediatr. 2019 Dec 9. doi: 10.1007/s12519-019-00294-8. https://www.ncbi.nlm.nih.gov/pubmed/31820221
OCTUBRE 2019
- Emine Sonmez H, Karaaslan C, de Jesus AA, Deniz Batu E, Anlar B, Sözeri B, Bilginer Y, Karaguzel D, Cagdas Ayvaz D, Tezcan I, Goldbach-Mansky R, Ozen S.
A clinical score to guide in decision making for monogenic type I IFNopathies
Pediatr Res. 2019 Oct 22. doi: 10.1038/s41390-019-0614-2. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/31641281 - Balcı-Peynircioğlu B, Kaya-Akça Ü, Arıcı ZS, Avcı E, Akkaya-Ulum ZY, Karadağ Ö, Kalyoncu U, Bilginer Y, Yılmaz E, Özen S.
Comorbidities in familial Mediterranean fever: analysis of 2000 genetically confirmed patients
Rheumatology (Oxford). 2019 Oct 10. pii: kez410. doi: 10.1093/rheumatology/kez410. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/31598713 - Yu MP, Xu XS, Zhou Q, Deuitch N, Lu MP.
Haploinsufficiency of A20 (HA20): updates on the genetics, phenotype, pathogenesis and treatment
World J Pediatr. 2019 Oct 5. doi: 10.1007/s12519-019-00288-6. [Epub ahead of print] Review.
https://www.ncbi.nlm.nih.gov/pubmed/31587140 - Balci S, Ekinci RMK, de Jesus AA, Goldbach-Mansky R, Yilmaz M.
Baricitinib experience on STING-associated vasculopathy with onset in infancy: A representative case from Turkey
Clin Immunol. 2019 Oct 15:108273. doi: 10.1016/j.clim.2019.108273. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31626957 - Tanatar A, Sönmez HE, Karadağ ŞG, Çakmak F, Çakan M, Demir F, Sözeri B, Ayaz NA.
Performance of Tel-Hashomer, Livneh, pediatric and new Eurofever/PRINTO classification criteria for familial Mediterranean fever in a referral center
Rheumatol Int. 2019 Oct 23. doi: 10.1007/s00296-019-04463-w. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31646357 - Lam MT, Coppola S, Krumbach OHF, Prencipe G, Insalaco A, Cifaldi C, et al.
A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function
J Exp Med. 2019 Oct 10. pii: jem.20190147. doi: 10.1084/jem.20190147. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31601675 - Zhao Y, Sato TS, Nielsen SM, Beer M, Huang M, Iyer RS, McGuire M, Ngo AV, Otjen JP, Panwar J, Stimec J, Thapa M, Toma P, Taneja A, Gove NE, Ferguson PJ.
Development of CROMRIS (ChRonic nonbacterial Osteomyelitis MRI Scoring) Tool and Evaluation of its Interrater Reliability.
J Rheumatol. 2019 Oct 1. pii: jrheum.190186. doi: 10.3899/jrheum.190186. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31575701 - Goenka A, Roderick M, Finn A, Ramanan AV.
The jigsaw puzzle of chronic non-bacterial osteomyelitis: are anti-IL17 therapies the next piece?
Rheumatology (Oxford). 2019 Oct 19. pii: kez492. doi: 10.1093/rheumatology/kez492. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31630190 - Boursier G, Rittore C, Georgin-Lavialle S, Belot A, Galeotti C, Hachulla E, Hentgen V, Rossi-Semerano L, Sarrabay G, Touitou AI.
Positive Impact of Expert Reference Center Validation on Performance of Next-Generation Sequencing for Genetic Diagnosis of Autoinflammatory Diseases
J Clin Med. 2019 Oct 18;8(10). pii: E1729. doi: 10.3390/jcm8101729.
https://www.ncbi.nlm.nih.gov/pubmed/31635385 - Imazio M, Andreis A, De Ferrari GM, Cremer PC, Mardigyan V, Maestroni S, et al.
Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study
Eur J Prev Cardiol. 2019 Oct 15:2047487319879534. doi: 10.1177/2047487319879534. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31610707 - Tartey S, Kanneganti TD.
Inflammasomes in the pathophysiology of autoinflammatory syndromes
J Leukoc Biol. 2019 Oct 14. doi: 10.1002/JLB.3MIR0919-191R. [Epub ahead of print] Review.
https://www.ncbi.nlm.nih.gov/pubmed/31608507
SEPTIEMBRE 2019
- Nezos A, Argyropoulou OD, Klinaki E, Marketos N, Karagianni P, Eliopoulos E, Vlachoyiannopoulos P, Maritsi DN, Tzioufas AG.
Molecular and clinical spectrum of four pedigrees of TRAPS in Greece: results from a national referral center.
Rheumatology (Oxford). 2019 Sep 27. pii: kez424. doi: 10.1093/rheumatology/kez424. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/31562507 - Poline J, Fogel O, Pajot C, Miceli-Richard C, Rybojad M, Galeotti C, Grouteau E, Hachulla E, Brissaud P, Cantagrel A, Mazereeuw Hautier J, Melki I, Petit A, Piram M, Sarrabay G, Wouters C, Vignon-Pennamen MD, Bourrat E, Meinzer U; French Society for Rheumatology and Inflammatory Diseases (SOFREMIP) and the Research Group of Pediatric Dermatology French Society (GRSFDP).
Early onset granulomatous arthritis, uveitis and skin rash: characterisation of skin involvement in Blau syndrome.
J Eur Acad Dermatol Venereol. 2019 Sep 21. doi: 10.1111/jdv.15963. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/31541486 - Alippe Y, Mbalaviele G.
Omnipresence of inflammasome activities in inflammatory bone diseases.
Semin Immunopathol. 2019 Sep 13. doi: 10.1007/s00281-019-00753-4. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/31524322 - Kessel C, Hedrich CM, Foell D.
Innately adaptive or truly autoimmune.
Arthritis Rheumatol. 2019 Sep 16. doi: 10.1002/art.41107. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/31383341 - Çakan M, Aktay Ayaz N, Keskindemirci G, Karadağ ŞG, Tanatar A, Sönmez HE.
Serum amyloid A as a biomarker in differentiating attacks of familial Mediterranean fever from acute febrile infections.
Clin Rheumatol. 2019 Sep 4. doi: 10.1007/s10067-019-04765-1. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/31485845 - Tezcan ME.
IL-1 blockers together with colchicine may be administered as first line therapy in familial Mediterranean fever with amyloidosis.
Med Hypotheses. 2019 Sep;130:109269. doi: 10.1016/j.mehy.2019.109269.
https://www.ncbi.nlm.nih.gov/pubmed/31383341
AGOSTO 2019
- Young S, Sharma N, Lee JH, Chitu V, Neumeister V, Sohr E, Stanley ER, Hedrich CM, Craig AWB.
Mast cells enhance sterile inflammation in chronic nonbacterial osteomyelitis.
Dis Model Mech. 2019 Aug 5. pii: dmm.040097. doi: 10.1242/dmm.040097.
https://www.ncbi.nlm.nih.gov/pubmed/31416928 - Tsuji S, Matsuzaki H, Iseki M, Nagasu A, Hirano H, Ishihara K, Ueda N, Honda Y, Horiuchi T, Nishikomori R, Morita Y, Mukai T.
Functional analysis of a novel G87V TNFRSF1A mutation in patients with TNF receptor-associated periodic syndrome.
Clin Exp Immunol. 2019 Aug 19. doi: 10.1111/cei.13365.
https://www.ncbi.nlm.nih.gov/pubmed/31429073 - Lopalco G, Venerito V, Leccese P, Emmi G, Cantarini L, Lascaro N, Di Scala G, Fabiani C, Rigante D, Iannone F.
Real-world effectiveness of apremilast in multirefractory mucosal involvement of Behçet's disease.
Ann Rheum Dis. 2019 Aug 10. pii: annrheumdis-2019-215437. doi: 10.1136/annrheumdis-2019-215437.
https://www.ncbi.nlm.nih.gov/pubmed/31401548 - Yu ZX, Song HM.
Toward a better understanding of type I interferonopathies: a brief summary, update and beyond.
World J Pediatr. 2019 Aug 3. doi: 10.1007/s12519-019-00273-z.
https://www.ncbi.nlm.nih.gov/pubmed/31377974 - Concha S, Hernández-Ojeda A, Contreras O, Mendez C, Talesnik E, Borzutzky A.
Chronic nonbacterial osteomyelitis in children: a multicenter case series.
Rheumatol Int. 2019 Aug 2. doi: 10.1007/s00296-019-04400-x.
https://www.ncbi.nlm.nih.gov/pubmed/31375886 - Deza G, Mensa-Vilaró A, March-Rodriguez A, Sánchez S, Pujol RM, Aróstegui JI, Giménez-Arnau AM.
Acquired Cold Urticaria vs. Autoinflammatory Diseases, Genetic and Clinical Profile and Differential Diagnosis: Study of a Cohort of Patients in a Tertiary Reference Centre.
Acta Derm Venereol. 2019 Aug 13. doi: 10.2340/00015555-3292.
https://www.ncbi.nlm.nih.gov/pubmed/31408184 - Aksentijevich I, Sampaio Moura N, Barron K.
Adenosine Deaminase 2 Deficiency.
In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews®[Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. 2019 Aug 8.
https://www.ncbi.nlm.nih.gov/pubmed/31393689 - Rowczenio DM, Youngstein T, Trojer H, Omoyinmi E, Baginska A, Brogan P, Papadopoulou C, Rezk T, Hawkins PN, Lachmann HJ.
British kindred with dominant FMF associated with high incidence of AA amyloidosis caused by novel MEFV variant, and a review of the literature.
Rheumatology (Oxford). 2019 Aug 5. pii: kez334. doi: 10.1093/rheumatology/kez334.
https://www.ncbi.nlm.nih.gov/pubmed/31384939 - Renko M, Lantto U, Tapiainen T.
Towards better diagnostic criteria for periodic fever, aphthous stomatitis, pharyngitis and adenitis syndrome.
Acta Paediatr. 2019 Aug;108(8):1385-1392.
https://www.ncbi.nlm.nih.gov/pubmed/30901126 - Accetturo M, D'Uggento AM, Portincasa P, Stella A.
Improvement of MEFV gene variants classification to aid treatment decision making in familial Mediterranean fever.
Rheumatology (Oxford). 2019 Aug 14.
https://www.ncbi.nlm.nih.gov/pubmed/31411330 - Atas N, Armagan B, Bodakci E, Satis H, Sari A, Bilge NSY, Salman RB, Yardımcı GK, Babaoglu H, Guler AA, Karadeniz H, Kilic L, Ozturk MA, Goker B, Haznedaroglu S, Kalyoncu U, Kasifoglu T, Tufan A.
Familial Mediterranean fever is associated with a wide spectrum of inflammatory disorders: results from a large cohort study.
Rheumatol Int. 2019 Aug 7. doi: 10.1007/s00296-019-04412-7.
https://www.ncbi.nlm.nih.gov/pubmed/31392498
JULIO 2019
- Li GM, Liu HM, Guan WZ, Xu H, Wu BB, Sun L.
Expanding the spectrum of A20 haploinsufficiency in two Chinese families: cases report.
BMC Med Genet. 2019 Jul 12;20(1):124.
https://www.ncbi.nlm.nih.gov/pubmed/31299923 - Papa R, Rusmini M, Volpi S, Caorsi R, Picco P, Grossi A, Caroli F, Bovis F, Musso V, Obici L, Castana C, Ravelli A, Van Gijn ME, Ceccherini I, Gattorno M.
Next generation sequencing panel in undifferentiated autoinflammatory diseases identify patients with colchicine-responder recurrent fevers.
Rheumatology (Oxford). 2019 Jul 19. pii: kez270. doi: 10.1093/rheumatology/kez270. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31325311 - Ter Haar NM, Eijkelboom C, Cantarini L, Papa R, Brogan PA, Kone-Paut I,
Clinical characteristics and genetic analyses of 187 patients with undefined autoinflammatorydiseases.
Ann Rheum Dis. 2019 Jul 5. pii: annrheumdis-2018-214472. doi: 10.1136/annrheumdis-2018-214472. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31278138 - Shin JI, Lee KH, Joo YH, Lee JM, Jeon J, Jung HJ et al.
Inflammasomes and autoimmune and rheumatic diseases: A comprehensive review.
J Autoimmun. 2019 Jul 17:102299. doi: 10.1016/j.jaut.2019.06.010. [Epub ahead of] https://www.ncbi.nlm.nih.gov/pubmed/31326231 - Papadopoulou C, Omoyinmi E, Standing A, Pain CE, Booth C, D'Arco F et al.
Monogenic mimics of Behçet's disease in the young.
Rheumatology (Oxford). 2019 Jul 1;58(7):1227-1238.
https://www.ncbi.nlm.nih.gov/pubmed/30715505 - Demir S, Sag E, Kaya Akca U, Hazirolan T, Bilginer Y, Ozen S.
The Challenge of Treating Pulmonary Vasculitis in Behçet Disease: Two Pediatric Cases.
Pediatrics. 2019 Jul 18. pii: e20190162. doi: 10.1542/peds.2019-0162. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31320468 - Yildiz M, Adrovic A, Tasdemir E, Baba-Zada K, Aydin M, Koker O et al.
Evaluation of co-existing diseases in children with familial Mediterranean fever.
Rheumatol Int. 2019 Jul 27. doi: 10.1007/s00296-019-04391-9. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31352561 - Signa S, Campione E, Rusmini M, Chiesa S, Grossi A, Omenetti A, et al.
Whole exome sequencing approach to childhood onset familial erythrodermic psoriasis unravels a novel mutation of CARD14 requiring unusual high doses of ustekinumab.
Pediatr Rheumatol Online J. 2019 Jul 8;17(1):37.
https://www.ncbi.nlm.nih.gov/pubmed/31286971 - Hospach T, Glowatzki F, Blankenburg F, Conzelmann D, Stirnkorb C, Müllerschön CS, von den Driesch P, Köhler LM, Rohlfs M, Klein C, Hauck F.
Scoping review of biological treatment of deficiency of interleukin-36 receptor antagonist (DITRA) in children and adolescents.
Pediatr Rheumatol Online J. 2019 Jul 8;17(1):37.
https://www.ncbi.nlm.nih.gov/pubmed/31286990 - Gernez Y, de Jesus AA, Alsaleem H, Macaubas C, Roy A, Lovell D, et al.
Severe autoinflammation in four patients with C-terminal variants in CDC42 successfully treated with IL-1β inhibition.
J Allergy Clin Immunol. 2019 Jul 1. pii: S0091-6749(19)30830-9. doi: 10.1016/j.jaci.2019.06.017. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31271789 - Elmi AA, Wynne K, Cheng IL, Eleftheriou D, Lachmann HJ, Hawkins PN, Brogan P.
Retrospective case series describing the efficacy, safety and cost-effectiveness of a vial-sharing programme for canakinumab treatment for paediatric patients with cryopyrin-associated periodic syndrome.
Pediatr Rheumatol Online J. 2019 Jul 8;17(1):36.
https://www.ncbi.nlm.nih.gov/pubmed/31287007 - Julia N, Katharina R, Hermann G, Annette HW, Henner M, Helge H, Christine H.
Physical activity and health-related quality of life in chronic non-bacterial osteomyelitis.
Pediatr Rheumatol Online J. 2019 Jul 18;17(1):45.
https://www.ncbi.nlm.nih.gov/pubmed/31319856 - Surace AEA, Hedrich CM.
The Role of Epigenetics in Autoimmune/Inflammatory Disease.
Front Immunol. 2019 Jul 4;10:1525.
https://www.ncbi.nlm.nih.gov/pubmed/31333659
JUNIO 2019
- Rowczenio D, Shinar Y, Ceccherini I, Sheils K, Van Gijn M, Patton SJ, Touitou I.
Current practices for the genetic diagnosis of autoinflammatory diseases: results of a European Molecular Genetics Quality Network Survey.
Eur J Hum Genet. 2019 Jun 11. doi: 10.1038/s41431-019-0439-9. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31186541 - Gellrich FF, Günther C.
Schnitzler syndrome.
Hautarzt. 2019 Jun 5. doi: 10.1007/s00105-019-4434-4. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31165908 - Brogan PA, Hofer M, Kuemmerle-Deschner JB, Koné-Paut I, Roesler J, Kallinich T, Horneff G, Calvo Penadés I, Sevilla-Perez B, Goffin L, Lauwerys BR, Lachmann HJ, Uziel Y, Wei X, Laxer RM.
Canakinumab provides rapid and sustained long-term efficacy and safety in patients with cryopyrin-associated periodic syndrome aged ≤5 years.
Arthritis Rheumatol. 2019 Jun 4. doi: 10.1002/art.41004. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31161734
ABRIL 2019
- Bettiol A, Lopalco G, Emmi G, Cantarini L, Urban ML, Vitale A, Denora N, Lopalco A, Cutrignelli A, Lopedota A, Venerito V, Fornaro M, Vannacci A, Rigante D, Cimaz R, Iannone F.
Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases
Int J Mol Sci. 2019 Apr 17;20(8). pii: E1898. doi: 10.3390/ijms20081898. Review.
https://www.ncbi.nlm.nih.gov/pubmed/30999610 - Andreasen CM, Jurik AG, Glerup M, Høs C, Mahler B, Hauge EM, Herlin T.
Response to Early-onset Pamidronate Treatment in Chronic Non-Bacterial Osteomyelitis: A Retrospective Single Center Study
J Rheumatol. 2019 Apr 15. pii: jrheum.181254. doi: 10.3899/jrheum.181254. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30988129 - Gattorno M, Hofer M, Federici S, Vanoni F, Bovis F, Aksentijevich I, Anton J, Arostegui JI, Barron K, Ben-Cherit E, Brogan PA, Cantarini L, Ceccherini I, De Benedetti F, Dedeoglu F, Demirkaya E, Frenkel J, Goldbach-Mansky R, Gul A, Hentgen V, Hoffman H, Kallinich T, Kone-Paut I, Kuemmerle-Deschner J, Lachmann HJ, Laxer RM, Livneh A, Obici L, Ozen S, Rowczenio D, Russo R, Shinar Y, Simon A, Toplak N, Touitou I, Uziel Y, van Gijn M, Foell D, Garassino C, Kastner D, Martini A, Sormani MP, Ruperto N.
Classification criteria for autoinflammatory recurrent fevers.
Ann Rheum Dis. 2019 Apr 24. pii: annrheumdis-2019-215048. doi: 10.1136/annrheumdis-2019-215048. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31018962 - Gibson KM, Morishita KA, Dancey P, Moorehead P, Drögemöller B, Han X, Graham J, Hancock RE, Foell D, Benseler S, Luqmani R, Yeung RSM, Shenoi S, Bohm M, Rosenberg AM, Ross CJ, Cabral DA, Brown KL; PedVas investigators network.
Identification of novel Adenosine Deaminase 2 gene variants and varied clinical phenotype in pediatric vasculitis.
Arthritis Rheumatol. 2019 Apr 22. doi: 10.1002/art.40913. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31008556 - Carmona-Rivera C, Khaznadar SS, Shwin KW, Irizarry-Caro JA, O'Neil LJ, Liu Y, Jacobson KA, Ombrello AK, Stone DL, Tsai WL, Kastner DL, Aksentijevich I, Kaplan MJ, Grayson PC.
Deficiency of adenosine deaminase 2 triggers adenosine-mediated NETosis and TNF production in patients with DADA2.
Blood. 2019 Apr 23. pii: blood.2018892752. doi: 10.1182/blood.2018892752. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31015188 - Ombrello AK, Qin J, Hoffmann PM, Kumar P, Stone D, Jones A, Romeo T, Barham B, Pinto-Patarroyo G, Toro C, Soldatos A, Zhou Q, Deuitch N, Aksentijevich I, Sheldon SL, Kelly S, Man A, Barron K, Hershfield M, Flegel WA, Kastner DL.
Treatment Strategies for Deficiency of Adenosine Deaminase 2.
N Engl J Med. 2019 Apr 18;380(16):1582-1584. doi: 10.1056/NEJMc1801927.
https://www.ncbi.nlm.nih.gov/pubmed/30995379 - Havnaer A, Han G.
Autoinflammatory Disorders: A Review and Update on Pathogenesis and Treatment.
Am J Clin Dermatol. 2019 Apr 17. doi: 10.1007/s40257-019-00440-y. [Epub ahead of print] Review.
https://www.ncbi.nlm.nih.gov/pubmed/30997665 - Sparud-Lundin C, Berg S, Fasth A, Karlsson A, Wekell P.
From uncertainty to gradually managing and awaiting recovery of a periodic condition- a qualitative study of parents´ experiences of PFAPA syndrome.
BMC Pediatr. 2019 Apr 8;19(1):99. doi: 10.1186/s12887-019-1458-y.
https://www.ncbi.nlm.nih.gov/pubmed/30961562
MARZO 2019
- Stella A, Cortellessa F, Scaccianoce G, Pivetta B, Settimo E, Portincasa P
Familial Mediterranean fever: breaking all the (genetic) rules
Rheumatology (Oxford) 2019 Mar; 58(3):463–467
https://doi.org/10.1093/rheumatology/key328 - Boursier G, Hentgen V, Sarrabay G, Koné-Paut I, Touitou I.
The Changing Concepts Regarding the Mediterranean Fever Gene: Toward a Spectrum of Pyrin-Associated Autoinflammatory Diseases with Variable Heredity.
J Pediatr. 2019 Mar 27. pii: S0022-3476(19)30271-9. doi: 10.1016/j.jpeds.2019.02.039. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30928144 - García-Robledo JE, Aragón CC, Nieto-AristizabalIván I, Posso-Osorio I, Cañas CA, Tobón GJ
Tofacitinib for familial Mediterranean fever: a new alternative therapy?
Rheumatology (Oxford) 2019 Mar; 58(3):553–554
https://doi.org/10.1093/rheumatology/key384 - Cakici EK, Şükür EDK, Özlü SG, Yazılıtaş F, Özdel S, Gür G, Eroğlu FK, Güngör T, Çelikkaya E, Bağlan E, Bülbül M.
MEFV gene mutations in children with Henoch-Schönlein purpura and their correlations-do mutations matter?
Clin Rheumatol. 2019 Mar 2. doi: 10.1007/s10067-019-04489-2. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30826945 - Briand C, Frémond M, Bessis D, Carbasse A, Rice GI, Bondet Vincent, Duffy D, Chatenoud L, Blanche S, Crow YJ, Neven B
Efficacy of JAK1/2 inhibition in the treatment of chilblain lupus due to TREX1 deficiency.
Ann Rheum Dis 2019 Mar;78(3):431-433.
https://ard.bmj.com/content/78/3/431 - Kilic H, Sahin S, Duman C, Adrovic A, Barut K, Turanli ET, Yildirim SR, Kizilkilic O, Kasapcopur O, Saltik S.
Spectrum of the neurologic manifestations in childhood-onset cryopyrin-associated periodic syndrome.
Eur J Paediatr Neurol. 2019 Mar 28. pii: S1090-3798(18)30566-X. doi: 10.1016/j.ejpn.2019.03.006. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30967326 - Jarosz-Griffiths HH, Holbrook J, Lara-Reyna S, McDermott MF
TNF receptor signalling in autoinflammatory diseases.
Int Immunol. 2019 Mar 6. pii: dxz024. doi: 10.1093/intimm/dxz024. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30838383 - Chuamanochan M, Weller K, Feist E, Kallinich T, Maurer M, Kümmerle-Deschner J, Krause K.
State of care for patients with systemic autoinflammatory diseases - Results of a tertiary care survey.
World Allergy Organ J. 2019 Mar 14;12(3):100019.
https://www.ncbi.nlm.nih.gov/pubmed/30937142 - Renko M, Lantto U, Tapiainen T.
Towards better diagnostic criteria for PFAPA (periodic fever, aphthous stomatitis, pharyngitis and adenitis) syndrome.
Acta Paediatr. 2019 Mar 22. doi: 10.1111/apa.14792. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30901126 - Blank N, Lorenz HM.
Idiopathic Pericarditis-an Autoinflammatory Disease?
Curr Rheumatol Rep. 2019 Mar 9;21(5):18.
https://www.ncbi.nlm.nih.gov/pubmed/30852700
FEBRERO 2019
- Karacan İ, Balamir A, Uğurlu S, Aydın AK, Everest E, Zor S, Önen MÖ, Daşdemir S, Özkaya O, Sözeri B, Tufan A, Yıldırım DG, Yüksel S, Ayaz NA, Ömeroğlu RE, Öztürk K, Çakan M, Söylemezoğlu O, Şahin S, Barut K, Adroviç A, Seyahi E, Özdoğan H, Kasapçopur Ö, Turanlı ET.
Diagnostic utility of a targeted next-generation sequencing gene panel in the clinical suspicion of systemic autoinflammatory diseases: a multi-center study.
Rheumatol Int. 2019 Feb 19. doi: 10.1007/s00296-019-04252-5. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30783801 - Aydın F, Çakar N, Özçakar ZB, Uncu N, Başaran Ö, Özdel S, Çelikel E, Elhan AH, Yalçınkaya F.
Clinical features and disease severity of Turkish FMF children carrying E148Q mutation.
J Clin Lab Anal. 2019 Feb 4:e22852. doi: 10.1002/jcla.22852. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30714637 - Wekell P.
Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis syndrome - PFAPA syndrome.
Presse Med. 2019 Feb;48(1 Pt 2):e77-e87. doi: 10.1016/j.lpm.2018.08.016. Epub 2019 Jan 22.
https://www.ncbi.nlm.nih.gov/pubmed/30683466
ENERO 2019
- Ekinci RMK, Balcı S, Akay E, Tumgor G, Dogruel D, Altintas DU, Yilmaz M.
Frequency of functional gastrointestinal disorders in children with familial Mediterranean fever.
Clin Rheumatol. 2019 Jan 31. doi: 10.1007/s10067-019-04452-1. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30706291 - Gaggiano C, Rigante D, Sota J, Grosso S, Cantarini L.
Treatment options for periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome in children and adults: a narrative review.
Clin Rheumatol. 2019 Jan;38(1):11-17. doi: 10.1007/s10067-018-4361-2. Epub 2018 Nov 28.
https://www.ncbi.nlm.nih.gov/pubmed/30488366 - C Papadopoulou, E Omoyinmi, A Standing, C E Pain, C Booth, F D’Arco, K Gilmour, M Buckland, D Eleftheriou, P A Brogan.
Monogenic mimics of Behçet’s disease in the Young.
Rheumatology 2019 Jan. https://doi.org/10.1093/rheumatology/key445
https://www.ncbi.nlm.nih.gov/pubmed/30715505
DICIEMBRE 2018
- Imayoshi M, Ogata Y, Yamamoto S.
A Case of Sporadic Blau Syndrome with an Uncommon Clinical Course.
Case Rep Rheumatol. 2018 Dec 30;2018:6292308. doi: 10.1155/2018/6292308
https://www.ncbi.nlm.nih.gov/pubmed/30693132
OCTUBRE 2018
- Hausmann JS.
Targeting cytokines to treat autoinflammatory diseases.
Clin Immunol. 2018 Oct 27. pii: S1521-6616(18)30432-7. doi: 10.1016/j.clim.2018.10.016. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30394352 - Hong Y, Standing ASI, Nanthapisal S, Sebire N, Jolles S, Omoyinmi E, Verstegen RH, Brogan PA, Eleftheriou D.
Autoinflammation due to homozygous S208 MEFV mutation
Ann Rheum Dis. 2018 Oct 24. pii: annrheumdis-2018-214102. doi: 10.1136/annrheumdis-2018-214102. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30355575
SEPTIEMBRE 2018
- Mensa-Vilaró A, García-Morato MB, de la Calle-Martin O, Franco-Jarava C, Martínez-Saavedra MT, González-Granado LI, González-Roca E, Fuster JL, Alsina L, Mutchinick OM, Balderrama-Rodríguez A, Ramos E, Modesto C, Mesa-Del-Castillo P, Ortego-Centeno N, Clemente D, Souto A, Palmou N, Remesal A, Leslie KS, Gómez de la Fuente E, Bravo Gallego LY, Campistol JM, Dhouib NG, Bejaoui M, Dutra LA, Terreri MT, Mosquera C, González T, Cañellas J, García-Ruiz de Morales JM, Wouters CH, Bosque MT, Cham WT, Jiménez-Treviño S, de Inocencio J, Bloomfield M, Pérez de Diego R, Martínez-Pomar N, Rodríguez-Pena R, González-Santesteban C, Soler-Palacín P, Casals F, Yagüe J, Allende LM, Rodríguez-Gallego JC, Colobran R, Martínez-Martínez L, López-Granados E, Aróstegui JI
Unexpected Relevant Role of Gene Mosaicism in Primary Immunodeficiency Diseases.
J Allergy Clin Immunol. 2018 Sep 28. pii: S0091-6749(18)31358-7. doi: 10.1016/j.jaci.2018.09.009. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30273710 - Labrousse M, Kevorkian-Verguet C, Boursier G, Rowczenio D, Maurier F, Lazaro E, Aggarwal M, Lemelle I, Mura T, Belot A, Touitou I, Sarrabay G.
Mosaicism in autoinflammatory diseases: Cryopyrin-associated periodic syndromes (CAPS) and beyond. A systematic review.
Crit Rev Clin Lab Sci. 2018 Sep;55(6):432-442
https://www.ncbi.nlm.nih.gov/pubmed/30035647 - Moghaddas F, Masters SL.
The classification, genetic diagnosis and modelling of monogenic autoinflammatory disorders.
Clin Sci (Lond). 2018 Sep 5;132(17):1901-1924
https://www.ncbi.nlm.nih.gov/pubmed/30185613 - Vanoni F, Caorsi R, Aeby S, Cochard M, Antón J, Berg S, Brik R, Dolezalova P, Koné-Paut I, Neven B, Ozen S, Pillet P, Stojanov S, Wouters C, Gattorno M, Hofer M.
Towards a new set of classification criteria for PFAPA syndrome.
Pediatr Rheumatol Online J. 2018 Sep 21;16(1):60.
https://www.ncbi.nlm.nih.gov/pubmed/30241480 - Keddie S, Parker T, Lachmann HJ, Ginsberg L.
Cryopyrin-Associated Periodic Fever Syndrome and the Nervous System.
Curr Treat Options Neurol. 2018 Sep 3;20(10):43
https://www.ncbi.nlm.nih.gov/pubmed/30175395 - Aeschlimann FA, Laxer RM
Haploinsufficiency of A20 and other paediatric inflammatory disorders with mucosal involvement.
Curr Opin Rheumatol. 2018 Sep;30(5):506-513
https://www.ncbi.nlm.nih.gov/pubmed/29916847 - Cardis MA, Montealegre Sanchez GA, Goldbach-Mansky R, Richard Lee CC, Cowen EW.
Recurrent fevers, progressive lipodystrophy and annular plaques in a child.
J Am Acad Dermatol. 2018 Sep 8. pii: S0190-9622(18)32498-8. doi: 10.1016/j.jaad.2018.08.043. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30205133 - Holzinger D, Foell D, Kessel C.
The role of S100 proteins in the pathogenesis and monitoring of autoinflammatory diseases.
Mol Cell Pediatr. 2018 Sep 25;5(1):7.
https://www.ncbi.nlm.nih.gov/pubmed/30255357 - Martinez-Rios C, Jariwala MP, Highmore K, Duffy KW, Spiegel L, Laxer RM, Stimec J
Imaging findings of sterile pyogenic arthritis, pyoderma gangrenosum and acne (PAPA) syndrome: differential diagnosis and review of the literature.
Pediatr Radiol. 2018 Sep 17. doi: 10.1007/s00247-018-4246-1. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30225645
AGOSTO 2018
- Rafiq NK, Lachmann H, Joensen F, Herlin T, Brogan PA.
Tocilizumab for the Treatment of Mevalonate Kinase Deficiency.
Case Rep Pediatr. 2018 Aug 26;2018:3514645.
https://www.ncbi.nlm.nih.gov/pubmed/30225156 - Sönmez HE, Esmeray P, Batu ED, Arıcı ZS, Demir S, Sağ E, Özen S, Bilginer Y.
Is age associated with disease severity and compliance to treatment in children with familial Mediterranean fever?
Rheumatol Int. 2018 Aug 7. doi: 10.1007/s00296-018-4123-0. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30088045 - Latour I, Noguera-Morel L, Colmenero I, Clemente D, Hernández-Martín A, López-Robledillo JC, Arostegui JI, Torrelo A.
Chronic urticaria in infants as the first manifestation of autoinflammatory disease.
Pediatr Dermatol. 2018 Aug 30. doi: 10.1111/pde.13619. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30168189 - Fabiani C, Vitale A, Rigante D, Emmi G, Lopalco G, Di Scala G, Sota J, Orlando I, Franceschini R, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L.
The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease.
Ocul Immunol Inflamm. 2018 Aug 27:1-7. doi: 10.1080/09273948.2018.1511810. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30148652 - Ben-Chetrit E, Gattorno M, Gul A, Kastner DL, Lachmann HJ, Touitou I, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO) and the AIDs Delphi study participants
Consensus proposal for taxonomy and definition of the autoinflammatory diseases (AIDs): a Delphi study.
Ann Rheum Dis. 2018 Aug 12. pii: annrheumdis-2017-212515. doi: 10.1136/annrheumdis-2017-212515. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30100561 - Sota J, Vitale A, Rigante D, Orlando I, Lucherini OM, Simpatico A, Lopalco G, Franceschini R, Galeazzi M, Frediani B, Fabiani C, Tosi GM, Cantarini L.
Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behçet's Disease.
Isr Med Assoc J. 2018 Aug;20(8):517-521.
https://www.ncbi.nlm.nih.gov/pubmed/30084580 - Ter Haar NM, van Delft ALJ, Annink KV, van Stel H, Al-Mayouf SM, Amaryan G, Anton J, Barron KS, Benseler S, Brogan PA, Cantarini L, Cattalini M, Cochino AV, de Benedetti F, Dedeoglu F, de Jesus AA, Demirkaya E, Dolezalova P, Durrant KL, Fabio G, Gallizzi R, Goldbach-Mansky R, Hachulla E, Hentgen V, Herlin T, Hofer M, Hoffman HM, Insalaco A, Jansson AF, Kallinich T, Kone-Paut I, Kozlova A, Kuemmerle-Deschner JB, Lachmann HJ, Laxer RM, Martini A, Nielsen S, Nikishina I, Ombrello AK, Özen S, Papadopoulou-Alataki E, Quartier P, Rigante D, Russo R, Simon A, Trachana M, Uziel Y, Ravelli A, Schulert G, Gattorno M, Frenkel J.
In silico validation of the Autoinflammatory Disease Damage Index.
Ann Rheum Dis. 2018 Aug 4. pii: annrheumdis-2018-213725. doi: 10.1136/annrheumdis-2018-213725. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30077992 - Reeves E, James E.
The role of polymorphic ERAP1 in autoinflammatory disease.
Biosci Rep. 2018 Aug 29;38(4). pii: BSR20171503. doi: 10.1042/BSR20171503. Print 2018 Sep 3.
https://www.ncbi.nlm.nih.gov/pubmed/30054427 - Grimwood C, Kone-Paut I, Piram M, Rossi-Semerano L, Hentgen V.
Health-related quality of life in children with PFAPA syndrome.
Orphanet J Rare Dis. 2018 Aug 9;13(1):132. doi: 10.1186/s13023-018-0878-3.
https://www.ncbi.nlm.nih.gov/pubmed/30092788 - Kettunen S, Lantto U, Koivunen P, Tapiainen T, Uhari M, Renko M.
Risk factors for periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome: a case-control study.
Eur J Pediatr. 2018 Aug;177(8):1201-1206. doi: 10.1007/s00431-018-3175-1. Epub 2018 May 25.
https://www.ncbi.nlm.nih.gov/pubmed/29799086
JULIO 2018
- Wang L, Rosé CD, Foley KP, Anton J, Bader-Meunier B, Brissaud P, Chédeville G, Cimaz R, Fernández-Martín J, Guly C, Hachulla E, Harjacek M, Mackensen F, Merino R, Modesto C, Naranjo Hernández A, Pajot C, Ramanan AV, Thatayatikom A, Thomée C, Vastert S, Votta BJ, Bertin J, Wouters CH.
S100A12 and S100A8/9 proteins are biomarkers of articular disease activity in Blau syndrome.
Rheumatology (Oxford). Volume 57, Issue 7, 1 July 2018, Pages 1299–1304. doi: 10.1093/rheumatology/key090. [Epub ahead of print] - Adrovic A, Sahin S, Barut K, Kasapcopur O.
Familial Mediterranean fever and periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome: shared features and main differences.
Rheumatol Int. 2018 Jul 17. doi: 10.1007/s00296-018-4105-2. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30019226
JUNIO 2018
- Hatemi G, Christensen R, Bang D, Bodaghi B, Celik AF, Fortune F, Gaudric J, Gul A, Kötter I, Leccese P, Mahr A, Moots R, Ozguler Y, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H.
2018 update of the EULAR recommendations for the management of Behçet's syndrome.
Ann Rheum Dis. 2018 Jun;77(6):808-818. doi: 10.1136/annrheumdis-2018-213225.
https://www.ncbi.nlm.nih.gov/pubmed/29625968 - Başaran Ö, Uncu N, Çakar N, Turanlı ET, Kiremitci S, Aydın F, Bayrakcı US.
C3 glomerulopathy in NLRP12-related autoinflammatory disorder: case-based review.
Rheumatol Int. 2018 Jun 27. doi: 10.1007/s00296-018-4092-3
https://www.ncbi.nlm.nih.gov/pubmed/29951964 - Hoffman HM, Broderick L.
JAK inhibitors in autoinflammation.
J Clin Invest. 2018 Jun 11. pii: 121526. doi: 10.1172/JCI121526
https://www.ncbi.nlm.nih.gov/pubmed/29889100 - Davis MDP, van der Hilst JCH.
Mimickers of Urticaria: Urticarial Vasculitis and Autoinflammatory Diseases.
J Allergy Clin Immunol Pract. 2018 Jun 2. pii: S2213-2198(18)30328-3. doi: 10.1016/j.jaip.2018.05.006
https://www.ncbi.nlm.nih.gov/pubmed/29871797 - Jamilloux Y, Belot A, Magnotti F, Benezech S, Gerfaud-Valentin M, Bourdonnay E, Walzer T, Sève P, Henry T.
Geoepidemiology and Immunologic Features of Autoinflammatory Diseases: a Comprehensive Review.
Clin Rev Allergy Immunol. 2018 Jun;54(3):454-479. doi: 10.1007/s12016-017-8613-8
https://www.ncbi.nlm.nih.gov/pubmed/28578473 - Rigante D, Frediani B, Cantarini L.
A Comprehensive Overview of the Hereditary Periodic Fever Syndromes.
Clin Rev Allergy Immunol. 2018 Jun;54(3):446-453. doi: 10.1007/s12016-016-8537-8
https://www.ncbi.nlm.nih.gov/pubmed/27068928
MAYO 2018
- Hatemi G, Christensen R, Bang D, Bodaghi B, Celik AF, Fortune F, Gaudric J, Gul A, Kötter I, Leccese P, Mahr A, Moots R, Ozguler Y, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H.
2018 update of the EULAR recommendations for the management of Behçet's syndrome.
Ann Rheum Dis. 2018 Jun;77(6):808-818. doi: 10.1136/annrheumdis-2018-213225.
https://www.ncbi.nlm.nih.gov/pubmed/29625968 - Kostik MM, Suspitsin EN, Guseva MN, Levina AS, Kazantseva AY, Sokolenko AP, Imyanitov EN.
Multigene sequencing reveals heterogeneity of NLRP12-related autoinflammatory disorders.
Rheumatol Int. 2018 May;38(5):887-893. doi: 10.1007/s00296-018-4002-8. Epub 2018 Mar 2.
https://www.ncbi.nlm.nih.gov/pubmed/29500522 - Alibaz-Oner F, Sawalha AH, Direskeneli H.
Management of Behçet's disease.
Curr Opin Rheumatol. 2018 May;30(3):238-242. doi:10.1097/BOR.0000000000000497.
https://www.ncbi.nlm.nih.gov/pubmed/29432223 - Gazi U, Agada ME, Ozkayalar H, Dalkan C, Sanlidag B, Safak MA, Mocan G, Bahceciler NO.
Tonsillar antimicrobial peptide (AMP) expression profiles of periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis (PFAPA) patients.
Int J Pediatr Otorhinolaryngol. 2018 Jul;110:100-104. doi: 10.1016/j.ijporl.2018.05.005. Epub 2018 May 8.
https://www.ncbi.nlm.nih.gov/pubmed/29859567 - Alam F, Hammoudeh M.
An Underlooked Cause of Periodic Fever (PFAPA) in an Adult Patient with No Response to Tonsillectomy.
Case Rep Rheumatol. 2018 May 2;2018:6580835. doi: 10.1155/2018/6580835. eCollection 2018.
https://www.ncbi.nlm.nih.gov/pubmed/29854539 - Steiner A, Harapas CR, Masters SL, Davidson S.
An Update on Autoinflammatory Diseases: Relopathies.
Curr Rheumatol Rep. 2018 May 30;20(7):39. doi: 10.1007/s11926-018-0749-x. Review.
https://www.ncbi.nlm.nih.gov/pubmed/29846841 - Harapas CR, Steiner A, Davidson S, Masters SL.
An Update on Autoinflammatory Diseases: Inflammasomopathies.
Curr Rheumatol Rep. 2018 May 30;20(7):40. doi: 10.1007/s11926-018-0750-4. Review.
https://www.ncbi.nlm.nih.gov/pubmed/29846819 - Davidson S, Steiner A, Harapas CR, Masters SL.
An Update on Autoinflammatory Diseases: Interferonopathies.
Curr Rheumatol Rep. 2018 May 30;20(7):38. doi: 10.1007/s11926-018-0748-y. Review.
https://www.ncbi.nlm.nih.gov/pubmed/29846818 - Zheng C, Huang Y, Ye Z, Wang Y, Tang Z, Lu J, Wu J, Zhou Y, Wang L, Huang Z, Yang H, Xue A.
Infantile Onset Intractable Inflammatory Bowel Disease Due to Novel Heterozygous Mutations in TNFAIP3 (A20).
Inflamm Bowel Dis. 2018 May 17. doi: 10.1093/ibd/izy165. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29788367 - Roig-Abraham N, Méndez-Hernández M, Martínez-Morillo M.
Chronic recurrent multifocal osteomyelitis in pediatrics: A diagnostic challenge.
Rev Esp Cir Ortop Traumatol. 2018 May 15. pii: S1888-4415(18)30071-7. doi: 10.1016/j.recot.2018.03.008. [Epub ahead of print] English, Spanish.
https://www.ncbi.nlm.nih.gov/pubmed/29776891 - Rigante D, Manna R, Verrecchia E, Marrocco R, Leone A.
Resolution of femoral metaphyseal dysplasia in CINCA syndrome after long-term treatment with interleukin-1 blockade.
Clin Rheumatol. 2018 May 16. doi: 10.1007/s10067-018-4145-8. [Epub ahead of print] Review.
https://www.ncbi.nlm.nih.gov/pubmed/29766377
ABRIL 2018
- Canna SW, Goldbach-Mansky R.
Introduction: Autoinflammatory Syndromes Special Issue-hidden mysteries in the corners of autoinflammation.
Int Immunol. 2018 Apr 25;30(5):181-182. doi: 10.1093/intimm/dxy022.
https://www.ncbi.nlm.nih.gov/pubmed/29697820 - Rama M, Duflos C, Melki I, Bessis D, Bonhomme A, Martin H, Doummar D, Valence S, Rodriguez D, Carme E, Genevieve D, Heimdal K, Insalaco A, Franck N14, Queyrel-Moranne V, Tieulie N, London J, Uettwiller F, Georgin-Lavialle S, Belot A, Koné-Paut I, Hentgen V, Boursier G, Touitou I, Sarrabay G.
A decision tree for the genetic diagnosis of deficiency of adenosine deaminase 2 (DADA2): a French reference centres experience.
Eur J Hum Genet. 2018 Apr 23. doi: 10.1038/s41431-018-0130-6. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29681619 - Emmi G, Vitale A, Silvestri E, Boddi M, Becatti M, Fiorillo C, Fabiani C, Frediani B, Emmi L, Scala GD, Goldoni M, Bettiol A, Vaglio A, Cantarini L, Prisco D.
Adalimumab-based treatment versus DMARDs for venous thrombosis in Behçet syndrome. A retrospective study of 70 patients with vascular involvement.
Arthritis Rheumatol. 2018 Apr 20. doi: 10.1002/art.40531. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29676522 - Scambler T, Holbrook J, Savic S, McDermott MF, Peckham D.
Autoinflammatory Disease in the Lung.
Immunology. 2018 Apr 19. doi: 10.1111/imm.12937. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29676014 - Fabiani C, Vitale A, Rigante D, Emmi G, Lopalco G, Sota J, Vannozzi L, di Scala G, Guerriero S, Orlando I, Franceschini R, Capozzoli M, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L.
Predictors of sustained clinical response in patients with Behçet's disease-related uveitis treated with infliximab and adalimumab.
Clin Rheumatol. 2018 Apr 18. doi: 10.1007/s10067-018-4092-4. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29671190 - Sanchez GAM, Reinhardt A, Ramsey S, Wittkowski H, Hashkes PJ, Berkun Y, Schalm S, Murias S, Dare JA, Brown D, Stone DL, Gao L, Klausmeier T, Foell D, Jesus AA, Chapelle DC, Kim H, Dill S, Colbert R, Failla L, Kost B, O'Brien M, Reynolds JC, Folio LR, Calvo KR, Paul SM, Weir N, Brofferio A, Soldatos A, Biancotto A, Cowen EW, Digiovanna JG, Gadina M, Lipton AJ, Hadigan C, Holland SM, Fontana J, Alawad AS, Brown RJ, Rother KI, Heller T, Brooks KM, Kumar P, Brooks SR, Waldman M, Singh HK, Nickeleit V, Silk M, Prakash A, Janes JM, Ozen S, Wakim PG, Brogan PA, Macias WL, Goldbach-Mansky R.
JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies.
J Clin Invest. 2018 Apr 12. pii: 98814. doi: 10.1172/JCI98814. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29649002 - Brucato A, Emmi G, Cantarini L, Di Lenarda A, Gattorno M, Lopalco G, Marcolongo R, Imazio M, Martini A, Prisco D.
Management of idiopathic recurrent pericarditis in adults and in children: a role for IL-1 receptor antagonism.
Intern Emerg Med. 2018 Apr 9. doi: 10.1007/s11739-018-1842-x. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29633070ç - Szymanski AM, Ombrello MJ.
Using genes to triangulate the pathophysiology of granulomatous autoinflammatory disease: NOD2, PLCG2 and LACC1.
Int Immunol. 2018 Apr 25;30(5):205-213. doi: 10.1093/intimm/dxy021.
https://www.ncbi.nlm.nih.gov/pubmed/29538758
MARZO 2018
- Girschick H, Finetti M, Orlando F, Schalm S, Insalaco A, Ganser G, Nielsen S, Herlin T, Koné-Paut I, Martino S, Cattalini M, Anton J, Mohammed Al-Mayouf S, Hofer M, Quartier P, Boros C, Kuemmerle-Deschner J, Pires Marafon D, Alessio M, Schwarz T, Ruperto N, Martini A, Jansson A, Gattorno M; PRINTO and the Eurofever registry.
The multifaceted presentation of chronic recurrent multifocal osteomyelitis: a series of 486 cases from the Eurofever international registry.
Rheumatology (Oxford). 2018 Mar 27. doi: 10.1093/rheumatology/key058. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29596638 - Van Gijn ME, Ceccherini I, Shinar Y, Carbo EC, Slofstra M, Arostegui JI, Sarrabay G, Rowczenio D, Omoyımnı E, Balci-Peynircioglu B, Hoffman HM, Milhavet F, Swertz MA, Touitou I.
New workflow for classification of genetic variants' pathogenicity applied to hereditary recurrent fevers by the International Study Group for Systemic Autoinflammatory Diseases (INSAID).
J Med Genet. 2018 Mar 29. pii: jmedgenet-2017-105216. doi: 10.1136/jmedgenet-2017-105216. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29599418 - Tanaka T, Yoshioka K, Nishikomori R, Sakai H, Abe J, Yamashita Y, Hiramoto R, Morimoto A, Ishii E, Arakawa H, Kaneko U, Ohshima Y, Okamoto N, Ohara O, Hata I, Shigematsu Y, Kawai T, Yasumi T, Heike T.
National survey of Japanese patients with mevalonate kinase deficiency reveals distinctive genetic and clinical characteristics.
Mod Rheumatol. 2018 Mar 2:1-7. doi: 10.1080/14397595.2018.1442639. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29451047 - Aydin F, Özçakar ZB, Çakar N, Çelikel E, Uncu N, Çelikel Acar B, Yalçinkaya F.
Sacroiliitis in Children With Familial Mediterranean Fever.
J Clin Rheumatol. 2018 Mar 29. doi: 10.1097/RHU.0000000000000770. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29596210
FEBRERO 2018
- Harel L, Hashkes PJ, Lapidus S, Edwards KM, Padeh S, Gattorno M, Marshall GS.
The First International Conference on Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis Syndrome.
J Pediatr. 2018 Feb;193:265-274.e3.
https://www.ncbi.nlm.nih.gov/pubmed/29246466 - Cherqaoui B, Rossi-Semerano L, Georgin-Lavialle S, Dusser P, Galeotti C, Piram M, Hentgenb V, Touitou I, Koné-Paut I.
Boundaries between familial Mediterranean fever and juvenile spondyloarthritis: Analysis of three French retrospective cohorts.
Joint Bone Spine. 2018 Feb 13. pii: S1297-319X(18)30013-7. doi: 10.1016/j.jbspin.2018.01.010. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29452306
ENERO 2018
- Awad F, Assrawi E, Louvrier C, Jumeau C, Georgin-Lavialle S, Grateau G, Amselem S, Giurgea I, Karabina SA.
Inflammasome biology, molecular pathology and therapeutic implications
Pharmacol Ther. 2018 Feb 18. pii: S0163-7258(18)30036-6. doi: 10.1016/j.pharmthera.2018.02.011
https://www.ncbi.nlm.nih.gov/pubmed/29466702 - De Pauli S, Lega S, Pastore S, Grasso DL, Bianco AMR, Severini GM, Tommasini A, Taddio A.
Neither hereditary periodic fever nor periodic fever, aphthae, pharingitis, adenitis: Undifferentiated periodic fever in a tertiary pediatric center
World J Clin Pediatr. 2018 Feb 8;7(1):49-55. doi: 10.5409/wjcp.v7.i1.49. eCollection 2018 Feb 8.
https://www.ncbi.nlm.nih.gov/pubmed/29456932 -
Aeschlimann FA, Batu ED, Canna SW, Go E, Gül A, Hoffmann P, Leavis HL, Ozen S, Schwartz DM, Stone DL, van Royen-Kerkof A, Kastner DL, Aksentijevich I, Laxer RM.
A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB mediated autoinflammatory disease.
Ann Rheum Dis. 2018 Jan 9. pii: annrheumdis-2017-212403. doi: 10.1136/annrheumdis-2017-212403. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29317407 -
Roderick MR, Sen ES, Ramanan AV.
Chronic recurrent multifocal osteomyelitis in children and adults: current understanding and areas for development.
Rheumatology (Oxford). 2018 Jan 1;57(1):41-48. doi: 10.1093/rheumatology/kex066.
https://www.ncbi.nlm.nih.gov/pubmed/28486628 -
Harel L, Hashkes PJ, Lapidus S, Edwards KM, Padeh S, Gattorno M, Marshall GS.
The First International Conference on Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis Syndrome.
J Pediatr. 2018 Feb;193:265-274.e3. doi: 10.1016/j.jpeds.2017.10.034. Epub 2017 Dec 12.
https://www.ncbi.nlm.nih.gov/pubmed/29246466
DICIEMBRE 2017
- Taddio A, Ferrara G, Insalaco A, Pardeo M, Gregori M, Finetti M, Pastore S, Tommasini A, Ventura A, Gattorno M.
Dealing with Chronic Non-Bacterial Osteomyelitis: a practical approach.
Pediatr Rheumatol Online J. 2017 Dec 29;15(1):87. doi: 10.1186/s12969-017-0216-7.
https://www.ncbi.nlm.nih.gov/pubmed/29287595 - Alsultan A, Basher E, Alqanatish J, Mohammed R, Alfadhel M.
Deficiency of ADA2 mimicking autoimmune lymphoproliferative syndrome in the absence of livedo reticularis and vasculitis.
Pediatr Blood Cancer. 2017 Dec 22. doi: 10.1002/pbc.26912. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29271561 - Thanarajasingam U, Jensen MA, Dorschner JM, Wampler Muskardin T, Ghodke-Puranik Y, Purmalek M, Eliopoulos E, Zervou MI, Goulielmos GN, Howard M, Kaplan MJ, Niewold TB.
Brief Report: A Novel ELANE Mutation Associated With Inflammatory Arthritis, Defective NETosis, and Recurrent Parvovirus Infection.
Arthritis Rheumatol. 2017 Dec;69(12):2396-2401.
https://www.ncbi.nlm.nih.gov/pubmed/28881492 - Mantovani A.
Wandering pathways in the regulation of innate immunity and inflammation.
J Autoimmun. 2017 Dec;85:1-5.
https://www.ncbi.nlm.nih.gov/pubmed/29079064 - Gallizzi R, Pidone C, Cantarini L, Finetti M, Cattalini M, Filocamo G, Insalaco A, Rigante D, Consolini R, Maggio MC, Civino A, Martino S, Olivieri AN, Fabio G, Pastore S, Mauro A, Sutera D, Trimarchi G, Ruperto N, Gattorno M, Cimaz R.
A national cohort study on pediatric Behçet's disease: cross-sectional data from an Italian registry.
Pediatr Rheumatol Online J. 2017 Dec 21;15(1):84.
https://www.ncbi.nlm.nih.gov/pubmed/29268757 - Ibáñez Alcalde MLM, Caldevilla Asenjo L, Calvo Rey C, García-Mon Marañés F, Blázquez Gamero D, Saavedra Lozano J, Navarro Gómez ML, Hernández-Sampelayo Matos T, Santos Sebastián M.
Características y evolución de una cohorte de niños con síndrome PFAPA en la Comunidad de Madrid.
Reumatol Clin. 2017 Dec 8. pii: S1699-258X(17)30274-7. doi: 10.1016/j.reuma.2017.10.015. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29229448 - Kadowaki T, Ohnishi H, Kawamoto N, Hori T, Nishimura K, Kobayashi C, Shigemura T, Ogata S, Inoue Y, Kawai T, Hiejima E, Takagi M, Imai K, Nishikomori R, Ito S, Heike T, Ohara O, Morio T, Fukao T, Kanegane H.
Haploinsufficiency of A20 causes autoinflammatory and autoimmune disorders.
J Allergy Clin Immunol. 2017 Dec 11. pii: S0091-6749(17)31885-7. doi: 10.1016/j.jaci.2017.10.039. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29241730 - Kiyani A, Parperis K, Parperis K.
Familial Mediterranean Fever Imitating Lupus Flare: A Rare Coexistence of an Autoimmune With an Autoinflammatory Disease.
J Clin Rheumatol. 2017 Dec 1. doi: 10.1097/RHU.0000000000000636. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29200027 - Sighart R, Rech J, Hueber A, Blank N, Löhr S, Reis A, Sticht H, Hüffmeier U.
Evidence for genetic overlap between adult onset Still's disease and hereditary periodic fever syndromes.
Rheumatol Int. 2017 Nov 20. doi: 10.1007/s00296-017-3885-0. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29159471
NOVIEMBRE 2017
- Bujan-Rivas S, Basagaña M, Sena F, Méndez M, Dordal MT, Gonzalez-Roca E, Ruiz-Ortiz E, Mensa-Vilaró A, Plaza S, Modesto C, Ordi-Ros J, Yagüe J, Martínez-Valle F, Aróstegui JI.
Novel evidences of atypical manifestations in cryopyrin-associated periodic syndromes.
Clin Exp Rheumatol. 2017 Nov-Dec;35 Suppl 108(6):27-31.
https://www.ncbi.nlm.nih.gov/pubmed/28079503 - Lasigliè D, Mensa-Vilaro A, Ferrera D, Caorsi R, Penco F, Santamaria G, Di Duca M, Amico G, Nakagawa K, Antonini F, Tommasini A, Consolini R, Insalaco A, Cattalini M, Obici L, Gallizzi R, Santarelli F, Del Zotto G, Severino M, Rubartelli A, Ravazzolo R, Martini A, Ceccherini I, Nishikomori R, Gattorno M, Arostegui JI, Borghini S.
Cryopyrin-associated Periodic Syndromes in Italian Patients: Evaluation of the Rate of Somatic NLRP3 Mosaicism and Phenotypic Characterization.
J Rheumatol. 2017 Nov;44(11):1667-1673
https://www.ncbi.nlm.nih.gov/pubmed/28916543 - Kim H, Brooks KM, Tang CC, Wakim P, Blake M, Brooks SR, Montealegre Sanchez GA, de Jesus AA, Huang Y, Tsai WL, Gadina M, Prakash A, Janes JM, Zhang X, Macias WL, Kumar P, Goldbach-Mansky R.
Pharmacokinetics, Pharmacodynamics, and Proposed Dosing of the Oral JAK1 and JAK2 Inhibitor Baricitinib in Pediatric and Young Adult CANDLE and SAVI Patients.
Clin Pharmacol Ther. 2017 Nov 14
https://www.ncbi.nlm.nih.gov/pubmed/29134648 - Ekinci RMK, Balci S, Serbes M, Dogruel D, Altintas DU, Yilmaz M.
Decreased serum vitamin B12 and vitamin D levels affect sleep quality in children with familial Mediterranean fever.
Rheumatol Int. 2017 Nov 15
https://www.ncbi.nlm.nih.gov/pubmed/29143127 - Heilig R, Broz P.
Function and mechanism of the pyrin inflammasome.
Eur J Immunol. 2017 Nov 16
https://www.ncbi.nlm.nih.gov/pubmed/29148036 - Sighart R, Rech J, Hueber A, Blank N, Löhr S, Reis A, Sticht H, Hüffmeier U.
Evidence for genetic overlap between adult onset Still's disease and hereditary periodic fever syndromes.
Rheumatol Int. 2017 Nov 20.
https://www.ncbi.nlm.nih.gov/pubmed/29159471 - Makay B, Gülez N.
Long-term follow-up of paediatric MEFV carriers.
Clin Rheumatol. 2017 Nov 3
https://www.ncbi.nlm.nih.gov/pubmed/29101676
OCTUBRE 2017
- Jiang H, He H, Chen Y, Huang W, Cheng J, Ye J, Wang A, Tao J, Wang C, Liu Q, Jin T, Jiang W, Deng X, Zhou R.
Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders.
J Exp Med. 2017 Oct 11. pii: jem.20171419. doi: 10.1084/jem.20171419. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29021150 - Brenner R, Ben-Zvi I, Shinar Y, Liphshitz I, Silverman B, Peled N, Levy C, Ben-Chitrit E, Livneh A, Kivity S.
Familial Mediterranean fever and incidence of cancer An analysis of 8534 patients with 258,803 person-years.
Arthritis Rheumatol. 2017 Oct 9. doi: 10.1002/art.40344. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/28992365 - Hashem H, Kelly SJ, Ganson NJ, Hershfield MS.
Deficiency of Adenosine Deaminase 2 (DADA2), an Inherited Cause of Polyarteritis Nodosa and a Mimic of Other Systemic Rheumatologic Disorders.
Curr Rheumatol Rep. 2017 Oct 5;19(11):70. doi: 10.1007/s11926-017-0699-8.
https://www.ncbi.nlm.nih.gov/pubmed/28983775 - Papa R, Doglio M, Lachmann HJ, Ozen S, Frenkel J, Simon A, Neven B, Kuemmerle-Deschner J, Ozgodan H, Caorsi R, Federici S, Finetti M, Trachana M, Brunner J, Bezrodnik L, Pinedo Gago MC, Maggio MC, Tsitsami E, Al Suwairi W, Espada G, Shcherbina A, Aksu G, Ruperto N, Martini A, Ceccherini I, Gattorno M; Paediatric Rheumatology International Trials Organisation (PRINTO) and the Eurofever Project.
A web-based collection of genotype-phenotype associations in hereditary recurrent fevers from the Eurofever registry
Orphanet J Rare Dis. 2017 Oct 18;12(1):167. doi: 10.1186/s13023-017-0720-3.
https://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/29047407 - Jamilloux Y, Lefeuvre L, Magnotti F, Martin A, Benezech S, Allatif O, Penel-Page M, Hentgen V, Sève P, Gerfaud-Valentin M, Duquesne A, Desjonquères M, Laurent A, Rémy-Piccolo V, Cimaz R, Cantarini L, Bourdonnay E, Walzer T, Py BF, Belot A, Henry T.
Familial Mediterranean fever mutations are hypermorphic mutations that specifically decrease the activation threshold of the Pyrin inflammasome.
Rheumatology (Oxford). 2017 Oct 12. doi: 10.1093/rheumatology/kex373. [Epub ahead of print]
https://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/29040788 - Hofmann SR, Kapplusch F, Girschick HJ, Morbach H, Pablik J, Ferguson PJ, Hedrich CM.
Chronic Recurrent Multifocal Osteomyelitis (CRMO): Presentation, Pathogenesis, and Treatment
Curr Osteoporos Rep. 2017 Oct 27. doi: 10.1007/s11914-017-0405-9. [Epub ahead of print] Review.
https://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/29080202 - Collison J.
Autoinflammation: Stem cell transplantation for DADA2
Nat Rev Rheumatol. 2017 Oct 20. doi: 10.1038/nrrheum.2017.175. [Epub ahead of print]
https://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/29051624
SEPTIEMBRE 2017
- Nakanishi H, Kawashima Y, Kurima K, Chae JJ, Ross AM, Pinto-Patarroyo G, Patel SK, Muskett JA, Ratay JS, Chattaraj P, Park YH, Grevich S, Brewer CC, Hoa M, Kim HJ, Butman JA, Broderick L, Hoffman HM, Aksentijevich I, Kastner DL, Goldbach-Mansky R, Griffith AJ.
NLRP3 mutation and cochlear autoinflammation cause syndromic and nonsyndromic hearing loss DFNA34 responsive to anakinra therapy.
Proc Natl Acad Sci U S A. 2017 Sep 12;114(37):E7766-E7775. doi: 10.1073/pnas.1702946114. Epub 2017 Aug 28.
https://www.ncbi.nlm.nih.gov/pubmed/28847925 - Hernández-Rodríguez J, Ruiz-Ortiz E, Yagüe J.
Monogenic autoinflammatory diseases: General concepts and presentation in adult patients.
Med Clin (Barc). 2017 Sep 15. pii: S0025-7753(17)30631-0. doi: 10.1016/j.medcli.2017.07.012. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/28923673
AGOSTO 2017
- Barut K, Sahin S, Adrovic A, Sinoplu AB, Yucel G, Pamuk G, Aydın AK, Dasdemir S, Turanlı ET, Buyru N, Kasapcopur O.
Familial Mediterranean fever in childhood: a single-center experience.
Rheumatol Int. 2017 Aug 21. doi: 10.1007/s00296-017-3796-0. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/28828621 - Todd I, Negm OH, Reps J, Radford P, Figueredo G, McDermott EM, Drewe E, Powell RJ, Bainbridge S, Hamed M, Crouch S, Garibaldi J, St-Gallay S, Fairclough LC, Tighe PJ.
A signalome screening approach in the autoinflammatory disease TNF Receptor Associated Periodic Syndrome (TRAPS) highlights the anti-inflammatory properties of drugs for repurposing.
Pharmacol Res. 2017 Aug 28. pii: S1043-6618(17)30561-3. doi: 10.1016/j.phrs.2017.08.012. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28860008 - Fabiani C, Emmi G, Lopalco G, Vannozzi L, Bacherini D, Guerriero S, Franceschini R, Frediani B, Iannone F, Tosi GM, Rigante D, Cantarini L.
Intravitreal Dexamethasone Implant as an Adjunct Weapon for Severe and Refractory Uveitis in Behçet's Disease.
Isr Med Assoc J. 2017 Jul;19(7):415-419.
https://www.ncbi.nlm.nih.gov/pubmed/28853535 - Torrelo A.
CANDLE Syndrome As a Paradigm of Proteasome-Related Autoinflammation.
Front Immunol. 2017 Aug 9;8:927. doi: 10.3389/fimmu.2017.00927. eCollection 2017.
https://www.ncbi.nlm.nih.gov/pubmed/28848544 - Moghaddas F, Llamas R, De Nardo D, Martinez-Banaclocha H, Martinez-Garcia JJ, Mesa-Del-Castillo P, Baker PJ, Gargallo V, Mensa-Vilaro A, Canna S, Wicks IP1,2,8, Pelegrin P, Arostegui JI, Masters SL.
A novel Pyrin-Associated Autoinflammation with Neutrophilic Dermatosis mutation further defines 14-3-3 binding of pyrin and distinction to Familial Mediterranean Fever.
Ann Rheum Dis. 2017 Aug 23. pii: annrheumdis-2017-211473. doi: 10.1136/annrheumdis-2017-211473. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28835462 - Skrabl-Baumgartner A, Plecko B, Schmidt WM, König N, Hershfield M, Gruber-Sedlmayr U, Lee-Kirsch MA.
Autoimmune phenotype with type I interferon signature in two brothers with ADA2 deficiency carrying a novel CECR1 mutation.
Pediatr Rheumatol Online J. 2017 Aug 22;15(1):67. doi: 10.1186/s12969-017-0193-x.
https://www.ncbi.nlm.nih.gov/pubmed/28830446 - Burillo-Sanz S, Montes-Cano MA, García-Lozano JR, Ortiz-Fernández L, Ortego-Centeno N, García-Hernández FJ, Espinosa G, Graña-Gil G, Sánchez-Bursón J, Rosa Juliá M, Solans R, Blanco R, Barnosi-Marín AC, Gómez De la Torre R, Fanlo P, Rodríguez-Carballeira M, Rodríguez-Rodríguez L, Camps T, Castañeda S, Alegre-Sancho JJ, Martín J, González-Escribano MF.
Mutational profile of rare variants in inflammasome-related genes in Behçet disease: A Next Generation Sequencing approach.
Sci Rep. 2017 Aug 16;7(1):8453. doi: 10.1038/s41598-017-09164-7.
https://www.ncbi.nlm.nih.gov/pubmed/28814775 - Bader-Meunier B, Van Nieuwenhove E, Breton S, Wouters C
Bone involvement in monogenic autoinflammatory syndromes.
Rheumatology (Oxford). 2017 Aug 22. doi: 10.1093/rheumatology/kex306.
https://www.ncbi.nlm.nih.gov/pubmed/28968889 - Cantarini L, Vitale A, Sicignano LL, Emmi G, Verrecchia E, Patisso I, Cerrito L, Fabiani C, Cevenini G, Frediani B, Galeazzi M, Rigante D, Manna R.
Diagnostic Criteria for Adult-Onset Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome.
Front Immunol. 2017 Aug 24;8:1018. doi: 10.3389/fimmu.2017.01018.
https://www.ncbi.nlm.nih.gov/pubmed/28970828
JULIO 2017
- Arostegui JI, Anton J, Calvo I, Robles A, Iglesias E, López-Montesinos B, Banchereau R, Hong S, Joubert Y, Junge G, Pascual V, Yagüe J.
Open-Label, Phase II Study to Assess the Efficacy and Safety of Canakinumab Treatment in Active Hyperimmunoglobulinemia D With Periodic Fever Syndrome.
Arthritis Rheumatol. 2017 Aug;69(8):1679-1688. doi: 10.1002/art.40146. Epub 2017 Jul 5.
https://www.ncbi.nlm.nih.gov/pubmed/28482144 - Ozen S, Demir S.
Monogenic Periodic Fever Syndromes: Treatment Options for the Pediatric Patient.
Paediatr Drugs. 2017 Aug;19(4):303-311. doi: 10.1007/s40272-017-0232-6.
https://www.ncbi.nlm.nih.gov/pubmed/28497352 - Omoyinmi E, Standing A, Keylock A, Price-Kuehne F, Melo Gomes S, Rowczenio D, Nanthapisal S, Cullup T, Nyanhete R, Ashton E, Murphy C, Clarke M, Ahlfors H, Jenkins L, Gilmour K, Eleftheriou D, Lachmann HJ, Hawkins PN, Klein N, Brogan PA.
Clinical impact of a targeted next-generation sequencing gene panel for autoinflammation and vasculitis.
PLoS One. 2017 Jul 27;12(7):e0181874. doi: 10.1371/journal.pone.0181874. eCollection 2017.
https://www.ncbi.nlm.nih.gov/pubmed/28750028
JUNIO 2017
- Taddio A, Zennaro F, Pastore S, Cimaz R.
An Update on the Pathogenesis and Treatment of Chronic Recurrent Multifocal Osteomyelitis in Children.
Paediatr Drugs. 2017 Jun;19(3):165-172.
https://www.ncbi.nlm.nih.gov/pubmed/28401420 - Kuemmerle-Deschner JB, Ozen S, Tyrrell PN, Kone-Paut I, Goldbach-Mansky R, Lachmann H, Blank N, Hoffman HM, Weissbarth-Riedel E, Hugle B, Kallinich T, Gattorno M, Gul A, Ter Haar N, Oswald M, Dedeoglu F, Cantarini L, Benseler SM.
Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS).
Ann Rheum Dis. 2017 Jun;76(6):942-947
https://www.ncbi.nlm.nih.gov/pubmed/27707729 - Kone-Paut I, Quartier P, Fain O, Grateau G, Pillet P, Le Blay P, Bonnet F, Despert V, Stankovic-Stojanovic K, Willemin L, Quéré S, Reigneau O, Hachulla E.
Real-World Experience and Impact of Canakinumab in Cryopyrin-Associated Periodic Syndrome: Results From a French Observational Study.
Arthritis Care Res (Hoboken). 2017 Jun;69(6):903-911.
https://www.ncbi.nlm.nih.gov/pubmed/27635935 - Manthiram K, Li SC, Hausmann JS, Amarilyo G, Barron K, Kim H, Nativ S, Lionetti G, Zeft A, Goldsmith D, Kimberlin D, Edwards K, Dedeoglu F, Lapidus S; Childhood Arthritis and Rheumatology Research Alliance (CARRA) PFAPA Subcommittee.
Physicians' perspectives on the diagnosis and management of periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome.
Rheumatol Int. 2017 Jun;37(6):883-889.
https://www.ncbi.nlm.nih.gov/pubmed/28271158
MAYO 2017
- Caorsi R, Penco F, Grossi A, Insalaco A, Omenetti A, Alessio M, Conti G, Marchetti F, Picco P, Tommasini A, Martino S, Malattia C, Gallizi R, Podda RA, Salis A, Falcini F, Schena F, Garbarino F, Morreale A, Pardeo M, Ventrici C, Passarelli C, Zhou Q, Severino M, Gandolfo C, Damonte G, Martini A, Ravelli A, Aksentijevich I, Ceccherini , Gattorno M.
ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study.
Ann Rheum Dis. 2017 May 18 [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/28522451 - Kuemmerle-Deschner JB, Ozen S, Tyrrell PN, Kone-Paut I, Goldbach-Mansky R, Lachmann H, Blank N, Hoffman HM, Weissbarth-Riedel E, Hugle B, Kallinich T, Gattorno M, Gul A, Ter Haar N, Oswald M, Dedeoglu F, Cantarini L, Benseler SM.
Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS).
Ann Rheum Dis. 2017 Jun;76(6):942-947. doi: 10.1136/annrheumdis-2016-209686. Epub 2016 Oct 4. Review.
https://www.ncbi.nlm.nih.gov/pubmed/27707729 - Kone-Paut I, Quartier P, Fain O, Grateau G, Pillet P, Le Blay P, Bonnet F, Despert V, Stankovic-Stojanovic K, Willemin L, Quéré S, Reigneau O, Hachulla E.
Real-World Experience and Impact of Canakinumab in Cryopyrin-Associated Periodic Syndrome: Results From a French Observational Study.
Arthritis Care Res (Hoboken). 2017 Jun;69(6):903-911. doi: 10.1002/acr.23083.
https://www.ncbi.nlm.nih.gov/pubmed/?term=27635935 - Manthiram K, Lapidus S, Edwards K.
Unraveling the pathogenesis of periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis through genetic, immunologic, and microbiologic discoveries: an update.
Curr Opin Rheumatol. 2017 May 26. doi: 10.1097/BOR.0000000000000418. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/28557837 - Mirouse A, Barete S, Monfort JB, Resche-Rigon M, Bouyer AS, Comarmond C, Sène D, Domont F, Ferfar Y, Cacoub P, Saadoun D.
Ustekinumab for Behçet's disease.
J Autoimmun. 2017 May 5. pii: S0896-8411(17)30142-7. doi: 10.1016/j.jaut.2017.05.002. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/28483439 - Ariza Jiménez AB, Núñez Cuadros E, Galindo Zavala R, Núñez Caro L, Díaz-Cordobés Rego G, Urda Cardona A.
Recurrent multifocal osteomyelitis in children: Experience in a tertiary care center.
Reumatol Clin. 2017 May 19. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/?term=28528870 - Nikiphorou E, Neocleous V, Phylactou LA, Psarelis S.
Successful use of tocilizumab in two cases of severe autoinflammatory disease with a single copy of the Mediterranean fever gene.
Rheumatology (Oxford). 2017 May 9. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/?term=28486679 - Sahin S, Adrovic A, Barut K, Ugurlu S, Turanli ET, Ozdogan H, Kasapcopur O.
Clinical, imaging and genotypical features of three deceased and five surviving cases with ADA2 deficiency.
Rheumatol Int. 2017 May 17. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/?term=28516235 - Gentileschi S, Rigante D, Vitale A, Sota J, Frediani B, Galeazzi M, Cantarini L.
Efficacy and safety of anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) complicated by severe renal failure: a report after long-term follow-up and review of the literature.
Clin Rheumatol. 2017 May 23. doi: 10.1007/s10067-017-3688-4. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28536823
ABRIL 2017
- Martorana D, Bonatti F, Mozzoni P, Vaglio A, Percesepe A.
Monogenic Autoinflammatory Diseases with Mendelian Inheritance: Genes, Mutations, and Genotype/Phenotype Correlations
Front Immunol. 2017 Apr 3;8:344. doi: 10.3389/fimmu.2017.00344. eCollection 2017. Review.
https://www.ncbi.nlm.nih.gov/pubmed/28421071 - Taddio A, Zennaro F, Pastore S, Cimaz R.
An Update on the Pathogenesis and Treatment of Chronic Recurrent Multifocal Osteomyelitis in Children
Paediatr Drugs. 2017 Apr 11. doi: 10.1007/s40272-017-0226-4. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/28401420
MARZO 2017
- Ter Haar NM, Annink KV, Al-Mayouf SM, Amaryan G, Anton J, Barron KS, Benseler SM, Brogan PA, Cantarini L, Cattalini M, Cochino AV, De Benedetti F, Dedeoglu F, De Jesus AA, Della Casa Alberighi O, Demirkaya E, Dolezalova P, Durrant KL, Fabio G, Gallizzi R, Goldbach-Mansky R, Hachulla E, Hentgen V, Herlin T, Hofer M, Hoffman HM, Insalaco A, Jansson AF, Kallinich T, Koné-Paut I, Kozlova A, Kuemmerle-Deschner JB, Lachmann HJ, Laxer RM, Martini A, Nielsen S, Nikishina I, Ombrello AK, Ozen S, Papadopoulou-Alataki E, Quartier P, Rigante D, Russo R, Simon A, Trachana M, Uziel Y, Ravelli A, Gattorno M, Frenkel J.
Development of the autoinflammatory disease damage index (ADDI).
Ann Rheum Dis. 2017 May;76(5):821-830. doi: 10.1136/annrheumdis-2016-210092
https://www.ncbi.nlm.nih.gov/pubmed/27811147 - Ben-Zvi I, Kukuy O, Giat E, Pras E, Feld O, Kivity S, Perski O, Bornstein G, Grossman C, Harari G, Lidar M, Livneh MA
Anakinra for Colchicine-Resistant Familial Mediterranean Fever: A Randomized, Double-Blind, Placebo-Controlled Trial.
Arthritis Rheumatol 2017 Apr;69(4):854–62 DOI: 10.1002/art.39995.
http://onlinelibrary.wiley.com/doi/10.1002/art.39995/abstract - Cox AJ, Zhao Y, Ferguson PJ.
Chronic Recurrent Multifocal Osteomyelitis and Related Diseases-Update on Pathogenesis.
Curr Rheumatol Rep. 2017 Apr;19(4):18. doi: 10.1007/s11926-017-0645-9.
https://www.ncbi.nlm.nih.gov/pubmed/28361334 - Sönmez HE, Özen S.
Clinical update on inflammasomopathies.
Int Immunol. 2017 Apr 6. doi: 10.1093/intimm/dxx020.
https://www.ncbi.nlm.nih.gov/pubmed/28387826 - Özen S, Batu ED, Demir S.
Familial Mediterranean Fever: Recent Developments in Pathogenesis and New Recommendations for Management.
Front Immunol. 2017 Mar 23;8:253. doi: 10.3389/fimmu.2017.00253.
https://www.ncbi.nlm.nih.gov/pubmed/28386255 - Manthiram K, Li SC, Hausmann JS, Amarilyo G, Barron K, Kim H, Nativ S, Lionetti G, Zeft A, Goldsmith D, Kimberlin D, Edwards K, Dedeoglu F, Lapidus S; Childhood Arthritis and Rheumatology Research Alliance (CARRA) PFAPA Subcommittee.
Physicians' perspectives on the diagnosis and management of periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome.
Rheumatol Int. 2017 Mar 7. doi: 10.1007/s00296-017-3688-3.
https://www.ncbi.nlm.nih.gov/pubmed/28271158 - Grayson PC, Yazici Y, Merideth M, Sen HN, Davis M, Novakovich E, Joyal E, Goldbach-Mansky R, Sibley CH
Treatment of mucocutaneous manifestations in Behçet's disease with anakinra: a pilot open-label study.
Arthritis Res Ther. 2017 Mar 24;19(1):69. doi: 10.1186/s13075-017-1222-3.
https://www.ncbi.nlm.nih.gov/pubmed/28335798 - Vinkel C, Thomsen SF.
Autoinflammatory syndromes associated with hidradenitis suppurativa and/or acne.
Int J Dermatol. 2017 Mar 27. doi: 10.1111/ijd.13603.
https://www.ncbi.nlm.nih.gov/pubmed/28345207
FEBRERO 2017
- Cheung MS, Theodoropoulou K, Lugrin J, Martinon F, Busso N, Hofer M.
Periodic Fever with Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis Syndrome Is Associated with a CARD8 Variant Unable To Bind the NLRP3 Inflammasome.
J Immunol. 2017 Mar 1;198(5):2063-2069. doi: 10.4049/jimmunol.1600760. Epub 2017 Jan 30.
https://www.ncbi.nlm.nih.gov/pubmed/28137891 - Sahin Y, Adrovic A, Barut K, Kutlu T, Cullu-Cokugras F, Sahin S, Kasapcopur O, Erkan T.
The frequency of the celiac disease among children with familial Mediterranean fever.
Mod Rheumatol. 2017 Feb 2:1-11. doi: 10.1080/14397595.2016.1270497. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28151032 - Hu J, Zhu Y, Zhang JZ, Zhang RG, Li HM.
A Novel Mutation in the Pyrin Domain of the NOD-like Receptor Family Pyrin Domain Containing Protein 3 in Muckle-Wells Syndrome.
Chin Med J (Engl). 2017 5th Mar;130(5):586-593. doi: 10.4103/0366-6999.200537.
https://www.ncbi.nlm.nih.gov/pubmed/28229991 - Mamoudjy N, Maurey H, Marie I, Koné-Paut I, Deiva K.
Neurological outcome of patients with cryopyrin-associated periodic syndrome (CAPS).
Orphanet J Rare Dis. 2017 Feb 14;12(1):33. doi: 10.1186/s13023-017-0589-1.
https://www.ncbi.nlm.nih.gov/pubmed/28196516 - Kukuy O, Livneh A, Mendel L, Benor A, Giat E, Perski O, Feld O, Kassel Y, Ben-Zvi I, Lidar M, Holtzman EJ, Leiba A.
Normal arterial stiffness in familial Mediterranean fever: evidence for a possible cardiovascular protective role of colchicine.
Clin Exp Rheumatol. 2017 Feb 9. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28229824 - Sandhya P, Vellarikkal SK, Nair A, Ravi R, Mathew J, Jayarajan R, Kumar A, Verma A, Sivadas A, Danda D, Sivasubbu S, Scaria V.
Egyptian tale from India: application of whole-exome sequencing in diagnosis of atypical familial Mediterranean fever.
Int J Dermatol. 2017 Feb 14. doi: 10.1111/ijd.13503. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28194777 - Vural S, Gundogdu M, Kundakci N, Ruzicka T.
Familial Mediterranean fever patients with hidradenitis suppurativa.
Chin Med J (Engl). 2017 5th Mar;130(5):586-593. doi: 10.4103/0366-6999.200537.
https://www.ncbi.nlm.nih.gov/pubmed/28229991 - Esaki M, Kawano S, Matsumoto T.
A rare cause of duodenojejunal pseudopolyposis: Report of a case of adult-onset familial Mediterranean fever.
Dig Endosc. 2017 Feb 9. doi: 10.1111/den.12843. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28181703 - Wada T, Toma T, Matsuda Y, Yachie A, Itami S, Taguchi Y, Murakami Y.
Microarray analysis of circulating microRNAs in familial Mediterranean fever.
Mod Rheumatol. 2017 Feb 6:1-18. doi: 10.1080/14397595.2017.1285845. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28165838 - Vitale A, Rigante D, Lucherini OM, De Palma A, Orlando I, Gentileschi S, Sota J, Simpatico A, Fabiani C, Galeazzi M, Frediani B, Cantarini L.
The diagnostic evaluation of patients with a suspected hereditary periodic fever syndrome: experience from a referral center in Italy.
Intern Emerg Med. 2017 Feb 13. doi: 10.1007/s11739-017-1622-z. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28194697
ENERO 2017
- Rowczenio DM1, Iancu DS2, Trojer H3, Gilbertson JA3, Gillmore JD3, Wechalekar AD3, Tekman M2, Stanescu HC2, Kleta R2, Lane T3, Hawkins PN3, Lachmann HJ3.
Autosomal dominant familial Mediterranean fever in Northern European Caucasians associated with deletion of p.M694 residue-a case series and genetic exploration.
Rheumatology (Oxford). 2017 Feb;56(2):209-213. doi: 10.1093/rheumatology/kew058. Epub 2016 May 5.
https://www.ncbi.nlm.nih.gov/pubmed/27150194 - Laskari K, Boura P, Dalekos GN, Garyfallos A, Karokis D, Pikazis D, Settas L, Skarantavos G, Tsitsami E, Sfikakis PP.
Longterm Beneficial Effect of Canakinumab in Colchicine-resistant Familial Mediterranean Fever.
J Rheumatol. 2017 Jan;44(1):102-109. doi: 10.3899/jrheum.160518. Epub 2016 Nov 15.
https://www.ncbi.nlm.nih.gov/pubmed/28042127
DICIEMBRE 2016
- Gattorno M, Obici L, Cattalini M, Tormey V, Abrams K, Davis N, Speziale A, Bhansali SG, Martini A, Lachmann HJ.
Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study.
Ann Rheum Dis. 2017 Jan;76(1):173-178.
https://www.ncbi.nlm.nih.gov/pubmed/27269295 - Torene R, Nirmala N, Obici L, Cattalini M, Tormey V, Caorsi R, Starck-Schwertz S, Letzkus M, Hartmann N, Abrams K, Lachmann H, Gattorno M.
Canakinumab reverses overexpression of inflammatory response genes in tumour necrosis factor receptor-associated periodic syndrome.
Ann Rheum Dis. 2017 Jan;76(1):303-309.
https://www.ncbi.nlm.nih.gov/pubmed/27474763 - Damiani G, Della Valle V, Iannone M, Dini V, Marzano AV.
Autoinflammatory Disease Damage Index (ADDI): a possible newborn also in hidradenitis suppurativa daily practice.
Ann Rheum Dis. 2016 Dec 23.
https://www.ncbi.nlm.nih.gov/pubmed/28011453 - Grandemange S, Sanchez E, Louis-Plence P, Tran Mau-Them F, Bessis D, Coubes C, Frouin E, Seyger M, Girard M, Puechberty J, Costes V, Rodière M, Carbasse A, Jeziorski E, Portales P, Sarrabay G, Mondain M, Jorgensen C, Apparailly F, Hoppenreijs E, Touitou I, Geneviève D.
A new autoinflammatory and autoimmune syndrome associated with NLRP1 mutations: NAIAD (NLRP1-associated autoinflammation with arthritis and dyskeratosis).
Ann Rheum Dis. 2016 Dec 13.
https://www.ncbi.nlm.nih.gov/pubmed/27965258 - Gohar F, Orak B, Kallinich T, Jeske M, Lieber M, von Bernuth H, Giese A, Weissbarth-Riedel E, Haas JP, Dressler F, Holzinger D, Lohse P, Neudorf U, Lainka E, Hinze C, Masjosthusmann K, Kessel C, Weinhage T, Foell D, Wittkowski H.
Correlation of Secretory Activity of Neutrophils With Genotype in Patients With Familial Mediterranean Fever.
Arthritis Rheumatol. 2016 Dec;68(12):3010-3022.
https://www.ncbi.nlm.nih.gov/pubmed/27333294 - Mensa-Vilaro A, Teresa Bosque M, Magri G, Honda Y, Martínez-Banaclocha H, Casorran-Berges M, Sintes J, González-Roca E, Ruiz-Ortiz E, Heike T, Martínez-Garcia JJ, Baroja-Mazo A, Cerutti A, Nishikomori R, Yagüe J, Pelegrín P, Delgado-Beltran C, Aróstegui JI.
Brief Report: Late-Onset Cryopyrin-Associated Periodic Syndrome Due to Myeloid-Restricted Somatic NLRP3 Mosaicism.
Arthritis Rheumatol. 2016 Dec;68(12):3035-3041.
https://www.ncbi.nlm.nih.gov/pubmed/27273849 - Batu ED, Kara Eroğlu F, Tsoukas P, Hausmann JS, Bilginer Y, Kenna MA, Licameli GR, Fuhlbrigge RC, Özen S, Dedeoğlu F.
Periodic Fever, Aphthosis, Pharyngitis, and Adenitis Syndrome: Analysis of Patients From Two Geographic Areas.
Arthritis Care Res (Hoboken). 2016 Dec;68(12):1859-1865.
https://www.ncbi.nlm.nih.gov/pubmed/27059542 - Shumpei Y, Imagawa T, Nishikomori R, Takada H, Abrams K, Lheritier K, Heike T, Hara T.
Long-term safety and efficacy of canakinumab in cryopyrin-associated periodic syndrome: results from an open-label, phase III pivotal study in Japanese patients.
Clin Exp Rheumatol. 2016 Dec 14.
https://www.ncbi.nlm.nih.gov/pubmed/27974104 - Schnabel A, Range U, Hahn G, Siepmann T, Berner R, Hedrich CM.
Unexpectedly high incidences of chronic non-bacterial as compared to bacterial osteomyelitis in children.
Rheumatol Int. 2016 Dec;36(12):1737-1745.
https://www.ncbi.nlm.nih.gov/pubmed/27730289
NOVIEMBRE 2016
- Touitou I, Sarrabay G.
Criteria for CAPS, is it all in the name?
Ann Rheum Dis. 2016 Nov 16.
https://www.ncbi.nlm.nih.gov/pubmed/27852576 - Ter Haar NM, Annink KV, Al-Mayouf SM, Amaryan G, Anton J, Barron KS, Benseler SM, Brogan PA, Cantarini L, Cattalini M, Cochino AV, De Benedetti F, Dedeoglu F, De Jesus AA, Della Casa Alberighi O, Demirkaya E, Dolezalova P, Durrant KL, Fabio G, Gallizzi R, Goldbach-Mansky R, Hachulla E, Hentgen V, Herlin T, Hofer M, Hoffman HM, Insalaco A, Jansson AF, Kallinich T, Koné-Paut I, Kozlova A, Kuemmerle-Deschner JB, Lachmann HJ, Laxer RM, Martini A, Nielsen S, Nikishina I, Ombrello AK, Ozen S, Papadopoulou-Alataki E, Quartier P, Rigante D, Russo R, Simon A, Trachana M, Uziel Y, Ravelli A, Gattorno M, Frenkel J.
Development of the autoinflammatory disease damage index (ADDI).
Ann Rheum Dis. 2016 Nov 3.
https://www.ncbi.nlm.nih.gov/pubmed/27811147 - Ter Haar NM, Jeyaratnam J, Lachmann HJ, Simon A, Brogan PA, Doglio M, Cattalini M, Anton J, Modesto C, Quartier P, Hoppenreijs E, Martino S, Insalaco A, Cantarini L, Lepore L, Alessio M, Calvo Penades I, Boros C, Consolini R, Rigante D, Russo R, Pachlopnik Schmid J, Lane T, Martini A, Ruperto N, Frenkel J, Gattorno M; Paediatric Rheumatology International Trials Organisation and Eurofever Project..
The Phenotype and Genotype of Mevalonate Kinase Deficiency: A Series of 114 Cases From the Eurofever Registry.
Arthritis Rheumatol. 2016 Nov;68(11):2795-2805.
https://www.ncbi.nlm.nih.gov/pubmed/27213830 - Ben-Zvi I, Kukuy O, Giat E, Pras E, Feld O, Kivity S, Lecturer S, Perski O, Bornstein G, Grossman C, Harari G, Lidar M, Livneh A.
Anakinra for colchicine resistant familial Mediterranean fever - A randomized, double blind, placebo-controlled trial.
Arthritis Rheumatol. 2016 Nov 11.
https://www.ncbi.nlm.nih.gov/pubmed/27860460 - Ueda N, Ida H, Washio M, Miyahara H, Tokunaga S, Tanaka F, Takahashi H, Kusuhara K, Ohmura K, Nakayama M, Ohara O, Nishikomori R, Minota S, Takei S, Fujii T, Ishigatsubo Y, Tsukamoto H, Tahira T, Horiuchi T.
Clinical and Genetic Features of Patients With TNFRSF1A Variants in Japan: Findings of a Nationwide Survey.
Arthritis Rheumatol. 2016 Nov;68(11):2760-2771.
https://www.ncbi.nlm.nih.gov/pubmed/27332769 - Haviv R, Hashkes PJ.
Canakinumab investigated for treating familial Mediterranean fever.
Expert Opin Biol Ther. 2016 Nov;16(11):1425-1434.
https://www.ncbi.nlm.nih.gov/pubmed/27603969 - Aksentijevich I, McDermott MF.
Lessons from characterization and treatment of the autoinflammatory syndromes.
Curr Opin Rheumatol. 2016 Nov 30.
https://www.ncbi.nlm.nih.gov/pubmed/27906774
OCTUBRE 2016
- Konukbay D, Gattorno M, Yildiz D, Frenkel J, Acikel C, Sozeri B, Makay B, Aktay Ayaz N, Barut K, Kisaarslan A, Bilginer Y, Karaman D, Peru H, Simsek D, Aydog O, Unsal E, Gunduz Z, Fidanci BE, Kone-Paut I, Kasapcopur O, Ravelli A, Ozen S, Demirkaya E; and the FMF Arthritis Vasculitis and Orphan disease Research in Paediatric Rheumatology.
A novel assessment tool for clinical care of patients with autoinflammatory disease: juvenile autoinflammatory disease multidimensional assessment report.
Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 102(6):129-135
https://www.ncbi.nlm.nih.gov/pubmed/27791950 - Ter Haar NM, Jeyaratnam J, Lachmann HJ, Simon A, Brogan PA, Doglio M, Cattalini M, Anton J, Modesto C, Quartier P, Hoppenreijs E, Martino S, Insalaco A, Cantarini L, Lepore L, Alessio M, Calvo Penades I, Boros C, Consolini R, Rigante D, Russo R, Pachlopnik Schmid J, Lane T, Martini A, Ruperto N, Frenkel J, Gattorno M; Paediatric Rheumatology International Trials Organisation and Eurofever Project.
The Phenotype and Genotype of Mevalonate Kinase Deficiency: A Series of 114 Cases From the Eurofever Registry
Arthritis Rheumatol. 2016 Nov;68(11):2795-2805.
https://www.ncbi.nlm.nih.gov/pubmed/27213830 - Schnabel A, Range U, Hahn G, Siepmann T, Berner R, Hedrich CM.
Unexpectedly high incidences of chronic non-bacterial as compared to bacterial osteomyelitis in children
Rheumatol Int. 2016 Oct 11
https://www.ncbi.nlm.nih.gov/pubmed/27730289
SEPTIEMBRE 2016
- Ozen S, Kuemmerle-Deschner JB, Cimaz R, Livneh A, Quartier P, Kone-Paut I, Zeft A, Spalding S, Gul A, Hentgen V, Savic S, Foeldvari I, Frenkel J, Cantarini L, Patel D, Weiss J, Marinsek N, Degun R, Lomax KG, Lachmann HJ.
International retrospective chart review of treatment patterns in severe FMF, TRAPS and MKD/HIDS.
Arthritis Care Res (Hoboken). 2016 Oct 9.
https://www.ncbi.nlm.nih.gov/pubmed/27723279 - Kuemmerle-Deschner JB, Ozen S, Tyrrell PN, Kone-Paut I, Goldbach-Mansky R, Lachmann H, Blank N, Hoffman HM, Weissbarth-Riedel E, Hugle B, Kallinich T, Gattorno M, Gul A, Ter Haar N, Oswald M, Dedeoglu F, Cantarini L, Benseler SM.
Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS).
Ann Rheum Dis. 2016 Oct 4.
https://www.ncbi.nlm.nih.gov/pubmed/27707729 - Xirotagaros G, Hernández-Ostiz S, Aróstegui JI, Torrelo A.
Newly Described Autoinflammatory Diseases in Pediatric Dermatology.
Pediatr Dermatol. 2016 Oct 4. doi: 10.1111/pde.12984.
https://www.ncbi.nlm.nih.gov/pubmed/27699831 - Varma R, Campbell G, Baxendale H.
Lesson of the month 1: Autoinflammatory syndromes - an unusual cause of pyrexia of unknown origin.
Clin Med (Lond). 2016 Oct;16(5):488-490.
https://www.ncbi.nlm.nih.gov/pubmed/27697817 - Vitale A, Emmi G, Lopalco G, Gentileschi S, Silvestri E, Fabiani C, Urban ML, Frediani B, Galeazzi M, Iannone F, Rigante D, Cantarini L.
Adalimumab effectiveness in Behçet's disease: short and long-term data from a multicenter retrospective observational study.
Clin Rheumatol. 2016 Sep 27. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/27679471 - Kim H, Sanchez GA, Goldbach-Mansky R.
Insights from Mendelian Interferonopathies: Comparison of CANDLE, SAVI with AGS, Monogenic Lupus.
J Mol Med (Berl). 2016 Oct;94(10):1111-1127.
https://www.ncbi.nlm.nih.gov/pubmed/27678529 - Beheshtian M, Izadi N, Kriegshauser G, Kahrizi K, Mehr EP, Rostami M, Hosseini M, Azad M, Montajabiniat M, Kariminejad A, Nemeth S, Oberkanins C, Najmabadi H.
Prevalence of common MEFV mutations and carrier frequencies in a large cohort of Iranian populations.
J Genet. 2016 Sep;95(3):667-74.
https://www.ncbi.nlm.nih.gov/pubmed/27659338 - Krause K, Tsianakas A, Wagner N, Fischer J, Weller K, Metz M, Church MK, Maurer M.
Efficacy and safety of canakinumab in Schnitzler's syndrome: a multi-center randomized placebo-controlled study.
J Allergy Clin Immunol. 2016 Sep 19.
https://www.ncbi.nlm.nih.gov/pubmed/27658762 - Ostring GT, Singh-Grewal D.
Periodic fevers and autoinflammatory syndromes in childhood.
J Paediatr Child Health. 2016 Sep;52(9):865-71.
https://www.ncbi.nlm.nih.gov/pubmed/27650143 - Pathak S, McDermott MF, Savic S.
Autoinflammatory diseases: update on classification diagnosis and management.
J Clin Pathol. 2016 Sep 19. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/27646526 - Caorsi R, Penco F, Schena F, Gattorno M.
Monogenic polyarteritis: the lesson of ADA2 deficiency.
Pediatr Rheumatol Online J. 2016 Sep 8;14(1):51.
https://www.ncbi.nlm.nih.gov/pubmed/27609179 - Ben-Ami T, Revel-Vilk S, Brooks R, Shaag A, Hershfield MS, Kelly SJ, Ganson NJ, Kfir-Erenfeld S, Weintraub M, Elpeleg O, Berkun Y, Stepensky P.
Extending the Clinical Phenotype of Adenosine Deaminase 2 Deficiency.
J Pediatr. 2016 Oct;177:316-20.
https://www.ncbi.nlm.nih.gov/pubmed/27514238
AGOSTO 2016
- Wekell P, Karlsson A, Berg S, Fasth A.
Review of autoinflammatory diseases, with a special focus on periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome.
Acta Paediatr. 2016 Oct;105(10):1140-51.
http://www.ncbi.nlm.nih.gov/pubmed/27426283 - Caorsi R, Penco F, Schena F, Gattorno M.
Monogenic polyarteritis: the lesson of ADA2 deficiency.
Pediatr Rheumatol Online J. 2016 Sep 8;14(1):51.
http://www.ncbi.nlm.nih.gov/pubmed/27609179 - Kone-Paut I, Quartier P, Fain O, Grateau G, Pillet P, Le Blay P, Bonnet F, Despert V, Stojanovic KS, Willemin L, Quéré S, Reigneau O, Hachulla E.
Real-world experience and impact of Canakinumab in cryopyrin-associated periodic syndrome: Results from the French observational study ENVOL.
Arthritis Care Res (Hoboken). 2016 Sep 16. doi: 10.1002/acr.23083. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27635935 - Shen M, Tang L, Shi X, Zeng X, Yao Q.
NLRP12 autoinflammatory disease: a Chinese case series and literature review.
Clin Rheumatol. 2016 Sep 16. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27633793 - Zhou Q, Yu X, Demirkaya E, Deuitch N, Stone D, Tsai WL, Kuehn HS, Wang H, Yang D, Park YH, Ombrello AK, Blake M, Romeo T, Remmers EF, Chae JJ, Mullikin JC, Güzel F, Milner JD, Boehm M, Rosenzweig SD, Gadina M, Welch SB, Özen S, Topaloglu R, Abinun M, Kastner DL, Aksentijevich I.
Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onsetautoinflammatory disease.
Proc Natl Acad Sci U S A. 2016 Sep 6;113(36):10127-32.
http://www.ncbi.nlm.nih.gov/pubmed/27559085 - Hofmann SR, Schnabel A, Rösen-Wolff A, Morbach H, Girschick HJ, Hedrich CM.
Chronic Nonbacterial Osteomyelitis: Pathophysiological Concepts and Current Treatment Strategies.
J Rheumatol. 2016 Sep 1. pii: jrheum.160256. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27585682 - Roderick MR, Shah R, Rogers V, Finn A, Ramanan AV.
Chronic recurrent multifocal osteomyelitis (CRMO) - advancing the diagnosis.
Pediatr Rheumatol Online J. 2016 Aug 30;14(1):47.
http://www.ncbi.nlm.nih.gov/pubmed/27576444 - Rusmini M, Federici S, Caroli F, et al.
Next-generation sequencing and its initial applications for molecular diagnosis of systemic auto-inflammatory diseases
Ann Rheum Dis 2016;75:1550-1557
http://ard.bmj.com/content/75/8/1550.abstract - König N, Fiehn C, Wolf C, Schuster M, Cura Costa E, Tüngler V, Alvarez HA, Chara O, Engel K, Goldbach-Mansky R, Günther C, Lee-Kirsch MA.
Familial chilblain lupus due to a gain-of-function mutation in STING.
Ann Rheum Dis. 2016 Aug 26. pii: annrheumdis-2016-209841. doi: 10.1136/annrheumdis-2016-209841. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27566796 - Torrelo A, Noguera-Morel L, Hernández-Martín A, Clemente D, Barja JM, Buzón L, Azorín D, de Jesús AA, López-Robledillo JC, Colmenero I, Kutzner H, Goldbach-Mansky R, Requena L.
Recurrent lipoatrophic panniculitis of children.
J Eur Acad Dermatol Venereol. 2016 Aug 12. doi: 10.1111/jdv.13858. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27515780 - Tran T, Moloney T, Adams MK, Shah SP.
Autoinflammatory retinopathy in chronic infantile neurological cutaneous and articular (CINCA) syndrome.
J AAPOS. 2016 Aug;20(4):365-8.
http://www.ncbi.nlm.nih.gov/pubmed/27320017 - Ben-Ami T, Revel-Vilk S, Brooks R, Shaag A, Hershfield MS, Kelly SJ, Ganson NJ, Kfir-Erenfeld S, Weintraub M, Elpeleg O, Berkun Y, Stepensky P.
Extending the Clinical Phenotype of Adenosine Deaminase 2 Deficiency.
J Pediatr. 2016 Aug 8. pii: S0022-3476(16)30487-5. doi: 10.1016/j.jpeds.2016.06.058. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27514238 - Frémond ML,Rodero MP,Jeremiah N, et al.
Efficacy of the Janus Kinase 1/2 Inhibitor Ruxolitinib in the Treatment of Vasculopathy Associated with TMEM173-Activating Mutations in three children.
2016 Aug 20. pii: S0091-6749(16)30797-7. doi: 10.1016/j.jaci.2016.07.015. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27554814 - Ginsberg S, Rosner I, Rozenbaum M, Slobodin G, Zilber K, Boulman N, Kaly L, Awisat A, Jiries N, Beyar-Katz O, Rimar D.
Autoinflammatory associated vasculitis.
Semin Arthritis Rheum. 2016 Jul 20. pii: S0049-0172(16)30122-6. doi: 10.1016/j.semarthrit.2016.07.007. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27612399 - Vento-Tormo R, Álvarez-Errico D, Garcia-Gomez A, Hernández-Rodríguez J, Buján S, Basagaña M, Méndez M, Yagüe J, Juan M, Aróstegui JI, Ballestar E.
DNA demethylation of inflammasome-associated genes is enhanced in patients with cryopyrin-associated periodic syndromes.
J Allergy Clin Immunol. 2016 Jul 6. pii: S0091-6749(16)30424-9. doi: 10.1016/j.jaci.2016.05.016. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27394913
JULIO 2016
- Ben-Chetrit E, Yazici H.
Non-thrombocytopenic purpura in familial Mediterranean fever-comorbidity with Henoch-Schönlein purpura or an additional rare manifestation of familial Mediterranean fever?
Rheumatology (Oxford). 2016 Jul;55(7):1153-8. doi: 10.1093/rheumatology/kev378. Epub 2015 Oct 13.
http://www.ncbi.nlm.nih.gov/pubmed/26464521 - Topaloglu R, Batu ED, Yıldız Ç, Korkmaz E, Özen S, Beşbaş N, Özaltın F.
Familial Mediterranean fever patients homozygous for E148Q variant.
Int J Rheum Dis. 2016 Jul 26. doi: 10.1111/1756-185X.12929. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27457448 - Gattorno M, Obici L, Cattalini M, Tormey V, Abrams K, Davis N, Speziale A, Bhansali SG, Martini A, Lachmann HJ.
Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study.
Ann Rheum Dis. 2016 Jun 7. pii: annrheumdis-2015-209031. doi: 10.1136/annrheumdis-2015-209031. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27269295 - Omenetti A, Carta S, Caorsi R, Finetti M, Marotto D, Lattanzi B, Jorini M, Delfino L, Penco F, Picco P, Buoncompagni A, Martini A, Rubartelli A, Gattorno M.
Disease activity accounts for long-term efficacy of IL-1 blockers in pyogenic sterile arthritis pyoderma gangrenosum and severe acne syndrome.
Rheumatology (Oxford). 2016 Jul;55(7):1325-35. doi: 10.1093/rheumatology/kew031. Epub 2016 Mar 17.
http://www.ncbi.nlm.nih.gov/pubmed/26989109
JUNIO 2016
- Vanoni F, Theodoropoulou K, Hofer M
PFAPA syndrome: a review on treatment and outcome.
Pediatr Rheumatol Online J. 2016 Jun 27;14(1):38. doi: 10.1186/s12969-016-0101-9.
http://www.ncbi.nlm.nih.gov/pubmed/27349388 - Volpi S, Picco P, Caorsi R, Candotti F, Gattorno M.
Type I interferonopathies in pediatric rheumatology.
Pediatr Rheumatol Online J. 2016 Jun 4;14(1):35. doi: 10.1186/s12969-016-0094-4. Review
http://www.ncbi.nlm.nih.gov/pubmed/27260006 - Sobolewska B, Angermair E, Deuter C, Doycheva D, Kuemmerle-Deschner J, Zierhut M.
NLRP3 A439V Mutation in a Large Family with Cryopyrin-associated Periodic Syndrome: Description of Ophthalmologic Symptoms in Correlation with Other Organ Symptoms.
J Rheumatol. 2016 Jun;43(6):1101-6. doi: 10.3899/jrheum.150681
http://www.ncbi.nlm.nih.gov/pubmed/27134254 - Imazio M, Adler Y, Charron P.
Recurrent Pericarditis: Modern Approach in 2016.Curr Cardiol Rep. 2016 Jun;18(6):50. doi: 10.1007/s11886-016-0727-8. Review.
http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27108360
MAYO 2016
- Domingues M, Estanqueiro P, Estevão MH, Salgado M.
Parenchymal Pulmonary Disease in Systemic Idiopathic Juvenile Arthritis: A Case Report.
Ann Paediatr Rheum. 2016; 5(1): 20-23
http://www.scopemed.org/fulltextpdf.php?mno=216895 - Akil I, Evrengul H
Do Biological Agents be Useful in the Treatment of Amyloidosis Related FMF?
Ann Paediatr Rheum. 2016; 5(1): 31-34
http://www.scopemed.org/fulltextpdf.php?mno=217985 - Barut K, Guler M, Sezen M, Kasapçopur O.
Inceased frequency of psoriasis in the families of the children with familial Mediterranean fever.
Clin Exp Rheumatol. 2016 May 24. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/27243382 - Eroglu F, Kasapçopur Ö, Beşbaş N, Ozaltin F, Bilginer Y, Barut K, et al.
Genetic and clinical features of cryopyrin-associated periodic syndromes in Turkish children.
Clin Exp Rheumatol. 2016 May 10. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/27191192 - Sun J, Feng M, Wu F, Ma X, Lu J, Kang M, et al.
Plasma miR-26a as a Diagnostic Biomarker Regulates Cytokine Expression in Systemic Juvenile Idiopathic Arthritis.
J Rheumatol. Published online before print June 1, 2016, doi: 10.3899/jrheum.150593
http://www.jrheum.org/content/early/2016/05/26/jrheum.150593.abstract?sid=114aa648-c3d6-4425-a497-3df5df451472 - Naselli A, Penco F, Cantarini L, Insalaco A, Alessio M, Tommasini A, et al.
Clinical Characteristics of Patients Carrying the Q703K Variant of the NLRP3 Gene: A 10-year Multicentric National Study.
J Rheumatol. June 2016 43(6):1093-100. doi: 10.3899/jrheum.150962
http://www.jrheum.org/content/43/6/1093.abstract - Sobolewska B, Angermair E, Deuter C, Doycheva D, Kuemmerle-Deschner J, Zierhut M.
NLRP3 A439V Mutation in a Large Family with Cryopyrin-associated Periodic Syndrome: Description of Ophthalmologic Symptoms in Correlation with Other Organ Symptoms.
J Rheumatol June 2016 43(6):1101-1106; published online before print May 1, 2016. doi: 10.3899/jrheum.150681
http://www.jrheum.org/content/43/6/1101.abstract - Junge G, Machein U.
Comment on: Real-life effectiveness of canakinumab in cryoprin-associated periodic syndrome.
Rheumatology first published online May 17, 2016. doi: 10.1093/rheumatology/kew234
http://rheumatology.oxfordjournals.org/content/early/2016/05/17/rheumatology.kew234.extract - Kullenberg T, Löfqvist M, Leinonen M, Goldbach-Mansky R, Olivecrona H.
Long-term safety profile of anakinra in patients with severe cryopyrin-associated periodic syndromes.
Rheumatology first published online May 3, 2016. doi: 10.1093/rheumatology/kew208
http://rheumatology.oxfordjournals.org/content/early/2016/05/02/rheumatology.kew208.abstract - Keer N, Hershfield M, Caskey T, Unizony S.
Novel compound heterozygous variants in CECR1 gene associated with childhood onset polyarteritis nodosa and deficiency of ADA2.
Rheumatology (2016) 55 (6): 1145-1147. doi: 10.1093/rheumatology/kew050.
http://rheumatology.oxfordjournals.org/content/55/6/1145.extract
ABRIL 2016
- Imazio M, Adler Y, Charron P.
Recurrent Pericarditis: Modern Approach in 2016.
Curr Cardiol Rep. 2016 Jun;18(6):50. doi: 10.1007/s11886-016-0727-8. Review.
http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27108360 - Rigante D, Frediani B, Cantarini L.
A Comprehensive Overview of the Hereditary Periodic Fever Syndromes.
Clin Rev Allergy Immunol. 2016 Apr 11. [Epub ahead of print] Review.
http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27068928 - Naselli A, Penco F, Cantarini L, Insalaco A, Alessio M, Tommasini A, Maggio C, Obici L, Gallizi R, Cimmino M, Signa S, Lucherini OM, Carta S, Caroli F, Martini A, Rubartelli A, Ceccherini I, Gattorno M.
Clinical Characteristics of Patients Carrying the Q703K Variant of the NLRP3 Gene: A 10-year Multicentric National Study.
J Rheumatol. 2016 Apr 1. pii: jrheum.150962.
http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27036377 - van der Hilst JCh, Moutschen M, Messiaen PE, Lauwerys BR, Vanderschueren S.
Efficacy of anti-IL-1 treatment in familial Mediterranean fever: a systematic review of the literature.
Biologics. 2016 Apr 4;10:75-80. doi: 10.2147/BTT.S102954. eCollection 2016.
http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27110096 - Lachmann HJ, Brogan PA.
Autoinflammation: When is familial Mediterranean fever 'severe'?
Nat Rev Rheumatol. 2016 Apr 25;12(5):256-8. doi: 10.1038/nrrheum.2016.55.
http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27108965 - Batu ED, Eroğlu FK, Tsoukas P, Hausmann JS, Bilginer Y, Kenna MA, Licameli GR, Fuhlbrigge RC, Özen S, Dedeoğlu F.
Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) syndrome: analysis of patients from two geographic areas.
Arthritis Care Res (Hoboken). 2016 Apr 5. doi: 10.1002/acr.22901
http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27059542 - Polat A, Acikel C, Sozeri B, Dursun I, Kasapcopur O, Gulez N, Simsek D, Saldir M, Dokurel I, Poyrazoglu H, Bakkaloglu S, Delibas A, Ekinci Z, Ayaz NA, Kandur Y, Peru H, Kurt YG, Polat SR, Unsal E, Makay B, Gok F, Ozen S, Demirkaya E; FMF Arthritis Vasculitis and Orphan Disease Research in Pediatric Rheumatology (FAVOR).
Comparison of the efficacy of once- and twice-daily colchicine dosage in pediatric patients with familial Mediterranean fever - a randomized controlled noninferiority trial.
Arthritis Res Ther. 2016 Apr 7;18(1):85. doi: 10.1186/s13075-016-0980-7.
http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27055417 - Dusser P, Hentgen V, Neven B, Koné-Paut I.
Is colchicine an effective treatment in periodic fever, aphtous stomatitis, pharyngitis, cervical adenitis (PFAPA) syndrome?
Joint Bone Spine. 2016 Apr 7. pii: S1297-319X(16)30005-7. doi: 10.1016/j.jbspin.2015.08.017
http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27068612 - Nanthapisal S, Murphy C, Omoyinmi E, Hong Y, Standing A, Berg S, Ekelund M, Jolles S, Harper L, Youngstein T, Gilmour K, Klein N, Eleftheriou D, Brogan PA.
Deficiency of adenosine deaminase type 2 (DADA2): A description of phenotype and genotype in 15 cases.
Arthritis Rheumatol. 2016 Apr 5. doi: 10.1002/art.39699. [Epub ahead of print] http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27059682
MARZO 2016
- Hofmann SR, Kubasch AS, Range U, Laass MW, Morbach H, Girschick HJ, Hedrich CM.
Serum biomarkers for the diagnosis and monitoring of chronic recurrent multifocal osteomyelitis (CRMO).
Rheumatol Int. 2016 Mar 21. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/27000045 - Durel CA, Aouba A, Bienvenu B, Deshayes S, Coppéré B, Gombert B, et al.
Observational Study of a French and Belgian Multicenter Cohort of 23 Patients Diagnosed in Adulthood With Mevalonate Kinase Deficiency
Medicine (Baltimore). 2016 Mar;95(11):e3027. doi: 10.1097/MD.0000000000003027.
http://www.ncbi.nlm.nih.gov/pubmed/26986117 - Koga T, Migita K, Kawakami A.
Biologic therapy in familial Mediterranean fever.
Mod Rheumatol. 2016 Mar 3:1-17. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/26939747 - Parker T, Keddie S, Kidd D, Lane T, Maviki M, Hawkins PN, Lachmann HJ, Ginsberg L.
Neurology of the cryopyrin-associated periodic fever syndrome.
Eur J Neurol. 2016 Mar 2. doi: 10.1111/ene.12965. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/26931528 - Lin DF, Yang WQ, Zhang PP, Lv Q, Jin O, Gu JR.
Clinical and prognostic characteristics of 158 cases of relapsing polychondritis in China and review of the literature.
Rheumatol Int. 2016 Mar 7. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26951051 - Buers I, Nitschke Y, Rutsch F.
Novel interferonopathies associated with mutations in RIG-I like receptors.
Cytokine Growth Factor Rev. 2016 Mar 11. pii: S1359-6101(16)30044-2. doi: 10.1016/j.cytogfr.2016.03.005. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26993858 - Hedrich CM
Shaping the spectrum - From autoinflammation to autoimmunity.
Clin Immunol. 2016 Mar 3;165:21-28. doi: 10.1016/j.clim.2016.03.002
http://www.ncbi.nlm.nih.gov/pubmed/26948930
FEBRERO 2016
- Lopalco G, Rigante D, Giannini M, Galeazzi M, Lapadula G, Iannone F, Cantarini L.
Safety profile of anakinra in the management of rheumatologic, metabolic and autoinflammatory disorders.
Clin Exp Rheumatol. 2016 Feb 26. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26940286 - Leuenberger M, Berner J, Di Lucca J, Fischer L, Kaparos N, Conrad C, Hohl D, So A, Gilliet M.
PASS Syndrome: An IL-1-Driven Autoinflammatory Disease.
Dermatology. 2016 Feb 27. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/26919742 - Akiyama M.
CARD14 alterations and psoriasis: are psoriasis and related disorders genetic autoinflammatory diseases?
Br J Dermatol. 2016 Feb;174(2):262. doi: 10.1111/bjd.14258.
http://www.ncbi.nlm.nih.gov/pubmed/26871918 - Sönnichsen A, Saulite I, Mangana J, Kerl K, Mehra T, Desislava I, Chang YT, Petrausch U, Schmid-Grendelmeier P, Hoetzenecker W, Cozzio A,Guenova E.
Interleukin-1 receptor antagonist (anakinra) for Schnitzler syndrome.
J Dermatolog Treat. 2016 Feb 10:1-3. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26864191 - Kahlenberg JM.
Anti-inflammatory panacea? The expanding therapeutics of interleukin-1 blockade.
Curr Opin Rheumatol. 2016 Feb 8. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26859478 - Yang JA, Choi JY, Kang EH, Ha YJ, Lee YJ, Song YW.
Clinical and Genetic Features of Korean Patients with Recurrent Fever and Multi-System Inflammation without Infectious or Autoimmune Evidence.
J Korean Med Sci. 2016 Feb;31(2):196-201. doi: 10.3346/jkms.2016.31.2.196. Epub 2016 Jan 26.
http://www.ncbi.nlm.nih.gov/pubmed/26839472 - Almeida de Jesus A, Goldbach-Mansky R.
Genetically defined autoinflammatory diseases.
Oral Dis. 2016 Feb 2. doi: 10.1111/odi.12448. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26837051
ENERO 2016
- Demirkaya E, Acikel C, Hashkes P, Gattorno M, Gul A, Ozdogan H, Turker T, Karadag O, Livneh A, Ben-Chetrit E, Ozen S; FMF Arthritis Vasculitis and Orphan disease Research in pediatric rheumatology (FAVOR).
Development and initial validation of international severity scoring system for familial Mediterranean fever (ISSF).
Ann Rheum Dis. 2016 Jan 28. pii: annrheumdis-2015-208671. doi: 10.1136/annrheumdis-2015-208671. [Epub ahead of print] http://ard.bmj.com/content/early/2016/01/28/annrheumdis-2015-208671.abstract - Ozen S, Demirkaya E, Erer B, Livneh A, Ben-Chetrit E, Giancane G, Ozdogan H, Abu I, Gattorno M, Hawkins PN, Yuce S, Kallinich T, Bilginer Y, Kastner D, Carmona L.
EULAR recommendations for the management of familial Mediterranean fever.
Ann Rheum Dis. 2016 Jan 22. pii: annrheumdis-2015-208690. doi: 10.1136/annrheumdis-2015-208690. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26802180
DICIEMBRE 2015
- Demirkaya E, Erer B, Ozen S, Ben-Chetrit E.
Efficacy and safety of treatments in Familial Mediterranean fever: a systematic review.
Rheumatol Int. 2015 Dec 19.
http://www.ncbi.nlm.nih.gov/pubmed/26687683 - Erer B, Demirkaya E, Ozen S, Kallinich T
What is the best acute phase reactant for familial Mediterranean fever follow-up and its role in the prediction of complications? A systematic review.
Rheumatol Int. 2015 Dec 28.
http://www.ncbi.nlm.nih.gov/pubmed/26712372
NOVIEMBRE 2015
- R Levy, L Gérard, J Kuemmerle-Deschner, H J Lachmann, I Koné-Paut, L Cantarini, P Woo, A Naselli, B Bader-Meunier, A Insalaco, S M Al-Mayouf, S Ozen, M Hofer, J Frenkel, C Modesto, I Nikishina, T Schwarz, S Martino, A Meini, P Quartier, A Martini, N Ruperto, B Neven, M Gattorno, for PRINTO and Eurofever
Extended report:Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry
Ann Rheum Dis 2015;74:2043-2049
doi:10.1136/annrheumdis-2013-204991
[Abstract] - Anna Mensa-Vilaro, Weng Tarng Cham, Swee Ping Tang, Sern Chin Lim, Eva González-Roca, Estibaliz Ruiz-Ortiz, Roziana Ariffin, Jordi Yagüe and Juan I. Aróstegui
First report of intrafamilial recurrence of Blau syndrome due to gonosomal NOD2 mosaicism
Arthritis & Rheumatology
DOI: 10.1002/art.39519
Abstract - Insoo Kang
Is the NLPR3 inflammasome “overheated” by pneumococcal vaccination in cryopyrin-associated periodic syndromes?
Arthritis & Rheumatology
DOI: 10.1002/art.39483
Abstract - Masaki Takeuchia, b, Daniel L. Kastnera, Elaine F. Remmersa
The immunogenetics of Behçet's disease: A comprehensive review
Journal of Autoimmunity
Volume 64, November 2015, Pages 137–148 - Jasmin Kuemmerle-Deschner, Assen Koitschev, Pascal Tyrrell, Stefan Plontke, Norbert Deschner, Sandra Hansmann, Katharina Ummenhofer, Peter Lohse, Christiane Koitschev, Susanne Benseler
Early detection of sensorineural hearing loss in Muckle-Wells-syndrome
Pediatric Rheumatology 2015, 13:43 (4 November 2015)
Abstract
OCTUBRE 2015
- Levy R, Gérard L, Kuemmerle-Deschner J, Lachmann HJ, Koné-Paut I, Cantarini L, et al.
Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry
Ann Rheum Dis 2015;74:2043-9
http://ard.bmj.com/content/74/11/2043.abstract - Anton J, Calvo I, Fernández-Martin J, Gamir ML, Merino R, Jimenez-Treviño S, Sevilla B, Cabades F, Bou R, Arostegui JI.
Efficacy and safety of canakinumab in cryopyrin-associated periodic syndromes: results from a Spanish cohort
Clin Exp Rheumatol. 2015 Aug 5. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/26243511 - Rusmini M, Federici S, Caroli F, Grossi A, Baldi M, Obici L, Insalaco A, Tommasini A, Caorsi R, Gallo E, Olivieri AN, Marzano A, Coviello D, Ravazzolo R, Martini A, Gattorno M, Ceccherini I.
Next-generation sequencing and its initial applications for molecular diagnosis of systemic auto-inflammatory diseases
Ann Rheum Dis. 2015 Sep 17. pii: annrheumdis-2015-207701. doi: 10.1136/annrheumdis-2015-207701. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26386126 - Koné-Paut I, Galeotti C.
Current treatment recommendations and considerations for cryopyrin-associated periodic syndrome
Expert Rev Clin Immunol. 2015 Oct;11(10):1083-92.
http://www.ncbi.nlm.nih.gov/pubmed/26312542
SEPTIEMBRE 2015
- Houx L, Hachulla E, Kone-Paut I, Quartier P, Touitou I, Guennoc X, Grateau G, Hamidou M, Neven B, Berthelot JM, Lequerré T, Pillet P, Lemelle I, Fischbach M, Duquesne A, Le Blay P, Le Jeunne C, Stirnemann J, Bonnet C, Gaillard D, Alix L, Touraine R, Garcier F, Bedane C, Jurquet AL, Duffau P, Smail A, Frances C, Grall-Lerosey M, Cathebras P, Tran TA, Morell-Dubois S, Pagnier A, Richez C, Cuisset L, Devauchelle-Pensec V.
Musculoskeletal Symptoms in Patients With Cryopyrin-Associated Periodic Syndromes: A Large Database Study.
Arthritis Rheumatol. 2015 Nov;67(11):3027-36. doi: 10.1002/art.39292.
http://www.ncbi.nlm.nih.gov/pubmed/26245507 - Fairclough LC, Stoop AA, Negm OH, Radford PM, Tighe PJ, Todd I.
Tumour necrosis factor receptor I blockade shows that TNF-dependent and TNF-independent mechanisms synergise in TNF receptor associated periodic syndrome.
Eur J Immunol. 2015 Oct;45(10):2937-44. doi: 10.1002/eji.201545769.
http://www.ncbi.nlm.nih.gov/pubmed/26202849 - ter Haar NM, Oswald M, Jeyaratnam J, Anton J, Barron KS, Brogan PA, Cantarini L, Galeotti C, Grateau G, Hentgen V, Hofer M, Kallinich T, Kone-Paut I, Lachmann HJ, Ozdogan H, Ozen S, Russo R, Simon A, Uziel Y, Wouters C, Feldman BM, Vastert SJ, Wulffraat NM, Benseler SM, Frenkel J, Gattorno M, Kuemmerle-Deschner JB.
Recommendations for the management of autoinflammatory diseases.
Ann Rheum Dis. 2015 Sep;74(9):1636-44. doi: 10.1136/annrheumdis-2015-207546.
http://www.ncbi.nlm.nih.gov/pubmed/26109736 - Bölükbasi B, Krause K.
Cutaneous manifestations of systemic autoinflammatory disorders.
Clin Dermatol. 2015 Sep-Oct;33(5):520-6. doi: 10.1016/j.clindermatol.2015.05.002.
http://www.ncbi.nlm.nih.gov/pubmed/26321397 - Caso F, Galozzi P, Costa L, Sfriso P, Cantarini L, Punzi L.
Autoinflammatory granulomatous diseases: from Blau syndrome and early-onset sarcoidosis to NOD2-mediated disease and Crohn's disease.
RMD Open. 2015 Jul 20;1(1):e000097. doi: 10.1136/rmdopen-2015-000097
http://www.ncbi.nlm.nih.gov/pubmed/26509073 - Zeybek C, Basbozkurt G, Gul D, Demirkaya E, Gok F.
A new mutation in Blau syndrome.
Case Rep Rheumatol. 2015;2015:463959. doi: 10.1155/2015/463959
http://www.ncbi.nlm.nih.gov/pubmed/25692065
AGOSTO 2015
- Koné-Paut I, Galeotti C.
Current treatment recommendations and considerations for cryopyrin-associated periodic syndrome.
Expert Rev Clin Immunol. 2015 Aug 27:1-10. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26312542. - Drobek A, Kralova J, Skopcova T, Kucova M, Novák P, Angelisová P, Otahal P, Alberich-Jorda M4, Brdicka T.
PSTPIP2, a Protein Associated with Autoinflammatory Disease, Interacts with Inhibitory Enzymes SHIP1 and Csk.
J Immunol. 2015 Aug 24. EPUB ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/26304991 - Edwan JH, Goldbach-Mansky R, Colbert RA.
Identification of IL-1β-producing monocytes that are susceptible to pyronecrotic cell death in patients with NOMID.
Arthritis Rheumatol. 2015 Aug 5. doi:10.1002/art.39307. EPUB ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/26245468 . - Houx L, Hachulla E, Kone-Paut I, Quartier P, Touitou I, Guennoc X, Grateau G, Hamidou M, Neven B, Berthelot JM, Lequerré T, Pillet P, Lemelle I, Fischbach M, Duquesne A, Le Blay P, Le Jeunne C, Stirnemann J, Bonnet C, Gaillard D, Alix L, Touraine R, Garcier F, Bedane C, Jurquet AL, Duffau P, Smail A, Frances C, Le Rosey-Grall M, Cathebras P, Tran TA, Morell-Dubois S, Pagnier A, Richez C, Cuisset L, Devauchelle-Pensec V.
Musculoskeletal Symptoms in Patients with Cryopyrin-Associated Periodic Syndromes: Large Database Study.
Arthritis Rheumatol.2015 Aug 5. doi:10.1002/art.39292. EPUB ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/26245507 - Yadlapati S, Efthimiou P.
Impact of IL-1 inhibition on fatigue associated with autoinflammatory syndromes.
Mod Rheumatol. 2015 Aug 3:1-6. EPUB ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/26140469
JUNIO 2015
- Ter Haar NM, Oswald M, Jeyaratnam J, Anton J, Barron KS, Brogan PA, Cantarini L, Galeotti C, Grateau G, Hentgen V, Hofer M, Kallinich T, Kone-Paut I, Lachmann HJ, Ozdogan H, Ozen S, Russo R, Simon A, Uziel Y, Wouters C, Feldman BM, Vastert SJ, Wulffraat NM, Benseler SM, Frenkel J, Gattorno M, Kuemmerle-Deschner JB.
Recommendations for the management of autoinflammatory diseases.
Ann Rheum Dis. 2015 Jun 24. pii: annrheumdis-2015-207546. doi: 10.1136/annrheumdis-2015-207546. [Epub ahead of print] Review.
http://www.ncbi.nlm.nih.gov/pubmed/26109736 - Kaiser D, Bolt I, Hofer M, Relly C, Berthet G, Bolz D and Saurenmann T
Chronic nonbacterial osteomyelitis in children: a retrospective multicenter study
Pediatr Rheumatol Online J. 2015 Jun 19;13:25. doi: 10.1186/s12969-015-0023-y.
http://www.ncbi.nlm.nih.gov/pubmed/26088861 - La Torre F1, Muratore M, Vitale A, Moramarco F, Quarta L, Cantarini L.
Canakinumab efficacy and long-term tocilizumab administration in tumor necrosis factor receptor-associated periodic syndrome (TRAPS).
Rheumatol Int. 2015 Jun 6. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26048626 - Rosé CD, Pans S, Casteels I, Anton J, Bader-Meunier B, Brissaud P, Cimaz R, Espada G, Fernandez-Martin J, Hachulla E, Harjacek M, Khubchandani R, Mackensen F, Merino R, Naranjo A, Oliveira-Knupp S, Pajot C, Russo R, Thomée C, Vastert S, Wulffraat N, Arostegui JI, Foley KP, Bertin J, Wouters CH.
Blau syndrome: cross-sectional data from a multicentre study of clinical, radiological and functional outcomes.
Rheumatology (2015) 54 (6): 1008-1016 doi:10.1093/rheumatology/keu437
http://www.ncbi.nlm.nih.gov/pubmed/25416713
MAYO 2015
- J. Serelis, S. Christaki, F. Skopouli
Remission of nephrotic syndrome due to AA-amyloidosis, complicating familiar Mediterranean fever, with tocilizumab
Clinical and Experimental Rheumatology online
http://www.clinexprheumatol.org/abstract.asp?a=8393 - O. Soylemezoglu, Y. Kandur, A. Duzova, O. Ozkaya, O. Kasapcopur, E. Baskin, K. Fidan, F. Yalcinkaya
Familial Mediterranean fever with a single MEFV mutation: comparison of rare and common mutations in a Turkish paediatric cohort.
Clinical and Experimental Rheumatology online
http://www.clinexprheumatol.org/abstract.asp?a=8910 - C. De Pieri, A. Taddio, A. Insalaco, E. Barbi, L. Lepore, A. Ventura, A. Tommasini
Different presentations of mevalonate kinase deficiency: a case series
Clinical and Experimental Rheumatology online
http://www.clinexprheumatol.org/abstract.asp?a=8465 - Chin-An Yang, Bor-Luen Chiang
Inflammasomes and human autoimmunity: A comprehensive review.
Journal of Autommunity, Available online 23 May 2015
http://www.sciencedirect.com/science/journal/aip/08968411 - Pavla Walsh, Prudence J. Manners, Jack Vercoe, David Burgner, and Kevin J. Murray
Chronic recurrent multifocal osteomyelitis in children: nine years’ experience at a statewide tertiary paediatric rheumatology referral centre
Rheumatology first published online May 3, 2015
doi:10.1093/rheumatology/kev013
http://rheumatology.oxfordjournals.org/content/early/2015/05/01/rheumatology.kev013.abstract
ABRIL 2015
- De Pieri C, Vuch J, De Martino E, Bianco AM, Ronfani L, Athanasakis E, Bortot B, Crovella S, Taddio A, Severini GM, Tommasini A.
Genetic profiling of autoinflammatory disorders in patients with periodic fever: a prospective study.
Pediatr Rheumatol Online J. 2015 Apr 10;13:11. doi: 10.1186/s12969-015-0006-z. eCollection 2015.
http://www.ncbi.nlm.nih.gov/pubmed/25866490
Acceso directo: http://www.ped-rheum.com/content/13/1/11 - Aksentijevich I.
Update on genetics and pathogenesis of autoinflammatory diseases: the last 2 years.
Semin Immunopathol. 2015 Apr 10. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25860799 - Lantto U, Koivunen P, Tapiainen T, Glumoff V, Hirvikoski P, Uhari M, Renko M.
Microbes of the tonsils in PFAPA (Periodic Fever, Aphtous stomatitis, Pharyngitis and Adenitis) syndrome - a possible trigger of febrile episodes.
APMIS. 2015 Apr 23. doi: 10.1111/apm.12383. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25907769 - Westendorp WF, Nederkoorn PJ, Aksentijevich I, Hak AE, Lichtenbelt KD, Braun KP.
Unexplained early-onset lacunar stroke and inflammatory skin lesions: Consider ADA2 deficiency
Neurology. 2015 Apr 17. pii: 10.1212/WNL.0000000000001581. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/25888558 - Ozen S, Batu ED.
The myths we believed in familial Mediterranean fever: what have we learned in the past years?
Semin Immunopathol. 2015 Apr 2
http://www.ncbi.nlm.nih.gov/pubmed/25832989
MARZO 2015
- Perko D, Debeljak M, Toplak N, Avčin T.
Clinical features and genetic background of the periodic Fever syndrome with aphthous stomatitis, pharyngitis, and adenitis: a single center longitudinal study of 81 patients.
Mediators Inflamm. 2015;2015:293417. doi: 10.1155/2015/293417. Epub 2015 Mar 4.
http://www.ncbi.nlm.nih.gov/pubmed/25821352 - Petrushkin H, Stanford M, Fortune F, Jawad AS.
Clinical Review: Familial Mediterranean Fever-An Overview of Pathogenesis, Symptoms, Ocular Manifestations, and Treatment.
Ocul Immunol Inflamm. 2015 Mar 11:1-9. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25760918
FEBRERO 2015
- Berody S, Galeotti C, Koné-Paut I, Piram M.
A restrospective survey of patients's journey before the diagnosis of mevalonate kinase deficiency.
Joint Bone Spine. 2015 Feb 9.
http://www.ncbi.nlm.nih.gov/pubmed/25677409 - Bayram MT, Çankaya T, Bora E, Kavukçu S, Ülgenalp A, Soylu A, Türkmen M.
Risk factors for subclinical inflammation in children with Familial Mediterranean fever.
Rheumatol Int. 2015 Feb 11.
http://www.ncbi.nlm.nih.gov/pubmed/25669438 - de Inocencio J, Mensa-Vilaro A, Tejada-Palacios P, Enriquez-Merayo E, González-Roca E, Magri G, Ruiz-Ortiz E, Cerutti A, Yagüe J, Aróstegui JI.
Somatic NOD2 mosaicism in Blau syndrome.
J Allergy Clin Immunol. 2015 Feb 25.
http://www.ncbi.nlm.nih.gov/pubmed/25724124 - Cantarini L, Vitale A, Bersani G, Nieves LM, Cattalini M, Lopalco G, Caso F, Costa L, Iannone F, Lapadula G, Galeazzi M, Ceribelli A, Brunetta E, Selmi C, Rigante D.
PFAPA syndrome and Behçet's disease: a comparison of two medical entities based on the clinical interviews performed by three different specialists.
Clin Rheumatol. 2015 Feb 10.
http://www.ncbi.nlm.nih.gov/pubmed/25665824 - Coll RC, Robertson AA, Chae JJ, Higgins SC, Muñoz-Planillo R, Inserra MC, Vetter I, Dungan LS, Monks BG, Stutz A, Croker DE, Butler MS, Haneklaus M, Sutton CE, Núñez G, Latz E, Kastner DL, Mills KH, Masters SL, Schroder K, Cooper MA, O'Neill LA.
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.
Nat Med. 2015 Mar;21(3):248-55.
http://www.ncbi.nlm.nih.gov/pubmed/25686105 - de Jesus AA, Canna SW, Liu Y, Goldbach-Mansky R.
Molecular Mechanisms in Genetically Defined Autoinflammatory Diseases: Disorders of Amplified Danger Signaling.
Annu Rev Immunol. 2015 Feb 20.
http://www.ncbi.nlm.nih.gov/pubmed/25706096 - Carta S, Penco F, Lavieri R, Martini A, Dinarello CA, Gattorno M, Rubartelli A.
Cell stress increases ATP release in NLRP3 inflammasome-mediated autoinflammatory diseases, resulting in cytokine imbalance.
Proc Natl Acad Sci U S A. 2015 Mar 3;112(9):2835-40.
http://www.ncbi.nlm.nih.gov/pubmed/25730877
ENERO 2015
- Wipff J, Costantino F, Lemelle I, Pajot C, Duquesne A, Lorrot M, Faye A, Bader-Meunier B, Brochard K, Despert V, Jean S, Grall-Lerosey M, Marot Y, Nouar D, Pagnier A, Quartier P, Job-Deslandre C.
A Large National Cohort of French Patients with Chronic Recurrent Multifocal Osteitis.
Arthritis Rheumatol. 2014 Dec 29. doi: 10.1002/art.39013. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/25545761 - Federici S, Sormani MP, Ozen S, Lachmann HJ, Amaryan G, Woo P, Koné-Paut I, Dewarrat N, Cantarini L, Insalaco A, Uziel Y, Rigante D,Quartier P, Demirkaya E, Herlin T, Meini A, Fabio G, Kallinich T, Martino S, Butbul AY, Olivieri A, Kuemmerle-Deschner J, Neven B,Simon A, Ozdogan H, Touitou I, Frenkel J, Hofer M, Martini A, Ruperto N, Gattorno M; for the Paediatric Rheumatology International Trials Organisation (PRINTO) and Eurofever Project.
Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers.
Ann Rheum Dis. 2015 Jan 30. pii: annrheumdis-2014-206580. doi: 10.1136/annrheumdis-2014-206580. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25637003 - Giancane G, Ter Haar NM, Wulffraat N, Vastert SJ, Barron K, Hentgen V, Kallinich T, Ozdogan H, Anton J, Brogan P, Cantarini L, Frenkel J,Galeotti C, Gattorno M, Grateau G, Hofer M, Kone-Paut I, Kuemmerle-Deschner J, Lachmann HJ, Simon A, Demirkaya E, Feldman B, Uziel Y, Ozen S.
Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever.
Ann Rheum Dis. 2015 Jan 27. pii: annrheumdis-2014-206844. doi: 10.1136/annrheumdis-2014-206844. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25628446
DICIEMBRE 2014
- Jeremiah N, Neven B, Gentili M, Callebaut I, Maschalidi S, Stolzenberg MC, et al.
Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations
J Clin Invest. 2014 Dec 1;124(12):5516-20. doi: 10.1172/JCI79100
http://www.ncbi.nlm.nih.gov/pubmed/25401470 - Başaran Ö, Uncu N, Çelikel BA, Taktak A, Gür G, Cakar N.
Interleukin-1 targeting treatment in familial Mediterranean fever: an experience of pediatric patients.
Mod Rheumatol. 2014 Dec 22:1-4.
http://www.ncbi.nlm.nih.gov/pubmed/25528863 - Caso F, Costa L, Rigante D, Vitale A, Cimaz R, Lucherini OM, Sfriso P, Verrecchia E, Tognon S, Bascherini V, Galeazzi M, Punzi L, Cantarini L.
Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis.
Autoimmun Rev. 2014 Dec;13(12):1220-1229.
http://www.ncbi.nlm.nih.gov/pubmed/25182201 - Boyle JP, Parkhouse R, Monie TP.
Insights into the molecular basis of the NOD2 signalling pathway.
Open Biol. 2014 Dec;4(12). pii: 140178.
http://www.ncbi.nlm.nih.gov/pubmed/25520185
NOVIEMBRE 2014
- Rosé CD, Pans S, Casteels I, Anton J, Bader-Meunier B, Brissaud P, Cimaz R, Espada G, Fernandez-Martin J, Hachulla E, Harjacek M, Khubchandani R, Mackensen F, Merino R, Naranjo A, Oliveira-Knupp S, Pajot C, Russo R, Thomee C, Vastert S, Wulffraat N, Arostegui JI, Foley KP, Bertin J, Wouters CH.
Blau syndrome: cross-sectional data from a multicentre study of clinical, radiological and functional outcomes.
Rheumatology (Oxford). 2014 Nov 20. pii: keu437. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/?term=25416713 - Hettinga YM, Verhagen FH, van Genderen M, de Boer JH.
Characteristics of childhood uveitis leading to visual impairment and blindness in the Netherlands.
Acta Ophthalmol. 2014 Dec;92(8):798-804.
http://www.ncbi.nlm.nih.gov/pubmed/?term=24975684 - Broderick L, De Nardo D, Franklin BS, Hoffman HM, Latz E.
The Inflammasome and Autoinflammatory Syndromes.
Annu Rev Pathol. 2014 Nov 19. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/?term=25423351 - Witsch-Baumgartner M, Touitou I.
Clinical utility gene card for: Prototypic hereditary recurrent fever syndromes (monogenic autoinflammatory syndromes).
Eur J Hum Genet. 2014 Nov 19. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/?term=25407006 - Ten Oever J, Kox M, van de Veerdonk FL, Mothapo KM, Slavcovici A, Jansen TL, Tweehuysen L, Giamarellos-Bourboulis EJ, Schneeberger PM, Wever PC, Stoffels M, Simon A, van der Meer J, Johnson MD, Kullberg BJ, Pickkers P, Pachot A, Joosten L, Netea MG.
The discriminative capacity of soluble Toll-like receptor (sTLR)2 and sTLR4 in inflammatory diseases.
BMC Immunol. 2014 Nov 19;15(1):55.
http://www.ncbi.nlm.nih.gov/pubmed/?term=25406630 - Jamilloux Y, Gerfaud-Valentin M, Martinon F, Belot A, Henry T, Sève P.
Pathogenesis of adult-onset Still's disease: new insights from the juvenile counterpart.
Immunol Res. 2014 Nov 12. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/?term=25388963 - Kitamura A, Sasaki Y, Abe T, Kano H, Yasutomo K.
An inherited mutation in NLRC4 causes autoinflammation in human and mice.
J Exp Med. 2014 Nov 17;211(12):2385-96.
http://www.ncbi.nlm.nih.gov/pubmed/?term=25385754 - Miller JJ, Venna N, Siva A.
Neuro-behçet disease and autoinflammatory disorders.
Semin Neurol. 2014 Sep;34(4):437-43.
http://www.ncbi.nlm.nih.gov/pubmed/?term=25369439 - Kanariou M, Tantou S, Varela I, Raptaki M, Petropoulou C, Nikas I, Valari M.
Successful management of cryopyrin-associated periodic syndrome with canakinumab in infancy.
Pediatrics. 2014 Nov;134(5):e1468-73.
http://www.ncbi.nlm.nih.gov/pubmed/?term=25349319 - Bernard NJ.
Autoinflammation: NLRC4 mutation causes rare autoinflammatory disease.
Nat Rev Rheumatol. 2014 Nov;10(11):635.
http://www.ncbi.nlm.nih.gov/pubmed/?term=25266450 - Tran TA, Pariente D, Guitton C, Delwail A, Barat-Houari M, Meinzer U.
Treatment of Erdheim-Chester disease with canakinumab.
Rheumatology (Oxford). 2014 Dec;53(12):2312-4.
http://www.ncbi.nlm.nih.gov/pubmed/?term=25234662 - Russo RA, Brogan PA.
Monogenic autoinflammatory diseases.
Rheumatology (Oxford). 2014 Nov;53(11):1927-1939.
http://www.ncbi.nlm.nih.gov/pubmed/?term=24831056 - Ling E, Israeli M, Klein T, Amir J, Harel L.
Periodic fever, aphthous stomatitis, pharyngitis and cervical adenopathy syndrome is associated with activation of GM-CSF and burst-like expression of IL-8 in peripheral blood.
Mod Rheumatol. 2014 Nov;24(6):997-1000.
http://www.ncbi.nlm.nih.gov/pubmed/?term=24670131 - Campanilho-Marques R, Brogan PA.
Mevalonate kinase deficiency in two sisters with therapeutic response to anakinra: case report and review of the literature.
Clin Rheumatol. 2014 Nov;33(11):1681-4.
http://www.ncbi.nlm.nih.gov/pubmed/?term=24531849 - Lachmann HJ, Papa R, Gerhold K, Obici L, Touitou I, Cantarini L, Frenkel J, Anton J, Kone-Paut I, Cattalini M, Bader-Meunier B, Insalaco A, Hentgen V, Merino R, Modesto C, Toplak N, Berendes R, Ozen S, Cimaz R, Jansson A, Brogan PA, Hawkins PN, Ruperto N, Martini A, Woo P, Gattorno M; Paediatric Rheumatology International Trials Organisation (PRINTO), the EUROTRAPS and the Eurofever Project.
The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry.
Ann Rheum Dis. 2014 Dec;73(12):2160-7.
http://www.ncbi.nlm.nih.gov/pubmed/?term=23965844
OCTUBRE 2014
- Kanariou M, Tantou S, Varela I, Raptaki M, Petropoulou C, Nikas I, Valari M.
Successful Management of Cryopyrin-Associated Periodic Syndrome With Canakinumab in Infancy.
Pediatrics. 2014 Oct 27. pii: peds.2013-3185. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/25349319 - Cantarini L, Lopalco G, Selmi C, Napodano S, De Rosa G, Caso F, Costa L, Iannone F, Rigante D.
Autoimmunity and autoinflammation as the yin and yang of idiopathic recurrent acute pericarditis.
Autoimmun Rev. 2014 Oct 11. pii: S1568-9972(14)00217-1. doi: 10.1016/j.autrev.2014.10.005. [Epub ahead of print] Review.
http://www.ncbi.nlm.nih.gov/pubmed/25308531 - Zhang X, Bogunovic D, Payelle-Brogard B, Francois-Newton V, Speer SD, Yuan C, Volpi S, Li Z, Sanal O, Mansouri D, Tezcan I, Rice GI, Chen C, Mansouri N, Mahdaviani SA, Itan Y, Boisson B, Okada S, Zeng L, Wang X, Jiang H, Liu W, Han T, Liu D, Ma T, Wang B, Liu M, Liu JY, Wang QK, Yalnizoglu D, Radoshevich L, Uzé G, Gros P, Rozenberg F, Zhang SY, Jouanguy E, Bustamante J, García-Sastre A, Abel L, Lebon P, Notarangelo LD, Crow YJ, Boisson-Dupuis S, Casanova JL, Pellegrini S.
Human intracellular ISG15 prevents interferon-α/β over-amplification and auto-inflammation.
Nature. 2014 Oct 12. doi: 10.1038/nature13801. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/25307056 - Yazici H, Talarico R, Hamuryudan V.
Self-criticism in Behçet's disease and other autoinflammatory conditions.
Clin Exp Rheumatol. 2014 Sep-Oct;32 Suppl 84(4):5-6. Epub 2014 Sep 29.
http://www.ncbi.nlm.nih.gov/pubmed/25268659 - Roberta Caorsi, Paolo Picco, Antonella Buoncompagni, Alberto Martini, and Marco Gattorno
Osteolytic Lesion in PAPA Syndrome Responding to Anti-interleukin 1 Treatmen
J Rheumatol November 2014 41(11):2333-2334; doi:10.3899/jrheum.140060
http://jrheum.org/content/41/11/2333.extract
SEPTIEMBRE 2014
- Carreño E, Guly CM, Chilov M, Hinchcliffe A, Arostegui JI, Lee RW, Dick AD, Ramanan AV.
Optic nerve and retinal features in uveitis associated with juvenile systemic granulomatous disease (Blau syndrome).
Acta Ophthalmol. 2014 Sep 10. doi: 10.1111/aos.12544. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/25209167 - Canna SW, de Jesus AA, Gouni S, Brooks SR, Marrero B, Liu Y, DiMattia MA, Zaal KJ, Sanchez GA, Kim H, Chapelle D, Plass N, Huang Y, Villarino AV, Biancotto A, Fleisher TA, Duncan JA, O'Shea JJ, Benseler S, Grom A, Deng Z, Laxer RM, Goldbach-Mansky R.
An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome.
Nat Genet. 2014 Sep 14. doi: 10.1038/ng.3089. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/25217959 - Martinon F, Aksentijevich I.
New players driving inflammation in monogenic autoinflammatory diseases.
Nat Rev Rheumatol. 2014 Sep 23. doi: 10.1038/nrrheum.2014.158. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/25247411 - Jéru I, Cochet E, Duquesnoy P, Hentgen V, Copin B, Mitjavila-Garcia MT, Sheykholeslami S, Le Borgne G, Dastot-Le Moal F, Malan V, Karabina S, Mahevas M, Chantot-Bastaraud S, Lecron JC, Faivre L, Amselem S.
Involvement of TNFRSF11A molecular defects in autoinflammatory disorders.
Arthritis Rheumatol. 2014 Sep;66(9):2621-2627.
http://www.ncbi.nlm.nih.gov/pubmed/24891336
AGOSTO 2014
- Caso F, Costa L, Rigante D, Vitale A, Cimaz R, Lucherini OM, Sfriso P, Verrecchia E, Tognon S, Bascherini V, Galeazzi M, Punzi L, Cantarini L.
Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis.
Autoimmun Rev. 2014 Aug 23. pii: S1568-9972(14)00154-2. doi: 10.1016/j.autrev.2014.08.010. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/25182201 - Liu Y, Jesus AA, Marrero B, Yang D, Ramsey SE, Montealegre Sanchez GA, et al.
Activated STING in a vascular and pulmonary syndrome.
N Engl J Med. 2014 Aug 7;371(6):507-18.
http://www.ncbi.nlm.nih.gov/pubmed/25029335 - Wouters CH, Maes A, Foley KP, Bertin J, Rose CD.
Blau Syndrome, the prototypic auto-inflammatory granulomatous disease.
Pediatr Rheumatol Online J. 2014 Aug 6;12:33.
http://www.ncbi.nlm.nih.gov/pubmed/25136265 - Yilmaz R1, Karaaslan E, Ozer S, Sonmezgoz E, Kazanci NO, Cakan N, Akbas A.
Hypovitaminosis D in Children with Familial Mediterranean Fever.
Clin Invest Med. 2014 Aug 1;37(4):E211.
http://www.ncbi.nlm.nih.gov/pubmed/25090260 - Dávila-Seijo P1, Hernández-Martín A1, Torrelo A2.
Autoinflammatory syndromes for the dermatologist.
Clin Dermatol. 2014 Jul-Aug;32(4):488-501. doi: 10.1016/j.clindermatol.2014.02.004. Epub 2014 Feb 28.
http://www.ncbi.nlm.nih.gov/pubmed/25017460 - Hofmann C1, Wurm M, Schwarz T, Neubauer H, Beer M, Girschick H, Morbach H.
A standardized clinical and radiological follow-up of patients with chronic non-bacterial osteomyelitis treated with pamidronate.
Clin Exp Rheumatol. 2014 Jul-Aug;32(4):604-9. Epub 2014 Jul 23.
http://www.ncbi.nlm.nih.gov/pubmed/25065777
Última actualización: 22 juniol 2026
ABRIL 2026
-
Al-Gawahiri M, de Jong EMGJ, Schatorjé EJH, Hoppenreijs EPAH, van den Reek JMPA, Seyger MMB.
Development of Arthritis in a Large Real-World Cohort of Patients With Pediatric Onset Psoriasis.
J Psoriasis Psoriatic Arthritis. 2026 Apr 25:24755303261446205. doi: 10.1177/24755303261446205. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/42046717/ -
Vallogini G, Michelotti A, Manzoni SM, Festa P, Putrino A, Uomo R, Gregori LM, Piga S, Fabrizio B, Galeotti A.
Temporomandibular Joint Involvement in Paediatric Patients Affected by Juvenile Idiopathic Arthritis.
J Oral Rehabil. 2026 Apr 24. doi: 10.1111/joor.70200. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/42028608/ -
Chasnyk V, Constantin T, Nikishina I, Bader-Meunier B, Breda L, Doležalová P, Rumba-Rozenfelde I, Wulffraat N, Akikusa J, Avcin T, Burgos-Vargas R, Chaitow J, Carlini L, Tsekouras V, Graham D, Borlenghi C, Vlahos B, Zang C, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).
Predictors of inactive disease and remission in children and young adults with juvenile idiopathic arthritis treated with etanercept.
Rheumatology (Oxford). 2026 Apr 20:keag198. doi: 10.1093/rheumatology/keag198. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/42011511/ -
Al-Gawahiri M, de Jong EMGJ, Schatorjé EJH, Hoppenreijs EPAH, van den Reek JMPA, Seyger MMB.
Development of Arthritis in a Large Real-World Cohort of Patients With Pediatric Onset Psoriasis.
J Psoriasis Psoriatic Arthritis. 2026 Apr 25:24755303261446205. doi: 10.1177/24755303261446205. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/42046717/
MARZO 2026
-
Brunner HI, Alexeeva E, Bandeira M, Carrasco R, Chaitow J, Chiraseveenuprapund P, et al; Paediatric Rheumatology International Trials Organisation (PRINTO) and Pediatric Rheumatology Collaborative Study Group (PRCSG).
Tofacitinib for the Treatment of Juvenile Idiopathic Arthritis: Patient-Reported Outcomes in a Phase 3, Randomized, Double-Blind, Placebo-Controlled Withdrawal Trial.
Arthritis Rheumatol. 2026 Mar;78(3):752-762. doi: 10.1002/art.43428.
https://pubmed.ncbi.nlm.nih.gov/41169192/ -
Weßling J, Leiskau C, Dressler F, Klemann C.
Methotrexate Therapy in Juvenile Idiopathic Arthritis: No Clinically Relevant Pulmonary Impairment but Frequent Transient Liver Enzyme Elevations in a Longitudinal Single-Center Pediatric Cohort of 274 Children Over 30 Years.
ACR Open Rheumatol. 2026 Mar;8(3):e90000. doi: 10.1002/acr2.90000.
https://pubmed.ncbi.nlm.nih.gov/41873148/ -
Morel Z, Espada G, Eraso R, Silva CA, Gutiérrez-Suárez R, Franco L, et al; Pan American League of Associations for Rheumatology (PANLAR).
Pan American League of Associations for Rheumatology: Recommendations for the Treatment of Oligoarticular Juvenile Idiopathic Arthritis.
J Clin Rheumatol. 2026 Mar 1;32(2):e55-e65. doi: 10.1097/RHU.0000000000002316.
https://pubmed.ncbi.nlm.nih.gov/41728909/ -
Mayer AS, Kimura Y.
Toward Optimal Treatment Outcomes in New-Onset Polyarticular-Course Juvenile Idiopathic Arthritis.
Paediatr Drugs. 2026 Mar;28(2):103-110. doi: 10.1007/s40272-025-00735-0.
https://pubmed.ncbi.nlm.nih.gov/41563700/ -
Mayer AS, Xiao R, Brandon TG, Weiss PF; Juvenile Axial Spondyloarthritis Research Taskforce (JAxSpRT).
Sex differences in clinical and imaging characteristics of axial juvenile spondyloarthritis.
Rheumatology (Oxford). 2026 Mar 5;65(3):keaf611. doi: 10.1093/rheumatology/keaf611.
https://pubmed.ncbi.nlm.nih.gov/41776826/ -
Sarısoy D, Aydın F, Taş Ö, Bahçeci O, Öksüz Aydın B, Erorhan E, et al.
Clinical predictors of relapse and severe disease phenotype in children with non-systemic juvenile idiopathic arthritis
Eur J Pediatr. 2026 Mar 24;185(4):205. doi: 10.1007/s00431-026-06842-5.
https://pubmed.ncbi.nlm.nih.gov/41872624/ -
Türkuçar S, Sözeri B, Sönmez HE, Şahin N, Açarı C, Dundar HA, et al.
Defining Inactivity of Juvenile Spondyloarthropathies: Delphi Study Among Pediatric Rheumatology Academy (PeRA) From Turkiye.
Int J Rheum Dis. 2026 Mar;29(3):e70606. doi: 10.1111/1756-185x.70606.
https://pubmed.ncbi.nlm.nih.gov/41821199/ - Queiro R, Braña I, Alvarez P, Loredo M, Pardo E, Burger S.
Comparative cost-utility analysis of ixekizumab, tofacitinib, and golimumab in psoriatic arthritis: a real-world Markov model simulation.
Expert Rev Pharmacoecon Outcomes Res. 2026 Mar;26(3):419-427. doi: 10.1080/14737167.2026.2629351
https://pubmed.ncbi.nlm.nih.gov/41657049/
FEBRERO 2026
- Hassan W, Mosa DM, Faleye A, Libe TT, Palalane E, Migowa A, Al Mayouf S, Foster H, Abu-Zaid MH, Hashad S, Hamdi W, Ferjani HL, Seri A, Lishan H, Dahou CM, Makhlouf Y, Taha Y, Fusseini YH, Messadi W, Sobh A, Nasef SI, Gacem O, Ngandeu M, Furia FF, Slimani S, Scott C, Hadef D.
PAFLAR guidelines for oligoarticular juvenile idiopathic arthritis.
Clin Rheumatol. 2026 Feb;45(2):1323-1336.
https://pubmed.ncbi.nlm.nih.gov/41492017/ - Sun HL, Kao YH, Yu HH, Wang LC, Wu CY, Yao TC; Committee of the Taiwan Academy of Pediatric Allergy, Asthma and Immunology.
Taiwan guideline for the diagnosis and management of juvenile idiopathic arthritis: Consensus statement of the Taiwan Academy of Pediatric Allergy, Asthma and Immunology.
J Microbiol Immunol Infect. 2026 Feb;59(1):1-11.
https://pubmed.ncbi.nlm.nih.gov/40514341/
ENERO 2026
- Hassan W, Mosa DM, Faleye A, Libe TT, Palalane E, Migowa A, et al.
PAFLAR guidelines for oligoarticular juvenile idiopathic arthritis.
Clin Rheumatol. 2026 Feb;45(2):1323-1336.
https://pubmed.ncbi.nlm.nih.gov/41492017/ - Wyszyńska J, Turska-Kmieć A, Neunhaeuserer D, di Salvo G, Del Torso S, Koletzko B, et al.
Sport Activities for Children and Adolescents: Part 2. Joint Position Statement of Paediatric Societies on Physical Activity and Sport Recommendations for Children With Specific Chronic Disease Conditions.
Acta Paediatr. 2026 Jan;115(1):58-72.
https://pubmed.ncbi.nlm.nih.gov/40995775/ - Weiss PF, Ruperto N, Quebe-Fehling E, Shew A, Pricop L, et al.
Juvenile Spondyloarthritis Disease Activity Index Validation in Enthesitis-Related Arthritis and Juvenile Psoriatic Arthritis in a Prospective Clinical Trial Setting.
J Rheumatol. 2026 Jan 1;53(1):85-94.
https://pubmed.ncbi.nlm.nih.gov/40953957/ - Inamo J, Fierkens R, Clay MR, Jonsson AH, Lin C, Hayes K, et al.
Spatial transcriptomics reveals immune-stromal crosstalk within the synovium of patients with juvenile idiopathic arthritis.
JCI Insight. 2025 Nov 21;11(1):e198074.
https://pubmed.ncbi.nlm.nih.gov/41269758/ - Abel D, Butler N, Chatterjee A, Tavlin S, Kellom K, Chang JC, et al.
Qualitative Exploration of Adherence to Methotrexate in Juvenile Idiopathic Arthritis.
J Pediatr. 2026 Jan;288:114798.
https://pubmed.ncbi.nlm.nih.gov/40887014/ - Marino A, Scirè CA, Baldassarre P, Ferrigno C, Costi S, Baldo F, et al.
Development of a scoring system to assist clinicians in the early referral of patients with suspected juvenile idiopathic arthritis: the EasyJIA score.
Arthritis Res Ther. 2026 Jan 9;28(1):28.
https://pubmed.ncbi.nlm.nih.gov/41508146/ - Tsai JJ, Liu LT, Lin PC, Wang YH, Lee YH, Wei JC.
Comparative risk of systemic autoimmune diseases in juvenile idiopathic arthritis treated with TNF-α or IL-6 inhibitors: a real-world cohort study.
Front Immunol. 2026 Jan 13;16:1744226.
https://pubmed.ncbi.nlm.nih.gov/41607798/ - Livermore P, Kupiec KH, Knight AM.
Mental health needs of children and young people with arthritis.
Arthritis Res Ther. 2026 Jan 18;28(1):39.
https://pubmed.ncbi.nlm.nih.gov/41549272/
DICIEMBRE 2025
- Hu YC, Huang YL, Yiao SY, Lin MT, Lin FJ, Yang YH
The epidemiology and biologics treatment patterns of juvenile idiopathic arthritis in Taiwan – an 8-year follow-up
Front Immunol. 2025 Dec 16;16:1712103. doi: 10.3389/fimmu.2025.1712103
https://pubmed.ncbi.nlm.nih.gov/41476969/ - Ozturk K, Aydin T, Baykal GO, Baglan E, Kose H, Kisaoglu H et al.
How early is early for JIA? Insights from the infantile-onset juvenile idiopathic arthritis patients of the PERA research group cohort
Rheumatology (Oxford). 2025 Dec 1;64(12):6278–6284
https://pubmed.ncbi.nlm.nih.gov/40811013/
OCTUBRE 2025
-
Correll C, Burciu A, Bansal A, Dennos A, Narayanswamy D, Aubrun E, Schanberg LE, Yuhan L, Schneider R, Balevic S, Kimura Y, Beukelman T; CARRA Registry investigators.
Long-term safety of canakinumab in patients with systemic juvenile idiopathic arthritis: 5-year results from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry.
Pediatr Rheumatol Online J. 2025 Oct 21;23(1):105.
https://pubmed.ncbi.nlm.nih.gov/41121260/ -
Abu-Rumeileh S, Mastrolia MV, Laurent A, Fouillet-Desjonqueres M, Zekre F, Pagnini I, Marrani E, Maccora I, Belot A, Simonini G.
Clinical predictors of remission in systemic juvenile idiopathic arthritis/Still's disease: insight from real-life data and the potential relevance of the 'window of opportunity'.
Clin Exp Rheumatol. 2025 Oct;43(10):1823-1829
https://pubmed.ncbi.nlm.nih.gov/41133354/ -
Balay-Dustrude E, Correia Marques M, Appenzeller S, Bracaglia C, Dedeoglu F, Eloseily E, Martinez Jimenez P, Ombrello MJ, Onel K, Twilt M, Zhao X, Minoia F, Shenoi S; CARRA systemic JIA Work Group and the PRES systemic JIA/MAS working party.
Clinical Features and Outcome Measures Across Still's Disease (sJIA and AOSD) Cohorts Worldwide: A Systematic Literature Review.
J Rheumatol. 2025 Oct 1:jrheum.2025-0822.
https://pubmed.ncbi.nlm.nih.gov/41033820/ -
Bektas E, Uludogan BC, Firlatan Yazgan B, Kilinc OC, Acar B, Kizilkaya O, et al.
Clinical significance of non-infectious procalcitonin elevation in Still's disease: A predictor of macrophage activation syndrome.
Rheumatology (Oxford). 2025 Oct 29:keaf575. doi: 10.1093/rheumatology/keaf575. Online ahead of print
https://pubmed.ncbi.nlm.nih.gov/41160497/ -
Shimizu M, Kaneko S, Shimbo A, Hatano M, Miyaoka F, Hayashi Y, Irabu H, Akutsu Y, Mori M.
Distinct expression profiles of inflammasome-associated genes in systemic juvenile idiopathic arthritis.
Rheumatology (Oxford). 2025 Oct 30:keaf576
https://pubmed.ncbi.nlm.nih.gov/41165588/
SEPTIEMBRE 2025
-
Miyamae T, Okamoto N, Inoue Y, Kubota T, Ebato T, Irabu H, et al.
Recommendations for the treatment of juvenile idiopathic arthritis with oligoarthritis or polyarthritis from the 2024 update of the Japan College of Rheumatology Clinical Practice Guidelines for the management of rheumatoid arthritis including juvenile idiopathic arthritis with oligoarthritis or polyarthritis - secondary publication.
Mod Rheumatol. 2025 Sep 2;35(5):894-908. doi: 10.1093/mr/roaf042.
https://pubmed.ncbi.nlm.nih.gov/40459241/ -
Weiss PF, Ruperto N, Quebe-Fehling E, Shew A, Pricop L, Pieterse CC, Brunner HI; Paediatric Rheumatology INternational Trials Organisation (PRINTO) and Pediatric Rheumatology Collaborative Study Group (PRCSG) Investigative Sites.
Juvenile Spondyloarthritis Disease Activity Index Validation in Enthesitis-Related Arthritis and Juvenile Psoriatic Arthritis in a Prospective Clinical Trial Setting.
J Rheumatol. 2025 Sep 15:jrheum.2025-0294. doi: 10.3899/jrheum.2025-0294. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40953957/ -
Alexeeva EI, Tsulukiya IT, Dvoryakovskaya TM, Kudlay DA, Kriulin IA, Botova MS, et al
Can We Successfully Discontinue Anti-Tumor Necrosis Factor-α Treatment in Children with Non-Systemic Juvenile Idiopathic Arthritis? The Experience of a Tertiary Center.
Biomedicines. 2025 Sep 24;13(10):2329. doi: 10.3390/biomedicines13102329
https://pubmed.ncbi.nlm.nih.gov/41153616/ -
Consolaro A, Ruperto N, Lovell DJ, Synoverska O, Abud-Mendoza C, Spindler A, et al.; Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG).
Clinically Inactive Disease and Remission in Patients With Juvenile Idiopathic Arthritis Receiving Tofacitinib: Post Hoc Analysis of a Phase III Trial.
J Rheumatol. 2025 Sep 1;52(9):919-926. doi: 10.3899/jrheum.2024-0536
https://pubmed.ncbi.nlm.nih.gov/40312101/ -
Tsai Z, Huber AM, Oen K, Proulx-Gauthier JP, Chédeville G, Boire G, et al; ReACCh-Out and CAPRI Registry Investigators.
Impact of Treatment Changes on Health-Related Quality of Life in Canadian Children withJuvenile Idiopathic Arthritis: Results from ReACCh-Out and CAPRI.
J Rheumatol. 2025 Sep 15:jrheum.2025-0377. doi: 10.3899/jrheum.2025-0377. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40953955/ -
Wong SKA, Tucker LB, Houghton K, Cabral DA, Chan M, Morishita KA, et al; ReACCh‐Out investigators.
A Tale of Many Canadas: Associations of Ancestry With Juvenile Idiopathic Arthritis Categories and Disease Severity at Presentation to Care.
ACR Open Rheumatol. 2025 Sep;7(9):e70092. doi: 10.1002/acr2.70092.
https://pubmed.ncbi.nlm.nih.gov/40887850/ -
Krishnan V, Keller SY, Chew C, Sims JT, Chang CY, Dow ER, Benschop RJ, Wang R, Ramanan AV.
Serum biomarkers associated with baricitinib response in patients with juvenile idiopathic arthritis: a post-hoc analysis of the phase 3 JUVE-BASIS trial.
Lancet Rheumatol. 2025 Sep 4:S2665-9913(25)00153-5. doi: 10.1016/S2665-9913(25)00153-5. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40915298/ -
Özçelik E, Çelikel E, Tekin ZE, Güngörer V, Karagöl C, Kaplan MM, et al.
Real-life data on treatment strategies for polyarticular juvenile idiopathic arthritis.
Eur J Pediatr. 2025 Sep 30;184(10):652. doi: 10.1007/s00431-025-06495-w.
https://pubmed.ncbi.nlm.nih.gov/41026294/ -
He L, Zhang D, Gapud EJ, Peng S, Belen O, Sahajwalla C, etr al.
Approval of Upadacitinib in Pediatric Patients with Active Polyarticular Juvenile Idiopathic Arthritis or Active Psoriatic Arthritis: A Regulatory Perspective.
J Clin Pharmacol. 2025 Sep 27. doi: 10.1002/jcph.70104. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/41014542/ - Bagri NK, Srivastava S, Singh Y, Neelamegan R, Upadhyay A, Kumar VS, et al.
Synovial Fluid Proteomic Signatures in Different Subtypes of Juvenile Idiopathic Arthritis.
Scand J Immunol. 2025 Sep;102(3):e70051. doi: 10.1111/sji.70051.
https://pubmed.ncbi.nlm.nih.gov/40855397/ - van Til JA, Kip MMA, Marinescu-Muster R, Groothuis-Oudshoorn K, Currie GR, Benseler SM, Swart JF, Vastert SJ, Wulffraat N, et al.
Development and Qualitative Evaluation of a Decision Support Tool for Withdrawal of Biologic Therapy in Nonsystemic Juvenile Idiopathic Arthritis.
MDM Policy Pract. 2025 Sep 29;10(2):23814683251364199. doi: 10.1177/23814683251364199.
https://pubmed.ncbi.nlm.nih.gov/41036268/ -
Verit G, Anwar D, Greenberg M, Cisek J, Hinrichs K, Mensah N, Kirker K.
Effects of Hydrotherapy on Juvenile Idiopathic Arthritis: A Systematic Review and Meta-Analysis.
Pediatr Phys Ther. 2025 Sep 18. doi: 10.1097/PEP.0000000000001256. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40982358/
JULIO 2025
-
Rheumatology Collaborative Study Group (PRCSG).
Clinically Inactive Disease and Remission in Patients With Juvenile Idiopathic Arthritis Receiving Tofacitinib: Post Hoc Analysis of a Phase III Trial.
J Rheumatol. 2025 Jul 1:jrheum.2024-0536. doi: 10.3899/jrheum.2024-0536. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40312101/ -
Srinivasalu H, Beukelman T, Dennos A, Chen A, Correll C, Ringold S, Balevic S; CARRA Registry Investigators.
Juvenile Psoriatic Arthritis Inception Cohort in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry: Characteristics and Early Disease Outcomes.
J Rheumatol. 2025 Jul 1:jrheum.2025-0066. doi: 10.3899/jrheum.2025-0066. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40592547/ - Mannion ML, Aswani MS, Hearld KR, Smitherman EA, Timmerman L, Curtis JR; CARRA Registry Investigators.
Disease activity at two consecutive registry visits and subsequent medication escalation for patients with juvenile idiopathic arthritis in the CARRA registry.
Pediatr Rheumatol Online J. 2025 Jul 22;23(1):77. doi: 10.1186/s12969-025-01130-2.
https://pubmed.ncbi.nlm.nih.gov/40696394/ -
Hügle B, Horneff G, Haas JP.
High rheumatoid factor does not diminish efficacy of TNF inhibitors in seropositive JIA.
Pediatr Rheumatol Online J. 2025 Jul 21;23(1):76. doi: 10.1186/s12969-025-01125-z.
https://pubmed.ncbi.nlm.nih.gov/40691795/ -
Huang J, Teh KL, Chen C, Das L, Arkachaisri T.
Efficacy and safety of anti-Tumor Necrosis Factor-α biosimilars in Juvenile Idiopathic Arthritis - a systematic review and meta-analysis.
Semin Arthritis Rheum. 2025 Jul 16;74:152792. doi: 10.1016/j.semarthrit.2025.152792. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40714372/ -
Piao Y, Xu X, Yao X, Li Y, Sun Y, Han T, Wang X, Mao H.
Paradoxical psoriasis in pediatric tumor necrosis factor-α inhibitor therapy database.
Pediatr Res. 2025 Jul 23. doi: 10.1038/s41390-025-04305-5. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40702205/ -
Alblooshi H, Mustafa N, Khalam AA, Bharathan A, Mohammed E, Baydoun I, et al.
A novel LACC1 variant c.658G>A (p. Asp220Asn) in familial juvenile arthritis: identification and functional analysis.
Hum Genomics. 2025 Jul 25;19(1):85. doi: 10.1186/s40246-025-00800-2.
https://pubmed.ncbi.nlm.nih.gov/40713900/ -
Sener S, Batu ED, Aliyev E, Basaran O, Saribas Z, Bilginer Y, Sener B, zen S.
Antinuclear antibodies staining patterns and titres in juvenile idiopathic arthritis.
Mod Rheumatol. 2025 Jul 5;35(4):762-766. doi: 10.1093/mr/roaf011.
https://pubmed.ncbi.nlm.nih.gov/39901832/ -
Demirkan FG, Guliyeva V, Akgün Ö, Ferjani HL, Nessib DB, Maatallah K, et al.
A tale of two regions: comparing clinical features and outcomes in pediatric enthesitis-related arthritis.
Pediatr Rheumatol Online J. 2025 Jul 29;23(1):82. doi: 10.1186/s12969-025-01095-2.
https://pubmed.ncbi.nlm.nih.gov/40730979/ - Snipaitiene A, Snipaitiene K, Slegeryte A, Buragaite-Staponkiene B, Baranauskaite A, Jarmalaite S, Jankauskaite L.
The utility of miR-16, miR-146a and miR-155 in serum and urine for juvenile idiopathic arthritis diagnostics and monitoring. - Pediatr Rheumatol Online J. 2025 Jul 28;23(1):79. doi: 10.1186/s12969-025-01136-w.
https://pubmed.ncbi.nlm.nih.gov/40722025/ -
Pudjihartono N, Ho D, O'Sullivan JM.
Machine learning using genotype and gene-expression data identifies alterations of genes involved in infection susceptibility, antigen presentation and cytokine signalling as key contributors to JIA risk prediction.
RMD Open. 2025 Jul 9;11(3):e005737. doi: 10.1136/rmdopen-2025-005737.
https://pubmed.ncbi.nlm.nih.gov/40633979/
JUNIO 2025
-
Quartier P, Belot A, Breton S, Carbasse A, Devauchelle V, Fautrel B et al.
French protocol for the diagnosis and management of juvenile idiopathic arthritis including pediatric-onset Still's disease.
Rev Med Interne. 2025 Jun 20:S0248-8663(25)00648-4. doi: 10.1016/j.revmed.2025.06.001. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40544011/ -
Miyamae T, Okamoto N, Inoue Y, Kubota T, Ebato T, Irabu H et al.
Recommendations for the Treatment of Juvenile Idiopathic Arthritis with Oligoarthritis or Polyarthritis from the 2024 update of the Japan College of Rheumatology Clinical Practice Guidelines for the management of Rheumatoid Arthritis including Juvenile Idiopathic Arthritis with Oligoarthritis or Polyarthritis- Secondary Publication.
Mod Rheumatol. 2025 Jun 3:roaf042. doi: 10.1093/mr/roaf042. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40459241/ -
Pellico MR, Pandolfi M, Amati A, Iannone C, Germinario S, Costi S et al.
The effectiveness and safety of rituximab in juvenile idiopathic arthritis: Hints from the ITHACA monocentric registry.
Semin Arthritis Rheum. 2025 Jun 18;74:152774. doi: 10.1016/j.semarthrit.2025.152774. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40561558/ -
Breda L, La Bella S, Di Ludovico A.
Biomarkers in juvenile idiopathic arthritis: towards precision diagnosis and personalized therapy?
Curr Opin Rheumatol. 2025 Jun 23. doi: 10.1097/BOR.0000000000001109. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40539554/ -
Weiss PF, Brandon TG, Aggarwal A, Burgos-Vargas R, Colbert RA, Horneff G et al.
Do the Provisional Paediatric Rheumatology International Trials Organisation Enthesitis/Spondylitis-Related Juvenile Idiopathic Arthritis Criteria Capture Youth With Axial Spondyloarthritis?
Arthritis Care Res (Hoboken). 2025 Jun;77(6):785-791. doi: 10.1002/acr.25491.
https://pubmed.ncbi.nlm.nih.gov/39721765/ -
Khalifa A, Elsaman AM, Hamed M, Aly H, Maaty A
Hip denervation: an approach for relieving pain, restoring function, and reducing inflammation in juvenile idiopathic arthritis patients.
Clin Rheumatol. 2025 Jun 19. doi: 10.1007/s10067-025-07490-0. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40536645/ -
La Bella S, Bayraktar D, Porreca A, Li LC, Attanasi M, Aliyev E et al.
Global variations in artificial intelligence-generated information on juvenile idiopathic arthritis.
Rheumatology (Oxford). 2025 Jun 12:keaf329. doi: 10.1093/rheumatology/keaf329. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40504018/ -
Frid P, Halbig JM, Alstergren P, Berstad JR, Cetrelli L, Feuerherm AJ et al.
Cytokines in saliva, serum, and temporomandibular joint synovial fluid in children with juvenile idiopathic arthritis: An explorative cross-sectional study.
Pediatr Rheumatol Online J. 2025 Jun 17;23(1):66. doi: 10.1186/s12969-025-01118-y.
https://pubmed.ncbi.nlm.nih.gov/40528176/
ABRIL 2025
-
Pedersen MJ, Høst C, Hansen SN, Klotsche J, Minden K, Deleuran B, Bech BH.
Increased school absence among children with juvenile idiopathic arthritis - a national matched comparison study
J Rheumatol. 2025 Apr 15:jrheum.2024-1182. doi: 10.3899/jrheum.2024-1182. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40233999/ -
Clemente D, Leon L, Nieto-Gonzalez JC, Boteanu AL, Trives Folguera L, García-Fernández AA, Amar Muñoz H, Palomeque A, López Robledillo JC, Abasolo L.
Incidence and reasons for biologic and targeted synthetic DMARD switching in juvenile idiopathic arthritis: a real- life stratified analysis
Pediatr Rheumatol Online J. 2025 Apr 24;23(1):42. doi: 10.1186/s12969-025-01097-0.
https://pubmed.ncbi.nlm.nih.gov/40275364/
MARZO 2025
-
Żuber Z, Podwójcic K, Szeląg M, Krajewska-Włodarczyk M, Batko K, Orleański M, et al
Epidemiology and comorbidity of juvenile idiopathic arthritis in Poland- a nationwide study.
Pediatr Rheumatol Online J. 2025 Mar 28;23(1):33. doi: 10.1186/s12969-025-01065-8.
https://pubmed.ncbi.nlm.nih.gov/40156029/ -
Naddei R, Burrone M, Ridella F, Uziel Y, Trachana M, Dolezalova P, Rumba-Rozenfelde I, Ruperto N, Ravelli A, Consolaro A.
Clinical insights into heterogeneity of rheumatoid factor negative polyarticular juvenile idiopathic arthritis across the world.
Pediatr Rheumatol Online J. 2025 Mar 19;23(1):30. doi: 10.1186/s12969-025-01072-9.
https://pubmed.ncbi.nlm.nih.gov/40108689/ -
Ekelund M, Szentpetery A, Arnstad ED, Aalto K, Fasth A, Glerup M, et al.
Clinical Impact of HLA-B27 on Juvenile Idiopathic Arthritis: Eighteen Years of Follow-up in the Population-Based Nordic Juvenile Idiopathic Arthritis Cohort.
ACR Open Rheumatol. 2025 Mar;7(3):e70005. doi: 10.1002/acr2.70005.
https://pubmed.ncbi.nlm.nih.gov/40114343/ -
Ge L, Gao Y, Chen X, Guo J, Zhang D, Yang Y.
Comparative efficacy and safety of etanercept and adalimumab in the treatment of polyarticular juvenile idiopathic arthritis.
BMC Pediatr. 2025 Mar 27;25(1):242. doi: 10.1186/s12887-025-05594-9.
https://pubmed.ncbi.nlm.nih.gov/40148850/ -
Boussaid S, Rekik S, Ferjani HL, Abbes M, Rahmouni S, Zouaoui K et al.
Pubertal disorders in juvenile idiopathic arthritis: a systemic review.
J Pediatr Endocrinol Metab. 2025 Mar 28. doi: 10.1515/jpem-2024-0412. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40150827/ -
Lundgren P, Papadopoulou M, Jernkrok R, Abedi N, Karlsson E, Damgaard M, et al.
Juvenile idiopathic arthritis during 20 years in Sweden: Characteristics of children, therapy interventions, occurrence of uveitis and ocular complications.
Acta Ophthalmol. 2025 Mar 3. doi: 10.1111/aos.17466. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40028966/ -
Cifuentes-Silva E, Inostroza-Mondaca M, Cabello-Verrugio C, Retamal-Espinoza M, Cancino-Jiménez J.
A narrative review of multidisciplinary rehabilitation in juvenile idiopathic arthrtis.
Clin Rheumatol. 2025 Mar 25. doi: 10.1007/s10067-025-07407-x. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40131596/ -
Shimizu M, Inoue E, Sakai R, Inoue Y, Mitsunaga K, Sugihara T, et al.
Verification of unmet medical needs in patients with juvenile idiopathic arthritis in Japan.
Mod Rheumatol. 2025 Mar 31:roaf032. doi: 10.1093/mr/roaf032. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40160024/ -
Yamazaki S, Kaneko S, Shimbo A, Irabu H, Ogino R, Miyamoto T, et al.
Overlapping Aicardi-Goutieres and Singleton-Merten syndromes with a heterozygous gain-of-function mutation in IFIH1 mimicking juvenile idiopathic arthritis.
Immunol Med. 2025 Mar 21:1-5. doi: 10.1080/25785826.2025.2479148. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40116369/
FEBRERO 2025
-
Rypdal V, Brunner HI, Feldman BM, Ruperto N, Aggarwal A, Angeles-Han ST, et al; Pediatric Rheumatology European Society, the Paediatric Rheumatology International Trials Organisation, the Pediatric Rheumatology Care & Outcome Improvement Network, and the Pediatric Rheumatology Collaborative Study Group.
Physician's global assessment of disease activity in juvenile idiopathic arthritis: consensus-based recommendations from an international task force.
Ann Rheum Dis. 2025 Feb 14:S0003-4967(25)00059-7.
https://pubmed.ncbi.nlm.nih.gov/39955164/ -
Sorokina LS, Artamonov AK, Kaneva MA, Gordeeva NA, Raupov RK, Mushkin AY, Ivanov DO, Kostik MM.
The Features of Children with Juvenile Idiopathic Arthritis with Cervical Spine Involvement in the Data from a Retrospective Study Cohort.
J Funct Morphol Kinesiol. 2025 Feb 15;10(1):68.
https://pubmed.ncbi.nlm.nih.gov/39982308/ -
Doğantan Ş, Taşkın SN, Yılmaz Yeğit C, Özdemir A.
Assessment of Pulmonary Function in Children with Juvenile Idiopathic Arthritis: A Cross-Sectional Study.
Children (Basel). 2025 Feb 28;12(3):309.
https://pubmed.ncbi.nlm.nih.gov/40150592/ -
Cagnotto G, Juhl CB, Ahlström F, Wikström F, Bruschettini M, Petersson I, Dreyer L, Compagno M.
Tumor necrosis factor (TNF) inhibitors for juvenile idiopathic arthritis.
Cochrane Database Syst Rev. 2025 Feb 20;2(2):CD013715.
https://pubmed.ncbi.nlm.nih.gov/39976227/ -
Zimmer A, Horneff G.
An update on the safety of biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis.
Expert Opin Drug Saf. 2025 Feb 16:1-16.
https://pubmed.ncbi.nlm.nih.gov/39946290/ - Rygg M, Ramos FO, Nordal EB.
What have we learned from long-term studies in juvenile idiopathic arthritis? - Prediction, classification, transition.
Pediatr Rheumatol Online J. 2025 Feb 19;23(1):18.
https://pubmed.ncbi.nlm.nih.gov/39972461/ -
Nozawa T, Iwata N, Igarashi T, Kobayashi I, Ota S, Yamada T, Bando E, Habiro K, Takei S.
Safety and effectiveness of intravenous abatacept for polyarticular-course juvenile idiopathic arthritis: An all-case postmarketing surveillance study.
Pediatr Rheumatol Online J. 2025 Feb 19;23(1):19.
https://pubmed.ncbi.nlm.nih.gov/39972375/ -
Młyńczyk J, Abramowicz P, Bernacka-Kusznierko I, Konstantynowicz J.
The quality of life assessment in children with juvenile idiopathic arthritis- comparison of PROMIS® generic and disease-specific cut-off points: a pilot study.
Rheumatol Int. 2025 Feb 24;45(3):61.
https://pubmed.ncbi.nlm.nih.gov/39992379/ -
de Araújo Pereira A, do Amaral E Castro A, Ahn I, Cecy Kuenzer Goes Esmanhotto P, Yui Aihara A, Irochima Pinheiro F, Sakamoto AP, de Medeiros Pinheiro M, Terreri MT.
Axial radiographic structural damage in patients with Enthesitis-Related Arthritis presents a distinct phenotype compared to adults with axial spondyloarthritis: A cross-sectional cohort study.
Rheumatol Int. 2025 Feb 20;45(3):54.
https://pubmed.ncbi.nlm.nih.gov/39976813/ -
Sener S, Batu ED, Aliyev E, Basaran O, Saribas Z, Bilginer Y, Sener B, Ozen S.
Antinuclear Antibodies Staining Patterns and Titers in Juvenile Idiopathic Arthritis.
Mod Rheumatol. 2025 Feb 4:roaf011.
https://pubmed.ncbi.nlm.nih.gov/39901832/ -
Ford JP, Soriano ER, Andreu M.
Evaluation of the psychometric properties of the Functional Ability Scale in children with juvenile idiopathic arthritis.
Reumatol Clin (Engl Ed). 2025 Feb;21(2):101802. Khadour FA, Khadour YA, Xu T
https://pubmed.ncbi.nlm.nih.gov/40064540/
ENERO 2025
-
Rebollo-Giménez AI, Pistorio A, Orsi SM, Ridella F, Aldera E, Carlini L, Natoli V, Burrone M, Rosina S, Naddei R, Consolaro A, Naredo E, Ravelli A.
Frequency of remission achievement in the pre-treat-to-target decade in juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2025 Jan 23;23(1):8. doi: 10.1186/s12969-025-01057-8.
https://pubmed.ncbi.nlm.nih.gov/39849509/ -
Beesley RP, Hyrich KL, Humphreys JH.
The incidence and prevalence of juvenile idiopathic arthritis differs between ethnic groups in England.
Rheumatology (Oxford). 2025 Jan 1;64(1):296-302. doi: 10.1093/rheumatology/kead700.
https://pubmed.ncbi.nlm.nih.gov/38135502/ -
Iman K, Akter L, Rahman MM, Laila K, Islam MI, Rahman SA.
Treatment of refractory poly articular course juvenile idiopathic arthritis with tofacitinib: Extended experience from Bangladesh.
PLoS One. 2025 Jan 24;20(1):e0312174. doi: 10.1371/journal.pone.0312174.
https://pubmed.ncbi.nlm.nih.gov/39854407/ -
Troiani R, La Bella S, Muselli M, D'Egidio M, Sassano G, Di Ludovico A, Di Donato G, Lauriola F, Altobelli E, Chiarelli F, Breda L.
Serum hepcidin evaluation as a promising biomarker in juvenile idiopathic arthritis.
Clin Exp Rheumatol. 2025 Jan;43(1):151-159. doi: 10.55563/clinexprheumatol/a51j2e. Epub 2024 Aug 27.
https://pubmed.ncbi.nlm.nih.gov/39212132/ -
Szentpetery A, Glerup M, Aalto K, Arnstad ED, Fasth A, Herlin T, Myrup C, Nordal E, Peltoniemi S, Rygg M, Gjertsen Rypdal V, Berntson L.
Characteristics That Predict Psoriatic Arthritis by the Classification Criteria for Psoriatic Arthritis in Patients With Juvenile Idiopathic Arthritis 18 Years After Disease Onset.
ACR Open Rheumatol. 2025 Jan;7(1):e11758. doi: 10.1002/acr2.11758. Epub 2024 Dec 10.
https://pubmed.ncbi.nlm.nih.gov/39659025/ -
Küçükali B, Yıldız Ç, Gülle BT, Gezgin Yıldırım D, Bakkaloğlu SA.
Evaluation of ILAR and PRINTO classifications for juvenile idiopathic arthritis: oligoarticular JIA vs early-onset ANA-positive JIA.
Clin Rheumatol. 2025 Jan 30. doi: 10.1007/s10067-025-07340-z. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39883305/ -
Dåstøl VØ, Haftorn KL, Rudsari HK, Jaholkowski PP, Størdal K, Håberg SE, Weinberg CR, Rider LG, Andreassen OA, Brantsæter AL, Caspersen IH, Sanner H.
Maternal seafood intake, dietary contaminant exposure, and risk of juvenile idiopathic arthritis: exploring gene-environment interactions.
Front Immunol. 2025 Jan 14;15:1523990. doi: 10.3389/fimmu.2024.1523990.
https://pubmed.ncbi.nlm.nih.gov/39877361/ -
Romano F, Di Scipio F, Baima G, Franco F, Aimetti M, Berta GN.
Health-Related Quality of Life in Juvenile Idiopathic Arthritis: A Systematic Review of Phase III Clinical Trials.
J Clin Med. 2025 Jan 3;14(1):254. doi: 10.3390/jcm14010254.
https://pubmed.ncbi.nlm.nih.gov/39797336/
NOVIEMBRE 2024
-
Ogbu EA, Brunner HI, Eloseily E, Aviel YB, Nanda K, Schmeling H et al.
Biomarker Changes in Response to Tofacitinib Treatment in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis.
Arthritis Care Res (Hoboken). 2024 Dec;76(12):1723-1732. doi: 10.1002/acr.25417. Epub 2024 Sep 17.
https://pubmed.ncbi.nlm.nih.gov/39135452/ -
Elsayed EK, El Sergany MAES, Aboelhawa MA, Baiomy NNM, El-Barbary AM.
Serum Biomarkers and Musculoskeletal Ultrasound for Assessment of Disease Activity in Patients With Juvenile Idiopathic Arthritis During Tocilizumab Therapy.
Int J Rheum Dis. 2024 Dec;27(12):e70007. doi: 10.1111/1756-185X.70007.
https://pubmed.ncbi.nlm.nih.gov/39668737/ -
Yıldız Ç, Küçükali B, C SSB, Şenol PE, Kutlar M, Belder N et al.
Intraarticular corticosteroid injections in pediatric rheumatology: insights from specialists.
Eur J Pediatr. 2024 Dec;183(12):5405-5410. doi: 10.1007/s00431-024-05817-8. Epub 2024 Oct 14.
https://pubmed.ncbi.nlm.nih.gov/39397078/ -
Balay-Dustrude E, Fennell J, Baszis K, Goh YI, Horton DB, Lee T et al.
Approaches and outcomes of adalimumab discontinuation in patients with well-controlled inflammatory arthritis: a systematic search and review.
Pediatr Rheumatol Online J. 2024 Dec 30;22(1):112. doi: 10.1186/s12969-024-01046-3.
https://pubmed.ncbi.nlm.nih.gov/39734203/ -
Huhtanen M, Mikola K, Kiukkonen A, Palotie T.
Maximal mouth opening is a simple method to evaluate the treatment outcome of temporomandibular joint arthritis in patients with juvenile idiopathic arthritis.
Acta Odontol Scand. 2024 Dec 18;83:682-689. doi: 10.2340/aos.v83.42438.
https://pubmed.ncbi.nlm.nih.gov/39692320/ -
Kwon J, Neeland MR, Ellis JA, Munro J, Saffery R, Novakovic B, Mansell T.
The plasma metabolome of juvenile idiopathic arthritis varies according to subtype and underlying inflammatory status.
Pediatr Rheumatol Online J. 2024 Dec 30;22:113. doi: 10.1186/s12969-024-01041-8.
https://pubmed.ncbi.nlm.nih.gov/39736759/
NOVIEMBRE 2024
-
Brunner HI, Shmagel A, Horneff G, Foeldvari I, Antón J, Ramanan AV, Qian Y, Unnebrink K, Hao S, Camp HS, Khan N, Liu W, Mohamed MF.
Pharmacokinetics, Efficacy, and Safety of Upadacitinib in Pediatric Patients with Polyarticular-Course Juvenile Idiopathic Arthritis: An Interim Analysis of an Open-label, Phase 1 Trial.
Arthritis Care Res (Hoboken). 2024 Nov 14. doi: 10.1002/acr.25465. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39542836/ -
Gao F, Zhang J, Deng J, Kuang W, Tan X, Li C, Li S, Liu X, Li C.
Clinical manifestations, treatment and prognosis of juvenile idiopathic arthritis with pulmonary involvement in China: a single centre study.
Clin Exp Rheumatol. 2024 Nov;42(11):2303-2311. doi: 10.55563/clinexprheumatol/udjbtq. Epub 2024 Sep 9.
https://pubmed.ncbi.nlm.nih.gov/39263798/ -
Sefer AP, Erguven M.
Evaluation of temporomandibular joint involvement in juvenile idiopathic arthritis patients.
Pediatr Rheumatol Online J. 2024 Nov 25;22(1):101.doi:10.1186/s12969-024-01031-w.
https://pubmed.ncbi.nlm.nih.gov/39587671/ -
Arneng SM, Jenssen IP, Lundestad A, Cetrelli L, Angenete O, Nordal E, Tylleskär KB, Romundstad PR, Rygg M.
The patient's voice: a cross-sectional study of physical health and disability in juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2024 Nov 18;22(1):100. doi: 10.1186/s12969-024-01034-7.
https://pubmed.ncbi.nlm.nih.gov/39558411/ -
Calvo Penadés I, Moreno Ruzafa E, Calzada-Hernández J, Mosquera Angarita J, López Montesinos B, Bou R, López Corbeto M, Sánchez-Manubens J, González Fernández MI, Carriquí Arenas S, Bittermann V, Estepa Guillén C, Rodríguez Díez L, Iglesias E, Marti Masanet M, LaCruz Pérez L, Peral C, De Lossada A, Valderrama M, Llevat N, Montoro M, Antón J.
Real-world psychosocial impact among patients with juvenile idiopathic arthritis and families in Spain.
Pediatr Rheumatol Online J. 2024 Nov 26;22(1):102. doi: 10.1186/s12969-024-01035-6.
https://pubmed.ncbi.nlm.nih.gov/39593042/ -
Musso-Daury L, Pascual Fernández T, López-Ortiz S, Pico De Las Heras M, Emanuele E, Lista S, Matey-Rodríguez C, Santos-Lozano A.
Conservative, Non-pharmacological Interventions for Pain Management in Juvenile Idiopathic Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Cureus. 2024 Nov 8;16(11):e73295. doi: 10.7759/cureus.73295.
https://pubmed.ncbi.nlm.nih.gov/39650967/ -
Tezer D, Başay BK, Başay Ö, Yener GO, Yüksel S.
Cognitive performance, psychiatric comorbidities, and quality of life in pediatric patients with juvenile idiopathic arthritis: a comparative analysis with healthy controls.
Child Neuropsychol. 2024 Nov 21:1-19. doi: 10.1080/09297049.2024.2426272. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39569588/ -
Ramos-Tiñini P, Menchaca-Aguayo H, Alpizar-Rodriguez D, Mercedes-Pérez E, Faugier-Fuentes E.
Application of the new classification proposal for juvenile idiopathic arthritis of the pediatric rheumatology international trials organization in a group of Mexican patients.
Front Pediatr. 2024 Nov 7;12:1476257. doi: 10.3389/fped.2024.1476257.
https://pubmed.ncbi.nlm.nih.gov/39575112/ -
Kulyk M, Dzhus M.
Factors associated with sarcopenia among young adults with juvenile idiopathic arthritis: a cross-sectional study.
BMC Musculoskelet Disord. 2024 Nov 18;25(1):923. doi: 10.1186/s12891-024-08051-3.
https://pubmed.ncbi.nlm.nih.gov/39558318/
OCTUBRE 2024
-
Hestetun SV, Rudsari HK, Jaholkowski P, Shadrin A, Haftorn KL, Andersen S, et al.
Incidence and genetic risk of juvenile idiopathic arthritis in Norway by latitude.
Arthritis Rheumatol. 2024 Oct 21. doi: 10.1002/art.43040. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39431377/ -
Dahlberg A, Tydén H, Jöud AS, Kahn F, Berthold E.
Screening for comorbid autoimmune disease should be considered in children with ANA positive juvenile idiopathic arthritis - results from the south-Swedish juvenile idiopathic arthritis cohort.
Pediatr Rheumatol Online J. 2024 Oct 19;22(1):92. doi: 10.1186/s12969-024-01030-x.
https://pubmed.ncbi.nlm.nih.gov/39425228/ -
Milatz F, Pedersen MJ, Klotsche J, Liedmann I, Niewerth M, Hospach A, et al.
Physical (in)activity and screen-based media use of adolescents with juvenile idiopathic arthritis over time - data from a German inception cohort.
Pediatr Rheumatol Online J. 2024 Oct 21;22(1):93. doi: 10.1186/s12969-024-01027-6.
https://pubmed.ncbi.nlm.nih.gov/39434096/
SEPTIEMBRE 2024
-
Glerup M, Kessel C, Foell D, Berntson L, Fasth A, Myrup C, et al; Nordic Study Group of Paediatric Rheumatology (NoSPeR).
Inflammatory biomarkers predicting long-term remission and active disease in juvenile idiopathic arthritis: a population-based study of the Nordic JIA cohort
RMD Open. 2024 Sep 5;10(3):e004317. doi: 10.1136/rmdopen-2024-004317.
https://pubmed.ncbi.nlm.nih.gov/39242113/ -
Abel D, Anderson D, Kallan MJ, Utidjian L, Burnham JM, Chang JC, et al.
Assessing Methotrexate Adherence in Juvenile Idiopathic Arthritis Using Electronic Health Record-Linked Pharmacy Dispensing Data.
Arthritis Care Res (Hoboken). 2024 Sep 23. doi: 10.1002/acr.25441. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39313474/ -
Vojinović J, Foeldvari I, Dehoorne J, Panaviene V, Susic G, Horneff G, et al; Paediatric Rheumatology International Trials Organisation (PRINTO).
Summary of Research: Ten-Year Safety and Clinical Benefit from Open-Label Etanercept Treatment in Children and Young Adults with Juvenile Idiopathic Arthritis.
Rheumatol Ther. 2024 Sep 12. doi: 10.1007/s40744-024-00703-z. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39264536/ -
Vega-Fernandez P, Rogers K, Avar-Aydin PO, Quinlan-Waters M, Huggins J, Brunner HI, Lovell DJ, et al.
Validation of the ankle-specific pediatric arthritis ultrasound scoring system in children with juvenile idiopathic arthritis.
Semin Arthritis Rheum. 2024 Sep 1;69:152545. doi: 10.1016/j.semarthrit.2024.152545. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39260231/ -
Snipaitiene A, Slegeryte A, Uktveris R, Sileikiene R, Jakucionis P, Baranauskaite A, Jankauskaite L.
The importance of ultrasound examination in care of juvenile idiopathic arthritis patients: 9 months follow-up study.
Front Pediatr. 2024 Sep 12;12:1414384. doi: 10.3389/fped.2024.1414384.
https://pubmed.ncbi.nlm.nih.gov/39328590/ -
Costello A, Rasooly I, Weiss P.
Rheum for Improvement? Delayed Diagnosis of Juvenile Idiopathic Arthritis: A Narrative Review.
Arthritis Care Res (Hoboken). 2024 Sep 22. doi: 10.1002/acr.25438. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39308000/ -
Randell RL, Reeve BB, Weitzman ER, von Scheven E, Zigler CK, Li Z, et al.
Pain Interference in Juvenile Idiopathic Arthritis.
J Rheumatol. 2024 Sep 18:jrheum.2024-0254. doi: 10.3899/jrheum.2024-0254. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39218453/ -
Gowda NC,Aggarwal A.
Primary Immunodeficiencies: When is it not just "JIA".
Best Pract Res Clin Rheumatol. 2024 Sep;38(3):101960. doi: 10.1016/j.berh.2024.101960.
https://pubmed.ncbi.nlm.nih.gov/38851969/ -
Päkkilä TS, Seppälä TS, Vähäsalo P, Karttunen TJ.
Histological synovitis score in juvenile idiopathic arthritis and other pediatric synovial inflammatory conditions
Pathol Res Pract. 2024 Sep 12;263:155588. doi: 10.1016/j.prp.2024.155588. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39303406/
AGOSTO 2024
-
Brunner HI, Pacheco-Tena C, Louw I, Vega-Cornejo G, Alexeeva E, Appenzeller S, et al; Pediatric Rheumatology Collaborative Study Group (PRCSG) and Paediatric Rheumatology International Trials Organisation (PRINTO).
Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label, Phase III Study.ÇJ Rheumatol. 2024 Aug 15:jrheum.2024-0298. doi: 10.3899/jrheum.2024-0298. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39089836/ -
Jittawattanarat B, Charuvanij S, Tangcheewinsirikul S, Sukharomana M.
Prevalence of HLA-B27, clinical characteristics and treatment outcomes in children with enthesitis-related arthritis.
BMC Pediatr. 2024 Aug 30;24(1):555. doi: 10.1186/s12887-024-05032-2.
https://pubmed.ncbi.nlm.nih.gov/39215234/ -
Kishimoto K, Asai S, Suzuki M, Sato R, Hasegawa J, Terabe K, Imagama S.
Clinical features of juvenile onset ankylosing spondylitis in Japanese patients.
Mod Rheumatol. 2024 Aug 29:roae065. doi: 10.1093/mr/roae065.
https://pubmed.ncbi.nlm.nih.gov/39206863/ -
Mori M.
Overview of the Treatment Goal, the Method of Evaluating Disease Activity/Physical Function, Activities of Daily Living, and Traditional Care for Systemic or Articular Juvenile Idiopathic Arthritis in Japan.
Children (Basel). 2024 Aug 6;11(8):952. doi: 10.3390/children11080952.
https://pubmed.ncbi.nlm.nih.gov/39201887/ -
Attuparambath S, Venkataraman S, Chanu AR, Handa G, Bagri N.
A Cross-Sectional Study Assessing the Functional Status in Children With Juvenile Idiopathic Arthritis and Its Correlation With Their Quality of Life and Burden on Caregivers.
Cureus. 2024 Aug 5;16(8):e66178. doi: 10.7759/cureus.66178.
https://pubmed.ncbi.nlm.nih.gov/39233946/ -
Yiğit RE, Ulu K, Çağlayan Ş, Sözeri B.
Real-life data of etanercept efficacy and safety in juvenile idiopathic arthritis: a 24-month retrospective study at a single center.
Expert Opin Biol Ther. 2024 Aug;24(8):855-862. doi: 10.1080/14712598.2024.2388193.
https://pubmed.ncbi.nlm.nih.gov/39088092/39088092/ -
Sidhique R, Bagri NK, Jana M, Pandey RM, Pandey S, Venkatesh P, et al.
Disease Damage in Juvenile Idiopathic Arthritis.
Indian J Pediatr. 2024 Aug 30. doi: 10.1007/s12098-024-05239-2.
https://pubmed.ncbi.nlm.nih.gov/39212855/ -
Harris JG, Bingham CA, Vora SS, Yildirim-Toruner C, Batthish M, Bullock DR, et al.
Using a collaborative learning health system approach to improve disease activity outcomes in children with juvenile idiopathic arthritis in the Pediatric Rheumatology Care and Outcomes Improvement
Network.
Front Pediatr. 2024 Aug 2;12:1434074. doi: 10.3389/fped.2024.1434074.
https://pubmed.ncbi.nlm.nih.gov/39156025/ -
Mördrup K, Jungner JG, Broström E, Palmblad K, Bartholdson C.
Benefits of a Juvenile Arthritis Support Program (JASP-1) for children recently diagnosed with Juvenile Idiopathic Arthritis and their parents.
BMC Rheumatol. 2024 Aug 15;8(1):35. doi: 10.1186/s41927-024-00404-8.
https://pubmed.ncbi.nlm.nih.gov/39143588/ -
Ohinmaa A, Wen J, Currie GR, Benseler SM, Swart JF, Vastert SJ, Yeung RSM,
Marshall DA. Validation of the EQ-5D-Y-5L parent-proxy version among children with juvenile idiopathic arthritis.
Qual Life Res. 2024 Aug 14. doi: 10.1007/s11136-024-03682-4.
https://pubmed.ncbi.nlm.nih.gov/39141175/ -
Pandya J, Menino Rosenbluth LJ, Adams AB.
Physical Activity and Sports for Children With Juvenile Idiopathic Arthritis.
HSS J. 2024 Aug;20(3):409-415. doi: 10.1177/15563316241247828.
https://pubmed.ncbi.nlm.nih.gov/39108443/ -
Saleh R, Sundberg E, Olsson M, Tengvall K, Alfredsson L, Kockum I, et al.
Genetic association of antinuclear antibodies with HLA in JIA patients: a Swedish cohort study.
Pediatr Rheumatol Online J. 2024 Aug 26;22(1):79. doi: 10.1186/s12969-024-01017-8.
https://pubmed.ncbi.nlm.nih.gov/39187888/ -
Tang H, Zhong Y, Wu Y, Huang Y, Liu Y, Chen J, et al.
Increased neutrophil extracellular trap formation in oligoarticular, polyarticular juvenile idiopathic arthritis and enthesitis-related arthritis: biomarkers for diagnosis and disease activity.
Front Immunol. 2024 Aug 9;15:1436193. doi: 10.3389/fimmu.2024.1436193.
https://pubmed.ncbi.nlm.nih.gov/39185410/ -
Pudjihartono N, Ho D, O'Sullivan JM.
Integrative analysis reveals novel insights into juvenile idiopathic arthritis pathogenesis and shared molecular pathways with associated traits.
Front Genet. 2024 Aug 8;15:1448363. doi: 10.3389/fgene.2024.1448363.
https://pubmed.ncbi.nlm.nih.gov/39175752/ -
Niibo P, Nikopensius T, Jagomägi T, Voog Ü, Haller T, Tõnisson N, et al.
Genetic susceptibility to temporomandibular joint involvement in juvenile idiopathic arthritis.
J Oral Rehabil. 2024 Aug 27. doi: 10.1111/joor.13834. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39192486/ -
Quilis N, Mesa-Del-Castillo Bermejo P, Boix P, Juanola O, Bernabeu P, Francés R, Andrés M.
Peripheral blood regulatory T cells and disease activity, quality of life, and outcomes in children with juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2024 Aug 1;22(1):69. doi: 10.1186/s12969-024-01006-x.
https://pubmed.ncbi.nlm.nih.gov/39090751/ - Haley EK, Barshad G, He A, Rice E, Sudman M, Thompson SD, et al.
Using Functional Genomic Data in Monocytes/Macrophages and Genotyping to Nominate Disease-Driving Single Nucleotide Polymorphisms and Target Genes in Juvenile Idiopathic Arthritis.
bioRxiv [Preprint]. 2024 Aug 19:2024.08.19.608312. doi: 10.1101/2024.08.19.608312.
https://pubmed.ncbi.nlm.nih.gov/39229078/
JULIO 2024
-
Brunner HI, Akikusa JD, Al-Abadi E, Bohnsack JF, Boteanu AL, Chedeville G, Cuttica R, De La Pena W, Jung L, Kasapcopur O, Kobusinska K, Schulert GS, Neiva C, Rivas-Chacon R, Rizo Rodriguez JC, Vazquez-Del Mercado M, Wagner-Weiner L, Weiss JE, Wouters C, Posner H, Wouters A, Chang C, White C, Kanik K, Liu S, Martini A, Lovell DJ, Ruperto N.
Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthrtis: preliminary results of an open-label, long-term extension study.
Ann Rheum Dis. 2024 Jul 20:ard-2023-225094. doi: 10.1136/ard-2023-225094. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/38849152/ -
Weiss PF, Brandon TG, Aggarwal A, Burgos-Vargas R, Colbert RA, Horneff G, et al.
Classification Criteria for Axial Disease in Youth with Juvenile Spondyloarthritis.
Arthritis Rheumatol. 2024 Jul 22. doi: 10.1002/art.42959. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39039899/ -
Balay-Dustrude E, Weiss JE, Goh YI, Rubin N, Bullock DR.
Intra-articular corticosteroid utilization and characterizations of use in juvenile idiopathic arthritis within the PR-COIN registry.
Front Pediatr. 2024 Jul 23;12:1423362. doi: 10.3389/fped.2024.1423362.
https://pubmed.ncbi.nlm.nih.gov/39108690/ -
Migowa AN, Hamdi W, Hashad S, Etayari H, Abushhaiwia A, Ferjani H, et al.
Development of the paediatric society of the African league against rheumatism (PAFLAR) JIA registry and clinical profile of JIA in Africa from the PAFLAR JIA registry.
Pediatr Rheumatol Online J. 2024 Jul 22;22(1):67. doi: 10.1186/s12969-024-01000-3.
https://pubmed.ncbi.nlm.nih.gov/39039515/ -
Baggett KH, Brandon TG, Xiao R, Weiss PF.
Association of Infant Breastfeeding and Juvenile Spondyloarthritis: A Case-Control Study.
J Rheumatol. 2024 Jul 1;51(7):708-714. doi: 10.3899/jrheum.2023-1203.
https://pubmed.ncbi.nlm.nih.gov/38561193/ -
Naddei R, Ridella F, Bovis F, Trincianti C, Avrusin I, Januskeviciute G, Burrone M, Rebollo-Giménez A, Minden K, Ekelund M, Barone P, Rumba-Rozenfelde I, Shafaie N, Swart JF, Ruperto N, Ravelli A, Consolaro A; Pediatric Rheumatology International Trials Organization (PRINTO).
Development and initial validation of parent and child versions of the Juvenile Arthritis Disease Activity Score.
Rheumatology (Oxford). 2024 Jul 4:keae326. doi: 10.1093/rheumatology/keae326. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/38964350/ -
Schmidt T, Mossberg A, Berthold E, Król P, Linge P, Bengtsson AA, Kahn F, Månsson B, Kahn R.
Synovial fibroblasts from children with oligoarticular juvenile idiopathic arthritis induce migration and prolong viability of neutrophils.
Front Pediatr. 2024 Jul 3;12:1376371. doi: 10.3389/fped.2024.1376371.
https://pubmed.ncbi.nlm.nih.gov/39022217/
JUNIO 2024
-
Balay-Dustrude E, Weiss NS, Sutton A, Shenoi S.
Predictors of Disease Activity in Patients With Juvenile Idiopathic Arthritis at 12 and 24 Months After Diagnosis.
ACR Open Rheumatol. 2024 Jun 17. doi: 10.1002/acr2.11701. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/38885948/ -
Polat MC, Çelikel E, Tekin ZE, Kurt T, Kaplan MM, Güngörer V, et al.
When should the use of biological agents be considered in persistent oligoarticular juvenile idiopathic arthritis patients?
Eur J Pediatr. 2024 Jun;183(6):2725-2731. doi: 10.1007/s00431-024-05538-y.
https://pubmed.ncbi.nlm.nih.gov/38554171/ -
Kearsley-Fleet L, Baildam E, Beresford MW, Douglas S, Foster HE, Southwood TR, Hyrich KL; UK JIA Biologics Register.
Outcomes after anti-tumour necrosis factor originator to biosimilar switching in children and young people with juvenile idiopathic arthritis in the UK: a national cohort study.
Lancet Rheumatol. 2024 Jun 3. doi: 10.1016/S2665-9913(24)00087-0. Epub ahead of print
https://pubmed.ncbi.nlm.nih.gov/38843858/ -
Brunner HI, Schulert GS, Sproles A, Thornton S, Cornejo GV, Antón J, et al; Pediatric Rheumatology Collaborative Study Group (PRCSG) and the Paediatric Rheumatology International Trials Organisation (PRINTO).
S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritis.
Arthritis Res Ther. 2024 Jun 25;26(1):125. doi: 10.1186/s13075-024-03347-0.
https://pubmed.ncbi.nlm.nih.gov/38918871/ -
Di Donato G, Attanasi M, Mariarita d' Angelo D, La Bella S, Di Ludovico A, Chiarelli F, Breda L.
Associations of C reactive protein to albumin ratio, neutrophil to lymphocyte ratio, platelet to lymphocyte ratio with disease activity in patients with juvenile idiopathic arthritis.
BMC Rheumatol. 2024 Jun 17;8(1):26. doi: 10.1186/s41927-024-00390-x.
https://pubmed.ncbi.nlm.nih.gov/38886765/ -
Ferrillo M, Gallizzi R, Marotta N, Longo UG, Spagnolo A, Ammendolia A, Giudice A, de Sire A.
Temporomandibular joint rehabilitative approaches for children and adolescents affected by juvenile idiopathic arthritis: A systematic review.
Int J Paediatr Dent. 2024 Jun 11. doi: 10.1111/ipd.13225. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/38863137/
-
Tharwat S, Nassar MK, Salem KM, Nassar MK.
Extraarticular manifestations of juvenile idiopathic arthritis and their impact on health-related quality of life.
Clin Rheumatol. 2024 May 26. doi: 10.1007/s10067-024-07008-0. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/38797812/ -
Marino A, Baldassarre P, Ferrigno C, Biuso A, Minutoli M, Baldo F, et al.
Pre-Rheumatology Referral Consultation and Investigation Pattern in Children with Joint Complaints: Focus on Juvenile Idiopathic Arthritis.
Children (Basel). 2024 May 16;11(5):600. doi: 10.3390/children11050600.
https://pubmed.ncbi.nlm.nih.gov/38790595/ - van Dijk BT, Bergstra SA, van den Berg JM, Schonenberg-Meinema D, van Suijlekom-Smit LWA, van Rossum MAJ, et al.
Increasing the etanercept dose in a treat-to-target approach in juvenile idiopathic arthritis: does it help to reach the target? A post-hoc analysis of the BeSt for Kids randomised clinical trial.
Pediatr Rheumatol Online J. 2024 May 10;22(1):53. doi: 10.1186/s12969-024-00989-x.
https://pubmed.ncbi.nlm.nih.gov/38730442/ - Möhlmann JE, de Roock S, Egas AC, Weijden ET, Doeleman MJH, Huitema ADR, et al
Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay.
Pediatr Rheumatol Online J. 2024 May 7;22(1):52. doi: 10.1186/s12969-024-00988-y.
https://pubmed.ncbi.nlm.nih.gov/38715014/ - Choong N, Batthish M, Berard RA, Chédeville G, Feldman BM, Houghton KM, Huber AM, James S, Proulx-Gauthier JP, Rumsey DG, Schmeling H, Toupin-April K, Guzman J; CAPRI Registry Investigators.
The Relationship of Fatigue, Pain Interference and Physical Disability in Children Newly Diagnosed with Juvenile Idiopathic Arthritis.
Arthritis Care Res (Hoboken). 2024 May 20. doi: 10.1002/acr.25377.
https://pubmed.ncbi.nlm.nih.gov/38769616/ -
Fusama M, Nakahara H, Miyamae T, Mori M, Urata Y, Kawahata K, et al.
Challenges Nurses Face in Providing Care for Patients with Juvenile Idiopathic Arthritis.
Mod Rheumatol. 2024 May 6:roae041. doi: 10.1093/mr/roae041.
https://pubmed.ncbi.nlm.nih.gov/38722031/
ABRIL 2024
-
Sener S, Aliyev E, Batu ED, Balik Z, Bayindir Y, Cam V, Basaran O, Bilginer Y, Ozen S.
Factors determining resistance to conventional disease-modifying anti-rheumatic drug treatment in oligoarticular juvenile idiopathic arthritis.
Clin Rheumatol. 2024 Apr 29. doi: 10.1007/s10067-024-06925-4. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/38683443/ -
Milatz F, Klotsche J, Niewerth M, Sengler C, Windschall D, Kallinich T, et al.
Anxiety and depression symptoms in adolescents and young adults with juvenile idiopathic arthritis: results of an outpatient screening.
arthritis Res Ther. 2024 Apr 10;26(1):82. doi: 10.1186/s13075-024-03312-x.
https://pubmed.ncbi.nlm.nih.gov/38600543/ -
Costello A, Twilt M, Lerman MA; CARRA Registry Investigators.
Provider assessment of the temporomandibular joint in Juvenile idiopathic arthritis: a retrospective analysis from the CARRA database.
Pediatr Rheumatol Online J. 2024 Apr 8;22(1):41. doi: 10.1186/s12969-024-00968-2.
https://pubmed.ncbi.nlm.nih.gov/38589909/
MARZO 2024
-
Shenoi S, Horneff G, Aggarwal A, Ravelli A.
Treatment of non-systemic juvenile idiopathic arthritis.
Nat Rev Rheumatol. 2024 Mar;20(3):170-181. doi: 10.1038/s41584-024-01079-8.
https://pubmed.ncbi.nlm.nih.gov/38321298/ -
Zajc Avramovič M, Toplak N, Markelj G, Emeršič N, Avčin T
Long-term follow-up of 109 children with juvenile idiopathic oligoarthritis after first intra-articular corticosteroid injection.
Arthritis Res Ther. 2024 Mar 14;26(1):69. doi: 10.1186/s13075-024-03303-y.
https://pubmed.ncbi.nlm.nih.gov/38486285/ -
Rypdal V, Glerup M, Rypdal M, Arnstad E, Aalto K, Berntson L, et al. ; Nordic Study Group of Pediatric Rheumatology (NoSPeR).
Disease activity trajectories from childhood to adulthood in the population-based Nordic juvenile idiopathic arthritis cohort.
RMD Open. 2024 Mar 8;10(1):e003759. doi: 10.1136/rmdopen-2023-003759.
https://pubmed.ncbi.nlm.nih.gov/38458760/ -
Cetrelli L, Lundestad A, Gil EG, Fischer J, Halbig J, Frid P, Angenete O, et al.
Serum and salivary inflammatory biomarkers in juvenile idiopathic arthritis-an explorative cross-sectional study.
Pediatr Rheumatol Online J. 2024 Mar 9;22(1):36. doi: 10.1186/s12969-024-00972-6.
https://pubmed.ncbi.nlm.nih.gov/38461338/ -
Sande NK, Kirkhus E, Lilleby V, Tomterstad AH, Aga AB, Flatø B, Bøyesen P.
Validity of an ultrasonographic joint-specific scoring system in juvenile idiopathic arthritis: a cross-sectional study comparing ultrasound findings of synovitis with whole-body magnetic resonance
maging and clinical assessment.
RMD Open. 2024 Mar 1;10(1):e003965. doi: 10.1136/rmdopen-2023-003965.
https://pubmed.ncbi.nlm.nih.gov/38428979/ -
Collin M, Christidis N, Hagelberg S, Arvidsson LZ, Larheim TA, Ernberg M, et al.
Temporomandibular involvement in children and adolescents with juvenile idiopathic arthritis: a 2-year prospective cohort study.
Sci Rep. 2024 Mar 6;14(1):5512. doi: 10.1038/s41598-024-56174-3.
https://pubmed.ncbi.nlm.nih.gov/38448491/
FEBRERO 2024
-
Tan J, Renton WD, Whittle SL, Takken T, Johnston RV, Tiller G, et al.
Methotrexate for juvenile idiopathic arthritis.
Cochrane Database Syst Rev. 2024 Feb 9;2(2):CD003129. doi: 10.1002/14651858.CD003129.pub2.
https://pubmed.ncbi.nlm.nih.gov/38334147/ -
Lokhandwala S, Townsend J, Ciurtin C.
Existing and Emerging Targeted Therapies in Juvenile Psoriatic Arthritis: Challenges and Unmet Needs.
Paediatr Drugs. 2024 Feb 4. doi: 10.1007/s40272-023-00618-2.
https://pubmed.ncbi.nlm.nih.gov/38310623/ - Fan J, Li X, Yang J, Zhang S, Qu H, Ji D, et al.
Revealing Novel Genomic Insights and Therapeutic Targets for Juvenile Idiopathic Arthritis through Omics. Rheumatology (Oxford).
2024 Feb 5:keae078. doi: 10.1093/rheumatology/keae078.
https://pubmed.ncbi.nlm.nih.gov/38317060/ -
Sabounji MM, Ndiaye A, Diallo S.
Profile of HLA-B27-positive enthesitis/spondylitis-related arthritis in Senegal, West Africa.
Pediatr Rheumatol Online J. 2024 Feb 29;22(1):31. doi: 10.1186/s12969-024-00969-1.
https://pubmed.ncbi.nlm.nih.gov/38424655/ -
Dimitrijevic Carlsson A, Wahlund K, Kindgren E, Frodlund M, Alstergren P.
Increase in stress contributes to impaired jaw function in juvenile idiopathic arthritis: a two-year prospective study.
Pediatr Rheumatol Online J. 2024 Feb 26;22(1):30. doi: 10.1186/s12969-024-00966-4.
https://pubmed.ncbi.nlm.nih.gov/38409027/ -
Avery CN, Russell ND, Steely CJ, Hersh AO, Bohnsack JF, Prahalad S, Jorde LB.
Shared genomic segments analysis identifies MHC class I and class III molecules as genetic risk factors for juvenile idiopathic arthritis.
HGG Adv. 2024 Feb 18;5(2):100277. doi: 10.1016/j.xhgg.2024.100277.
https://pubmed.ncbi.nlm.nih.gov/38369753/ -
Hernández-Huirache HG, Armenta-Medina D, Rodea-Montero ER. Clinical,
Immunological and Inflammatory Characteristics among Mexican Children with Different Subtypes of Juvenile Idiopathic Arthritis: Exploring the Correlation between Anti-Cyclic Citrullinated Peptide (anti-CCP) and Rheumatoid Factor (RF).
Pediatr Rep. 2024 Feb 7;16(1):151-162. doi: 10.3390/pediatric16010014.
https://pubmed.ncbi.nlm.nih.gov/38391002/ -
Starkhammar Johansson C, Dimitrijevic Carlsson A, Wahlund K, Alstergren P.
Periodontal Health in Children with Juvenile idiopathic arthritis.
Eur J Paediatr Dent. 2024 Feb 1;25:1. doi: 10.23804/ejpd.2024.1913. PMID: 38353519.
https://pubmed.ncbi.nlm.nih.gov/38353519/ -
Sequeira SB, McCormick BP, Hasenauer MD, McKinstry R, Ebert F, Boucher HR.
Juvenile Idiopathic Arthritis is Associated With Early Medical and Surgical Complications Following Primary Total Hip Arthroplasty: A National Database Study.
Arthroplast Today. 2024 Feb 5;26:101289. doi: 10.1016/j.artd.2023.101289.
https://pubmed.ncbi.nlm.nih.gov/38344442/ -
Butler S, Sculley D, Santos D, Girones X, Singh-Grewal D, Coda A.
Using Digital Health Technologies to Monitor Pain, Medication Adherence and Physical Activity in Young People with Juvenile Idiopathic Arthritis: A Feasibility Study.
Healthcare (Basel). 2024 Feb 2;12(3):392. doi: 10.3390/healthcare12030392.
https://pubmed.ncbi.nlm.nih.gov/38338277/ -
Kim D, Song J, Mancuso N, Mangul S, Jung J, Jang W.
Large-scale integrative analysis of juvenile idiopathic arthritis for new insight into its pathogenesis.
Arthritis Res Ther. 2024 Feb 10;26(1):47. doi: 10.1186/s13075-024-03280-2.
https://pubmed.ncbi.nlm.nih.gov/38336809/ -
Tuomi AK, Rebane K, Arnstad ED, Berntson L, Fasth A, Glerup M, et al.
Body mass index is associated with health-related quality of life and disease characteristics in young adults with juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2024 Feb 2;22(1):25. doi: 10.1186/s12969-023-00931-7.
https://pubmed.ncbi.nlm.nih.gov/38308280/
ENERO 2024
-
Shoop-Worrall SJ, Macintyre VG, Ciurtin C, Cleary G, McErlane F, Wedderburn LR; Childhood Arthritis Prospective Study (CAPS) Principle Investigators; Hyrich KL.
Overlap of ILAR and Preliminary PRINTO Classification Criteria for Non-Systemic Juvenile Idiopathic Arthritis in an Established UK Cohort: Results from the Childhood Arthritis Prospective Study.
Arthritis Care Res (Hoboken). 2024 Jan 11. doi: 10.1002/acr.25296. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/38212149/ -
Vojinović J, Foeldvari I, Dehoorne J, Panaviene V, Susic G, Horneff G, et al.
Ten-year safety and clinical benefit from open-label etanercept treatment in children and young adults with juvenile idiopathic arthritis.
Rheumatology (Oxford). 2024 Jan 4;63(1):140-148. doi: 10.1093/rheumatology/kead183.
https://pubmed.ncbi.nlm.nih.gov/37140539/ -
Lovell DJ, Tzaribachev N, Henrickson M, Simonini G, Griffin TA, Alexeeva E, et al.
Safety and effectiveness of abatacept in juvenile idiopathic arthritis: results from the PRINTO/PRCSG registry.
Rheumatology (Oxford). 2024 Jan 18:keae025. doi: 10.1093/rheumatology/keae025. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/38243722/ -
Milatz F, Albrecht K, Minden K, Marschall U, Klotsche J, Callhoff J.
Mental comorbidities in adolescents and young adults with juvenile idiopathic arthritis: an analysis of German nationwide health insurance data.
Pediatr Rheumatol Online J. 2024 Jan 5;22(1):10. doi: 10.1186/s12969-023-00948-y.
https://pubmed.ncbi.nlm.nih.gov/38183044/ -
Mazzoni A, Annunziato F, Maggi L.
T lymphocytes-related cell network in the pathogenesis of juvenile idiopathic arthritis: a key point for personalized treatment.
Curr Opin Rheumatol. 2024 Jan 1;36(1):40-45. doi: 10.1097/BOR.0000000000000991.
https://pubmed.ncbi.nlm.nih.gov/37905987/
DICIEMBRE 2023
-
Costi S, Armiraglio E, Pregnolato F, Chighizola CB, Marino A, Randelli PS, et al.
Diagnostic and prognostic role of synovial tissue analysis in juvenile idiopathic arthritis: a monocentric study.
RMD Open. 2023 Dec 14;9(4):e003296. doi: 10.1136/rmdopen-2023-003296.
https://pubmed.ncbi.nlm.nih.gov/38097272/ -
Antón J, Moreno Ruzafa E, Lopez Corbeto M, Bou R, Sánchez Manubens J, Carriquí Arenas S, et al.
Real-World Health Care Outcomes and Costs Among Patients With Juvenile Idiopathic Arthritis in Spain.
J Health Econ Outcomes Res. 2023 Dec 20;10(2):141-149. doi: 10.36469/001c.85088.
https://pubmed.ncbi.nlm.nih.gov/38145114/ -
Krarup H, Pedersen TK, Frid P, Nørholt SE.
Long-Term Follow-Up of Orthognathic Surgery in 19 Patients with Juvenile Idiopathic Arthritis.
J Oral Maxillofac Res. 2023 Dec 31;14(4):e4. doi: 10.5037/jomr.2023.14404.
https://pubmed.ncbi.nlm.nih.gov/38222878/ -
Polat MC, Çelikel E, Tekin ZE, Güngörer V, Kurt T, Tekgöz N, et al.
Assessment of quality of life and physical activity in patients with oligoarticular juvenile idiopathic arthritis in remission.
Eur J Pediatr. 2023 Dec 10. doi: 10.1007/s00431-023-05367-5. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/38071637/ -
Bingham CA, Harris JG, Qiu T, Gilbert M, Vora SS, Yildirim-Toruner C, et al.
Pediatric Rheumatology Care and Outcomes Improvement Network's Quality Measure Set to Improve Care of Children With Juvenile Idiopathic Arthritis.
Arthritis Care Res (Hoboken). 2023 Dec;75(12):2442-2452. doi: 10.1002/acr.25168.
https://pubmed.ncbi.nlm.nih.gov/37308458/ -
Lato-Kariakin E, Kuźnik-Trocha K, Gruenpeter A, Komosińska-Vassev K, Olczyk K, Winsz-Szczotka K.
Investigation of Glycosaminoglycans in Urine and Their Alteration in Patients with Juvenile Idiopathic Arthritis.
Biomolecules. 2023 Dec 2;13(12):1737. doi: 10.3390/biom13121737.
https://pubmed.ncbi.nlm.nih.gov/38136608/
NOVIEMBRE 2023
-
Gheshlaghi N, Thomas M, Trehan N, Harrison M, De Vera MA.
Reporting of determinants of health inequities and participant characteristics in randomized controlled trials of juvenile idiopathic arthritis in Canada: a scoping review.
Pediatr Rheumatol Online J. 2023 Nov 6;21(1):134. doi: 10.1186/s12969-023-00917-5.
https://pubmed.ncbi.nlm.nih.gov/37932754/ -
Knieper AM, von Stuckrad ASL, Minden K, Goetzke CC, Kallinich T.
Monogenic variants in Laccase domain-containing 1 (LACC1) as the cause of juvenile arthritis.
Z Rheumatol. 2023 Nov 3. German. doi: 10.1007/s00393-023-01442-2.
https://pubmed.ncbi.nlm.nih.gov/37921883/ -
Ronsivalle V, Marrapodi MM, Tirupathi S, Afnan L, Cicciù M, Minervini G.
Prevalence of temporomandibular disorders in juvenile idiopathic arthritis evaluated with diagnostic criteria for temporomandibular disorders: A systematic review with meta-analysis.
J Oral Rehabil. 2023 Nov 27. doi: 10.1111/joor.13625.
https://pubmed.ncbi.nlm.nih.gov/38012098/ - Halbig JM, Jönsson B, Gil EG, Åstrøm AN, Rypdal V, Frid P, Augdal TA, Fischer J, Cetrelli L, Rygg M, Lundestad A, Tylleskär K, Nordal E;
Norwegian JIA Study – Temporo-mandibular Involvement, Oral Health, Uveitis, Bone Health, Quality of Life in Children with Juvenile Idiopathic Arthritis. Oral health-related quality of life, impaired physical health and orofacial pain in children and adolescents with juvenile idiopathic arthritis - a prospective multicenter cohort study.
BMC Oral Health. 2023 Nov 20;23(1):895. doi: 10.1186/s12903-023-03510-0.
https://pubmed.ncbi.nlm.nih.gov/37986155/ -
Valenzise M, D'Amico F, Tripodi E, Zirilli G, Alibrandi A, Gallizzi R, Sutera D, Cafarella G, Lugarà C, Wasniewska MG.
Thyroid function in pediatric patients with juvenile idiopathic arthritis.
Endocrine. 2023 Nov 20. doi: 10.1007/s12020-023-03600-7
https://pubmed.ncbi.nlm.nih.gov/37982947/ - Gicchino MF, Marzuillo P, Melone R, Zarrilli S, Miraglia Del Giudice E, Olivieri AN, Di Sessa A.
The dual role of body mass index on Juvenile Idiopathic Arthritis course: a pediatric experience.
Eur J Pediatr. 2023 Nov 28. doi: 10.1007/s00431-023-05348-8.
https://pubmed.ncbi.nlm.nih.gov/38015262/
OCTUBRE 2023
-
Nguyen K, Barsalou J, Basodan D, Batthish M, Benseler SM, Berard RA, et al; ReACCh-Out and CAPRI Registry Investigators.
A decade of progress in juvenile idiopathic arthritis treatments and outcomes in Canada: results from ReACCh-Out and the CAPRI registry.
Rheumatology (Oxford). 2023 Oct 18:kead560. doi: 10.1093/rheumatology/kead560. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37851400/ -
d'Angelo DM, Attanasi M, Di Donato G, Lapergola G, Cannataro G, Flacco M, et al.
Serum calprotectin and joint ultrasound in the definition of disease relapse in non-systemic juvenile idiopathic arthritis: a prospective longitudinal study.
Clin Exp Rheumatol. 2023 Oct 13. doi: 10.55563/clinexprheumatol/qumh2o. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37877377/ -
McErlane F, Boeri M, Bussberg C, Cappelleri JC, Germino R, Stockert L, et al.
Adolescent and caregiver preferences for juvenile idiopathic arthritis treatment: a discrete-choice experiment.
Pediatr Rheumatol Online J. 2023 Oct 21;21(1):129. doi: 10.1186/s12969-023-00906-8.
https://pubmed.ncbi.nlm.nih.gov/37865801/ -
Vassis S, Resnick CM, Nørgaard M, Strawn KM, Grove H, Noeldeke B, et al
Impact of physiotherapy on orofacial manifestations of juvenile idiopathic arthritis
Pediatr Rheumatol Online J. 2023 Oct 12;21(1):116. doi: 10.1186/s12969-023-00900-0.
https://pubmed.ncbi.nlm.nih.gov/37828517/
AGOSTO 2023
-
Kaplan MM, Kurt T, Polat MC, Sezer M, Ekici Tekin Z, Çelikel E, et al.
Predictors of relapse in patients with oligoarticular juvenile idiopathic arthritis in remission off medication.
Eur J Pediatr. 2023 Aug 1. doi: 10.1007/s00431-023-05123-9. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37526705/ -
Loredo C, Yañez P, Hernández-Díaz C, Cruz-Arenas E, Ventura-Ríos L.
Low prevalence of subclinical synovitis in patients with juvenile idiopathic arthritis (JIA) in long-term clinical remission on medication.
Clin Rheumatol. 2023 Aug 5. doi: 10.1007/s10067-023-06729-y. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37542584/ -
Gupta A.
Serum Calprotectin in Juvenile Idiopathic Arthritis: A Hope or Hype?
Indian J Pediatr. 2023 Aug 17. doi: 10.1007/s12098-023-04803-6. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37587382/ -
Zulian F, Pierobon B, Zannin ME, Politi C, Vittadello F, Meneghel A, Tirelli F, Martini G.
Monoarticular juvenile idiopathic arthritis as a distinct clinical entity A proof-of-concept study.
Pediatr Rheumatol Online J. 2023 Aug 10;21(1):81. doi: 10.1186/s12969-023-00869-w.
https://pubmed.ncbi.nlm.nih.gov/37563674/ -
Spekking K, Anink J, de Boer P, Bergstra SA, van den Berg JM, Schonenberg-Meinema D, et al.
Significant pain decrease in children with non-systemic Juvenile Idiopathic Arthritis treated to target: results over 24 months of follow up
Pediatr Rheumatol Online J. 2023 Aug 26;21(1):90. doi: 10.1186/s12969-023-00874-z.
https://pubmed.ncbi.nlm.nih.gov/37633893/ - Wu P, Huang C, Liao PF, Ruperto N, Zeng H.
Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis.
Int J Rheum Dis. 2023 Aug 11. doi: 10.1111/1756-185X.14845. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37563978/ -
Siu WHS, Wang CJ, Wu CT, Wu CY, Ou LS.
C1-C2 subluxation in enthesitis-related arthritis: two case reports and literature review of ten cases.
Pediatr Rheumatol Online J. 2023 Aug 3;21(1):77. doi: 10.1186/s12969-023-00862-3.
https://pubmed.ncbi.nlm.nih.gov/37537687/ -
Sapountzi E, Tsinopoulou VR, Kotanidou EP, Giza S, Galli-Tsinopoulou A.
Coexistence of Autoimmune Thyroiditis and Juvenile Idiopathic Arthritis
Cureus. 2023 Aug 30;15(8):e44384. doi: 10.7759/cureus.44384. eCollection 2023 Aug.
https://pubmed.ncbi.nlm.nih.gov/37654906/ - Ribeiro SCCR, Sales LP, Fernandes AL, Perez MO, Takayama L, Caparbo VF, et al.
Bone erosions associated with systemic bone loss on HR-pQCT in women with long standing polyarticular juvenile idiopathic arthritis
Semin Arthritis Rheum. 2023 Aug 5;63:152247. doi: 10.1016/j.semarthrit.2023.152247. Online ahead of print. - https://pubmed.ncbi.nlm.nih.gov/37595510/
-
Zhao WJ, Deng JH, Li CF.
Lipid profiles in patients with juvenile idiopathic arthritis: a systematic literature review and meta-analysis.
Lipids Health Dis. 2023 Aug 25;22(1):136. doi: 10.1186/s12944-023-01885-1. Erratum in: Lipids Health Dis. 2023 Sep 8;22(1):148.
https://pubmed.ncbi.nlm.nih.gov/37626321/ - Hestetun S, Andersen S, Sanner H, Størdal K.
- Antibiotic exposure in prenatal and early life and risk of juvenile idiopathic arthritis: a nationwide register-based cohort study
- RMD Open. 2023 Aug;9(3):e003333. doi: 10.1136/rmdopen-2023-003333.
- https://pubmed.ncbi.nlm.nih.gov/37648397/
-
Ozer Y, Yildiz M, Turan H, Tarcin G, Bingol Aydin D, Gunalp A, et al.
Ovarian reserve in children with juvenile idiopathic arthritis using biologic disease-modifying anti-rheumatic drugs
Clin Rheumatol. 2023 Aug 30. doi: 10.1007/s10067-023-06747-w. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37646858/ -
Chaplin H, Bosworth A, Simpson C, Wilkins K, Meehan J, Nikiphorou E, Moss-Morris R, Lempp H, Norton S.
Refractory inflammatory arthritis definition and model generated through patient and multi-disciplinary professional modified Delphi process.
PLoS One. 2023 Aug 9;18(8):e0289760. doi: 10.1371/journal.pone.0289760.
https://pubmed.ncbi.nlm.nih.gov/37556424/ -
Edupuganti S, Khine S, Gupta R, Yadav D, Singh A.
Secukinumab-Induced Crohn's Disease in a Patient Treated for Juvenile Idiopathic Arthritis
Cureus. 2023 Aug 20;15(8):e43825. doi: 10.7759/cureus.43825. eCollection 2023 Aug.
https://pubmed.ncbi.nlm.nih.gov/37736437/ -
Currie GR, Kennedy BL, Benseler SM, Yeung RSM, Swart JF, Vastert SJ, et al.
Managing juvenile idiopathic arthritis within the context of their life: What we learnt from children and youth living with juvenile idiopathic arthritis and their parents.
Musculoskeletal Care. 2023 Aug 19. doi: 10.1002/msc.1805. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37596866/ -
Lineham B, Maggs R, Pandit H, Sharma H, Foster P.
Outcomes of ankle joint distraction in a paediatric and young adult cohort presenting with symptomatic ankle arthritis.
J Pediatr Orthop B. 2023 Aug 7. doi: 10.1097/BPB.0000000000001115. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37548659/ -
Tomé C, Oliveira-Ramos F, Campanilho-Marques R, Mourão AF, Sousa S, Marques C, et al.
Children with extended oligoarticular and polyarticular juvenile idiopathic arthritis have alterations in B and T follicular cell subsets in peripheral blood and a cytokine profile sustaining B cell activation
RMD Open. 2023 Aug;9(3):e002901. doi: 10.1136/rmdopen-2022-002901.
https://pubmed.ncbi.nlm.nih.gov/37652558/
JULIO 2023
-
Oliveira Ramos F, Rodrigues AM, Melo AT, Aguiar F, Brites L, Azevedo S, et al.
Influence of the timing of biological treatment initiation on Juvenile Idiopathic Arthritis long-term outcomes.
Arthritis Res Ther. 2023 Sep 21;25(1):177. doi: 10.1186/s13075-023-03166-9.
https://pubmed.ncbi.nlm.nih.gov/37735435/ -
Bagri NK, Chew C, Ramanan AV.
Scope of JAK Inhibitors in Children: Recent Evidence and Way Forward.
Paediatr Drugs. 2023 Sep 29. doi: 10.1007/s40272-023-00594-7.
https://pubmed.ncbi.nlm.nih.gov/37775678/ -
Pedersen ML, Neve-Græsbøll A, Herlin T, Glerup M.
Biologic switching patterns among children with non-systemic juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2023 Sep 23;21(1):107. doi: 10.1186/s12969-023-00897-6.
https://pubmed.ncbi.nlm.nih.gov/37742033/ -
Baraliakos X, van der Heijde D, Sieper J, Inman RD, Kameda H, Li Y, Bu X, et al
Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy: 1-year results from the open-label extension of a phase III study.
Arthritis Res Ther. 2023 Sep 18;25(1):172. doi: 10.1186/s13075-023-03128-1.
https://pubmed.ncbi.nlm.nih.gov/37723577/ -
Perrin T, Coutier L, Ranchoup J, Rifard A, Eymery M, Ohlmann C, et al.
Methotrexate does not affect lung function in children with juvenile idiopathic arthritis.
Pediatr Pulmonol. 2023 Sep 13. doi: 10.1002/ppul.26681. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37701972/ -
Şahin N, Özdemir Çiçek S, Paç Kısaarslan A, Dursun İ, Poyrazoğlu MH, Düşünsel R.
The effect of intra-articular steroid injection on the cartilage and tendon thicknesses in juvenile idiopathic arthritis.
Mod Rheumatol. 2023 Sep 27:road093. doi: 10.1093/mr/road093. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37757466/ -
Karadağ ŞG, Coskuner T, Demirkan FG, Sonmez HE, Ozdel S, Çakan M, et al.
Do the features of juvenile psoriatic arthritis change according to age? A comprehensive evaluation of the PeRA Research Group Registry.
Rheumatology (Oxford). 2023 Sep 19:kead496. doi: 10.1093/rheumatology/kead496. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37725366/ -
McGrath T, Guzman J, Tucker L, Shiff NJ, Yaskina M, Tupper S, Rumsey DG; ReACCh-Out Investigators.
Predictors of persisting pain in children with Juvenile Idiopathic Arthritis: a case control study nested in the ReACCh-Out cohort.
Pediatr Rheumatol Online J. 2023 Sep 16;21(1):102. doi: 10.1186/s12969-023-00885-w.
https://pubmed.ncbi.nlm.nih.gov/37715224/ -
Peltoniemi SOO, Glerup M, Lahdenne P, Eklund KK, Aalto K.
Disease characteristics of HLA-B27 positive and negative finnish patients with juvenile idiopathic arthritis- results of the 18-year cohort follow-up study.
Pediatr Rheumatol Online J. 2023 Sep 1;21(1):94. doi: 10.1186/s12969-023-00878-9.
https://pubmed.ncbi.nlm.nih.gov/37658392/ -
Alshaya M, Alrasheed A, Almutairi N, Albanaqi I, Laxer RM, Alhammad A.
Reactive Arthritis in Children: Case report and Narrative Review and Proposed therapy.
Curr Pediatr Rev. 2023 Sep 13. doi: 10.2174/1573396320666230913103007. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37702166/
JULIO 2023
-
Ozdel S, Sönmez HE, Çağlayan Ş, Akgün Ö, Aydın T, Baba Ö et al.How common is remission in rheumatoid factor-positive juvenile idiopathic arthritis patients? The multicenter Pediatric Rheumatology Academy (PeRA) research group experience.
Pediatr Rheumatol Online J. 2023 Jul 20;21(1):72. doi: 10.1186/s12969-023-00860-5.
https://pubmed.ncbi.nlm.nih.gov/37475055/ -
Pelassa S, Raggi F, Rossi C, Bosco MC.
MicroRNAs in Juvenile Idiopathic Arthritis: State of the Art and Future Perspectives.
Biology (Basel). 2023 Jul 12;12(7):991. doi: 10.3390/biology12070991.
https://pubmed.ncbi.nlm.nih.gov/37508421/ -
McIntosh SM, Kerut C, Hollenshead PP, Askins DH, Mansourian K, Palowsky ZR et al.
Golimumab for Polyarticular Juvenile Idiopathic Arthritis and Psoriatic Arthritis: Pharmacologic and Clinical Considerations.
Life (Basel). 2023 Jul 21;13(7):1601. doi: 10.3390/life13071601.
https://pubmed.ncbi.nlm.nih.gov/37511975/ -
De Nardi L, Pastore S, Rispoli F, Tesser A, Pin A, Taddio A, Tommasini A.
Type I interferon signature as a possible new marker for stratification of patients with juvenile idiopathic arthritis.
Clin Exp Rheumatol. 2023 Jul;41(7):1548-1552. doi: 10.55563/clinexprheumatol/b37xbd.
https://pubmed.ncbi.nlm.nih.gov/37140616/ -
Polat MC, Ekici Tekin Z, Çelikel E, Güngörer V, Kurt T, Kaplan MM et al.
The Juvenile Spondyloarthritis Disease Activity Index Is a Useful Tool in Enthesitis-Related Arthritis: Real-Life Data.
J Clin Rheumatol. 2023 Jul 27. doi: 10.1097/RHU.0000000000002001. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37496150/ -
Bansal N, Pasricha C, Kumari P, Jangra S, Kaur R, Singh R.
A comprehensive overview of juvenile idiopathic arthritis: From pathophysiology to management.
Autoimmun Rev. 2023 Jul;22(7):103337. doi: 10.1016/j.autrev.2023.103337.
https://pubmed.ncbi.nlm.nih.gov/37068698/ -
Zhao W, Li C, Deng J.
A systematic review and meta-analysis of environmental factors associated with juvenile idiopathic arthritis.
Int J Rheum Dis. 2023 Jul;26(7):1235-1247. doi: 10.1111/1756-185X.14729.
https://pubmed.ncbi.nlm.nih.gov/37309290/ -
Elfving A, Harila-Saari A, Nilsson L, Berntson L.
An explorative study on proteomic analyses related to inflammation and pain in children with juvenile idiopathic arthritis.
BMC Pediatr. 2023 Jul 15;23(1):365. doi: 10.1186/s12887-023-04181-0.
https://pubmed.ncbi.nlm.nih.gov/37454049/ -
Heshin-Bekenstein M, Baron S, Schulert G, Shusterman A, Fidel V, Ben-Shahar Y, Shukrun R, Binenbaum Y, Elhasid R.
Neutrophils extracellular traps formation may serve as a biomarker for disease activity in oligoarticular juvenile idiopathic arthritis: a pilot study.
Arthritis Res Ther. 2023 Jul 31;25(1):135. doi: 10.1186/s13075-023-03104-9.
https://pubmed.ncbi.nlm.nih.gov/37525216/ -
Cafarotti A, Marcovecchio ML, Lapergola G, Di Battista C, Marsili M, Basilico R et al.
Kidney function and renal resistive index in children with juvenile idiopathic arthritis.
Clin Exp Med. 2023 Jul;23(3):759-766. doi: 10.1007/s10238-022-00898-x.
https://pubmed.ncbi.nlm.nih.gov/36129558/ -
Al-Jaberi L, Simonds MM, Brescia AMC.
CCL24, CXCL9 and CXCL10 are increased in synovial fluid in patients with juvenile idiopathic arthritis requiring advanced treatment.
Rheumatology (Oxford). 2023 Jul 5;62(7):2594-2600. doi: 10.1093/rheumatology/keac617.
https://pubmed.ncbi.nlm.nih.gov/36342195/
MAYO 2023
-
Brunner HI, Tzaribachev N, Louw I, Penades IC, Avila-Zapata F, Horneff G, et al; Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG) investigators.
Long-Term Maintenance of Clinical Responses by Individual Patients With Polyarticular-Course Juvenile Idiopathic Arthritis Treated With Abatacept.
Arthritis Care Res (Hoboken). 2023 May 23. doi: 10.1002/acr.25156. Epub ahead of print
https://pubmed.ncbi.nlm.nih.gov/37221146/ -
Vojinović J, Foeldvari I, Dehoorne J, Panaviene V, Susic G, Horneff G, et al; Paediatric Rheumatology International Trials Organisation (PRINTO).
Ten-year safety and clinical benefit from open-label etanercept treatment in children and young adults with juvenile idiopathic arthritis.
Rheumatology (Oxford). 2023 May 4:kead183. doi: 10.1093/rheumatology/kead183. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37140539/ -
Chan OM, Lai BM, Leung AS, Leung TF, Ho AC.
High prevalence of sacroiliitis and early structural changes in the sacroiliac joint in children with enthesitis-related arthritis: findings from a tertiary centre in Hong Kong.
Pediatr Rheumatol Online J. 2023 May 3;21(1):45. doi: 10.1186/s12969-023-00825-8.
https://pubmed.ncbi.nlm.nih.gov/37138335/ -
Tsitsami E, Sarrigeorgiou I, Tsinti M, Rouka EC, Zarogiannis SG, Lymberi P.
Natural autoimmunity in oligoarticular juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2023 May 3;21(1):44. doi: 10.1186/s12969-023-00823-w.
https://pubmed.ncbi.nlm.nih.gov/37138302/ -
Altaffer AL, Weiss P.
Clinical features, treatment, and outcomes of celiac-associated arthritis: a retrospective cohort study.
Pediatr Rheumatol Online J. 2023 May 2;21(1):43. doi: 10.1186/s12969-023-00822-x.
https://pubmed.ncbi.nlm.nih.gov/37131195/ -
Sukharomana M, Charuvanij S.
Outcomes of intraarticular triamcinolone acetonide injection in children with non-systemic juvenile idiopathic arthritis.
Clin Rheumatol. 2023 Jun;42(6):1665-1674. doi: 10.1007/s10067-023-06569-w.
https://pubmed.ncbi.nlm.nih.gov/36892711/
ABRIL 2023
-
Bousquet B, Kellenberger CJ, Caprio RM, Jindal S, Resnick CM.
Does Magnetic Resonance Imaging Distinguish Juvenile Idiopathic Arthritis From Other Causes of Progressive Temporomandibular Joint Destruction?
J Oral Maxillofac Surg. 2023 Apr 4:S0278-2391(23)00331-2. doi: 10.1016/j.joms.2023.03.016. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37086749/ -
Cooper SM, Currie GR, Kromm S, Twilt M, Marshall DA.
Evaluating key performance indicators of the process of care in juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2023 Apr 21;21(1):37. doi: 10.1186/s12969-023-00818-7
https://pubmed.ncbi.nlm.nih.gov/37085775/ -
Kyllönen MS, Kautiainen H, Jääskeläinen E, Puolakka K, Vähäsalo P.
Use of psychotropic medication in incident juvenile idiopathic arthritis patients from 2000 to 2014: a case-control cohort study.
Clin Exp Rheumatol. 2023 Apr 6. doi: 10.55563/clinexprheumatol/26u6uu. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37083175/ -
Nijhuis L, Swart JF, Prakken BJ, V Loosdregt J, Vastert SJ.
The clinical and experimental treatment of Juvenile Idiopathic Arthritis.
Clin Exp Immunol. 2023 Apr 19:uxad045. doi: 10.1093/cei/uxad045. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37074076/ -
Schanberg LE, Mulugeta LY, Akinlade B, Brunner HI, Chen J, Colbert RA, Delgaizo V, Gastonguay MR, Glaser R, Imundo L, Lovell DJ, Leu JH, Mostafa NM, Nelson RM, Nigrovic PA, Nikolov NP, Rider LG, Rothwell R, Sahajwalla C, Singh R, Sinha V, Yancey CL, Yao L.
Therapeutics Development in Polyarticular Course Juvenile Idiopathic Arthritis (pcJIA): Extrapolation, Dose Selection and Clinical Trial Design; Workshop Proceedings and Recent Updates.
Arthritis Rheumatol. 2023 Apr 17. doi: 10.1002/art.42534. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37067688/ -
Backström M, Salo H, Kärki J, Aalto K, Rebane K, Levälampi T, Grönlund MM, Kröger L, Pohjankoski H, Hietanen M, Korkatti K, Kuusalo L, Rantalaiho V, Huhtakangas J, Relas H, Pääkkö T, Löyttyniemi E, Sokka-Isler T, Vähäsalo P.
The feasibility of existing JADAS10 cut-off values in clinical practice: a study of data from The Finnish Rheumatology Quality Register.
Pediatr Rheumatol Online J. 2023 Apr 14;21(1):35. doi: 10.1186/s12969-023-00814-x.
https://pubmed.ncbi.nlm.nih.gov/37060076/ -
Otobo TM, Tolend M, Meyers AB, Sudol-Szopinska I, Joshi S, Stimec J, Herregods N, Jaremko JL, Tse SML, Haroon N, Moineddin R, Tzaribachev N, Appenzeller S, Znajdek M, Perez M, Ligha AE, Jans L, Inarejos Clemente EJ, Weiss P, Papakonstantinou O, Kirkhus E, van Rossum MAJ, Rumsey DG, Carrino J, Akikusa JD, Conaghan PG, Doria AS.
Determination of Relative Weightings for Sacroiliac Joint Pathologies in the OMERACT Juvenile Arthritis Magnetic Resonance Imaging Sacroiliac Joint Score.
J Clin Med. 2023 Apr 6;12(7):2729. doi: 10.3390/jcm12072729.
https://pubmed.ncbi.nlm.nih.gov/37048812/ -
Kirchner S, Klotsche J, Liedmann I, Niewerth M, Feldman D, Dressler F, Foeldvari I, Foell D, Haas JP, Horneff G, Hospach A, Kallinich T, Kuemmerle-Deschner JB, Moenkemoeller K, Weller-Heinemann F, Windschall D, Minden K, Sengler C.
Adherence, helpfulness and barriers to treatment in juvenile idiopathic arthritis - data from a German Inception cohort.
Pediatr Rheumatol Online J. 2023 Apr 12;21(1):31. doi: 10.1186/s12969-023-00811-0.
https://pubmed.ncbi.nlm.nih.gov/37046303/ -
Roemer J, Klein A, Horneff G.
Prevalence and risk factors of depressive symptoms in children and adolescents with juvenile idiopathic arthritis.
Rheumatol Int. 2023 Apr 11. doi: 10.1007/s00296-023-05323-4. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37039854/ -
Hamad Saied M, van Straalen JW, de Roock S, de Joode-Smink GCJ, Swart JF, Wulffraat NM, Jansen MHA.
Safety of Measles-Mumps-Rubella booster vaccination in patients with juvenile idiopathic arthritis: A long-term follow-up study.
Vaccine. 2023 Apr 7:S0264-410X(23)00381-X. doi: 10.1016/j.vaccine.2023.03.074. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37032229/ -
Brix N, Glerup M, Foell D, Kessel C, Wittkowski H, Berntson L, Fasth A, Nielsen S, Nordal E, Rygg M, Hasle H, Herlin T; Nordic Study Group of Pediatric Rheumatology (NoSPeR) group.
Inflammatory Biomarkers Can Differentiate ALL with Arthropathy from JIA Better Than Standard Blood Tests.
JPediatr. 2023 Apr 4:113406. doi: 10.1016/j.jpeds.2023.113406. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37023943/ -
Backström M, Tarkiainen M, Gottlieb BS, Trincianti C, Qiu T, Morgan E, Lovell DJ, Bovis F, Löyttyniemi E, Ruperto N, Vähäsalo P, Consolaro A.
Paediatric rheumatologists do not score the physician's global assessment of juvenile idiopathic arthritis disease activity in the same way.
Rheumatology (Oxford). 2023 Apr 2:kead151. doi: 10.1093/rheumatology/kead151. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37004166/
MARZO 2023
-
Tanatar A, Akgün Ö, Çağlayan Ş, Bağlan E, Otar Yener G, Öztürk K, Çakan M, Sönmez HE, Sözeri B, Aktay Ayaz N.
Withdrawal of biologic therapy in juvenile idiopathic arthritis due to remission: predictors of flare and outcomes.
Expert Opin Biol Ther. 2023 Mar;23(3):305-313. doi: 10.1080/14712598.2023.2185132.
https://pubmed.ncbi.nlm.nih.gov/36825474/ -
Hamdi W, Ferjani H, Carlomagno R, Dusser P, Echaubard S, Belot A, et al.
Factors associated with poor prognosis of hip arthritis in juvenile idiopathic arthritis: Data from the JIR cohort.
Musculoskeletal Care. 2023 Mar 10. doi: 10.1002/msc.1755. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36896923/ -
Sukharomana M, Charuvanij S.
Outcomes of intraarticular triamcinolone acetonide injection in children with non-systemic juvenile idiopathic arthritis.
Clin Rheumatol. 2023 Mar 9. doi: 10.1007/s10067-023-06569-w. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36892711/ -
Chausset A, Lambert C, Belot A, Merlin E, Cannizzaro E, Kone-Paut I, et al.
Individual and environmental determinants associated with longer times to access pediatric rheumatology centers for patients with juvenile idiopathic arthritis, a JIR cohort study.
Pediatr Rheumatol Online J. 2023 Mar 14;21(1):24. doi: 10.1186/s12969-023-00809-8.
https://pubmed.ncbi.nlm.nih.gov/36918902/ -
Sande NK, Lilleby V, Aga AB, Kirkhus E, Flatø B, Bøyesen P.
Associations between power Doppler ultrasound findings and B-mode synovitis and clinical arthritis in juvenile idiopathic arthritis using a standardised scanning approach and scoring system.
RMD Open. 2023 Mar;9(1):e002937. doi: 10.1136/rmdopen-2022-002937.
https://pubmed.ncbi.nlm.nih.gov/36963783/ -
Felis-Giemza A, Chmurzyńska K, Kołodziejczyk B, Gazda A.
Revising diagnosis of juvenile idiopathic arthritis in adults: a single-center retrospective study.
Rheumatol Int. 2023 Mar 1. doi: 10.1007/s00296-023-05293-7. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36859560/ -
Wittmann N, Mishra N, Gramenz J, Kuthning D, Behrendt AK, Bossaller L, Meyer-Bahlburg A.
Inflammasome activation and formation of ASC specks in patients with juvenile idiopathic arthritis.
Front Med (Lausanne). 2023 Mar 1;10:1063772. doi: 10.3389/fmed.2023.1063772.
https://pubmed.ncbi.nlm.nih.gov/36936231/
FEBRERO 2023
-
Maccora I, Oliverio T, Pagnini I, Marrani E, Mastrolia MV, Simonini G.
Baricitinib for juvenile idiopathic arthritis: a monocentric case series
Ann Rheum Dis. 2023 Feb 8:ard-2022-223815. doi: 10.1136/ard-2022-223815.
https://pubmed.ncbi.nlm.nih.gov/36754594/ -
Glerup M, Tagkli A, Küseler A, Christensen AE, Verna C, Bilgrau AE, Nørholt SE, Herlin T, Pedersen TK, Stoustrup P.
Incidence of orofacial manifestations of juvenile idiopathic arthritis from diagnosis to adult care transition: a population-based cohort study.
Arthritis Rheumatol. 2023 Feb 20. doi: 10.1002/art.42481. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36806745/ -
Gruca M, Orczyk K, Zamojska J, Niewiadomska-Jarosik K, Stańczyk J, Smolewska E.
Why and How Should We Assess the Cardiovascular Risk in Patients with Juvenile Idiopathic Arthritis? A Single-Centre Experience with Carotid Intima-Media Measurements.
Children (Basel). 2023 Feb 22;10(3):422. doi: 10.3390/children10030422.
https://pubmed.ncbi.nlm.nih.gov/36979980/ -
Zemthangpuii F, Maheshwari A, Gulati S, Sharma S, Mahto D, Chandra J.
Serum Calprotectin Levels in Different Subtypes of Juvenile Idiopathic Arthritis (JIA) and Its Correlation with Quantitative CRP and JADAS-27Z
Indian J Pediatr. 2023 Feb 10. doi: 10.1007/s12098-022-04414-7. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36763251/ -
Khawaja K, Kalas R, Almasri N.
Subtype frequency, demographic features, treatment and outcome of Juvenile Arthritis in one Centre in Abu Dhabi in the United Arab Emirates.
Pediatr Rheumatol Online J. 2023 Feb 7;21(1):14. doi: 10.1186/s12969-023-00796-w.
https://pubmed.ncbi.nlm.nih.gov/36750870/ -
Rochette E, Saidi O, Merlin É, Duché P.
Physical activity as a promising alternative for young people with juvenile idiopathic arthritis: Towards an evidence-based prescription.
Front Immunol. 2023 Feb 13;14:1119930. doi: 10.3389/fimmu.2023.1119930.
https://pubmed.ncbi.nlm.nih.gov/36860845/ -
Bento da Silva A, Lourenço MH, Gonçalves MJ, Branco JC, Costa M, Mourão AF.
Arthritis or maybe not? Pachydermodactyly: the great mimicker of juvenile idiopathic arthritis
ARP Rheumatol. 2023 Feb 18. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36802346/ -
Imbach KJ, Treadway NJ, Prahalad V, Kosters A, Arafat D, Duan M, Gergely T, Ponder LA, Chandrakasan S, Ghosn EEB, Prahalad S, Gibson G.
Profiling the peripheral immune response to ex vivo TNF stimulation in untreated juvenile idiopathic arthritis using single cell RNA sequencing.
Pediatr Rheumatol Online J. 2023 Feb 15;21(1):17. doi: 10.1186/s12969-023-00787-x.
https://pubmed.ncbi.nlm.nih.gov/36793127/ -
Guo Y, Fang Y, Zhang T, Pan Y, Wang P, Fan Z, Yu H.
Axial involvement in enthesitis-related arthritis: results from a single-center cohort
Pediatr Rheumatol Online J. 2023 Feb 6;21(1):13. doi: 10.1186/s12969-023-00792-0.
https://pubmed.ncbi.nlm.nih.gov/36747282/ -
Feng R, Lu M, Yin C, Xu K, Liu L, Xu P.
Identification of candidate genes and pathways associated with juvenile idiopathic arthritis by integrative transcriptome-wide association studies and mRNA expression profiles.
Arthritis Res Ther. 2023 Feb 8;25(1):19.
https://pubmed.ncbi.nlm.nih.gov/36755318/
ENERO 2023
-
De Somer L, Bader-Meunier B, Breton S, Brachi S, Wouters C, Zulian F.
Dry synovitis, a rare entity distinct from juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2023 Jan 23;21(1):7. doi: 10.1186/s12969-023-00789-9
https://pubmed.ncbi.nlm.nih.gov/36691078/ -
Naveen R, Guleria S, Mohindra N, Aggarwal A.
Predictors of long-term functional outcomes of juvenile idiopathic arthritis-enthesitis related arthritis: a single centre experience.
Rheumatology (Oxford). 2023 Jan 25:kead032. doi: 10.1093/rheumatology/kead032. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36702467/ -
Naddei R, Rebollo-Giménez A, Burrone M, Natoli V, Rosina S, Consolaro A, Ravelli A.
Juvenile Psoriatic Arthritis: Myth or Reality? An Unending Debate.
J Clin Med. 2023 Jan 3;12(1):367. doi: 10.3390/jcm12010367.
https://pubmed.ncbi.nlm.nih.gov/36615167/ -
La Bella S, Rinaldi M, Di Ludovico A, Di Donato G, Di Donato G, Salpietro V, Chiarelli F, Breda L.
Genetic Background and Molecular Mechanisms of Juvenile Idiopathic Arthritis.
Int J Mol Sci. 2023 Jan 17;24(3):1846. doi: 10.3390/ijms24031846.
https://pubmed.ncbi.nlm.nih.gov/36768167/ -
Murias S, Boteanu A, Calvo I, Nuñez E, Bravo B, Bustabad S, Camacho M, Clemente D, Graña J, de Inocencio J, Lacruz L, Mesa-Del-Castillo P, Nieto-González JC, Pinedo MDC, Quesada E, Vargas C, Antón J.
What drives the decision to optimise biological treatment in children and youngsters with juvenile idiopathic arthritis? A discrete-choice experiment.
Reumatol Clin (Engl Ed). 2023 Jan;19(1):26-33. doi: 10.1016/j.reumae.2022.11.002.
https://pubmed.ncbi.nlm.nih.gov/36603964/ -
Stoustrup P, Resnick CM, Abramowicz S, Pedersen TK, Michelotti A, Küseler A, et al.
Temporomandibular Joint Juvenile Arthritis Working Group. Management of Orofacial Manifestations of Juvenile Idiopathic Arthritis: Interdisciplinary Consensus-Based Recommendations.
Arthritis Rheumatol. 2023 Jan;75(1):4-14. doi: 10.1002/art.42338. Epub 2022 Nov 25.
https://pubmed.ncbi.nlm.nih.gov/36041065/ -
d'Angelo DM, Attanasi M, Di Donato G, Lapergola G, Flacco M, Chiarelli F, Altobelli E, Breda L.
The Role of Serum Calprotectin in Defining Disease Outcomes in Non-Systemic Juvenile Idiopathic Arthritis: A Pilot Study.
Int J Mol Sci. 2023 Jan 14;24(2):1671. doi: 10.3390/ijms24021671.
https://pubmed.ncbi.nlm.nih.gov/36675189/ -
Zare N, Mansoubi M, Coe S, Najafi AA, Bailey K, Harrison K, Sheehan J, Dawes H, Barker K.
An investigation into the relationship between nutritional status, dietary intake, symptoms and health-related quality of life in children and young people with juvenile idiopathic arthritis: a systematic review and meta-analysis.
BMC Pediatr. 2023 Jan 2;23(1):3. doi: 10.1186/s12887-022-03810-4.
https://pubmed.ncbi.nlm.nih.gov/36593466/
DICIEMBRE 2022
-
Badin D, Leland CR, Bronheim RS, Balmuri N, Lee RJ.
Synovectomy in juvenile idiopathic arthritis: A systematic review and meta-analysis
Medicine (Baltimore). 2022 Dec 9;101(49):e32278. doi: 10.1097/MD.0000000000032278.
https://pubmed.ncbi.nlm.nih.gov/36626489/ -
Wedderburn LR, Ramanan AV, Croft AP, Hyrich KL, Dick A; CLUSTER Consortium.
Towards molecular-pathology informed clinical trials in childhood arthritis to achieve precision medicine in juvenile idiopathic arthritis
Ann Rheum Dis. 2022 Dec 5:annrheumdis-2022-222553. doi: 10.1136/ard-2022-222553. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36600186/ -
Duran G, Bayraktar D, Kalkan AC, Turkucar S, Makay B, Unsal SE, Genc A.
Investigating Wrist Joint Position Sense and Hand Functions in Children With Polyarticular Juvenile Idiopathic Arthritis With Wrist Involvement
Clin Pediatr (Phila). 2022 Dec 29:99228221147175. doi: 10.1177/00099228221147175. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36579857/ -
Sunthornsup W, Vilaiyuk S, Soponkanaporn S.
Effect of educational brochure compared with video on disease-related knowledge in patients with juvenile idiopathic arthritis: A randomized controlled trial
Front Pediatr. 2022 Dec 9;10:1048949. doi: 10.3389/fped.2022.1048949. eCollection 2022.
https://pubmed.ncbi.nlm.nih.gov/36568417/ -
Frkovic M, Kujundzic M, Cavka M, Jelusic M.
Successful use of adalimumab as a conservative treatment for bilateral knee lipoma arborescens in patient with psoriatic juvenile idiopathic arthritis - case report and review of literature
Front Pediatr. 2022 Dec 6;10:1014536. doi: 10.3389/fped.2022.1014536. eCollection 2022.
https://pubmed.ncbi.nlm.nih.gov/36561488/ -
Kasap Cuceoglu M, Basaran O, Soyer O, Ozen S.
Hypersensitivity to Biological Treatments in Juvenile Idiopathic Arthritis: How Should It Be Managed?
J Clin Med. 2022 Dec 8;11(24):7291. doi: 10.3390/jcm11247291.
https://pubmed.ncbi.nlm.nih.gov/36555908/ -
Elnaggar RK, Elfakharany MS.
Aqua-Plyometric Exercises-Induced Changes in Muscle Strength, Bone Mineral Properties, and Physical Fitness in Patients With Juvenile Idiopathic Arthritis: A 12-Week, Randomized Controlled Trial
Pediatr Exerc Sci. 2022 Dec 19:1-8. doi: 10.1123/pes.2022-0044. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36535274/ -
Roberts JE, Williams K, Dallas J, Eckert M, Huie L, Smitherman E, Soulsby WD, Zhao Y, Son MBF; CARRA Registry Investigators.
Insurance Status and TNF Inhibitor Initiation Among Children with JIA in the Childhood Arthritis and Rheumatology Research Alliance Registry
J Rheumatol. 2022 Dec 15:jrheum.220871. doi: 10.3899/jrheum.220871. Online ahead of print.PMID: 36521922
https://pubmed.ncbi.nlm.nih.gov/36521922/ -
Berntson L, Palm J, Axling F, Zarelius P, Hellström PM, Webb DL.
Haptoglobin in Juvenile Idiopathic Arthritis
Pediatr Rheumatol Online J. 2022 Dec 15;20(1):117. doi: 10.1186/s12969-022-00777-5.
https://pubmed.ncbi.nlm.nih.gov/36517828/ -
Del Giudice E, de Roock S, Vastert SJ, Wulffraat NM, Swart JF, van Dijkhuizen EHP.
Patients' and parents' satisfaction to improve patient care in JIA: factors determining acceptable symptom state measured with JAMAR
Rheumatology (Oxford). 2022 Dec 14:keac658. doi: 10.1093/rheumatology/keac658. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36515484/ -
Jonyk L, Sagawa Junior Y, Tordi N, Ballot Schmit C.
Description of physical activity in children with juvenile idiopathic arthritis using accelerometry
Arch Pediatr. 2022 Dec 10:S0929-693X(22)00227-5. doi: 10.1016/j.arcped.2022.11.003. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36513538/ -
Berthold E, Dahlberg A, Jöud A, Tydén H, Månsson B, Kahn F, Kahn R.
The risk of depression and anxiety is not increased in individuals with juvenile idiopathic arthritis - results from the south-Swedish juvenile idiopathic arthritis cohort
Pediatr Rheumatol Online J. 2022 Dec 9;20(1):114. doi: 10.1186/s12969-022-00765-9.
https://pubmed.ncbi.nlm.nih.gov/36494819/ -
Gieling J, van den Bemt B, Hoppenreijs E, Schatorjé E.
Discontinuation of biologic DMARDs in non-systemic JIA patients: a scoping review of relapse rates and associated factors
Pediatr Rheumatol Online J. 2022 Dec 5;20(1):109. doi: 10.1186/s12969-022-00769-5.
https://pubmed.ncbi.nlm.nih.gov/36471348/ -
Stoustrup P, Rahimi H, Twilt M, Goh YI, Pedersen TK, Herlin T, Spiegel L;
Temporomandibular joint Juvenile Arthritis Work group (TMJaw) Assessment of orofacial symptoms in juvenile idiopathic arthritis: Validation of a consensus-based short patient questionnaire
J Rheumatol. 2022 Dec 1:jrheum.220667. doi: 10.3899/jrheum.220667. Online ahead of print.PMID: 36455952
https://pubmed.ncbi.nlm.nih.gov/36455952/ -
Frenkel Y, Kraushar I, Hamad Saied M, Haviv R, Uziel Y, Heshin-Bekenstein M, Ling E, Amarilyo G, Harel L, Tirosh I, Spielman S, Berkun Y, Butbul Aviel Y.
Obstacles in Early Diagnosis of Children With Juvenile Idiopathic Arthritis: A Nationwide Israeli Retrospective Study
J Rheumatol. 2022 Dec 1:jrheum.220359. doi: 10.3899/jrheum.220359. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36455949/
NOVIEMBRE 2022
-
Horneff G, Borchert J, Heinrich R, Kock S, Klaus P, Dally H, Hagemann C, Diesing J, Schönfelder T.
Incidence, prevalence, and comorbidities of juvenile idiopathic arthritis in Germany: a retrospective observational cohort health claims database study.
Pediatr Rheumatol Online J. 2022 Nov 16;20(1):100. doi:10.1186/s12969-022-00755-x.
https://pubmed.ncbi.nlm.nih.gov/36384690/ -
van Straalen JW, de Roock S, Giancane G, Consolaro A, Rygg M, Nordal EB, Rubio-Pérez N, Jelusic M, De Inocencio J, Vojinovic J, Wulffraat NM, Bruijning-Verhagen PCJ, Ruperto N, Swart JF; Paediatric Rheumatology International Trials Organisation (PRINTO).
Real-world comparison of the effects of etanercept and adalimumab on well-being in non-systemic juvenile idiopathic arthritis: a propensity score matched cohort study.
Pediatr Rheumatol Online J. 2022 Nov 14;20(1):96. doi: 10.1186/s12969-022-00763-x.
https://pubmed.ncbi.nlm.nih.gov/36376976/ -
Broekaert IJ, Klein A, Windschall D, Rogalski B, Weller-Heinemann F, Oommen P, et al.
Development of Inflammatory Bowel Disease in Children with Juvenile Idiopathic Arthritis Treated with Biologics.
J Pediatr Gastroenterol Nutr. 2022 Nov 17. doi: 10.1097/MPG.0000000000003656. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36399775/ -
Hahn T, Daymont C, Beukelman T, Groh B, Hays K, Bingham CA, Scalzi L; CARRA Registry investigators.
Intraarticular steroids as DMARD-sparing agents for juvenile idiopathic arthritis flares: Analysis of the Childhood Arthritis and Rheumatology Research Alliance Registry.
Pediatr Rheumatol Online J. 2022 Nov 25;20(1):107. doi:10.1186/s12969-022-00770-y.
https://pubmed.ncbi.nlm.nih.gov/36434731/ -
Baydoun S, Jousse-Joulin S, Saraux A, Dusser-Benesty P, Borocco C, Galeotti C, et al.
Criteria Associated with Treatment Decisions in Juvenile Idiopathic Arthritis with a Focus on Ultrasonography: Results from the JIRECHO Cohort.
Rheumatol Ther. 2022 Nov 23:1-14. doi: 10.1007/s40744-022-00512-2. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36427176/ -
Bardan I, Fagerli KM, Sexton J, Kvien TK, Bakland G, Mielnik P, Hu Y, Lien G, Flatø B, Molberg Ø, Kristianslund EK, Aga AB.
Treatment response to tumor necrosis factor inhibitors and methotrexate monotherapy in adults with juvenile idiopathic arthritis: Data from NORDMARD.
J Rheumatol. 2022 Nov 15:jrheum.220645. doi: 10.3899/jrheum.220645. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36379571/ -
van Straalen JW, de Roock S, Giancane G, Alexeeva E, Koskova E, Mesa-Del-Castillo Bermejo P, Zulian F, Civino A, Montin D, Wulffraat NM, Ruperto N, Swart JF; Paediatric Rheumatology International Trials Organisation (PRINTO).
Prevalence of familial autoimmune diseases in juvenile idiopathic arthritis: results from the international Pharmachild registry.
Pediatr Rheumatol Online J. 2022 Nov 18;20(1):103. doi:10.1186/s12969-022-00762-y.
https://pubmed.ncbi.nlm.nih.gov/36401230/ -
Giacalone VD, Cammarata-Mouchtouris A, Moncada-Giraldo D, Shenoy SPV, Ponder LA, Gergely TR, et al
Immunometabolic Analysis of Synovial Fluid from Juvenile Idiopathic Arthritis Patients.
Immunohorizons. 2022 Nov 1;6(11):768-778. doi: 10.4049/immunohorizons.2200052.
https://pubmed.ncbi.nlm.nih.gov/36445361 - Stoll ML, Wang J, Kau CH, Pierce MK, Morrow CD, Geurs NC.
Pro-Inflammatory Oral Microbiota in Juvenile Spondyloarthritis: A Pilot Study
Children (Basel). 2022 Nov 17;9(11):1764. doi: 10.3390/children9111764.
https://pubmed.ncbi.nlm.nih.gov/36421212/
OCTUBRE 2022
-
Oommen PT, Strauss T, Baltruschat K, Foeldvari I, Deuter C, Ganser G, et al.
Update of evidence- and consensus-based guidelines for the treatment of juvenile idiopathic arthritis (JIA) by the German Society of Pediatric and Juvenile Rheumatic Diseases (GKJR): New perspectives on interdisciplinary care.
Clin Immunol. 2022 Sep 30;245:109143. doi: 10.1016/j.clim.2022.109143. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36191738/ -
Civino A, Bovis F, Ponzano M, Alighieri G, Prete E, Sorrentino S, Magni-Manzoni S, Vinti L, Romano M, Santoro N, Filocamo G, Belotti T, Santarelli F, Gorio C, Cattalini M, Stabile G, Conter V, Rondelli R, Pession A, Ravelli A; ONCOREUM Study group.
Development and initial validation of the ONCOREUM score to differentiate childhood cancer with arthropathy from juvenile idiopathic arthritis.
J Pediatr. 2022 Oct 3:S0022-3476(22)00868-X. doi: 10.1016/j.jpeds.2022.09.046. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36202241/ -
Thiele F, Klein A, Klotsche J, Windschall D, Dressler F, Kuemmerle-Deschner J, Minden K, Foeldvari I, Foell D, Mrusek S, Oommen PT, Horneff G.
Biologics with or without methotrexate in treatment of polyarticular juvenile idiopathic arthritis: effectiveness, safety and drug survival.
Rheumatology (Oxford). 2022 Oct 12:keac587. doi: 10.1093/rheumatology/keac587. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36222562/ - Raggi F, Cangelosi D, Consolaro A, Rossi C, Pelassa S, Cortese K, Gagliani MC, Morini M, Segalerba D, Brignole C, Bocca P, Marimpietri D, Trincianti C, Ravelli A, Eva A, Bosco MC
Extracellular vesicle-derived microRNAs as potential biomarkers in oligoarticular juvenile idiopathic arthritis patients: methodological challenges and new perspectives.
Clin Transl Med. 2022 Oct;12(10):e1067. doi: 10.1002/ctm2.1067.
https://pubmed.ncbi.nlm.nih.gov/36178089/
-
Yamasaki Y, Nakamura A, Kubota T, Mitsunobu T, Moriyama M, Takei S, Okamoto Y.
Rheumatoid factor value for determining the first biologic agent to use for non-systemic juvenile idiopathic arthritis.
Mod Rheumatol. 2022 Oct 5:roac125. doi: 10.1093/mr/roac125. Online ahead of print.PMID: 36197747.
https://pubmed.ncbi.nlm.nih.gov/36197747/
AGOSTO 2022
-
Udaondo C, Núñez Cuadros E, Murias S, Remesal A, Alcobendas R, Guerrero C, Guillen-Martin S, Escuredo M, Aleo E, Alonso D, Tagarro A, De Santiago E, Camacho-Lovillo M, Diaz F, Arenas D, Camacho P, Lirola MJ, Díaz Almirón M, Calvo C.
Are infections in children with juvenile idiopathic arthritis more frequent than in healthy children? A prospective multicenter observational study.
Front Pediatr. 2022 Aug 11;10:917731. doi: 10.3389/fped.2022.917731.
https://pubmed.ncbi.nlm.nih.gov/36034561/ -
Schujovitzky D, Ziv A, Heshin Bekenstein M, Eylon S, Grossman Z, Hashkes PJ, Uziel Y, Haviv R.
Measuring the knowledge of juvenile idiopathic arthritis among Israeli paediatricians and paediatric orthopaedic surgeons: what needs to be improved?
Clin Exp Rheumatol. 2022 Aug 5. doi: 10.55563/clinexprheumatol/7j9es3.
https://pubmed.ncbi.nlm.nih.gov/35930493/ - Brunner HI, Foeldvari I, Alexeeva E, Ayaz NA, Calvo Penades I, Kasapcopur O, et al; Paediatric Rheumatology INternational Trials Organization (PRINTO) and Pediatric Rheumatology Collaborative Study Group (PRCSG).
Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial.
Ann Rheum Dis. 2022 Aug 12:annrheumdis-2022-222849. doi: 10.1136/ard-2022-222849.
https://pubmed.ncbi.nlm.nih.gov/35961761/ -
Bakry R, Klein MA, Horneff G.
Oral or Parenteral Methotrexate for the Treatment of Polyarticular Juvenile Idiopathic Arthritis.
Eur J Rheumatol. 2022 Aug 9. doi: 10.5152/eurjrheum.2022.21090.
https://pubmed.ncbi.nlm.nih.gov/35943454/ -
Ringold S, Dennos AC, Kimura Y, Beukelman T, Shrader P, Phillips TA, Kohlheim M, Schanberg LE, Yeung RSM, Horton DB; CARRA Registry Investigators.
Disease Recapture Rates After Medication Discontinuation and Flare in JIA: An Observational Study within the Childhood Arthritis and Rheumatology Research Alliance Registry.
Arthritis Care Res (Hoboken). 2022 Aug 3. doi: 10.1002/acr.24994.
https://pubmed.ncbi.nlm.nih.gov/35921198/ -
Burgos-Vargas R, Loyola-Sanchez A, Ramiro S, Reding-Bernal A, Alvarez-Hernandez E, van der Heijde D, Vázquez-Mellado J.
A randomized, double-blind, placebo-controlled 12-week trial of infliximab in patients with juvenile-onset spondyloarthritis.
Arthritis Res Ther. 2022 Aug 8;24(1):187. doi: 10.1186/s13075-022-02877-9.
https://pubmed.ncbi.nlm.nih.gov/35941676/ -
Hata T, Hirata A, Ota R, Hosohata K, Nishihara M, Neo M, Katsumata T.
Biologic Disease-Modifying and Other Anti-Rheumatic Drugs Use in Patients with Moderate-to-Severe Juvenile Idiopathic Arthritis Based on a Japanese Nationwide Claims Database.
Ther Clin Risk Manag. 2022 Aug 24;18:843-853. doi: 10.2147/TCRM.S375890.
https://pubmed.ncbi.nlm.nih.gov/36046102/ -
Park J, Batthish M, Berard RA, Chédeville G, Proulx-Gauthier JP, Rumsey DG, Tucker LB, Wong S, Guzman J; CAPRI Registry Investigators.
Comparing Canadian pediatric rheumatology practice to the 2019 ACR Juvenile Idiopathic Arthritis guidelines. Results from the CAPRI Registry
Rheumatology (Oxford). 2022 Aug 17:keac468. doi: 10.1093/rheumatology/keac468.
https://pubmed.ncbi.nlm.nih.gov/35977388/ -
Stoustrup P, Resnick CM, Abramowicz S, Pedersen TK, Michelotti A, Küseler A, et al; Temporomandibular Joint Juvenile Arthritis Working group (TMJaw).
Management of orofacial manifestations of juvenile idiopathic arthritis: Interdisciplinary consensus-based recommendations.
Arthritis Rheumatol. 2022 Aug 30. doi: 10.1002/art.42338. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36041065/ -
Koker O, Aliyeva A, Sahin S, Adrovic A, Yildiz M, Haslak F, Gunalp A, Barut K, Kasapcopur O.
An overview of the relationship between juvenile idiopathic arthritis and potential environmental risk factors: Do early childhood habits or habitat play a role in the affair?
Int J Rheum Dis. 2022 Aug 30. doi: 10.1111/1756-185X.14431.
https://pubmed.ncbi.nlm.nih.gov/36039559/ -
Brandelli YN, Stone M, Westheuser V, Huber AM, Joshi N, Reid A, Stringer E, Stevens D.
Parent Risk Perceptions, Physical Literacy, and Fundamental Movement Skills in Children With Juvenile Idiopathic Arthritis
Pediatr Phys Ther. 2022 Aug 12. doi: 10.1097/PEP.0000000000000948.
https://pubmed.ncbi.nlm.nih.gov/35960134/ -
Zhang J, Hu S, Luo X, Huang C, Cao Q.
Causal association of juvenile idiopathic arthritis-associated uveitis with depression and anxiety: a bidirectional Mendelian randomization study.
Int Ophthalmol. 2022 Aug 10. doi: 10.1007/s10792-022-02462-8.
https://pubmed.ncbi.nlm.nih.gov/35947254/ -
Mensink MO, Eijkelkamp N, Veldhuijzen DS, Wulffraat NM.
Feasibility of quantitative sensory testing in juvenile idiopathic arthritis
Pediatr Rheumatol Online J. 2022 Aug 9;20(1):63. doi: 10.1186/s12969-022-00715-5.
https://pubmed.ncbi.nlm.nih.gov/35945540/ -
Cetrelli L, Bletsa A, Lundestad A, Gil EG, Fischer J, Halbig J, Frid P, Angenete O, Lillevoll I, Rosén A, Tylleskär KB, Luukko K, Nordal E, Åstrøm AN, Skeie MS, Feuerherm AJ, Sen A, Rygg M.
Vitamin D, oral health, and disease characteristics in juvenile idiopathic arthritis: a multicenter cross-sectional study.
BMC Oral Health. 2022 Aug 8;22(1):333. doi: 10.1186/s12903-022-02349-1.
https://pubmed.ncbi.nlm.nih.gov/35941635/ -
Weiss JE.
Prediction model for juvenile idiopathic arthritis: Challenges and opportunities
J Pediatr. 2022 Aug 5:S0022-3476(22)00706-5. doi: 10.1016/j.jpeds.2022.07.045.
https://pubmed.ncbi.nlm.nih.gov/35934127/ -
Dąbkowska K, Wojdas M, Kuźnik-Trocha K, Wisowski G, Gruenpeter A, Komosińska-Vassev K, Olczyk K, Winsz-Szczotka K.
GAAGs, COMP, and YKL-40 as Potential Markers of Cartilage Turnover in Blood of Children with Juvenile Idiopathic Arthritis Treated with Etanercept-Relationship with ADAMTS4, ADAMTS5, and PDGF-BB.
J Clin Med. 2022 Aug 29;11(17):5069. doi: 10.3390/jcm11175069.
https://pubmed.ncbi.nlm.nih.gov/36079004/ -
Zeller L, Tyrrell PN, Wang S, Fischer N, Haas JP, Hügle B.
α2-fraction and haptoglobin as biomarkers for disease activity in oligo- and polyarticular juvenile idiopathic arthritis
Pediatr Rheumatol Online J. 2022 Aug 13;20(1):66. doi: 10.1186/s12969-022-00721-7.
https://pubmed.ncbi.nlm.nih.gov/35964131/
JULIO 2022
-
Gerss J, Tedy M, Klein A, Horneff G, Miranda-Garcia M, Kessel C, Holzinger D, Stanevica V, Swart JF, Cabral DA, Brunner HI, Foell D.
Prevention of disease flares by risk-adapted stratification of therapy withdrawal in juvenile idiopathic arthritis: results from the PREVENT-JIA trial.
Ann Rheum Dis. 2022 Jul;81(7):990-997. doi: 10.1136/annrheumdis-2021-222029.
https://pubmed.ncbi.nlm.nih.gov/35260388/ -
Srinivasalu H, Oliver M, Stoll ML, Weiss PF, Colbert RA; CARRA Juvenile Spondyloarthritis Workgroup.
Survey of current practices in the management of anti-TNF failure in juvenile spondyloarthritis.
Clin Exp Rheumatol. 2022 Jul;40(7):1442-1446. doi: 10.55563/clinexprheumatol/gyrtjo.
https://pubmed.ncbi.nlm.nih.gov/35485412/ -
García-Fernández A, Briones-Figueroa A, Calvo-Sanz L, Andreu-Suárez Á, Boteanu A.
Evaluation of flare rate and reduction strategies for bDMARDs in juvenile idiopathic arthritis: real world data from a single-centre cohort.
Rheumatol Int. 2022 Jul;42(7):1133-1142. doi: 10.1007/s00296-022-05108-1.
https://pubmed.ncbi.nlm.nih.gov/35304642/ -
Lim LSH, Shobhan S, Lokku A, Ringold S, Pullenayegum E.
Latent classes of early response trajectories to biologics initiation in juvenile idiopathic arthritis: an analysis of four trials.
Pediatr Rheumatol Online J. 2022 Jul 30;20(1):57. doi: 10.1186/s12969-022-00719-1.
https://pubmed.ncbi.nlm.nih.gov/35907978/ -
McAlpine SM, Roberts SE, Hargreaves BKV, Bullock C, Ramsey S, Stringer E, Lang B, Huber A, György B, Erdélyi F, Issekutz TB, Dérfalvi B.
Differentially expressed inflammation-regulating microRNAs in oligoarticular juvenile idiopathic arthritis.
J Rheumatol. 2022 Jul 15:jrheum.220160. doi: 10.3899/jrheum.220160. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35840148/ -
Tollisen A, Selvaag AM, Aasland A, Ingebrigtsen T, Sagen J, Lerdal A, Flatø B.
Personally Generated Quality of Life Outcomes in Adults With Juvenile Idiopathic Arthritis.
J Rheumatol. 2022 May 15:jrheum.211245. doi: 10.3899/jrheum.211245. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35569834/ -
Oskarsdottir SA, Kristjansdottir A, Gudmundsdottir JA, Kamban SW, Licina ZA, Gudmundsdottir DB, Gudjonsdottir B.
Musculoskeletal pain and its effect on daily activity and behaviour in Icelandic children and youths with juvenile idiopathic arthritis: a cross-sectional case-control study.
Pediatr Rheumatol Online J. 2022 Jul 15;20(1):48. doi: 10.1186/s12969-022-00706-6.
https://pubmed.ncbi.nlm.nih.gov/35841034/ -
Grazziotin LR, Currie G, Twilt M, IJzerman MJ, Kip MMA, Koffijberg H, Bonsel G, Benseler SM, Swart JF, Vastert SJ, Wulffraat NM, Yeung RSM, Armbrust W, van den Berg JM, Marshall DA.
Factors associated with care- and health-related quality of life of caregivers of children with juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2022 Jul 23;20(1):51. doi: 10.1186/s12969-022-00713-7.
https://pubmed.ncbi.nlm.nih.gov/35870932/ -
Han H, Xiao JH, Weng Y, Liang H, Han C, Yi C, Lin K, Wu H.
Evidence of persistent glial cell dysfunction in the anterior cingulate cortex of juvenile idiopathic arthritis children: a proton MRS study.
Pediatr Rheumatol Online J. 2022 Jul 27;20(1):53. doi: 10.1186/s12969-022-00711-9.
https://pubmed.ncbi.nlm.nih.gov/35897107/ -
Tiller G, Renton WD, Tan J, Whittle S, Avery J, Munro J, Buchbinder R.
Modified Delphi study to identify priority clinical questions for the Australian living guidelines for the management of Juvenile Idiopathic Arthritis.
Pediatr Rheumatol Online J. 2022 Jul 23;20(1):52. doi: 10.1186/s12969-022-00710-w.
https://pubmed.ncbi.nlm.nih.gov/35870945/
JUNIO 2022
-
Furness L, Riley P, Wright N, Banka S, Eyre S, Jackson A, Briggs TA.
Monogenic disorders as mimics of juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2022 Jun 18;20(1):44. doi: 10.1186/s12969-022-00700-y.
https://pubmed.ncbi.nlm.nih.gov/35717242/ -
Shiff NJ, Shrader P, Correll CK, Dennos A, Phillips T, Beukelman T; CARRA Registry Investigators.
Trajectories of disease activity in patients with JIA in the Childhood Arthritis and Rheumatology Research Alliance Registry.
Rheumatology (Oxford). 2022 Jun 15:keac335. doi: 10.1093/rheumatology/keac335. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35703945/ -
Goodman SM, Springer BD, Chen AF, Davis M, Fernandez DR, Figgie M, et al.
2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
Arthritis Rheumatol. 2022 Jun 20. doi: 10.1002/art.42140. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35732511/ -
Marino A, Orsini F, Pregnolato F, Cimaz R.
Tumor Necrosis Factor-α Inhibition Before and After Rituximab Treatment in Juvenile Idiopathic Arthritis: What Shall We Expect? A Pilot Study.
J Rheumatol. 2022 Jun;49(6):654-656. doi: 10.3899/jrheum.211039. Epub 2022 Mar 15.
https://pubmed.ncbi.nlm.nih.gov/35293329/ -
Shipa MR, Heyer N, Mansoor R, Deakin CT, Madenidou AV, Bouraioui A et al.
Adalimumab or etanercept as first line biologic therapy in enthesitis related arthritis (ERA) - a drug-survival single centre study spanning 10 years.
Semin Arthritis Rheum. 2022 Aug;55:152038. doi: 10.1016/j.semarthrit.2022.152038. Epub 2022 May 28.
https://pubmed.ncbi.nlm.nih.gov/35660170/ -
Rahman MM, Laila K, Rahman SA.
Efficacy and safety of tofacitinib in the treatment of refractory cases of polyarticular course juvenile idiopathic arthritis: A study from Bangladesh.
Int J Rheum Dis. 2022 Jun;25(6):678-684. doi: 10.1111/1756-185X.14324. Epub 2022 Apr 18.
https://pubmed.ncbi.nlm.nih.gov/35435319/ -
Oen K, Toupin-April K, Feldman BM, Berard RA, Duffy CRM, Tucker LB et al.
Validation of the parent global assessment as a health-related quality of life measure in juvenile idiopathic arthritis: Results from ReACCh-Out.
Rheumatology (Oxford). 2022 Jun 17;keac350. doi: 10.1093/rheumatology/keac350. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35713497/ -
Akca UK, Batu ED, Sener S, Balik Z, Cuceoglu MK, Atalay E, Basaran O, Bilginer Y, Ozen S.
The performances of the ILAR, ASAS, and PRINTO classification criteria in ERA patients: a comparison study.
Clin Rheumatol. 2022 Jun;41(6):1785-1792. doi: 10.1007/s10067-022-06080-8. Epub 2022 Jan 29.
https://pubmed.ncbi.nlm.nih.gov/35091782/ -
Storwick JA, Brett AC, Buhler K, Chin A, Schmeling H, Johnson NA, Fritzler MJ, Choi MY.
Prevalence and titres of antinuclear antibodies in juvenile idiopathic arthritis: A systematic review and meta-analysis.
Autoimmun Rev. 2022 Jun;21(6):103086. doi: 10.1016/j.autrev.2022.103086. Epub 2022 Apr 6.
https://pubmed.ncbi.nlm.nih.gov/35398272/ -
Majumder S, Guleria S, Aggarwal A.
IL-36γ in enthesitis-related juvenile idiopathic arthritis and its association with disease activity.
Clin Exp Immunol. 2022 Jun 11;208(2):212-219. doi: 10.1093/cei/uxac027.
https://pubmed.ncbi.nlm.nih.gov/35325069/ -
McKenna D, McLaughlin D, Campbell C, Mulholland M, Thompson A, Loughran C, Jackson P, Rooney M.
Fifteen-minute guide to managing oligoarticular juvenile idiopathic arthritis.
Arch Dis Child Educ Pract Ed. 2022 Jun;107(3):175-181. doi: 10.1136/archdischild-2020-321088. Epub 2021 Jun 3.
https://pubmed.ncbi.nlm.nih.gov/34083213/ -
Kostik MM, Gaidar EV, Sorokina LS, Avrusin IS, Nikitina TN, Isupova EA et al.
Uveitis Is a Risk Factor for Juvenile Idiopathic Arthritis' Significant Flare in Patients Treated With Biologics.
Front Pediatr. 2022 Jun 15;10:849940. doi: 10.3389/fped.2022.849940. eCollection 2022.
https://pubmed.ncbi.nlm.nih.gov/35783325/ -
Taxter A, Donaldson BC, Rigdon J, Harry O.
Association Between Patient-Reported Outcomes and Treatment Failure in Juvenile Idiopathic Arthritis.
ACR Open Rheumatol. 2022 Jun 17. doi: 10.1002/acr2.11444. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35715962/ - Keskitalo PL, Kangas SM, Sard S, Pokka T, Glumoff V, Kulmala P, Vähäsalo P.
Myeloid-related protein 8/14 in plasma and serum in patients with new-onset juvenile idiopathic arthritis in real-world setting in a single center.
Pediatr Rheumatol Online J. 2022 Jun 16;20(1):42. doi: 10.1186/s12969-022-00701-x.
https://pubmed.ncbi.nlm.nih.gov/35710418/
MAYO 2022
-
Chang MH, Bocharnikov AV, Case SM, Todd M, Laird-Gion J, Alvarez-Baumgartner M, Nigrovic PA.
Patterns of arthritis flare reveal joint-specific memory together with sustained risk for new joint accumulation.
Arthritis Rheumatol. 2022 May 23. doi: 10.1002/art.42240. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35606924/ -
Kip MMA, de Roock S, Currie G, Marshall DA, Grazziotin LR, Twilt M, et al
Pharmacological treatment patterns in patients with juvenile idiopathic arthritis in the Netherlands: a real-world data analysis.
Rheumatology (Oxford). 2022 May 18:keac299. doi: 10.1093/rheumatology/keac299. Online ahead of print..
https://pubmed.ncbi.nlm.nih.gov/35583252/ -
Brunello F, Tirelli F, Pegoraro L, Dell'Apa F, Alfisi A, Calzamatta G, Folisi C, Zulian F.
New Insights on Juvenile Psoriatic Arthritis.
Front Pediatr. 2022 May 26;10:884727. doi: 10.3389/fped.2022.884727.
https://pubmed.ncbi.nlm.nih.gov/35722498/ -
Smith AD, Saqib B, Lee RR, Shoop-Worrall S, Hyrich KL, McDonagh JE, Cordingley L.
Is time a healer? How quality of life changes over time reported by parents of children and young people with Juvenile Idiopathic Arthritis.
Rheumatology (Oxford). 2022 May 24:keac312. doi: 10.1093/rheumatology/keac312. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35608307/ -
Tollisen A, Selvaag AM, Aasland A, Ingebrigtsen T, Sagen J, Lerdal A, Flatø B.
Personally Generated Quality of Life Outcomes in Adults With Juvenile Idiopathic Arthritis.
J Rheumatol. 2022 May 15:jrheum.211245. doi: 10.3899/jrheum.211245. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35569834/
ABRIL 2022
-
Sumner EJ, Almeida B, Palman J, Bale P, Heard C, Holzinger D, Roth J, Foell D, Robinson E, Ursu S, Wallace C, Gilmour K, Wedderburn LR, Ralph E.
Use of MRP8/14 in clinical practice as a predictor of outcome after methotrexate withdrawal in patients with juvenile idiopathic arthritis.
Clin Rheumatol. 2022 Apr 29. doi: 10.1007/s10067-022-06165-4. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35486225/ -
Mannion ML, Cron RQ.
Therapeutic strategies for treating juvenile idiopathic arthritis.
Curr Opin Pharmacol. 2022 Apr 20;64:102226. doi: 10.1016/j.coph.2022.102226. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35461129/ -
Torres-Fernandez D, Perez-Heras I, Fernandez-Manso B, Galán Del Río P, Gonzalez-Granado LI, de Inocencio J.
IgA deficiency and autoimmune comorbidities in Juvenile Idiopathic Arthritis.
An Pediatr (Engl Ed). 2022 Apr 19:S2341-2879(22)00050-3. doi: 10.1016/j.anpede.2022.03.004. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35459637/ -
van Straalen JW, van Stigt Thans M, Wulffraat NM, de Roock S, Swart JF.
A diagnostic prediction model for separating juvenile idiopathic arthritis and chronic musculoskeletal pain syndrome.
J Pediatr. 2022 Apr 20:S0022-3476(22)00344-4. doi: 10.1016/j.jpeds.2022.04.029. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35460700/ -
Naddei R, Di Gennaro S, Guarino A, Troncone R, Alessio M, Discepolo V.
In a large Juvenile Idiopathic Arthritis (JIA) cohort, concomitant celiac disease is associated with family history of autoimmunity and a more severe JIA course: a retrospective study.
Pediatr Rheumatol Online J. 2022 Apr 22;20(1):31. doi: 10.1186/s12969-022-00689-4.
https://pubmed.ncbi.nlm.nih.gov/35459143/ -
de Sonnaville WFC, Steenks MH, Speksnijder CM, Wulffraat NM, Rosenberg AJWP.
Challenging the silent temporomandibular joint paradigm in children with juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2022 Apr 2;20(1):22. doi: 10.1186/s12969-022-00681-y.
https://pubmed.ncbi.nlm.nih.gov/35366915/
MARZO 2022
-
Chun A, Muhammad LN, De Ranieri D.
Comparison of efficacy between triamcinolone acetonide and triamcinolone hexacetonide for intraarticular therapy in juvenile idiopathic arthritis: a retrospective analysis.
BMC Rheumatol. 2022 Mar 31;6(1):18. doi: 10.1186/s41927-022-00249-z.
https://pubmed.ncbi.nlm.nih.gov/35354497/ -
Lee JJY, Eng SWM, Guzman J, Duffy CM, Tucker LB, Oen K, Yeung RSM, Feldman BM; ReACCh-Out Investigators.
A comparison of Juvenile Idiopathic Arthritis classification systems with the Research in Arthritis in Canadian Children, Emphasizing Outcomes (ReACCh-Out) cohort.
Arthritis Rheumatol. 2022 Mar 14. doi: 10.1002/art.42113. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35289119/ -
Fingerhutová Š, Jančová E, Doležalová P.
Anakinra in Paediatric Rheumatology and Periodic Fever Clinics: Is the Higher Dose Safe?
Front Pediatr. 2022 Mar 7;10:823847. doi: 10.3389/fped.2022.823847
https://pubmed.ncbi.nlm.nih.gov/35321008/ -
Alongi A, Giancane G, Naddei R, Natoli V, Ridella F, Burrone M, Rosina S, Chedeville G, Alexeeva E, Horneff G, Foeldvari I, Filocamo G, Constantin T, Ruperto N, Ravelli A, Consolaro A; Pediatric Rheumatology International Trials Organization (PRINTO).
Drivers of non-zero physician global scores during periods of inactive disease in juvenile idiopathic arthritis.
RMD Open. 2022 Mar;8(1):e002042. doi: 10.1136/rmdopen-2021-002042.
https://pubmed.ncbi.nlm.nih.gov/35256534/
FEBRERO 2022
-
El Tal T, Ryan ME, Feldman BM, Bingham A, Burnham J, Batthish M, Bullock D, Ferraro K, Gilbert M, Gillispie-Taylor M, Gottlieb B, Harris JG, Hazen M, Laxer RM, Lee TC, Lovell D, Mannion M, Noonan L, Oberle E, Taylor J, Weiss JE, Yildirim Toruner C, Morgan EM.
Consensus Approach to a Treat to Target Strategy in Juvenile Idiopathic Arthritis Care: Report from the 2020 PR-COIN Consensus Conference.
J Rheumatol. 2022 Feb 1:jrheum.210709. doi: 10.3899/jrheum.210709.
https://pubmed.ncbi.nlm.nih.gov/35105705/ -
Schulz C, Fuehner S, Schlüter B, Fobker M, Sengler C, Klotsche J, Niewerth M, Minden K, Foell D.
Prevalence of autoantibodies in patients with juvenile idiopathic arthritis: results from the German inception cohort ICON-JIA.
Pediatr Rheumatol Online J. 2022 Feb 2;20(1):8. doi: 10.1186/s12969-022-00668-9.
https://pubmed.ncbi.nlm.nih.gov/35109858/ -
Poddighe D, Romano M, Dossybayeva K, Abdukhakimova D, Galiyeva D, Demirkaya E.J.
Celiac Disease in Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Disorders.
Clin Med. 2022 Feb 18;11(4):1089. doi: 10.3390/jcm11041089
https://pubmed.ncbi.nlm.nih.gov/35207358/ -
Zic C.
Considerations for the Primary Care Provider Caring for Patients with Juvenile Idiopathic Arthritis Receiving Biologic Therapy.
Pediatr Ann. 2022 Feb;51(2):e54-e56. doi: 10.3928/19382359-20220118-02. Epub 2022 Feb 1.
https://pubmed.ncbi.nlm.nih.gov/35156891/ -
McHugh A, Chan A, Herrera C, Park JM, Balboni I, Gerstbacher D, Hsu JJ, Lee T, Thienemann M, Frankovich J.
Profiling Behavioral and Psychological Symptoms in Children undergoing treatment for Spondyloarthritis and Polyarthritis.
J Rheumatol. 2022 Feb 1:jrheum.210489. doi: 10.3899/jrheum.210489.
https://pubmed.ncbi.nlm.nih.gov/35105715/ -
Collin M, Ernberg M, Christidis N, Hedenberg-Magnusson B.
Salivary biomarkers in children with juvenile idiopathic arthritis and healthy age-matched controls: a prospective observational study.
Sci Rep. 2022 Feb 25;12(1):3240. doi: 10.1038/s41598-022-07233-0.
https://pubmed.ncbi.nlm.nih.gov/35217774/ -
Zhang J.
Mendelian Randomization Study Implies Causal Linkage Between Telomere Length and Juvenile Idiopathic Arthritis in a European Population.
J Inflamm Res. 2022 Feb 15;15:977-986. doi: 10.2147/JIR.S354619.
https://pubmed.ncbi.nlm.nih.gov/35210806/ -
Chen G, Deutsch GH, Schulert G, Zheng H, Jang S, Trapnell B, Lee P, Macaubas C, Ho K, Schneider C, Saper VE, de Jesus AA, Krasnow M, Grom A, Goldbach-Mansky R, Khatri P, Mellins ED, Canna SW.
Serum proteome analysis of systemic JIA and related lung disease identifies distinct inflammatory programs and biomarkers.
Arthritis Rheumatol. 2022 Feb 21. doi: 10.1002/art.42099. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35189047/ -
Al-Naimi A, Toma H, Hamad SG, Ben Omran T.
Farber Disease Mimicking Juvenile Idiopathic Arthritis: The First Reported Case in Qatar and Review of the Literature.
Case Rep Genet. 2022 Feb 10;2022:2555235. doi: 10.1155/2022/2555235.
https://pubmed.ncbi.nlm.nih.gov/35186337/ -
Lewis KA, Osier N, Carrasco R, Chiou J, Carter P, Garcia A, Flowers E, Gennatas ED, Nguyen C, Rana A, Brown SA, Tiziani S.
Serine, N-acetylaspartate differentiate adolescents with juvenile idiopathic arthritis compared with healthy controls: a metabolomics cross-sectional study.
Pediatr Rheumatol Online J. 2022 Feb 10;20(1):12. doi: 10.1186/s12969-022-00672-z.
https://pubmed.ncbi.nlm.nih.gov/35144633/ - Butler S, Sculley D, Santos D, Fellas A, Gironès X, Singh-Grewal D, Coda A.
Effectiveness of eHealth and mHealth Interventions Supporting Children and Young People Living With Juvenile Idiopathic Arthritis: Systematic Review and Meta-analysis.
J Med Internet Res. 2022 Feb 2;24(2):e30457. doi: 10.2196/30457.
https://pubmed.ncbi.nlm.nih.gov/35107431/
ENERO 2022
-
Verstegen RHJ, Shrader P, Balevic SJ, Beukelman T, Correll C, Dennos A, Phillips T, Feldman BM; CARRA Registry investigators.
Dosing Variation at Initiation of Adalimumab and Etanercept is not Associated with Clinical Outcomes in Juvenile Idiopathic Arthritis: A Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry study.
Arthritis Care Res (Hoboken). 2022 Jan 18. doi: 10.1002/acr.24859.
https://pubmed.ncbi.nlm.nih.gov/35040593/ -
Glerup M, Arnstad ED, Rypdal V, Peltoniemi S, Aalto K, Rygg M, Nielsen S, Fasth A, Berntson L, Nordal E, Herlin T; Nordic Study Group of Pediatric Rheumatology (NoSPeR).
Changing patterns in treatment, remission status and categories in a long-term Nordic cohort study of juvenile idiopathic arthritis.
Arthritis Care Res (Hoboken). 2022 Jan 10. doi: 10.1002/acr.24857.
https://pubmed.ncbi.nlm.nih.gov/35015381/ -
Martini A, Lovell DJ, Albani S, Brunner HI, Hyrich KL, Thompson SD, Ruperto N.
Juvenile idiopathic arthritis.
Nat Rev Dis Primers. 2022 Jan 27;8(1):5. doi: 10.1038/s41572-021-00332-8.
https://pubmed.ncbi.nlm.nih.gov/35087087/ -
Zhao Y, Sullivan E, Son MB, Beukelman T.
Psoriasis rate is increased by the exposure to TNF inhibition in children with JIA.
Ann Rheum Dis. 2022 Jan 27:annrheumdis-2021-221694. doi: 10.1136/annrheumdis-2021-221694.
https://pubmed.ncbi.nlm.nih.gov/35086815/ -
Kaya Akca U, Batu ED, Sener S, Balik Z, Kasap Cuceoglu M, Atalay E, Basaran O, Bilginer Y, Ozen S.
The performances of the ILAR, ASAS, and PRINTO classification criteria in ERA patients: a comparison study.
Clin Rheumatol. 2022 Jan 29. doi: 10.1007/s10067-022-06080-8.
https://pubmed.ncbi.nlm.nih.gov/35091782/ -
Gavra H, Tirosh I, Spielman S, Greenberger S, Amarylio G, Harel L, Ben-Amitai D, Avitan-Hersh E, Yonatan BA.
Validation of the psoriasis epidemiology screening tool (PEST) and the new early arthritis for psoriatic patients (EARP) in pediatric population: pilot study.
Clin Rheumatol. 2022 Jan 14. doi: 10.1007/s10067-021-06009-7.
https://pubmed.ncbi.nlm.nih.gov/35028742/ -
Rubin S, Ohana O, Goldberg O, Peled O, Gendler Y, Habot-Wilner Z, Levinsky Y, Tal R, Harel L, Amarilyo G.
The efficacy and safety of intra-articular injection of triamcinolone acetonide versus triamcinolone hexacetonide for treatment of juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2022 Jan 29;20(1):5. doi: 10.1186/s12969-022-00666-x.
https://pubmed.ncbi.nlm.nih.gov/35093116/ -
van Dijkhuizen EHP, Ridella F, Naddei R, Trincianti C, Avrusin I, Mazzoni M, Sutera D, Ayaz NA, Penades IC, Constantin T, Herlin T, Oliveira SK, Rygg M, Sanner H, Susic G, Sztajnbok F, Varbanova B, Ruperto N, Ravelli A, Consolaro A; Paediatric Rheumatology International Trials Organisation (PRINTO).
Validity and reliability of four parent/patient reported outcome measures for juvenile idiopathic arthritis remote monitoring.
Arthritis Care Res (Hoboken). 2022 Jan 10. doi: 10.1002/acr.24855.
https://pubmed.ncbi.nlm.nih.gov/35015379/ -
Yarwood A, Shoop-Worrall S, Lopez-Isac E, Smith SL, Morris AP; Childhood Arthritis Prospective Study (CAPS) group, Bowes JD, Tordoff M, Hyrich KL, Thomson W, Eyre S.
No evidence that genetic predictors of susceptibility predict changes in core outcomes in JIA.
Rheumatology (Oxford). 2022 Jan 7:keab942. doi: 10.1093/rheumatology/keab942.
https://pubmed.ncbi.nlm.nih.gov/35015833/ -
Van Der Heijden H, Fatou B, Sibai D, Hoyt K, Taylor M, Cheung K, Lemme J, Cay M, Goodlett B, Lo J, Hazen MM, Halyabar O, Meidan E, Schreiber R, Jaimes C, Ecklund K, Henderson LA, Chang MH, Nigrovic PA, Sundel RP, Steen H, Upadhyay J.
Proteomics based markers of clinical pain severity in juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2022 Jan 15;20(1):3. doi: 10.1186/s12969-022-00662-1.
https://pubmed.ncbi.nlm.nih.gov/35033099/ -
Fischer J, Dirks J, Klaussner J, Haase G, Holl-Wieden A, Hofmann C, Hackenberg S, Girschick H, Morbach H.
Effect of Clonally Expanded PD-1high CXCR5-CD4+ Peripheral T Helper Cells on B Cell Differentiation in the Joints of Patients With Antinuclear Antibody-Positive Juvenile Idiopathic Arthritis.
Arthritis Rheumatol. 2022 Jan;74(1):150-162. doi: 10.1002/art.41913.
https://pubmed.ncbi.nlm.nih.gov/34196496/
DICIEMBRE 2021
-
Młyńczyk J, Abramowicz P, Stawicki MK, Konstantynowicz J.
Non-disease specific patient-reported outcome measures of health-related quality of life in juvenile idiopathic arthritis: a systematic review of current research and practice.
Rheumatol Int. 2021 Dec 31;1-13. doi: 10.1007/s00296-021-05077-x. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34971434/ -
Jones JT, Smith C, Becker ML, Lovell D, CARRA Registry Investigators.
Down Syndrome-Associated Arthritis Cohort in the New Childhood Arthritis and Rheumatology Research Alliance Registry: Clinical Characteristics, Treatment, and Outcomes.
Arthritis Care Res (Hoboken). 2021 Dec;73(12):1739-1745. doi: 10.1002/acr.24418.
https://pubmed.ncbi.nlm.nih.gov/33242376/ -
Giancane G, Campone C, Gicchino MF, Alongi A, Bava C, Rosina S et al.
Determinants of Discordance Between Criteria for Inactive Disease and Low Disease Activity in Juvenile Idiopathic Arthritis.
Arthritis Care Res (Hoboken). 2021 Dec;73(12):1722-1729. doi: 10.1002/acr.24415. Epub 2021 Oct 11.
https://pubmed.ncbi.nlm.nih.gov/33242352/ -
Bhardwaj U, Bagri NK, Lodha R, Kabra SK, Velpandian T, Pandey RV.
Efficacy of Pulse Dexamethasone in non-systemic Juvenile Idiopathic Arthritis: a double-blind randomised controlled trial.
Rheumatology (Oxford). 2021 Dec 9;keab914. doi: 10.1093/rheumatology/keab914. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34888654/ -
Garner AJ, Saatchi R, Ward O, Hawley DP.
Juvenile Idiopathic Arthritis: A Review of Novel Diagnostic and Monitoring Technologies.
Healthcare (Basel). 2021 Dec 4;9(12):1683. doi: 10.3390/healthcare9121683.
https://pubmed.ncbi.nlm.nih.gov/34946409/ -
Sol Funk R, Becker ML.
Metabolomic Profiling Identifies Exogenous and Microbiota-Derived Metabolites as Markers of Methotrexate Efficacy in Juvenile Idiopathic Arthritis.
Front Pharmacol. 2021 Dec 9;12:768599. doi: 10.3389/fphar.2021.768599. eCollection 2021.
https://pubmed.ncbi.nlm.nih.gov/34955838/ -
Bagri NK, Karmakar S, Haldar P, Lodha R, Kabra SK.
Role of Serum MRP8/14 in Predicting Response to Methotrexate in Children With Juvenile Idiopathic Arthritis.
J Clin Rheumatol. 2021 Dec 1;27(8):e336-e341. doi: 10.1097/RHU.0000000000001406.
https://pubmed.ncbi.nlm.nih.gov/32658390/
NOVIEMBRE 2021
-
Ruperto N, Brunner HI, Synoverska O, Ting TV, Mendoza CA, Spindler A, et al for the Paediatric Rheumatology International Trials Organisation (PRINTO) and Pediatric Rheumatology Collaborative Study Group (PRCSG).
Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial.
Lancet. 2021 Nov 27;398(10315):1984-1996. doi: 10.1016/S0140-6736(21)01255-1.
https://pubmed.ncbi.nlm.nih.gov/34767764/ -
Mora JR, Wong R, Shaikh M, Askelson M.
Analysis of the Immunogenicity from Abatacept-Treated Pediatric Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: Findings From Two Phase III Clinical Trials.
ACR Open Rheumatol. 2021 Nov 18. doi: 10.1002/acr2.11375. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34792858/ -
Balevic SJ, Becker ML, Gonzalez D, Funk RS.
Low Etanercept Concentrations in Children With Obesity and Juvenile Idiopathic Arthritis.
J Pediatr Pharmacol Ther. 2021;26(8):809-814. doi: 10.5863/1551-6776-26.8.809.
https://pubmed.ncbi.nlm.nih.gov/34790070/ -
Oliveira Ramos F, Rodrigues A, Magalhaes Martins F, Melo AT, Aguiar F, Brites L, et al.
Health-related quality of life and disability in adults with juvenile idiopathic arthritis: comparison with adult-onset rheumatic diseases.
RMD Open. 2021 Nov;7(3):e001766. doi: 10.1136/rmdopen-2021-001766.
https://pubmed.ncbi.nlm.nih.gov/34819385/ -
Gomes CMF, Terreri MT, Moraes-Pinto MI, Pinheiro MM.
Performance of 4 methods for screening of latent tuberculosis infection in patients with chronic inflammatory arthritis under TNFα inhibitors: a 24-month prospective study.
Adv Rheumatol. 2021 Nov 27;61(1):71. doi: 10.1186/s42358-021-00226-z.
https://pubmed.ncbi.nlm.nih.gov/34838126/ -
Reiser C, Zeltner NA, Rettenbacher B, Baumgaertner P, Huemer M, Huemer C.
Explaining juvenile idiopathic arthritis to paediatric patients using illustrations and easy-to-read texts: improvement of disease knowledge and adherence to treatment.
Pediatr Rheumatol Online J. 2021 Nov 8;19(1):158. doi: 10.1186/s12969-021-00644-9.
https://pubmed.ncbi.nlm.nih.gov/34749738/ -
Lundberg V, Eriksson C, Lind T, Coyne I, Fjellman-Wiklund A.
How children with juvenile idiopathic arthritis view participation and communication in healthcare encounters: a qualitative study.
Pediatr Rheumatol Online J. 2021 Nov 2;19(1):156. doi: 10.1186/s12969-021-00642-x.
https://pubmed.ncbi.nlm.nih.gov/34727931/ -
Hügle B, Krumrey-Langkammerer M, Haas JP.
Infection with SARS-CoV-2 causes flares in patients with juvenile idiopathic arthritis in remission or inactive disease on medication.
Pediatr Rheumatol Online J. 2021 Nov 29;19(1):163. doi: 10.1186/s12969-021-00653-8.
https://pubmed.ncbi.nlm.nih.gov/34844609/ -
Roß J, Foeldvari I, Krajewski KL, Butscheidt S, Beil FT, Stücker R, Spiro AS.
Does Juvenile Idiopathic Arthritis Affect the Course of Legg-Calvé-Perthes Disease? A Case-Control Study with a Mean Follow-Up of 8 Years.
Children (Basel). 2021 Nov 5;8(11):1014. doi: 10.3390/children8111014.
https://pubmed.ncbi.nlm.nih.gov/34828727/ -
Omar AA, Ahmed S, Rodrigues JC, Kayiza A, Owino L.
Progressive pseudorheumatoid dysplasia misdiagnosed as juvenile idiopathic arthritis: a case report.
J Med Case Rep. 2021 Nov 8;15(1):551. doi: 10.1186/s13256-021-03082-z.
https://pubmed.ncbi.nlm.nih.gov/34749805/ -
Clarke SL, Mitchell RE, Sharp GC, Ramanan AV, Relton CL.
Vitamin D levels and risk of juvenile idiopathic arthritis: A Mendelian randomization study.
Arthritis Care Res (Hoboken). 2021 Nov 8. doi: 10.1002/acr.24815. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34748291/
OCTUBRE 2021
-
Wu J, Wang L, Xu Y, Zhang Z, Yan X, An Y, Zhang Y, Tang X.
Multicentric Carpo-Tarsal Osteolysis Syndrome Mimicking Juvenile Idiopathic Arthritis: Two case reports and review of the literature.
Front Pediatr. 2021 Oct 15;9:745812. doi: 10.3389/fped.2021.745812. eCollection 2021.
https://pubmed.ncbi.nlm.nih.gov/34722426/ -
Horneff G, Klein A, Láday M, Lunt M, de Roock S, Ruperto N, Schoemaker C, Vijatov-Djuric G, Vojinovic J, Vougiouka O, Wulffraat NM; UK JIA Biologics Registers Investigators Group; Paediatric Rheumatology International Trials Organisation (PRINTO), Hyrich KL, Minden K, Swart JF.
Burden of comorbid conditions in children and young people with juvenile idiopathic arthritis: a collaborative analysis of 3 JIA registries.
Rheumatology (Oxford). 2021 Oct 6:keab641. doi: 10.1093/rheumatology/keab641. Online ahead of print.PMID:34613385
https://pubmed.ncbi.nlm.nih.gov/34613385/ -
García-Rodríguez F, Gamboa-Alonso A, Jiménez-Hernández S, Ochoa-Alderete L, Barrientos-Martínez VA, Alvarez-Villalobos NA, Luna-Ruíz GA, Peláez-Ballestas I, Villarreal-Treviño AV, de la O-Cavazos ME, Rubio-Pérez N.
Economic impact of Juvenile Idiopathic Arthritis: a systematic review.
Pediatr Rheumatol Online J. 2021 Oct 9;19(1):152. doi: 10.1186/s12969-021-00641-y.
https://pubmed.ncbi.nlm.nih.gov/34627296/ -
Cavagnetto D, Abate A, Caprioglio A, Cressoni P, Maspero C.
Three-dimensional volumetric evaluation of the different mandibular segments using CBCT in patients affected by juvenile idiopathic arthritis: a cross-sectional study.
Prog Orthod. 2021 Oct 1;22(1):32. doi: 10.1186/s40510-021-00380-6.
https://pubmed.ncbi.nlm.nih.gov/34595615/
SEPTIEMBRE 2021
-
Kearsley-Fleet L, Klotsche J, van Straalen JW, Costello W, D'Angelo G, Giancane G, Trincianti C, Van Dijkhuizen EHP, Alongi A, Mazzoni M, Swart JF, Nikishina I, Lahdenne P, Rutkowska-Sak L, Avcin T, Quartier P, Panaviene V, Uziel Y, Pruunsild C, Vargova V, Vilaiyuk S, Dolezalova P, Ringold S, Garrone M, Ruperto N, Ravelli A, Consolaro A; Paediatric Rheumatology International Trials Organisation.
Definition and Validation of the American College of Rheumatology 2021 Juvenile Arthritis Disease Activity Score Cutoffs for Disease Activity States in Juvenile Idiopathic Arthritis.
Arthritis Rheumatol. 2021 Sep 28. doi: 10.1002/art.41879. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34582120/ -
Costello R, McDonagh J, Hyrich K, Humphreys J.
Incidence and prevalence of Juvenile Idiopathic Arthritis in the United Kingdom 2000-2018: results from the Clinical Practice Research Datalink.
Rheumatology (Oxford). 2021 Sep 29:keab714. doi: 10.1093/rheumatology/keab714. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34586398/ -
van Straalen JW, Krol RM, Giancane G, Panaviene V, Ailioaie LM, Doležalová P, Cattalini M, Susic G, Sztajnbok F, Maritsi D, Constantin T, Sawhney S, Rygg M, Oliveira SK, Nordal EB, Saad-Magalhaes C, Rubio-Perez N, Jelusic M, de Roock S, Wulffraat NM, Ruperto N, Swart JF; Paediatric Rheumatology International Trials Organisation (PRINTO).
Increased incidence of inflammatory bowel disease on etanercept in juvenile idiopathic arthritis regardless of concomitant methotrexate use.
Rheumatology (Oxford). 2021 Sep 11:keab678. doi: 10.1093/rheumatology/keab678. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34508559/ -
Filosco F, Giallongo A, Leonardi S, Tomaselli V, Barone P.
Early intra-articular corticosteroid injection is predictor of remission of juvenile idiopathic arthritis.
Minerva Pediatr (Torino). 2021 Sep 13. doi: 10.23736/S2724-5276.21.06343-6. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34515444/ -
Grazziotin LR, Currie G, Twilt M, Ijzerman MJ, Kip MMA, Koffijberg H, et al.; UCAN CAN-DU, UCAN CURE consortia.
Evaluation of Real-World Healthcare Resource Utilization and Associated Costs in Children with Juvenile Idiopathic Arthritis: A Canadian Retrospective Cohort Study.
Rheumatol Ther. 2021 Sep;8(3):1303-1322. doi: 10.1007/s40744-021-00331-x. Epub 2021 Jul 18.
https://pubmed.ncbi.nlm.nih.gov/34275124/ -
Kindgren E, Ludvigsson J.
Infections and antibiotics during fetal life and childhood and their relationship to juvenile idiopathic arthritis: a prospective cohort study.
Pediatr Rheumatol Online J. 2021 Sep 16;19(1):145. doi: 10.1186/s12969-021-00611-4.
https://pubmed.ncbi.nlm.nih.gov/34530851/ -
Lassoued Ferjani H, Maatallah K, Miri S, Triki W, Nessib DB, Kaffel D, Hamdi W.
Enthesitis-related arthritis: monitoring and specific tools.
J Pediatr (Rio J). 2021 Sep 28:S0021-7557(21)00121-2. doi: 10.1016/j.jped.2021.08.002. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34597529/ -
Saidi O, Rochette E, Bourdier P, Ratel S, Merlin E, Pereira B, Duché P.
Sleep in children and adolescents with juvenile idiopathic arthritis: a systematic review and meta-analysis of case-control studies.
Sleep. 2021 Sep 15:zsab233. doi: 10.1093/sleep/zsab233. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34525202/ -
Arif CA, Randy C, Matthew S, Serhat S, Brian K, Peter W, Jue W, Viet V, Linh T, How KC.
Comparison of the condyle-fossa relationship and resorption between patients with and without Juvenile Idiopathic Arthritis (JIA).
J Oral Maxillofac Surg. 2021 Sep 12:S0278-2391(21)01114-9. doi: 10.1016/j.joms.2021.09.004. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34627744/ -
Rajendiran A, Klemm P, Schippers A, Scheufen A, Schwarz T, Peitz J, Brandenburg LO, Wagner N, Consolaro A, Raggi F, Bosco MC, Luedde T, Foell D, Denecke B, Horneff G, Ohl K, Tenbrock K.
miR-23a contributes to T cellular redox metabolism in juvenile idiopathic oligoarthritis.
Rheumatology (Oxford). 2021 Sep 24:keab709. doi: 10.1093/rheumatology/keab709. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34559194/ -
Yamazaki S, Shimizu M, Akutsu Y, Shimbo A, Mori M
Tacrolimus as an alternative treatment for patients with juvenile idiopathic arthritis.
Mod Rheumatol. 2021 Sep 20:roab055. doi: 10.1093/mr/roab055. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34918100/
AGOSTO 2021
-
Thiele F, Klein A, Hospach A, Windschall D, Mrusek S, Ruehlmann JM, Horneff G.
Efficacy and Safety of Etanercept Biosimilars Compared with the Originator for Treatment of Juvenile Arthritis: A Prospective Observational Study.
ACR Open Rheumatol. 2021 Aug 27. doi: 10.1002/acr2.11325. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34449981/ -
Beukelman T, Lougee A, Matsouaka RA, Collier D, Rumsey DG, Schenfeld J, Stryker S, Twilt M, Kimura Y; CARRA Registry Investigators.
Patterns of etanercept use in juvenile idiopathic arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry.
Pediatr Rheumatol Online J. 2021 Aug 21;19(1):131. doi: 10.1186/s12969-021-00625-y.
https://pubmed.ncbi.nlm.nih.gov/34419107/ -
Upadhyay J, Lemme J, Cay M, Van Der Heijden H, Sibai D, Goodlett B, Lo J, Hoyt K, Taylor M, Hazen MM, Halyabar O, Meidan E, Schreiber R, Chang MH, Nigrovic PA, Jaimes C, Henderson LA, Ecklund K, Sundel RP.
A multidisciplinary assessment of pain in juvenile idiopathic arthritis.
Semin Arthritis Rheum. 2021 Aug;51(4):700-711. doi: 10.1016/j.semarthrit.2021.05.011.
https://pubmed.ncbi.nlm.nih.gov/34139523/ -
Cardoso I, Frederiksen P, Specht IO, Händel MN, Thorsteinsdottir F, Heitmann BL, Kristensen LE.
Age and Sex Specific Trends in Incidence of Juvenile Idiopathic Arthritis in Danish Birth Cohorts from 1992 to 2002: A Nationwide Register Linkage Study
Int J Environ Res Public Health. 2021 Aug 6;18(16):8331. doi: 10.3390/ijerph18168331.
https://pubmed.ncbi.nlm.nih.gov/34444082/ -
Sahin S, Acari C, Sonmez HE, Kilic FZ, Sag E, Dundar HA, Adrovic A, Demir S, Barut K, Bilginer Y, Sozeri B, Unsal E, Ozen S, Kasapcopur O
Frequency of juvenile idiopathic arthritis and associated uveitis in pediatric rheumatology clinics in Turkey: A retrospective study, JUPITER.
Pediatr Rheumatol Online J. 2021 Aug 23;19(1):134. doi: 10.1186/s12969-021-00613-2.
https://pubmed.ncbi.nlm.nih.gov/34425847/ -
Gil EG, Åstrøm AN, Lie SA, Rygg M, Fischer J, Rosén A, Bletsa A, Luukko K, Shi XQ, Halbig J, Frid P, Cetrelli L, Tylleskär K, Rosendahl K, Skeie MS.
Dental caries in children and adolescents with juvenile idiopathic arthritis and controls: a multilevel analysis.
BMC Oral Health. 2021 Aug 25;21(1):417. doi: 10.1186/s12903-021-01758-y.
https://pubmed.ncbi.nlm.nih.gov/34433437/ - Zaripova LN, Midgley A, Christmas SE, Beresford MW, Baildam EM, Oldershaw RA.
Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches
Pediatr Rheumatol Online J. 2021 Aug 23;19(1):135. doi: 10.1186/s12969-021-00629-8.
https://pubmed.ncbi.nlm.nih.gov/34425842/
JULIO 2021
-
Schiappapietra B, Bava C, Rosina S, Pistorio A, Mongelli F, Pederzoli S, Verazza S, Lanni S, Muratore V, Davì S, Dalprà S, Varnier GC, Bertamino M, Suffia C, Bracciolini G, Giancane G, Consolaro A, Ravelli A.
A prediction rule for polyarticular extension in oligoarticular-onset juvenile idiopathic arthritis.
Clin Exp Rheumatol. 2021 Jul-Aug;39(4):913-919. Epub 2021 May 5. PMID: 34001309.
https://pubmed.ncbi.nlm.nih.gov/34001309/ -
Rumsey DG, Lougee A, Matsouaka R, Collier DH, Schanberg LE, Schenfeld J, Shiff NJ, Stoll ML, Stryker S, Weiss PF, Beukelman T; Childhood Arthritis and Rheumatology Research Alliance Registry Investigators.
Juvenile Spondyloarthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry: High Biologic Use, Low Prevalence of HLA-B27, and Equal Sex Representation in Sacroiliitis.
Arthritis Care Res (Hoboken). 2021 Jul;73(7):940-946. doi: 10.1002/acr.24537. PMID: 33331139.
https://pubmed.ncbi.nlm.nih.gov/33331139/ -
de Sonnaville WFC, Speksnijder CM, Zuithoff NPA, Verkouteren DRC, Wulffraat NW, Steenks MH, Rosenberg AJWP.
Mandibular range of motion in children with juvenile idiopathic arthritis with and without clinically established temporomandibular joint involvement and in healthy children; a cross-sectional study.
Pediatr Rheumatol Online J. 2021 Jul 3;19(1):106. doi: 10.1186/s12969-021-00583-5. PMID: 34217306; PMCID: PMC8254997.
https://pubmed.ncbi.nlm.nih.gov/34217306/ -
Xu D, Zhang Y, Zhang ZY, Tang XM.
Association between high mobility group box 1 protein and juvenile idiopathic arthritis: a prospective longitudinal study.
Pediatr Rheumatol Online J. 2021 Jul 12;19(1):112. doi: 10.1186/s12969-021-00587-1. PMID: 34247641; PMCID: PMC8273958.
https://pubmed.ncbi.nlm.nih.gov/34247641/
JUNIO 2021
-
Silvia Rosina, Valentina Natoli, Stefania Santaniello, Chiara Trincianti, Alessandro Consolaro, Angelo Ravelli.
Novel biomarkers for prediction of outcome and therapeutic response in juvenile idiopathic arthritis.
Expert Rev Clin Immunol. 2021 Jun 17. doi: 10.1080/1744666X.2021.1945441. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34139935/ -
Yukiko Kimura, Laura E Schanberg, George A Tomlinson et al.
The Childhood Arthritis & Rheumatology Research Alliance Start Time Optimization of Biologics in Polyarticular Juvenile Idiopathic Arthritis Study (STOP-JIA): A Comparative Effectiveness Study of CARRA Consensus Treatment Plans for Untreated Polyarticular JIA.
Arthritis Rheumatol. 2021 Jun 8. doi: 10.1002/art.41888. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34105312/ -
Mei Sing Ong, Sarah Ringold, Yukiko Kimura et al.
Improved disease course associated with early initiation of biologics in untreated polyarticular Juvenile Idiopathic Arthritis: A trajectory analysis of the STOP-JIA study.
Arthritis Rheumatol. 2021 Jun 8. doi: 10.1002/art.41892. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34105303/ -
R Naveen, Namita Mohindra, Neeraj Jain, Sanjukta Majumder, Amita Aggarwal.
Hip involvement in children with enthesitis related arthritis (ERA) is associated with poor outcomes in adulthood.
Clin Rheumatol. 2021 Jun 25;1-9. doi: 10.1007/s10067-021-05807-3. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34169374/ -
Liane D Heale, Kristin M Houghton, Elham Rezaei et al.
Clinical and psychosocial stress factors are associated with decline in physical activity over time in children with juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2021 Jun 29;19(1):97. doi: 10.1186/s12969-021-00584-4.
https://pubmed.ncbi.nlm.nih.gov/34187498/ -
Sulaiman M Al-Mayouf, Abeer Alrasheedi, Iman Almsellati et al.
Familial aggregation of juvenile idiopathic arthritis with other autoimmune diseases: Impact on clinical characteristics, disease activity status and disease damage.
Int J Rheum Dis. 2021 Jun 29. doi: 10.1111/1756-185X.14167. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34184820/ -
Lillemor Berntson.
A pilot study of possible anti-inflammatory effects of the specific carbohydrate diet in children with juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2021 Jun 10;19(1):88. doi: 10.1186/s12969-021-00577-3.
https://pubmed.ncbi.nlm.nih.gov/34112181/ -
Colleen Nesbitt, Gregor Kuntze, Clodagh Toomey et al.
Secondary consequences of juvenile idiopathic arthritis in children and adolescents with knee involvement: physical activity, adiposity, fitness, and functional performance.
Rheumatol Int. 2021 Jun 16. doi: 10.1007/s00296-021-04920-5. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34132889/ -
Micol Romano, Valeria Gerloni, Orazio De Lucia et al.
Serum calprotectin (S100A8/9), clinical and ultrasound assessment in patients with juvenile idiopathic arthritis.
Clin Exp Rheumatol. 2021 Jun 8. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34128789/ -
La C, Lê PQ, Ferster A, et al.
Serum calprotectin (S100A8/A9): a promising biomarker in diagnosis and follow-up in different subgroups of juvenile idiopathic arthritis.
RMD Open 2021;7:e001646. doi:10.1136/ rmdopen-2021-001646
https://pubmed.ncbi.nlm.nih.gov/34108235/
MAYO 2021
-
Pagnini I, Scavone M, Maccora I, Mastrolia MV, Marrani E, Bertini F, Lamot L, Simonini G.
The Development of Extra-Articular Manifestations in Children With Enthesitis-Related Arthritis: Natural Course or Different Disease Entity?
Front Med (Lausanne). 2021 May 13;8:667305. doi: 10.3389/fmed.2021.667305
https://pubmed.ncbi.nlm.nih.gov/34055840/ -
Kip MMA, de Roock S, van den Berg I, Currie G, Marshall DA, Grazziotin LR, Twilt M, Yeung RSM, Benseler SM, Vastert SJ, Wulffraat N, Swart JF, IJzerman MJ.
Costs of hospital-associated care for patients with juvenile idiopathic arthritis in the Dutch healthcare system.
Arthritis Care Res (Hoboken). 2021 May 2. doi:10.1002/acr.24621
https://pubmed.ncbi.nlm.nih.gov/33938161/ -
Ganeva M, Fuehner S, Kessel C, Klotsche J, Niewerth M, Minden K, Foell D, Hinze CH, Wittkowski H.
Trajectories of disease courses in the inception cohort of newly diagnosed patients with JIA (ICON-JIA): the potential of serum biomarkers at baseline.
Pediatr Rheumatol Online J. 2021 May 1;19(1):64. doi:10.1186/s12969-021-00553-x
https://pubmed.ncbi.nlm.nih.gov/33933108/
-
Öman A, Dicksved J, Engstrand L, Berntson L
Fecal microbiota in children with juvenile idiopathic arthritis treated with methotrexate or etanercept
Pediatr Rheumatol Online J. 2021 Apr 26;19(1):55
https://pubmed.ncbi.nlm.nih.gov/33902613/
MARZO 2021
-
Lovell DJ, Huang B, Chen C, Angeles-Han ST, Simon TA, Brunner HI.
Prevalence of autoimmune diseases and other associated conditions in children and young adults with juvenile idiopathic arthritis.
RMD Open. 2021 Mar;7(1):e001435. doi: 10.1136/rmdopen-2020-001435.
https://pubmed.ncbi.nlm.nih.gov/33731444/ -
Nigrovic PA, Colbert RA, Holers VM, Ozen S, Ruperto N, Thompson SD, Wedderburn LR, Yeung RSM, Martini A.
Biological classification of childhood arthritis: roadmap to a molecular nomenclature.
Nat Rev Rheumatol. 2021 Mar 17. doi: 10.1038/s41584-021-00590-6. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/33731872/ -
Harhay R, Jeelani W, Agbor BTA, Hennon T, Wrotniak BH, Abdul-Aziz R.
Response to treatment with intra-articular triamcinolone hexacetonide and triamcinolone acetonide in oligo articular juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2021 Mar 20;19(1):36. doi: 10.1186/s12969-021-00520-6.
https://pubmed.ncbi.nlm.nih.gov/33743721/ -
Raab A, Kallinich T, Huscher D, Foeldvari I, Weller-Heinemann F, Dressler F, Kuemmerle-Deschner JB, Klein A, Horneff G.
Outcome of children with oligoarticular juvenile idiopathic arthritis compared to polyarthritis on methotrexate - data of the German BIKER registry.
Pediatr Rheumatol Online J. 2021 Mar 22;19(1):41. doi: 10.1186/s12969-021-00522-4.
https://pubmed.ncbi.nlm.nih.gov/33752685/ -
Yue X, Huang B, Hincapie AL, Wigle PR, Qiu T, Li Y, Morgan EM, Guo JJ.
Prescribing Patterns and Impact of Factors Associated with Time to Initial Biologic Therapy among Children with Non-systemic Juvenile Idiopathic Arthritis.
Paediatr Drugs. 2021 Mar;23(2):171-182. doi: 10.1007/s40272-021-00436-4.
https://pubmed.ncbi.nlm.nih.gov/33651370/ -
Doeleman MJH, de Roock S, Buijsse N, Klein M, Bonsel GJ, Seyfert-Margolis V, Swart JF, Wulffraat NM.
Monitoring patients with juvenile idiopathic arthritis using health-related quality of life.
Pediatr Rheumatol Online J. 2021 Mar 22;19(1):40. doi: 10.1186/s12969-021-00527-z.
https://pubmed.ncbi.nlm.nih.gov/33752695/ -
Rapley T, May C, Smith N, Foster HE.
'Snakes & Ladders': factors influencing access to appropriate care for children and young people with suspected juvenile idiopathic arthritis- a qualitative study
Pediatr Rheumatol Online J. 2021 Mar 23;19(1):43. doi: 10.1186/s12969-021-00531-3.
https://pubmed.ncbi.nlm.nih.gov/33757545/ -
Pearce C, Newman S, Mulligan K.
Illness Uncertainty in Parents of Children with Juvenile Idiopathic Arthritis.
ACR Open Rheumatol. 2021 Mar 12. doi: 10.1002/acr2.11238. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/33710801/ -
Arnstad ED, Glerup M, Rypdal V, Peltoniemi S, Fasth A, Nielsen S, et al; Nordic Study Group of Pediatric Rheumatology (NoSPeR).
Fatigue in young adults with juvenile idiopathic arthritis 18 years after disease onset: data from the prospective Nordic JIA cohort.
Pediatr Rheumatol Online J. 2021 Mar 18;19(1):33. doi: 10.1186/s12969-021-00499-0.
https://pubmed.ncbi.nlm.nih.gov/33736650/ -
d'Angelo DM, Di Donato G, Breda L, Chiarelli F.
Growth and puberty in children with juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2021 Mar 12;19(1):28. doi: 10.1186/s12969-021-00521-5.
https://pubmed.ncbi.nlm.nih.gov/33712046/
FEBRERO 2021
-
Thiele F, Klein A, Windschall D, Hospach A, Foeldvari I, Minden K, Weller-Heinemann F, Horneff G.
Comparative risk of infections among real-world users of biologics for juvenile idiopathic arthritis: data from the German BIKER registry.
Rheumatol Int. 2021 Feb 16. doi: 10.1007/s00296-020-04774-3.
https://pubmed.ncbi.nlm.nih.gov/33590331/ -
Arkachaisri T, Teh KL, Book YX, Hoh SF, Gao X, Das L.
Enthesitis Related Arthritis in a Longitudinal Southeast Asian Registry: High Prevalence of HLA-B27, Different Sacroiliitis Risk Factors and Less Common Drug-Free Remission.
J Clin Med. 2021 Feb 3;10(4):568. doi: 10.3390/jcm10040568.
https://pubmed.ncbi.nlm.nih.gov/33546269/ -
Thomas M, Bonacorsi S, Simon AL, Mallet C, Lorrot M, Faye A, Dingulu G, Caseris M, Boneca IG, Aupiais C, Meinzer U.
Acute monoarthritis in young children: comparing the characteristics of patients with juvenile idiopathic arthritis versus septic and undifferentiated arthritis.
Sci Rep. 2021 Feb 9;11(1):3422. doi: 10.1038/s41598-021-82553-1.
https://pubmed.ncbi.nlm.nih.gov/33564018/ -
Shi CL, Zhang Y, Zhang ZY, Zhou J, Tang XM.
Comparative Efficacy and Safety of Non-Steroidal Anti-Inflammatory Drugs in Patients With Juvenile Idiopathic Arthritis: A Systematic Review and Network Meta-analysis.
Indian Pediatr. 2021 Feb 15;58(2):162-168.
https://pubmed.ncbi.nlm.nih.gov/33632948/ -
Reyhan I, Zhukov OS, Lagier RJ, Bridgforth RF, Williams GJ, Popov JM, Naides SJ, Reiff A.
Prevalence and significance of serum 14-3-3eta in juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2021 Feb 16;19(1):14. doi: 10.1186/s12969-021-00502-8.
https://pubmed.ncbi.nlm.nih.gov/33593401/ -
Lohse A, Lemelle I, Pillet P, Duquesne A, Ballot C, Tran TA, Sparsa L, Goumy L, Reumaux H, Rossi L, Solau-Gervais E, Arbault A, Alleyrat C, Guillemin F, Devauchelle-Pensec V.
Therapeutic alliance is associated to treatment adherence in children with juvenile idiopathic arthritis.
Joint Bone Spine. 2021 Feb 6:105151. doi: 10.1016/j.jbspin.2021.105151.
https://pubmed.ncbi.nlm.nih.gov/33561531/ -
Räisänen L, Viljakainen H, Sarkkola C, Kolho KL.
Perinatal risk factors for pediatric onset type 1 diabetes, autoimmune thyroiditis, juvenile idiopathic arthritis, and inflammatory bowel diseases.
Eur J Pediatr. 2021 Feb 23. doi: 10.1007/s00431-021-03987-3.
https://pubmed.ncbi.nlm.nih.gov/33624160/ -
Bhalla AK, Kaur H, Singh S.
Auxological dynamics of children with Juvenile Idiopathic Arthritis: a mixed-longitudinal study from Chandigarh, North India.
Anthropol Anz. 2021 Feb 15. doi: 10.1127/anthranz/2021/1314.
https://pubmed.ncbi.nlm.nih.gov/33595591/
-
Alexeeva E, Horneff G, Dvoryakovskaya T, Denisova R, Nikishina I, Zholobova E, Malievskiy V, Santalova G, Stadler E, Balykova L, Spivakovskiy Y, Kriulin I, Alshevskaya A, Moskalev A.
Early combination therapy with etanercept and methotrexate in JIA patients shortens the time to reach an inactive disease state and remission: results of a double-blind placebo-controlled trial.
Pediatr Rheumatol Online J. 2021 Jan 6;19(1):5. doi: 10.1186/s12969-020-00488-9. PMID: 33407590; PMCID: PMC7788754.
https://pubmed.ncbi.nlm.nih.gov/33407590/ -
Ghantous N, Heshin-Bekenstein M, Dequattro K, Lakovsky Y, Hendel AM, Rappoport N, Aviel YB, Tirosh I, Harel L, Weiss PF, Gensler L, Mackenzie J, Amarilyo G.
Do geography and ethnicity play a role in juvenile Spondyloarthritis? A multi-center binational retrospective study.
Pediatr Rheumatol Online J. 2021 Jan 6;19(1):4. doi: 10.1186/s12969-020-00489-8. PMID: 33407634; PMCID: PMC7788991.
https://pubmed.ncbi.nlm.nih.gov/33407634/ -
Meng X, Hou X, Wang P, Glessner JT, Qu HQ, March ME, Zhang S, Qi X, Zhu C, Nguyen K, Gao X, Li X, Liu Y, Zhou W, Zhang S, Li J, Sun Y, Yang J, Sleiman PMA, Xia Q, Hakonarson H, Li J.
Association of novel rare coding variants with juvenile idiopathic arthritis.
Ann Rheum Dis. 2021 Jan 6:annrheumdis-2020-218359. doi: 10.1136/annrheumdis-2020-218359. Epub ahead of print. PMID: 33408077.
https://pubmed.ncbi.nlm.nih.gov/33408077/ -
McDonald J, Cassedy A, Altaye M, Andringa J, Cooper AM, Drews-Botsch C, Engelhard G Jr, Hennard T, Holland GN, Jenkins K, Lambert SR, Lipscomb J, McCracken C, McCurdy DK, Mwase N, Prahalad S, Shantha J, Stahl E, Miraldi Utz V, Walker AA, Yeh S, Angeles-Han ST.
Comprehensive assessment of quality of life, functioning and mental health in children with juvenile idiopathic arthritis and non-infectious uveitis.
Arthritis Care Res (Hoboken). 2021 Jan 9. doi: 10.1002/acr.24551. Epub ahead of print. PMID: 33421338.
https://pubmed.ncbi.nlm.nih.gov/33421338/ -
Ruperto N, Brunner HI, Tzaribachev N, Vega-Cornejo G, Louw I, Cimaz R, Dare J, Espada G, Faugier E, Ferrandiz M, Gerloni V, Quartier P, Silva CA, Wagner-Weiner L, Gandhi Y, Passarell J, Nys M, Wong R, Martini A, Lovell DJ; Pediatric Rheumatology Collaborative Study Group (PRCSG) and the Paediatric Rheumatology International Trials Organisation (PRINTO).
Absence of Association Between Abatacept Exposure and Initial Infection in Patients With Juvenile Idiopathic Arthritis.
J Rheumatol. 2021 Jan 15:jrheum.200154. doi: 10.3899/jrheum.200154. Epub ahead of print. PMID: 33452173.
https://pubmed.ncbi.nlm.nih.gov/33452173/ -
Lipinska J, Kaszkowiak M, Malachowska B, Swidrowska-Jaros J, Smolewska E.
Concentration of survivin in children with oligo- and polyarticular juvenile idiopathic arthritis (JIA): diagnostic and prognostic value-a single-center study.
Arthritis Res Ther. 2021 Jan 26;23(1):40. doi: 10.1186/s13075-021-02424-y. PMID: 33494811; PMCID: PMC7836505.
https://pubmed.ncbi.nlm.nih.gov/33494811/
DICIEMBRE 2020
-
Chhabra A, Robinson C, Houghton K, Cabral DA, Morishita K, Tucker LB, Petty RE, Larché M, Batthish M, Guzman J.
Long-term outcomes and disease course of children with juvenile idiopathic arthritis in the ReACCh-Out cohort: a two-centre experience.
Rheumatology (Oxford). 2020 Dec 1;59(12):3727-3730
https://pubmed.ncbi.nlm.nih.gov/32402087/ -
Yue X, Huang B, Hincapie AL, Wigle PR, Li Y, Qiu T, Lovell DJ, Morgan EM, Guo JJ.
Comparative effectiveness and persistence of TNFi and non-TNFi in juvenile idiopathic arthritis: a large pediatric rheumatology center in US.
Rheumatology (Oxford). 2020 Dec 28:keaa877
https://pubmed.ncbi.nlm.nih.gov/33369673/ -
Rumsey DG, Lougee A, Matsouaka R, Collier DH, Schanberg LE, Schenfeld J, Shiff NJ, Stoll ML, Stryker S, Weiss PF, Beukelman T; CARRA Registry Investigators.
Juvenile Spondyloarthritis in the CARRA Registry: High Biologic Use, Low Prevalence of HLA-B27, and Equal Sex Representation in Sacroiliitis.
Arthritis Care Res (Hoboken). 2020 Dec 16. doi: 10.1002/acr.24537
https://pubmed.ncbi.nlm.nih.gov/33331139/ -
Weiss PF, Fuhlbrigge RC, von Scheven E, Lovell DJ, Colbert RA, Brunner HI; PRCSG Advisory Council, the CARRA Executive Committee.
Children with enthesitis-related arthritis could benefit from treatments targeted for adults with spondyloarthritis.
Arthritis Care Res (Hoboken). 2020 Dec 5. doi: 10.1002/acr.24529
https://pubmed.ncbi.nlm.nih.gov/33278336/ -
Cánovas R, Cobb J, Brozynska M, Bowes J, Li YR, Smith SL, Hakonarson H, Thomson W, Ellis JA, Abraham G, Munro JE, Inouye M.
Genomic risk scores for juvenile idiopathic arthritis and its subtypes.
Ann Rheum Dis. 2020 Dec;79(12):1572-1579
https://pubmed.ncbi.nlm.nih.gov/32887683/ -
Bridges JM, Stoll ML.
Treatment of Juvenile Spondyloarthritis: Where We Stand.
Paediatr Drugs. 2020 Dec;22(6):603-615
https://pubmed.ncbi.nlm.nih.gov/32885389/ -
Marino A, De Souza M, Giani T, Cimaz R.
Pharmacotherapy for juvenile spondyloarthritis: an overview of the available therapies.
Expert Opin Pharmacother. 2020 Dec;21(17):2161-2168
https://pubmed.ncbi.nlm.nih.gov/32726179/ -
Viscuso D, Storari M, Aprile M, Denotti G.
Temporomandibular Disorders and Juvenile Idiopathic Arthritis: Scoping review with a case report.
Eur J Paediatr Dent. 2020 Dec;21(4):303-308
https://pubmed.ncbi.nlm.nih.gov/33337907/ -
Öman A, Dicksved J, Engstrand L, Berntson L.
Fecal microbiota in untreated children with Juvenile Idiopathic Arthritis - a comparison with healthy children and healthy siblings.
J Rheumatol. 2020 Dec 1:jrheum.200551
https://pubmed.ncbi.nlm.nih.gov/33262301/ -
Butler S, Sculley D, Santos DS, Fellas A, Gironès X, Singh-Grewal D, Coda A.
Usability of eHealth and Mobile Health Interventions by Young People Living With Juvenile Idiopathic Arthritis: Systematic Review.
JMIR Pediatr Parent. 2020 Dec 1;3(2):e15833
https://pubmed.ncbi.nlm.nih.gov/33258786/ -
Toupin-April K, Huber AM, Duffy CM, Proulx L, Morgan EM, Cohen JS, Gaboury I, Li LC, Tugwell P, Stinson J; JIA Option Map Group.
Development and Acceptability of a Patient Decision Aid for Pain Management in Juvenile Idiopathic Arthritis: The JIA Option Map.
Patient. 2020 Dec;13(6):719-728
https://pubmed.ncbi.nlm.nih.gov/33033937/ -
Nagy A, Mosdosi B, Simon D, Dergez T, Berki T.
Peripheral Blood Lymphocyte Analysis in Oligo- and Polyarticular Juvenile Idiopathic Arthritis Patients Receiving Methotrexate or Adalimumab Therapy: A Cross-Sectional Study.
Front Pediatr. 2020 Dec 10;8:614354
https://pubmed.ncbi.nlm.nih.gov/33363071/ -
Yildiz M, Dedeoglu R, Akdeniz B, Adrovic A, Haslak F, Karagozlu F, Koker O, Ulug N, Sahin S, Barut K, Oztunc F, Kasapcopur O.
Systolic and Diastolic Cardiac Functions in Juvenile Spondyloarthropathies.
J Clin Rheumatol. 2020 Dec 15
https://pubmed.ncbi.nlm.nih.gov/33337801/ -
Metzemaekers M, Malengier-Devlies B, Yu K, Vandendriessche S, Yserbyt J, Matthys P, De Somer L, Wouters C, Proost P.
Synovial fluid neutrophils from patients with juvenile idiopathic arthritis display a hyperactivated phenotype.
Arthritis Rheumatol. 2020 Dec 2. doi: 10.1002/art.41605
https://pubmed.ncbi.nlm.nih.gov/33264510/
NOVIEMBRE 2020
-
Bava C, Mongelli F, Pistorio A, Bertamino M, Bracciolini G, Dalprà S, Davì S, Lanni S, Muratore V, Pederzoli S, Rosina S, Schiappapietra B, Suffia C, Varnier GC, Verazza S, Giancane G, Consolaro A, Ravelli A.
Analysis of arthritis flares after achievement of inactive disease with methotrexate monotherapy in juvenile idiopathic arthritis
Clin Exp Rheumatol. 2020 Nov 12.
https://pubmed.ncbi.nlm.nih.gov/33200734/ - Chang JC, Xiao R, Burnham JM, Weiss PF.
Longitudinal assessment of racial disparities in juvenile idiopathic arthritis disease activity in a treat-to-target intervention.
Pediatr Rheumatol Online J. 2020 Nov 13;18(1):88
https://pubmed.ncbi.nlm.nih.gov/33187519/ - Fazaa A, Sellami M, Ouenniche K, Miladi S, Kassab S, Chekili S, Ben Abdelghani K, Laatar A.
Physical activity assessment in children and adolescents with juvenile idiopathic arthritis compared with controls.
Arch Pediatr. 2020 Nov 26:S0929-693X(20)30245-1. doi: 10.1016/j.arcped.2020.10.008.
https://pubmed.ncbi.nlm.nih.gov/33250332/ - Simonds MM, Schlefman AR, McCahan SM, Sullivan KE, Rose CD, Brescia AC.
Juvenile idiopathic arthritis fibroblast-like synoviocytes influence chondrocytes to alter BMP antagonist expression demonstrating an interaction between the two prominent cell types involved in endochondral bone formation.
Pediatr Rheumatol Online J. 2020 Nov 16;18(1):89.
https://pubmed.ncbi.nlm.nih.gov/33198759/ - Lunt LE, Shoop-Worrall S, Smith N, Cleary G, McDonagh J, Smith AD, Thomson W, McErlane F.
Validation of novel patient-centred juvenile idiopathic arthritis-specific patient-reported outcome and experience measures (PROMs/PREMs).
Pediatr Rheumatol Online J. 2020 Nov 19;18(1):91.
https://pubmed.ncbi.nlm.nih.gov/33213474/ - Yan, Y., Rychlik, K.L., Rosenman, M.B. et al.
Use of PROMIS® to screen for depression in children with arthritis.
Pediatr Rheumatol 18, 92 (2020).
https://pubmed.ncbi.nlm.nih.gov/33228749/ - Frid P, Baraniya D, Halbig J, Rypdal V, Songstad NT, Rosèn A, Berstad JR, Flatø B, Alakwaa F, Gil EG, Cetrelli L, Chen T, Al-Hebshi NN, Nordal E, Al-Haroni M.
Salivary Oral Microbiome of Children With Juvenile Idiopathic Arthritis: A Norwegian Cross-Sectional Study.
Front Cell Infect Microbiol. 2020 Nov 4;10:602239. doi: 10.3389/fcimb.2020.602239.
https://pubmed.ncbi.nlm.nih.gov/33251163/
OCTUBRE 2020
-
Brunner HI, Wong R, Nys M, Kou TD, Dominique A, Martini A, Lovell DJ, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG).
Abatacept: A Review of the Treatment of Polyarticular-Course Juvenile Idiopathic
Arthritis.Paediatr Drugs. 2020 Oct 8. doi: 10.1007/s40272-020-00422-2. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/33029724/ -
Armaroli G, Klein A, Ganser G, Ruehlmann MJ, Dressler F, Hospach A, Minden K, Trauzeddel R, Foeldvari I, Kuemmerle-Deschner J, Weller-Heinemann F, Urban A, Horneff G.
Long-term safety and effectiveness of etanercept in JIA: an 18-year experience from the BiKeR registry.
Arthritis Res Ther. 2020 Oct 29;22(1):258. doi: 10.1186/s13075-020-02326-5.
https://pubmed.ncbi.nlm.nih.gov/33121528/ -
Vernocchi P, Marini F, Capuani G, Tomassini A, Conta G, Del Chierico F, Malattia C, De Benedetti F, Martini A, Dallapiccola B, van Dijkhuizen EHP, Miccheli A, Putignani L.
Fused Omics Data Models Reveal Gut Microbiome Signatures Specific of Inactive Stage of Juvenile Idiopathic Arthritis in Pediatric Patients.
Microorganisms. 2020 Oct 6;8(10):E1540. doi: 10.3390/microorganisms8101540.
https://pubmed.ncbi.nlm.nih.gov/33036309/ -
López-Isac E, Smith SL, Marion MC, Wood A, Sudman M, Yarwood A, Shi C, Gaddi VP, Martin P, Prahalad S, Eyre S, Orozco G, Morris A, Langefeld C, Thompson SD, Thomson W, Bowes J.
Combined genetic analysis of juvenile idiopathic arthritis clinical subtypes identifies novel risk loci, target genes and key regulatory mechanisms.
Ann Rheum Dis. 2020 Oct 26:annrheumdis-2020-218481. doi: 10.1136/annrheumdis-2020-218481. Online ahead of print
https://pubmed.ncbi.nlm.nih.gov/33106285/ -
Fischer J, Skeie MS, Rosendahl K, Tylleskär K, Lie S, Shi XQ, Gil EG, Cetrelli L, Halbig J, von Wangenheim Marti L, Rygg M, Frid P, Stoustrup P, Rosèn A.
Prevalence of temporomandibular disorder in children and adolescents with juvenile idiopathic arthritis - a Norwegian cross- sectional multicentre study.
BMC Oral Health. 2020 Oct 13;20(1):282. doi: 10.1186/s12903-020-01234-z.PMID: 33050890
https://pubmed.ncbi.nlm.nih.gov/33050890/ -
Frid P, Augdal TA, Larheim TA, Halbig J, Rypdal V, Songstad NT, Rosén A, Tylleskär KB, Berstad JR, Flatø B, Stoustrup P, Rosendahl K, Kirkhus E, Nordal E.
Efficacy and safety of intraarticular corticosteroid injections in adolescents with juvenile idiopathic arthritis in the temporomandibular joint: a Norwegian 2-year prospective multicenter pilot study.
Pediatr Rheumatol Online J. 2020 Oct 1;18(1):75. doi: 10.1186/s12969-020-00464-3
https://pubmed.ncbi.nlm.nih.gov/32998740/ -
Weiss PF, Chauvin NA.
Imaging in the diagnosis and management of axial spondyloarthritis in children
Best Pract Res Clin Rheumatol. 2020 Oct 6:101596. doi: 10.1016/j.berh.2020.101596. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/33036917/
SEPTIEMBRE 2020
-
Cánovas R, Cobb J, Brozynska M, Bowes J, Li YR, Smith SL, Hakonarson H, Thomson W, Ellis JA, Abraham G, Munro JE, Inouye M.
Genomic risk scores for juvenile idiopathic arthritis and its subtypes.
Ann Rheum Dis. 2020 Sep 4:annrheumdis-2020-217421. doi: 10.1136/annrheumdis-2020-217421. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32887683/ -
Dedeoglu R, Yildiz M, Karagozlu F, Oztunc F, Ulug N, Akdeniz B, Adrovic A, Haslak F, Sahin S, Barut K, Kasapcopur O.
Unexpected increase of aortic stiffness in juvenile Spondyloarthropathies.
Cardiol Young. 2020 Sep 17:1-9. doi: 10.1017/S1047951120002796. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32938508/ -
Paç Kısaarslan A, Şahin N, Özdemir Çiçek S, Gündüz Z, Poyrazoğlu H, Düşünsel R.
Evaluation of familial Mediterranean fever patients concomitant with juvenile spondyloarthropathy.
Mod Rheumatol. 2020 Sep 7:1-7. doi: 10.1080/14397595.2020.1812809. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32815445/ -
Boyko Y, Ivanova V, Vakaruk M, Kozina T, Shevchenko N, Vaizer N, Synoverska O, Chubata O, Marchuk O, Havrylyuk A.
Blood calprotectin in children with juvenile idiopathic arthritis: relationship to flare development after discontinuation of treatment.
Reumatologia. 2020;58(4):202-207. doi: 10.5114/reum.2020.98431.
https://pubmed.ncbi.nlm.nih.gov/32921826/ -
Mannion ML, Xie F, Horton DB, Ringold S, Correll CK, Dennos A, Beukelman T; CARRA Registry Investigators.
Biologic Switching among Non-Systemic Juvenile Idiopathic Arthritis Patients: A Cohort Study in the Childhood Arthritis and Rheumatology Research Alliance Registry.
J Rheumatol. 2020 Sep 15:jrheum.200437. doi: 10.3899/jrheum.200437. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32934124/ -
Malattia C, Ruperto N, Pederzoli S, Palmisani E, Pistorio A, Wouters C, Dolezalova P, Flato B, Garay S, Giancane G, Wells C, Douglass W, Brunner HI, De Benedetti F, Ravelli A; Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG).
Tocilizumab may slow radiographic progression in patients with systemic or polyarticular-course juvenile idiopathic arthritis: post hoc radiographic analysis from two randomized controlled trials
Arthritis Res Ther. 2020 Sep 10;22(1):211. doi: 10.1186/s13075-020-02303-y
https://pubmed.ncbi.nlm.nih.gov/32912276/ -
Brunner HI, Ruperto N, Zuber Z, Cuttica R, Keltsev V, Xavier RM, Burgos-Vargas R, Calvo Penades I, Silverman ED, Espada G, Ferrandiz Zavaler M, Kimura Y, Duarte C, Job-Deslandre C, Joos R, Douglass W, Wimalasundera S, Bharucha KN, Wells C, Lovell DJ, Martini A, De Benedetti F; Paediatric Rheumatology International Trials Organisation (PRINTO), the Pediatric Rheumatology Collaborative Study Group (PRCSG).
Efficacy and Safety of Tocilizumab for Polyarticular-Course Juvenile Idiopathic Arthritis in the Open-Label 2-Year Extension of a Phase 3 Trial.
Arthritis Rheumatol. 2020 Sep 20. doi: 10.1002/art.41528. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32951358/ -
Ozdel S, Baglan E, Cakıcı EK, Yazılıtas F, Yücel H, Senel S, Bulbul M.
Clinical Features in 305 Patients with Juvenile Idiopathic Arthritis: A Single Center Turkish Study
Pediatr Int. 2020 Sep 24. doi: 10.1111/ped.14481. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32969552/ -
Roszkiewicz J, Michałek D, Ryk A, Swacha Z, Szmyd B, Smolewska E.
The impact of single nucleotide polymorphisms in ADORA2A and ADORA3 genes on the early response to methotrexate and presence of therapy side effects in children with juvenile idiopathic arthritis: Results of a preliminary study.
Int J Rheum Dis. 2020 Sep 23. doi: 10.1111/1756-185X.13972. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32969158/ -
Pawlaczyk-Kamienska T, Pawlaczyk-Wróblewska E, Borysewicz-Lewicka M.
Early diagnosis of temporomandibular joint arthritis in children with juvenile idiopathic arthritis. A systematic review.
Eur J Paediatr Dent. 2020 Sep;21(3):219-226. doi: 10.23804/ejpd.2020.21.03.12.
https://pubmed.ncbi.nlm.nih.gov/32893656/ -
Lypka M, Shah K, Jones J.
Prosthetic temporomandibular joint reconstruction in a cohort of adolescent females with juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2020 Sep 4;18(1):68. doi: 10.1186/s12969-020-00453-6.
https://pubmed.ncbi.nlm.nih.gov/32887620/ -
Thakral A, Pinto D, Miller M, Curran ML, Klein-Gitelman M, French DD.
Direct Healthcare Costs Associated with Oligoarticular Juvenile Idiopathic Arthritis at a Single Center.
Int J Rheumatol. 2020 Sep 1;2020:5640425. doi: 10.1155/2020/5640425.
https://pubmed.ncbi.nlm.nih.gov/32952562/ -
Al-Mayouf SM, Hashad S, Khawaja K, Alrasheedi A, Abdwani R, Abushhaiwia A, AlSuwaiti M, Alzyoud R, Al Abrawi S, Asiri A, Alshaikh M, Sharif E, Muzaffer M, Alsewairi W, Zlenti M, Kawaja E, Almutairi M, Majeed M, Lotfy H, AlMarri M, Almutairi N; Pediatric Arab Rheumatology Group (PRAG).
Cumulative damage in juvenile idiopathic arthritis: A multi-center study from the Pediatric Rheumatology Arab Group (PRAG).
Arthritis Care Res (Hoboken). 2020 Sep 4. doi: 10.1002/acr.24436. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32886859/ -
Fathalla BM, Elgabaly EA, Tayoun AA.
Coexistence of a novel WISP3 pathogenic variant and an MEFV mutation in an Arabic family with progressive pseudorheumatoid dysplasia mimicking polyarticular juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2020 Sep 7;18(1):69. doi: 10.1186/s12969-020-00462-5.
https://pubmed.ncbi.nlm.nih.gov/32894151/
AGOSTO 2020
- Klein-Wieringa IR, Brinkman DMC, Ten Cate R, Hissink Muller PCE.
Update on the treatment of nonsystemic juvenile idiopathic arthritis including treatment-to-target: is (drug-free) inactive disease already possible?
Curr Opin Rheumatol. 2020 Sep;32(5):403-413.doi: 10.1097/BOR.0000000000000727.
https://pubmed.ncbi.nlm.nih.gov/32657803/ - Roszkiewicz J, Swacha Z, Smolewska E.
Prefilled pen versus prefilled syringe: a pilot study evaluating two different methods of methotrexate subcutaneous injection in patients with JIA
Pediatr Rheumatol Online J. 2020 Aug 12;18(1):64. doi: 10.1186/s12969-020-00455-4.
https://pubmed.ncbi.nlm.nih.gov/32787934/ - Brix N, Rosthøj S, Glerup M, Hasle H, Herlin T.
Identifying acute lymphoblastic leukemia mimicking juvenile idiopathic arthritis in children
PLoS One. 2020 Aug 11;15(8):e0237530. doi: 10.1371/journal.pone.0237530. eCollection 2020.
https://pubmed.ncbi.nlm.nih.gov/32780759/ - Turmel-Roy J, Bédard MA, Millette M, Simonyan D, Proulx-Gauthier JP, Rousseau-Nepton I.
Risk of adrenal insufficiency following intra-articular or periarticular corticosteroid injections among children with chronic arthritis.
J Pediatr Endocrinol Metab. 2020 Aug 26:/j/jpem.ahead-of-print/jpem-2020-0219/jpem-2020-0219.xml. doi: 10.1515/jpem-2020-0219.
https://pubmed.ncbi.nlm.nih.gov/32845867/ - Antonarakis GS, Blanc A, Courvoisier DS, Scolozzi P.
Effect of intra-articular corticosteroid injections on pain and mouth opening in juvenile idiopathic arthritis with temporomandibular involvement: A systematic review and meta-analysis
J Craniomaxillofac Surg. 2020 Aug;48(8):772-778. doi: 10.1016/j.jcms.2020.06.010. Epub 2020 Jun 27.
https://pubmed.ncbi.nlm.nih.gov/32680671/ - Bridges JM, Stoll ML
Treatment of Juvenile Spondyloarthritis: Where We Stand.
Paediatr Drugs. 2020 Sep 3. doi: 10.1007/s40272-020-00416-0.
https://pubmed.ncbi.nlm.nih.gov/32885389/ - Al-Mayouf SM, Hashad S, Khawaja K, Alrasheedi A, Abdwani R, Abushhaiwia A, AlSuwaiti M, Alzyoud R, Al Abrawi S, Asiri A, Alshaikh M, Sharif E, Muzaffer M, Alsewairi W, Zlenti M, Kawaja E, Almutairi M, Majeed M, Lotfy H, AlMarri M, Almutairi N; Pediatric Arab Rheumatology Group (PRAG).
Cumulative damage in juvenile idiopathic arthritis: A multi-center study from the Pediatric Rheumatology Arab Group (PRAG)
Arthritis Care Res (Hoboken). 2020 Sep 4. doi: 10.1002/acr.24436.
https://pubmed.ncbi.nlm.nih.gov/32886859/ - Gicchino MF, Di Sessa A, Guarino S, Miraglia Del Giudice E, Olivieri AN, Marzuillo P.
Prevalence of and factors associated to chronic kidney disease and hypertension in a cohort of children with juvenile idiopathic arthritis.
Eur J Pediatr. 2020 Aug 29. doi: 10.1007/s00431-020-03792-4.
https://pubmed.ncbi.nlm.nih.gov/32860100/ - Hussain KS, Gulati R, Satheesh S, Negi VS.
Early-onset subclinical cardiovascular damage assessed by non-invasive methods in children with Juvenile Idiopathic Arthritis: analytical cross-sectional study.
Rheumatol Int. 2020 Aug 28. doi: 10.1007/s00296-020-04689-z.
https://pubmed.ncbi.nlm.nih.gov/32857280/ - Lundberg V, Sandlund M, Eriksson C, Janols R, Lind T, Fjellman-Wiklund A.
How children and adolescents with juvenile idiopathic arthritis participate in their healthcare: health professionals' views.
Disabil Rehabil. 2020 Sep 2:1-8. doi: 10.1080/09638288.2020.1811406.
https://pubmed.ncbi.nlm.nih.gov/32875956/ - Pinchi V, Bianchi I, Pradella F, Vitale G, Focardi M, Tonni I, Ferrante L, Bucci A.Int
Dental age estimation in children affected by juvenile rheumatoid arthritis.
J Legal Med. 2020 Aug 20. doi: 10.1007/s00414-020-02395-w.
https://pubmed.ncbi.nlm.nih.gov/32820356/ - Ht Kwok C, Learoyd AE, Canet-Pons J, Trang T, Fitzgerald M.
Spinal interleukin-6 contributes to central sensitisation and persistent pain hypersensitivity in a model of juvenile idiopathic arthritis
Brain Behav Immun. 2020 Aug 10;S0889-1591(20)31007-2. doi: 10.1016/j.bbi.2020.08.004. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32791212/ - Fischer J, Dirks J, Haase G, Holl-Wieden A, Hofmann C, Girschick H, Morbach H.
IL-21+CD4+ T helper cells co-expressing IFN-γ and TNF-α accumulate in the joints of antinuclear antibody positive patients with juvenile idiopathic arthritis
Clin Immunol. 2020 Aug;217:108484. doi: 10.1016/j.clim.2020.108484.
https://pubmed.ncbi.nlm.nih.gov/32485239/ - Avar-Aydin PO, Nepesov S, Barut K, Sahin S, Adrovic A, Cokugras HC, Kasapcopur O.
Decreased frequency of allergy in juvenile idiopathic arthritis: results of a case-control study.
Mod Rheumatol. 2020 Aug 20:1-19. doi: 10.1080/14397595.2020.1812820.
https://pubmed.ncbi.nlm.nih.gov/32815440/ -
Schmidt T, Berthold E, Arve-Butler S, Gullstrand B, Mossberg A, Kahn F, Bengtsson AA, Månsson B, Kahn R.
Children with oligoarticular juvenile idiopathic arthritis have skewed synovial monocyte polarization pattern with functional impairment-a distinct inflammatory pattern for oligoarticular juvenile arthritis
Arthritis Res Ther. 2020 Aug 12;22(1):186.doi: 10.1186/s13075-020-02279-9.
https://pubmed.ncbi.nlm.nih.gov/32787920/ - Pawlaczyk-Kamieńska T, Kulczyk T, Pawlaczyk-Wróblewska E, Borysewicz-Lewicka M, Niedziela M.
Limited Mandibular Movements as a Consequence of Unilateral or Asymmetrical Temporomandibular Joint Involvement in Juvenile Idiopathic Arthritis Patients
J Clin Med. 2020 Aug 8;9(8):E2576. doi: 10.3390/jcm9082576.
https://pubmed.ncbi.nlm.nih.gov/32784489/
JULIO 2020
- Brunner HI, Chen C, Bovis F, De Benedetti F, Espada G, Joos R, Akikusa J, Chaitow J, Boteanu AL, Kimura Y, Rietschel C, Siri D, Smolewska E, Schmeling H, Brown DE, Martini A, Lovell DJ, Huang B, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG).
Functional Ability and Health-Related Quality of Life in Randomized Controlled Trials of Tocilizumab in Patients With Juvenile Idiopathic Arthritis.
Arthritis Care Res (Hoboken). 2020 Jul 23. doi: 10.1002/acr.24384. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32702212/ - Lovell DJ, Brunner HI, Reiff AO, Jung L, Jarosova K, Němcová D, Mouy R, Sandborg C, Bohnsack JF, Elewaut D, Gabriel C, Higgins G, Kone-Paut I, Jones OY, Vargová V, Chalom E, Wouters C, Lagunes I, Song Y, Martini A, Ruperto N.
Long-term outcomes in patients with polyarticular juvenile idiopathic arthritis receiving adalimumab with or without methotrexate.
RMD Open. 2020 Jul;6(2):e001208. doi: 10.1136/rmdopen-2020-001208.
https://pubmed.ncbi.nlm.nih.gov/32665432/ -
Aranda-Valera IC, Arias de la Rosa I, Roldán-Molina R, Ábalos-Aguilera MDC, Torres-Granados C, Patiño-Trives A, Luque-Tevar M, Ibáñez-Costa A, Guzmán-Ruiz R, Malagón MDM, Escudero-Contreras A, López-Pedrera C, Collantes-Estévez E, Barbarroja N.
Subclinical cardiovascular risk signs in adults with juvenile idiopathic arthritis in sustained remission.
Pediatr Rheumatol Online J. 2020 Jul 14;18(1):59. doi: 10.1186/s12969-020-00448-3.
https://pubmed.ncbi.nlm.nih.gov/32665015/ - Nicek A, Talib N, Lovell D, Smith C, Becker ML, Jones JT.
Assessment and treatment of Down syndrome-associated arthritis: a survey of pediatric rheumatologists.
Pediatr Rheumatol Online J. 2020 Jul 13;18(1):57. doi: 10.1186/s12969-020-00445-6.
https://pubmed.ncbi.nlm.nih.gov/32660497/ - Lalloo C, Harris LR, Hundert AS, Berard R, Cafazzo J, Connelly M, Feldman BM, Houghton K, Huber A, Laxer RM, Luca N, Schmeling H, Spiegel L, Tucker LB, Pham Q, Davies-Chalmers CC, Stinson JN.
The iCanCope pain self-management application for adolescents with juvenile idiopathic arthritis: a pilot randomized controlled trial.
Rheumatology (Oxford). 2020 Jul 2:keaa178. doi: 10.1093/rheumatology/keaa178. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32613229/ - Jiang K, Kessler H, Park Y, Sudman M, Thompson SD, Jarvis JN.
Broadening our understanding of the genetics of Juvenile Idiopathic Arthritis(JIA): Interrogation of three dimensional chromatin structures and genetic regulatory elements within JIA-associated risk loci.
PLoS One. 2020 Jul 30;15(7):e0235857. doi: 10.1371/journal.pone.0235857. eCollection 2020.
https://pubmed.ncbi.nlm.nih.gov/32730263/ - Klein-Wieringa IR, Brinkman DMC, Ten Cate R, Hissink Muller PCE.
Update on the treatment of nonsystemic juvenile idiopathic arthritis including treatment-to-target: is (drug-free) inactive disease already possible?
Curr Opin Rheumatol. 2020 Jul 9. doi: 10.1097/BOR.0000000000000727. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32657803/ - Chhabra A, Oen K, Huber AM, Shiff NJ, Boire G, Benseler SM, Berard RA, Scuccimarri R, Feldman BM, Lim LSH, Barsalou J, Bruns A, Cabral DA, Chédeville G, Ellsworth J, Houghton K, Lang B, Morishita K, Rumsey DG, Rosenberg AM, Tse SM, Watanabe Duffy K, Duffy CM, Guzman J; ReACCh-Out Investigators.
Real-World Effectiveness of Common Treatment Strategies for Juvenile Idiopathic Arthritis: Results From a Canadian Cohort.
Arthritis Care Res (Hoboken). 2020 Jul;72(7):897-906. doi: 10.1002/acr.23922. Epub 2020 Jun 5.
https://pubmed.ncbi.nlm.nih.gov/31074591/ -
Klein A, Minden K, Hospach A, Foeldvari I, Weller-Heinemann F, Trauzeddel R, Huppertz HI, Horneff G.
Treat-to-target study for improved outcome in polyarticular juvenile idiopathic arthritis.
Ann Rheum Dis. 2020 Jul;79(7):969-974. doi: 10.1136/annrheumdis-2019-216843. Epub 2020 Apr 16.
https://pubmed.ncbi.nlm.nih.gov/32299797/
JUNIO 2020
-
Rubinstein TB, Bullock DR, Ardalan K, Mowrey WB, Brown NM, Bauman LJ, Stein RE.
Adverse Childhood Experiences are Associated with Childhood-Onset Arthritis in a National Sample of US Youth: An Analysis of the 2016 National Survey of Children's Health.
J Pediatr. 2020 Jun 15:S0022-3476(20)30748-4. doi: 10.1016/j.jpeds.2020.06.046.
https://pubmed.ncbi.nlm.nih.gov/32553837/ -
Chamlati R, Connolly B, Laxer R, Stimec J, Panwar J, Tse S, Muthusami P, Amaral J, Temple M, Parra DA.
Image guided sacroiliac joint corticosteroid injections in children: an 18-year single-center retrospective study.
Pediatr Rheumatol Online J. 2020 Jun 17;18(1):52. doi: 10.1186/s12969-020-00435-8.
https://pubmed.ncbi.nlm.nih.gov/32552835/ -
Meneghetti TC, Padilha TMH, Azevedo VF, Cat MNL, Sarolli BMS, de Carvalho VO.
The musculoskeletal impairment negatively impacts the quality of life of children and adolescents with psoriasis.
Adv Rheumatol. 2020 Jun 17;60(1):33. doi: 10.1186/s42358-020-00136-6.
https://pubmed.ncbi.nlm.nih.gov/32552795/ -
Shiari R, Salar N, Parvneh VJ, Rahmani K, Yeganeh MH, Shiari S.
Midfoot Arthritis in Children: Is There Any Relation With Malignancy?
Clin Med Insights Arthritis Musculoskelet Disord. 2020 Jun 8;13:1179544120924643.
https://pubmed.ncbi.nlm.nih.gov/32550767/ -
Xin L, He F, Li S, Zhou ZX, Ma XL.
Intestinal microbiota and juvenile idiopathic arthritis: current understanding and future prospective.
World J Pediatr. 2020 Jun 12. doi: 10.1007/s12519-020-00371-3.
https://pubmed.ncbi.nlm.nih.gov/32533534/ -
Ricciuto A, Sherman PM, Laxer RM.
Gut microbiota in chronic inflammatory disorders: A focus on pediatric inflammatory bowel diseases and juvenile idiopathic arthritis.
Clin Immunol. 2020 Jun;215:108415. doi: 10.1016/j.clim.2020.108415.
https://pubmed.ncbi.nlm.nih.gov/32278875/ -
Dave M, Rankin J, Pearce M, Foster HE.
Global prevalence estimates of three chronic musculoskeletal conditions: club foot, juvenile idiopathic arthritis and juvenile systemic lupus erythematosus.
Pediatr Rheumatol Online J. 2020 Jun 12;18(1):49. doi: 10.1186/s12969-020-00443-8.
https://pubmed.ncbi.nlm.nih.gov/32532304/ -
Elnaggar RK, Mahmoud WS, Moawd SA, Azab AR.
Impact of core stability exercises on bone mineralization and functional capacity in children with polyarticular juvenile idiopathic arthritis: a randomized clinical trial.
Clin Rheumatol. 2020 Jun 8. doi: 10.1007/s10067-020-05219-9.
https://pubmed.ncbi.nlm.nih.gov/32514677/ -
Simon TA, Harikrishnan GP, Kawabata H, Singhal S, Brunner HI, Lovell DJ.
Prevalence of co-existing autoimmune disease in juvenile idiopathic arthritis: a cross-sectional study.
Pediatr Rheumatol Online J. 2020 Jun 5;18(1):43. doi: 10.1186/s12969-020-00426-9.
https://pubmed.ncbi.nlm.nih.gov/32503658/ -
Stoustrup P, Twilt M, Herlin T.
Systemic Treatment for Temporomandibular Joint Arthritis in Juvenile Idiopathic Arthritis.
J Rheumatol. 2020 Jun 1;47(6):793-795. doi: 10.3899/jrheum.191169.
https://pubmed.ncbi.nlm.nih.gov/32482885/ -
Bagge-Petersen CM, Skovdal M, Langstrup H.
The socio-material self-care practices of children living with hemophilia or juvenile idiopathic arthritis in Denmark.
Soc Sci Med. 2020 Jun;255:113022. doi: 10.1016/j.socscimed.2020.113022.
https://pubmed.ncbi.nlm.nih.gov/32422525/ -
Bollhalder A, Patcas R, Eichenberger M, Müller L, Schroeder-Kohler S, Saurenmann RK, Kellenberger CJ.
Magnetic Resonance Imaging Followup of Temporomandibular Joint Inflammation, Deformation, and Mandibular Growth in Juvenile Idiopathic Arthritis Patients Receiving Systemic Treatment.
J Rheumatol. 2020 Jun 1;47(6):909-916. doi: 10.3899/jrheum.190168.
https://pubmed.ncbi.nlm.nih.gov/31523042/
MAYO 2020
- Kattackal TR, Cavallo S, Brosseau L, Sivakumar A, Del Bel MJ, Dorion M, Ueffing E, Toupin-April K
Assessing the reporting quality of physical activity programs in randomized controlled trials for the management of juvenile idiopathic arthritis using three standardized assessment tools.
Pediatr Rheumatol Online J. 2020 May 24;18(1):41.
https://doi.org/10.1186/s12969-020-00434-9 - Kuntze G, Nettel-Aguirre A, Brooks J, Esau S, Nesbitt C, Mosher D, Twilt M, Benseler S, Ronsky JL, Emery CA
Consequences of Juvenile Idiopathic Arthritis on Single Leg Squat Performance in Youth.
Arthritis Care Res (Hoboken). 2020 May 14
https://doi.org/10.1002/acr.24254 - Ayaz NA, Karadağ ŞG, Koç R, Demirkan FG, Çakmak F, Sönmez HE.
Patient satisfaction and clinical effectiveness of switching from intravenous tocilizumab to subcutaneous tocilizumab in patients with juvenile idiopathic arthritis: an observational study.
Rheumatol Int. 2020 May 16.
https://doi.org/10.1007/s00296-020-04596-3 - Chhabra A, Robinson C, Houghton K, Cabral DA, Morishita K, Tucker LB, Petty RE, Larché M, Batthish M, Guzman J.
Long-term outcomes and disease course of children with juvenile idiopathic arthritis in the ReACCh-Out cohort: a two-centre experience.
Rheumatology (Oxford). 2020 May 13:keaa118.
https://doi.org/10.1093/rheumatology/keaa118 - Tanya M, Teh KL, Das L, Hoh SF, Gao X, Arkachaisri T.
Juvenile idiopathic arthritis in Southeast Asia: the Singapore experience over two decades.
Clin Rheumatol. 2020 May 16.
https://doi.org/10.1007/s10067-020-05081-9
ABRIL 2020
- Weiss PF, Roth
Juvenile-Versus Adult-Onset Spondyloarthritis: Similar, but Different.
J.Rheum Dis Clin North Am. 2020 May;46(2):241-257. doi: 10.1016/j.rdc.2020.01.003.
https://pubmed.ncbi.nlm.nih.gov/32340699 - Schoemaker CG, Swart JF, Wulffraat NM
Treating juvenile idiopathic arthritis to target: what is the optimal target definition to reach all goals?
Pediatr Rheumatol Online J. 2020 Apr 16;18(1):34. doi: 10.1186/s12969-020-00428-7.
https://pubmed.ncbi.nlm.nih.gov/32299430
MARZO 2020
- Barber CEH, Barnabe C, Benseler S, Chin R, Johnson N, Luca N, Miettunen P, Twilt M, Veeramreddy D, Shiff NJ, Schmeling H.
Patient factors associated with waiting time to pediatric rheumatologist consultation for patients with juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2020 Mar 6;18(1):22. doi: 10.1186/s12969-020-0413-7.
https://www.ncbi.nlm.nih.gov/pubmed/32143720 - Cimaz R, Maioli G, Calabrese G.
Current and emerging biologics for the treatment of juvenile idiopathic arthritis.
Expert Opin Biol Ther. 2020 Mar 2:1-16. doi: 10.1080/14712598.2020.1733524. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32116038 - Barber CEH, Twilt M, Pham T, Currie GR, Benseler S, Yeung RSM, Batthish M, Blanchette N, Guzman J, Lang B, LeBlanc C, Levy DM, O'Brien C, Schmeling H, Soon G, Spiegel L, Whitney K, Marshall DA
A Canadian evaluation framework for quality improvement in childhood arthritis: key performance indicators of the process of care.
Arthritis Res Ther. 2020 Mar 19;22(1):53.
https://www.ncbi.nlm.nih.gov/pubmed/32192528 - Bridgewood C, Sharif K, Sherlock J, Watad A, McGonagle D.
Interleukin-23 pathway at the enthesis: The emerging story of enthesitis in spondyloarthropathy.
Immunol Rev. 2020 Mar;294(1):27-47.
https://www.ncbi.nlm.nih.gov/pubmed/31957051 - Majumder S, Aggarwal A.
Juvenile idiopathic arthritis and the gut microbiome: Where are we now?
Best Pract Res Clin Rheumatol. 2020 Mar 11:101496. doi: 10.1016/j.berh.2020.101496. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32171669 - Ali M, Kaddafy S, Abdelaziz A, Abonar A, Hanafy M, Hussein H, Shabana H, Abd El-Hmid R, Ali M.
PADI4 (rs2240340), PDCD1 (rs10204525), and CTLA4 (231775) Gene Polymorphisms and Polyarticular Juvenile Idiopathic Arthritis.
Br J Biomed Sci. 2020 Mar 12. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32163016 - Sperling LC, Lockshin B, Darling T.
Eruptive collagenomas associated with adalimumab treatment of juvenile rheumatoid arthritis.
J Cutan Pathol. 2020 Mar;47(3):197-201. doi: 10.1111/cup.13594. No abstract available.
https://www.ncbi.nlm.nih.gov/pubmed/32037611
FEBRERO 2020
- Batthish M, Berard R, Cabral D, Bolaria R, Chédeville G, Duffy C, Gerhold K, Gerschman T, Huber A, Proulx-Gauthier JP, Rosenberg A, Rumsey D, Schmeling H, Shiff N, Soon G, Bruns A, Tucker L, Guzman J; Canadian Alliance of Pediatric Rheumatology Investigators .
A new Canadian inception cohort for juvenile idiopathic arthritis: The Canadian Alliance of Pediatric Rheumatology Investigators Registry.
Rheumatology (Oxford). 2020 Feb 11. pii: keaa006. doi: 10.1093/rheumatology/keaa006.
https://www.ncbi.nlm.nih.gov/pubmed/32044978 - Özdel S, Bağlan E, Çakıcı EK, Yazılıtas F, Gür G, Çelikkaya E, Güngör T, Bülbül M.
Similarities between pediatric FMF patients with sacroiliitis and pediatric juvenile spondyloarthropathy patients with sacroiliitis: a preliminary study.
Acta Clin Belg. 2020 Feb 3:1-6. doi: 10.1080/17843286.2020.1724450.
https://www.ncbi.nlm.nih.gov/pubmed/32009575 - Schoemaker CG, Wulffraat NM, Vastert SJ.
The patient and parent perspective on methotrexate in recent Juvenile Idiopathic Arthritis guidelines.
Arthritis Rheumatol. 2020 Feb 23. doi: 10.1002/art.41234.
https://www.ncbi.nlm.nih.gov/pubmed/32090463 - Lavilla P, Manzanares Á, Rabadán E, de Inocencio J.
Juvenile idiopathic arthritis and Turner's syndrome.
An Pediatr (Barc). 2020 Feb 11. pii: S1695-4033(20)30004-7. doi:10.1016/j.anpedi.2019.12.005.
https://www.ncbi.nlm.nih.gov/pubmed/32057710 - Cedströmer AL, Andlin-Sobocki A, Abbu N, Hedenberg-Magnusson B, Dahlström L, Berntson L.
Condylar alterations and facial growth in children with juvenile idiopathic arthritis.
J Orofac Orthop. 2020 Feb 20. doi: 10.1007/s00056-020-00216-8.
https://www.ncbi.nlm.nih.gov/pubmed/32077980 - Merle CL, Hoffmann R, Schmickler J, Rühlmann M, Challakh N, Haak R, Schmalz G, Ziebolz D.
Comprehensive Assessment of Orofacial Health and Disease Related Parameters in Adolescents with Juvenile Idiopathic Arthritis-A Cross-Sectional Study.
J Clin Med. 2020 Feb 13;9(2). pii: E513. doi: 10.3390/jcm9020513.
https://www.ncbi.nlm.nih.gov/pubmed/32069957 - Winsz-Szczotka K, Kuźnik-Trocha K, Gruenpeter A, Wojdas M, Dąbkowska K, Olczyk K.
Association of Circulating COMP and YKL-40 as Markers of Metabolic Changes of Cartilage with Adipocytokines in Juvenile Idiopathic Arthritis.
Metabolites. 2020 Feb 10;10(2). pii: E61. doi: 10.3390/metabo10020061.
https://www.ncbi.nlm.nih.gov/pubmed/32050571
ENERO 2020
- Rezaei E, Hogan D, Trost B, Kusalik AJ, Boire G, Cabral DA, Campillo S, Chédeville G, Chetaille AL, Dancey P, Duffy C, Watanabe Duffy K, Gordon J, Guzman J, Houghton K, Huber AM, Jurencak R, Lang B, Morishita K, Oen KG, Petty RE, Ramsey SE, Scuccimarri R, Spiegel L, Stringer E, Taylor-Gjevre RM, Tse SML, Tucker LB, Turvey SE, Tupper S, Yeung RSM, Benseler S, Ellsworth J, Guillet C, Karananayake C, Muhajarine N, Roth J, Schneider R, Rosenberg AM.
Clinical and associated inflammatory biomarker features predictive of short-term outcomes in non-systemic juvenile idiopathic arthritis.
Rheumatology (Oxford). 2020 Jan 9. pii: kez615. doi: 10.1093/rheumatology/kez615. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/31919503 - Barendregt AM, Veldkamp SR, Hissink Muller PCE, van de Geer A, Aarts C, van Gulik EC, Schilham MW, Kessel C, Keizer MP, Hemke R, Nassar-Sheikh Rashid A, Dolman KM, Schonenberg-Meinema D, Ten Cate R, van den Berg JM, Maas M, Kuijpers TW.
MRP8/14 and neutrophil elastase for predicting treatment response and occurrence of flare in patients with juvenile idiopathic arthritis.
Rheumatology (Oxford). 2020 Jan 6. pii: kez590. doi: 10.1093/rheumatology/kez590. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/31904851 - Henrey A, Rypdal V, Rypdal M, Loughin T, Nordal E, Guzman J; ReACCh-Out and NoSPeR Investigators.
Validation of prediction models of severe disease course and non-achievement of remission in juvenile idiopathic arthritis part 2: results of the Nordic model in the Canadian cohort.
Arthritis Res Ther. 2020 Jan 15;22(1):10. doi: 10.1186/s13075-019-2091-8.
https://www.ncbi.nlm.nih.gov/pubmed/31941530 - Klein A, Becker I, Minden K, Hospach A, Schwarz T, Foeldvari I, Huegle B, Borte M, Weller-Heinemann F, Dressler F, Kuemmerle-Deschner J, Oommen PT, Foell D, Trauzeddel R, Rietschel C, Horneff G.
Biologic Therapies in Polyarticular Juvenile Idiopathic Arthritis. Comparison of Long-Term Safety Data from the German BIKER Registry.
ACR Open Rheumatol. 2020 Jan;2(1):37-47. doi: 10.1002/acr2.11091. Epub 2019 Nov 24.
https://www.ncbi.nlm.nih.gov/pubmed/31943968 - McErlane F, Armitt G, Cobb J, Bailey K, Cleary G, Douglas S, Lunt L, Rashid A, Sampath S, Shoop-Worrall S, Smith N, Foster H, Thomson W.
CAPTURE-JIA: a consensus-derived core dataset to improve clinical care for children and young people with juvenile idiopathic arthritis.
Rheumatology (Oxford). 2020 Jan 1;59(1):137-145. doi: 10.1093/rheumatology/kez214.
https://www.ncbi.nlm.nih.gov/pubmed/31243450 - Kyvsgaard N, Thastum M, Mikkelsen TS, Christensen AE, Herlin T.
Coping strategies and anxiety in association with methotrexate-induced nausea in juvenile idiopathic arthritis.
Rheumatol Int. 2020 Jan 29. doi: 10.1007/s00296-020-04520-9. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/31996982 - Bhattacharya S, Misra R, Aggarwal A.
Patients with enthesitis related arthritis show similar monocyte function pattern as seen in adult axial spondyloarthropathy.
Pediatr Rheumatol Online J. 2020 Jan 15;18(1):6. doi: 10.1186/s12969-020-0403-9.
https://www.ncbi.nlm.nih.gov/pubmed/31941549 - Spel L, Martinon F.
Inflammasomes contributing to inflammation in arthritis.
Immunol Rev. 2020 Jan 16. doi: 10.1111/imr.12839. [Epub ahead of print] Review.
https://www.ncbi.nlm.nih.gov/pubmed/31944344 - Solmaz D, Bakirci S, Kimyon G, Gunal EK, Dogru A, Bayindir O, Dalkilic E, Ozisler C, Can M, Akar S, Cetin GY, Yavuz S, Kilic L, Tarhan EF, Kucuksahin O, Omma A, Gonullu E, Yildiz F, Ersozlu ED, Cinar M, Al-Onazi A, Erden A, Tufan MA, Yilmaz S, Pehlevan S, Kalyoncu U, Aydin SZ.
Impact of Having Family History of Psoriasis or Psoriatic Arthritis on Psoriatic Disease.
Arthritis Care Res (Hoboken). 2020 Jan;72(1):63-68. doi: 10.1002/acr.23836.
https://www.ncbi.nlm.nih.gov/pubmed/30680951
DICIEMBRE 2019
- Vieira MC, Tosta PG, Nicole FM, Roberto LEV, Vianna JGP, Castro PC, Lourenço RB, Serrano EV, Valim V, Luchi WM.
Chronic Inflammatory Arthropathy Preceding Acute Systemic Manifestations of Sarcoidosis: A Possible Overlap of Idiopathic Juvenile Arthritis and Sarcoidosis.
Case Rep Rheumatol. 2019 Dec 7;2019:6483245
https://www.ncbi.nlm.nih.gov/pubmed/31886005 - Horton DB, Salas J, Wec A, Kohlheim M, Kapadia P, Beukelman T, Boneparth A, Haverkamp K, Mannion ML, Moorthy LN, Ringold S, Rosenthal M.
Making Decisions About Stopping Medicines for Well-Controlled Juvenile Idiopathic Arthritis: A Mixed-Methods Study of Patients and Caregivers.
Arthritis Care Res (Hoboken). 2019 Dec 27. doi: 10.1002/acr.24129.
https://www.ncbi.nlm.nih.gov/pubmed/31880862 - Seaman SC, Hong S, Dlouhy BJ, Menezes AH.
Current management of juvenile idiopathic arthritis affecting the craniovertebral junction.
Childs Nerv Syst. 2019 Dec 16. doi: 10.1007/s00381-019-04469-6
https://www.ncbi.nlm.nih.gov/pubmed/31845026 - Tarkiainen M, Tynjälä P, Vähäsalo P, Kröger L, Aalto K, Lahdenne P.
Health-related quality of life during early aggressive treatment in patients with polyarticular juvenile idiopathic arthritis: results from randomized controlled trial.
Pediatr Rheumatol Online J. 2019 Dec 16;17(1):80
https://www.ncbi.nlm.nih.gov/pubmed/31842940 - Grevich S, Lee P, Leroux B, Ringold S, Darveau R, Henstorf G, Berg J, Kim A, Velan E, Kelly J, Baltuck C, Reeves A, Leahey H, Hager K, Brittnacher M, Hayden H, Miller S, McLean J, Stevens A.
Oral health and plaque microbial profile in juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2019 Dec 16;17(1):81.
https://www.ncbi.nlm.nih.gov/pubmed/31842923 - Giani T, Madera A, Cimaz R.
Association of juvenile idiopathic arthritis and morphea: a case series.
Clin Rheumatol. 2019 Dec 14. doi: 10.1007/s10067-019-04850-5
https://www.ncbi.nlm.nih.gov/pubmed/31838640 - Ortega-Avila AB, Cervera-Garvi P, Ramos-Petersen L, Gijon-Nogueron G.
Systematic review of measurement instruments for patients with juvenile idiopathic arthritis in the foot and ankle.
Eur J Phys Rehabil Med. 2019 Dec 13. doi: 10.23736/S1973-9087.19.05827-1
https://www.ncbi.nlm.nih.gov/pubmed/31833737 - Arvonen M, Vänni P, Sarangi AN, V Tejesvi M, Vähäsalo P, Aggarwal A, Stoll ML.
Microbial orchestra in juvenile idiopathic arthritis: Sounds of disarray?
Immunol Rev. 2019 Dec 13. doi: 10.1111/imr.12826.
https://www.ncbi.nlm.nih.gov/pubmed/31833578 - Rypdal V, Guzman J, Henrey A, Loughin T, Glerup M, Arnstad ED, Aalto K, Rygg M, Nielsen S, Herlin T, Fasth A, Berntson L, Rypdal M, Nordal E; ReACCh-Out and NoSPeR Investigators.
Validation of prediction models of severe disease course and non-achievement of remission in juvenile idiopathic arthritis: part 1-results of the Canadian model in the Nordic cohort.
Arthritis Res Ther. 2019 Dec 5;21(1):270.
https://www.ncbi.nlm.nih.gov/pubmed/31806043 - Stoustrup P, Herlin T, Spiegel L, Rahimi H, Koos B, Pedersen TK, Twilt M; Temporomandibular joint Juvenile Arthritis Work group (TMJaw).
Standardizing the clinical orofacial examination in Juvenile idiopathic arthritis: An interdisciplinary, consensus-based, short screening protocol.
J Rheumatol. 2019 Dec 1. pii: jrheum.190661. doi: 10.3899/jrheum.190661
https://www.ncbi.nlm.nih.gov/pubmed/31787607 - Martini A.
Are there new targets for juvenile idiopathic arthritis?
Semin Arthritis Rheum. 2019 Dec;49(3S):S11-S13
https://www.ncbi.nlm.nih.gov/pubmed/31779842
OCTUBRE 2019
- Lucafò M, Franzin M, Lagatolla C, Franca R, Bramuzzo M, Stocco G, Decorti G.
Validation and adaptation of a German screening tool to identify patients at risk of juvenile idiopathic arthritis
Clin Transl Sci. 2019 Nov 1. doi: 10.1111/cts.12722. [Epub ahead of print] Review.
https://www.ncbi.nlm.nih.gov/pubmed/31667541 - Berthold E, Månsson B, Kahn R.
Outcome in juvenile idiopathic arthritis: a population-based study from Sweden.
Arthritis Res Ther. 2019 Oct 28;21(1):218. doi: 10.1186/s13075-019-1994-8.
https://www.ncbi.nlm.nih.gov/pubmed/31661011 - Foley C, Floudas A, Canavan M, Biniecka M, MacDermott EJ, Veale DJ, Mullan RH, Killeen OG, Fearon U.
Increased T cell plasticity with dysregulation of T follicular helper, T peripheral helper and T regulatory cell responses in children with JIA and Down syndrome-associated arthritis
Arthritis Rheumatol. 2019 Oct 27. doi: 10.1002/art.41150. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/31657128 - Luijten MAJ, Terwee CB, van Oers HA, Joosten MMH, van den Berg JM, Schonenberg-Meinema D, Dolman KM, Ten Cate R, Roorda LD, Grootenhuis MA, van Rossum MAJ, Haverman L.
Psychometric properties of the pediatric Patient-Reported Outcomes Measurement Information System (PROMIS®) item banks in a Dutch clinical sample of children with Juvenile Idiopathic Arthritis
Arthritis Care Res (Hoboken). 2019 Oct 18. doi: 10.1002/acr.24094. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/31628731 - Sule S, Fontaine K.
Coronary Artery Disease in Adults with History of Juvenile Arthritis
Arthritis Care Res (Hoboken). 2019 Oct 10. doi: 10.1002/acr.24087. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/31600032 - Stoustrup P, Twilt M.
Improving treatment of the temporomandibular joint in juvenile idiopathic arthritis: let's face it
Expert Rev Clin Immunol. 2019 Oct 16:1-3. doi: 10.1080/1744666X.2020.1676151. [Epub ahead of print].
https://www.ncbi.nlm.nih.gov/pubmed/31575293
SEPTIEMBRE 2019
- Leong JY, Chen P, Yeo JG, Ally F, Chua C, Nur Hazirah S, Poh SL, Pan L, Lai L, Lee ESC, Bathi LDT, Arkachaisri T, Lovell D, Albani S; Pediatric Rheumatology Collaborative Study Group.
Immunome perturbation is present in patients with juvenile idiopathic arthritis who are in remission and will relapse upon anti-TNFα withdrawal.
Ann Rheum Dis. 2019 Sep 20. pii: annrheumdis-2019-216059. doi: 10.1136/annrheumdis-2019-216059. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/31540934
- Glerup M, Stoustrup P, Hauge L, Rypdal V, Nordal E, Frid P, Arnstad ED, Rygg M, Thorarensen O, Ekelund M, Berntson L, Fasth A, Nilsson H, Peltoniemi S, Aalto K, Arte S, Toftedal P, Nielsen S, Kreiborg S, Herlin T, Pedersen TK.
Long-term Outcomes of Temporomandibular Joints in Juvenile Idiopathic Arthritis.
J Rheumatol. 2019 Sep 15. pii: jrheum.190231. doi: 10.3899/jrheum.190231. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/31523047
- Bollhalder A, Patcas R, Eichenberger M, Müller L, Schroeder-Kohler S, Saurenmann RK, Kellenberger CJ.
Magnetic Resonance Imaging Follow-up of Temporomandibular Joint Inflammation, Deformation and Mandibular Growth in Juvenile Idiopathic Arthritis Patients on Systemic Treatment.
J Rheumatol. 2019 Sep 15. pii: jrheum.190168. doi: 10.3899/jrheum.190168. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/31523042
- Khraishi M, Millson B, Woolcott J, Jones H, Marshall L, Ruperto N.
Reduction in the utilization of prednisone or methotrexate in Canadian claims data following initiation of etanercept in pediatric patients with juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2019 Sep 10;17(1):64. doi: 10.1186/s12969-019-0358-x.
https://www.ncbi.nlm.nih.gov/pubmed/31500631
- Glerup M, Thiel S, Rypdal V, Arnstad ED, Ekelund M, Peltoniemi S, Aalto K, Rygg M, Nielsen S, Fasth A, Berntson L, Nordal E, Herlin T; Nordic Study Group of Pediatric Rheumatology (NoSPeR).
Complement lectin pathway protein levels reflect disease activity in juvenile idiopathic arthritis: a longitudinal study of the Nordic JIA cohort.
Pediatr Rheumatol Online J. 2019 Sep 9;17(1):63. doi: 10.1186/s12969-019-0367-9.
https://www.ncbi.nlm.nih.gov/pubmed/31500626
- Hissink Muller PCE, van Braak WG, Schreurs D, Nusman CM, Bergstra SA, Hmke R, Schonenberg-Meinema D, van den Berg JM, Kuijpers TW, Koopman-Keemink Y, van Rossum MAJ, van Suijlekom-Smit LWA, Brinkman DMC, Allaart CF, Ten Cate R, Maas M.
No radiographic wrist damage after treatment to target in recent-onset juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2019 Sep 4;17(1):62. doi: 10.1186/s12969-019-0362-1.
https://www.ncbi.nlm.nih.gov/pubmed/31484539
- Elham Rezaei, Daniel Hogan, Brett Trost, Anthony J Kusalik, Gilles Boire, David A Cabral, Sarah Campillo, Gaëlle Chédeville, Anne-Laure Chetaille, Paul Dancey,
Ciaran Duffy, Karen Watanabe Duffy, Simon W M Eng, John Gordon, Jaime Guzman, Kristin Houghton, Adam M Huber, Roman Jurencak, Bianca Lang, Ronald M Laxer, Kimberly Morishita, Kiem G Oen, Ross E Petty, Suzanne E Ramsey, Stephen W Scherer, Rosie Scuccimarri, Lynn Spiegel, Elizabeth Stringer, Regina M Taylor-Gjevre, Shirley M L Tse, Lori B Tucker, Stuart E Turvey, Susan Tupper, Richard F Wintle, Rae S M Yeung, Alan M Rosenberg, BBOP Study Group.
Associations of clinical and inflammatory biomarker clusters with juvenile idiopathic arthritis categories
Rheumatology, kez382, https://doi.org/10.1093/rheumatology/kez382
https://academic.oup.com/rheumatology/article-abstract/doi/10.1093/rheumatology/kez382/5570882/
- Giancane G, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).
Treatment of juvenile idiopathic arthritis: what's new?
Curr Opin Rheumatol. 2019 Sep;31(5):428-435. doi:10.1097/BOR.0000000000000632.
https://www.ncbi.nlm.nih.gov/pubmed/31169547
- Guzman J, Oen K, Loughin T.
Predicting disease severity and remission in juvenile idiopathic arthritis: are we getting closer?
Curr Opin Rheumatol. 2019 Sep;31(5):436-449.
https://www.ncbi.nlm.nih.gov/pubmed/31085941
AGOSTO 2019
- Brunner HI, Nanda K, Toth M, Foeldvari I, Bohnsack J, Milojevic D, Rabinovich CE, Kingsbury DJ, Marzan K, Chalom E, Horneff G, Kuester RM, Dare JA, Trachana M, Jung LK, Olson J, Minden K, Quartier P, Bereswill M, Kalabic J, Kupper H, Lovell DJ, Martini A, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG).
Safety and Effectiveness of Adalimumab in Patients With Polyarticular Course of Juvenile Idiopathic Arthritis: STRIVE Registry 7-Year Interim Results.
Arthritis Care Res (Hoboken). 2019 Aug 17. doi: 10.1002/acr.24044.
https://www.ncbi.nlm.nih.gov/pubmed/31421019 - Barber CEH, Lix LM, Lacaille D, Marshall DA, Kroeker K, Benseler S, Twilt M, Schmeling H, Barnabe C, Hazlewood GS, Bykerk V, Homik J, Thorne JC, Burt J, Mosher D, Katz S, Shiff NJ.
Testing population-based performance measures identifies gaps in juvenile idiopathic arthritis(JIA) care.
BMC Health Serv Res. 2019 Aug 14;19(1):572.
https://www.ncbi.nlm.nih.gov/pubmed/31412858 - Drechsel P, Stüdemann K, Niewerth M, Horneff G, Fischer-Betz R, Seipelt E, Spähtling-Mestekemper S, Aries P, Zink A, Klotsche J, Minden K.
Pregnancy outcomes in DMARD-exposed patients with juvenile idiopathic arthritis-results from a JIA biologic registry.
Rheumatology (Oxford). 2019 Aug 14. pii: kez309. doi: 10.1093/rheumatology/kez309.
https://www.ncbi.nlm.nih.gov/pubmed/31412128 - Lunt LE, Bosworth A, Bezzant M, Walker-Bone K, Hyrich KL, Thomson W, McDonagh JE, Verstappen SMM.
A UK study: vocational experiences of young adults with juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2019 Aug 6;17(1):54.
https://www.ncbi.nlm.nih.gov/pubmed/31387599 - Shih YJ, Yang YH, Lin CY, Chang CL, Chiang BL.
Enthesitis-related arthritis is the most common category of juvenile idiopathic arthritis in Taiwan and presents persistent active disease.
Pediatr Rheumatol Online J. 2019 Aug 23;17(1):58. https://www.ncbi.nlm.nih.gov/pubmed/31443722
JULIO 2019
- Flanagan ER, Benham H, Figueroa J, Diaz J, Tress J, Sherry DD.
Retrospective review of immobilization vs. immediate resumption of activity in patients with Oligoarticular juvenile idiopathic arthritis following knee injections.
Pediatr Rheumatol Online J. 2019 Jul 12;17(1):42.
https://www.ncbi.nlm.nih.gov/pubmed/31299977 - Verstegen RHJ, McMillan R, Feldman BM, Ito S, Laxer RM
Towards therapeutic drug monitoring of TNF inhibitors for children with juvenile idiopathic arthritis: a scoping review.
Rheumatology (Oxford). 2019 Jul 23. pii: kez285. doi: 10.1093/rheumatology/kez285. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31335941 - Giancane G, Muratore V, Marzetti V, Quilis N, Benavente BS, Bagnasco F, Alongi A, Civino A, Quartulli L, Consolaro A, Ravelli A.
Disease activity and damage in juvenile idiopathic arthritis: methotrexate era versus biologic era.
Arthritis Res Ther. 2019 Jul 8;21(1):168.
https://www.ncbi.nlm.nih.gov/pubmed/31287015 - Shoop-Worrall SJW, Wu Q, Davies R, Hyrich KL, Wedderburn LR.
Predicting disease outcomes in juvenile idiopathic arthritis: challenges, evidence, and new directions.
Lancet Child Adolesc Health. 2019 Jul 19. pii: S2352-4642(19)30188-9. doi: 10.1016/S2352-4642(19)30188-9. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31331873 - Buckley L, Ware E, Kreher G, Wiater L, Mehta J, Burnham JM.
Outcome Monitoring and Clinical Decision Support in Polyarticular Juvenile Idiopathic Arthritis.
J Rheumatol. 2019 Jul 15. pii: jrheum.190268. doi: 10.3899/jrheum.190268. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31308202 - Nordal E, Rypdal V, Arnstad ED, Aalto K, Berntson L, Ekelund M, F et al.
Participation in school and physical education in juvenile idiopathic arthritis in a Nordic long-term cohort study.
Pediatr Rheumatol Online J. 2019 Jul 15;17(1):44.
https://www.ncbi.nlm.nih.gov/pubmed/31307487 - El Miedany Y, El Gaafary M, Lotfy H, El Aroussy N, Mekkawy D, Nasef SI, Farag Y, Almedany S, Wassif G; PRINTO Egypt.
Shared decision-making aid for juvenile idiopathic arthritis: moving from informative patient education to interactive critical thinking.
Clin Rheumatol. 2019 Jul 20. doi: 10.1007/s10067-019-04687-y. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31327085 - Ayaz NA, Karadağ ŞG, Çakmak F, Çakan M, Tanatar A, Sönmez HE.
Leflunomide treatment in juvenile idiopathic arthritis.
Rheumatol Int. 2019 Jul 20. doi: 10.1007/s00296-019-04385-7. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31327053 - Kyvsgaard N, Mikkelsen TS, Thastum M, Christensen AE, Wehner PS, Nysom K, Herlin T.
Increased methotrexate intolerance in juvenile idiopathic arthritis compared to acute lymphoblastic leukaemia in children.
PLoS One. 2019 Jul 11;14(7):e0219539.
https://www.ncbi.nlm.nih.gov/pubmed/31295288 - Lee RR, Rashid A, Ghio D, Thomson W, Cordingley L.
"Seeing Pain Differently": A Qualitative Investigation Into the Differences and Similarities of Pain and Rheumatology Specialists' Interpretation of Multidimensional Mobile Health Pain Data From Children and Young People With Juvenile Idiopathic Arthritis.
JMIR Mhealth Uhealth. 2019 Jul 2;7(7):e12952.
https://www.ncbi.nlm.nih.gov/pubmed/31267979 - Kindgren E, Guerrero-Bosagna C, Ludvigsson J.
Heavy metals in fish and its association with autoimmunity in the development of juvenile idiopathic arthritis: a prospective birth cohort study.
Pediatr Rheumatol Online J. 2019 Jul 2;17(1):33
https://www.ncbi.nlm.nih.gov/pubmed/31266504 - Xiao Y, Liu H, Chen L, Wang Y, Yao X, Jiang X.
Association of microRNAs genes polymorphisms with arthritis: a systematic review and meta-analysis.
Biosci Rep. 2019 Jul 18;39(7). pii: BSR20190298. doi: 10.1042/BSR20190298.
https://www.ncbi.nlm.nih.gov/pubmed/31235484 - Mease PJ, Gladman DD, Collier DH, Ritchlin CT, Helliwell PS, Liu L, Kricorian G, Chung JB.
Etanercept and Methotrexate as Monotherapy or in Combination for Psoriatic Arthritis: Primary Results From a Randomized, Controlled Phase III Trial.
Arthritis Rheumatol 2019 Jul; 71(7):1112-1124.
https://onlinelibrary.wiley.com/doi/abs/10.1002/art.40851
JUNIO 2019
- Murias Loza S, Graña Gil G
Response to: Current Status of Treatment With Intra-Articular Infiltrations in Juvenile Idiopathic Arthritis.
Reumatol Clin. 2019 Jun 26. pii: S1699-258X(19)30106-8. doi: 10.1016/j.reuma.2019.05.006.
https://www.ncbi.nlm.nih.gov/pubmed/31255549 - Khan S, Mancini J, Hopper C, Rennick JE.
Perceptions of methotrexate intolerance and its impact on daily life in school-age children with juvenile idiopathic arthritis.
J Pediatr Nurs. 2019 Jun 26;48:49-54. doi: 10.1016/j.pedn.2019.06.004. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31254860 - Giani T, De Masi S, Maccora I, Tirelli F, Simonini G, Falconi M, Cimaz R
The Influence of Overweight and Obesity on Treatment Response in Juvenile Idiopathic Arthritis.
Front Pharmacol. 2019 Jun 12;10:637. doi: 10.3389/fphar.2019.00637.
https://www.ncbi.nlm.nih.gov/pubmed/31249526 - Hanns L, Radziszewska A, Suffield L, Josephs F, Chaplin H, Peckham H, Sen D, Christie D, Carvalho LA, Ioannou Y.
Anxiety associates with pain and disability but not increased measures of inflammation for adolescent patients with juvenile idiopathic arthritis.
Arthritis Care Res (Hoboken). 2019 Jun 14. doi: 10.1002/acr.24006. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31199593 - Nigrovic PA, Martínez-Bonet M, Thompson SD.
Implications of juvenile idiopathic arthritis genetic risk variants for disease pathogenesis and classification.
Curr Opin Rheumatol. 2019 Jun 4. doi: 10.1097/BOR.0000000000000637. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31169548 - Giancane G, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).
Treatment of juvenile idiopathic arthritis: what's new?
Curr Opin Rheumatol. 2019 Jun 4. doi: 10.1097/BOR.0000000000000632. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31169547 - Busch R, Kollnberger S, Mellins ED.
HLA associations in inflammatory arthritis: emerging mechanisms and clinical implications.
Nat Rev Rheumatol. 2019 Jun;15(6):364-381. doi: 10.1038/s41584-019-0219-5.
https://www.ncbi.nlm.nih.gov/pubmed/31092910
ABRIL 2019
- Ringold S, Angeles-Han ST, Beukelman T, Lovell D, Cuello CA, Becker ML, Colbert RA, Feldman BM, Ferguson PJ, Gewanter H, Guzman J, Horonjeff J, Nigrovic PA, Ombrello MJ, Passo M, Stoll ML, Rabinovich E, Schneider R, Halyabar O, Hays K, Shah AA, Sullivan N, Szymanski AM, Turgunbaev M, Turner A, Reston J.
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis.
Arthritis Care Res (Hoboken). 2019 Apr 25. doi: 10.1002/acr.23870. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31021516 - Stoustrup P, Glerup M, Bilgrau AE, Küseler A, Verna C, Christensen AE, Kristensen KD, Nørholt SE, Twilt M, Herlin T, Pedersen TK.
Cumulative Incidence of Orofacial Manifestations in Early Juvenile Idiopathic Arthritis: A Regional, Three Year Cohort Study
Arthritis Care Res (Hoboken). 2019 Apr 11. doi: 10.1002/acr.23899. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30973675 - Hara R, Umebayashi H, Takei S, Okamoto N, Iwata N, Yamasaki Y, Nakagishi Y, Kizawa T, Kobayashi I, Imagawa T, Kinjo N, Amano N, Takahashi Y, Mori M, Itoh Y, Yokota S.
Intravenous abatacept in Japanese patients with polyarticular-course juvenile idiopathic arthritis: results from a phase III open-label study.
Pediatr Rheumatol Online J. 2019 Apr 30;17(1):17. doi: 10.1186/s12969-019-0319-4.
https://www.ncbi.nlm.nih.gov/pubmed/31039807
MARZO 2019
- Kearsley-Fleet L, Vicente González L, Steinke D, Davies R, De Cock D, Baildam E, Beresford MW, Foster HE, Southwood TR, Thomson W, Hyrich KL; Biologics for Children with Rheumatic Diseases (BCRD) Study and the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study (BSPAR-ETN).
Methotrexate persistence and adverse drug reactions in patients with juvenile idiopathic arthritis.
Rheumatology (Oxford). 2019 Mar 8. pii: kez048. doi: 10.1093/rheumatology/kez048. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30851113 - Pardeo M, Wang J, Ruperto N, Alexeeva E, Chasnyk V, Schneider R, Horneff G, Huppertz HI, Minden K, Onel K, Zemel L, Martin A, Koné-Paut I, Siamopoulou-Mavridou A, Silva CA, Porter-Brown B, Bharucha KN, Brunner HI, De Benedetti F; Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG) .
Neutropenia During Tocilizumab Treatment Is Not Associated With Infection Risk in Systemic or Polyarticular-Course Juvenile Idiopathic Arthritis.
J Rheumatol. 2019 Mar 1. pii: jrheum.180795. doi: 10.3899/jrheum.180795. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30824645 - Doeleman MJH, van Maarseveen EM, Swart JF.
Immunogenicity of biologic agents in juvenile idiopathic arthritis: a systematic review and meta-analysis.
Rheumatology (Oxford). 2019 Feb 26. pii: kez030. doi: 10.1093/rheumatology/kez030. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/30809664 - Shiff NJ, Oen K, Kroeker K, Lix LM.
Trends in Population-Based Incidence and Prevalence of Juvenile Idiopathic Arthritis in Manitoba, Canada.
Arthritis Care Res (Hoboken). 2019 Mar;71(3):413-418.
https://www.ncbi.nlm.nih.gov/pubmed/29799673 - Rabionet R, Remesal A, Mensa-Vilaró A, Murías S, Alcobendas R, González-Roca E, Ruiz-Ortiz E, Antón J, Iglesias E, Modesto C, Comas D, Puig A, Drechsel O, Ossowski S, Yagüe J, Merino R, Estivill X, Arostegui JI.
Biallelic loss-of-function LACC1/FAMIN Mutations Presenting as Rheumatoid Factor-Negative Polyarticular Juvenile Idiopathic Arthritis.
Sci Rep. 2019 Mar 14;9(1):4579.
https://www.ncbi.nlm.nih.gov/pubmed/30872671 - Hinze CH, Foell D, Johnson AL, Spalding SJ, Gottlieb BS, Morris PW, Kimura Y, Onel K, Li SC, Grom AA, Taylor J, Brunner HI, Huggins JL, Nocton JJ, Haines KA, Edelheit BS, Shishov M, Jung LK, Williams CB, Tesher MS, Costanzo DM, Zemel LS, Dare JA, Passo MH, Ede KC, Olson JC, Cassidy EA, Griffin TA, Wagner-Weiner L, Weiss JE, Vogler LB, Rouster-Stevens KA, Beukelman T, Cron RQ, Kietz D, Schikler K, Mehta J, Ting TV, Verbsky JW, Eberhard AB, Huang B, Giannini EH, Lovell DJ.
Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy.
Arthritis Rheumatol. 2019 Mar;71(3):451-459.
https://www.ncbi.nlm.nih.gov/pubmed/30225949 - Rosser EC, Lom H, Bending D, Duurland CL, Bajaj-Elliott M, Wedderburn LR.
Innate Lymphoid Cells and T Cells Contribute to the Interleukin-17A Signature Detected in the Synovial Fluid of Patients With Juvenile Idiopathic Arthritis.
Arthritis Rheumatol. 2019 Mar;71(3):460-467.
https://www.ncbi.nlm.nih.gov/pubmed/30350355 - Sperling CD, Kjaer SK, Hargreave M, Jensen A.
Risk of juvenile idiopathic arthritis among children conceived after fertility treatment: a nationwide registry-based cohort study.
Hum Reprod. 2019 Mar 30. pii: dez035. doi: 10.1093/humrep/dez035. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30927428 - Lourenço DMR, Kozu K, Aikawa NE, Sallum AME, Campos LMA, Abdo CHN, Pereira RMR, Baracat EC, Bonfá E, Silva CA.
Sexual function in female juvenile idiopathic arthritis patients.
Adv Rheumatol. 2019 Mar 22;59(1):13. doi: 10.1186/s42358-019-0058-8.
https://www.ncbi.nlm.nih.gov/pubmed/30902114 - Pitta AC, Ferreira GRV, Tomioka RB,Elitsur R, Hollenbeck A, Tasan L, Torok KS, Cassidy E, Blasiole B, Parsons E, Acock C, Angelelli J, Angelelli IC.
Efficacy and cost savings with the use of a minimal sedation / anxiolysis protocol for intra-articular corticosteroid injections in children with juvenile idiopathic arthritis: a retrospective review of prospectively collected data.
Pediatr Rheumatol Online J. 2019 Mar 20;17(1):11.
https://www.ncbi.nlm.nih.gov/pubmed/30894194 - Tollisen A, Selvaag AM, Aasland A, Lerdal A, Flatø B.
Longitudinal health status from early disease to adulthood and associated prognostic factors in juvenile idiopathic arthritis.
J Rheumatol. 2019 Mar 15. pii: jrheum.180948. doi: 10.3899/jrheum.180948. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/30877211 - Kavadichanda CG, Seth G, Kumar G, Gulati R, Negi VS.
Clinical correlates of HLA-B*27 and its subtypes in enthesitis-related arthritis variant of juvenile idiopathic arthritis in south Indian Tamil patients.
Int J Rheum Dis. 2019 Mar 18. doi: 10.1111/1756-185X.13551. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30884197
FEBRERO 2019
- Yong SB, Huang JY, Chiou JY, Wei JC.
Adult outcome of juvenile idiopathic arthritis: A nationwide population-based retrospective cohort study in Taiwan.
Int J Rheum Dis. 2019 Feb 27. doi: 10.1111/1756-185X.13527. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30816022 - Eng SWM, Aeschlimann FA, van Veenendaal M, Berard RA, Rosenberg AM, Morris Q, Yeung RSM; ReACCh-Out Research Consortium.
Patterns of joint involvement in juvenile idiopathic arthritis and prediction of disease course: A prospective study with multilayer non-negative matrix factorization.
PLoS Med. 2019 Feb 26;16(2):e1002750. doi: 10.1371/journal.pmed.1002750.
https://www.ncbi.nlm.nih.gov/pubmed/30807586 - Glerup M, Rypdal V, Arnstad ED, Ekelund M, Peltoniemi S, Aalto K, Rygg M, Toftedal P, Nielsen S, Fasth A, Berntson L, Nordal E, Herlin T; Nordic Study Group of Pediatric Rheumatology (NoSPeR)
Long-term outcomes in juvenile idiopathic arthritis: 18 years of follow-up in the population-based Nordic Juvenile Idiopathic Arthritis (JIA) cohort.
Arthritis Care Res (Hoboken). 2019 Feb 14. doi: 10.1002/acr.23853.
https://www.ncbi.nlm.nih.gov/pubmed/30762291 - Kyllönen MS, Kautiainen H, Puolakka K, Vähäsalo P.
The mortality rate and causes of death among juvenile idiopathic arthritis patients in Finland.
Clin Exp Rheumatol. 2019 Feb 11. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/30767877 - Grande SW, Longacre MR, Palmblad K, Montan MV, Berquist RP, Hager A, Kotzbauer G.
Empowering Young People Living With Juvenile Idiopathic Arthritis to Better Communicate With Families and Care Teams: Content Analysis of Semistructured Interviews.
JMIR Mhealth Uhealth. 2019 Feb 22;7(2):e10401. doi: 10.2196/10401.
https://www.ncbi.nlm.nih.gov/pubmed/30794202 - Martínez Del Val E, Rodríguez Martínez A, Sánchez Becerra V, Cruz Rojo J, Enríquez Merayo E, Barral Mena E, de Inocencio Arocena J.
Characteristics of synovial fluid in patients with juvenile idiopathic arthritis
An Pediatr (Barc). 2019 Feb 16. pii: S1695-4033(19)30019-0. doi: 10.1016/j.anpedi.2019.01.004.
https://www.ncbi.nlm.nih.gov/pubmed/30782446 - Panwar J, Tse SML, Lim L, Tolend MA, Radhakrishnan S, Salman M, Moineddin R, Doria AS, Stimec J.
Spondyloarthritis Research Consortium of Canada Scoring System for Sacroiliitis in JuvenileSpondyloarthritis/Enthesitis-related Arthritis: A Reliability, Validity, and Responsiveness Study.
J Rheumatol. 2019 Feb 1. pii: jrheum.180222. doi: 10.3899/jrheum.180222.
https://www.ncbi.nlm.nih.gov/pubmed/30709956 - Beukelman T, Nigrovic PA.
Juvenile Idiopathic Arthritis: An Idea Whose Time Has Gone?
J Rheumatol. 2019 Feb;46(2):124-126. doi: 10.3899/jrheum.180922.
https://www.ncbi.nlm.nih.gov/pubmed/30710000 - Uziel Y.
Juvenile Idiopathic Arthritis-Education, Knowledge, and Patient Outcomes.
J Pediatr. 2019 Feb 5. pii: S0022-3476(19)30113-1.
https://www.ncbi.nlm.nih.gov/pubmed/30737036 - Rumsey DG, Guzman J, Rosenberg AM, Huber AM, Scuccimarri R, Shiff NJ, Bruns A, Feldman BM, Eurich DT; Research in Arthritis in Canadian Children Emphasizing Outcomes Investigators.
Children with Enthesitis Have Worse Quality of Life, Function, and Pain, Irrespective of their Juvenile Arthritis Category.
Arthritis Care Res (Hoboken). 2019 Feb 11. doi: 10.1002/acr.23844.
https://www.ncbi.nlm.nih.gov/pubmed/30740939 - Milatz F, Klotsche J, Niewerth M, Geisemeyer N, Trauzeddel R, Weißbarth-Riedel E, Kallinich T, Peitz J, Hartmann M, Minden K.
Participation in school sports among children and adolescents with juvenile idiopathic arthritis in the German National Paediatric Rheumatologic Database, 2000-2015: results from a prospective observational cohort study.
Pediatr Rheumatol Online J. 2019 Feb 11;17(1):6. doi: 10.1186/s12969-019-0306-9.
https://www.ncbi.nlm.nih.gov/pubmed/30744659 - Tarakçı E, Arman N, Barut K, Adroviç A, Kasapçopur Ö.
Fatigue and sleep in children and adolescents with juvenile idiopathic arthritis:a cross-sectional study
Turk J Med Sci. 2019 Feb 11;49(1):58-65. doi: 10.3906/sag-1711-167.
https://www.ncbi.nlm.nih.gov/pubmed/30761857
ENERO 2019
- Pavo MR, de Inocencio J.
Pediatrician Beliefs about Juvenile Idiopathic Arthritis May Result in Referral Delays: A Spanish National Survey.
J Pediatr. 2019 Jan 21. pii: S0022-3476(18)31812-2. doi: 10.1016/j.jpeds.2018.12.038. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30679051 - Stoustrup P, Resnick CM, Pedersen TK, Abramowicz S, Michelotti A, Küseler A, Verna C, Kellenberger CJ, Berit Nordal E, Caserta G, Jankovska I, Halbig JM, Kristensen KD, Arvidsson LZ, Spiegel L, Stoll ML, Lerman M, Glerup M, Defabianis P, Frid P, Alstergren P, Cron RQ, Ringold S, Nørholt SE, Peltomäki T, Herlin T, Peacock ZS, Twilt M; TMJ Juvenile Arthritis Working Group.
Standardizing Terminology and Assessment for Orofacial Conditions in Juvenile Idiopathic Arthritis: International, Multidisciplinary Consensus-based Recommendations.
J Rheumatol. 2019 Jan 15. pii: jrheum.180785. doi: 10.3899/jrheum.180785. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30647179 - Guzman J, Henrey A, Loughin T, Berard RA, Shiff NJ, Jurencak R, Huber AM, Oen K, Gerhold K, Feldman BM, Scuccimarri R, Houghton K, Chédeville G, Morishita K, Lang B, Dancey P, Rosenberg AM, Barsalou J, Bruns A, Watanabe Duffy K, Benseler S, Duffy CM, Tucker LB; ReACCh-Out Investigators.
Predicting Which Children with Juvenile Idiopathic Arthritis Will Not Attain Early Remission with Conventional Treatment: Results from the ReACCh-Out Cohort.
J Rheumatol. 2019 Jan 15. pii: jrheum.180456. doi: 10.3899/jrheum.180456. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30647178 - De Filippo C, Di Paola M, Giani T, Tirelli F, Cimaz R.
Gut microbiota in children and altered profiles in juvenile idiopathic arthritis.
J Autoimmun. 2019 Jan 9. pii: S0896-8411(18)30650-4. doi: 10.1016/j.jaut.2019.01.001. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30638708
DICIEMBRE 2018
- van Dijkhuizen EHP, Del Chierico F, Malattia C, Russo A, Pires Marafon D, Ter Haar NM, Magni-Manzoni S, Vastert SJ, Dallapiccola B, Prakken B, Martini A, De Benedetti F, Putignani L.
Microbiome analytics of the gut microbiota in juvenile idiopathic arthritis patients: an observational, longitudinal cohort study.
Arthritis Rheumatol. 2018 Dec 28. doi: 10.1002/art.40827. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/30592383 - Sengler C, Zink J, Klotsche J, Niewerth M, Liedmann I, Horneff G, Kessel C, Ganser G, Thon A, Haas JP, Hospach A, Weller-Heinemann F, Heiligenhaus A, Foell D, Zink A, Minden K
Vitamin D deficiency is associated with higher disease activity and the risk for uveitis in juvenile idiopathic arthritis - data from a German inception cohort.
Arthritis Res Ther. 2018 Dec 13;20(1):276. doi: 10.1186/s13075-018-1765-y.
https://www.ncbi.nlm.nih.gov/pubmed/30545399 - Więch P, Sałacińska I, Bazaliński D, Dąbrowski M
Body composition and phase angle as an indicator of nutritional status in children with juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2018 Dec 27;16(1):82. doi: 10.1186/s12969-018-0297-y.
https://www.ncbi.nlm.nih.gov/pubmed/30587206
NOVIEMBRE 2018
- Jeamsripong S, Charuvanij S
Features distinguishing juvenile idiopathic arthritis among children with musculoskeletal complaints.
World J Pediatr. 2018 Nov 29. doi: 10.1007/s12519-018-0212-0. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30498888 - Leong JY, Guan YJ, Albani S, Arkachaisri T
Recent advances in our understanding of the pathogenesis of juvenile idiopathic arthritis and their potential clinical implications.
Expert Rev Clin Immunol. 2018 Nov;14(11):933-944. doi: 10.1080/1744666X.2018.1529757.
https://www.ncbi.nlm.nih.gov/pubmed/30269617
OCTUBRE 2018
- Marino A, Stagi S, Simonini G, Carli N, Caparello MC, Giani T, Pagnini I, De Masi S, Cimaz R.
Growth and body mass index in a cohort of patients with juvenile idiopathic arthritis: effects of second line treatments.
Clin Exp Rheumatol. 2018 Sep-Oct;36(5):929-933. Epub 2018 Jul 19.
https://www.ncbi.nlm.nih.gov/pubmed/30148444 - Leschied JR, Smith EA, Baker S, Khalatbari S, Aronovich S.
Contrast-enhanced MRI compared to direct joint visualization at arthroscopy in pediatric patients with suspected temporomandibular joint synovitis
Pediatr Radiol. 2018 Oct 31. doi: 10.1007/s00247-018-4291-9. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30382321 - Kearsley-Fleet L, Sampath S, McCann LJ, Baildam E, Beresford MW, Davies R, De Cock D, Foster HE, Southwood TR, Thomson W, Hyrich KL.
Use and effectiveness of rituximab in children and young people with juvenile idiopathic arthritisin a cohort study in the United Kingdom
Rheumatology (Oxford). 2018 Oct 24. doi: 10.1093/rheumatology/key306. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30358861 - Oude Voshaar MAH, Das Gupta Z, Bijlsma JWJ, Boonen A, Chau J, Courvoisier DS, Curtis JR, Ellis B, Ernestam S, Gossec L, Hale C, Hornjeff J, Leung KYY, Lidar M, Mease P, Michaud K, Mody GM, Ndosi M, Opava CH, Pinheiro GRC, Salt M, Soriano ER, Taylor WJ, Voshaar MJH, Weel AEAM, de Wit M, Wulffraat N, van de Laar MAFJ, Vonkeman HE.
The International Consortium for Health Outcome Measurement (ICHOM)Set of Outcomes that Matter to People Living with Inflammatory Arthritis Consensus from an international Working Group
Arthritis Care Res (Hoboken). 2018 Oct 24. doi: 10.1002/acr.23799. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30358135 - Nørgaard M, Herlin T.
Specific Sport Habits, Leisure-Time and School-Educational Physical Activity in Children with Juvenile Idiopathic Arthritis - Patterns and Barriers
Arthritis Care Res (Hoboken). 2018 Oct 24. doi: 10.1002/acr.23795. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/30354015 - Rosser EC, Lom H, Bending D, Duurland CL, Bajaj-Elliott M, Wedderburn LR.
Brief Report: Innate lymphoid cells and T-cells contribute to the IL-17A signature detected in the synovial fluid of patients with Juvenile Idiopathic Arthritis
Arthritis Rheumatol. 2018 Oct 22. doi: 10.1002/art.40731. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30350355
SEPTIEMBRE 2018
- Cabrera N, Lega JC, Kassai B, Wouters C, Kondi A, Cannizzaro E, Woerner A, Chausset A, Roethlisberger S, Jeanneret C, Aeschlimann F, Malik S, Duquesne A, Kaiser D, Higel L, Maes A, Berthet G, Hentgen V, Kone-Paut I, Belot A, Hofer M.
Safety of biological agents in paediatric rheumatic diseases: a real-life multicenter retrospective study using the JIRcohorte database.
Joint Bone Spine. 2018 Sep 7. pii: S1297-319X(18)30283-5. doi: 10.1016/j.jbspin.2018.08.003. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30201476 - Scott C, Chan M, Slamang W, Okong'o L, Petty R, Laxer RM, Katsicas MM, Fredrick F, Chipeta J, Faller G, Pileggi G, Saad-Magalhaes C, Wouters C, Foster HE, Kubchandani R, Ruperto N, Russo R.
Juvenile arthritis management in less resourced countries (JAMLess): consensus recommendations from the Cradle of Humankind.
Clin Rheumatol. 2018 Sep 28. doi: 10.1007/s10067-018-4304-y. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30267356 - Öman A, Hansson T, Carlsson M, Berntson L.
Evaluation of screening for celiac disease in children with juvenile idiopathic arthritis.
Acta Paediatr. 2018 Sep 28. doi: 10.1111/apa.14598. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30265401 - Hunter H.
Etanercept or adalimumab: which is a better biological therapy for juvenile idiopathic arthritis?
Arch Dis Child. 2018 Sep 27. pii: archdischild-2018-315528. doi: 10.1136/archdischild-2018-315528. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30262509 - Nieto-González JC, Monteagudo I
Estado actual del tratamiento con infiltraciones intraarticulares en la artritis idiopática juvenil
Reumatol Clin. 2018 Sep 19. pii: S1699-258X(18)30174-8. doi: 10.1016/j.reuma.2018.07.015. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30243614 - Ventura-Ríos L, Faugier E, Barzola L, De la Cruz-Becerra LB, Sánchez-Bringas G, García AR, Maldonado R, Roth J, Hernández-Díaz C.
Reliability of ultrasonography to detect inflammatory lesions and structural damage in juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2018 Sep 17;16(1):58
https://www.ncbi.nlm.nih.gov/pubmed/30223838 - Chi H, Teng J, Yang C, Su Y.
Bone tumors developed in patients with juvenile inflammatory arthritis after anti-TNFα therapy.
Immunotherapy. 2018 Sep;10(12):1033-1039.
https://www.ncbi.nlm.nih.gov/pubmed/30185135 - Powell AP, English J.
Exercise for Athletes with Inflammatory Arthritis.
Curr Sports Med Rep. 2018 Sep;17(9):302-307
https://www.ncbi.nlm.nih.gov/pubmed/30204634
AGOSTO 2018
- Demir F, Çebi AH, Kalyoncu M.
Evaluation of plasma microRNA expressions in patients with juvenile idiopathic arthritis.
Clin Rheumatol. 2018 Aug 31. doi: 10.1007/s10067-018-4277-x. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30171379 - Alexeeva E, Dvoryakovskaya T, Denisova R, Sleptsova T, Isaeva K, Chomahidze A, Fetisova A, Mamutova A, Alshevskaya A, Gladkikh V, Moskalev A.
Comparative Analysis of the Etanercept Efficacy in Children with Juvenile Idiopathic Arthritis Under the Age of 4 Years and Children of Older Age Groups Using the Propensity Score Matching Method.
Mod Rheumatol. 2018 Aug 28:1-20. doi: 10.1080/14397595.2018.1516329. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30149747 - Smith CJF, Förger F, Bandoli G, Chambers CD.
Factors associated with preterm delivery among women with rheumatoid arthritis and juvenile idiopathic arthritis.
Arthritis Care Res (Hoboken). 2018 Aug 21. doi: 10.1002/acr.23730. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30133181 - Bašić J, Vojinović J, Jevtović-Stoimenov T, Despotović M, Sušić G,Lazarević D, Milošević V, Cvetković M, Pavlović D.
Vitamin D receptor gene polymorphism influences lipid profile in patients with juvenile idiopathic arthritis.
Clin Rheumatol. 2018 Aug 20. doi: 10.1007/s10067-018-4264-2. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30128913 - Ferguson ID, Griffin P, Michel JJ, Yano H, Gaffen SL, Mueller RG, Dvergsten JA, Piganelli JD, Rosenkranz ME, Kietz DA, Vallejo AN.
T Cell Receptor-Independent, CD31/IL-17A-Driven Inflammatory Axis Shapes Synovitis in Juvenile Idiopathic Arthritis.
Front Immunol. 2018 Aug 6;9:1802. doi: 10.3389/fimmu.2018.01802.
https://www.ncbi.nlm.nih.gov/pubmed/30127787 - Okamoto N, Yokota S, Takei S, Okura Y, Kubota T, Shimizu M, Nozawa T, Iwata N, Umebayashi H, Kinjo N, Kunishima T, Yasumura J, Mori M.
Clinical Practice Guidance for Juvenile Idiopathic Arthritis (JIA) 2018.
Mod Rheumatol. 2018 Aug 21:1-53. doi: 10.1080/14397595.2018.1514724. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30126298 - Rochette E, Merlin E, Hourdé C, Evrard B, Peraira B, Echaubard S, Duché P.
Inflammatory Response 24 h Post-Exercise in Youth with Juvenile Idiopathic Arthritis.
Int J Sports Med. 2018 Aug 17. doi: 10.1055/a-0640-9063. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30119133 - Zanwar A, Phatak S, Aggarwal A.
Prospective validation of the Juvenile Spondyloarthritis Disease Activity Index in children with enthesitis-related arthritis.
Rheumatology (Oxford). 2018 Aug 9. doi: 10.1093/rheumatology/key246. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30107576 - Rocha FAC, Landim JIVD, Aguiar MG, Accioly JPE, Lechiu CN, Costa LHA, Júnior CNR, da Rocha LN, Rocha HAL.
Evaluation of disease activity in a low-income juvenile idiopathic arthritis cohort.
Rheumatol Int. 2018 Aug 13. doi: 10.1007/s00296-018-4128-8. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30101369 - Throm AA, Moncrieffe H, Orandi AB, Pingel JT, Geurs TL, Miller HL, Daugherty AL, Malkova ON, Lovell DJ, Thompson SD, Grom AA, Cooper MA, Oh ST, French AR.
Identification of enhanced IFN-γ signaling in polyarticular juvenile idiopathic arthritis with mass cytometry.
JCI Insight. 2018 Aug 9;3(15). pii: 121544. doi: 10.1172/jci.insight.121544. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30089725 - Waite-Jones JM, Swallow V.
Peer-based social support for young-people with Juvenile Arthritis: views of young people, parents/carers and healthcare professionals within the UK.
J Pediatr Nurs. 2018 Aug 2. pii: S0882-5963(18)30205-7. doi: 10.1016/j.pedn.2018.07.012. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30078727 - Mars NJ, Kerola AM, Kauppi MJ, Pirinen M, Elonheimo O, Sokka-Isler T.
Healthcare costs and outcomes in adult patients with juvenile idiopathic arthritis: a population-based study.
Scand J Rheumatol. 2018 Aug 2:1-7. doi: 10.1080/03009742.2018.1475580. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30070935 - Mars NJ, Kerola AM, Kauppi MJ, Pirinen M, Elonheimo O, Sokka-Isler T.
Healthcare costs and outcomes in adult patients with juvenile idiopathic arthritis: a population-based study.
Scand J Rheumatol. 2018 Aug 2:1-7. doi: 10.1080/03009742.2018.1475580. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30070935 - Weiss PF, Colbert RA.
Juvenile Spondyloarthritis: A Distinct Form of Juvenile Arthritis.
Pediatr Clin North Am. 2018 Aug;65(4):675-690. doi: 10.1016/j.pcl.2018.03.006.
https://www.ncbi.nlm.nih.gov/pubmed/30031493 - Bharucha KN, Brunner HI, Calvo Penadés I, Nikishina I, Rubio-Pérez N, Oliveira S, Kobusinska K, Schmeling H, Sztajnbok F, Weller-Heinemann F, Zholobova E, Zulian F, Allen R, Chaitow J, Frane J, Wells C, Ruperto N, De Benedetti F; Paediatric Rheumatology International Trials Organisation and the Pediatric Rheumatology Collaborative Study Group.
Growth During Tocilizumab Therapy for Polyarticular-course Juvenile Idiopathic Arthritis: 2-year Data from a Phase III Clinical Trial.
J Rheumatol. 2018 Aug;45(8):1173-1179. doi: 10.3899/jrheum.170326. Epub 2018 Jul 1.
https://www.ncbi.nlm.nih.gov/pubmed/29961686
JULIO 2018
- Minden K, Horneff G, Niewerth M, Seipelt E, Aringer M, Aries P, Foeldvari I, Haas JP, Klein A, Tatsis S, Tenbrock K, Zink A, Klotsche J.
The time of DMARD start in Juvenile Idiopathic Arthritis determines the likelihood of a drug-free remission in young adulthood.
Arthritis Care Res (Hoboken). 2018 Jul 25. doi: 10.1002/acr.23709. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/30044538 - Arnstad ED, Rypdal V, Peltoniemi S, Herlin T, Berntson L, Fasth A, Nielsen S, Glerup M, Ekelund M, Zak M, Aalto K, Nordal E, Romundstad PR, Rygg M; Nordic Study Group of Pediatric Rheumatology (NoSPeR).
Early self-reported pain in juvenile idiopathic arthritis (JIA) is related to long-term outcomes. Results from the Nordic JIA cohort study.
Arthritis Care Res (Hoboken). 2018 Jul 28. doi: 10.1002/acr.23715. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30055093 - Rahimi H, Twilt M, Herlin T, Spiegel L, Pedersen TK, Küseler A, Stoustrup P.
Orofacial symptoms and oral health-related quality of life in juvenile idiopathic arthritis: a two-year prospective observational study.
Pediatr Rheumatol Online J. 2018 Jul 13;16(1):47. doi: 10.1186/s12969-018-0259-4.
https://www.ncbi.nlm.nih.gov/pubmed/30005677 - Simonini G, Ferrara G, Pontikaki I, Scoccimarro E, Giani T, Taddio A, Meroni PL, Cimaz R.
Flares After Withdrawal of Biologic Therapies in Juvenile Idiopathic Arthritis: Clinical and Laboratory Correlates of Remission Duration.
Arthritis Care Res (Hoboken). 2018 Jul;70(7):1046-1051. doi: 10.1002/acr.23435. Epub 2018 Apr 24.
https://www.ncbi.nlm.nih.gov/pubmed/28973842 - Brunner HI, Tzaribachev N, Vega-Cornejo G, Louw I, Berman A, Calvo Penadés I, Antón J, Ávila-Zapata F, Cuttica R, Horneff G, Foeldvari I, Keltsev V, Kingsbury DJ, Viola DO, Joos R, Lauwerys B, Paz Gastañaga ME, Rama ME, Wouters C, Bohnsack J, Breedt J, Fischbach M, Lutz T, Minden K, Miraval T, Ally MMTM, Rubio-Pérez N, Solau Gervais E, van Zyl R, Li X, Nys M, Wong R, Banerjee S, Lovell DJ, Martini A, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG).
Subcutaneous Abatacept in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: Results From a Phase III Open-Label Study.
Arthritis Rheumatol. 2018 Jul;70(7):1144-1154. doi: 10.1002/art.40466. Epub 2018 May 20.
https://www.ncbi.nlm.nih.gov/pubmed/29481737 - Klotsche J, Minden K, Niewerth M, Horneff G.
Time spent in inactive disease before MTX withdrawal is relevant with regard to the flare risk in patients with JIA.
Ann Rheum Dis.2018 Jul;77(7):996-1002. doi: 10.1136/annrheumdis-2017-211968. Epub 2018 Feb 16.
https://www.ncbi.nlm.nih.gov/pubmed/29453217
JUNIO 2018
- Piancino MG, Cannavale R, Dalmasso P, Tonni I, Garagiola U, Perillo L, Olivieri AN.
Cranial structure and condylar asymmetry of patients with juvenile idiopathic arthritis: a risky growth pattern.
Clin Rheumatol. 2018 Jun 21. doi: 10.1007/s10067-018-4180-5
https://www.ncbi.nlm.nih.gov/pubmed/29931517 - van Dijkhuizen EHP, Aidonopoulos O, Ter Haar NM, Pires Marafon D, Magni-Manzoni S, Ioannidis YE, Putignani L, Vastert SJ, Malattia C, De Benedetti F, Martini A; MD-Paedigree Consortium.
Prediction of inactive disease in juvenile idiopathic arthritis: a multicentre observational cohort study.
Rheumatology (Oxford). 2018 Jun 20. doi: 10.1093/rheumatology/key148
https://www.ncbi.nlm.nih.gov/pubmed/29931340 - Ohl K, Nickel H, Moncrieffe H, Klemm P, Scheufen A, Föll D, Wixler V, Schippers A, Wagner N, Wedderburn LR, Tenbrock K.
The transcription factor CREM drives an inflammatory phenotype of T cells in oligoarticular juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2018 Jun 20;16(1):39. doi: 10.1186/s12969-018-0253-x
https://www.ncbi.nlm.nih.gov/pubmed/29925386 - Ferrara G, Pastore S, Sancin L, Torelli L, Radillo O, Bramuzzo M, Bibalo C, Tommasini A, Ventura A, Taddio A.
Fecal Calprotectin to Detect Inflammatory Bowel Disease in Juvenile Idiopathic Arthritis.
J Rheumatol. 2018 Jun 15. pii: jrheum.171200. doi: 10.3899/jrheum.171200
https://www.ncbi.nlm.nih.gov/pubmed/29907671 - Isola G, Perillo L, Migliorati M, Matarese M, Dalessandri D, Grassia V, Alibrandi A, Matarese G.
The impact of temporomandibular joint arthritis on functional disability and global health in patients with juvenile idiopathic arthritis.
Eur J Orthod. 2018 Jun 6. doi: 10.1093/ejo/cjy034
https://www.ncbi.nlm.nih.gov/pubmed/29878100 - Unal E, Batu ED, Sonmez HE, Arici ZS, Arin G, Karaca NB, Sag E, Demir S, Hakli DA, Ozcadirci A, Oflaz FB, Alpar R, Bilginer Y, Ozen S.
A new biopsychosocial and clinical questionnaire to assess juvenile idiopathic arthritis: JAB-Q.
Rheumatol Int. 2018 Jun 5. doi: 10.1007/s00296-018-4075-4
https://www.ncbi.nlm.nih.gov/pubmed/29869009 - Zisman D, Stoll ML, Butbul Aviel Y, Mellins ED.
Juvenile Psoriatic Arthritis: A Report from the GRAPPA 2017 Annual Meeting.
J Rheumatol Suppl. 2018 Jun;94:11-16. doi: 10.3899/jrheum.180131
https://www.ncbi.nlm.nih.gov/pubmed/29858347 - Naz S, Asif M, Naz F, Farooq H, Hamid MH.
Spectrum of Joint Deformities in Children with Juvenile Idiopathic Arthritis.
J Coll Physicians Surg Pak. 2018 Jun;28(6):470-473. doi: 10.29271/jcpsp.2018.06.470
https://www.ncbi.nlm.nih.gov/pubmed/29848426 - Bishop JC, Britton JF, Murphy AM, Sule S, Mitchell S, Takemoto C, Collaco JM, Karnsakul W, Cuffari C, Dietz E, Bodurtha J.
Juvenile Idiopathic Arthritis Associated with Combined JP-HHT Syndrome: A Novel Phenotype Associated with a Novel Variant in SMAD4.
J Pediatr Genet. 2018 Jun;7(2):78-82. doi: 10.1055/s-0037-1609060
https://www.ncbi.nlm.nih.gov/pubmed/29707409 - Ravelli A, Consolaro A, Horneff G, Laxer RM, Lovell DJ, Wulffraat NM, Akikusa JD, Al-Mayouf SM, Antón J, Avcin T, Berard RA, Beresford MW, Burgos-Vargas R, Cimaz R, De Benedetti F, Demirkaya E, Foell D, Itoh Y, Lahdenne P, Morgan EM, Quartier P, Ruperto N, Russo R, Saad-Magalhães C, Sawhney S, Scott C, Shenoi S, Swart JF, Uziel Y, Vastert SJ, Smolen JS.
Treating juvenile idiopathic arthritis to target: recommendations of an international task force.
Ann Rheum Dis. 2018 Jun;77(6):819-828. doi: 10.1136/annrheumdis-2018-213030
https://www.ncbi.nlm.nih.gov/pubmed/29643108 - Heath-Watson S, Sule S.
Living with Juvenile Idiopathic Arthritis: Parent and Physician Perspectives.
Rheumatol Ther. 2018 Jun;5(1):1-4. doi: 10.1007/s40744-018-0098-2
https://www.ncbi.nlm.nih.gov/pubmed/29480358 - Hinks A, Marion MC, Cobb J, Comeau ME, Sudman M, Ainsworth HC, Bowes J; Juvenile Idiopathic Arthritis Consortium for Immunochip, Becker ML, Bohnsack JF, Haas JP, Lovell DJ, Mellins ED, Nelson JL, Nordal E, Punaro M, Reed AM, Rose CD, Rosenberg AM, Rygg M, Smith SL, Stevens AM, Videm V, Wallace CA, Wedderburn LR, Yarwood A, Yeung RSM, Langefeld CD, Thompson SD, Thomson W, Prahalad S.
Brief Report: The Genetic Profile of Rheumatoid Factor-Positive Polyarticular Juvenile Idiopathic Arthritis Resembles That of Adult Rheumatoid Arthritis.
Arthritis Rheumatol. 2018 Jun;70(6):957-962. doi: 10.1002/art.40443
https://www.ncbi.nlm.nih.gov/pubmed/29426059 - Bridgewood C, Watad A, Cuthbert RJ, McGonagle D.
Spondyloarthritis: new insights into clinical aspects, translational immunology and therapeutics.
Curr Opin Rheumatol. 2018 Jun 9. doi: 10.1097/BOR.0000000000000529
https://www.ncbi.nlm.nih.gov/pubmed/29889692 - Ravelli A, Consolaro A, Horneff G, Laxer RM, Lovell DJ, Wulffraat NM, Akikusa JD, Al-Mayouf SM, Antón J, Avcin T, Berard RA, Beresford MW, Burgos-Vargas R, Cimaz R, De Benedetti F, Demirkaya E, Foell D, Itoh Y, Lahdenne P, Morgan EM, Quartier P, Ruperto N, Russo R, Saad-Magalhães C, Sawhney S, Scott C, Shenoi S, Swart JF, Uziel Y, Vastert SJ, Smolen JS.
Treating juvenile idiopathic arthritis to target: recommendations of an international task force.
Ann Rheum Dis. 2018 Jun;77(6):819-828. doi: 10.1136/annrheumdis-2018-213030.
https://www.ncbi.nlm.nih.gov/pubmed/29643108 - Zisman D, Stoll ML, Butbul Aviel Y, Mellins ED.
Juvenile Psoriatic Arthritis: A Report from the GRAPPA 2017 Annual Meeting.
J Rheumatol Suppl. 2018 Jun;94:11-16. doi: 10.3899/jrheum.180131.
https://www.ncbi.nlm.nih.gov/pubmed/29858347 - Helliwell PS, Gladman DD, Gottlieb AB.
Prologue: 2017 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
J Rheumatol Suppl. 2018 Jun;94:1-3. doi: 10.3899/jrheum.180129.
https://www.ncbi.nlm.nih.gov/pubmed/29858345 - Naz S, Asif M, Naz F, Farooq H, Hamid MH.
Spectrum of Joint Deformities in Children with Juvenile Idiopathic Arthritis.
J Coll Physicians Surg Pak. 2018 Jun;28(6):470-473. doi: 10.29271/jcpsp.2018.06.470.
https://www.ncbi.nlm.nih.gov/pubmed/29848426
MAYO 2018
- Ravelli A, Consolaro A, Horneff G, Laxer RM, Lovell DJ, Wulffraat NM, Akikusa JD, Al-Mayouf SM, Antón J, Avcin T, Berard RA, Beresford MW, Burgos-Vargas R, Cimaz R, De Benedetti F, Demirkaya E, Foell D, Itoh Y, Lahdenne P, Morgan EM, Quartier P, Ruperto N, Russo R, Saad-Magalhães C, Sawhney S, Scott C, Shenoi S, Swart JF, Uziel Y, Vastert SJ, Smolen JS.
Treating juvenile idiopathic arthritis to target: recommendations of an international task force.
Ann Rheum Dis. 2018 Jun;77(6):819-828. doi: 10.1136/annrheumdis-2018-213030.
https://www.ncbi.nlm.nih.gov/pubmed/29643108 - Ringold S, Nigrovic PA, Feldman BM, Tomlinson GA, von Scheven E, Wallace CA, Huber AM, Schanberg LE, Li SC, Weiss PF, Fuhlbrigge RC, Morgan EM, Kimura Y.
The Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans: Toward Comparative Effectiveness in the Pediatric Rheumatic Diseases.
Arthritis Rheumatol. 2018 May;70(5):669-678. doi: 10.1002/art.40395. Epub 2018 Mar 31.
https://www.ncbi.nlm.nih.gov/pubmed/29333701 - Rypdal V, Arnstad ED, Aalto K, Berntson L, Ekelund M, Fasth A, Glerup M, Herlin T, Nielsen S, Peltoniemi S, Zak M, Rygg M, Rypdal M, Nordal E; Nordic Study Group of Pediatric Rheumatology (NoSPeR).
Predicting unfavorable long-term outcome in juvenile idiopathic arthritis: results from the Nordic cohort study.
Arthritis Res Ther. 2018 May 3;20(1):91. doi: 10.1186/s13075-018-1571-6.
https://www.ncbi.nlm.nih.gov/pubmed/29724248 - Karacan I, Uğurlu S, Şahin S, Everest E, Kasapçopur Ö, Tolun A, Özdoğan H, Turanli ET.
LACC1 Gene Defects in Familial Form of Juvenile Arthritis.
J Rheumatol. 2018 May;45(5):726-728. doi: 10.3899/jrheum.170834. No abstract available.
https://www.ncbi.nlm.nih.gov/pubmed/29717096 - Listing M, Mönkemöller K, Liedmann I, Niewerth M, Sengler C, Listing J, Foell D, Heiligenhaus A, Klein A, Horneff G, Ganser G, Haas JP, Klotsche J, Minden K.
The majority of patients with newly diagnosed juvenile idiopathic arthritis achieve a health-related quality of life that is similar to that of healthy peers: results of the German multicenter inception cohort (ICON).
Arthritis Res Ther. 2018 May 30;20(1):106. doi: 10.1186/s13075-018-1588-x.
https://www.ncbi.nlm.nih.gov/pubmed/29848349 - Aquilani A, Pires Marafon D, Marasco E, Nicolai R, Messia V, Perfetti F, Magni-Manzoni S, De Benedetti F.
Predictors of Flare Following Etanercept Withdrawal in Patients with Rheumatoid Factor-negative Juvenile Idiopathic Arthritis Who Reached Remission while Taking Medication.
J Rheumatol. 2018 May 1. pii: jrheum.170794. doi: 10.3899/jrheum.170794. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29717035 - Finch SL, Rosenberg AM, Vatanparast H.
Vitamin D and juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2018 May 16;16(1):34. doi: 10.1186/s12969-018-0250-0. Review.
https://www.ncbi.nlm.nih.gov/pubmed/29769136 - Tollisen A, Selvaag AM, Aulie HA, Lilleby V, Aasland A, Lerdal A, Flatø B.
Physical Functioning, Pain, and Health-Related Quality of Life in Adults With Juvenile Idiopathic Arthritis: A Longitudinal 30-Year Followup Study.
Arthritis Care Res (Hoboken). 2018 May;70(5):741-749. doi: 10.1002/acr.23327. Epub 2018 Mar 7.
https://www.ncbi.nlm.nih.gov/pubmed/28732134 - Nalbanti P, Kanakoudi-Tsakalidou F, Trachana M, Pratsidou-Gertsi P, Farmaki E, Bamidis P, Papachristou F.
Juvenile idiopathic arthritis in the biologic era: predictors of the disease progression and need for early introduction of biologic treatment.
Rheumatol Int. 2018 May 29. doi: 10.1007/s00296-018-4062-9. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29845429 - Salonen PH, Säilä H, Salonen JH, Linna M, Helminen M, Kauppi MJ.
Pneumonia in children with juvenile idiopathic arthritis in Finland 1999-2014: a nationwide retrospective register linkage study.
Clin Exp Rheumatol. 2018 May-Jun;36(3):502-507. Epub 2017 Dec 27.
https://www.ncbi.nlm.nih.gov/pubmed/29303705 - Rapoff MA.
Assessing Barriers to Therapeutic Regimens for Young People with Juvenile Idiopathic Arthritis.
J Rheumatol. 2018 May;45(5):588-589. doi: 10.3899/jrheum.171399. No abstract available.
https://www.ncbi.nlm.nih.gov/pubmed/29717093 - Favier LA, Taylor J, Loiselle Rich K, Jones KB, Vora SS, Harris JG, Gottlieb BS, Robbins L, Lai JT, Lee T, Kohlheim M, Gill J, Bouslaugh L, Young A, Griffin N, Morgan EM, Modi AC.
Barriers to Adherence in Juvenile Idiopathic Arthritis: A Multicenter Collaborative Experience and Preliminary Results.
J Rheumatol. 2018 May;45(5):690-696. doi: 10.3899/jrheum.171087. Epub 2018 Feb 1.
https://www.ncbi.nlm.nih.gov/pubmed/29419467 - Zisman D, Stoll ML, Butbul Aviel Y, Mellins ED.
Juvenile Psoriatic Arthritis: A Report from the GRAPPA 2017 Annual Meeting.
J Rheumatol Suppl. 2018 Jun;94:11-16. doi: 10.3899/jrheum.180131.
https://www.ncbi.nlm.nih.gov/pubmed/29858347 - Stoll ML, Amin D, Powell KK, Poholek CH, Strait RH, Aban I, Beukelman T, Young DW, Cron RQ, Waite PD.
Risk Factors for Intraarticular Heterotopic Bone Formation in the Temporomandibular Joint in Juvenile Idiopathic Arthritis.
J Rheumatol. 2018 May 15. pii: jrheum.171306. doi: 10.3899/jrheum.171306. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29764966 - Samad A, Stoll ML, Lavi I, Hsu JJ, Strand V, Robinson TN, Mellins ED, Zisman D; CARRA Legacy Registry Investigators.
Adiposity in Juvenile Psoriatic Arthritis.
J Rheumatol. 2018 Mar;45(3):411-418. doi: 10.3899/jrheum.170598. Epub 2017 Dec 15.
https://www.ncbi.nlm.nih.gov/pubmed/29247150 - Fellas A, Singh-Grewal D, Santos D, Coda A.
Physical Examination Tools Used to Identify Swollen and Tender Lower Limb Joints in Juvenile Idiopathic Arthritis: A Scoping Review.
Arthritis. 2018 May 15;2018:3408162. doi: 10.1155/2018/3408162. eCollection 2018. Review.
https://www.ncbi.nlm.nih.gov/pubmed/29862076 - Helliwell PS, Gladman DD, Gottlieb AB.
Prologue: 2017 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
J Rheumatol Suppl. 2018 Jun;94:1-3. doi: 10.3899/jrheum.180129.
https://www.ncbi.nlm.nih.gov/pubmed/29858345 - Janicka-Szczepaniak M, Orczyk K, Szymbor K, Chlebna-Sokół D, Smolewska E.
Is it possible to predict a risk of osteoporosis in patients with juvenile idiopathic arthritis? A study of serum levels of bone turnover markers.
Acta Biochim Pol. 2018 May 30. doi: 10.18388/abp.2017_2561. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29850656 - Naz S, Asif M, Naz F, Farooq H, Hamid MH.
Spectrum of Joint Deformities in Children with Juvenile Idiopathic Arthritis.
J Coll Physicians Surg Pak. 2018 Jun;28(6):470-473. doi: 10.29271/jcpsp.2018.06.470.
https://www.ncbi.nlm.nih.gov/pubmed/29848426 - Feger DM, Longson N, Dodanwala H, Ostrov BE, Olsen NJ, June RR.
Comparison of Adults With Polyarticular Juvenile Idiopathic Arthritis to Adults With Rheumatoid Arthritis: A Cross-sectional Analysis of Clinical Features and Medication Use.
J Clin Rheumatol. 2018 May 17. doi: 10.1097/RHU.0000000000000819. [Epub ahead of print
https://www.ncbi.nlm.nih.gov/pubmed/29781829
ABRIL 2018
- Shoop-Worrall SJ, Verstappen SM, McDonagh JE, Baildam E, Chieng A, Davidson J, Foster H, Ioannou Y, McErlane F, Wedderburn LR, Thomson W, Hyrich KL.
Long term outcomes following achievement of clinically inactive disease in juvenile idiopathic arthritis: the importance of definition.
Arthritis Rheumatol. 2018 Apr 12. doi: 10.1002/art.40519. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/29648683 - Ravelli A, Consolaro A, Horneff G, Laxer RM, Lovell DJ, Wulffraat NM, Akikusa JD, Al-Mayouf SM, Antón J, Avcin T, Berard RA, Beresford MW, Burgos-Vargas R, Cimaz R, De Benedetti F, Demirkaya E, Foell D, Itoh Y, Lahdenne P, Morgan EM, Quartier P, Ruperto N, Russo R, Saad-Magalhães C, Sawhney S, Scott C, Shenoi S, Swart JF, Uziel Y, Vastert SJ, Smolen JS.
Treating juvenile idiopathic arthritis to target: recommendations of an international task force.
Ann Rheum Dis. 2018 Apr 11. pii: annrheumdis-2018-213030. doi: 10.1136/annrheumdis-2018-213030. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29643108 - Bielak M, Husmann E, Weyandt N, Haas JP, Hügle B, Horneff G, Neudorf U, Lutz T, Lilienthal E, Kallinich T, Tenbrock K, Berendes R, Niehues T, Wittkowski H, Weißbarth-Riedel E, Heubner G, Oommen P, Klotsche J, Foell D, Lainka E.
IL-6 blockade in systemic juvenile idiopathic arthritis - achievement of inactive disease and remission (data from the German AID-registry).
Pediatr Rheumatol Online J. 2018 Apr 5;16(1):22. doi: 10.1186/s12969-018-0236-y.
https://www.ncbi.nlm.nih.gov/pubmed/29622022 - El-Barbary AM, Hussein MS, Almedany SH, Rageh EM, Alsalawy AM, Aboelhawa MA, Elkholy RM, Shafik NM, Elharoun AS.
Role of Interleukin 37 as a Novel Proangiogenic Factor in Juvenile Idiopathic Arthritis.
J Clin Rheumatol. 2018 Apr 16. doi: 10.1097/RHU.0000000000000779. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/29683837 - de Inocencio J, Anton J, Calvo Penades I, Mesa Del Castillo Bermejo P, Alcobendas R, Boteanu AL, Bou R, Iglesias E, González Fernandez MI, López Montesinos B, Santin P, Alcañiz Rodriguez P, Lorente Sanchez MJ, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).
The Castilian Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).
Rheumatol Int. 2018 Apr;38(Suppl 1):91-98. doi: 10.1007/s00296-018-3976-6. Epub 2018 Apr 7.
https://www.ncbi.nlm.nih.gov/pubmed/29637328 - Lovell DJ, Brunner HI, Ringold S, Weiss PF, Martin N, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).
The American English version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).
Rheumatol Int. 2018 Apr;38(Suppl 1):35-42. doi: 10.1007/s00296-018-3984-6. Epub 2018 Apr 7.
https://www.ncbi.nlm.nih.gov/pubmed/29637338 - Martin N, Davidson J, Anderson C, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).
The British English version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).
Rheumatol Int. 2018 Apr;38(Suppl 1):67-73. doi: 10.1007/s00296-018-3985-5. Epub 2018 Apr 7.
https://www.ncbi.nlm.nih.gov/pubmed/29637357 - Quartier P, Hofer M, Wouters C, Truong TTT, Duong NP, Agbo-Kpati KP, Uettwiller F, Melki I, Mouy R, Bader-Meunier B, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).
The French version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).
Rheumatol Int. 2018 Apr;38(Suppl 1):195-201. doi: 10.1007/s00296-018-3951-2. Epub 2018 Apr 7.
https://www.ncbi.nlm.nih.gov/pubmed/29637356 - Weitzman ER, Wisk LE, Salimian PK, Magane KM, Dedeoglu F, Hersh AO, Kimura Y, Mandl KD, Ringold S, Natter M.
Adding patient-reported outcomes to a multisite registry to quantify quality of life and experiences of disease and treatment for youth with juvenile idiopathic arthritis.
J Patient Rep Outcomes. 2018;2. pii: 16. doi: 10.1186/s41687-017-0025-2. Epub 2018 Jan 4.
https://www.ncbi.nlm.nih.gov/pubmed/29645010 - Stoll ML, Kau CH, Waite PD, Cron RQ.
Temporomandibular joint arthritis in juvenile idiopathic arthritis, now what?
Pediatr Rheumatol Online J. 2018 Apr 25;16(1):32. doi: 10.1186/s12969-018-0244-y.
https://www.ncbi.nlm.nih.gov/pubmed/29695255 - Hanns L, Cordingley L, Galloway J, Norton S, Carvalho LA, Christie D, Sen D, Carrasco R, Rashid A, Foster H, Baildam E, Chieng A, Davidson J, Wedderburn LR, Hyrich K, Thomson W, Ioannou Y.
Depressive symptoms, pain and disability for adolescent patients with juvenile idiopathic arthritis: results from the Childhood Arthritis Prospective Study.
Rheumatology (Oxford). 2018 Apr 25. doi: 10.1093/rheumatology/key088. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/29697850
MARZO 2018
- Sherman G, Nemet D, Moshe V, Consolaro A, Ravelli A, Ruperto N, Uziel Y; Paediatric Rheumatology International Trials Organisation (PRINTO).
Disease activity, overweight, physical activity and screen time in a cohort of patients with juvenileidiopathic arthritis.
Clin Exp Rheumatol. 2018 Mar 21. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29600947 - Sontichai W, Vilaiyuk S.
The correlation between the Childhood Health Assessment Questionnaire and disease activity in juvenile idiopathic arthritis.
Musculoskeletal Care. 2018 Mar 24. doi: 10.1002/msc.1239. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29573557 - Jeyaratnam J, Ter Haar NM, Lachmann HJ, Kasapcopur O, Ombrello AK, Rigante D, Dedeoglu F, Baris EH, Vastert SJ, Wulffraat NM, Frenkel J.
The safety of live-attenuated vaccines in patients using IL-1 or IL-6 blockade: an international survey.
Pediatr Rheumatol Online J. 2018 Mar 21;16(1):19. doi: 10.1186/s12969-018-0235-z.
https://www.ncbi.nlm.nih.gov/pubmed/29562920https://www.ncbi.nlm.nih.gov/pubmed/29562920 - Marino A, Real-Fernández F, Rovero P, Giani T, Pagnini I, Cimaz R, Simonini G.
Anti-adalimumab antibodies in a cohort of patients with juvenile idiopathic arthritis: incidence and clinical correlations.
Clin Rheumatol. 2018 Mar 5. doi: 10.1007/s10067-018-4057-7. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29508177 - Chen Y, Zou K, Sun J, Yang Y, Liu G.
Associations between gene polymorphisms and treatment outcomes of methotrexate in patients with juvenile idiopathic arthritis.
Pharmacogenomics. 2018 Mar 28. doi: 10.2217/pgs-2017-0208. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29589488 - Vidovic M, Lamot L, Lamot M, Harjacek M.
Intraarticular infliximab therapy in patients with juvenile idiopathic arthritis: the role of musculoskeletal ultrasound and disease activity scores in monitoring therapy response.
Clin Exp Rheumatol. 2018 Mar 21. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29600948
FEBRERO 2018
- Brunner HI, Tzaribachev N, Vega-Cornejo G, Louw I, Berman A, Penadés IC, Antón J, Ávila-Zapata F, Cuttica R, Horneff G, Foeldvari I, Keltsev V, Kingsbury DJ, Viola DO, Joos R, Lauwerys B, Paz Gastañaga ME, Rama ME, Wouters C, Bohnsack J, Breedt J, Fischbach M, Lutz T, Minden K, Miraval T, Ally MM, Rubio-Pérez N, Solau Gervais E, van Zyl R, Li X, Nys M, Wong R, Banerjee S, Lovell DJ, Martini A, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO)the Pediatric Rheumatology Collaborative Study Group (PRCSG).
Subcutaneous Abatacept in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: Results From a Phase III Open-Label Study
Arthritis Rheumatol. 2018 Feb 26. doi: 10.1002/art.40466. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29481737 - Heath-Watson S, Sule S.
Living with Juvenile Idiopathic Arthritis: Parent and Physician Perspectives
Rheumatol Ther. 2018 Feb 26. doi: 10.1007/s40744-018-0098-2. [Epub ahead of print]
https://www-ncbi-nlm-nih-gov/pubmed/29480358 - Hinks A, Marion MC, Cobb J, Comeau ME, Sudman M, Ainsworth HC, Bowes J; Juvenile ArthritisConsortium for Immunochip, Becker ML, Bohnsack JF, Haas JP, Lovell DJ, Mellins ED, Nelson JL, Nordal E, Punaro M, Reed AM, Rose CD, Rosenberg AM, Rygg M, Smith SL, Stevens AM, Videm V, Wallace CA, Wedderburn LR, Yarwood A, Yeung RS, Langefeld CD, Thompson SD, Thomson W, Prahalad S.
The genetic profile of RF-positive polyarticular juvenile idiopathic arthritis (JIA) resembles adult rheumatoid arthritis (RA)
Arthritis Rheumatol. 2018 Feb 9. doi: 10.1002/art.40443.
https://www.ncbi.nlm.nih.gov/pubmed/29426059 - van Dijkhuizen EHP, Egert T, Egert Y, Costello W, Schoemaker C, Fernhout M, Kepic M, Martini A, Scala S, Rotstein-Grein I, Vastert SJ, Wulffraat NM.
Patient's experiences with the care for juvenile idiopathic arthritis across Europe
Pediatr Rheumatol Online J. 2018 Feb 8;16(1):10. doi: 10.1186/s12969-018-0226-0.
https://www.ncbi.nlm.nih.gov/pubmed/29422094 - Klotsche J, Minden K, Niewerth M, Horneff G.
Ann Rheum Dis. 2018 Feb 16. pii: annrheumdis-2017-211968. doi: 10.1136/annrheumdis-2017-211968
Time spent in inactive disease before MTX withdrawal is relevant with regard to the flare risk in patients with JIA
https://www.ncbi.nlm.nih.gov/pubmed/29453217
ENERO 2018
-
Hinze CH, Holzinger D, Lainka E, Haas JP, Speth F, Kallinich T, Rieber N, Hufnagel M, Jansson AF, Hedrich C, Winowski H, Berger T, Foeldvari I, Ganser G, Hospach A, Huppertz HI, Mönkemöller K, Neudorf U, Weißbarth-Riedel E, Wittkowski H, Horneff G, Foell D; PRO-KIND SJIA project collaborators.
Practice and consensus-based strategies in diagnosing and managing systemic juvenile idiopathic arthritis in Germany.
Pediatr Rheumatol Online J. 2018 Jan 22;16(1):7. doi: 10.1186/s12969-018-0224-2.
https://www.ncbi.nlm.nih.gov/pubmed/29357887 -
Gohar F, Anink J, Moncrieffe H, Van Suijlekom-Smit LWA, Prince FHM, van Rossum MAJ, Dolman KM, Hoppenreijs EPAH, Ten Cate R, Ursu S, Wedderburn LR, Horneff G, Frosch M, Foell D, Holzinger D.
S100A12 Is Associated with Response to Therapy in Juvenile Idiopathic Arthritis.
J Rheumatol. 2018 Jan 15. pii: jrheum.170438. doi: 10.3899/jrheum.170438. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29335345 -
Antonarakis GS, Courvoisier DS, Hanquinet S, Dhouib A, Carlomagno R, Hofer M, Scolozzi P.
Benefit of Temporomandibular Joint Lavage With Intra-Articular Steroids Versus Lavage Alone in the Management of Temporomandibular Joint Involvement in Juvenile Idiopathic Arthritis.
J Oral Maxillofac Surg. 2018 Jan 8. pii: S0278-2391(18)30007-7. doi: 10.1016/j.joms.2017.12.030. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/29391161 -
Marasco E, Aquilani A, Cascioli S, Moneta GM, Caiello I, Farroni C, Giorda E, D'Oria V, Pires Marafon D, Magni-Manzoni S, Carsetti R, De Benedetti F.
Switched Memory B Cells Are Increased In Oligoarticular And Polyarticular Juvenile Idiopathic Arthritis And Their Change Over Time Is Related To Response To TNF Inhibitors.
Arthritis Rheumatol. 2018 Jan 5. doi: 10.1002/art.40410. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29316374 -
Schenck S, Rosenbauer J, Niewerth M, Klotsche J, Minden K, Schwarz T, Foeldvari I, Horneff G, Weller-Heinemann F, Holl RW, Thon A.
Comorbidity of Type 1 Diabetes Mellitus in Patients with Juvenile Idiopathic Arthritis.
J Pediatr. 2018 Jan;192:196-203. doi: 10.1016/j.jpeds.2017.07.050.
https://www.ncbi.nlm.nih.gov/pubmed/29246341
DICIEMBRE 2017
- Ruperto N, Brunner HI, Zuber Z, Tzaribachev N, Kingsbury DJ, Foeldvari I, et al for the Pediatric Rheumatology International Trials Organization (PRINTO) and Pediatric Rheumatology Collaborative Study Group (PRCSG).
Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: results of a phase 1, open-label, multicenter study.
Pediatr Rheumatol Online J. 2017 Dec 28;15(1):86.
https://www.ncbi.nlm.nih.gov/pubmed/29282090 - Pastore S, Naviglio S, Canuto A, Lepore L, Martelossi S, Ventura A, Taddio A.
Serious Adverse Events Associated with Anti-Tumor Necrosis Factor Alpha Agents in Pediatric-Onset Inflammatory Bowel Disease and Juvenile Idiopathic Arthritis in A Real-Life Setting.
Paediatr Drugs. 2017 Dec 6. doi: 10.1007/s40272-017-0267-8. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29214394 - Samad A, Stoll ML, Lavi I, Hsu JJ, Strand V, Robinson TN, Mellins ED, Zisman D; for the CARRA Legacy Registry Investigators.
Adiposity in Juvenile Psoriatic Arthritis.
J Rheumatol. 2017 Dec 15. pii: jrheum.170598. doi: 10.3899/jrheum.170598. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29247150 - Ursin K, Lydersen S, Skomsvoll JF, Wallenius M.
Disease Activity of Juvenile Idiopathic Arthritis during and after Pregnancy: A Prospective Multicenter Study.
J Rheumatol. 2017 Dec 1. pii: jrheum.161410. doi: 10.3899/jrheum.161410. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29196380 - Ramanathan K, Glaser A, Lythgoe H, Ong J, Beresford MW, Midgley A, Wright HL.
Neutrophil activation signature in juvenile idiopathic arthritis indicates the presence of low-density granulocytes.
Rheumatology (Oxford). 2017 Dec 12. doi: 10.1093/rheumatology/kex441. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29240923 - Sura A, Failing C, Sturza J, Stannard J, Riebschleger M.
Patient characteristics associated with response to NSAID monotherapy in children with systemic juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2018 Jan 5;16(1):2.
https://www.ncbi.nlm.nih.gov/pubmed/29304824 - Kostik MM, Isupova EA, Chikova IA, Dubko MF, Masalova VV, Snegireva LS, Kalashnikova OV, Chasnyk VG.
Reasons for inactive disease and flare in systemic onset juvenile idiopathic arthritis patients during tocilizumab treatment.
Clin Exp Rheumatol. 2017 Dec 15. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29303703
NOVIEMBRE 2017
- Shoop-Worrall SJW, Kearsley-Fleet L, Thomson W, Verstappen SMM, Hyrich KL.
How common is remission in juvenile idiopathic arthritis: A systematic review.
Semin Arthritis Rheum. 2017 Dec;47(3):331-337
https://www.ncbi.nlm.nih.gov/pubmed/28625712 - Kinard BE, Abramowicz S.
Juvenile Idiopathic Arthritis Practice Patterns Among Oral and Maxillofacial Surgeons.
J Oral Maxillofac Surg. 2017 Nov;75(11):2333.e1-2333.e8
https://www.ncbi.nlm.nih.gov/pubmed/28822720 - Hügle B, Spiegel L, Hotte J, Wiens S, Herlin T, Cron RQ, Stoll ML, Vinod S, Stoustrup P, Pedersen TK, Twilt M.
Isolated Arthritis of the Temporomandibular Joint as the Initial Manifestation of Juvenile Idiopathic Arthritis.
J Rheumatol. 2017 Nov;44(11):1632-1635
https://www.ncbi.nlm.nih.gov/pubmed/28864647 - Fotis L, Shaikh N, Baszis KW, Samson CM, Lev-Tzion R, French AR, Tarr PI.
Serologic Evidence of Gut-driven Systemic Inflammation in Juvenile Idiopathic Arthritis.
J Rheumatol. 2017 Nov;44(11):1624-1631
https://www.ncbi.nlm.nih.gov/pubmed/28916545 - Cepika AM, Banchereau R, Segura E, Ohouo M, Cantarel B, Goller K, Cantrell V, Ruchaud E, Gatewood E, Nguyen P, Gu J, Anguiano E, Zurawski S, Baisch JM, Punaro M, Baldwin N, Obermoser G, Palucka K, Banchereau J, Amigorena S, Pascual V.
A multidimensional blood stimulation assay reveals immune alterations underlying systemic juvenile idiopathic arthritis.
J Exp Med. 2017 Nov 6;214(11):3449-3466
https://www.ncbi.nlm.nih.gov/pubmed/28935693 - Azzouz DF, Silverman GJ.
Is Gut Microbial LPS a Potential Trigger of Juvenile Idiopathic Arthritis?
J Rheumatol. 2017 Nov;44(11):1569-1571
https://www.ncbi.nlm.nih.gov/pubmed/29093074 - Glerup M, Herlin T, Twilt M.
Clinical Outcome and Long-term Remission in JIA.
Curr Rheumatol Rep. 2017 Nov 4;19(12):75
https://www.ncbi.nlm.nih.gov/pubmed/29101579 - Horneff G, Klein A, Ganser G, Sailer-Höck M, Günther A, Foeldvari I, Weller-Heinemann F.
Protocols on classification, monitoring and therapy in children's rheumatology (PRO-KIND): results of the working group Polyarticular juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2017 Nov 7;15(1):78
https://www.ncbi.nlm.nih.gov/pubmed/29116003 - Swart JF, van Dijkhuizen EHP, Wulffraat NM, de Roock S.
Clinical Juvenile Arthritis Disease Activity Score proves to be a useful tool in treat-to-target therapy in juvenile idiopathic arthritis.
Ann Rheum Dis. 2017 Nov 14
https://www.ncbi.nlm.nih.gov/pubmed/29138257 - França CMP, Sallum AME, Braga ALF, Strufaldi FL, Silva CAA, Farhat SCL.
Risk Factors Associated with Juvenile Idiopathic Arthritis: Exposure to Cigarette Smoke and Air Pollution from Pregnancy to Disease Diagnosis.
J Rheumatol. 2017 Nov 15
https://www.ncbi.nlm.nih.gov/pubmed/29142039 - Cooper M, Rouhi A, Barber CEH.
A Systematic Review of Quality Measures for Inflammatory Arthritis.
J Rheumatol. 2017 Nov 15Horneff G, Schulz AC, Klotsche J, Hospach A, Minden K, Foeldvari I, Trauzeddel R,
https://www.ncbi.nlm.nih.gov/pubmed/29142026 - Ganser G, Weller-Heinemann F, Haas JP.
Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry.
Arthritis Res Ther. 2017 Nov 22;19(1):256
https://www.ncbi.nlm.nih.gov/pubmed/29166924 - Rashid A, Cordingley L, Carrasco R, Foster HE, Baildam EM, Chieng A, Davidson JE, Wedderburn LR, Ioannou Y, McErlane F, Verstappen SMM, Hyrich KL, Thomson W.
Patterns of pain over time among children with juvenile idiopathic arthritis.
Arch Dis Child. 2017 Nov 25
https://www.ncbi.nlm.nih.gov/pubmed/29175824 - Grevich S, Shenoi S.
Update on the management of systemic juvenile idiopathic arthritis and role of IL-1 and IL-6 inhibition.
Adolesc Health Med Ther. 2017 Nov 9;8:125-135
https://www.ncbi.nlm.nih.gov/pubmed/29184458 - Hammaker D, Firestein GS.
Epigenetics of inflammatory arthritis.
Curr Opin Rheumatol. 2017 Nov 30
https://www.ncbi.nlm.nih.gov/pubmed/29194108 - McErlane F, Carrasco R, Kearsley-Fleet L, Baildam EM, Wedderburn LR, Foster HE, Ioannou Y, Chieng SEA, Davidson JE, Thomson W, Hyrich KL.
Growth patterns in early juvenile idiopathic arthritis: Results from the Childhood Arthritis Prospective Study (CAPS).
Semin Arthritis Rheum. 2017 Nov 7
https://www.ncbi.nlm.nih.gov/pubmed/29217290
OCTUBRE 2017
- Onuora S.
Juvenile idiopathic arthritis: Evidence of gut-driven inflammation in new JIA.
Nat Rev Rheumatol. 2017 Oct 5. doi: 10.1038/nrrheum.2017.168. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/28978993 - Cimaz R, Marino A, Martini A.
How I treat juvenile idiopathic arthritis: A state of the art review.
Autoimmun Rev. 2017 Oct;16(10):1008-1015. doi: 10.1016/j.autrev.2017.07.014.
https://www.ncbi.nlm.nih.gov/pubmed/28778702 - Nigrovic PA, Raychaudhuri S, Thompson SD.
Genetics and the classification of arthritis in adults and children.
Arthritis Rheumatol. 2017 Oct 12. doi: 10.1002/art.40350. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29024575 - Zervou MI, Dimopoulou DG, Eliopoulos E, Trachana M, Pratsidou-Gkertsi P, Andreou A, Sidiropoulos P, Spandidos DA, Garyfallos A, Goulielmos GN.
Τhe genetics of juvenile idiopathic arthritis: Searching for new susceptibility loci.
Mol Med Rep. 2017 Oct 5. doi: 10.3892/mmr.2017.7733. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/28990043 - Simonini G, Ferrara G, Pontikaki I, Scoccimarro E, Giani T, Taddio A, Meroni PL, Cimaz R.
Flares after withdrawal of biologic therapies in juvenile idiopathic arthritis: Clinical and laboratory correlates of remission duration.
Arthritis Care Res (Hoboken). 2017 Oct 3. doi: 10.1002/acr.23435. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/28973842 - Adrovic A, Sezen M, Barut K, Sahin S, Acikel C, Demirkaya E, Kasapcopur O.
The performance of classification criteria for juvenile spondyloarthropathies.
Rheumatol Int. 2017 Oct 10. doi: 10.1007/s00296-017-3837-8. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29018906 - Stoor P, Hodzic Z, Arte S.
Surgical Treatment of Dentofacial Deformities Caused by Juvenile Idiopathic Arthritis
J Craniofac Surg. 2017 Oct 16. doi: 10.1097/SCS.0000000000004029. [Epub ahead of print]
https://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/29040144 - De Silvestri A, Capittini C, Poddighe D, Marseglia GL, Mascaretti L, Bevilacqua E, Pasi A, Martinetti M, Tinelli C.
HLA-DRB1 alleles and juvenile idiopathic arthritis: Diagnostic clues emerging from a meta-analysis
Autoimmun Rev. 2017 Oct 13. pii: S1568-9972(17)30257-4. doi: 10.1016/j.autrev.2017.10.007. [Epub ahead of print] Review.
https://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/29037901 - Ammerlaan J, van Os-Medendorp H, de Boer-Nijhof N, Scholtus L, Kruize AA, van Pelt P, Prakken B, Bijlsma H.
Short term effectiveness and experiences of a peer guided web-based self-management intervention for young adults with juvenile idiopathic arthritis
Pediatr Rheumatol Online J. 2017 Oct 13;15(1):75. doi: 10.1186/s12969-017-0201-1.
https://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/29029616
SEPTIEMBRE 2017
- Cepika AM, Banchereau R, Segura E, Ohouo M, Cantarel B, Goller K, Cantrell V, Ruchaud E, Gatewood E, Nguyen P, Gu J, Anguiano E, Zurawski S, Baisch JM, Punaro M, Baldwin N, Obermoser G, Palucka K, Banchereau J, Amigorena, Pascual V.
A multidimensional blood stimulation assay reveals immune alterations underlying systemic juvenile idiopathic arthritis.
J Exp Med. 2017 Sep 21. pii: jem.20170412. doi: 10.1084/jem.20170412. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/28935693 - Brunelli JB, Schmidt AR, Sallum AME, Goldenstein-Schainberg C, Bonfá E, Silva CA, Aikawa NE.
High rate of serious infection in juvenile idiopathic arthritis patients under biologic therapy in a real-life setting.
Mod Rheumatol. 2017 Sep 26:1-7. doi: 10.1080/14397595.2017.1349059.
https://www.ncbi.nlm.nih.gov/pubmed/28949278 - Weiss PF, Xiao R, Brandon TG, Pagnini I, Wright TB, Beukelman T, Morgan-DeWitt E, Feudtner C.
Comparative Effectiveness of Tumor Necrosis Factor Agents and Disease-modifying Antirheumatic Therapy in Children with Enthesitis-related Arthritis: The First Year after Diagnosis.
J Rheumatol. 2017 Sep 15. pii: jrheum.170251. doi: 10.3899/jrheum.170251. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/28916542 - Hügle B, Spiegel L, Hotte J, Wiens S, Herlin T, Cron RQ, Stoll ML, Vinod S, Stoustrup P, Pedersen TK, Twilt M.
Isolated Arthritis of the Temporomandibular Joint as the Initial Manifestation of Juvenile Idiopathic Arthritis.
J Rheumatol. 2017 Sep 1. pii: jrheum.170263. doi: 10.3899/jrheum.170263. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/28864647 - Fotis L, Shaikh N, Baszis KW, Samson CM, Lev-Tzion R, French AR, Tarr PI.
Serologic Evidence of Gut-driven Systemic Inflammation in Juvenile Idiopathic Arthritis.
J Rheumatol. 2017 Sep 15. pii: jrheum.161589. doi: 10.3899/jrheum.161589. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/28916545 - Giancane G, Alongi A, Rosina S, Calandra S, Consolaro A, Ravelli A.
Open issues in the assessment and management of pain in juvenile idiopathic arthritis.
Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 107(5):123-126.
https://www.ncbi.nlm.nih.gov/pubmed/28967364 - Shiff NJ, Tupper S, Oen K, Guzman J, Lim H, Lee CH, et al.
Trajectories of pain severity in juvenile idiopathic arthritis: results from the Research in Arthritis in Canadian Children Emphasizing Outcomes cohort.
Pain. 2017 Sep 18. doi: 10.1097/j.pain.0000000000001064. [Epub ahead of print].
https://www.ncbi.nlm.nih.gov/pubmed/28937578 - Céspedes Cruz AI, Méndez Núñez M, Solís Vallejo E, Zeferino Cruz M, Torres Jiménez AR, Ocampo Sánchez V, Flores Meza B, Quintana Ruiz N.
Frequency of auditory involvement and of associated factors in patients with juvenile idiopathic arthritis.
Reumatol Clin. 2017 Sep 8. pii: S1699-258X(17)30179-1. doi: 10.1016/j.reuma.2017.07.003. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28923429 - Mendelson A, Rabinowicz N, Reis Y, Amarilyo G, Harel L, Hashkes PJ, Uziel Y.
Comics as an educational tool for children with juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2017 Sep 2;15(1):69. doi: 10.1186/s12969-017-0198-5.
https://www.ncbi.nlm.nih.gov/pubmed/28865469
AGOSTO 2017
- Murdaca G, Negrini S, Magnani O, Penza E, Pellecchio M, Gulli R, Mandich P, Puppo F.
Update upon efficacy and safety of etanercept for the treatment of spondyloarthritis and juvenile idiopathic arthritis.
Mod Rheumatol. 2017 Aug 24:1-15. doi: 10.1080/14397595.2017.1366006. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/28837372 - Guzman J, Kerr T, Ward LM, Ma J, Oen K, Rosenberg AM, Feldman BM, Boire G, Houghton K, Dancey P, Scuccimarri R, Bruns A, Huber AM, Watanabe Duffy K, Shiff NJ, Berard RA, Levy DM, Stringer E, Morishita K, Johnson N, Cabral DA, Larché M, Petty RE, Laxer RM, Silverman E, Miettunen P, Chetaille AL, Haddad E, Spiegel L, Turvey SE, Schmeling H, Lang B, Ellsworth J, Ramsey SE, Roth J, Campillo S, Benseler S, Chédeville G, Schneider R, Tse SML, Bolaria R, Gross K, Feldman D, Cameron B, Jurencak R, Dorval J, LeBlanc C, St Cyr C, Gibbon M, Yeung RSM, Duffy CM, Tucker LB.
Growth and weight gain in children with juvenile idiopathic arthritis: results from the ReACCh-Out cohort.
Pediatr Rheumatol Online J. 2017 Aug 22;15(1):68. doi: 10.1186/s12969-017-0196-7.
https://www.ncbi.nlm.nih.gov/pubmed/28830457 - Belot A.
New Classification for Juvenile Idiopathic Arthritis: Is the Tower of Babel Falling?
Joint Bone Spine. 2017 Aug 4. pii: S1297-319X(17)30143-4. doi: 10.1016/j.jbspin.2017.08.001. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/28826661 - Rodríguez C, Castillo DM, De Avila J, Mosquera ÁC, Lafaurie GI. Romero-Sánchez C, Malagón C, Vargas C, Fernanda Torres M, Moreno LC.
Porphyromonas Gingivalis and IgG1 and IgG2 Subclass Antibodies in Patients with Juvenile Idiopathic Arthritis.
J Dent Child (Chic). 2017 May 15;84(2):72-79.
https://www.ncbi.nlm.nih.gov/pubmed/28814366 - Morgan EM, Riebschleger MP, Horonjeff J, Consolaro A, Munro JE, Thornhill S, Beukelman T, Brunner HI, Creek EL, Harris JG, Horton DB, Lovell DJ, Mannion ML, Olson JC, Rahimi H, Gallo MC, Calandra S, Ravelli A, Ringold S, Shenoi S, Stinson J, Toupin-April K, Strand V, Bingham CO 3rd.
Evidence for Updating the Core Domain Set of Outcome Measures for Juvenile Idiopathic Arthritis: Report from a Special Interest Group at OMERACT 2016.
J Rheumatol. 2017 Aug 15. pii: jrheum.161389. doi: 10.3899/jrheum.161389. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/28811355 - Cai RA, Beste D, Chaplin H, Varakliotis S, Suffield L, Josephs F, Sen D, Wedderburn LR, Ioannou Y, Hailes S, Eleftheriou D.
Developing and Evaluating JIApp: Acceptability and Usability of a Smartphone App System to Improve Self-Management in Young People With Juvenile Idiopathic Arthritis.
JMIR Mhealth Uhealth. 2017 Aug 15;5(8):e121. doi: 10.2196/mhealth.7229.
https://www.ncbi.nlm.nih.gov/pubmed/28811270 - Camacho-Lovillo MS, Bulnes-Ramos A, Goycochea-Valdivia W, Fernández-Silveira L1, Núñez-Cuadros E, Neth O, Pérez-Romero P.
Immunogenicity and safety of influenza vaccination in patients with juvenile idiopathic arthritis on biological therapy using the microneutralization assay.
Pediatr Rheumatol Online J. 2017 Aug 7;15(1):62. doi: 10.1186/s12969-017-0190-0.
https://www.ncbi.nlm.nih.gov/pubmed/28784185 - Cimaz R, Marino A, Martini A.
How I treat juvenile idiopathic arthritis: A state of the art review.
Autoimmun Rev. 2017 Aug 1. pii: S1568-9972(17)30197-0. doi: 10.1016/j.autrev.2017.07.014. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/28778702 - Yuwen W, Lewis FM, Walker AJ, Ward TM.
Struggling in the Dark to Help My Child: Parents' Experience in Caring for a Young Child with Juvenile Idiopathic Arthritis.
J Pediatr Nurs. 2017 Aug 1. pii: S0882-5963(17)30016-7. doi: 10.1016/j.pedn.2017.07.007. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/28778610 - Limenis E, Feldman BM, Achonu C, Batthish M, Lang B, Mclimont M, Ota S, Ramanan A, Scuccimarri R, Young NL, Schneider R.
Proposed Core Set of Items for Measuring Disease Activity in Systemic Juvenile Idiopathic Arthritis.
J Rheumatol. 2017 Aug 1. pii: jrheum.161534. doi: 10.3899/jrheum.161534. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/28765240
JULIO 2017
- Armbrust W, Bos GJFJ, Wulffraat NM, van Brussel M, Cappon J, Dijkstra PU, Geertzen JHB, Legger GE, van Rossum MAJ, Sauer PJJ, Lelieveld OTHM.
Internet Program for Physical Activity and Exercise Capacity in Children With Juvenile Idiopathic Arthritis: A Multicenter Randomized Controlled Trial.
Arthritis Care Res (Hoboken). 2017 Jul 21. doi: 10.1002/acr.23327. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/27696793 - Tollisen A, Selvaag AM, Aulie HA, Lilleby V, Aasland A, Lerdal A, Flatø B.
Physical Functioning, Pain and Health-Related Quality of Life in Adults with Juvenile Idiopathic Arthritis: A Longitudinal 30-Year Follow-Up Study.
Arthritis Care Res (Hoboken). 2017 Jul 21. doi: 10.1002/acr.23327. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/28732134 - Shoop-Worrall SJW, Verstappen SMM, Baildam E, Chieng A, Davidson J, Foster H, Ioannou Y, McErlane F, Wedderburn LR, Thomson W, Hyrich KL.
How common is clinically inactive disease in a prospective cohort of patients with juvenile idiopathic arthritis? The importance of definition.
Ann Rheum Dis. 2017 Aug;76(8):1381-1388. doi: 10.1136/annrheumdis-2016-210511. Epub 2017 Apr 7.
https://www.ncbi.nlm.nih.gov/pubmed/28389553 - Zajc Avramovič M, Dolžan V , Toplak N, Accetto M, Lusa L, Avčin T.
Relationship Between Polymorphisms in Methotrexate Pathway Genes and Outcome of MethotrexateTreatment in a Cohort of 119 Patients with Juvenile Idiopathic Arthritis
J Rheumatol. 2017 Aug;44(8):1216-1223. doi: 10.3899/jrheum.160950. Epub 2017 Jun 1.
https://www.ncbi.nlm.nih.gov/pubmed/28572465 - Antoun MB, Adamsbaum C, Semerano L, Paut IK, Rossi-Semerano L.
Clinical predictors of magnetic resonance imaging-detected sacroiliitis in children with enthesitis related arthritis.
Joint Bone Spine. 2017 Jul 27. pii: S1297-319X(17)30136-7. doi: 10.1016/j.jbspin.2017.07.003. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/28757344 - Maritsi DN, Coffin SE, Argyri I, Vartzelis G, Spyridis N, Tsolia MN.
Immunogenicity and safety of the inactivated hepatitis A vaccine in children with juvenile idiopathic arthritis on methotrexate treatment: a matched case-control study.
Clin Exp Rheumatol. 2017 Jul-Aug;35(4):711-715. Epub 2017 Jul 13.
https://www.ncbi.nlm.nih.gov/pubmed/28721859 - McIntosh LA, Marion MC, Sudman M, Comeau ME, Becker ML, Bohnsack JF, Fingerlin TE, Griffin TA, Haas JP, Lovell DJ, Maier LA, Nigrovic PA, Prahalad S, Punaro M, Rosé CD, Wallace CA, Wise CA; Boston Children's JIA Registry; German Society for Pediatric Rheumatology (GKJR); JIA Gene Expression Studies; NIAMS JIA Genetic Registry; TREAT Study; Understanding TNF Therapy in JIA Project, Moncrieffe H, Howard TD, Langefeld CD, Thompson SD.
Genome-wide association meta-analysis reveals novel juvenile idiopathic arthritis susceptibility loci.
Arthritis Rheumatol. 2017 Jul 18. doi: 10.1002/art.40216. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28719732
JUNIO 2017
- Alexeeva EI, Namazova-Baranova LS, Bzarova TM, Valieva SI, Denisova RV, Sleptsova TV, Isaeva KB, Chomahidze AM, Taibulatov NI, Fetisova AN, Karaseva AV, Baranov AA.
Predictors of the response to etanercept in patients with juvenile idiopathic arthritis without systemic manifestations within 12 months: results of an open-label, prospective study conducted at the National Scientific and Practical Center of Children's Health, Russia.
Pediatr Rheumatol Online J. 2017 Jun 14;15(1):51.
https://www.ncbi.nlm.nih.gov/pubmed/28615036 - Brinkman WB, Lipstein EA, Taylor J, Schoettker PJ, Naylor K, Jones K, Vora SS, Mims CC, Roth-Wojcicki E, Gottlieb B, Griffin N, Lannon C, Morgan E.
Design and implementation of a decision aid for juvenile idiopathic arthritis medication choices.
Pediatr Rheumatol Online J. 2017 Jun 5;15(1):48
https://www.ncbi.nlm.nih.gov/pubmed/28583183 - Moncrieffe H, Bennett MF, Tsoras M, Luyrink LK, Johnson AL, Xu H, Dare J, Becker ML, Prahalad S, Rosenkranz M, O'Neil KM, Nigrovic PA, Griffin TA, Lovell DJ, Grom AA, Medvedovic M, Thompson SD.
Transcriptional profiles of JIA patient blood with subsequent poor response to methotrexate.
Rheumatology (Oxford). 2017 Jun 3. doi: 10.1093/rheumatology/kex206. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/?term=28582527 - Gorczyca D, Postępski J, Czajkowska A, Paściak M, Prescha A, Olesińska E, Gruenpeter A, Lachór-Motyka I, Szponar B.
The profile of polyunsaturated fatty acids in juvenile idiopathic arthritis and association with disease activity.
Clin Rheumatol. 2017 Jun;36(6):1269-1279
https://www.ncbi.nlm.nih.gov/pubmed/28247163 - Halonen S, Kankaanpää E, Kari J, Parmanne P, Relas H, Kronström K, Luosujärvi R, Peltomaa R.
Synovial fluid detection in intra-articular injections using a bioimpedance probe (BIP) needle-a clinical study.
Clin Rheumatol. 2017 Jun;36(6):1349-1355.
https://www.ncbi.nlm.nih.gov/pubmed/26873101 - Scheuern A, Tyrrell PN, Haas JP, Hügle B.
Countermeasures against methotrexate intolerance in juvenile idiopathic arthritis instituted by parents show no effect.
Rheumatology (Oxford). 2017 Jun 1;56(6):901-906.
https://www.ncbi.nlm.nih.gov/pubmed/28122960
MAYO 2017
- Imane Elbinoune; Bouchra Amine; Samira Rostom; Siham Shyen; Dalal Elbadri; Majda Ezzahri; Nada Mawani; Fanata Moussa; Sanae Gueddari; Wabi Moudjibou; Mariam Erraoui; Jihane Bahha; Redouane Abouqal; Bouchra Chkirate; Najia Hajjaj-Hassouni
Discordance between physician’s and parent’s global assessments in juvenile idiopathic arthritis.
Ann Paediatr Rheum. 2017; 5(3): 71-78
https://www.ncbi.nlm.nih.gov/pubmed/?term=16782733 - Berard RA, Laxer RM.
Learning the hard way: clinical trials in juvenile idiopathic arthritis.
Ann Rheum Dis. 2017 May 25. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/?term=28546255 - Frid P, Nordal E, Bovis F, Giancane G, Larheim TA, Rygg M, Pires Marafon D, De Angelis D, Palmisani E, Murray KJ, Oliveira S, Simonini G, Corona F, Davidson J, Foster H, Steenks MH, Flato B, Zulian F, Baildam E, Saurenmann RK, Lahdenne P, Ravelli A, Martini A, Pistorio A, Ruperto N; Paediatric Rheumatology International Trials Organisation.
Temporomandibular Joint Involvement in Association With Quality of Life, Disability, and High Disease Activity in Juvenile Idiopathic Arthritis.
Arthritis Care Res (Hoboken). 2017 May;69(5):677-686. doi: 10.1002/acr.23003.
https://www.ncbi.nlm.nih.gov/pubmed/27564918 - Gmuca S, Xiao R, Brandon TG, Pagnini I, Wright TB, Beukelman T, Morgan EM, Weiss PF.
Multicenter inception cohort of enthesitis-related arthritis: variation in disease characteristics and treatment approaches.
Arthritis Res Ther. 2017 May 2;19(1):84. doi: 10.1186/s13075-017-1297-x.
https://www.ncbi.nlm.nih.gov/pubmed/?term=PMC5414167 - Giancane G, Alongi A, Ravelli A.
Update on the pathogenesis and treatment of juvenile idiopathic arthritis.
Curr Opin Rheumatol. 2017 May 22. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28538013 - Kindgren E, Fredrikson M, Ludvigsson J.
Early feeding and risk of Juvenile idiopathic arthritis: a case control study in a prospective birth cohort.
Pediatr Rheumatol Online J. 2017 May 26;15(1):46. doi: 10.1186/s12969-017-0175-z.
https://www.ncbi.nlm.nih.gov/pubmed/?term=28549465 - Schlichtiger J, Haas JP, Barth S, Bisdorff B, Hager L, Michels H, Hügle B, Radon K.
Education and employment in patients with juvenile idiopathic arthritis - a standardized comparison to the German general population.
Pediatr Rheumatol Online J. 2017 May 22;15(1):45. doi: 10.1186/s12969-017-0172-2.
https://www.ncbi.nlm.nih.gov/pubmed/?term=28532479 - Coda A, Sculley D, Santos D, Girones X, Brosseau L, Smith DR, Burns J, Rome K, Munro J, Singh-Grewal D.
Harnessing interactive technologies to improve health outcomes in juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2017 May 16;15(1):40. doi: 10.1186/s12969-017-0168-y.
https://www.ncbi.nlm.nih.gov/pubmed/?term=28511689 - Ključevšek D, Emeršič N, Toplak N, Avčin T.
Clinical and MRI outcome of cervical spine lesions in children with juvenile idiopathic arthritis treated with anti-TNFα drugs early in disease course.
Pediatr Rheumatol Online J. 2017 May 15;15(1):38. doi: 10.1186/s12969-017-0173-1.
https://www.ncbi.nlm.nih.gov/pubmed/?term=28506237 - Bell SW, Shenoi S, Nelson JL, Bhatti P, Mueller BA.
Juvenile idiopathic arthritis in relation to perinatal and maternal characteristics: a case control study.
Pediatr Rheumatol Online J. 2017 May 11;15(1):36. doi: 10.1186/s12969-017-0167-z.
https://www.ncbi.nlm.nih.gov/pubmed/?term=28494794 - Moncrieffe H, Bennett MF, Tsoras M, Luyrink LK, Johnson AL, Xu H, Dare J, Becker ML, Prahalad S, Rosenkranz M, O'Neil KM, Nigrovic PA, Griffin TA, Lovell DJ, Grom AA, Medvedovic M, Thompson SD.
Transcriptional profiles of JIA patient blood with subsequent poor response to methotrexate.
Rheumatology (Oxford). 2017 Jun 3. doi: 10.1093/rheumatology/kex206. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/?term=28582527 - Alberdi-Saugstrup M1,2,3, Zak M4, Nielsen S4, Herlin T5, Nordal E6, Berntson L7, Fasth A8, Rygg M9,10, Klaus Müller4,11; Nordic Study Group of Pediatric Rheumatology (NoSPeR).
High-sensitive CRP as a predictive marker of long-term outcome in juvenile idiopathic arthritis.
Rheumatol Int. 2017 May;37(5):695-703. doi: 10.1007/s00296-017-3657-x. Epub 2017 Mar 10.
https://www.ncbi.nlm.nih.gov/pubmed/?term=28283733 - Luque Ramos A, Hoffmann F, Albrecht K, Klotsche J, Zink A, Minden K.
Transition to adult rheumatology care is necessary to maintain DMARD therapy in young people with juvenile idiopathic arthritis.
Semin Arthritis Rheum. 2017 May 12
https://www.ncbi.nlm.nih.gov/pubmed/28583690
ABRIL 2017
- Lee WJ, Lee TA, Suda KJ, Calip GS, Briars L, Schumock GT.
Risk of serious bacterial infection associated with tumour necrosis factor-alpha inhibitors in children with juvenile idiopathic arthritis
Rheumatology (Oxford). 2017 Apr 18. doi: 10.1093/rheumatology/kex049. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/28431162 - Rumsey DG, Guzman J, Rosenberg AM, Huber AM, Scuccimarri R, Shiff NJ, Bruns A, Feldman BM, Eurich DT; ReACCh-Out Investigators
Characteristics and Course of Enthesitis in a Juvenile Idiopathic Arthritis Inception Cohort.
Arthritis Care Res (Hoboken). 2017 Apr 20. doi: 10.1002/acr.23256. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/28426894 - Beukelman T, Kimura Y, Ilowite NT, Mieszkalski K, Natter MD, Burrell G, Best B, Jones J, Schanberg LE; CARRA Registry Investigators
The new Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry: design, rationale, and characteristics of patients enrolled in the first 12 months
Pediatr Rheumatol Online J. 2017 Apr 17;15(1):30. doi: 10.1186/s12969-017-0160-6.
https://www.ncbi.nlm.nih.gov/pubmed/28416023 - Weiß A, Minden K, Listing J, Foeldvari I, Sieper J, Rudwaleit M.
Course of patients with juvenile spondyloarthritis during 4 years of observation, juvenile part of GESPIC
RMD Open. 2017 Mar 21;3(1):e000366. doi: 10.1136/rmdopen-2016-000366. eCollection 2017.
https://www.ncbi.nlm.nih.gov/pubmed/28405472 - Selvaag AM, Kirkhus E, Törnqvist L, Lilleby V, Aulie HA, Flatø B.
Radiographic damage in hands and wrists of patients with juvenile idiopathic arthritis after 29 years of disease duration.
Pediatr Rheumatol Online J. 2017 Apr 11;15(1):20. doi: 10.1186/s12969-017-0151-7.
https://www.ncbi.nlm.nih.gov/pubmed/28399930 - Navallas M, Inarejos EJ, Iglesias E, Cho Lee GY, Rodríguez N, Antón J.
MR Imaging of the Temporomandibular Joint in Juvenile Idiopathic Arthritis: Technique and Findings
Radiographics. 2017 Mar-Apr;37(2):595-612. doi: 10.1148/rg.2017160078.
https://www.ncbi.nlm.nih.gov/pubmed/28287946
MARZO 2017
- Shoop-Worrall SJ, Verstappen SM, Baildam E, Chieng A, Davidson J, Foster H, Ioannou Y, McErlane F, Wedderburn LR, Thomson W, Hyrich KL.
How common is clinically inactive disease in a prospective cohort of patients with juvenile idiopathic arthritis? The importance of definition.
Ann Rheum Dis. 2017 Apr 7. pii: annrheumdis-2016-210511. doi: 10.1136/annrheumdis-2016-210511. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/28389553 - Roszkiewicz J, Smolewska E.
In the Pursuit of Methotrexate Treatment Response Biomarker in Juvenile Idiopathic Arthritis-Are We Getting Closer to Personalised Medicine?
Curr Rheumatol Rep. 2017 Apr;19(4):19. doi: 10.1007/s11926-017-0646-8
https://www.ncbi.nlm.nih.gov/pubmed/28361333 - Armbrust W, Bos GJ, Geertzen JH, Sauer PJ, Dijkstra PU, Lelieveld OT.
Measuring Physical Activity in Juvenile Idiopathic Arthritis: Activity Diary Versus Accelerometer.
J Rheumatol. 2017 Apr 1. pii: jrheum.160671. doi: 10.3899/jrheum.160671. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/28365580 - Oen K, Guzman J, Dufault B, Tucker LB, Shiff NJ, Watanabe Duffy K, Lee JJ, Feldman BM, Berard RA, Dancey P, Huber AM, Scuccimarri R, Cabral DA, Morishita KA, Ramsey SE, Rosenberg AM, Boire G, Benseler SM, Lang B, Houghton K, Miettunen PM, Chédeville G, Levy DM, Bruns A, Schmeling H, Haddad E, Yeung RS, Duffy CM; Research in Arthritis in Canadian Children emphasizing Outcomes (ReACCh-Out) investigators.
Health-related quality of life in an inception cohort of children with Juvenile Idiopathic Arthritis: A longitudinal analysis.
Arthritis Care Res (Hoboken). 2017 Mar 20. doi: 10.1002/acr.23236. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/28320056 - Alberdi-Saugstrup M, Zak M, Nielsen S, Herlin T, Nordal E, Berntson L, Fasth A, Rygg M, Klaus Müller; Nordic Study Group of Pediatric Rheumatology (NoSPeR).
High-sensitive CRP as a predictive marker of long-term outcome in juvenile idiopathic arthritis.
Rheumatol Int. 2017 Mar 10. doi: 10.1007/s00296-017-3657-x.
https://www.ncbi.nlm.nih.gov/pubmed/28283733 - Hashaad NI, Fawzy RM, Elazem AA, Youssef MI.
Serum calreticulin as a novel biomarker of juvenile idiopathic arthritis disease activity.
Eur J Rheumatol. 2017 Mar;4(1):19-23. doi: 10.5152/eurjrheum.2017.160071.
https://www.ncbi.nlm.nih.gov/pubmed/28293448 - Kwon HJ, Kim YL, Lee HS, Lee SM.
A study on the physical fitness of children with juvenile rheumatoid arthritis.
J Phys Ther Sci. 2017 Mar;29(3):378-383. doi: 10.1589/jpts.29.378.
https://www.ncbi.nlm.nih.gov/pubmed/28356614 - Frittoli RB, Longui BS, Silva AM, Filho AA, Monteiro MÂ, Appenzeller S.
Effects of the use of growth hormone in children and adolescents with juvenile idiopathic arthritis: a systematic review.
Rev Bras Reumatol Engl Ed. 2017 Mar - Apr;57(2):100-106. doi: 10.1016/j.rbre.2016.07.009.
https://www.ncbi.nlm.nih.gov/pubmed/28343613 - Kessel C, Lippitz K, Weinhage T, Hinze C, Wittkowski H, Holzinger D, Fall N, Grom AA, Gruen N, Foell D.
Pro-inflammatory cytokine environments can drive IL-17 over-expression by γδT cells in systemicjuvenile idiopathic arthritis.
Arthritis Rheumatol. 2017 Mar 15. doi: 10.1002/art.40099. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/28296284 - Lee M, Isaacs J.
The novel use of combined IL-1 and IL-6 inhibition in a patient with severe, aggressive, erosive, systemic-onset juvenile idiopathic arthritis.
Eur J Rheumatol. 2017 Mar;4(1):68-69. doi: 10.5152/eurjrheum.2016.055.
https://www.ncbi.nlm.nih.gov/pubmed/28293458
FEBRERO 2017
- Zisman D, Gladman DD, Stoll ML, Strand V, Lavi I, Hsu JJ, Mellins ED; and the CARRA Legacy Registry Investigators.
The Juvenile Psoriatic Arthritis Cohort in the CARRA Registry: Clinical Characteristics, Classification, and Outcomes.
J Rheumatol. 2017 Feb 1. pii: jrheum.160717. doi: 10.3899/jrheum.160717. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28148698 - Hissink Muller PC, Brinkman DM, Schonenberg D, Koopman-Keemink Y, Brederije IC, Bekkering WP, Kuijpers TW, van Rossum MA, van Suijlekom-Smit LW, van den Berg JM, Allaart CF, Ten Cate R.
A comparison of three treatment strategies in recent onset non-systemic Juvenile Idiopathic Arthritis: initial 3-months results of the BeSt for Kids-study.
Pediatr Rheumatol Online J. 2017 Feb 6;15(1):11. doi: 10.1186/s12969-017-0138-4.
https://www.ncbi.nlm.nih.gov/pubmed/28166785 - Ekelund M, Aalto K, Fasth A, Herlin T, Nielsen S, Nordal E, Peltoniemi S, Rygg M, Zak M, Berntson L; Nordic Study Group of Pediatric Rheumatology (NoSPeR).
Psoriasis and associated variables in classification and outcome of juvenile idiopathic arthritis - an eight-year follow-up study.
Pediatr Rheumatol Online J. 2017 Feb 22;15(1):13. doi: 10.1186/s12969-017-0145-5.
https://www.ncbi.nlm.nih.gov/pubmed/28222745 - Alberdi-Saugstrup M, Enevold C, Zak M, Nielsen S, Nordal E, Berntson L, Fasth A, Rygg M, Müller K; Nordic Study Group of Pediatric Rheumatology (NoSPeR).
Non-HLA gene polymorphisms in juvenile idiopathic arthritis: associations with disease outcome.
Scand J Rheumatol. 2017 Feb 1:1-8. doi: 10.1080/03009742.2016.1238959. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28145159 - Adriano LS, de França Fonteles MM, de Fátima Menezes Azevedo M, Beserra MP, Romero NR.
Medication adherence in patients with juvenile idiopathic arthritis.
Rev Bras Reumatol Engl Ed. 2017 Jan - Feb;57(1):23-29. doi: 10.1016/j.rbre.2016.05.004. Epub 2016 May 30.
https://www.ncbi.nlm.nih.gov/pubmed/28137399 - Wulffraat N.
The value of old drugs for juvenile idiopathic arthritis.
Lancet. 2017 Feb 2. pii: S0140-6736(17)30180-0. doi: 10.1016/S0140-6736(17)30180-0. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28162780 - Nusman CM, Hemke R, Lavini C, Schonenberg-Meinema D, van Rossum MA, Dolman KM, van den Berg JM, Maas M, Kuijpers TW.
Dynamic contrast-enhanced magnetic resonance imaging can play a role in predicting flare in juvenile idiopathic arthritis.
Eur J Radiol. 2017 Mar;88:77-81. doi: 10.1016/j.ejrad.2017.01.003. Epub 2017 Jan 4.
https://www.ncbi.nlm.nih.gov/pubmed/28189212 - Xia Y, Cui P, Li Q, Liang F, Li C, Yang J.
Extremely elevated IL-18 levels may help distinguish systemic-onset juvenile idiopathic arthritis from other febrile diseases.
Braz J Med Biol Res. 2017 Feb 16;50(2):e5958. doi: 10.1590/1414-431X20165958.
https://www.ncbi.nlm.nih.gov/pubmed/28225869 - Skrabl-Baumgartner A, Christine Hauer A, Erwa W, Jahnel J.
HLA genotyping as first-line screening tool for coeliac disease in children with juvenile idiopathic arthritis.
Arch Dis Child. 2017 Feb 23. pii: archdischild-2016-311544. doi: 10.1136/archdischild-2016-311544. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28232458 - Dewoolkar M, Cimaz R, Chickermane PR, Khubchandani RP.
Course, Outcome and Complications in Children with Systemic Onset Juvenile Idiopathic Arthritis.
Indian J Pediatr. 2017 Feb 23. doi: 10.1007/s12098-017-2293-5. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28229369 - Wiens AD, Prahalad S, Inan OT, Wiens AD, Prahalad S, Inan OT, Wiens AD, Inan OT, Prahalad S.
VibroCV: a computer vision-based vibroarthrography platform with possible application to Juvenile Idiopathic Arthritis.
Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:4431-4434. doi:10.1109/EMBC.2016.7591710.
https://www.ncbi.nlm.nih.gov/pubmed/28227495 - Park SK, Hwang PH, Yun SK, Kim HU, Park J.
Tumor Necrosis Factor Alpha Blocker-Induced Erythrodermic Sarcoidosis in with Juvenile Rheumatoid Arthritis: A Case Report and Review of the Literature.
Ann Dermatol. 2017 Feb;29(1):74-78. doi: 10.5021/ad.2017.29.1.74. Epub 2017 Feb 3.
https://www.ncbi.nlm.nih.gov/pubmed/28223750 - Wang Y, Chen L, Li F, Bao M, Zeng J, Xiang J, Luo H, Li J, Tang L.
TLR4 rs41426344 increases susceptibility of rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA) in a central south Chinese Han population.
Pediatr Rheumatol Online J. 2017 Feb 21;15(1):12. doi: 10.1186/s12969-017-0137-5.
https://www.ncbi.nlm.nih.gov/pubmed/28222760 - Adriano LS1, de França Fonteles MM2, de Fátima Menezes Azevedo M3, Beserra MP2, Romero NR2.
Medication adherence in patients with juvenile idiopathic arthritis.
Rev Bras Reumatol Engl Ed. 2017 Jan - Feb;57(1):23-29. doi: 10.1016/j.rbre.2016.05.004. Epub 2016 May 30.
https://www.ncbi.nlm.nih.gov/pubmed/28137399 - Mizuta M, Shimizu M, Nakagishi Y, Kasai K, Yachie A.
Bicipital synovial cyst associated with systemic juvenile idiopathic arthritis: new insights obtained from unique pathological findings.
Int J Rheum Dis. 2017 Feb 10. doi: 10.1111/1756-185X.12994. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28185428 - Hisa K, Yanagimachi MD, Naruto T, Miyamae T, Kikuchi M, Hara R, Imagawa T, Yokota S, Mori M.
PADI4 and the HLA-DRB1 shared epitope in juvenile idiopathic arthritis.
PLoS One. 2017 Feb 9;12(2):e0171961. doi: 10.1371/journal.pone.0171961. eCollection 2017.
https://www.ncbi.nlm.nih.gov/pubmed/28182665 - Uziel Y.
Juvenile Idiopathic Arthritis in the Era of International Cooperation.
Rambam Maimonides Med J. 2017 Jan 30;8(1). doi: 10.5041/RMMJ.10278.
https://www.ncbi.nlm.nih.gov/pubmed/28178439 - Sarkar S, Alam MM, Das G, Datta S.
Inflammatory Markers and Disease Activity in Juvenile Idiopathic Arthritis.
Indian J Pediatr. 2017 Feb 8. doi: 10.1007/s12098-017-2292-6. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28176230 - Stinson J, Connelly M, Huber A, Luca N, Spiegel L, Tsimicalis A, Luca S, Tajuddin N, Berard R, Barsalou J, Campillo S, Dancey P, Duffy C, Feldman B, Johnson N, McGrath P, Shiff N, Tse S, Tucker L, Victor J.
Development and usability testing of an iPad and desktop psycho-educational game for children with Juvenile Idiopathic Arthritis and their parents.
J Pain. 2016 Apr;17(4S):S106. doi: 10.1016/j.jpain.2016.01.335. Epub 2016 Mar 24.
https://www.ncbi.nlm.nih.gov/pubmed/28162331 - Srivastava R, Phatak S, Aggarwal A.
ERAP1 rs30187 single nucleotide polymorphism does not confer disease susceptibility in North Indian children with enthesitis-related arthritis.
Clin Rheumatol. 2017 Feb 4. doi: 10.1007/s10067-017-3560-6. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28161768 - Macedo de Menezes L, Deon Rizzatto SM, Martinelli Santayana de Lima E, Baccarin Matje PR, Picarelli MM.
Juvenile idiopatic arthritis in orthodontics: Case report with a 6-year follow-up.
Am J Orthod Dentofacial Orthop. 2017 Feb;151(2):384-396. doi: 10.1016/j.ajodo.2015.12.032.
https://www.ncbi.nlm.nih.gov/pubmed/28153169 - Horton DB, Onel KB, Beukelman T, Ringold S.
Attitudes and Approaches for Withdrawing Drugs for Children with Clinically Inactive Nonsystemic JIA: A Survey of the Childhood Arthritis and Rheumatology Research Alliance.
J Rheumatol. 2017 Feb 1. pii: jrheum.161078. doi: 10.3899/jrheum.161078. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28148696 - Al-Mayouf SM, Naji H, Alismail K, Alazami AM, Sheikh F, Conca W, Al-Mousa H.
Evolving spectrum of LRBA deficiency-associated chronic arthritis: is there a causative role in juvenile idiopathic arthritis?
Clin Exp Rheumatol. 2017 Jan 27. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28134088 - Glerup M, Herlin T, Twilt M.
Remission rate is not dependent on the presence of antinuclear antibodies in juvenile idiopathic arthritis.
Clin Rheumatol. 2017 Mar;36(3):671-676. doi: 10.1007/s10067-017-3540-x. Epub 2017 Jan 17.
https://www.ncbi.nlm.nih.gov/pubmed/28097448 - Pasini AM, Gagro A, Roić G, Vrdoljak O, Lujić L, Žutelija-Fattorini M.
Ataxia Telangiectasia and Juvenile Idiopathic Arthritis.
Pediatrics. 2017 Feb;139(2). pii: e20161279. doi: 10.1542/peds.2016-1279. Epub 2017 Jan 12.
https://www.ncbi.nlm.nih.gov/pubmed/28082406 - Merker J, Hartmann M, Kreuzpointner F, Schwirtz A, Haas JP.
Excellent balance skills despite active and inactive juvenile idiopathic arthritis - unexpected results of a cross-sectional study.
Clin Exp Rheumatol. 2017 Jan-Feb;35(1):161-168. Epub 2017 Jan 5.
https://www.ncbi.nlm.nih.gov/pubmed/28079509 - Nakamura H, Sugai T, Kato M, Hatanaka KC, Atsumi T
Subcutaneous panniculitis-like T-cell lymphoma with haemophagocytic syndrome during tocilizumab therapy for juvenile idiopathic arthritis.
Clin Exp Rheumatol. 2017 Jan-Feb;35(1):174. Epub 2017 Jan 5.
https://www.ncbi.nlm.nih.gov/pubmed/28079502 - Burden-Teh E, Thomas KS, Rangaraj S, Cranwell J, Murphy R.
Early recognition and detection of juvenile psoriatic arthritis: a call for a standardized approach to screening.
Clin Exp Dermatol. 2017 Mar;42(2):153-160. doi: 10.1111/ced.13010. Epub 2017 Jan 2.
https://www.ncbi.nlm.nih.gov/pubmed/28044348
ENERO 2017
- Ravelli A, Davì S, Bracciolini G, Pistorio A, Consolaro A, van Dijkhuizen EH, Lattanzi B, Filocamo G, Verazza S, Gerloni V, Gattinara M, Pontikaki I, Insalaco A, De Benedetti F, Civino A, Presta G, Breda L, Marzetti V, Pastore S, Magni-Manzoni S, Maggio MC, Garofalo F, Rigante D, Gattorno M, Malattia C, Picco P, Viola S, Lanni S, Ruperto N, Martini A; Italian Pediatric Rheumatology Study Group.
Intra-articular corticosteroids versus intra-articular corticosteroids plus methotrexate in oligoarticular juvenile idiopathic arthritis: a multicentre, prospective, randomised, open-label trial.
Lancet. 2017 Feb 2. pii: S0140-6736(17)30065-X. doi: 10.1016/S0140-6736(17)30065-X. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/28162781 - Taylor J, Giannini EH, Lovell DJ, Huang B, Morgan E.
Lack of Concordance in Inter-Rater Scoring of the Provider's Global Assessment of Children with Juvenile Idiopathic Arthritis with Low Disease Activity.
Arthritis Care Res (Hoboken). 2017 Jan 24. doi: 10.1002/acr.23203. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/28118522 - Hissink Muller PC, Brinkman DM, Schonenberg D, Koopman-Keemink Y, Brederije IC, Bekkering WP, Kuijpers TW, van Rossum MA, van Suijlekom-Smit LW, van den Berg JM, Allaart CF, Ten Cate R.
A comparison of three treatment strategies in recent onset non-systemic Juvenile Idiopathic Arthritis: initial 3-months results of the BeSt for Kids-study.
Pediatr Rheumatol Online J. 2017 Feb 6;15(1):11. doi: 10.1186/s12969-017-0138-4.
https://www.ncbi.nlm.nih.gov/pubmed/28166785 - Aalto K, Lahdenne P, Kolho KL
Fecal calprotectin in juvenile idiopathic arthritis patients related to drug use.
Pediatr Rheumatol Online J. 2017 Jan 31;15(1):9. doi: 10.1186/s12969-016-0132-2.
https://www.ncbi.nlm.nih.gov/pubmed/28143478 - Glerup M, Herlin T, Twilt M.
Remission rate is not dependent on the presence of antinuclear antibodies in juvenile idiopathic arthritis.
Clin Rheumatol. 2017 Jan 17. doi: 10.1007/s10067-017-3540-x. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/28097448
DICIEMBRE 2016
- Verazza S, Davì S, Consolaro A, Bovis F, Insalaco A, Magni-Manzoni S, Nicolai R, Marafon DP, De Benedetti F, Gerloni V, Pontikaki I, Rovelli F, Cimaz R, Marino A, Zulian F, Martini G, Pastore S, Sandrin C, Corona F, Torcoletti M, Conti G, Fede C, Barone P, Cattalini M, Cortis E, Breda L, Olivieri AN, Civino A, Podda R, Rigante D, La Torre F, D'Angelo G, Jorini M, Gallizzi R, Maggio MC, Consolini R, De Fanti A, Muratore V, Alpigiani MG, Ruperto N, Martini A, Ravelli A; Italian Pediatric Rheumatology Study Group.
Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept.
Pediatr Rheumatol Online J. 2016 Dec 20;14(1):68.
https://www.ncbi.nlm.nih.gov/pubmed/27993144 - Armbrust W, Lelieveld OH, Tuinstra J, Wulffraat NM, Bos GJ, Cappon J, van Rossum MA, Sauer PJ, Hagedoorn M.
Fatigue in patients with Juvenile Idiopathic Arthritis: relationship to perceived health, physical health, self-efficacy, and participation.
Pediatr Rheumatol Online J. 2016 Dec 6;14(1):65.
https://www.ncbi.nlm.nih.gov/pubmed/27919265 - Hinks A, Bowes J, Cobb J, Ainsworth HC, Marion MC, Comeau ME, Sudman M, Han B; Juvenile Arthritis Consortium for Immunochip., Becker ML, Bohnsack JF, de Bakker PI, Haas JP, Hazen M, Lovell DJ, Nigrovic PA, Nordal E, Punnaro M, Rosenberg AM, Rygg M, Smith SL, Wise CA, Videm V, Wedderburn LR, Yarwood A, Yeung RS, Prahalad S, Langefeld CD, Raychaudhuri S, Thompson SD, Thomson W.
Fine-mapping the MHC locus in juvenile idiopathic arthritis (JIA) reveals genetic heterogeneity corresponding to distinct adult inflammatory arthritic diseases.
Ann Rheum Dis. 2016 Dec 20.
https://www.ncbi.nlm.nih.gov/pubmed/27998952 - Ombrello MJ, Arthur VL, Remmers EF, Hinks A, Tachmazidou I, Grom AA, Foell D, Martini A, Gattorno M, Özen S, Prahalad S, Zeft AS, Bohnsack JF, Ilowite NT, Mellins ED, Russo R, Len C, Hilario MO, Oliveira S, Yeung RS, Rosenberg AM, Wedderburn LR, Anton J, Haas JP, Rosen-Wolff A, Minden K, Tenbrock K, Demirkaya E, Cobb J, Baskin E, Signa S, Shuldiner E, Duerr RH, Achkar JP, Kamboh MI, Kaufman KM, Kottyan LC, Pinto D, Scherer SW, Alarcón-Riquelme ME, Docampo E, Estivill X, Gül A; British Society of Pediatric and Adolescent Rheumatology (BSPAR) Study Group, Inception Cohort of Newly Diagnosed Patients with Juvenile Idiopathic Arthritis (ICON-JIA) Study Group, Childhood Arthritis Prospective Study (CAPS) Group, Randomized Placebo Phase Study of Rilonacept in sJIA (RAPPORT) Investigators, Sparks-Childhood Arthritis Response to Medication Study (CHARMS) Group, Biologically Based Outcome Predictors in JIA (BBOP) Group., Langefeld CD, Thompson S, Zeggini E, Kastner DL, Woo P, Thomson W.
Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications.
Ann Rheum Dis. 2016 Dec 7
https://www.ncbi.nlm.nih.gov/pubmed/27927641 - Klotsche J, Raab A, Niewerth M, Sengler C, Ganser G, Kallinich T, Niehues T, Hufnagel M, Thon A, Hospach T, Horneff G, Minden K.
Outcome and Trends in Treatment of Systemic Juvenile Idiopathic Arthritis in the German National Pediatric Rheumatologic Database, 2000-2013.
Arthritis Rheumatol. 2016 Dec;68(12):3023-3034.
https://www.ncbi.nlm.nih.gov/pubmed/27332999 - Resnick CM, Vakilian PM, Breen M, Zurakowski D, Caruso P, Henderson L, Nigrovic PA, Kaban LB, Peacock ZS.
Quantifying Temporomandibular Joint Synovitis in Children With Juvenile Idiopathic Arthritis.
Arthritis Care Res (Hoboken). 2016 Dec;68(12):1795-1802.
https://www.ncbi.nlm.nih.gov/pubmed/27110936 - Luca NJ, Burnett HF, Ungar WJ, Moretti ME, Beukelman T, Feldman BM, Schwartz G, Bayoumi AM.
Cost-Effectiveness Analysis of First-Line Treatment With Biologic Agents in Plyarticular Juvenile Idiopathic Arthritis
Arthritis Care Res (Hoboken). 2016 Dec;68(12):1803-1811.
https://www.ncbi.nlm.nih.gov/pubmed/27059807 - Horneff G, Klein A, Oommen PT, Hospach A, Foeldvari I, Feddersen I, Minden K.
Update on malignancies in children with juvenile idiopathic arthritis in the German BIKER Registry.
Clin Exp Rheumatol. 2016 Nov-Dec;34(6):1113-1120.
https://www.ncbi.nlm.nih.gov/pubmed/27749226 - Guzman J, Henrey A, Loughin T, Berard RA, Shiff NJ, Jurencak R, Benseler SM, Tucker LB; on behalf of the ReACCh-Out Investigators.
Predicting Which Children with Juvenile Idiopathic Arthritis Will Have a Severe Disease Course: Results from the ReACCh-Out Cohort.
J Rheumatol. 2016 Dec 15.
https://www.ncbi.nlm.nih.gov/pubmed/27980015
NOVIEMBRE 2016
- Kallinich T, Thorwarth A, von Stuckrad SL, Rösen-Wolff A, Luksch H, Hundsdoerfer P, Minden K, Krawitz P.
Juvenile arthritis caused by a novel FAMIN (LACC1) mutation in two children with systemic and extended oligoarticular course.
Pediatr Rheumatol Online J. 2016 Nov 24;14(1):63.
https://www.ncbi.nlm.nih.gov/pubmed/27881174 - Lipinska J, Lipinska S, Kasielski M, Smolewska E.
Anti-MCV and anti-CCP antibodies-diagnostic and prognostic value in children with juvenile idiopathic arthritis (JIA).
Clin Rheumatol. 2016 Nov;35(11):2699-2706.
https://www.ncbi.nlm.nih.gov/pubmed/27457366 - Horneff G, Klein A, Klotsche J, Minden K, Huppertz HI, Weller-Heinemann F, Kuemmerle-Deschner J, Haas JP, Hospach A.
Comparison of treatment response, remission rate and drug adherence in polyarticular juvenile idiopathic arthritis patients treated with etanercept, adalimumab or tocilizumab.
Arthritis Res Ther. 2016 Nov 24;18(1):272.
https://www.ncbi.nlm.nih.gov/pubmed/27881144 - Nozawa T, Nishimura K, Ohara A, Hara R, Ito S.
Primary varicella infection in children with systemic juvenile idiopathic arthritis under tocilizumab therapy.
Mod Rheumatol. 2016 Nov 16:1-19.
https://www.ncbi.nlm.nih.gov/pubmed/27846755 - Bohr AH, Pedersen FK, Nielsen CH, Müller KG.
Lipoprotein cholesterol fractions are related to markers of inflammation in children and adolescents with juvenile idiopathic arthritis: a cross sectional study.
Pediatr Rheumatol Online J. 2016 Nov 11;14(1):61.
https://www.ncbi.nlm.nih.gov/pubmed/27835952 - Capone M, Maggi L, Santarlasci V, Rossi MC, Mazzoni A, Montaini G, Cimaz R, Ramazzotti M, Piccinni MP, Barra G, De Palma R, Liotta F, Maggi E, Romagnani S, Annunziato F, Cosmi L.
Chitinase 3-like-1 is produced by human Th17 cells and correlates with the level of inflammation in juvenile idiopathic arthritis patients.
Clin Mol Allergy. 2016 Nov 8;14:16.
https://www.ncbi.nlm.nih.gov/pubmed/27826220 - Maggi L, Cimaz R, Capone M, Santarlasci V, Rossi MC, Mazzoni A, Montaini G, Pagnini I, Giani T, Simonini G, Scaletti C, Liotta F, Maggi E, Annunziato F, Cosmi L.
Immunosuppressive Activity of Abatacept on Circulating T Helper Lymphocytes from Juvenile Idiopathic Arthritis Patients.
Int Arch Allergy Immunol. 2016;171(1):45-53.
https://www.ncbi.nlm.nih.gov/pubmed/27820937 - Nisihara R, Skare T, Jardim AC, Utiyama SR.
Celiac disease autoantibodies in juvenile idiopathic arthritis.
Rheumatol Int. 2016 Nov 2.
https://www.ncbi.nlm.nih.gov/pubmed/27807636 - Tu ZQ, Xue HY, Chen W, Cao LF, Zhang WQ.
Identification of potential peripheral blood diagnostic biomarkers for patients with juvenile idiopathic arthritis by bioinformatics analysis.
Rheumatol Int. 2016 Nov 19.
https://www.ncbi.nlm.nih.gov/pubmed/27866247
OCTUBRE 2016
- Davies R, Southwood T, Kearsley-Fleet L, Lunt M, Baildam E, Beresford MW, Foster HE, Douglas S, Thomson W, De Cock D; BCRD Study Group.; BSPAR-ETN Study Group., Hyrich KL.
Mortality rates are increased in patients with systemic juvenile idiopathic arthritis.
Arch Dis Child. 2016 Oct 31
https://www.ncbi.nlm.nih.gov/pubmed/27799155 - Davies R, Carrasco R, Foster HE, Baildam EM, Chieng SE, Davidson JE, Ioannou Y, Wedderburn LR, Thomson W, Hyrich KL.
Treatment prescribing patterns in patients with juvenile idiopathic arthritis (JIA): Analysis from the UK Childhood Arthritis Prospective Study (CAPS)
Semin Arthritis Rheum. 2016 Oct;46(2):190-5
https://www.ncbi.nlm.nih.gov/pubmed/27422803 - Geven EJ, van den Bosch MH, Di Ceglie I, Ascone G, Abdollahi-Roodsaz S, Sloetjes AW, Hermann S, Schäfers M, van de Loo FA, van der Kraan PM, Koenders MI, Foell D, Roth J, Vogl T, van Lent PL.
S100A8/A9, a potent serum and molecular imaging biomarker for synovial inflammation and joint destruction in seronegative experimental arthritis
Arthritis Res Ther. 2016 Oct 24;18(1):247
https://www.ncbi.nlm.nih.gov/pubmed/27776554
SEPTIEMBRE 2016
- Cellucci T, Guzman J, Petty RE, Batthish M, Benseler SM, Ellsworth JE, Houghton KM, LeBLANC CM, Huber AM, Luca N, Schmeling H, Shiff NJ, Soon GS, Tse SM. Pediatric Committee of the Canadian Rheumatology Association.
Management of Juvenile Idiopathic Arthritis 2015: A Position Statement from the Pediatric Committee of the Canadian Rheumatology Association.
J Rheumatol. 2016 Oct;43(10):1773-1776.
https://www.ncbi.nlm.nih.gov/pubmed/27698103 - Windschall D, Horneff G.
Safety and efficacy of etanercept and adalimumab in children aged 2 to 4 years with juvenile idiopathic arthritis.
Clin Rheumatol. 2016 Oct 5.
https://www.ncbi.nlm.nih.gov/pubmed/27709443 - Verwoerd A, Ter Haar NM, de Roock S, Vastert SJ, Bogaert D.
The human microbiome and juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2016 Sep 20;14(1):55.
https://www.ncbi.nlm.nih.gov/pubmed/27650128 - Beukelman T, Xie F, Baddley JW, Chen L, Mannion ML, Saag KG, Zhang J, Curtis JR.
The risk of hospitalized infection following initiation of biologic agents versus methotrexate in the treatment of juvenile idiopathic arthritis.
Arthritis Res Ther. 2016 Sep 22;18(1):210.
https://www.ncbi.nlm.nih.gov/pubmed/27655411 - Aupiais C, Basmaci R, Ilharreborde B, Blachier A, Desmarest M, Job-Deslandre C, Faye A, Bonacorsi S, Alberti C, Lorrot M.
Arthritis in children: comparison of clinical and biological characteristics of septic arthritis and juvenile idiopathic arthritis.
Arch Dis Child. 2016 Sep 21.
https://www.ncbi.nlm.nih.gov/pubmed/27655660 - Bahrami T, Soltani S, Moazzami K, Yekaninejad MS, Salmaninejad A, Soltaninejad E, Ziaee V, Rezaei N.
Association of PTPN22 Gene Polymorphisms with Susceptibility to Juvenile Idiopathic Arthritis in Iranian Population.
Fetal Pediatr Pathol. 2016 Oct 12:1-7
https://www.ncbi.nlm.nih.gov/pubmed/27732119 - Ziaee V, Maddah M, Harsini S, Rezaei A, Sadr M, Zoghi S, Moradinejad MH, Rezaei N.
Association of interleukin-1 family gene polymorphisms with juvenile idiopathic arthritis in Iranian population.
Allergol Immunopathol (Madr). 2016 Oct 4.
https://www.ncbi.nlm.nih.gov/pubmed/27717726 - Isola G1, Ramaglia L, Cordasco G, Lucchese A, Fiorillo L, Matarese G.
The effect of a functional appliance in the management of temporomandibular
joint disorders in patients with juvenile idiopathic arthritis.
Minerva Stomatol. 2016 Sep 13.
https://www.ncbi.nlm.nih.gov/pubmed/27716739 - Gaur P, Myles A, Misra R, Aggarwal A.
Intermediate monocytes are increased in Enthesitis Related Arthritis a category of Juvenile idiopathic arthritis.
Clin Exp Immunol. 2016 Oct 5.
https://www.ncbi.nlm.nih.gov/pubmed/27706807 - Armbrust W, Joyce Bos GJ, Wulffraat NM, van Brussel M, Cappon J, Dijkstra PU, Geertzen JH, Legger GE, van Rossum MA, Sauer PJ, Lelieveld OT.
Internet program for physical activity and exercise capacity in children with juvenile idiopathic arthritis: a multicenter randomized controlled trial.
Arthritis Care Res (Hoboken). 2016 Oct 1.
https://www.ncbi.nlm.nih.gov/pubmed/27696793 - Put K, Vandenhaute J, Avau A, Van Nieuwenhuijze A, Brisse E, Dierckx T, Rutgeerts O, Garcia-Perez J, Toelen J, Waer M, Leclercq G, Goris A, Van Weyenbergh J, Liston A, de Somer L, Wouters C, Matthys P11.
Inflammatory gene expression profile and defective IFN-γ and granzyme K in natural killer cells of systemic juvenile idiopathic arthritis patients.
Arthritis Rheumatol. 2016 Oct 1.
https://www.ncbi.nlm.nih.gov/pubmed/27696741 - Memari AH, Chamanara E, Ziaee V, Kordi R, Raeeskarami SR.
Behavioral Problems in Juvenile Idiopathic Arthritis: A Controlled Study to Examine the Risk of Psychopathology in a Chronic Pediatric Disorder.
Int J Chronic Dis. 2016;2016:5726236.
https://www.ncbi.nlm.nih.gov/pubmed/27656678 - Lantz JM, Joshi S, OʼHearn M.
The Effects of Orthopedic Manual Physical Therapy in the Management of Juvenile Idiopathic Arthritis: A Case Report.
Pediatr Phys Ther. 2016 Winter;28(4):490-7.
https://www.ncbi.nlm.nih.gov/pubmed/27661250 - Maggi L, Cosmi L, Simonini G, Annunziato F, Cimaz R.
T cell subpopulations in juvenile idiopathic arthritis and their modifications after biotherapies.
Autoimmun Rev. 2016 Sep 15.
https://www.ncbi.nlm.nih.gov/pubmed/27640318 - Lipstein EA, Lovell DJ, Denson LA, Kim SC, Spencer C, Britto MT.
Parents' information needs and influential factors when making decisions about TNF-α inhibitors.
Pediatr Rheumatol Online J. 2016 Sep 15;14(1):53.
https://www.ncbi.nlm.nih.gov/pubmed/27641835 - Ziaee V, Maddah M, Moradinejad MH, Rezaei A, Zoghi S, Sadr M, Harsini S, Rezaei N.
Association of interleukin-6 single nucleotide polymorphisms with juvenile idiopathic arthritis.
Clin Rheumatol. 2016 Sep 20.
https://www.ncbi.nlm.nih.gov/pubmed/27646136 - Abinun M, Lane JP, Wood M, Friswell M, Flood TJ, Foster HE.
Infection-Related Death among Persons with Refractory Juvenile Idiopathic Arthritis.
Emerg Infect Dis. 2016 Oct;22(10):1720-7.
https://www.ncbi.nlm.nih.gov/pubmed/27648582 - De Rosa G, De Nisco A, Piastra M, Valentini P, Rigante D.
Efficacy of high-dose methylprednisolone pulses in a child with noninfectious persistent pleuropericarditis revealing systemic juvenile idiopathic arthritis.
Reumatismo. 2016 Sep 9;68(2):114-5.
https://www.ncbi.nlm.nih.gov/pubmed/27608803 - Zeft AS, Prahalad S, Schneider R, Dedeoglu F, Weiss PF, Grom AA, Mix C, Pope Rd CA.
Systemic onset juvenile idiopathic arthritis and exposure to fine particulate air pollution.
Clin Exp Rheumatol. 2016 Sep-Oct;34(5):946-952.
https://www.ncbi.nlm.nih.gov/pubmed/27607024 - Mannion ML, Xie F, Baddley J, Chen L, Curtis JR, Saag K, Zhang J, Beukelman T.
Analysis of health care claims during the peri-transfer stage of transition from pediatric to adult care among juvenile idiopathic arthritis patients.
Pediatr Rheumatol Online J. 2016 Sep 5;14(1):49.
https://www.ncbi.nlm.nih.gov/pubmed/27596158 - Ibrahim EF, Rashid A, Thomas M.
Linked semiconstrained and unlinked total elbow replacement in juvenile idiopathic arthritis: a case comparison series with mean 11.7-year follow-up.
J Shoulder Elbow Surg. 2016 Aug 31.
https://www.ncbi.nlm.nih.gov/pubmed/27592371
AGOSTO 2016
- Weiss PF.
Update on enthesitis-related arthritis.
Curr Opin Rheumatol. 2016 Sep;28(5):530-6.
http://www.ncbi.nlm.nih.gov/pubmed/27466726 - Zeft AS, Prahalad S, Schneider R, Dedeoglu F, Weiss PF, Grom AA, Mix C, Pope CA.
Systemic onset juvenile idiopathic arthritis and exposure to fine particulate air pollution.
Clin Exp Rheumatol. 2016 Sep 1. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/27607024 - Yokota S, Itoh Y, Morio T, et al
Tocilizumab in systemic juvenile idiopathic arthritis in a real-world clinical setting: results from 1 year of postmarketing surveillance follow-up of 417 patients in Japan
Ann Rheum Dis 2016;75:1654-1660
http://ard.bmj.com/content/75/9/1654.abstract - Kearsley-Fleet L, Davies R, Baildam E et al
Factors associated with choice of biologic among children with Juvenile Idiopathic Arthritis: results from two UK paediatric biologic registers
Rheumatology (Oxford) 2016; 55(9):1556-65.
http://rheumatology.oxfordjournals.org/content/55/9/1556.abstract - Stinson J, Ahola Kohut S, Forgeron P, Amaria K, Bell M, Kaufman M, Luca N, Luca S, Harris L, Victor C, Spiegel L.
The iPeer2Peer Program: a pilot randomized controlled trial in adolescents with Juvenile Idiopathic Arthritis.
Pediatr Rheumatol Online J. 2016 Sep 2;14(1):48.
http://www.ncbi.nlm.nih.gov/pubmed/27590668 - Kavanaugh A, McInnes IB, Mease PJ, Hall S, Chinoy H, Kivitz AJ, Wang Z, Mpofu S.
Efficacy of Subcutaneous Secukinumab in Patients with Active Psoriatic Arthritis Stratified by Prior Tumor Necrosis Factor Inhibitor Use: Results from the Randomized Placebo-controlled FUTURE 2 Study.
J Rheumatol. 2016 Sep;43(9):1713-7.
http://www.ncbi.nlm.nih.gov/pubmed/27307536 - Van der Heijde D, Landewé RB, Mease PJ, et al.
Secukinumab provides significant and sustained inhibition of joint structural damage in a phase III study of active Psoriatic Arthritis
Arthritis Rheumatol 2016; 68 (8):1914-21.
http://onlinelibrary.wiley.com/doi/10.1002/art.39685/pdf - Mease PJ, van der Heijde D, Ritchlin CT, Okada M, Cuchacovich RS, Shuler CL, Lin CY, Braun DK, Lee CH, Gladman DD; SPIRIT-P1 Study Group.
Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1.
Ann Rheum Dis. 2016 Aug 23. pii: annrheumdis-2016-209709. doi: 10.1136/annrheumdis-2016-209709. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/27553214 - Frid P, Nordal E, Bovis F, Giancane G, Larheim TA, Rygg M, Pires Marafon D, De Angelis D, Palmisani E, Murray KJ, Oliveira S, Simonini G, Corona F, Davidson J, Foster H, Steenks MH, Flato B, Zulian F, Baildam E, Saurenmann RK,
Temporomandibular Joint Involvement is Associated with Quality of Life, Disability and High Disease Activity in Juvenile Idiopathic Arthritis.
Arthritis Care Res (Hoboken). 2016 Aug 26. doi: 10.1002/acr.23003. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27564918 - Doğruel D, Yılmaz M, Bingöl G, Altıntaş DU, Güneşer Kendirli S.
Fraction of exhaled nitric oxide as a predictor in juvenile idiopathic arthritis progression.
Clin Rheumatol. 2016 Aug 10. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/27511473 - Peters S, Ota S, Bolous E, Reich E, Chait S, Feldman BM.
The Responsiveness of the Modified Childhood Health Assessment Questionnaire.
J Rheumatol. 2016 Aug 1. pii: jrheum.151139. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27481906 - Thorsen SU, Pipper CB, Alberdi-Saugstrup M, Nielsen S, Cohen A, Lundqvist M, Thygesen LC, Ascherio A, Svensson J.
No association between vitamin D levels around time of birth and later risk of developing oligo- and polyarticular juvenile idiopathic arthritis: a Danish case-cohort study.
Scand J Rheumatol. 2016 Jul 27:1-8. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27460412
JULIO 2016
- Becker I, Horneff G.
Risk of serious infection in juvenile idiopathic arthritis patients associated with TNF-inhibitors and disease activity in the German BIKER registry.
Arthritis Care Res (Hoboken). 2016 Jul 7. doi: 10.1002/acr.22961. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27390133 - Arvonen M, Berntson L, Pokka T, Karttunen TJ, Vähäsalo P, Stoll ML.
Gut microbiota-host interactions and juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2016 Jul 22;14(1):44. doi: 10.1186/s12969-016-0104-6.
http://www.ncbi.nlm.nih.gov/pubmed/27448997 - Bos GJ, Lelieveld OT, Armbrust W, Sauer PJ, Geertzen JH, Dijkstra PU.
Physical activity in children with Juvenile Idiopathic Arthritis compared to controls.
Pediatr Rheumatol Online J. 2016 Jul 7;14(1):42. doi: 10.1186/s12969-016-0102-8.
http://www.ncbi.nlm.nih.gov/pubmed/27387754 - Henderson LA, Volpi S, Frugoni F, Janssen E, Kim S, Sundel RP, Dedeoglu F, Lo MS, Hazen MM, Beth Son M, Mathieu R, Zurakowski D, Yu N, Lebedeva T2, Fuhlbrigge RC, Walter JE, Nee Lee Y, Nigrovic PA, Notarangelo LD.
Next-Generation Sequencing Reveals Restriction and Clonotypic Expansion of Treg Cells in Juvenile Idiopathic Arthritis.
Arthritis Rheumatol. 2016 Jul;68(7):1758-68. doi: 10.1002/art.39606.
http://www.ncbi.nlm.nih.gov/pubmed/26815131 - Gohar F, Kessel C, Lavric M, Holzinger D, Foell D.
Review of biomarkers in systemic juvenile idiopathic arthritis: helpful tools or just playing tricks?
Arthritis Res Ther. 2016 Jul 13;18:163. doi: 10.1186/s13075-016-1069-z.
http://www.ncbi.nlm.nih.gov/pubmed/27411444
JUNIO 2016
- Díaz-Peña R, Vidal-Castiñeira JR, López-Vázquez A, López-Larrea C.
HLA-B*40:01 Is Associated with Ankylosing Spondylitis in HLA-B27-positive Populations.
J Rheumatol. 2016 Jun;43(6):1255-6. doi: 10.3899/jrheum.151096.
http://www.ncbi.nlm.nih.gov/pubmed/27252503 - Kristensen KD, Stoustrup P, Küseler A, Pedersen TK, Twilt M, Herlin T
Clinical predictors of temporomandibular joint arthritis in juvenile idiopathic arthritis: A systematic literature review.
Semin Arthritis Rheum. 2016 Jun;45(6):717-32. doi: 10.1016/j.semarthrit.2015.11.006
http://www.ncbi.nlm.nih.gov/pubmed/26708936 - Janow G, Schanberg LE, Setoguchi S, Hasselblad V, Mellins ED, Schneider R, Kimura Y; CARRA Legacy Registry Investigators.
The Systemic Juvenile Idiopathic Arthritis Cohort of the Childhood Arthritis and Rheumatology Research Alliance Registry: 2010-2013.
J Rheumatol. 2016 Jun 15. pii: jrheum.150997
http://www.ncbi.nlm.nih.gov/pubmed/27307527 - Walters HM, Pan N, Lehman TJ, Adams A, Kalliolias GD, Zhu YS, Santiago F, Nguyen J, Sitaras L, Cunningham-Rundles S, Walsh TJ, Toussi SS.
The impact of disease activity and tumour necrosis factor-α inhibitor therapy on cytokine levels in juvenile idiopathic arthritis.
Clin Exp Immunol. 2016 Jun;184(3):308-17. doi: 10.1111/cei.12782
http://www.ncbi.nlm.nih.gov/pubmed/26934060 - Zamora-Legoff JA, Krause ML, Crowson CS, Muskardin TW, Mason T, Matteson EL.
Treatment of patients with juvenile idiopathic arthritis (JIA) in a population-based cohort.
Clin Rheumatol. 2016 Jun;35(6):1493-9. doi: 10.1007/s10067-016-3190-4
http://www.ncbi.nlm.nih.gov/pubmed/26825065 - Taddio A, Cattalini M, Simonini G, Cimaz R.
Recent advances in the use of Anti-TNFα therapy for the treatment of juvenile idiopathic arthritis.
Expert Rev Clin Immunol. 2016 Jun;12(6):641-9. doi:10.1586/1744666X.2016.1146132
http://www.ncbi.nlm.nih.gov/pubmed/26809126 - Pichler J, Ong C, Shah N, Sebire N, Kiparrissi F, Borrelli O, Pilkington C, Elawad M
Histopathological features of gastrointestinal mucosal biopsies in children with juvenile idiopathic arthritis.
Pediatr Res. 2016 Jun;79(6):895-901. doi: 10.1038/pr.2016.27.
http://www.ncbi.nlm.nih.gov/pubmed/26882369
MAYO 2016
- Klotsche J, Niewerth M, Haas JP, Huppertz HI, Zink A, Horneff G et al.
Extended report: Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA).
Ann Rheum Dis 2016;75:855-861. doi:10.1136/annrheumdis-annrheumdis-2014-206747.
http://ard.bmj.com/content/75/5/855.abstract - Demirkaya E, Lanni S, Bovis F, Galasso R, Ravelli A, Palmisani E, et al.
A Meta-Analysis to Estimate the Placebo Effect in Randomized Controlled Trials in Juvenile Idiopathic Arthritis.
Arthritis Rheumatol 68:1540–1550. doi:10.1002/art.39583
http://onlinelibrary.wiley.com/doi/10.1002/art.39583/abstract - Alcobendas R, Rodríguez-Vidal A, Pascual-Salcedo D, Murias S, Remesal A, Diego C, et al.
Monitoring serum etanercept levels in juvenile idiopathic arthritis: a pilot study.
Clin Exp Rheumatol 2016 Apr 28. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/27156742 - Akmatov M, Stumme M, Pessler F.
Real-life practice of methotrexate toxicity monitoring in juvenile idiopathic arthritis in Germany, Switzerland and Austria: results of a cross-sectional assessment conducted in 2012.
Clin Exp Rheumatol. 2016 Apr 28. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27156925 - Quartier P.
Choice of biologic drug among children with juvenile idiopathic arthritis.
Rheumatology first published online May 11, 2016. doi: 10.1093/rheumatology/kew209
http://rheumatology.oxfordjournals.org/content/early/2016/05/11/rheumatology.kew209.extract - Kearsley-Fleet L, Davies R, Lunt M, Southwood TR, Hyrich KL.
Factors associated with improvement in disease activity following initiation of etanercept in children and young people with Juvenile Idiopathic Arthritis: results from the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study.
Rheumatology (2016) 55 (5): 840-847. doi: 10.1093/rheumatology/kev434
http://rheumatology.oxfordjournals.org/content/55/5/840.abstract
ABRIL 2016
- Kinard BE, Bouloux GF, Prahalad S, Vogler L, Abramowicz S
Arthroscopy of the Temporomandibular Joint in Patients With Juvenile Idiopathic Arthritis
J Oral Maxillofac Surg. 2016 Jan 22. pii: S0278-2391(16)00120-8. doi: 10.1016/j.joms.2016.01.028. [Epub ahead of print] http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/26896757 - Barth S, Haas JP, Schlichtiger J, Molz J, Bisdorff B, Michels H, Hügle B, Radon K.
Long-Term Health-Related Quality of Life in German Patients with Juvenile Idiopathic Arthritis in Comparison to German General Population.
PLoS One. 2016 Apr 26;11(4):e0153267. doi: 10.1371/journal.pone.0153267. eCollection 2016.
http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27115139 - Consolaro A, Giancane G, Schiappapietra B, Davì S, Calandra S, Lanni S, Ravelli A.
Clinical outcome measures in juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2016 Apr 18;14(1):23. doi: 10.1186/s12969-016-0085-5. Review.
http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27089922 - Kuhlmann A, Schmidt T, Treskova M, López-Bastida J, Linertová R, Oliva-Moreno J, Serrano-Aguilar P, Posada-de-la-Paz M, Kanavos P, Taruscio D, Schieppati A, Iskrov G, Péntek M, Delgado C, von der Schulenburg JM, Persson U, Chevreul K, Fattore G; BURQOL-RD Research Network.
Social/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe.
Eur J Health Econ. 2016 Apr 16. [Epub ahead of print] http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27086322 - Livermore P, Eleftheriou D, Wedderburn LR.
The lived experience of juvenile idiopathic arthritis in young people receiving etanercept
Pediatr Rheumatol Online J. 2016 Apr 12;14(1):21. doi: 10.1186/s12969-016-0083-7.
http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27068023 - Consolaro A, Ravelli A.
Unraveling the Phenotypic Variability of Juvenile Idiopathic Arthritis across Races or Geographic Areas - Key to Understanding Etiology and Genetic Factors?
J Rheumatol. 2016 Apr;43(4):683-5. doi: 10.3899/jrheum.160173.
http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27037240 - El Assar de la Fuente S, Angenete O, Jellestad S, Tzaribachev N, Koos B, Rosendahl K.
Juvenile idiopathic arthritis and the temporomandibular joint: A comprehensive review.
J Craniomaxillofac Surg. 2016 May;44(5):597-607. doi: 10.1016/j.jcms.2016.01.014. Epub 2016 Feb 3.
http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/26924432
MARZO 2016
- Constantin T, Foeldvari I, Vojinovic J, Horneff G, Burgos-Vargas R, Nikishina I, Akikusa JD, Avcin T, Chaitow J, Koskova E, Lauwerys BR, Calvo Penades I, Flato B, Gamir ML, Huppertz HI, Raad JJ, Jarosova K, Anton J, Macku M, Otero Escalante WJ, Rutkowska-Sak L, Trauzeddel R, Velez-Sanchez PJ, Wouters C, Wajdula J, Zang C, Bukowski J, Woodworth D, Vlahos B, Martini A, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).
Two-year Efficacy and Safety of Etanercept in Pediatric Patients with Extended Oligoarthritis, Enthesitis-related Arthritis, or Psoriatic Arthritis.
J Rheumatol. 2016 Mar 1. pii: jrheum.150430. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26932344 - McErlane F, Foster HE, Carrasco R, Baildam EM, Chieng SE, Davidson JE, Ioannou Y, Wedderburn LR, Thomson W, Hyrich KL.
Trends in paediatric rheumatology referral times and disease activity indices over a ten-year period among children and young people with Juvenile Idiopathic Arthritis: results from the childhood arthritis prospective Study.
Rheumatology (Oxford). 2016 Mar 25. pii: kew021. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/27016664 - Chan MO, Petty RE, Guzman J; ReACCh-Out Investigators.
A Family history of Psoriasis in a first-degree relative in children with JIA: to include or exclude?
J Rheumatol. 2016 Mar 15. pii: jrheum.150555. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/26980584 - Turnier JL, Brunner HI.
Tocilizumab for treating juvenile idiopathic arthritis.
Expert Opin Biol Ther. 2016 Apr;16(4):559-66. doi: 10.1517/14712598.2016.1150997
http://www.ncbi.nlm.nih.gov/pubmed/26848760 - Makay B, Gücenmez ÖA, Ünsal E.
Inactive disease in Enthesitis-related Arthritis: Association of increased body mass index.
J Rheumatol. 2016 Mar 15. pii: jrheum.151208. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26980582 - Katsicas MM, Russo R.
Biologic agents in juvenile spondyloarthropathies.
Pediatr Rheumatol Online J. 2016 Mar 12;14(1):17. doi: 10.1186/s12969-016-0076-6
http://www.ncbi.nlm.nih.gov/pubmed/26968522 - Gómez-Ramírez O, Gibbon M, Berard R, Jurencak R, Green J, Tucker L, Shiff N, Guzman J
A recurring rollercoaster ride: a qualitative study of the emotional experiences of parents of children with juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2016 Mar 9;14(1):13. doi: 10.1186/s12969-016-0073-9.
http://www.ncbi.nlm.nih.gov/pubmed/26961237 - Lin CH, Lin CL, Shen TC, Wei CC.
Epidemiology and risk of juvenile idiopathic arthritis among children with allergic diseases: a nationwide population-based study.
Pediatr Rheumatol Online J. 2016 Mar 10;14(1):15. doi: 10.1186/s12969-016-0074-8.
http://www.ncbi.nlm.nih.gov/pubmed/26965056 - Schulert GS, Fall N, Harley JB, Shen N, Lovell DJ, Thornton S, Grom AA.
Monocyte microRNA expression in active systemic juvenile idiopathic arthritis implicates miR-125a-5p in polarized monocyte phenotypes.
Arthritis Rheumatol. 2016 Mar 25. doi: 10.1002/art.39694. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27014994 - Finkel TH, Li J, Wei Z, Wang W, Zhang H, Behrens EM, et al.
Variants in CXCR4 associate with juvenile idiopathic arthritis susceptibility.
BMC Med Genet. 2016 Mar 22;17(1):24. doi: 10.1186/s12881-016-0285-3.
http://www.ncbi.nlm.nih.gov/pubmed/27005825
FEBRERO 2016
- Clement CC, Moncriefe H, Lele A, Janow G, Becerra A, Bauli F, Saad FA, Perino G, Montagna C, Cobelli N, Hardin J, Stern LJ, Ilowite N, Porcelli SA, Santambrogio L.
Autoimmune response to transthyretin in juvenile idiopathic arthritis.
JCI Insight. 2016 Feb;1(2). pii: e85633. Epub 2016 Feb 25.
http://www.ncbi.nlm.nih.gov/pubmed/26973882 - Scheuern A, Fischer N, McDonald J, Brunner HI, Haas JP, Hügle B.
Mutations in the MTHFR gene are not associated with Methotrexate intolerance in patients with juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2016 Feb 29;14(1):11. doi: 10.1186/s12969-016-0071-y.
http://www.ncbi.nlm.nih.gov/pubmed/26928923 - El Assar de la Fuente S, Angenete O, Jellestad S, Tzaribachev N, Koos B, Rosendahl K.
Juvenile idiopathic arthritis and the temporomandibular joint: A comprehensive review.
J Craniomaxillofac Surg. 2016 Feb 3. pii: S1010-5182(16)00028-7. doi: 10.1016/j.jcms.2016.01.014. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26924432 - Nicolai R, Cortis E, Ravà L, Bracaglia C, Pardeo M, Insalaco A, Buonuomo PS, Tozzi AE, De Benedetti F.
Herpes Virus Infections During Treatment With Etanercept in Juvenile Idiopathic Arthritis.
J Pediatric Infect Dis Soc. 2016 Mar;5(1):76-9. doi: 10.1093/jpids/piu078. Epub 2014 Jul 31.
http://www.ncbi.nlm.nih.gov/pubmed/26908493 - Race DL, Sims-Gould J, Tucker LB, Duffy CM, Feldman DE, Gibbon M, Houghton KM, Stinson JN, Stringer E, Tse SM, McKay HA.
'It might hurt, but you have to push through the pain': Perspectives on physical activity from children with juvenile idiopathic arthritis and their parents.
J Child Health Care. 2016 Feb 23. pii: 1367493516632616. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26907570 - Fay M1, Rapley T, Foster H, Pain C, Gerrand C.
Can Seeding in the Clinic Reach a Wide Audience? A Proof of Concept Study on Spreading a Health Message About Juvenile Idiopathic Arthritis Using a Shareable Online Video.
Interact J Med Res. 2016 Feb 22;5(1):e6. doi: 10.2196/ijmr.4608.
http://www.ncbi.nlm.nih.gov/pubmed/26903485 - Mani P, Uno K, Duong M, Wolski K, Spalding S, Husni ME, Nicholls SJ.
HDL function and subclinical atherosclerosis in juvenile idiopathic arthritis.
Cardiovasc Diagn Ther. 2016 Feb;6(1):34-43. doi: 10.3978/j.issn.2223-3652.2015.12.14.
http://www.ncbi.nlm.nih.gov/pubmed/26885490 - Pichler J, Ong C, Shah N, Sebire N, Kiparrissi F, Borrelli O, Pilkington C, Elawad M.
Histopathological features of gastrointestinal mucosal biopsies in children with juvenile idiopathic arthritis.
Pediatr Res. 2016 Feb 16. doi: 10.1038/pr.2016.27. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26882369 - Evensen K, Aulie HA, Rønning OM, Flatø B, Russell D.
Carotid Atherosclerosis in Adult Patients with Persistently Active Juvenile Idiopathic Arthritis Compared with Healthy Controls.
J Rheumatol. 2016 Feb 15. pii: jrheum.150499. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26879363 - Fitzpatrick L, Broadaway KA, Ponder L, Angeles-Han ST, Jenkins K, Rouster-Stevens K, Pelajo CF, Conneely K, Epstein MP, Lopez-Benitez J,Vogler LB, Prahalad S; CARRA Registry Investigators.
Phenotypic Characterization of Juvenile Idiopathic Arthritis in African American Children.
J Rheumatol. 2016 Feb 15. pii: jrheum.150891. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26879356 - Aguiar F, Brito I.
Structural damage to the hip in systemic juvenile idiopathic arthritis: A case of regression with Anakinra.
Reumatol Clin. 2016 Feb 9. pii: S1699-258X(16)00004-8. doi: 10.1016/j.reuma.2015.12.007. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26872537 - Lange L, Thiele GM, McCracken C, Wang G, Ponder LA, Angeles-Han ST, Rouster-Stevens KA, Hersh AO, Vogler LB, Bohnsack JF, Abramowicz S, Mikuls TR, Prahalad S.
Symptoms of periodontitis and antibody responses to Porphyromonas gingivalis in juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2016 Feb 9;14(1):8. doi: 10.1186/s12969-016-0068-6.
http://www.ncbi.nlm.nih.gov/pubmed/26861944 - Anderson JH, Anderson KR, Aulie HA, Crowson CS, Mason TG, Ardoin SP, Reed AM, Flatø B.
Juvenile idiopathic arthritis and future risk for cardiovascular disease: a multicenter study.
Scand J Rheumatol. 2016 Feb 8:1-5. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26854592 - van Dijkhuizen EH, Pouw JN, Scheuern A, Hügle B, Hardt S, Ganser G, Kümmerle-Deschner JB, Horneff G, Holzinger D, Bulatović Ćalasan M,Wulffraat NM.
Methotrexate intolerance in oral and subcutaneous administration in patients with juvenile idiopathic arthritis: a cross-sectional, observational study.
Clin Exp Rheumatol. 2016 Jan-Feb;34(1):148-54. Epub 2016 Feb 2.
http://www.ncbi.nlm.nih.gov/pubmed/26843067 - Barth S, Schlichtiger J, Bisdorff B, Hügle B, Michels H, Radon K, Haas JP.
Association between drug intake and incidence of malignancies in patients with Juvenile Idiopathic Arthritis: a nested case-control study.
Pediatr Rheumatol Online J. 2016 Feb 3;14(1):6. doi: 10.1186/s12969-016-0066-8.
http://www.ncbi.nlm.nih.gov/pubmed/26842529 - Kapusta MA.
A Portrait of Juvenile Arthritis with Multiple Joint Abnormalities.
J Rheumatol. 2016 Feb;43(2):450-1. doi: 10.3899/jrheum.150356.
http://www.ncbi.nlm.nih.gov/pubmed/26834249 - Ehrmann Feldman D, Vinet É, Bernatsky S, Duffy C, Hazel B, Meshefedjian G, Sylvestre MP, Bérard A.
Birth Outcomes in Women with a History of Juvenile Idiopathic Arthritis.
J Rheumatol. 2016 Feb 1. pii: jrheum.150592. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26834215 - Hsieh YJ, Darvann TA, Hermann NV, Larsen P, Liao YF, Bjoern-Joergensen J, Kreiborg S.
Facial morphology in children and adolescents with juvenile idiopathic arthritis and moderate to severe temporomandibular joint involvement.
Am J Orthod Dentofacial Orthop. 2016 Feb;149(2):182-91. doi: 10.1016/j.ajodo.2015.07.033.
http://www.ncbi.nlm.nih.gov/pubmed/26827974 - Macaubas C, Wong E, Zhang Y, Nguyen KD, Lee J, Milojevic D, Shenoi S, Stevens AM, Ilowite N, Saper V, Lee T, Mellins ED.
Altered signaling in systemic juvenile idiopathic arthritis monocytes.
Clin Immunol. 2016 Feb;163:66-74. doi: 10.1016/j.clim.2015.12.011. Epub 2015 Dec 31.
http://www.ncbi.nlm.nih.gov/pubmed/26747737
ENERO 2016
- Kearsley-Fleet L, Davies R, Baildam E, Beresford MW, Foster HE, Southwood TR, Thomson W, Hyrich KL.
Factors associated with choice of biologic among children with Juvenile Idiopathic Arthritis: results from two UK paediatric biologic registers.
Rheumatology (Oxford). 2016 Jan 4. pii: kev429. [Epub ahead of print] http://rheumatology.oxfordjournals.org/content/early/2016/01/03/rheumatology.kev429.full.pdf+html - Hilderson D, Moons P, Van der Elst K, Luyckx K, Wouters C, Westhovens R.
The clinical impact of a brief transition programme for young people with juvenile idiopathic arthritis: results of the DON'T RETARD project.
Rheumatology (Oxford). 2016 Jan;55(1):133-42. doi: 10.1093/rheumatology/kev284. Epub 2015 Aug 28.
http://www.ncbi.nlm.nih.gov/pubmed/26320142
DICIEMBRE 2015
- Esbjörnsson, A.-C., Iversen, M. D., André, M., Hagelberg, S., Schwartz, M. H. and Broström, E. W
Effect of Intraarticular Corticosteroid Foot Injections on Walking Function in Children With Juvenile Idiopathic Arthritis
Arthritis Care Res, 67: 1693–1701. doi: 10.1002/acr.22624
http://www.ncbi.nlm.nih.gov/pubmed/26017638 - Markula-Patjas K, Valta H, Pekkinen M, Andersson S, Aalto K, Lahdenne P, Viljakainen H, Mäkitie O.
Body composition and adipokines in patients with juvenile idiopathic arthritis and systemic glucocorticoids
Clin Exp Rheumatol. 2015 Nov-Dec;33(6):924-30
http://www.ncbi.nlm.nih.gov/pubmed/26315132 - Srivastava R, Agnihotry S, Aggarwal R, Bajpai P, Aggarwal A.
HLA-B27 subtypes in enthesitis-related arthritis category of juvenile idiopathic arthritis and ankylosing spondylitis in northern India.
Clin Exp Rheumatol. 2015 Nov-Dec;33(6):931-5.
http://www.ncbi.nlm.nih.gov/pubmed/26314893
- Nigrovic PA.
Autoinflammation and autoimmunity in systemic juvenile idiopathic arthritis.
Proc Natl Acad Sci U S A. 2015 Dec 29;112(52):15785-6. doi: 10.1073/pnas.1521837113.
http://www.ncbi.nlm.nih.gov/pubmed/26677874 - Stoustrup P, Kristensen KD, Küseler A, Pedersen TK, Herlin T
Temporomandibular joint steroid injections in patients with juvenile idiopathic arthritis: an observational pilot study on the long-term effect on signs and symptoms.
Pediatr Rheumatol Online J. 2015 Dec 21;13(1):62. doi: 10.1186/s12969-015-0060-6.
http://www.ncbi.nlm.nih.gov/pubmed/26689191 - Mulligan K, Wedderburn LR, Newman S
The experience of taking methotrexate for juvenile idiopathic arthritis: results of a cross-sectional survey with children and young people.
Pediatr Rheumatol Online J. 2015 Dec 12;13(1):58. doi: 10.1186/s12969-015-0052-6.
http://www.ncbi.nlm.nih.gov/pubmed/26653415 - Bohr AH, Nielsen S, Müller K, Karup Pedersen F, Andersen LB
Reduced physical activity in children and adolescents with Juvenile Idiopathic Arthritis despite satisfactory control of inflammation.
Pediatr Rheumatol Online J. 2015 Dec 10;13(1):57. doi: 10.1186/s12969-015-0053-5.
http://www.ncbi.nlm.nih.gov/pubmed/26653716 - Keller H, Müller LM, Markic G, Schraner T, Kellenberger CJ, Saurenmann RK.
Is early TMJ involvement in children with juvenile idiopathic arthritis clinically detectable? Clinical examination of the TMJ in comparison with contrast enhanced MRI in patients with juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2015 Dec 9;13(1):56. doi: 10.1186/s12969-015-0056-2.
http://www.ncbi.nlm.nih.gov/pubmed/26646650 - Brosseau L, Toupin-April K, Wells GA, Smith CA, Pugh AG, Stinson JN, Duffy CM, Gifford W, Moher D, Sherrington C, Cavallo S, De Angelis G, Loew L, Rahman P, Marcotte R, Taki J, Bisaillon J, King J, Coda A, Hendry GJ, Gauvreau J, Hayles M, Hayles K, Feldman B, Kenny GP, Li JX, Briggs AM, Martini R, Feldman DE, Maltais DB, Tupper S, Bigford S, Bisch M
Ottawa Panel Evidence-Based Clinical Practice Guidelines for Foot Care in the Management of Juvenile Idiopathic Arthritis.
Arch Phys Med Rehabil. 2015 Dec 17. pii: S0003-9993(15)01480-X. doi: 10.1016/j.apmr.2015.11.011.
http://www.ncbi.nlm.nih.gov/pubmed/26707409
NOVIEMBRE 2015
- Patompong Ungprasert, Narat Srivali, Charat Thongprayoon
Risk of Cardiovascular Disease in Patients with Juvenile Idiopathic Arthritis: A Systematic Review and Meta-analysis
Ann Paediatr Rheum. 2015; 4(3): 48-52
doi: 10.5455/apr.073020151756 - E H Pieter van Dijkhuizen, Nico M Wulffraat
Extended report:Early predictors of prognosis in juvenile idiopathic arthritis: a systematic literature review
Ann Rheum Dis 2015;74:1996-2005 Published Online First: 24 June 2014 doi:10.1136/annrheumdis-2014-205265
[Abstract] - S. Shenoi, M.L. Shaffer and C.A. Wallace
Environmental risk factors and early life exposures for Juvenile Idiopathic Arthritis; a case: Control study
Arthritis Care & Research
DOI: 10.1002/acr.22806
Abstract - Rubén Burgos-Vargas, Shirley M. L. Tse, Gerd Horneff, Aileen L. Pangan, Jasmina Kalabic, Sandra Goss, Kristina Unnebrink and Jaclyn K. Anderson
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study of Adalimumab in Pediatric Patients With Enthesitis-Related Arthritis (pages 1503–1512)
Arthritis Care & Research
DOI: 10.1002/acr.22657
Abstract - Aimee O. Hersh, Sampath Prahalad
Immunogenetics of juvenile idiopathic arthritis: A comprehensive review
Journal of Autoimmunity
Volume 64, November 2015, Pages 113–124 - Deborah Barthel, Gerd Ganser, Rolf-Michael Kuester, Nils Onken, Kirsten Minden, Hermann Josef Girschick, Anton Hospach, and Gerd Horneff
Inflammatory Bowel Disease in Juvenile Idiopathic Arthritis Patients Treated with Biologics
J Rheumatol November doi:10.3899/jrheum.140472
Abstract - Janneke Anink, Femke H. M. Prince, Maryanne Dijkstra, Marieke H. Otten, Marinka Twilt, Rebecca ten Cate, Simone L. Gorter, Yvonne Koopman-Keemink, Marion A. J. van Rossum, Esther P. A. Hoppenreijs, and Lisette W. A. van Suijlekom-Smit
Long-term quality of life and functional outcome of patients with juvenile idiopathic arthritis in the biologic era: a longitudinal follow-up study in the Dutch Arthritis and Biologicals in Children Register
Rheumatology (2015) 54 (11): 1964-1969 doi:10.1093/rheumatology/kev195
Abstract - Simon Tarp, Gil Amarilyo, Ivan Foeldvari, Robin Christensen, Jennifer M. P. Woo, Neta Cohen, Tracy D. Pope, and Daniel E. Furst
Efficacy and safety of biological agents for systemic juvenile idiopathic arthritis: a systematic review and meta-analysis of randomized trials
Rheumatology
doi:10.1093/rheumatology/kev382
Abstract - Lucie Brosseau, Désirée B. Maltais, Glen P. Kenny, Ciarán M. Duffy, Jennifer Stinson, Sabrina Cavallo, Karine Toupin-April, Debbie Ehrmann Feldman, Annette Majnemer, Isabelle J. Gagnon, and Marie-Ève Mathieu
What we can learn from existing evidence about physical activity for juvenile idiopathic arthritis?
Rheumatology
doi:10.1093/rheumatology/kev389
Extract
OCTUBRE 2015
- Anink J, Prince FH, Dijkstra M, Otten MH, Twilt M, Ten Cate R, Gorter SL, Koopman-Keemink Y, van Rossum MA, Hoppenreijs EP, van Suijlekom-Smit LW.
Long-term quality of life and functional outcome of patients with juvenile idiopathic arthritis in the biologic era: a longitudinal follow-up study in the Dutch Arthritis and Biologicals in Children Register.
Rheumatology (Oxford). 2015 Nov;54(11):1964-9. doi: 10.1093/rheumatology/kev195
http://www.ncbi.nlm.nih.gov/pubmed/26078219 - van Dijkhuizen EHP, Wulffraat NM.
Early predictors of prognosis in juvenile idiopathic arthritis: a systematic literature review.
Ann Rheum Dis 2015;74:1996-2005
http://ard.bmj.com/content/74/11/1996.abstract - Ravelli A, Consolaro A, Schiappapietra B, Martini A
The conundrum of juvenile psoriatic arthritis
Clin Exp Rheumatol. 2015 Sep-Oct;33(5 Suppl 93):40-3. Epub 2015 Oct 15. Review
http://www.ncbi.nlm.nih.gov/pubmed/26470604 - Obeid J, Nguyen T, Cellucci T, Larché MJ, Timmons BW.
Effects of acute exercise on circulating endothelial and progenitor cells in children and adolescents with juvenile idiopathic arthritis and healthy controls: a pilot study
Pediatr Rheumatol Online J. 2015 Oct 12;13(1):41. doi: 10.1186/s12969-015-0038-4.
http://www.ncbi.nlm.nih.gov/pubmed/26458943 - Backström M, Tynjälä P, Ylijoki H, Aalto K, Kärki J, Pohjankoski H, Keskitalo P, Sard S, Hietanen M, Lehto H, Kauko T, Vähäsalo P.
Finding specific 10-joint Juvenile Arthritis Disease Activity Score (JADAS10) and clinical JADAS10 cut-off values for disease activity levels in non-systemic juvenile idiopathic arthritis: a Finnish multicentre study.
Rheumatology (Oxford). 2015 Oct 7. pii: kev353. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/26447164 - Du N, Jiang K, Sawle AD, Frank MB, Wallace CA, Zhang A, Jarvis JN.
Dynamic tracking of functional gene modules in treated juvenile idiopathic arthritis
Genome Med. 2015 Oct 24;7(1):109.
http://www.ncbi.nlm.nih.gov/pubmed/26497493 - Barthel D, Ganser G, Kuester RM, Onken N, Minden K, Girschick HJ, Hospach A, Horneff G.
Inflammatory Bowel Disease in Juvenile Idiopathic Arthritis Patients Treated with Biologics
J Rheumatol. 2015 Sep 15. pii: jrheum.140472.
http://www.ncbi.nlm.nih.gov/pubmed/26373564
SEPTIEMBRE 2015
- Ogdie A, Weiss P.
The Epidemiology of Psoriatic Arthritis.
Rheum Dis Clin North Am. 2015 Nov;41(4):545-68. doi: 10.1016/j.rdc.2015.07.001
http://www.ncbi.nlm.nih.gov/pubmed/26476218 - Taxter AJ, Wileyto EP, Behrens EM, Weiss PF.
Patient-reported Outcomes across Categories of Juvenile Idiopathic Arthritis
J Rheumatol October 2015 42(10):1914-21;doi:10.3899/jrheum.150092
http://www.jrheum.org/content/42/10/1914.abstract - Sieper J. van der Heijde D, Dougados M, Maksymowych WP, Scott BB, Boice JA, Berd Y, Bergman G, Curtis S, Tzontcheva A, Huyck S and Weng HH.
A Randomized, Double-Blind, Placebo-Controlled, Sixteen-Week Study of Subcutaneous Golimumab in Patients With Active Nonradiographic Axial Spondyloarthritis.
Arthritis Rheumatol 2015;67(10):2702–12
http://onlinelibrary.wiley.com/doi/10.1002/art.39257/epdf - Lovell DJ, Ruperto N, Mouy R, Paz E, Rubio-Pérez N, Silva CA, et al for the Pediatric Rheumatology Collaborative Study Group and the Paediatric Rheumatology International Trials Organisation
Long-Term Safety, Efficacy, and Quality of Life in Patients With Juvenile Idiopathic Arthritis Treated With Intravenous Abatacept for Up to Seven Years
Arthritis Rheumatol 2015;67(10):2759-70
http://onlinelibrary.wiley.com/doi/10.1002/art.39234/epdf - Guzman J, Oen K, Tucker LB, Huber AM, Shiff N, Gilles Boire G, et al.
The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort
Ann Rheum Dis 2015;74:1861-7 Published Online First: 13 June 2014
http://ard.bmj.com/content/74/10/1854.abstract - Ogata A, Atsum Ti, Fukuda T, Hirabayashi Y, Inaba M, Ishiguro N et al.
Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis
Arthritis Care Res (Hoboken). 2015 Oct;67(10):1354-62. doi: 10.1002/acr.22598.
http://onlinelibrary.wiley.com/doi/10.1002/acr.22598/epdf - Yamasaki Y, Takei S, Imanaka H, Nerome Y, Kubota T, Nonaka Y, Akaike H, Takezaki T, Kawano Y.
Prediction of long-term remission of oligo/polyarticular juvenile idiopathic arthritis with S100A12 and Vascular Endothelial Growth Factor.
Mod Rheumatol. 2015 Oct 16:1-23. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26474088 - Mourão AF, Santos MJ, Mendonça S, Oliveira-Ramos F, Salgado M, Estanqueiro P, Melo-Gomes J, Martins F, Lopes A, Bettencourt BF, Bruges-Armas J, Costa J, Furtado C, Figueira R, Brito I, Branco J, Fonseca JE, Canhão H
Genetic Predictors of Poor Prognosis in Portuguese Patients with Juvenile Idiopathic Arthritis: Data from Reuma.pt.
J Immunol Res. 2015;2015:706515. doi: 10.1155/2015/706515. Epub 2015 Oct 4
http://www.ncbi.nlm.nih.gov/pubmed/26504858 - Kanetaka T, Mori M, Nishimura KI, Nozawa T, Kikuchi M, Sakurai N, Hara R, Yamazaki K, Yokota S.
Characteristics of FDG-PET findings in the diagnosis of systemic juvenile idiopathic arthritis.
Mod Rheumatol. 2015 Sep 29:1-6. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26417716 - Hyrich KL, Baildam E, Pickford H, Chieng A, Davidson JE, Foster H, Gardner-Medwin J, Wedderburn LR, Thomson W.
Influence of past breast feeding on pattern and severity of presentation of juvenile idiopathic arthritis.
Arch Dis Child. 2015 Sep 14. pii: archdischild-2014-308117. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/26369575
AGOSTO 2015
- Dilandro G, De Cosmi V, Corona F, Torcoletti M, Petaccia A, Filocamo G, Budelli A, Agostoni C.
May biscuits contribute to iron balance? An observation in children with juvenile idiopatic arthritis.
Int J Food Sci Nutr. 2015 Aug 27:1-4. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/26313813 - Hersh AO, Prahalad S.
Immunogenetics of juvenile idiopathic arthritis: A comprehensive review.
J Autoimmun. 2015 Aug 21. pii: S0896-8411(15)30020-2. doi: 10.1016/j.jaut.2015.08.002. EPUB ahead of print
http://www.ncbi.nlm.nih.gov/pubmed/26305060 - Steigerwald KA, Ilowite NT.
Novel treatment options for juvenile idiopathic arthritis.
Expert Rev Clin Pharmacol. 2015 Sep;8(5):559-73. doi: 10.1586/17512433.2015.1061428
http://www.ncbi.nlm.nih.gov/pubmed/26294075 - Lomholt JJ, Thastum M, Christensen AE, Leegaard A, Herlin T.
Cognitive behavioral group intervention for pain and well-being in children with juvenile idiopathic arthritis: A study of feasibility and preliminary efficacy.
Pediatr Rheumatol Online J. 2015 Aug 21;13:35. doi: 10.1186/s12969-015-0032-x.
http://www.ncbi.nlm.nih.gov/pubmed/26293657 - Chiaroni-Clarke RC, Li YR, Munro JE, Chavez RA, Scurrah KJ, Pezic A, Akikusa JD, Allen RC, Piper SE, Becker ML, Thompson SD, Lie BA, Flato B, Forre O, Punaro M, Wise C, Saffery R, Finkel TH, Hakonarson H, Ponsonby AL, Ellis JA.
The association of PTPN22 rs2476601 with juvenile idiopathic arthritis is specific to females.
Genes Immun. 2015 Aug 20. doi:10.1038/gene.2015.32. EPUB ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/26291515 - Ammerlaan JJ, Scholtus LW, Drossaert CH, van Os-Medendorp H, Prakken B, Kruize AA, Bijlsma JJ.
Feasibility of a Website and a Hospital-Based Online Portal for Young Adults With Juvenile Idiopathic Arthritis: Views and Experiences of Patients.
JMIR Res Protoc. 2015 Aug 14;4(3) doi:10.2196/resprot.3952.
http://www.ncbi.nlm.nih.gov/pubmed/26276373 - Mou Y, Zhang P, Li Q, Lin Z, Liao Z, Wei Q, Gu J.
Clinical Features in Juvenile-Onset Ankylosing Spondylitis Patients Carrying Different B27 Subtypes.
Biomed Res Int. 2015;2015:594878. doi:10.1155/2015/594878.EPUB 2015 Jul 26.
http://www.ncbi.nlm.nih.gov/pubmed/26273634 - Farr S, Girsch W.
The Hand and Wrist in Juvenile Rheumatoid Arthritis.
J Hand Surg Am. 2015 Aug 10. pii:S0363-5023(15)00826-6. doi: 10.1016/j.jhsa.2015.06.111. EPUB ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/26272796 - Shenoi S, Ou JN, Ni C, Macaubas C, Gersuk VH, Wallace CA, Mellins ED, Stevens AM.
Comparison of Biomarkers for Systemic Juvenile Idiopathic Arthritis.
Pediatr Res. 2015 Aug 12. doi:10.1038/pr.2015.144. EPUB ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/26267155 - Santos D, Silva C, Silva M.
Oral health and quality of life of children and adolescents with juvenile idiopathic arthritis according to their caregivers' perceptions.
Spec Care Dentist. 2015 Aug 8. doi:10.1111/scd.12129. EPUB ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/26255878 - Devauchelle-Pensec V, Thepaut M, Pecquery R, Houx L.
Managing monoarthritis in children.
Joint Bone Spine. 2015 Aug 4. pii:S1297-319X(15)00110-4. doi: 10.1016/j.jbspin.2015.06.004. EPUB ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/26253943 - Anink J, Van Suijlekom-Smit LW, Otten MH, Prince FH4, van Rossum MA5, Dolman KM, Hoppenreijs EP, Ten Cate R, Ursu S, Wedderburn LR, Horneff G, Frosch M, Vogl T, Gohar F, Foell D, Roth J, Holzinger D.
MRP8/14 serum levels as a predictor of response to starting and stopping anti-TNF treatment in juvenile idiopathic arthritis.
Arthritis Res Ther. 2015 Aug 7;17:200. doi:10.1186/s13075-015-0723-1.
http://www.ncbi.nlm.nih.gov/pubmed/26249667 - Gaur P, Misra R, Aggarwal A.
Natural Killer cells and gamma-delta T cells alterations in Enthesitis Related Arthritis category of Juvenile idiopathic arthritis.
Clin Immunol. 2015 Aug 2. pii:S1521-6616(15)30015-2. doi: 10.1016/j.clim.2015.07.012. EPUB ahead of print
http://www.ncbi.nlm.nih.gov/pubmed/26244610 - Leksell E, Hallberg U, Magnusson B, Ernberg M, Hedenberg-Magnusson B.
Perceived Oral Health and Care of Children with Juvenile Idiopathic Arthritis: A Qualitative Study.
J Oral Facial Pain Headache. 2015 Summer;29(3):223-30.doi: 10.11607/ofph.1293.
http://www.ncbi.nlm.nih.gov/pubmed/26244430 - Aggarwal A, Misra DP.
Enthesitis-related arthritis.
Clin Rheumatol. 2015 Aug 2. EPUB ahead of print
http://www.ncbi.nlm.nih.gov/pubmed/26233720 - Abdwani R, Abdalla E, Al Abrawi S, Al-Zakwani I
Epidemiology of juvenile idiopathic arthritis in Oman.
Pediatr Rheumatol Online J. 2015 Aug 1;13(1):33. doi:10.1186/s12969-015-0030-z.
http://www.ncbi.nlm.nih.gov/pubmed/26232056
JULIO 2015
- Weiss PF, Xiao R, Biko DM, Chauvin NA
Sacroiliitis at diagnosis of juvenile spondyloarthritis assessed by radiography, magnetic resonance imaging, and clinical examination.
Arthritis Care Res (Hoboken). 2015 Jul 20. doi: 10.1002/acr.22665. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26212574 - Burgos-Vargas R, Tse SM, Horneff G, Pangan AL, Kalabic J, Goss S, Unnebrink K, Anderson JK
A randomized, double-blind, placebo-controlled, multicenter study of adalimumab in pediatric patients with enthesitis-related arthritis.
Arthritis Care Res (Hoboken). 2015 Jul 20. doi: 10.1002/acr.22657. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26223543 - Esbjörnsson AC, Aalto K, Broström EW, Fasth A, Herlin T, Nielsen S, Nordal E, Peltoniemi S, Rygg M, Zak M, Berntson L
Ankle arthritis predicts polyarticular disease course and unfavourable outcome in children with juvenile idiopathic arthritis.
Clin Exp Rheumatol. 2015 Jul 23. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26213158 - Pardeo M, Pires Marafon D, Insalaco A, Bracaglia C, Nicolai R, Messia V, De Benedetti F.
Anakinra in Systemic Juvenile Idiopathic Arthritis: A Single-center Experience.
J Rheumatol. 2015 Aug;42(8):1523-7. doi: 10.3899/jrheum.141567. Epub 2015 Jun 1.
http://www.ncbi.nlm.nih.gov/pubmed/26034148 - Ilisson J, Zagura M, Zilmer K, Salum E, Heilman K, Piir A, Tillmann V, Kals J, Zilmer M, Pruunsild C
Increased carotid artery intima-media thickness and myeloperoxidase level in children with newly diagnosed juvenile idiopathic arthritis.
Arthritis Res Ther. 2015 Jul 16;17:180. doi: 10.1186/s13075-015-0699-x.
http://www.ncbi.nlm.nih.gov/pubmed/26179062 - Armbrust W, Bos JJ, Cappon J, van Rossum MA, Sauer PJ, Wulffraat N, van Wijnen VK, Lelieveld OT.
Design and acceptance of Rheumates@Work, a combined internet-based and in person instruction model, an interactive, educational, and cognitive behavioral program for children with juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2015 Jul 23;13(1):31. doi: 10.1186/s12969-015-0029-5.
http://www.ncbi.nlm.nih.gov/pubmed/26202161 - Oren-Ziv A, Hoppenstein D, Shles A, Uziel Y.
Sedation methods for intra-articular corticosteroid injections in Juvenile Idiopathic Arthritis: a review.
Pediatr Rheumatol Online J. 2015 Jul 4;13(1):28. doi: 10.1186/s12969-015-0021-0.
http://www.ncbi.nlm.nih.gov/pubmed/26141717 - Lochbühler N, Saurenmann RK, Müller L, Kellenberger CJ
Magnetic Resonance Imaging Assessment of Temporomandibular Joint Involvement and Mandibular Growth Following Corticosteroid Injection in Juvenile Idiopathic Arthritis.
J Rheumatol. 2015 Aug;42(8):1514-22. doi: 10.3899/jrheum.141502. Epub 2015 Jun 1.
http://www.ncbi.nlm.nih.gov/pubmed/26034145
JUNIO 2015
- Calvo I, Antón J, López Robledillo JC, de Inocencio J, Gamir ML, Merino R, Lacruz L, Camacho M, Rua MJ, Bustabad S, Díaz Cordovés-Rego G.
Recomendaciones para el uso de metotrexato en pacientes con artritis idiopática juvenil.
An Pediatr (Barc). 2015 Jun 12. pii: S1695-4033(15)00223-4. doi: 10.1016/j.anpedi.2015.05.005.
http://www.ncbi.nlm.nih.gov/pubmed/26077957 - Mandl P, Navarro-Compán V, Terslev L, Aegerter P, van der Heijde D, D'Agostino MA, Baraliakos X, Pedersen SJ, Jurik AG, Naredo E, Schueller-Weidekamm C, Weber U, Wick MC, Bakker PA, Filippucci E, Conaghan PG, Rudwaleit M, Schett G, Sieper J, Tarp S, Marzo-Ortega H, Østergaard M.
EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice.
Ann Rheum Dis. 2015 Jul;74(7):1327-1339. doi: 10.1136/annrheumdis-2014-206971.
http://www.ncbi.nlm.nih.gov/pubmed/25837448 - Zangi HA, Ndosi M, Adams J, Andersen L, Bode C, Boström C, van Eijk-Hustings Y, Gossec L, Korandová J, Mendes G, Niedermann K, Primdahl J, Stoffer M, Voshaar M, van Tubergen A.
EULAR recommendations for patient education for people with inflammatory arthritis.
Ann Rheum Dis. 2015 Jun;74(6):954-62. doi: 10.1136/annrheumdis-2014-206807.
http://www.ncbi.nlm.nih.gov/pubmed/25735643 - Otten MH, Anink J, Prince FH, Twilt M, Vastert SJ, Ten Cate R, Hoppenreijs EP, Armbrust W, Gorter SL, van Pelt PA, Kamphuis SS, Dolman KM, Swart JF, van den Berg JM, Koopman-Keemink Y, van Rossum MA, Wulffraat NM, van Suijlekom-Smit LW.
Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register.
Ann Rheum Dis. 2015 Jul;74(7):1379-86. doi: 10.1136/annrheumdis-2013-204641.
http://www.ncbi.nlm.nih.gov/pubmed/24641940 - Brunner HI, Ruperto N, Zuber Z, Keane C, Harari O, Kenwright A, Lu P, Cuttica R, Keltsev V, Xavier RM, Calvo I, Nikishina I, Rubio-Pérez N, Alexeeva E, Chasnyk V, Horneff G, Opoka-Winiarska V, Quartier P, Silva CA, Silverman E, Spindler A, Baildam E, Gámir ML, Martin A, Rietschel C, Siri D, Smolewska E, Lovell D,Martini A, De Benedetti F; Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG); Paediatric Rheumatology International Trials Organisation PRINTO and the Pediatric Rheumatology Collaborative Study Group PRCSG.
Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial.
Ann Rheum Dis. 2015 Jun;74(6):1110-7. doi: 10.1136/annrheumdis-2014-205351.
http://www.ncbi.nlm.nih.gov/pubmed/24834925 - Miller J, Ponsonby AL, Pezic A, Kemp A, Piper SE, Akikusa JD, Allen RC, Munro JE, Ellis JA
Sibling Exposure and Risk of Juvenile Idiopathic Arthritis
Arthritis Rheumatol. 2015 Jul;67(7):1951-8
http://www.ncbi.nlm.nih.gov/pubmed/25809130 - Tarkiainen M, Tynjälä P, Vähäsalo P, Lahdenne P.
Occurrence of adverse events in patients with JIA receiving biologic agents: long-term follow-up in a real-life setting.
Rheumatology (Oxford). 2015 Jul;54(7):1170-6. doi: 10.1093/rheumatology/keu457.
http://www.ncbi.nlm.nih.gov/pubmed/25504896 - Rasu RS, Cline SK, Shaw JW, Hayes O, Agbor Bawa W, Cifaldi MA.
Impact of JIA on parents' work absences.
Rheumatology (Oxford). 2015 Jul;54(7):1177-85. doi: 10.1093/rheumatology/keu414.
http://www.ncbi.nlm.nih.gov/pubmed/25504895 - Gmuca S, Weiss PF.
Juvenile spondyloarthritis.
Curr Opin Rheumatol. 2015 Jul;27(4):364-72. doi: 10.1097/BOR.0000000000000185.
http://www.ncbi.nlm.nih.gov/pubmed/26002028
MAYO 2015
- Jaime Guzman, Kiem Oen, Adam M Huber, Karen Watanabe Duffy, Gilles Boire, Natalie Shiff , et al.
The risk and nature of flares in juvenile idiopathic arthritis: results from the ReACCh-Out cohort.
Ann Rheum Disdoi:10.1136/annrheumdis-2014-207164
http://ard.bmj.com/content/early/2015/05/17/annrheumdis-2014-207164.abstract - Deepak R. Jadon, Gavin Shaddick, Amelia Jobling, Athimalaipet V. Ramanan and Raj Sengupta.
Clinical Outcomes and Progression to Orthopedic Surgery in Juvenile- Versus Adult-Onset Ankylosing Spondylitis (pages 651–657)
Arthritis Care & Research. Article first published online: 24 APR 2015 | DOI: 10.1002/acr.22500
http://onlinelibrary.wiley.com/doi/10.1002/acr.22500/abstract - Caroline Y. Chang, Rika M. L. Meyer and Andreas O. Reiff
Impact of Medication Withdrawal Method on Flare-Free Survival in Patients with Juvenile Idiopathic Arthritis on Combination Therapy (pages 658–666)
Arthritis Care & Research. Article first published online: 24 APR 2015 | DOI: 10.1002/acr.22477
http://onlinelibrary.wiley.com/doi/10.1002/acr.22477/abstract - Susan Shenoi, Samantha Bell, Carol A. Wallace and Beth A. Mueller
Juvenile Idiopathic Arthritis in Relation to Maternal Prenatal Smoking (pages 725–730)
Arthritis Care & Research. Article first published online: 24 APR 2015 | DOI: 10.1002/acr.22471
http://onlinelibrary.wiley.com/doi/10.1002/acr.22471/abstract - Anuj Shukla, Priyanka Gaur, and Amita Aggarwal.
Tenascin-C Levels, A Toll-like Receptor 4 Ligand, in Enthesitis-related Arthritis Category of Juvenile Idiopathic Arthritis: A Cross-sectional and Longitudinal Study
J Rheumatol May 2015 42(5):891-896; 2015, doi:10.3899/jrheum.141365
http://jrheum.org/content/42/5/891.abstract - Claas Hinze, Faekah Gohar & Dirk Foell
Management of juvenile idiopathic arthritis: hitting the target.
Nature Reviews Rheumatology 11, 290–300 (2015) doi:10.1038/nrrheum.2014.212
http://www.nature.com/nrrheum/journal/v11/n5/abs/nrrheum.2014.212.html - Steenks MH, Giancane G, de Leeuw RRJ, Bronkhorst EM, van Es RJJ, Koole R, van Bruggen HW and Wulffraat NM
Temporomandibular joint involvement in Juvenile Idiopathic Arthritis: reliability and validity of a screening protocol for the rheumatologist.
Pediatric Rheumatology 2015, 13:15 (7 May 2015)
http://www.ped-rheum.com/content/13/1/15 - Philomine A. van Pelt, Constance H. C. Drossaert, Aike A. Kruize, Jaap Huisman, Radboud J. E. M. Dolhain, and Nico M. Wulffraat
Use and perceived relevance of health-related Internet sites and online contact with peers among young people with juvenile idiopathic arthritis.
Rheumatology first published online May 20, 2015
doi:10.1093/rheumatology/kev193 http://rheumatology.oxfordjournals.org/content/early/2015/05/19/rheumatology.kev193.abstract
ABRIL 2015
- Klotsche J, Niewerth M, Haas JP, Huppertz HI, Zink A, Horneff G, Minden K.
Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA).
Ann Rheum Dis. 2015 Apr 29. doi: 10.1136/annrheumdis-annrheumdis-2014-206747.
http://www.ncbi.nlm.nih.gov/pubmed/25926155 - Martini G, Biscaro F, Boscaro E, Calabrese F, Lunardi F, Facco M, Agostini C, Zulian F, Fadini GP.
Reduced levels of circulating progenitor cells in juvenile idiopathic arthritis are counteracted by anti TNF-α therapy.
BMC Musculoskelet Disord. 2015 Apr 30;16(1):103. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25925313 - Horneff G, Foeldvari I, Minden K, Trauzeddel R, Kümmerle-Deschner JB, Tenbrock K, Ganser G, Huppertz HI.
Efficacy and safety of etanercept in enthesitis-related arthritis juvenile idiopathic arthritis: Results from a phase 3 randomized double-blind study.
Arthritis Rheumatol. 2015 Apr 17. doi: 10.1002/art.39145. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25891010 - Scardapane A, Ferrante R, Nozzi M, Savino A, Antonucci I, Dadorante V, Balsamo M, Stuppia L, Chiarelli F, Breda L.
TNF-α gene polymorphisms and juvenile idiopathic arthritis: Influence on disease outcome and therapeutic response.
Semin Arthritis Rheum. 2015 Feb 19. pii: S0049-0172(15)00013-X. doi: 10.1016/j.semarthrit.2015.02.003. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25837015
MARZO 2015
- Miller J, Ponsonby AL, Pezic A, Kemp A, Piper SE, Akikusa JD, Allen RC, Munro JE, Ellis JA.
Sibling exposure and risk of juvenile idiopathic arthritis in the ChiLdhood Arthritis Risk factor Identification sTudY (CLARITY).
Arthritis Rheumatol. 2015 Mar 25. doi: 10.1002/art.39129. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25809130 - Arvonen M, Virta LJ, Pokka T, Kröger L, Vähäsalo P.
Repeated Exposure to Antibiotics in Infancy: A Predisposing Factor for Juvenile Idiopathic Arthritis or a Sign of This Group's Greater Susceptibility to Infections?
J Rheumatol. 2015 Mar;42(3):521-6. doi: 10.3899/jrheum.14034
http://www.ncbi.nlm.nih.gov/pubmed/25320218 - Chickermane PR, Khubchandani RP.
Evaluation of the benefits of sequential addition of leflunomide in patients with polyarticular course juvenile idiopathic arthritis failing standard dose methotrexate.
Clin Exp Rheumatol. 2015 Feb 18. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25738527 - Dijkstra ME, Anink J, van Pelt PA, Hazes JM, van Suijlekom-Smit LW.
Patient-reported Joint Count in Juvenile Idiopathic Arthritis: The Reliability of a Manikin Format.
J Rheumatol. 2015 Mar;42(3):527-33. doi: 10.3899/jrheum.140073.
http://www.ncbi.nlm.nih.gov/pubmed/25433530 - Mease P, Sieper J, Van den Bosch F, Rahman P, Karunaratne PM, Pangan AL.
Randomized Controlled Trial of Adalimumab in Patients With Nonpsoriatic Peripheral Spondyloarthritis
Arthritis Rheum 2015 Apr; 67(4):914-923. DOI: 10.1002/art.39008
http://onlinelibrary.wiley.com/doi/10.1002/art.39008/epdf - Deodhar A, Braun J, Inman RD, van der Heijde D, Zhou Y, Xu S, Han C, Hsu B
Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 5-year results of the GO-RAISE study
Ann Rheum Dis 2015;74:757-761. doi:10.1136/annrheumdis-2014-205862
http://ard.bmj.com/content/74/4/757.full.pdf+html - Hermann G, Thon A, Mönkemöller K, Lilienthal E, Klinkert C, Holder M et al
Comorbidity of Type 1 Diabetes and Juvenile Idiopathic Arthritis
J Pediatr. 2015 Apr;166(4):930-935.e3. doi: 10.1016/j.jpeds.2014.12.026
http://www.ncbi.nlm.nih.gov/pubmed/25641245 - Félicie Costantino F, Talpin A, Said-Naha R, Goldberg M, Henny J, Chiocchia G, Garchon HJ, Zins M, Breban M
Prevalence of spondyloarthritis in reference to HLA-B27 in the French population: results of the GAZEL cohort
Ann Rheum Dis 2015;74:689-693. doi:10.1136/annrheumdis-2013-204436
http://ard.bmj.com/content/74/4/689.abstract - Howland S, Fisher K
Looking through the patient lens - Improving best practice for young people with juvenile idiopathic arthritis transitioning into adult care.
Springerplus. 2015 Mar 5;4:111
http://www.ncbi.nlm.nih.gov/pubmed/25774337 - Araujo GR, Fonseca JE, Fujimura PT, Cunha-Junior JP, Silva CH, Mourão AF, Canhão H, Goulart LR, Gonçalves J, Ueira-Vieira C.
Anti-type II collagen antibodies detection and avidity in patients with oligoarticular and polyarticular forms of juvenile idiopathic arthritis.
Immunol Lett. 2015 Mar 20. pii: S0165-2478(15)00041-3. doi: 10.1016/j.imlet.2015.03.006. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/25800643
FEBRERO 2015
- van Dijkhuizen EH, Bulatović Ćalasan M, Pluijm SM, de Rotte MC, Vastert SJ, Kamphuis S, de Jonge R, Wulffraat NM.
Prediction of Methotrexate Intolerance in Juvenile Idiopathic Arthritis: a prospective, observational cohort study.
Pediatr Rheumatol Online J. 2015 Feb 18;13:5.
http://www.ncbi.nlm.nih.gov/pubmed/25745368 - Schenck S, Niewerth M, Sengler C, Trauzeddel R, Thon A, Minden K, Klotsche J.
Prevalence of overweight in children and adolescents with juvenile idiopathic arthritis.
Scand J Rheumatol. 2015 Mar 6:1-8.
http://www.ncbi.nlm.nih.gov/pubmed/25742802 - Chickermane PR, Khubchandani RP.
Evaluation of the benefits of sequential addition of leflunomide in patients with polyarticular course juvenile idiopathic arthritis failing standard dose methotrexate.
Clin Exp Rheumatol. 2015 Feb 18.
http://www.ncbi.nlm.nih.gov/pubmed/25738527 - Aupiais C, Ilharreborde B, Doit C, Blachier A, Desmarest M, Job-Deslandre C, Mazda K, Faye A, Bonacorsi S, Alberti C, Lorrot M.
Aetiology of arthritis in hospitalised children: an observational study.
Arch Dis Child. 2015 Mar 2.
http://www.ncbi.nlm.nih.gov/pubmed/25732253 - Shady MM, Fathy HA, Ali A, Youness ER, Fathy GA.
Association of neopterin as a marker of immune system activation and juvenile rheumatoid arthritis activity.
J Pediatr (Rio J). 2015 Feb 26.
http://www.ncbi.nlm.nih.gov/pubmed/25727025 - Rusak M, Radzikowska U, Glowinska-Olszewska B, Dobrenko E, Piotrowska-Jastrzebska J, Dabrowska M, Bodzenta-Lukaszyk A, Bossowski A, Moniuszko M.
Endothelial progenitor cell levels in juvenile idiopathic arthritis patients; effects of anti-inflammatory therapies.
Pediatr Rheumatol Online J. 2015 Feb 19;13:6.
http://www.ncbi.nlm.nih.gov/pubmed/25705139 - Aguiar CL, Pan N, Adams A, Barinstein L, Lehman TJ.
Anaphylaxis to anakinra in a pediatric patient with systemic juvenile idiopathic arthritis successfully treated with canakinumab: a case-based review.
Clin Rheumatol. 2015 Feb 20.
http://www.ncbi.nlm.nih.gov/pubmed/25697878 - Winsz-Szczotka K, Kuźnik-Trocha K, Komosińska-Vassev K, Wisowski G, Gruenpeter A, Lachór-Motyka I, Żegleń B, Lemski W, Olczyk K.
Plasma and urinary glycosaminoglycans in the course of juvenile idiopathic arthritis.
Biochem Biophys Res Commun. 2015 Feb 13.
http://www.ncbi.nlm.nih.gov/pubmed/25684189 - Renton W1, Whitehead B.
Myositis as a presenting feature of systemic onset juvenile idiopathic arthritis.
J Paediatr Child Health. 2015 Feb;51(2):233.
http://www.ncbi.nlm.nih.gov/pubmed/25677488 - Young CM, Horst DM, Murakami JW, Shiels WE 2nd.
Ultrasound-guided corticosteroid injection of the subtalar joint for treatment of juvenile idiopathic arthritis.
Pediatr Radiol. 2015 Feb 12.
http://www.ncbi.nlm.nih.gov/pubmed/25672519 - Nimmrich S, Horneff G.
Incidence of herpes zoster infections in juvenile idiopathic arthritis patients.
Rheumatol Int. 2015 Mar;35(3):465-70.
http://www.ncbi.nlm.nih.gov/pubmed/25583050
ENERO 2015
- Wakil SM, Monies DM, Abouelhoda M, Al-Tassan N, Al-Dusery H, Naim EA, Al-Younes B, Shinwari J, Al-Mohanna FA, Meyer BF, Al-Mayouf S.
Association of a Mutation in LACC1 With a Monogenic Form of Systemic Juvenile Idiopathic Arthritis.
Arthritis Rheumatol. 2015 Jan;67(1):288-95. doi: 10.1002/art.38877.
http://www.ncbi.nlm.nih.gov/pubmed/25220867 - Lianne Kearsley-Fleet, Kimme L Hyrich, Rebecca Davies, Mark Lunt, and Taunton R Southwood on behalf of the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study
Growth in children and adolescents with juvenile idiopathic arthritis over 2 years of treatment with etanercept: results from the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study
Rheumatology first published online January 30, 2015.
doi:10.1093/rheumatology/keu489
http://rheumatology.oxfordjournals.org/content/early/2015/01/29/rheumatology.keu489.abstract - Ćalasan MB, den Boer E, de Rotte MC, Vastert SJ, Kamphuis S, de Jonge R, Wulffraat NM.
Methotrexate polyglutamates in erythrocytes are associated with lower disease activity in juvenile idiopathic arthritis patients.
Ann Rheum Dis. 2015 Feb;74(2):402-7. doi: 10.1136/annrheumdis-2013-203723. Epub 2013 Nov 28.
http://www.ncbi.nlm.nih.gov/pubmed/24288013 - Nimmrich S, Horneff G.
Incidence of herpes zoster infections in juvenile idiopathic arthritis patients.
Rheumatol Int. 2015 Jan 13. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25583050
DICIEMBRE 2014
- Berard RA, Tomlinson G, Li X, Oen K, Rosenberg AM, Feldman BM, Yeung RS, Bombardier C.
Description of active joint count trajectories in juvenile idiopathic arthritis.
J Rheumatol. 2014 Dec;41(12):2466-73. doi: 10.3899/jrheum.130835
http://www.ncbi.nlm.nih.gov/pubmed/25274882 - Aikawa NE, França IL, Ribeiro AC, Sallum AM, Bonfa E, Silva CA.
Short and long-term immunogenicity and safety following the 23-valent polysaccharide pneumococcal vaccine in juvenile idiopathic arthritis patients under conventional DMARDs with or without anti-TNF therapy.
Vaccine. 2014 Dec 29. pii: S0264-410X(14)01683-1. doi: 10.1016/j.vaccine.2014.12.030. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25554240 - Chiaroni-Clarke RC, Munro JE, Chavez RA, Pezic A, Allen RC, Akikusa JD, Piper SE, Saffery R, Ponsonby AL, Ellis JA.
Independent confirmation of juvenile idiopathic arthritis genetic risk loci previously identified by immunochip array analysis.
Pediatr Rheumatol Online J. 2014 Dec 16;12:53. doi: 10.1186/1546-0096-12-53
http://www.ncbi.nlm.nih.gov/pubmed/25540605 - Lundbäck P, Stridh P, Klevenvall L, Jenkins R, Fischer M, Sundberg E, Andersson U, Antoine D, Harris HE.
Characterization of the inflammatory properties of actively released HMGB1 in juvenile idiopathic arthritis.
Antioxid Redox Signal. 2014 Dec 22 [Epub ahead of print].
http://www.ncbi.nlm.nih.gov/pubmed/25532033 - van Dijkhuizen EP, Wulffraat NM.
Prediction of methotrexate efficacy and adverse events in patients with juvenile idiopathic arthritis: a systematic literature review.
Pediatr Rheumatol Online J. 2014 Dec 11;12:51. doi: 10.1186/1546-0096-12-51
http://www.ncbi.nlm.nih.gov/pubmed/25525416 - Brunner H, Lomax KG, Levy S.
Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of Rilonacept in the Treatment of Systemic Juvenile Idiopathic Arthritis: Comment on the article by Ilowite et al.
Arthritis Rheumatol. 2014 Dec 15. doi: 10.1002/art.38992.
http://www.ncbi.nlm.nih.gov/pubmed/25512026 - Ilowite NT for the RAPPORT Investigators.
Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of Rilonacept in the Treatment of Systemic Juvenile Idiopathic Arthritis.
Arthritis Rheumatol. 2014 Dec 15. doi: 10.1002/art.38991. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25511916 - Lamot L, Borovecki F, Tambic Bukovac L, Vidovic M, Perica M, Gotovac K, Harjacek M.
Aberrant expression of shared master-key genes contributes to the immunopathogenesis in patients with juvenile spondyloarthritis.
PLoS One. 2014 Dec 15;9(12):e115416.
http://www.ncbi.nlm.nih.gov/pubmed/25506924 - Tarkiainen M, Tynjälä P, Vähäsalo P, Lahdenne P.
Occurrence of adverse events in patients with JIA receiving biologic agents: long-term follow-up in a real-life setting.
Rheumatology (Oxford). 2014 Dec 10. pii: keu457. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25504896 - Rasu RS, Cline SK, Shaw JW, Hayes O, Agbor Bawa W, Cifaldi MA.
Impact of JIA on parents' work absences.
Rheumatology (Oxford). 2014 Dec 10. pii: keu414. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25504895 - De Benedetti F1, Brunner H, Ruperto N, Schneider R, Xavier R, Allen R, Brown D, Chaitow J, Pardeo M, Espada G, Gerloni V, Myones B, Frane J, Wang J, Lipman TH, Bharucha KN, Martini A, Lovell D; the Paediatric Rheumatology International Trials Organisation (PRINTO); Pediatric Rheumatology Collaborative Study Group (PRCSG)
Catch-up growth during tocilizumab therapy for systemic juvenile idiopathic arthritis: Results from the TENDER trial.
Arthritis Rheumatol. 2014 Dec 10. doi: 10.1002/art.38984. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25504861 - Salonen PH, Säilä H, Salonen JH, Vuorela M, Kautiainen H, Lyytikäinen O, Kauppi MJ, Leirisalo-Repo M, Repo H.
Bloodstream infections among children with juvenile idiopathic arthritis: a prospective study from the onset of disease.
Clin Exp Rheumatol. 2014 Nov-Dec;32(6):979-83.
http://www.ncbi.nlm.nih.gov/pubmed/25436839 - Bryan AR, Rabinovich CE.
Enthesitis-related arthritis: time to re-define?
Curr Rheumatol Rep. 2014 Dec;16(12):466.
http://www.ncbi.nlm.nih.gov/pubmed/25366933 - Weiss JE, Luca NJ, Boneparth A, Stinson
Assessment and management of pain in juvenile idiopathic arthritis.
Paediatr Drugs. 2014 Dec;16(6):473-81.
http://www.ncbi.nlm.nih.gov/pubmed/25331986
NOVIEMBRE 2014
- Dijkstra ME, Anink J, van Pelt PA, Hazes JM, van Suijlekom-Smit LW.
Patient-reported Joint Count in Juvenile Idiopathic Arthritis: The Reliability of a Manikin Format.
J Rheumatol. 2014 Nov 29. pii: jrheum.140073. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/?term=25433530 - Salem KM, Radhakrishnan A, Behrbalk E, Boszczyk BM.
The surgical management of atlanto-axial subluxation in juvenile rheumatoid arthritis.
Eur Spine J. 2014 Nov 27. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/?term=25427669 - Schulert GS, Grom AA.
Pathogenesis of Macrophage Activation Syndrome and Potential for Cytokine-Directed Therapies.
Annu Rev Med. 2014 Nov 5. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/?term=25386930 - van den Broek T, Hoppenreijs E, Meerding J, Scholman R, Otten HG, Swart JF, Martini A, Prakken B, de Jager W.
Cytokine profiling at disease onset: support for classification of young antinuclear antibody-positive patients as a separate category of juvenile idiopathic arthritis.
Ann Rheum Dis. 2014 Nov 10. pii: annrheumdis-2014-206424. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/?term=25384964 - Adunuri NR, Feldman BM.
A critical appraisal of studies measuring Quality of Life in Juvenile Idiopathic Arthritis.
Arthritis Care Res (Hoboken). 2014 Nov 10. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/?term=25384887 - Rigante D, Bosco A, Esposito S.
The Etiology of Juvenile Idiopathic Arthritis.
Clin Rev Allergy Immunol. 2014 Nov 12. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/?term=25384710 - Bryan AR, Rabinovich CE.
Enthesitis-Related Arthritis: Time to Re-define?
Curr Rheumatol Rep. 2014 Dec;16(12):466.
http://www.ncbi.nlm.nih.gov/pubmed/?term=25366933 - Consolaro A, Schiappapietra B, Dalprà S, Calandra S, Martini A, Ravelli A.
Optimisation of disease assessments in juvenile idiopathic arthritis.
Clin Exp Rheumatol. 2014 Nov-Dec;32 Suppl 85(5):126-130.
http://www.ncbi.nlm.nih.gov/pubmed/?term=25365101 - Shimizu M, Nakagishi Y, Yoshida A, Yachie A.
Serum interleukin 18 as a diagnostic remission criterion in systemic juvenile idiopathic arthritis.
J Rheumatol. 2014 Nov;41(11):2328-30.
http://www.ncbi.nlm.nih.gov/pubmed/?term=25362722 - Guzman J, Gómez-Ramírez O, Jurencak R, Shiff NJ, Berard RA, Duffy CM, Oen K, Petty RE, Benseler SM, Brant R, Tucker LB.
What matters most for patients, parents, and clinicians in the course of juvenile idiopathic arthritis? A qualitative study.
J Rheumatol. 2014 Nov;41(11):2260-9.
http://www.ncbi.nlm.nih.gov/pubmed/?term=25225279 - Zhao Y, Wallace C.
Judicious use of biologicals in juvenile idiopathic arthritis.
Curr Rheumatol Rep. 2014 Nov;16(11):454.
http://www.ncbi.nlm.nih.gov/pubmed/?term=25218736 - Eng SW, Duong TT, Rosenberg AM, Morris Q, Yeung RS; REACCH OUT and BBOP Research Consortia.
The biologic basis of clinical heterogeneity in juvenile idiopathic arthritis.
Arthritis Rheumatol. 2014 Dec;66(12):3463-75
http://www.ncbi.nlm.nih.gov/pubmed/?term=25200124 - Funk RS, van Haandel L, Leeder JS, Becker ML.
Folate depletion and increased glutamation in juvenile idiopathic arthritis patients treated with methotrexate.
Arthritis Rheumatol. 2014 Dec;66(12):3476-85.
http://www.ncbi.nlm.nih.gov/pubmed/?term=25186097 - Akioka S.
Bivalent HPV vaccine safety depending on subtypes of juvenile idiopathic arthritis.
Ann Rheum Dis. 2014 Dec;73(12):e75.
http://www.ncbi.nlm.nih.gov/pubmed/?term=25165031 - Schmeling H, Horneff G, Benseler SM, Fritzler MJ.
Pharmacogenetics: can genes determine treatment efficacy and safety in JIA?
Nat Rev Rheumatol. 2014 Nov;10(11):682-690.
http://www.ncbi.nlm.nih.gov/pubmed/?term=25112604 - Minoia F, Davì S, Horne A, Demirkaya E, Bovis F, Li C, Lehmberg K, Weitzman S, Insalaco A, Wouters C, Shenoi S, Espada G, Ozen S, Anton J, Khubchandani R, Russo R, Pal P, Kasapcopur O, Miettunen P, Maritsi D, Merino R, Shakoory B, Alessio M, Chasnyk V, Sanner H, Gao YJ, Huasong Z, Kitoh T, Avcin T, Fischbach M, Frosch M, Grom A, Huber A, Jelusic M, Sawhney S, Uziel Y, Ruperto N, Martini A, Cron RQ, Ravelli A; Pediatric Rheumatology International Trials Organization, the Childhood Arthritis and Rheumatology Research Alliance, the Pediatric Rheumatology Collaborative Study Group, and the Histiocyte Society.
Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients.
Arthritis Rheumatol. 2014 Nov;66(11):3160-9.
http://www.ncbi.nlm.nih.gov/pubmed/?term=25077692 - Esposito S, Corona F, Barzon L, Cuoco F, Squarzon L, Marcati G, Torcoletti M, Gambino M, Palù G, Principi N.
Immunogenicity, safety and tolerability of a bivalent human papillomavirus vaccine in adolescents with juvenile idiopathic arthritis.
Expert Rev Vaccines. 2014 Nov;13(11):1387-93.
http://www.ncbi.nlm.nih.gov/pubmed/?term=25066387 - Shimizu M, Ueno K, Ishikawa S, Tokuhisa Y, Inoue N, Yachie A.
Treatment of refractory polyarticular juvenile idiopathic arthritis with tacrolimus.
Rheumatology (Oxford). 2014 Nov;53(11):2120-2.
http://www.ncbi.nlm.nih.gov/pubmed/?term=25065006 - Weiss PF, Colbert RA, Xiao R, Feudtner C, Beukelman T, DeWitt EM, Pagnini I, Wright TB, Wallace CA.
Development and retrospective validation of the juvenile spondyloarthritis disease activity index.
Arthritis Care Res (Hoboken). 2014 Dec;66(12):1775-82.
http://www.ncbi.nlm.nih.gov/pubmed/?term=PMC4245319 - Kaufman KM, Linghu B, Szustakowski JD, Husami A, Yang F, Zhang K, Filipovich AH, Fall N, Harley JB, Nirmala NR, Grom AA.
Whole-exome sequencing reveals overlap between macrophage activation syndrome in systemic juvenile idiopathic arthritis and familial hemophagocytic lymphohistiocytosis.
Arthritis Rheumatol. 2014 Dec;66(12):3486-95.
http://www.ncbi.nlm.nih.gov/pubmed/?term=25047945 - Coulson EJ, Hanson HJ, Foster HE.
What does an adult rheumatologist need to know about juvenile idiopathic arthritis?
Rheumatology (Oxford). 2014 Dec;53(12):2155-2166.
http://www.ncbi.nlm.nih.gov/pubmed/?term=24987157 - Consolaro A, Negro G, Chiara Gallo M, Bracciolini G, Ferrari C, Schiappapietra B, Pistorio A, Bovis F, Ruperto N, Martini A, Ravelli A.
Defining criteria for disease activity States in nonsystemic juvenile idiopathic arthritis based on a three-variable juvenile arthritis disease activity score.
Arthritis Care Res (Hoboken). 2014 Nov;66(11):1703-9.
http://www.ncbi.nlm.nih.gov/pubmed/?term=24980508 - Bechtold S, Simon D.
Growth abnormalities in children and adolescents with juvenile idiopathic arthritis.
Rheumatol Int. 2014 Nov;34(11):1483-8.
http://www.ncbi.nlm.nih.gov/pubmed/?term=24760485
OCTUBRE 2014
- Grom AA.
Canakinumab for the treatment of systemic juvenile idiopathic arthritis.
Expert Rev Clin Immunol. 2014 Nov;10(11):1427-35. Epub 2014 Oct 1.
http://www.ncbi.nlm.nih.gov/pubmed/25269376 - Berard RA, Tomlinson G, Li X, Oen K, Rosenberg AM, Feldman BM, Yeung RS, Bombardier C.
Description of Active Joint Count Trajectories in Juvenile Idiopathic Arthritis.
J Rheumatol. 2014 Oct 1. pii: jrheum.130835. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25274882 - Levy D.
Trends in medication usage in juvenile idiopathic arthritis: prescribing trends or trends in prescribers?
J Rheumatol. 2014 Oct;41(10):1903-5. doi: 10.3899/jrheum.140946. No abstract available.
http://www.ncbi.nlm.nih.gov/pubmed/25275091 - Brabnikova-Maresova K, Jarosova K, Pavelka K, Stepan JJ.
Serum sclerostin in adult high-activity patients with juvenile idiopathic arthritis.
Arthritis Res Ther. 2014 Oct 4;16(5):460. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25280749 - Jadon D, Shaddick G, Jobling A, Ramanan AV, Sengupta R.
Clinical outcomes and progression to orthopedic surgery in juvenile versus adult-onset ankylosing spondylitis.
Arthritis Care Res (Hoboken). 2014 Oct 20. doi: 10.1002/acr.22500. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25331747 - Selvaag AM, Aulie HA, Lilleby V, Flatø B.
Disease progression into adulthood and predictors of long-term active disease in juvenile idiopathic arthritis.
Ann Rheum Dis. 2014 Oct 31. pii: annrheumdis-2014-206034. doi: 10.1136/annrheumdis-2014-206034. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25362042 - Weiss JE, Luca NJ, Boneparth A, Stinson J.
Assessment and Management of Pain in Juvenile Idiopathic Arthritis.
Paediatr Drugs. 2014 Oct 21. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25331986 - Anjali Patwardhan, Michael Gardner , Bert Bachrach, Prasad Bichu, Timothy Joseph Hayes
The Juvenile Idiopathic Arthritis Patients Run a Higher Risk for Dyslipidemia as Compared to Adults with Arthritis
Ann Paediatr Rheum. 2014; 3(3): 116-125
http://www.scopemed.org/?mno=160450 - Anne M Selvaag1, Hanne A Aulie1, Vibke Lilleby1, Berit Flatø.
Disease progression into adulthood and predictors of long-term active disease in juvenile idiopathic arthritis
Ann Rheum Dis doi:10.1136/annrheumdis-2014-206034
http://ard.bmj.com/content/early/2014/10/31/annrheumdis-2014-206034.abstract - Suzanne M.M. Verstappen, Joanna Cobb, Helen E Foster, Bo Fu, Eileen Baildam, Lucy R Wedderburn, Joyce E Davidson, John Ioannou, Alice Chieng, Kimme L Hyrich and Wendy Thomson
Low socio-economic status is associated with high physical limitations and low illness self-perception in patients with juvenile idiopathic arthritis: Results from the Childhood Arthritis Prospective Study (CAPS)
Accepted manuscript online: 3 SEP 2014 01:20PM EST | DOI: 10.1002/acr.22466
http://onlinelibrary.wiley.com/doi/10.1002/acr.22466/abstract - Kati P. Markula-Patjas, Kaisa K. Ivaska, Minna Pekkinen, Sture Andersson, Eeva Moilanen, Heli T. Viljakainen, and Outi Mäkitie
High Adiposity and Serum Leptin Accompanied by Altered Bone Turnover Markers in Severe Juvenile Idiopathic Arthritis
J Rheumatol published online before print October 15, 2014, doi:10.3899/jrheum.131107
http://jrheum.org/content/early/2014/10/08/jrheum.131107.abstract - Miika Arvonen, Lauri J. Virta, Tytti Pokka, Liisa Kröger, and Paula Vähäsalo
Repeated Exposure to Antibiotics in Infancy: A Predisposing Factor for Juvenile Idiopathic Arthritis or a Sign of This Group’s Greater Susceptibility to Infections?
J Rheumatol published online before print October 15, 2014, doi:10.3899/jrheum.140348
http://jrheum.org/content/early/2014/10/08/jrheum.140348.abstract - Jaime Guzman, Oralia Gómez-Ramírez, Roman Jurencak, Natalie J. Shiff, Roberta A. Berard, Ciaran M. Duffy, Kiem Oen, Ross E. Petty, Susanne M. Benseler, Rollin Brant, and Lori B. Tucker
What Matters Most for Patients, Parents, and Clinicians in the Course of Juvenile Idiopathic Arthritis? A Qualitative Study
J Rheumatol November 2014 41(11):2260-2269; published online before print September 15, 2014, doi:10.3899/jrheum.131536
http://jrheum.org/content/41/11/2260.abstract - Cartwright T, Fraser E, Edmunds S, Wilkinson N, Jacobs K.
Journeys of adjustment: the experiences of adolescents living with juvenile idiopathic arthritis.
Child Care Health Dev. 2014 Oct 6. doi: 10.1111/cch.12206. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25287720
SEPTIEMBRE 2014
- Wallace CA, Ringold S, Bohnsack J, Spalding SJ, Brunner HI, Milojevic D, Schanberg LE, Higgins GC, O'Neil KM, Gottlieb BS, Hsu J, Punaro MG, Kimura Y, Hendrickson A.
Extension Study of Participants from the Trial of Early Aggressive Therapy in Juvenile Idiopathic Arthritis.
J Rheumatol. 2014 Sep 1. pii: jrheum.140347. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/25179849 - Chang CY, Meyer RM, Reiff AO.
Impact of Medication Withdrawal Method on Flare-free Survival in Patients withJuvenile Idiopathic Arthritis on Combination Therapy.
ArthritisCare Res(Hoboken).2014 Sep 12. doi:10.1002/acr.22477.[Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/25220674 - Cedströmer AL, Ahlqwist M, Andlin-Sobocki A, Berntson L, Hedenberg-Magnusson B, Dahlström L.
Temporomandibular condylar alterations in juvenile idiopathic arthritis most common in longitudinally severe disease despite medical treatment.
Pediatr Rheumatol Online J.2014 Sep 14;12(1):43.
http://www.ncbi.nlm.nih.gov/pubmed/25249821
- Kavanaugh A, McInnes IB, Mease P, Krueger GG, Gladman D, van der Heijde D, Zhou Y, Lu J, Leu JH, Goldstein N, Beutler A.
Clinical efficacy, radiographic and safety findings through 5 years of subcutaneous golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of a randomised, placebo-controlled trial (the GO-REVEAL study).
Ann Rheum Dis. 2014 Sep;73(9):1689-94. doi: 10.1136/annrheumdis-2013-204902.
http://www.ncbi.nlm.nih.gov/pubmed/24748630 - Munro J, Murray K, Boros C, Chaitow J, Allen RC, Akikusa J, Adib N, Piper SE, Singh-Grewal D; Australian Paediatric Rheumatology Group.
Australian Paediatric Rheumatology Group standards of care for the management of juvenile idiopathic arthritis.
J Paediatr Child Health. 2014 Sep;50(9):663-6. doi: 10.1111/jpc.12462
http://www.ncbi.nlm.nih.gov/pubmed/25156704 -
Schmeling H1, Minden K, Foeldvari I, Ganser G, Hospach T, Horneff G.
Efficacy and safety of Adalimumab as first and second used biologic agent in juvenile idiopathic arthritis - the German Biologics JIA Registry (BiKeR).
Arthritis Rheumatol. 2014 Sep; 66(9):2580-2589.
http://www.ncbi.nlm.nih.gov/pubmed/24942886 - Ilowite NT, Prather K, Lokhnygina Y, Schanberg LE, Elder M, Milojevic D, Verbsky JW, Spalding SJ, Kimura Y, Imundo LF, Punaro MG, Sherry DD, Tarvin SE,Zemel LS, Birmingham JD, Gottlieb BS, Miller ML, O'Neil K, Ruth NM, Wallace CA, Singer NG, Sandborg CI.
The randomized placebo phase study of rilonacept in the treatment of systemic juvenile idiopathic arthritis(RAPPORT).
Arthritis Rheumatol. 2014 Sep; 66(9):2570-2579.
http://www.ncbi.nlm.nih.gov/pubmed/24839206 - Moncrieffe H1, Prahalad S, Thompson SD.
Genetics of juvenile idiopathic arthritis: new tools bring new approaches.
Curr Opin Rheumatol. 2014 Sep;26(5):579-84.
http://www.ncbi.nlm.nih.gov/pubmed/25010442 - Nirmala N1, Grom A, Gram H.
Biomarkers in systemic juvenile idiopathic arthritis: a comparison with biomarkers in cryopyrin-associated periodic syndromes.
Curr Opin Rheumatol. 2014 Sep;26(5):543-52.
http://www.ncbi.nlm.nih.gov/pubmed/25050926
AGOSTO 2014
- Murias S, Alcobendas R, Pascual-Salcedo D, Remesal A, Peralta J, Merino R.
Anti-adalimumab antibodies in paediatric rheumatology patients: a pilot experience.
Rheumatology (Oxford). 2014 Aug 7. pii: keu305. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25102859 - Haverman L, van Oers HA, Maurice-Stam H, Kuijpers TW, Grootenhuis MA, van Rossum MA.
Health related quality of life and parental perceptions of child vulnerability among parents of a child with juvenile idiopathic arthritis: results from a web-based survey.
Pediatr Rheumatol Online J. 2014 Aug 7;12:34.
http://www.ncbi.nlm.nih.gov/pubmed/25120411 - Huynh D, Kavanaugh A
Psoriatic arthritis: current therapy and future approaches.
Rheumatology (Oxford). 2014 Aug 14. pii: keu237. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/25125588 - Schmeling H, Horneff G, Benseler SM, Fritzler MJ.
Pharmacogenetics: can genes determine treatment efficacy and safety in JIA?
Nat Rev Rheumatol. 2014 Aug 12. doi: 10.1038/nrrheum.2014.140.
http://www.ncbi.nlm.nih.gov/pubmed/25112604 - Albarouni M, Becker I, Horneff G.
Predictors of response to methotrexate in juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2014 Aug 13;12:35. doi: 10.1186/1546-0096-12-35.
http://www.ncbi.nlm.nih.gov/pubmed/25143761 - Clin Rev Allergy Immunol. 2014 Aug 1. [Epub ahead of print]Ocular Involvement in Juvenile Idiopathic Arthritis: Classification and Treatment.
Foeldvari I.
http://www.ncbi.nlm.nih.gov/pubmed/25081063 - Rheumatol Int. 2014 Aug 3.
Efficacy and safety of TNF-alpha antagonists in children with juvenile idiopathic arthritis who started treatment under 4 years of age.
Giménez-Roca C1, Iglesias E, Torrente-Segarra V, Bou R, Sánchez-Manubens J, Calzada-Hernández J, Hernández S, Ricart S, Antón J.
http://www.ncbi.nlm.nih.gov/pubmed/25086629 - J Rheumatol. 2014 Aug 1.
Determinants of Vitamin D Levels in Children, Adolescents, and Young Adults with Juvenile Idiopathic Arthritis.
Stagi S, Bertini F, Cavalli L, Matucci-Cerinic M, Brandi ML, Falcini F.
http://www.ncbi.nlm.nih.gov/pubmed/25086083
JULIO 2014
- Koos B, Twilt M, Kyank U, Fischer-Brandies H, Gassling V, Tzaribachev N.
Reliability of Clinical Symptoms in Diagnosing Temporomandibular Joint Arthritis in Juvenile Idiopathic Arthritis.
J Rheumatol. 2014 Jul 1. pii: jrheum.131337. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24986847 - J Rheumatol. 2014 Jul;41(7):1416-25. doi: 10.3899/jrheum.131494. Epub 2014 Jun 15.
Female sex and oligoarthritis category are not risk factors for uveitis in italian children with juvenile idiopathic arthritis.
Calandra S1, Gallo MC1, Consolaro A1, Pistorio A1, Lattanzi B1, Bovis F1, Muratore V1, De Marco R1, Martini A1, Ravelli A2.
http://www.ncbi.nlm.nih.gov/pubmed/24931957 - Coulson EJ1, Hanson HJ1, Foster HE2.
What does an adult rheumatologist need to know about juvenile idiopathic arthritis?
Rheumatology (Oxford). 2014 Jul 1.
http://www.ncbi.nlm.nih.gov/pubmed/24987157 - Miyamae T1, Tanaka E, Kishi T, Matsuyama T, Igarashi T, Fujikawa S, Taniguchi A, Momohara S, Yamanaka H.
Long-term outcome of 114 adult JIA patients in a non-pediatric rheumatology institute in Japan.
Mod Rheumatol. 2014 Jul 14:1-5.
http://www.ncbi.nlm.nih.gov/pubmed/25019624 - Davì S1, Minoia F, Pistorio A, Horne A, Consolaro A, Rosina S, Bovis F, Cimaz R, Gamir ML, Ilowite N, Kone-Paut I, Feitosa de Oliveira SK, McCurdy D, Silva CA,Sztajnbok F, Tsitsami E, Unsal E, Weiss JE, Wulffraat N, Abinun M, Aggarwal A, Apaz MT, Astigarraga I, Corona F, Cuttica R, D'Angelo G, Eisenstein EM,Hashad S, Lepore L, Mulaosmanovic V, Nielsen S, Prahalad S, Rigante D, Stanevicha V, Sterba G, Susic G, Takei S, Trauzeddel R, Zletni M, Ruperto N, Martini A, Cron RQ, Ravelli A; on behalf of the Pediatric Rheumatology International Trials Organization; the Childhood Arthritis & Rheumatology Research Alliance; the Pediatric Rheumatology Collaborative Study Group; the Histiocyte Society.
Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
Arthritis Rheumatol. 2014 Jul 7. doi: 10.1002/art.38769. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/25041889 - Arthritis Rheumatol. 2014 Jul 21.
Whole exome sequencing reveals overlap between macrophage activation syndrome in systemic juvenile idiopathic arthritis and familial hemophagocytic lymphohistiocytosis.
Kaufman KM1, Linghu B, Szustakowski JD, Husami A, Yang F, Zhang K, Filipovich A, Fall N, Harley JB, Nirmala NR, Grom AA.
http://www.ncbi.nlm.nih.gov/pubmed/25047945 - Weiss PF1, Colbert RA, Xiao R, Feudtner C, Beukelman T, Morgan DeWitt E, Pagnini I, Wright TB, Wallace CA.
Development and retrospective validation of the juvenile spondyloarthritis disease activity (JSpADA) index.
Arthritis Care Res (Hoboken). 2014 Jul 21.
http://www.ncbi.nlm.nih.gov/pubmed/25047959 - Ahmed S1, Ali SR1, Ishaque S1, Sami N2
Clinical and biochemical characteristics of children with juvenile idiopathic arthritis.
J Coll Physicians Surg Pak. 2014 Jul;24(7):498-502.
http://www.ncbi.nlm.nih.gov/pubmed/25052974 - Reinards TH1, Albers HM1, Brinkman DM2, Kamphuis SS3, van Rossum MA4, Girschick HJ5, Wouters C6, Hoppenreijs EP7, Saurenmann RK8, Hinks A9, Ellis JA10, Bakker E11, Verduijn W12, Slagboom P13, Huizinga TW14, Toes RE14, Houwing-Duistermaat JJ15, Ten Cate R1, Schilham MW16.
CD226 (DNAM-1) is associated with susceptibility to juvenile idiopathic arthritis.
Ann Rheum Dis. 2014 Jul 23.
http://www.ncbi.nlm.nih.gov/pubmed/25057181 - Esposito S1, Corona F, Barzon L, Cuoco F, Squarzon L, Marcati G, Torcoletti M, Gambino M, Palù G, Principi N.
Immunogenicity, safety and tolerability of a bivalent human papillomavirus vaccine in adolescents with juvenile idiopathic arthritis.
Expert Rev Vaccines. 2014 Jul 28:1-7. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/25066387 - Lin C1, MacKenzie JD2, Courtier JL2, Gu JT2, Milojevic D3.
Magnetic resonance imaging findings in juvenile spondyloarthropathy and effects of treatment observed on subsequent imaging.
Pediatr Rheumatol Online J. 2014 Jul 11;12:25. doi: 10.1186/1546-0096-12-25. eCollection 2014.
http://www.ncbi.nlm.nih.gov/pubmed/25067925 - Moore TL1, Gillian BE, Crespo-Pagnussat S, Feller L, Chauhan AK.
Measurement and evaluation of isotypes of anti-citrullinated fibrinogen and anti-citrullinated alpha-enolase antibodies in juvenile idiopathic arthritis.
Clin Exp Rheumatol. 2014 Jul 17. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/25068682 - Minoia F1, Davì S, Horne A, Demirkaya E, Bovis F, Li C, Lehmberg K, Weitzman S, Insalaco A, Wouters C, Shenoi S, Espada G, Ozen S, Anton J, Khubchandani R, Russo R, Pal P, Kasapcopur O, Miettunen P, Maritsi D, Merino R, Shakoory B, Alessio M, Chasnyk V, Sanner H, Gao Y, Huasong Z, Kitoh T, Avcin T,Fischbach M, Frosch M, Grom A, Huber A, Jelusic M, Sawhney S, Uziel Y, Ruperto N, Martini A, Cron RQ, Ravelli A; on behalf of the Pediatric Rheumatology International Trials Organization; the Childhood Arthritis & Rheumatology Research Alliance; the Pediatric Rheumatology
Collaborative Study Group, and the Histiocyte Society.
Clinical features, treatment and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis A multinational, multicenter study of 362 patients.
Arthritis Rheumatol. 2014 Jul 30. doi: 10.1002/art.38802. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/25077692
JUNIO 2014
- Nigrovic PA.
Review: is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis?
Arthritis Rheumatol. 2014 Jun;66(6):1405-13
http://www.ncbi.nlm.nih.gov/pubmed/24623686 - Autmizguine J, Cohen-Wolkowiez M, Ilowite N, For The Rapport Investigators.
Rilonacept pharmacokinetics in children with systemic juvenile idiopathic arthritis.
J Clin Pharmacol. 2014 Jul 30. doi: 10.1002/jcph.372. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/25079592 -
Consolaro A1, Negro G, Gallo MC, Bracciolini G, Ferrari C, Schiappapietra B, Pistorio A, Bovis F, Ruperto N, Martini A, Ravelli A.Defining criteria for disease activity states in non-systemic juvenile idiopathic arthritis based on a three-variable Juvenile Arthritis Disease Activity Score.Arthritis Care Res (Hoboken). 2014 Jun 30. doi: 10.1002/acr.22393. [Epub ahead of print]
-
Van Dijkhuizen EH1, Wulffraat NM2.Early predictors of prognosis in juvenile idiopathic arthritis: a systematic literature review.Ann Rheum Dis. 2014 Jun 24. pii: annrheumdis-2014-205265. doi: 10.1136/annrheumdis-2014-205265. [Epub ahead of print]
- Liu YC, Tu YL, Wu RC, Huang JL, Yao TC
Life-threatening pneumonitis complicating low-dose methotrexate treatment for juvenile idiopathic arthritis in a child
Pediatr Emerg Care. 2014 Jun;30(6):415-7
http://www.ncbi.nlm.nih.gov/pubmed/24892681 - Lipstein EA, Dodds CM, Lovell DJ, Denson LA, Britto MT.
Making decisions about chronic disease treatment: a comparison of parents and their adolescent children.
Health Expect. 2014 Jun 3. doi: 10.1111/hex.12210. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24889468 - Ritchlin CT.
Psoriatic Enthesitis: An Update from the GRAPPA 2013 Annual Meeting.
J Rheumatol. 2014 Jun;41(6):1220-3. doi: 10.3899/jrheum.140174.
http://www.ncbi.nlm.nih.gov/pubmed/24882856
MAYO 2014
- Ortop Traumatol Rehabil. 2014 May 7;16(2):185-95. doi: 10.5604/15093492.1105236.
Physiotherapy in pauciarticular juvenile idiopathic arthritis. Case study.
Zuk B1, Kaczor Z2, Zuk-Drążyk B3, Księżopolska-Orłowska K1.
http://www.ncbi.nlm.nih.gov/pubmed/25041889 -
Sztajnbok F, Boechat NL, Ribeiro SB, Oliveira SK, Sztajnbok DC, Sant'Anna CC.Tuberculin skin test and ELISPOT/T. SPOT.TB in children and adolescents with juvenile idiopathic arthritisPediatr Rheumatol Online J. 2014 May 22;12:17. doi: 10.1186/1546-0096-12-17
-
Stevens A, Meyer S, Hanson D, Clayton P, Donn RP.Network analysis identifies protein clusters of functional importance in juvenile idiopathic arthritisArthritis Res Ther. 2014 May 8;16(3):R109. doi: 10.1186/ar4559.
-
Sjakste T, Paramonova N, Rumba-Rozenfelde I, Trapina I, Sugoka O, Sjakste N.Juvenile Idiopathic Arthritis Subtype- and Sex-specific Associations with Genetic Variants in the PSMA6/PSMC6/PSMA3 Gene Cluster.Pediatr Neonatol. 2014 May 26. pii: S1875-9572(14)00063-1. doi: 10.1016/j.pedneo.2014.01.007. [Epub ahead of print]
-
Lotfy HM, Kandil ME, Issac MS, Salah S, Ismail NA, Abdel Mawla MAMEFV Mutations in Egyptian Children with Systemic-Onset Juvenile Idiopathic Arthritis.Mol Diagn Ther. 2014 May 27. [Epub ahead of print]
- Bulatović Ćalasan M1, Wulffraat NM.
Methotrexate in juvenile idiopathic arthritis: towards tailor-made treatment.
Expert Rev Clin Immunol. 2014 May 26:1-12. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/24857620 - Berntson L.
Anti-inflammatory effect by exclusive enteral nutrition (EEN) in a patient with juvenile idiopathic arthritis (JIA): brief report.
Clin Rheumatol. 2014 May 23. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/24852669 - Guzman J1, Oen K2, Tucker LB1, Huber AM3, Shiff N4, Boire G5, Scuccimarri R6, Berard R7, Tse SM8, Morishita K1, Stringer E3, Johnson N9, Levy DM8, Duffy KW10, Cabral DA1, Rosenberg AM4, Larché M11, Dancey P12, Petty RE1, Laxer RM8, Silverman E8, Miettunen P9, Chetaille AL13, Haddad E14, Houghton K1,Spiegel L8, Turvey SE1, Schmeling H9, Lang B3, Ellsworth J15, Ramsey S3, Bruns A5, Campillo S6, Benseler S9, Chédeville G6, Schneider R8, Yeung R8, Duffy CM10; for the ReACCh-Out investigators.
The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort.
Ann Rheum Dis. 2014 May 19. pii: annrheumdis-2014-205372. doi: 10.1136/annrheumdis-2014-205372. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/24842571 - Kaminiarczyk-Pyzalka D, Adamczak K, Mikos H, Klimecka I, Moczko J, Niedziela M.
Serum TNF-alpha levels and indicators of disease activity in children with oligoarticular juvenile idiopathic arthritis(oJIA) in the first year of the disease.
Clin Lab. 2014;60(5):799-807.
http://www.ncbi.nlm.nih.gov/pubmed/24839823 - Brunner HI1, Ruperto N2, Zuber Z3, Keane C4, Harari O4, Kenwright A4, Lu P5, Cuttica R6, Keltsev V7, Xavier RM8, Calvo I9, Nikishina I10, Rubio-Pérez N11,Alexeeva E12, Chasnyk V13, Horneff G14, Opoka-Winiarska V15, Quartier P16, Silva CA17, Silverman E18, Spindler A19, Baildam E20, Gámir ML21, Martin A22,Rietschel C23, Siri D24, Smolewska E25, Lovell D1, Martini A26, De Benedetti F27; for the Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG).
Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial.
Ann Rheum Dis. 2014 May 16. pii: annrheumdis-2014-205351. doi: 10.1136/annrheumdis-2014-205351. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/24834925 - Aoki C1, Inaba Y, Choe H, Kaneko U, Hara R, Miyamae T, Imagawa T, Mori M, Oba MS, Yokota S, Saito T.
Discrepancy Between Clinical and Radiological Responses to Tocilizumab Treatment in Patients with Systemic-onset Juvenile Idiopathic Arthritis.
J Rheumatol. 2014 May 1. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/24786929 - Wallace CA1, Giannini EH, Spalding SJ, Hashkes PJ, O'Neil KM, Zeft AS, Szer IS, Ringold S, Brunner HI, Schanberg LE, Sundel RP, Milojevic DS, Punaro MG,Chira P, Gottlieb BS, Higgins GC, Ilowite NT, Kimura Y, Johnson A, Huang B, Lovell DJ.
Clinically Inactive Disease in a Cohort of Children with New-onset Polyarticular Juvenile Idiopathic ArthritisTreated with Early Aggressive Therapy: Time to Achievement, Total Duration, and Predictors.
J Rheumatol. 2014 May 1. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/24786928 - Jiang K1, Sawle AD, Frank MB, Chen Y, Wallace CA, Jarvis JN.
Whole blood gene expression profiling predicts therapeutic response at six months in patients with polyarticular juvenile idiopathic arthritis.
Arthritis Rheumatol. 2014 May;66(5):1363-71. doi: 10.1002/art.38341.
http://www.ncbi.nlm.nih.gov/pubmed/24782192 - Brescia AC1, Simonds MM, McCahan SM, Fawcett PT, Rose CD.
The Role of Transforming Growth Factor β Signaling in Fibroblast-like Synoviocytes From Patients With Oligoarticular Juvenile Idiopathic Arthritis: Dysregulation of Transforming Growth Factor β Signaling, Including Overexpression of Bone Morphogenetic Protein 4, May Lead to a Chondrocyte Phenotype and May Contribute to Bony Hypertrophy.
Arthritis Rheumatol. 2014 May;66(5):1352-62. doi: 10.1002/art.38336.
http://www.ncbi.nlm.nih.gov/pubmed/24782191 -
Leow OM, Lim LK, Ooi PL, Shek LP, Ang EY, Son MB1.Intra-articular glucocorticoid injections in patients with juvenile idiopathic arthritis in a Singapore hospital.
Singapore Med J. 2014 May;55(5):248-52. -
Lotfy HM1, Kandil ME, Issac MS, Salah S, Ismail NA, Abdel Mawla MA.
MEFV Mutations in Egyptian Children with Systemic-Onset Juvenile Idiopathic Arthritis.Mol Diagn Ther. 2014 May 27. [Epub ahead of print]
ABRIL 2014
- Fanaras N1, Parry NS2, Matthews NS3.
Multidisciplinary Approach in the Management of Absolute Trismus With Bilateral Temporomandibular Joint Replacements for a Patient With Juvenile Idiopathic Arthritis.
J Oral Maxillofac Surg. 2014 Apr 30.
http://www.ncbi.nlm.nih.gov/pubmed/25085804 - Aulie HA1, Selvaag AM, Günther A, Lilleby V, Molberg O, Hartmann A, Holdaas H, Flatø B.
Arterial haemodynamics and coronary artery calcification in adult patients with juvenile idiopathic arthritis.
Ann Rheum Dis. 2014 Apr 2. doi: 10.1136/annrheumdis-2013-204804. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24695010 - Ana F. Mourão, Maria J. Santos, José Melo-Gomes, Fernando M. Martins, José A. Costa, Filipa Ramos, Iva Brito, Cátia Duarte, Ricardo Figueira, GuilhermeFigueiredo, Carolina Furtado, Ana Lopes, Margarida Oliveira, Ana Rodrigues, Manuel Salgado, Miguel Sousa, Jamie C. Branco, João E. Fonseca and Helena Canhão
Using the Juvenile Arthritis Disease Activity Score Based on Erythrocyte Sedimentation Rate or C-Reactive Protein Level: Results From the Portuguese Register
Arthritis Care Res.2014 Apr 66(4):585–591. doi: 10.1002/acr.22215
http://onlinelibrary.wiley.com/doi/10.1002/acr.22215/abstract - Curr Rheumatol Rep. 2014 Apr;16(4):410. doi: 10.1007/s11926-014-0410-2.
Importance of adherence in the outcome of juvenile idiopathic arthritis.
Len CA, Miotto E Silva VB, Terreri MT.
http://www.ncbi.nlm.nih.gov/pubmed/24504596
MARZO 2014
-
de Oliveira Sato J, Albuquerque Pedrosa Fernandes T, Bicalho do Nascimento C, Corrente JE, Saad-Magalhaes C.Probability of remission of juvenile idiopathic arthritis following treatment with steroid joint injectionClin Exp Rheumatol. 2014 Mar-Apr;32(2):291-6.
-
Lovell DJ, Ruperto N, Mouy R, Paz E, Rubio-Perez N, Silva CA et al.A169: cumulative long-term safety, efficacy and patient-reported outcomes in children with juvenile idiopathic arthritis treated with intravenous abatacept: up to 7 years of treatment.Arthritis Rheumatol. 2014 Mar;66 Suppl 11:S218-9. doi: 10.1002/art.38595.
- Otten MH1, Anink J, Prince FH, Twilt M, Vastert SJ, Ten Cate R, Hoppenreijs EP, Armbrust W, Gorter SL, van Pelt PA, Kamphuis SS, Dolman KM, Swart JF, van den Berg JM, Koopman-Keemink Y, van Rossum MA, Wulffraat NM, van Suijlekom-Smit LW.
Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register.
Ann Rheum Dis. 2014 Mar 18.doi: 10.1136/annrheumdis-2013-204641. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24641940 - Stagi S, Cavalli L, Signorini C, Bertini F, Cerinic MM, Brandi ML, Falcini F.
Bone mass and quality in patients with juvenile idiopathic arthritis: longitudinal evaluation of bone massdeterminants using dual energy X-ray absorptiometry, peripheral quantitative computed tomography, and quantitative ultrasonography.
Arthritis Res Ther. 2014 Mar 31;16(2):R83. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24684763 - Ann Rheum Dis. 2014 Mar 1;73 Suppl 1:A95. doi: 10.1136/annrheumdis-2013-205124.220.
Children with juvenile idiopathic arthritis (JIA): findings in videocapillaroscopy.
Uceda J, Velloso ML, Martínez R, Marenco JL.
http://www.ncbi.nlm.nih.gov/pubmed/24489354 - J Rheumatol. 2014 Mar;41(3):547-53. doi: 10.3899/jrheum.130563. Epub 2014 Feb 1.
Limitations in the Classification of Childhood-onset Rheumatoid Arthritis.
Ferrell EG1, Ponder LA, Minor LS, Angeles-Han ST, Kennedy CW, Rouster-Stevens KA, Rohani-Pichavant M, Vogler LB, Prahalad S.
http://www.ncbi.nlm.nih.gov/pubmed/24488421 - Curr Rheumatol Rep. 2014 Mar;16(3):406. doi: 10.1007/s11926-013-0406-3.
Current developments in the use of biomarkers for juvenile idiopathic arthritis.
Duurland CL, Wedderburn LR.
http://www.ncbi.nlm.nih.gov/pubmed/24445961 - Duurland CL, Wedderburn LR.
Current developments in the use of biomarkers for juvenile idiopathic arthritis.
Curr Rheumatol Rep. 2014 Mar;16(3):406. doi: 10.1007/s11926-013-0406-3.
http://www.ncbi.nlm.nih.gov/pubmed/24445961 - Rheumatology (Oxford). 2014 Mar 4. [Epub ahead of print]Definition of improvement in juvenile idiopathic arthritis using the Juvenile Arthritis Disease Activity Score.
Horneff G, Becker I.
http://www.ncbi.nlm.nih.gov/pubmed/24599918 - Rheumatology (Oxford). 2014 Mar 4. [Epub ahead of print]Predictors of response to etanercept in polyarticular-course juvenile idiopathic arthritis.
Geikowski T1, Becker I, Horneff G; on behalf of the German BIKER Registry Collaborative Study Group.
http://www.ncbi.nlm.nih.gov/pubmed/24599916
FEBRERO 2014
- J Foot Ankle Res. 2014 Feb 6;7(1):10. doi: 10.1186/1757-1146-7-10.
An exploration of parents' preferences for foot care in juvenile idiopathic arthritis: a possible role for the discrete choice experiment.
Hendry GJ, Turner DE, Gardner-Medwin J, Lorgelly PK, Woodburn J.
http://www.ncbi.nlm.nih.gov/pubmed/24502508 - Clin Biochem. 2014 Feb 1. pii: S0009-9120(14)00055-1 [Epub ahead of print]Influence of proteolytic-antiproteolytic enzymes and prooxidative-antioxidative factors on proteoglycan alterations in children with juvenile idiopathic arthritis.
Winsz-Szczotka K, Komosińska-Vassev K, Kuźnik-Trocha K, Gruenpeter A, Lachór-Motyka I, Olczyk K.
http://www.ncbi.nlm.nih.gov/pubmed/24495859 - Indian J Pediatr. 2014 Feb 5. [Epub ahead of print]Spirometric Evaluation in Juvenile Idiopathic Arthritis: Data from Eastern India.
Alam MM1, Ray B, Sarkar S, Mandal O, Mondal R, Hazra A, Das NK.
http://www.ncbi.nlm.nih.gov/pubmed/24493318 - Nat Rev Rheumatol. 2014 Feb 4. doi: 10.1038/nrrheum.2014.4. [Epub ahead of print]Neural mechanisms underlying the pain of juvenile idiopathic arthritis.
de Lalouvière LL, Ioannou Y, Fitzgerald M.
http://www.ncbi.nlm.nih.gov/pubmed/24492386 - Clin Exp Rheumatol. 2014 Feb 24. [Epub ahead of print]Endothelial function, arterial wall mechanics and intima media thickness in juvenile idiopathic arthritis.
Satija M, Yadav TP, Sachdev N, Chhabra A, Jahan A, Dewan V.
http://www.ncbi.nlm.nih.gov/pubmed/24564946 - BMC Musculoskelet Disord. 2014 Feb 21;15(1):51. [Epub ahead of print]The association between lean mass and bone mineral content in the high disease activity group of adult patients with juvenile idiopathic arthritis.
Brabnikova Maresova K, Jarosova K, Pavelka K, Stepan JJ.
http://www.ncbi.nlm.nih.gov/pubmed/24558956 - Autoimmunity. 2014 Feb 20. [Epub ahead of print]Genetic background of juvenile idiopathic arthritis.
Chistiakov DA1, Savost'anov KV, Baranov AA.
http://www.ncbi.nlm.nih.gov/pubmed/24555814 - Clin J Pain. 2014 Feb 14. [Epub ahead of print]Comparison of Average Weekly Pain Using Recalled Paper and Momentary Assessment Electronic Diary Reports in Children with Arthritis.
Stinson JN, Jibb LA, Lalloo C, Feldman BM, McGrath PJ, Petroz GC, Streiner D, Dupuis A, Gill N, Stevens BJ.
http://www.ncbi.nlm.nih.gov/pubmed/24535055 - Nurs Child Young People. 2014 Feb 11;26(1):26-9. doi: 10.7748/ncyp2014.02.26.1.26.e393.
Juvenile idiopathic arthritis: updated guide to administering methotrexate
Livermore P.
http://www.ncbi.nlm.nih.gov/pubmed/24517621 - Arthritis Rheumatol. 2014 Feb;66(2):470-8. doi: 10.1002/art.38245.
The p38-Mediated Rapid Down-Regulation of Cell Surface gp130 Expression Impairs Interleukin-6 Signaling in the Synovial Fluid of Juvenile Idiopathic Arthritis Patients.
Honke N, Ohl K, Wiener A, Bierwagen J, Peitz J, Di Fiore S, Fischer R, Wagner N, Wüller S, Tenbrock K.
http://www.ncbi.nlm.nih.gov/pubmed/24504821 - Arthritis Rheumatol. 2014 Feb;66(2):462-9. doi: 10.1002/art.38223.
Self-reported pain and disease symptoms persist in juvenile idiopathic arthritis despite treatment advances: an electronic diary study.
Bromberg MH, Connelly M, Anthony KK, Gil KM, Schanberg LE.
http://www.ncbi.nlm.nih.gov/pubmed/24504820 - Klotsche J, Minden K, Thon A, Ganser G, Urban A, Horneff G.
Improvement in health-related quality of life for children with juvenile idiopathic arthritis after start of treatment with etanercept.
Arthritis Care Res (Hoboken). 2014 Feb;66(2):253-62. doi: 10.1002/acr.22112.
http://www.ncbi.nlm.nih.gov/pubmed/23983081 - Seid M, Huang B, Niehaus S, Brunner HI, Lovell DJ.
Determinants of health-related quality of life in children newly diagnosed with juvenile idiopathic arthritis.
Arthritis Care Res (Hoboken). 2014 Feb;66(2):263-9. doi: 10.1002/acr.22117.
http://www.ncbi.nlm.nih.gov/pubmed/23983144 - Bromberg MH, Connelly M, Anthony KK, Gil KM, Schanberg LE.
Self-reported pain and disease symptoms persist in juvenile idiopathic arthritis despite treatment advances: an electronic diary study.
Arthritis Rheumatol. 2014 Feb;66(2):462-9. doi: 10.1002/art.38223.
http://www.ncbi.nlm.nih.gov/pubmed/24504820 - Goulabchand R, Mouterde G, Barnetche T, Lukas C, Morel J, Combe B.
Effect of tumour necrosis factor blockers on radiographic progression of psoriatic arthritis: a systematic review and meta-analysis of randomised controlled trials.
Ann Rheum Dis. 2014 Feb 1;73(2):414-9. doi: 10.1136/annrheumdis-2012-202641. Epub 2013 Jan 25.
http://www.ncbi.nlm.nih.gov/pubmed/23355079 - Bulatovic Calasan M, de Vries LD, Vastert SJ, Heijstek MW, Wulffraat NM.
Interpretation of the Juvenile Arthritis Disease Activity Score: responsiveness, clinically important differences and levels of disease activity in prospective cohorts of patients with juvenile idiopathic arthritis.
Rheumatology (Oxford). 2014 Feb;53(2):307-12. doi: 10.1093/rheumatology/ket310. Epub 2013 Oct 24.
http://www.ncbi.nlm.nih.gov/pubmed/24162034 - Theander E, Husmark T, Alenius GM, Larsson PT, Teleman A, Geijer M, Lindqvist URC.
Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA)
Ann Rheum Dis 2014;73:407-413 doi:10.1136/annrheumdis-2012-201972
http://ard.bmj.com/content/73/2/407.abstract - McInnes IB, Sieper J, Braun J, Emery P, van der Heijde D, Isaacs JD et al.
Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial
Ann Rheum Dis 2014;73:349-356 Published Online First: 29 January 2013
http://ard.bmj.com/content/73/2/349.abstract - Alcântara AC, Leite CA, Leite AC, Sidrim JJ, Silva FS Jr, Rocha FA.
A Longterm Prospective Real-life Experience with Leflunomide in Juvenile Idiopathic Arthritis.
J Rheumatol. 2014 Feb;41(2):338-44. doi: 10.3899/jrheum.130294. Epub 2013 Dec 15.
http://www.ncbi.nlm.nih.gov/pubmed/24334641 - Limenis E, Grosbein HA, Feldman BM.
The relationship between physical activity levels and pain in children with juvenile idiopathic arthritis.
J Rheumatol. 2014 Feb;41(2):345-51. doi: 10.3899/jrheum.130734. Epub 2013 Dec 15.
http://www.ncbi.nlm.nih.gov/pubmed/24334648
ENERO 2014
- Foeldvari I, Tzaribachev N, Cron RQ.
Results of a multinational survey regarding the diagnosis and treatment of temporomandibular joint involvement in juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2014 Jan 25;12(1):6. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24461073 - Weiss PF, Chauvin NA, Klink AJ, Localio R, Feudtner C, Jaramillo D, Colbert RA, Sherry DD, Keren R.
Detection of enthesitis in children with enthesitis-related arthritis: dolorimetry compared to ultrasonography.
Arthritis Rheumatol. 2014 Jan; 66(1):218-27. doi: 10.1002/art.38197.
http://www.ncbi.nlm.nih.gov/pubmed/24449586 - Kostik MM, Smirnov AM, Demin GS, Scheplyagina LA, Larionova VI.
Juvenile idiopathic arthritis patients and their skeletal status: possible role of vitamin D receptor gene polymorphism.
Mol Biol Rep. 2014 Jan 12. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24415299 - Finnegan S, Robson J, Scaife C, McAllister C, Pennington SR, Gibson DS, Rooney ME.
Synovial membrane protein expression differs between juvenile idiopathic arthritis subtypes in early disease.
Arthritis Res Ther. 2014 Jan 13;16(1):R8. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24410838 - Poddubnyy D, Hermann KG, Callhoff J, Listing J, Sieper J.
Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS).
Ann Rheum Dis. 2014 Jan 3. doi: 10.1136/annrheumdis-2013-204248. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24389297 - Jiang K, Sawle AD, Frank MB, Chen Y, Wallace CA, Jarvis JN.
Whole blood gene expression profiling predicts therapeutic response in polyarticular juvenile idiopathic arthritis at 6 months.
Arthritis Rheum. 2014 Jan 8. doi: 10.1002/art.38341. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24402890 - Hugle B, Burgos-Vargas R, Inman RD, O'Shea F, Laxer RM, Stimec J, Whitney-Mahoney K, Duvnjak M, Anderson M, Tse SM.
Long-term outcome of anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondyloarthritis.
Clin Exp Rheumatol. 2014 Jan 3. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24387974 - Pastore S, Gortani G, Taddio A, Barbi E.
Procedural sedation for intra-articular corticosteroid injections in juvenile idiopathic arthritis (JIA) should be a standard of care.
Eur J Pediatr. 2014 Jan 3. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24384792 - Armbrust W, Kaak JG, Bouma J, Lelieveld OT, Wulffraat NM, Sauer PJ, van Sonderen E.
Assessment of disease activity by patients with juvenile idiopathic arthritis and the parents compared to the assessment by pediatric rheumatologists.
Pediatr Rheumatol Online J. 2013 Dec 24;11(1):48. doi: 10.1186/1546-0096-11-48.
http://www.ncbi.nlm.nih.gov/pubmed/24368009 - Albers HM, Reinards TH, Brinkman DM, Kamphuis SS, van Rossum MA, Hoppenreijs EP, Girschick HJ, Wouters C, Saurenmann RK, Bakker E, Verduijn W, Slagboom P, Huizinga TW, Toes RE, Houwing-Duistermaat JJ, Ten Cate R, Schilham MW.
Genetic variation in VTCN1 (B7-H4) is associated with course of disease in juvenile idiopathic arthritis.
Ann Rheum Dis. 2013 Dec 17. doi: 10.1136/annrheumdis-2013-204466. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24347572
DICIEMBRE 2013
- Armbrust W, Kaak JG, Bouma J, Lelieveld OT, Wulffraat NM, Sauer PJ, van Sonderen E.
Assessment of disease activity by patients with juvenile idiopathic arthritis and the parents compared to the assessment by pediatric rheumatologists.
Pediatr Rheumatol Online J. 2013 Dec 24;11(1):48. doi: 10.1186/1546-0096-11-48.
http://www.ncbi.nlm.nih.gov/pubmed/24368009 - Albers HM, Reinards TH, Brinkman DM, Kamphuis SS, van Rossum MA, Hoppenreijs EP, Girschick HJ, Wouters C, Saurenmann RK, Bakker E, Verduijn W, Slagboom P, Huizinga TW, Toes RE, Houwing-Duistermaat JJ, Ten Cate R, Schilham MW.
Genetic variation in VTCN1 (B7-H4) is associated with course of disease in juvenile idiopathic arthritis.
Ann Rheum Dis. 2013 Dec 17. doi: 10.1136/annrheumdis-2013-204466. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24347572 - Vastert SJ, de Jager W, Noordman BJ, Holzinger D, Kuis W, Prakken BJ, Wulffraat NM.
Effectiveness of first line use of recombinant IL-1RA treatment in steroid naïve systemic juvenile idiopathic arthritis: Results of a prospective cohort study.
Arthritis Rheum. 2013 Dec 18. doi: 10.1002/art.38296. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24352936 - Consolaro A, Ruperto N, Bracciolini G, Frisina A, Gallo MC, Pistorio A, Verazza S, Negro G, Gerloni V, Goldenstein-Schainberg C, Sztajnbok F, Wulffraat NM,Martini A, Ravelli A; for the Paediatric Rheumatology International Trials Organization (PRINTO).
Defining criteria for high disease activity in juvenile idiopathic arthritis based on the Juvenile Arthritis Disease Activity Score.
Ann Rheum Dis. 2013 Dec 17. doi: 10.1136/annrheumdis-2013-204186. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24347571 - Rothmund F, Gerss J, Ruperto N, Däbritz J, Wittkowski H, Frosch M, Wulffraat NM, Wedderburn LR, Holzinger D, Gohar F, Vastert SJ, Brik R, Deslandre CJ,Melo-Gomes JA, Magalhães CS, Barcellona R, Russo R, Gattorno M, Martini A, Roth J, Foell D; for the Paediatric Rheumatology International Trials Organization (PRINTO).
Validation of relapse risk biomarkers for routine use in patients with juvenile idiopathic arthritis.
Arthritis Care Res (Hoboken). 2013 Dec 10. doi: 10.1002/acr.22248. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24339418 - Ringold S, Weiss PF, Colbert RA, Dewitt EM, Lee T, Onel K, Prahalad S, Schneider R, Shenoi S, Vehe RK, Kimura Y; for the Juvenile Idiopathic Arthritis Research Committee of the Children's Arthritis and Rheumatology Research Alliance (CARRA).
Childhood arthritis and rheumatology research alliance consensus treatment plans for new onset polyarticular juvenile idiopathic arthritis.
Arthritis Care Res (Hoboken). 2013 Dec 10. doi: 10.1002/acr.22259. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24339215 - Uettwiller F, Perlbarg J, Pinto G, Bader-Meunier B, Mouy R, Compeyrot-Lacassagne S, Melki I, Wouters C, Prieur AM, Landais P, Polak M, Quartier P.
Effect of Biologic Treatments on Growth in Children with Juvenile Idiopathic Arthritis.
J Rheumatol. 2013 Dec 1. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24293576 - Shafferman A, Fontaine KR, Cron RQ, Beukelman T.
Changes in Body Mass Index in Children with Juvenile Idiopathic Arthritis Treated with Tumor Necrosis Factor Inhibitors.
J Rheumatol. 2013 Dec 1. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24293573
NOVIEMBRE 2013
- McErlane F, Beresford MW, Baildam EM, Thomson W, Hyrich KL.
Recent developments in disease activity indices and outcome measures for juvenile idiopathic arthritis.
Rheumatology (Oxford). 2013 Nov;52(11):1941-51. doi: 10.1093/rheumatology/ket150
http://www.ncbi.nlm.nih.gov/pubmed/23630368 - Zhou J, Tang X, Ding Y, An Y, Zhao X.
Natural killer cell activity and frequency of killer cell immunoglobulin-like receptors in children with different forms of juvenile idiopathic arthritis.
Pediatr Allergy Immunol. 2013 Nov;24(7):691-6.
http://www.ncbi.nlm.nih.gov/pubmed/24112428
OCTUBRE 2013
- Mawani N, Amine B, Rostom S, El Badri D, Ezzahri M, Moussa F, Shyen S, Gueddari S, Wabi M, Shkirat B, Hassouni NH.
Moroccan parents caring for children with juvenile idiopathic arthritis: positive and negative aspects of their experiences.
Pediatr Rheumatol Online J. 2013 Oct 20;11(1):39. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24138932 - Goodman SB, Hwang K, Imrie S.
High Complication Rate in Revision Total Hip Arthroplasty in Juvenile Idiopathic Arthritis.
Clin Orthop Relat Res. 2013 Oct 18. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24136805 - Shyen S, Amine B, Rostom S, El Badri D, Ezzahri M, Mawani N, Moussa F, Gueddari S, Wabi M, Abouqal R, Chkirate B, Hajjaj-Hassouni N.
Sleep and its relationship to pain, dysfunction, and disease activity in juvenile idiopathic arthritis.
Clin Rheumatol. 2013 Oct 19. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24135889 - Cedströmer AL, Andlin-Sobocki A, Berntson L, Hedenberg-Magnusson B, Dahlström L.
Temporomandibular signs, symptoms, joint alterations and disease activity in juvenile idiopathic arthritis -- an observational study.
Pediatr Rheumatol Online J. 2013 Oct 17;11(1):37. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24134193 - Pelegrín L, Casaroli-Marano R, Antón J, Carmen García de Vicuña M, Molina-Prat N, Ignacio Aróstegui J, Yagüe J, Ríos J, Adán A.
Predictive Value of Selected Biomarkers, Polymorphisms, and Clinical Features for Oligoarticular Juvenile Idiopathic Arthritis-associated Uveitis.
Ocul Immunol Inflamm. 2013 Oct 16. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24131380
SEPTIEMBRE 2013
- Castillo-Gallego C, Aydin SZ, Emery P, McGonagle DG, Marzo-Ortega H.
Magnetic Resonance Imaging Assessment of Axial Psoriatic Arthritis: Extent of Disease Relates to HLA–B27.
Arthritis Rheum 2013 Sep;65(9):2274-8.
http://onlinelibrary.wiley.com/doi/10.1002/art.38050/abstract - Ringold S, Weiss PF, Beukelman T, Dewitt EM, Ilowite NT, Kimura Y, Laxer RM, Lovell DJ, Nigrovic PA, Robinson AB, Vehe RK.
2013 Update of the 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for the Medical Therapy of Children With Systemic Juvenile Idiopathic Arthritis and Tuberculosis Screening Among Children Receiving Biologic Medications.
Arthritis Rheum. 2013 Oct;65(10):2499-2512 doi: 10.1002/art.38092.
http://www.ncbi.nlm.nih.gov/pubmed/24092554
AGOSTO 2013
- Tambralli A, Beukelman T, Weiser P, Atkinson TP, Cron RQ, Stoll ML.
High Doses of Infliximab in the Management of Juvenile Idiopathic Arthritis
J Rheumatol. 2013 Aug 15. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/23950184
JULIO 2013
-
Schierbeck H, Pullerits R, Pruunsild C, Fischer M, Holzinger D, Laestadius A, Sundberg E, Erlandsson Harris H.HMGB1 Levels Are Increased in Patients with Juvenile Idiopathic Arthritis, Correlate with Early Onset of Disease, and Are Independent of Disease Duration.J Rheumatol. 2013 Jul 15. [Epub ahead of print]
-
Gorelik M, Fall N, Altaye M, Barnes MG, Thompson SD, Grom AA, Hirsch R.Follistatin-like Protein 1 and the Ferritin/Erythrocyte Sedimentation Rate Ratio Are Potential Biomarkers for Dysregulated Gene Expression and Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis.J Rheumatol. 2013 Jul;40(7):1191-9. doi: 10.3899/jrheum.121131. Epub 2013 May 15.
-
Papadopoulou C, Kostik M, Gonzalez-Fernandez MI, Bohm M, Nieto-Gonzalez JC, Pistorio A, Lanni S, Consolaro A, Martini A, Ravelli A.Delineating the role of multiple intra-articular corticosteroid injections in the management of juvenile idiopathic arthritis in the biologic era.Arthritis Care Res (Hoboken). 2013 Jul;65 (7):1112-20. doi: 10.1002/acr.21947.
JUNIO 2013
-
Anink J, Otten MH, Gorter SL, Prince FH, van Rossum MA, van den Berg JM, van Pelt PA, Kamphuis S, Brinkman DM, Swen WA, Swart JF, Wulffraat NM, Dolman KM, Koopman-Keemink Y, Hoppenreijs EP, Armbrust W, Ten Cate R, van Suijlekom-Smit LW.Treatment choices of paediatric rheumatologists for juvenile idiopathic arthritis: etanercept or adalimumab?Rheumatology (Oxford). 2013 Jun 4. [Epub ahead of print]
-
Hinks A, Cobb J, Marion MC, et al.Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis.Nat Genet. 2013 Jun;45(6):664-9. doi: 10.1038/ng.2614.
MAYO 2013
- Otten MH, Prince FH, Anink J, Ten Cate R, Hoppenreijs EP, Armbrust W, Koopman-Keemink Y, van Pelt PA, Kamphuis S, Gorter SL,Dolman KM, Swart JF, van den Berg JM, Wulffraat NM, van Rossum MA, van Suijlekom-Smit LW.
Effectiveness and safety of a second and third biological agent after failing etanercept in juvenile idiopathic arthritis: results from the Dutch National ABC Register.
Ann Rheum Dis. 2013 May;72(5):721-7. doi: 10.1136/annrheumdis-2011-201060. Epub 2012 Jun 23.
http://www.ncbi.nlm.nih.gov/pubmed/22730374 - Horneff G, Burgos-Vargas R, Constantin T, Foeldvari I, Vojinovic J, Chasnyk VG, Dehoorne J, Panaviene V, Susic G, Stanevica V, Kobusinska K, Zuber Z, Mouy R, Rumba-Rozenfelde I, Breda L, Dolezalova P, Job-Deslandre C, Wulffraat N, Alvarez D, Zang C, Wajdula J, Woodworth D, Vlahos B, Martini A, Ruperto N; for the Paediatric Rheumatology International Trials Organisation (PRINTO).
Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: Part 1 (week 12) of the CLIPPER study.
Ann Rheum Dis. 2013 May 21. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/ 23696632 - Pelajo CF, Angeles-Han ST, Prahalad S, Sgarlat CM, Davis TE, Miller LC, Lopez-Benitez JM.
Evaluation of the association between Hispanic ethnicity and disease activity and severity in a large cohort of patients with juvenile idiopathic arthritis.
Rheumatol Int. 2013 May 10. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/23660749 - Saha A, Chopra Y, Theis JD, Vrana JA, Sethi S.
AA Amyloidosis Associated With Systemic-Onset Juvenile Idiopathic Arthritis.
Am J Kidney Dis. 2013 May 9. pii: S0272-6386 (13) 00675-6.
doi: 10.1053/j.ajkd.2013.02.377. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/23664546 - Dey S, Jahan A, Yadav TP, Bhagwani DK, Sachdev N.
Measurement of Bone Mineral Density by Dual Energy X-ray Absorptiometry in Juvenile Idiopathic Arthritis.
Indian J Pediatr. 2013 May 4. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/23645223 - Leegaard A, Lomholt JJ, Thastum M, Herlin T.
Decreased Pain Threshold in Juvenile Idiopathic Arthritis: A Cross-sectional Study.
J Rheumatol. 2013 May 1. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/23637324 - Berntson L, Nordal E, Aalto K, Peltoniemi S, Herlin T, Zak M, Nielsen S, Rygg M; for the Nordic Study Group of Paediatric Rheumatology.
HLA-B27 Predicts a More Chronic Disease Course in an 8-year Followup Cohort of Patients with Juvenile Idiopathic Arthritis.
J Rheumatol 2013 May;40(5):725-731.
http://www.ncbi.nlm.nih.gov/pubmed/23547219 - Lomholt JJ, Thastum M, Herlin T.
Pain experience in children with juvenile idiopathic arthritis treated with anti-TNF agents compared to non-biologic standard treatment.
Pediatr Rheumatol Online J. 2013 May 6;11(1):21. doi: 10.1186/1546-0096-11-21.
http://www.ncbi.nlm.nih.gov/pubmed/23641813 - Kröger L, Piippo-Savolainen E, Tyrväinen E, Penttilä P, Kröger H.
Osteochondral lesions in children with juvenile idiopathic arthritis.
Pediatr Rheumatol Online J. 2013 May 1;11(1):18. doi: 10.1186/1546-0096-11-18.
http://www.ncbi.nlm.nih.gov/pubmed/23634779 - Kimura Y, Weiss JE, Haroldson KL et al.
Pulmonary Hypertension and Other Potentially Fatal Pulmonary Complications in Systemic Juvenile Idiopathic Arthritis†
Arthritis Care Res (Hoboken). 2013 May; 65:745-52.
http://onlinelibrary.wiley.com/doi/10.1002/acr.21889/abstract - Hurd A, Beukelman T.
Infectious complications in juvenile idiopathic arthritis.
Curr Rheumatol Rep. 2013 May;15:327. doi: 10.1007/s11926-013-0327-1.
http://www.ncbi.nlm.nih.gov/pubmed/23529583 -
Tuompo R, Hannu T, Mattila L, Siitonen A, Leirisalo-Repo M.Reactive arthritis following Salmonella infection: a population-based study.Scand J Rheumatol. 2013 May;42(3):196-202. doi: 10.3109/03009742.2012.739201.
-
Bertilsson L, Andersson-Gäre B, Fasth A, Petersson IF, Forsblad-d'Elia H.Disease Course, Outcome, and Predictors of Outcome in a Population-based Juvenile Chronic Arthritis Cohort Followed for 17 Years.J Rheumatol. 2013 May;40(5):715-24. doi: 10.3899/jrheum.120602.
ABRIL 2013
- Moncrieffe H, Ursu S, Holzinger D, Patrick F, Kassoumeri L, Wade A, Roth J, Wedderburn LR.
A subgroup of juvenile idiopathic arthritis patients who respond well to methotrexate are identified by the serum biomarker MRP8/14 protein
Rheumatology (Oxford). 2013 Apr 25. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/23620557 - Collado P, Naredo E, Calvo C, Gamir ML, Calvo I, García ML, Merino R, Graña J, Bustabab S, Garrido J; on behalf of the ECO-JIA Study Group.
Reduced joint assessment vs comprehensive assessment for ultrasound detection of synovitis in juvenile idiopathic arthritis.
Rheumatology (Oxford). 2013 Apr 25. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/23620551 - Prince FH, van Suijlekom-Smit LW.
Cost of Biologics in the Treatment of Juvenile Idiopathic Arthritis: A Factor not to be Overlooked.
Paediatr Drugs. 2013 Apr 21. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/23606042 - Hinks A, Cobb J, Marion MC et al.
Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis.
Nat Genet. 2013 Apr 21. doi: 10.1038/ng.2614. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/23603761 - Harrold LR, Salman C, Shoor S, Curtis JR, Asgari MM, Gelfand JM, Wu JJ, Herrinton LJ.
Incidence and Prevalence of Juvenile Idiopathic Arthritis Among Children in a Managed Care Population, 1996-2009.
J Rheumatol. 2013 Apr 15. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/23588938 - Ishikawa S, Shimizu M, Ueno K, Sugimoto N, Yachie A.
Soluble ST2 as a marker of disease activity in systemic juvenile idiopathic arthritis.
Cytokine. 2013 Apr 3. pii: S1043-4666(13)00109-9. doi: 10.1016/j.cyto.2013.03.007. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/23561929 - Anink J, Otten MH, Prince FH, Hoppenreijs EP, Wulffraat NM, Swart JF, Ten Cate R, van Rossum MA, van den Berg JM, Dolman KM, Koopman-Keemink Y, Armbrust W, Kamphuis S, van Pelt PA, Gorter SL, van Suijlekom-Smit LW.
Tumour necrosis factor-blocking agents in persistent oligoarticular juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children Register.
Rheumatology (Oxford). 2013 Apr;52(4):712-7. doi: 10.1093/rheumatology/kes373. Epub 2012 Dec 24.
http://www.ncbi.nlm.nih.gov/pubmed/23267169 - De Sanctis S, Marcovecchio ML, Gaspari S, Del Torto M, Mohn A, Chiarelli F, Breda L.
Etanercept Improves Lipid Profile and Oxidative Stress Measures in Patients with Juvenile Idiopathic Arthritis.
J Rheumatol. 2013 Apr 1. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/23547210 - Burmester GR, Panaccione R, Gordon KB, McIlraith MJ, Lacerda AP.
Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease.
Ann Rheum Dis. 2013 Apr;72(4):517-24. doi: 10.1136/annrheumdis-2011-201244. Epub 2012 May 5.
http://www.ncbi.nlm.nih.gov/pubmed/22562972
MARZO 2013
- Głowińska-Olszewska B, Bossowski A, Dobreńko E, Hryniewicz A, Konstantynowicz J, Milewski R, Luczyński W, Piotrowska-Jastrzębska J, Kowal-Bielecka O.
Subclinical cardiovascular system changes in obese patients with juvenile idiopathic arthritis.
Mediators Inflamm. 2013;2013:436702. doi: 10.1155/2013/436702. Epub 2013 Mar 11.
http://www.ncbi.nlm.nih.gov/pubmed/23554546 - Butbul Aviel Y, Tyrrell P, Schneider R, Dhillon S, Feldman BM, Laxer R, Saurenmann RK, Spiegel L, Cameron B, Tse SM, Silverman E.
Juvenile Psoriatic Arthritis (JPsA): juvenile arthritis with psoriasis?
Pediatr Rheumatol Online J. 2013 Mar 15;11:11. doi: 10.1186/1546-0096-11-11.
http://www.ncbi.nlm.nih.gov/pubmed/23497068 - Coulson EJ, Ng WF, Goff I, Foster HE.
Cardiovascular risk in juvenile idiopathic arthritis.
Rheumatology (Oxford). 2013 Mar 15. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/23502074 - Stoll ML, Morlandt AB, Teerawattanapong S, Young D, Waite PD, Cron RQ.
Safety and efficacy of intra-articular infliximab therapy for treatment-resistant temporomandibular joint arthritis in children: a retrospective study.
Rheumatology (Oxford). 2013 Mar;52(3):554-9. doi: 10.1093/rheumatology/kes318. Epub 2012 Dec 5.
http://rheumatology.oxfordjournals.org/content/52/3/554.full.pdf+html
FEBRERO 2013
- Solari N, Palmisani E, Consolaro A, Pistorio A, Viola S, Buoncompagni A, Gattorno M, Picco P, Ruperto N, Malattia C, Martini A, Ravelli A.
Factors associated with achievement of inactive disease in children with juvenile idiopathic arthritis treated with etanercept.
J Rheumatol. 2013 Feb;40(2):192-200. doi: 10.3899/jrheum.120842. Epub 2012 Dec 1.
http://www.ncbi.nlm.nih.gov/pubmed/23204218
ENERO 2013
-
Ungar WJ, Costa V, Burnett HF, Feldman BM, Laxer RM.The use of biologic response modifiers in polyarticular-course juvenile idiopathic arthritis: A systematic review.Semin Arthritis Rheum. 2013 Jan 18. pii: S0049-0172(12)00263-6. doi: 10.1016/j.semarthrit. 2012.10.006. [Epub ahead of print]
- Russo RA, Katsicas MM.
Patients with Very Early-onset Systemic Juvenile Idiopathic Arthritis Exhibit More Inflammatory Features and a Worse Outcome.
J Rheumatol 2013 Jan 15. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/23322471
DICIEMBRE 2012
-
De Benedetti F, Brunner HI, Ruperto N, Kenwright A, Wright S, Calvo I, Cuttica R, Ravelli A, Schneider R, Woo P, Wouters C, Xavier R, Zemel L, Baildam E, Burgos-Vargas R, Dolezalova P, Garay SM, Merino R, Joos R, Grom A, Wulffraat N, Zuber Z, Zulian F, Lovell DJ, and Martini A, for the PRINTO and PRCSG.Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis.N Engl J Med 2012; 367:2385-2395. December 20, 2012 DOI: 10.1056/NEJMoa1112802
-
Ruperto N, Brunner HI, Quartier P, Constantin T, Wulffraat N, Horneff G, Brik R, McCann L, Kasapcopur O, Rutkowska-Sak L, Schneider R, Berkun Y, Calvo I, Erguven M, Goffin L, Hofer M, Kallinich T, Oliveira SK, Uziel Y, Viola S, Nistala K, Wouters C, Cimaz R, Ferrandiz MA, Flato B, Gamir ML, Kone-Paut I, Grom A, Magnusson B, Ozen S, Sztajnbok F, Lheritier K, Abrams K, Kim D, Martini A and Lovell DJ, M.D., M.P.H. fo rthe PRINTO and PRCSG.Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic ArthritisN Engl J Med 2012; 367:2396-2406. December 20, 2012 DOI: 10.1056/NEJMoa1205099
NOVIEMBRE 2012
-
Otten MH, Anink J,Spronk S,van Suijlekom-Smit LW.Efficacy of biological agents in juvenile idiopathic arthritis: a systematic review using indirect comparisons.Ann Rheum Dis 2012 Nov 21. [Epub ahead of print]
SEPTIEMBRE 2012
- Stoll ML, Sharpe T, Beukelman T, Good J, Young D, Cron RQ.
Risk factors for temporomandibular joint arthritis in children with juvenile idiopathic arthritis.
J Rheumatol 2012 Sep;39(9):1880-7. doi: 10.3899/jrheum.111441. Epub 2012 May 15.
http://www.ncbi.nlm.nih.gov/pubmed/22589268 - Burnett HF, Regier DA, Feldman BM, Miller FA, Ungar WJ.
Parents' preferences for drug treatments in juvenile idiopathic arthritis: a discrete choice experiment.
Arthritis Care Res (Hoboken). 2012 Sep;64(9):1382-91. doi: 10.1002/acr.21698.
http://www.ncbi.nlm.nih.gov/pubmed/22504893 - Nordstrom BL, Mines D, Gu Y, Mercaldi C, Aquino P, Harrison MJ.
Risk of malignancy in children with juvenile idiopathic arthritis not treated with biologic agents.
Arthritis Care Res (Hoboken). 2012 Sep;64(9):1357-64. doi: 10.1002/acr.21709.
http://www.ncbi.nlm.nih.gov/pubmed/22511558 - Klein A, Kaul I, Foeldvari I, Ganser G, Urban A, Horneff G.
Efficacy and safety of oral and parenteral methotrexate therapy in children with juvenile idiopathic arthritis: an observational study with patients from the German Methotrexate Registry.
Arthritis Care Res (Hoboken). 2012 Sep;64(9):1349-56. doi: 10.1002/acr.21697
http://www.ncbi.nlm.nih.gov/pubmed/22649024
JULIO 2012
- DeWitt EM, Kimura Y, Beukelman T, Nigrovic PA, Onel K, Prahalad S, Schneider R, Stoll ML, Angeles-Han S, Milojevic D, Schikler KN, Vehe RK, Weiss JE, Weiss P, Ilowite NT, Wallace CA; Juvenile Idiopathic Arthritis Disease-specific Research Committee of Childhood Arthritis Rheumatology and Research Alliance.
Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis.
Arthritis Care Res (Hoboken). 2012 Jul;64(7):1001-10. doi: 10.1002/acr.21625.
http://www.ncbi.nlm.nih.gov/pubmed/22290637
JUNIO 2012
- Wallace CA, Giannini EH, Spalding SJ, Hashkes PJ, O'Neil KM, Zeft AS, Szer IS, Ringold S, Brunner HI, Schanberg LE, Sundel RP, Milojevic D, Punaro MG, Chira P, Gottlieb BS, Higgins GC, Ilowite NT, Kimura Y, Hamilton S, Johnson A, Huang B, Lovell DJ; Childhood Arthritis and Rheumatology Research Alliance.
Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis.
Arthritis Rheum. 2012 Jun;64(6):2012-21. doi: 10.1002/art.34343. Epub 2011 Dec 19.
http://www.ncbi.nlm.nih.gov/pubmed/22183975
ABRIL 2012
- Furst DE, Keystone EC, Braun J, Breedveld FC, Burmester GR, De Benedetti F, Dörner T, Emery P, Fleischmann R, Gibofsky A, Kalden JR, Kavanaugh A, Kirkham B, Mease P, Sieper J, Singer NG, Smolen JS, Van Riel PL, Weisman MH, Winthrop K.
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011.
Ann Rheum Dis. 2012 Apr;71 Suppl 2:i2-45.
http://www.ncbi.nlm.nih.gov/pubmed/22460137
FEBRERO 2012
- Dueckers G, Guellac N, Arbogast M, Dannecker G, Foeldvari I, Frosch M, Ganser G, Heiligenhaus A, Horneff G, Illhardt A, Kopp I, Krauspe R, Markus B, Michels H, Schneider M, Singendonk W, Sitter H, Spamer M, Wagner N, Niehues T.
Evidence and consensus based GKJR guidelines for the treatment of juvenile idiopathic arthritis.
Clin Immunol. 2012 Feb;142(2):176-93. Epub 2011 Oct 26.
http://www.ncbi.nlm.nih.gov/pubmed/22154868 -
Eberhard BA, Ilowite NT, Sison C.A dose schedule for intraarticular steroids in juvenile arthritis.
J Rheumatol. 2012 Feb;39(2):374-6. Epub 2011 Dec 1.
Autmizguine J, Cohen-Wolkowiez M, Ilowite N, For The Rapport Investigators.
Rilonacept pharmacokinetics in children with systemic juvenile idiopathic arthritis.
J Clin Pharmacol. 2014 Jul 30. doi: 10.1002/jcph.372. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/25079592
Última actualización: 15 abril 2026
MARZO 2026
-
Wortmann C, Backes J, Rothaus K, Kasper M, Lapp T, Heinz C, Heiligenhaus A.
Cataract Surgery with IOL Implantation in Children with Chronic Anterior Uveitis Associated with Juvenile Idiopathic Arthritis (JIA) or Antinuclear Antibody (ANA)-Positive Uveitis: Mid-term Results and Predictors for Outcome.
Am J Ophthalmol. 2026 Mar;283:45-54. doi: 10.1016/j.ajo.2025.11.043.
https://pubmed.ncbi.nlm.nih.gov/41344531/ -
Pei M, Qian Y, Liu X, Zhao C, Gao F, Zhang M.
Visual prognosis of Behcet's uveitis patients in China and its associated factors.
Front Immunol. 2026 Mar 17;17:1617653. doi: 10.3389/fimmu.2026.1617653.
https://pubmed.ncbi.nlm.nih.gov/41924254/ -
Luo H, Chen B, Zhang X.
Novel application for the JAK inhibitor baricitinib in the treatment of Vogt-Koyanagi-Harada disease: a prospective cohort study.
Front Immunol. 2026 Mar 17;17:1736522. doi: 10.3389/fimmu.2026.1736522.
https://pubmed.ncbi.nlm.nih.gov/41924279/
FEBRERO 2026
-
Patel A, Acharya NR, Solebo AL.
Novel advances in juvenile idiopathic arthritis associated uveitis.
Arthritis Res Ther. 2026 Feb 27;28(1):62.
https://pubmed.ncbi.nlm.nih.gov/41761332/ -
Asghar E, Puthussery JC, de Boer J, Miraldi Utz V.
Paediatric Neoplastic Uveitis Masquerade Syndromes.
Ocul Immunol Inflamm. 2026 Feb;34(2):229-241.
https://pubmed.ncbi.nlm.nih.gov/41401403/
ENERO 2026
- Song BM, VanDevoorde R, Graham TB, Gangaputra S.
Early Initiation of TNF Inhibitors for Tubulointerstitial Nephritis and Uveitis (TINU).
Ocul Immunol Inflamm. 2026 Jan;34(1):184-188
https://pubmed.ncbi.nlm.nih.gov/41287192/
DICIEMBRE 2025
- Chung YR, Lam D, Mainguy A, Fardeau C, Couret C, Weber M et al.
Long-Term Effects of Adalimumab in Juvenile Idiopathic Arthritis-Associated Uveitis: 3- and 6-Year Results of the ADJUVITE Trial
Ocul Immunol Inflamm. 2025 Dec;33(10):2265-2271
https://pubmed.ncbi.nlm.nih.gov/40334099/ - Khan S, Saigal K, Sheth S, Maleki
A Intravenous Golimumab in the Treatment of Juvenile Idiopathic Arthritis and Its Associated Uveitis
Ocul Immunol Inflamm. 2025 Dec;33(10):2245–2249.
https://pubmed.ncbi.nlm.nih.gov/39207387/ - Zamani R, Tahghighi Sharabian F, Zamani Khorasgani A, Zarei M, Ziaee V
Patterns and Outcomes of Childhood Non-Infectious Uveitis: A Retrospective Cohort and Review of Literature
Ocul Immunol Inflamm. 2025 Dec;33(10):2279–2287
https://pubmed.ncbi.nlm.nih.gov/40674665/
SEPTIEMBRE 2025
-
Ramanan AV, Guly CM, Simonini G, Keller S, Sen P, Holzkaemper T, Araújo J, Quartier P.
Effectiveness and safety of baricitinib for juvenile idiopathic arthritis associated uveitis or chronic anterior antinuclear antibody positive uveitis.
Arthritis Care Res (Hoboken). 2025 Sep 14. doi: 10.1002/acr.25644. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40947519/ -
Sota J, Breda L, Paroli MP, Hashad S, de-la-Torre A, Guerriero S, et al.
Tocilizumab effectiveness in paediatric non-infectious uveitis: data from the International AIDA Network Registries on ocular inflammatory disorders.
Br J Ophthalmol. 2025 Sep 23;109(10):1151-1154. doi: 10.1136/bjo-2025-327410.
https://pubmed.ncbi.nlm.nih.gov/40413020/ -
Foeldvari I, Solebo A, Petrushkin H, Angeles-Han ST, Bangsgaard R, Calzada-Hernández J, Constantin T, de Boer J, Díaz-Cascajosa J, Glerup M, Ingels H, Kramer S, Miserocchi E, Nordal E, Saurenmann RK, Simonini G, Swart JF, Titz J, Antón J.
Monitoring of Juvenile Idiopathic Arthritis-Associated Uveitis in Long-Term Disease Remission: Consensus-Based Recommendations From the Multinational Interdisciplinary Working Group for Uveitis in Childhood.
Arthritis Care Res (Hoboken). 2025 Sep;77(9):1106-1111. doi: 10.1002/acr.25542.
https://pubmed.ncbi.nlm.nih.gov/40176504/ -
Marino A, Cicinelli MV, Miserocchi E, Costi S, Baldo F, Gattinara MV, et al.
Recurrence Risk in Pediatric Noninfectious Uveitis During Adalimumab Tapering: An International Multicenter Retrospective Study.
Arthritis Rheumatol. 2025 Sep;77(9):1254-1262. doi: 10.1002/art.43165.
https://pubmed.ncbi.nlm.nih.gov/40172495/ -
Lundgren P, Papadopoulou M, Jernkrok R, Abedi N, Karlsson E, Damgaard M, et al.
Juvenile idiopathic arthritis during 20 years in Sweden: Characteristics of children, therapy interventions, occurrence of uveitis and ocular complications.
Acta Ophthalmol. 2025 Sep;103(6):652-661. doi: 10.1111/aos.17466.
https://pubmed.ncbi.nlm.nih.gov/40028966/ -
Bezci Aygun F, Akgoz Koyuncuoglu M, Kadayıfcılar S, Ozen S.
Clinical characteristics and long-term outcomes of Vogt-Koyanagi-Harada disease in pediatric age group.
BMC Ophthalmol. 2025 Sep 26;25(1):509. doi: 10.1186/s12886-025-04334-y.
https://pubmed.ncbi.nlm.nih.gov/41013312/ -
Karaca I, Thng ZX, Bromeo A, Mobasserian A, Hung JH, Akhavanrezayat A et al
Efficacy and Safety of Biologics in Pediatric Noninfectious Retinal Vasculitis
Am J Ophthalmol. 2025 Sep;277:57-70. doi: 10.1016/j.ajo.2025.05.002.
https://pubmed.ncbi.nlm.nih.gov/40374140/
JULIO 2025
-
Peng X, Liu Q, Lin L, Dong L.
The incidence and risk factors of uveitis in children with juvenile idiopathic arthritis (JIA): a meta -analysis and literature review.
Pediatr Rheumatol Online J. 2025 Jul 14;23(1):71. doi: 10.1186/s12969-025-01122-2.
https://pubmed.ncbi.nlm.nih.gov/40660199/ -
Zamani R, Tahghighi Sharabian F, Zamani Khorasgani A, Zarei M, Ziaee V.
Patterns and Outcomes of Childhood Non-Infectious Uveitis: A Retrospective Cohort and Review of Literature.
Ocul Immunol Inflamm. 2025 Jul 17:1-9. doi: 10.1080/09273948.2025.2522297. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40674665/
JUNIO 2025
-
Yakovlev AA, Gaidar EV, Sorokina LS, Nikitina TN, Kalashnikova OV, Kostik MM.
Uveitis associated with juvenile idiopathic arthritis and chronic idiopathic uveitis in children: A retrospective cohort study.
World J Clin Pediatr. 2025 Jun 9;14(2):100336. doi: 10.5409/wjcp.v14.i2.100336.
https://pubmed.ncbi.nlm.nih.gov/40491729/ -
Ramanan PAV.
Pathogenesis and targets in uveitis.
Semin Arthritis Rheum. 2025 Jun;72S:152692. doi: 10.1016/j.semarthrit.2025.152692.
https://pubmed.ncbi.nlm.nih.gov/40055021/
ABRIL 2025
-
Foeldvari I, Solebo A, Petrushkin H, Angeles-Han ST, Bangsgaard R, Calzada-Hernández J, Constantin T, de Boer J, Díaz-Cascajosa J, Glerup M, Ingels H, Kramer S, Miserocchi E, Nordal E, Saurenmann RK, Simonini G, Swart JF, Titz J, Antón J.
Monitoring of Juvenile Idiopathic Arthritis-Associated Uveitis in Long-Term Disease Remission: Consensus-Based Recommendations From the Multinational Interdisciplinary Working Group for Uveitis in Childhood
Arthritis Care Res (Hoboken). 2025 Apr 2. doi: 10.1002/acr.25542. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40176504/ -
Gaggiano C, de-la-Torre A, Guerriero S, Costi S, Ragab G, Paroli MP, et al; AIDA Network.
Adalimumab Monotherapy or Combination Therapy With Methotrexate in Paediatric Uveitis: Data From the AIDA Network Uveitis Registry
Clin Exp Ophthalmol. 2025 Apr 4. doi: 10.1111/ceo.14534. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40181732/ -
Marino A, Cicinelli MV, Miserocchi E, Costi S, Baldo F, Gattinara MV, et al.
Recurrence Risk in Pediatric Non-Infectious Uveitis during Adalimumab Tapering: An International Multicenter Retrospective Study
Arthritis Rheumatol. 2025 Apr 2. doi: 10.1002/art.43165. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40172495/
MARZO 2025
-
Zhang H, Liu Y, Feng X, Ji X, Chen Q, Lum F, Gangaputra S.
Juvenile Idiopathic Arthritis Associated Anterior Uveitis Among Pediatric Patients in the IRIS Registry from 2013-2017.
Ocul Immunol Inflamm. 2025 Mar 31:1-8. doi: 10.1080/09273948.2025.2480658. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40163582/ -
Hong EH, Kim J, Kang MH, Park SW, Tran ANT, Karaca I, et al.
Epidemiologic Study of Pediatric Uveitis and its Ophthalmic Complications Using the Korean National Health Insurance Claim Database.
Am J Ophthalmol. 2025 Mar 14;275:1-13. doi: 10.1016/j.ajo.2025.03.019. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40089173/ -
Baquet-Walscheid K, Minden K, Niewerth M, Dressler F, Foeldvari I, Foell D, et al.
Course of uveitis in children with juvenile idiopathic arthritis (JIA): Five years follow-up data from a prospective multicenter Inception Cohort of Newly diagnosed patients with JIA (ICON-JIA) study
Arthritis Res Ther. 2025 Mar 20;27(1):61. doi: 10.1186/s13075-025-03531-w.
https://pubmed.ncbi.nlm.nih.gov/40114262/ -
Lundgren P, Papadopoulou M, Jernkrok R, Abedi N, Karlsson E, Damgaard M, et al.
Juvenile idiopathic arthritis during 20 years in Sweden: Characteristics of children, therapy interventions, occurrence of uveitis and ocular complications.
Acta Ophthalmol. 2025 Mar 3. doi: 10.1111/aos.17466. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40028966/ -
Maccora I, Wouters C, Rosè CD, Maniscalco V, de Masi S, Mastrolia MV, et al.
Treatment of uveitis in Blau syndrome: A systematic review and meta-analysis.
J Autoimmun. 2025 Mar 26;153:103401. doi: 10.1016/j.jaut.2025.103401. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40147219/ -
Vidic Krhlikar N, Tomšič M, Jaki Mekjavić P, Klobučar P, Vidović Valentinčič N.
Case report: Effectiveness of Janus kinase inhibitors in the management of isolated noninfectious uveitis: a case series
Front Pharmacol. 2025 Mar 6;16:1509404. doi: 10.3389/fphar.2025.1509404.
https://pubmed.ncbi.nlm.nih.gov/40115257/ -
Shunyakova J, Reynolds M, Taylor A, Sieck EG, Walsh JT, Hassman LM.
Case Report: ROSAH syndrome presents diagnostic and therapeutic challenges.
Front Ophthalmol (Lausanne). 2025 Mar 25;5:1535805. doi: 10.3389/fopht.2025.1535805.
https://pubmed.ncbi.nlm.nih.gov/40201710/
FEBRERO 2025
-
Solebo AL, Kellett S, McLoone E, Petrushkin H, Gonzalez-Martin J, Ashworth J, Choi J, Pilling RF, Armon K, Warrier K, Sharma SM, Rahi JS; Members of the UNICORNS (Uveitis in Childhood National Cohort Study) Group.
Incidence, sociodemographic and presenting clinical features of childhood non-infectious uveitis: findings from the UK national inception cohort study.
Br J Ophthalmol. 2025 Feb 13:bjo-2024-326674.
https://pubmed.ncbi.nlm.nih.gov/39933878/ -
Gülmez Sevim D, Sener H, Ozer F, Unlu M, Evereklioglu C.
Clinical Features, Complications, and Treatment Outcomes of Pediatric Pars Planitis Cases in a Tertiary Referral Center.
Ocul Immunol Inflamm. 2025 Feb 13:1-7.
https://pubmed.ncbi.nlm.nih.gov/39946199/ -
Sharon Y, Karchever K, Goren L, Rozanes E, Janetos T, Reitblat O, et al.
Pediatric Uveitis: Impact of Anti-Tumor Necrosis Factor-Alpha on Ocular Complications.
Ocul Immunol Inflamm. 2025 Feb 11:1-8.
https://pubmed.ncbi.nlm.nih.gov/39931957/ -
Gauderon A, Eandi C, Koryllou A, Hoogewoud F, Theodoropoulou K, Guex-Crosier Y.
Inflammatory Choroidal Neovascularization in Pediatric Uveitis: A Case Series.
Klin Monbl Augenheilkd. 2025 Feb 10. English. doi: 10.1055/a-2467-1804.
https://pubmed.ncbi.nlm.nih.gov/39929206/ -
Abroug N, Dridi T, Mourali M, Nabi W, Ksiaa I, Kechida M, et al.
Vitreous hemorrhage in patients with uveitis: a comparative study between adults and children.
Int Ophthalmol. 2025 Feb 7;45(1):60.
https://pubmed.ncbi.nlm.nih.gov/39918620/
DICIEMBRE 2024
-
Acharya NR, Ramanan AV, Coyne AB, Dudum KL, Rubio EM, Woods SM, et al; ADJUST Study Group.
Stopping of adalimumab in juvenile idiopathic arthritis-associated uveitis (ADJUST): a multicentre, double-masked, randomised controlled trial.
Lancet. 2025 Jan 25;405(10475):303-313. doi: 10.1016/S0140-6736(24)02468-1.
https://pubmed.ncbi.nlm.nih.gov/39863370/
DICIEMBRE 2024
-
Acharya NR, Ramanan AV, Coyne AB, Dudum KL, Rubio EM, Woods SM, et al; ADJUST Study Group.
Stopping of adalimumab in juvenile idiopathic arthritis-associated uveitis (ADJUST): a multicentre, double-masked, randomised controlled trial.
Lancet. 2025 Jan 25;405(10475):303-313. doi: 10.1016/S0140-6736(24)02468-1.
https://pubmed.ncbi.nlm.nih.gov/39863370/ -
Solebo AL, Foeldvari I.
Reducing the risk of visual disability for children with juvenile idiopathic arthritis uveitis through disease surveillance: past and future challenges.
Pediatr Rheumatol Online J. 2025 Jan 20;23(1):4. doi: 10.1186/s12969-024-01037-4.
https://pubmed.ncbi.nlm.nih.gov/39833902/ -
Iaccheri B, De Santi N, Cerquaglia A, Della Lena F, Bianchi E, Fruttini D, Gerli V, Chhablani J, Cagini C, Fiore T.
Choroidal vascularity analysis in patients with juvenile idiopathic arthritis without acute uveitis.
Clin Exp Rheumatol. 2025 Jan;43(1):145-150. doi: 10.55563/clinexprheumatol/nddba1. Epub 2024 Oct 3.
https://pubmed.ncbi.nlm.nih.gov/39360359/
DICIEMBRE 2024
-
Gunzinger JM, Kitay A, Meier F, Böni C, Palmer Sarott S, Simonsz-Tóth B, Gerth-Kahlert C.
Demography in Swiss paediatric uveitis: a retrospective cohort study.
J Ophthalmic Inflamm Infect. 2024 Dec 18;14(1):65. doi: 10.1186/s12348-024-00448-4.
https://pubmed.ncbi.nlm.nih.gov/39694956/ -
Riskalla MM, Barbar-Smiley FA, Marka NA, Lerman MA.
Uveitis treatment in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry: response to tumour necrosis factor inhibitors.
Clin Exp Rheumatol. 2024 Dec 20. doi: 10.55563/clinexprheumatol/08z0v4. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39711401/
NOVIEMBRE 2024
-
Mesa-Del-Castillo P, Yago Ugarte I, Bolarín JM, Martínez D, López Montesinos B, Barranco González H, et al.
Childhood-Onset Non-Infectious Uveitis in the "Biologic Era". Results From Spanish Multicenter Multidisciplinary Real-World Clinical Settings.
Ocul Immunol Inflamm. 2024 Nov;32(9):2159-2169. doi: 10.1080/09273948.2024.2336609.
https://pubmed.ncbi.nlm.nih.gov/38728578/ -
Maccora I, Altaye M, Greis KD, Brunner HI, Duell A, Haffey WD, Nguyen T, Quinlan-Waters M, Schulert GS, Sproles A, Utz VM, Thornton S, Angeles-Han ST.
Candidate Tear-Based Uveitis Biomarkers in Children with JIA Based on Arthritis Activity and Topical Corticosteroid Use.
Ocul Immunol Inflamm. 2024 Nov 25:1-10. doi: 10.1080/09273948.2024.2428846. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39586039/ -
Cheng H, Zhu H, Shen G, Cheng Y, Gong J, Deng J.
Ocular findings in neurosyphilis: a retrospective study from 2012 to 2022.
Front Neurol. 2024 Nov 28;15:1472274. doi: 10.3389/fneur.2024.1472274.
https://pubmed.ncbi.nlm.nih.gov/39669107/ -
Sharon Y, Ben-David G, Nisgav Y, Amarilyo G, Shapira G, Israel-Elgali I, et al.
MicroRNAs as Biomarkers for Uveitis in Juvenile Idiopathic Arthritis.
Ocul Immunol Inflamm. 2024 Nov 19:1-7. doi: 10.1080/09273948.2024.2428417. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39561030/ - Sriranganathan A, Grad J, Miranda RN, Dhillon J, Saleh S, Felfeli T.
Humanistic Burden of Noninfectious Uveitis: A Systematic Review and Meta-Analysis.
Am J Ophthalmol. 2024 Nov 9;271:43-59. doi: 10.1016/j.ajo.2024.10.027. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39522581/
OCTUBRE 2024
-
Chang MH, Barbar-Smiley F, Akoghlanian S, Drew J, Angeles-Han ST, Quinlan-Waters M, et al; CARRA Uveitis Workgroup and the CARRA Registry Investigators.
Implementation study of the CARRA Uveitis Consensus Treatment Plans: feasibility for clinical practice and applicability for research.
Pediatr Rheumatol Online J. 2024 Oct 7;22(1):88. doi: 10.1186/s12969-024-01022-x.
https://pubmed.ncbi.nlm.nih.gov/39375683/ -
Bajraktari G, Jukić T, Kalauz M, Oroz M, Bertetić AR, Vukojević N.
Evaluation of postoperative outcomes after cataract surgery in patients with Juvenile Idiopathic Arthritis-Associated Uveitis.
Eur J Ophthalmol. 2024 Oct 15:11206721241290272. doi: 10.1177/11206721241290272. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39403026/
SEPTIEMBRE 2024
-
Lavallee C, Ahrens M, Davidson S, Goheer H, Shuster A, Lerman MA.
Measurable Outcomes of an Ophthalmology and Rheumatology Coordinated Care Clinic.
Arthritis Care Res (Hoboken). 2024 Sep 15. doi: 10.1002/acr.25433. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39279137/ -
Juan HY, Sheu SJ, Hwang DK.
Review of Janus Kinase Inhibitors as Therapies for Noninfectious Uveitis.
J Ocul Pharmacol Ther. 2024 Sep 24. doi: 10.1089/jop.2024.0100. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39315932/ -
Shah SM, Prabhu P, Biswas J.
Intravitreal steroid implants in the management of noninfectious intermediate and posterior uveitis.
Indian J Ophthalmol. 2024 Sep 19. doi: 10.4103/IJO.IJO_712_24. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39297478/ -
Stolowy N, Aulanier A, Osswald D, Zanin E, Benso C, Attia R, et al.
Serum angiotensin-converting enzyme has low diagnostic value for pediatric sarcoid uveitis.
J Fr Ophtalmol. 2024 Sep 20;47(9):104292. doi: 10.1016/j.jfo.2024.104292. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39305654/ -
Maccora I, Simonini G, Guly CM, Ramanan AV.
Management of JIA associated uveitis.
Best Pract Res Clin Rheumatol. 2024 Sep;38(3):101979. doi: 10.1016/j.berh.2024.101979.
https://pubmed.ncbi.nlm.nih.gov/39048481/ -
Nasir S, Ali MH, Patel A, Kelgaonkar A, Nayak S, Tyagi M, Murthy S, Basu S.
Visual Impairment at Presentation in Pediatric Uveitis: A Multicentric Study in 477 Children Across Southern and Eastern India.
Ocul Immunol Inflamm. 2024 Sep 11:1-5. doi: 10.1080/09273948.2024.2401134. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39259662/
AGOSTO 2024
-
Khan S, Saigal K, Sheth S, Maleki A.
Intravenous Golimumab in the Treatment of Juvenile Idiopathic Arthritis and Its Associated Uveitis.
Ocul Immunol Inflamm. 2024 Aug 29:1-5. doi: 10.1080/09273948.2024.2391985.
https://pubmed.ncbi.nlm.nih.gov/39207387/
JULIO 2024
-
Del-Prado-Sánchez C, Llorca-Cardeñosa A, Yeste-Mayoral B, Grixolli-Mazzon S, Barros-Centeno MF, Díaz-Cascajosa J, Antón J, Calzada-Hernández J, Mosquera JM, Carriqui S, Zacarías A, Morales-Ballús M.
Optical coherence tomography for the screening of anterior chamber inflammation in paediatric patients diagnosed with juvenile idiopathic arthritis.
Clin Exp Rheumatol. 2024 Jul;42(7):1507-1512. doi: 10.55563/clinexprheumatol/t7pn4v. Epub 2024 May 21.
https://pubmed.ncbi.nlm.nih.gov/38819950/ -
Tordoff M, Smith SL, Lawson-Tovey S; UK JIA Biologics Register, CAPS, CHARMS, CLUSTER, JIAGC; Dick AD, Beresford MW, Ramanan AV, Hyrich KL, Morris AP, Eyre S, Wedderburn LR, Bowes J; CLUSTER consortium.
Integration of genetic and clinical risk factors improves the risk classification of uveitis in patients with juvenile idiopathic arthritis.
Arthritis Rheumatol. 2024 Jul 19. doi: 10.1002/art.42955. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39030878/ -
Maccora I, Accardo V, Cattalini M, Pagnini I, Taddio A, Marrani E, La Torre F, Mastrolia MV, Bellicini I, Pastore S, Simonini G.
Uveitis as predictor of disease flare after the first anti-TNF withdrawal in oligoarticular and polyarticular juvenile idiopathic arthritis: a multicentric Italian experience.
Clin Exp Rheumatol. 2024 Jul 4. doi: 10.55563/clinexprheumatol/3mxsll. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/38976296/ -
Gonçalves H, Alves S, Correia-Costa L, Miranda V, Zilhão C.
Non-infectious uveitis referred for pediatric rheumatologic assessment and management: A Portuguese retrospective study.
Mod Rheumatol. 2024 Jul 6;34(4):798-805. doi: 10.1093/mr/road083.
https://pubmed.ncbi.nlm.nih.gov/37572107/ -
Koru L, Esen F, Turkyilmaz O, Kucuk E, Kaya F, Aydin Z, Haslak F, Ozturk K.
Clinical characteristics of pediatric noninfectious uveitis and risk factors for severe disease: a single-center study.
Clin Rheumatol. 2024 Jul 27. doi: 10.1007/s10067-024-07072-6. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39066867/
MAYO 2024
-
Sota J, Guerriero S, Lopalco G, Tufan A, Ragab G, AlMaglouth I, et al.
Impact of HLA-B51 on Uveitis and Retinal Vasculitis: Data from the AIDA International Network Registries on Ocular Inflammatory Disorders.
Ocul Immunol Inflamm. 2024 May 17:1-8. doi: 10.1080/09273948.2024.2346815.
https://pubmed.ncbi.nlm.nih.gov/38759215/
ABRIL 2024
-
Foeldvari I, Bohn M, Petrushkin H, Angeles Han S, Bangsgaard R, Calzada-Hernández J, Constantin T, de Boer JH, Díaz-Cascajosa J, Edelsten C, Glerup M, Ingels H, Kramer S, Miserocchi E, Nordal E, Saurenmann RK, Simonini G, Solebo AL, Titz J, Anton J.
A practical approach to uveitis screening in children with juvenile idiopathic arthritis.
Br J Ophthalmol. 2024 Apr 4:bjo-2023-324406. doi: 10.1136/bjo-2023-324406. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/38575198/
MARZO 2024
-
Dutta Majumder P, Abraham S, Sudharshan S, Janarthanan M, Ramanan AV.
Tofacitinib for Refractory Uveitis and Scleritis in Children: A Case Series.
Ocul Immunol Inflamm. 2024 Mar 5:1-4. doi: 10.1080/09273948.2024.2323671. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/38441607/ -
Tarsia M, Vitale A, Gaggiano C, Sota J, Maselli A, Bellantonio C,et al.
Effectiveness and Safety of Biosimilars in Pediatric Non-infectious Uveitis: Real-Life Data from the International AIDA Network Uveitis Registry.
Ophthalmol Ther. 2024 Mar;13(3):761-774. doi: 10.1007/s40123-023-00863-1
https://pubmed.ncbi.nlm.nih.gov/38206518/ -
Zhong L, Wang W, Tang X, Zhang Y, Gou L, Wang L, et al.
Phenotype of Takayasu-like vasculitis and cardiopathy in patients with Blau syndrome.
Clin Rheumatol. 2024 Mar;43(3):1171-1181. doi: 10.1007/s10067-024-06876-w.
https://pubmed.ncbi.nlm.nih.gov/38253779/ -
Yargi-Ozkocak B, Altan C, Kemer-Atik B, Basarir B.
Evaluation of Optical Coherence Tomography Angiography Findings in Pars Planitis and Multiple Sclerosis Associated Intermediate Uveitis in Remission.
Curr Eye Res. 2024 Mar 3:1-8. doi: 10.1080/02713683.2024.2323520. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/38433455/ -
Garbrecht JL, Powell ZR, McClard CK, Noori J.
Frosted branch angiitis in a patient with systemic juvenile idiopathic arthritis: a case report.
BMC Ophthalmol. 2024 Mar 5;24(1):106. doi: 10.1186/s12886-024-03373-1.
https://pubmed.ncbi.nlm.nih.gov/38443873/
FEBRERO 2024
-
Chen WD, Wu CH, Wu PY, Lin CP, Ou LS, Hwang DK, et al.
Taiwan ocular inflammation society consensus recommendations for the management of juvenile idiopathic arthritis-associated uveitis.
J Formos Med Assoc. 2024 Feb 28:S0929-6646(24)00110-4. doi: 10.1016/j.jfma.2024.02.010.
https://pubmed.ncbi.nlm.nih.gov/38423923/ -
Mapelli C, Miserocchi E, Nassisi M, Beretta GB, Marelli L, Leone G, Marino A, Chighizola C, Cincinelli G, Giani T, Nucci P, Viola F, Filocamo G, Minoia F.
Predictors of lack of response to methotrexate in juvenile idiopathic arthritis associated uveitis.
Rheumatology (Oxford). 2024 Feb 8:keae079. doi: 10.1093/rheumatology/keae079.
https://pubmed.ncbi.nlm.nih.gov/38331409/ -
Zhang J, Zhou P, Hu S, Cai S, He T.
Causal inference between serum bilirubin levels and juvenile idiopathic arthritis-associated uveitis: A bidirectional Mendelian randomization study.
Health Sci Rep. 2024 Feb 1;7(2):e1847. doi: 10.1002/hsr2.1847.
https://pubmed.ncbi.nlm.nih.gov/38313187/ -
Rojas-Carabali W, Mejía-Salgado G, Villabona-Martínez V, Barraquer-López D, Cifuentes-González C, Marroquín G, Guarnizo Zuccardi PDR, de-la-Torre A.
Uveitis and Dry Eye Disease in Children: A Cross-Sectional Comparative Study.
Ocul Immunol Inflamm. 2024 Feb 20:1-7. doi: 10.1080/09273948.2024.2317416.
https://pubmed.ncbi.nlm.nih.gov/38376892/
ENERO 2024
-
Nguyen AT, Koné-Paut I, Dusser P.
Diagnosis and Management of Non-Infectious Uveitis in Pediatric Patients.
Paediatr Drugs. 2024 Jan;26(1):31-47. doi: 10.1007/s40272-023-00596-5.
https://pubmed.ncbi.nlm.nih.gov/37792254/ -
Tungsattayathitthan U, Tesavibul N, Choopong P, Treeratsakulchai C, Ngathaweesuk Y, Sanphan W, Boonsopon S.
Efficacy of golimumab in patients with refractory non-infectious panuveitis.
Sci Rep. 2024 Jan 25;14(1):2179. doi: 10.1038/s41598-024-52526-1.
https://pubmed.ncbi.nlm.nih.gov/38273077/ -
Ede K, Shishov M, Wershba E, Goswami N, Gorry S, Joseph M, Mirea L, O'Neil J.
Screening for juvenile idiopathic arthritis associated uveitis with laser flare photometry in the pediatric rheumatology office: a prospective observational study.
Pediatr Rheumatol Online J. 2024 Jan 26;22(1):22. doi: 10.1186/s12969-024-00961-9.
https://pubmed.ncbi.nlm.nih.gov/38279120/
DICIEMBRE 2023
-
Marino A, Marelli L, Nucci P, Caporali R, Miserocchi E.
Subcutaneous Tocilizumab in Juvenile Idiopathic Arthritis Associated Uveitis.
Ocul Immunol Inflamm. 2023 Dec;31(10):1997-2000. doi: 10.1080/09273948.2022.2161916.
https://pubmed.ncbi.nlm.nih.gov/36657742/ - Huard J, Mihailescu SD, Muraine M, Raymond S, Grall Lerosey M, Gueudry J.
Effectiveness and Safety of Weekly Adalimumab for Non-Infectious Chronic Anterior Uveitis in Children.
Ocul Immunol Inflamm. 2023 Dec;31(10):2039-2049. doi: 10.1080/09273948.2023.2279682.
https://pubmed.ncbi.nlm.nih.gov/37972236/ -
Khochtali S, Ozdal P, AlBloushi AF, Nabi W, Khairallah M.
Pediatric Pars Planitis: A Review.
Ocul Immunol Inflamm. 2023 Dec;31(10):1915-1929. doi: 10.1080/09273948.2023.2279683.
https://pubmed.ncbi.nlm.nih.gov/37976519/ -
Maghsoudlou P, Abraham AR, El-Ashry M, Chew C, Mohd N, Ramanan AV, Dick AD.
Uveitis Associated with Monogenic Autoinflammatory Syndromes in Children.
Ocul Immunol Inflamm. 2023 Dec;31(10):1930-1943. doi: 10.1080/09273948.2023.2282610.
https://pubmed.ncbi.nlm.nih.gov/38051595/ -
Yalçındağ FN, Özdal P, Özyazgan Y, Batıoğlu F, Tugal-Tutkun I; BUST Study Group.
Pediatric Uveitis in Turkey: The National Registry Report II.
Ocul Immunol Inflamm. 2023 Dec;31(10):1971-1977. doi: 10.1080/09273948.2022.2110900.
https://pubmed.ncbi.nlm.nih.gov/36083691/ -
Janetos TM, Lee PHA, Goldstein DA.
Tubulointerstitial Nephritis and Uveitis Syndrome in Pediatric Patients.
Ocul Immunol Inflamm. 2023 Dec;31(10):1955-1964. doi: 10.1080/09273948.2023.2279689.
https://pubmed.ncbi.nlm.nih.gov/37983806/ -
Dehoorne JL, Groth H, Carlé E, De Schrijver I, Sys C, Delbeke P, Kreps EO, Renson T, Bonroy C.
Defining a therapeutic range for adalimumab serum concentrations in the management of pediatric noninfectious uveitis, a step towards personalized treatment.
Pediatr Rheumatol Online J. 2023 Dec 20;21(1):148. doi: 10.1186/s12969-023-00928-2.
https://pubmed.ncbi.nlm.nih.gov/38124137/
NOVIEMBRE 2023
-
van Meerwijk C, Kuiper J, van Straalen J, Ayuso VK, Wennink R, Haasnoot AM, Kouwenberg C, de Boer J.
Uveitis Associated with Juvenile Idiopathic Arthritis.
Ocul Immunol Inflamm. 2023 Nov 15:1-9. doi: 10.1080/09273948.2023.2278060.
https://pubmed.ncbi.nlm.nih.gov/37966463/ -
Gentile P, Ragusa E, Bolletta E, De Simone L, Gozzi F, Cappella M, Fastiggi M, De Fanti A, Cimino L.
Epidemiology of Pediatric Uveitis.
Ocul Immunol Inflamm. 2023 Nov 3:1-10. doi: 10.1080/09273948.2023.2271988.
https://pubmed.ncbi.nlm.nih.gov/37922466/ -
Fukuda Y, Yawata N, Hasegawa E, Yamana S, Shirane M, Ito T, Takeda A, Sonoda M, Eguchi K, Ishimura M, Ohga S, Sonoda KH.
Clinical Features of Pediatric Uveitis at a Tertiary Referral Center in the Western Region of Japan.
Ocul Immunol Inflamm. 2023 Nov 2:1-7. doi: 10.1080/09273948.2023.2273363.
https://pubmed.ncbi.nlm.nih.gov/37917805/ -
Foeldvari I, Petrushkin H.
How should we approach management of childhood onset chronic anterior uveitis refractory to adalimumab?
Expert Rev Clin Immunol. 2023 Nov 21:1-10. doi: 10.1080/1744666X.2023.2284845.
https://pubmed.ncbi.nlm.nih.gov/37990508/
OCTUBRE 2023
-
Nguyen AT, Koné-Paut I, Dusser P.
Diagnosis and Management of Non-Infectious Uveitis in Pediatric Patients.
Paediatr Drugs. 2023 Oct 4. doi: 10.1007/s40272-023-00596-5. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37792254/ -
Kouwenberg CV, Spierings J, de Groot EL, de Boer JH, Kalinina Ayuso V.
Involvement of the systemic microcirculation in pediatric uveitis.
Pediatr Rheumatol Online J. 2023 Oct 2;21(1):109. doi: 10.1186/s12969-023-00896-7.
https://pubmed.ncbi.nlm.nih.gov/37784087/
SEPTIEMBRE 2023
-
Burlo F, Tumminelli C, Pastore S, Stocco G, Curci D, Lucafò M, et al.
Subcutaneous tocilizumab in the management of non-infectious uveitis in children: a brief report.
Pediatr Rheumatol Online J. 2023 Sep 12;21(1):99. doi: 10.1186/s12969-023-00883-y.
https://pubmed.ncbi.nlm.nih.gov/37700264/ -
Fonollosa A, Pelegrín L, García-Morillo S, Buján-Rivas S, Distefano L, Robles-Maruenda A, Fernández-Martín J, González-García A, Garcia-Aparicio Á, Ortego-Centeno N, Llorenç V, Sainz de la Maza M, Pinedo C, Sopeña B, Cocho L, Carreño E, Blanco R, Antón J, Pérez-Quintana M, Marques-Soares JR, Artaraz J, Ruiz-Arruza I, Soto-Peleteiro A, Gómez-Caverzaschi V, Araújo O, Espinosa G, Adan A, Fabiani C, Cantarini L, Hernández-Rodríguez J; Spanish Society of Ocular Inflammation (SEIOC) and the AutoInflammatory Diseases Alliance (AIDA) Network.
Ocular involvement in adult and paediatric patients with monogenic autoinflammatory diseases: a Spanish multicentre retrospective study.
Clin Exp Rheumatol. 2023 Sep 28. doi: 10.55563/clinexprheumatol/ukegcc. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37812477/ -
Değirmenci MFK, Yalçındağ FN.
Are optical coherence tomography and fluorescein angiography comparable for detection of macular edema in Behçet uveitis?
Graefes Arch Clin Exp Ophthalmol. 2023 Sep 29. doi: 10.1007/s00417-023-06249-0. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37773289/ -
Gupta RB, Ilin J, Gottlieb CC.
Efficacy of intravitreal dexamethasone implant used as monotherapy for the treatment of macular edema in non-infectious uveitis: a retrospective análisis
J Ophthalmic Inflamm Infect. 2023 Sep 18;13(1):42. doi: 10.1186/s12348-023-00360-3.
https://pubmed.ncbi.nlm.nih.gov/37721556/ -
Kemer Atik B, Altan C, Yargı Özkoçak B, Basarir B.
Clinical Features and Course in Patients Diagnosed with Ocular Sarcoidosis without Previously Known Systemic Disease at a Tertiary Referral Center in Turkey
Ocul Immunol Inflamm. 2023 Sep 27:1-7. doi: 10.1080/09273948.2023.2258397. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37756621/ -
Yılmaz Tuğan B, Sarıhan M, Kasap M, Akpınar G, Karabaş L, Şahin N, et al
Is tear proteome profile a predictor of developing uveitis in ANA-positive patients with oligoarticular juvenile idiopathic arthritis?
Graefes Arch Clin Exp Ophthalmol. 2023 Sep 29. doi: 10.1007/s00417-023-06251-6. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37773290/
JULIO 2023
-
Vitale A, Casa FD, Guerriero S, Ragab G, Mauro A, Caggiano V, et al.
Efficacy and Safety of Adalimumab in Pediatric Non-infectious Non-anterior Uveitis: Real-life Experience From the International AIDA Network Uveitis Registry.
Ophthalmol Ther. 2023 Aug;12(4):1957-1971. doi: 10.1007/s40123-023-00712-1. Epub 2023 May 11.
https://pubmed.ncbi.nlm.nih.gov/37166627/ -
Evereklioglu C, Sonmez HK, Sevim DG, Arda H, Sener H, Polat OA, Horozoglu F.
Adalimumab rapidly controls both anterior and posterior inflammation in patients with ocular Behçet syndrome and non-infectious uveitis refractory to conventional therapy: a prospective, 6-month follow-up investigation.
Int Ophthalmol. 2023 Aug 9. doi: 10.1007/s10792-023-02846-4. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37555889/ -
Gonçalves HJB, Zilhão C, Miranda V, Alves S, Correia L.
Non-infectious uveitis referred for pediatric rheumatologic assessment and management: a Portuguese retrospective study
Mod Rheumatol. 2023 Aug 12:road083. doi: 10.1093/mr/road083. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37572107/ -
Lafay C, Assad Z, Ouldali N, Quoc EB, Clement A, Durand C, Fares S, Faye A, Eveillard LA, Kaguelidou F, Titah C, Valtuille Z, Vinit C, Meinzer U, Dumaine C.
Increased Incidence of Pediatric Uveitis Associated with the COVID-19 Pandemic Occurring Before COVID-19 Vaccine Implementation: A Time-Series Analysis.
J Pediatr. 2023 Aug 21;263:113682. doi: 10.1016/j.jpeds.2023.113682. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37611738/ -
Ghadiri N, Injarie A.
Lights, camera, knowledge: Can patient education videos have a blockbuster impact in paediatric uveitis?
Eye (Lond). 2023 Aug 16. doi: 10.1038/s41433-023-02697-4. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37587375/
JULIO 2023
-
Maleki A, Patel PD, Foster CS.
Juvenile idiopathic arthritis and its associated uveitis.
Expert Rev Clin Immunol. 2023 Jul-Dec;19(9):1157-1169. doi: 10.1080/1744666X.2023.2231154. Epub 2023 Jul 4.
https://pubmed.ncbi.nlm.nih.gov/37401872/ -
Świerczyńska M, Tronina A, Filipek E.
Analysis of Peripapillary Retinal Nerve Fiber Layer Thickness in Acute Anterior Uveitis among Children with HLA-B27-Positive Juvenile Idiopathic Arthritis.
J Clin Med. 2023 Jul 22;12(14):4842. doi: 10.3390/jcm12144842.
https://pubmed.ncbi.nlm.nih.gov/37510957/
JUNIO 2023
-
Vitale A, Casa FD, Guerriero S, Ragab G, Mauro A, Caggiano V, et al.
Efficacy and Safety of Adalimumab in Pediatric Non-infectious Non-anterior Uveitis: Real-life Experience From the International AIDA Network Uveitis Registry.
Ophthalmol Ther. 2023 May 11. doi: 10.1007/s40123-023-00712-1. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37166627/ -
Quartier P, Saadoun D, Belot A, Errera MH, Kaplanski G, Kodjikian L, et al.
French recommendations for the management of non-infectious chronic uveitis.
Rev Med Interne. 2023 May;44(5):227-252. doi: 10.1016/j.revmed.2023.04.002. Epub 2023 May 3.
https://pubmed.ncbi.nlm.nih.gov/37147233/ -
Maccora I, Land P, Miraldi Utz V, Angeles-Han ST.
Therapeutic potential of JAK inhibitors in juvenile idiopathic arthritis-associated uveitis.
Expert Rev Clin Immunol. 2023 May 11:1-4. doi: 10.1080/1744666X.2023.2207823. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37114341/ -
Martins A, Ganhão S, Oliveira Pinheiro F, Granjo Morais C, Rodrigues M, Leuzinger-Dias M, Figueira L, Brito I.
Uveitis in patients with oligoarticular juvenile idiopathic arthritis and juvenile spondyloarthritis/enthesitis related arthritis: is there any difference?
Reumatismo. 2023 May 8;75(1). doi: 10.4081/reumatismo.2023.1561.
https://pubmed.ncbi.nlm.nih.gov/37154253/ -
Sivakoti P, Swaminathan M, Magesan K, Pyare R, George AE, Ganesh SK, Biswas J, Dutta Majumder P.
Visual outcome in pediatric uveitis: A retrospective data review in 277 children.
Indian J Ophthalmol. 2023 May;71(5):2158-2161. doi: 10.4103/ijo.IJO_1993_22.
https://pubmed.ncbi.nlm.nih.gov/37203097/
MARZO 2023
-
van Straalen JW, Akay G, Kouwenberg CV, de Roock S, Kalinina Ayuso V, Wulffraat NM, de Boer J, Swart JF.
Methotrexate therapy associated with a reduced rate of new-onset uveitis in patients with biological-naïve juvenile idiopathic arthritis
RMD Open. 2023 Apr;9(2):e003010. doi: 10.1136/rmdopen-2023-003010.
https://pubmed.ncbi.nlm.nih.gov/37094979/ -
Maccora I, Land P, Miraldi Utz V, Angeles-Han ST.
Therapeutic potential of JAK inhibitors in juvenile idiopathic arthritis-associated uveitis.
Expert Rev Clin Immunol. 2023 Apr 28. doi: 10.1080/1744666X.2023.2207823. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37114341/ -
Maccora I, Marrani E, Pagnini I, Mastrolia MV, de Libero C, Caputo R, Simonini G.
Challenges and management of childhood noninfectious chronic uveitis.
Expert Rev Clin Immunol. 2023 Apr 3:1-13. doi: 10.1080/1744666X.2023.2198210. Online ahead of print.PMID: 36996498
https://pubmed.ncbi.nlm.nih.gov/36996498/
FEBRERO 2023
-
Iannone C, Marelli L, Costi S, Pellico MR, La Franca L, Caporali R, Miserocchi E.
Tocilizumab in Juvenile Idiopathic Arthritis Associated Uveitis, a Narrative Review.
Children (Basel). 2023 Feb 23;10(3):434. doi: 10.3390/children10030434.
https://pubmed.ncbi.nlm.nih.gov/36979992/ -
Rodier-Bonifas C, Rochet E, Seve P, Duquesne A, Nguyen AM, Denis P, et al.
Uveitis in children: Epidemiological, clinical and prognostic characteristics
J Fr Ophtalmol. 2023 Feb;46(2):163-172. doi: 10.1016/j.jfo.2022.08.005.
https://pubmed.ncbi.nlm.nih.gov/36642594/ -
Oliveira Pinheiro F, Leuzinger-Dias M, Fernandes BM, Fonseca D, Vilaça J, Figueira L, Brito I.
Outcome of Uveitis in Juvenile Idiopathic Arthritis and Spondyloarthritis Patients - A 5-Year Follow-Up Study.
ARP Rheumatol. 2023 Feb 26. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36842134/ -
Corredores J, Vofo B, Amer R.
Uveitis in Children: The Role of Biological Agents in Its Management.
Biomedicines. 2023 Feb 20;11(2):629. doi: 10.3390/biomedicines11020629.
https://pubmed.ncbi.nlm.nih.gov/36831165/ -
Alarfaj G, Alahmadi G, Alabdullah H, Al-Khars W, Al-Hammad F.
Pattern of Uveitis at a Tertiary Eye Hospital in Eastern Province of Saudi Arabia and Comparison with Local Literature.
Ocul Immunol Inflamm. 2023 Feb 6:1-5. doi: 10.1080/09273948.2022.2128822.
https://pubmed.ncbi.nlm.nih.gov/36745705/ -
van Meerwijk CLLI, Wieringa WG, de Boer JH, Jansonius NM, Los LI.
Factors Associated With Glaucoma Surgery in Pediatric Non-Infectious Uveitis
Ocul Immunol Inflamm. 2023 Feb 2:1-6. doi: 10.1080/09273948.2023.2166849.
https://pubmed.ncbi.nlm.nih.gov/36731522/
ENERO 2023
-
Markomichelakis NN, Aissopou EK, Chatzistefanou KI.
Pediatric Non-Infectious Uveitis: Long-Term Outcomes and Complications.
Ocul Immunol Inflamm. 2023 Jan 24:1-8. doi: 10.1080/09273948.2022.2162422. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36693268/
DICIEMBRE 2022
-
Kim BH, Chang IB, Lee S, Oh BL, Hong IH.
Incidence and Prevalence of Pediatric Noninfectious Uveitis in Korea: A Population-Based Study
J Korean Med Sci. 2022 Dec 19;37(49):e344. doi: 10.3346/jkms.2022.37.e344.
https://pubmed.ncbi.nlm.nih.gov/36536545/ - Leinonen S.
A Nordic screening guideline for juvenile idiopathic arthritis-related uveitisActa Ophthalmol. 2022 Dec 2. doi: 10.1111/aos.15299. Online ahead of print.
NOVIEMBRE 2022
-
Bison HS, Janetos TM, Gao HM, Zhang DL, Song J, Bohnsack BL.
Comparison of Uveitis Incidence by Medication in Juvenile Idiopathic Arthritis and Implications for Screening.
Am J Ophthalmol. 2022 Nov 11;247:70-78. doi: 10.1016/j.ajo.2022.11.010. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36375593/ -
Angeles-Han ST, Srivastava SK.
Screening, Monitoring, and Treating Children with Juvenile Idiopathic Arthritis-Associated Uveitis: Visualizing Better Outcomes.
J Rheumatol. 2022 Nov 15:jrheum.221092. doi: 10.3899/jrheum.221092. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36379581/ -
Karaca I, Uludag G, Matsumiya W, Regenold J, Or C, Mobasserian A, Halim MS, Zaidi M, Lajevardi S, Dongchau A, Ghoraba H, Nguyen QD.
Six-month outcomes of infliximab and tocilizumab therapy in non-infectious retinal vasculitis.
Eye (Lond). 2022 Nov 28. doi: 10.1038/s41433-022-02315-9. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36443499/ -
Babel AT, Chin EK, Almeida DRP.
Long-Acting Fluocinolone Acetonide Intravitreal Implant for Recurrent Bilateral Non-Infectious Posterior Uveitis.
Int Med Case Rep J. 2022 Nov 22;15:665-669. doi: 10.2147/IMCRJ.S384356.
https://pubmed.ncbi.nlm.nih.gov/36444172/ -
Guerriero S, Palmieri R, Craig F, La Torre F, Albano V, Alessio G, et al.
Psychological Effects and Quality of Life in Parents and Children with JIA-Associated Uveitis.
Children (Basel). 2022 Nov 30;9(12):1864. doi: 10.3390/children9121864.
https://pubmed.ncbi.nlm.nih.gov/36553308/
OCTUBRE 2022
-
Berard R, Ng HY, Human A, Piskin D, Dhalla M, Gottlieb C, et al.
Canadian Rheumatology Association Recommendations for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-associated Uveitis.
J Rheumatol. 2022 Oct 15:jrheum.220261. doi: 10.3899/jrheum.220261. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36243417/
AGOSTO 2022
-
Shivpuri A, Turtsevich I, Solebo AL, Compeyrot-Lacassagne S.
Pediatric uveitis: Role of the pediatrician
Front Pediatr. 2022 Aug 1;10:874711. doi: 10.3389/fped.2022.874711. eCollection 2022.
https://pubmed.ncbi.nlm.nih.gov/35979409/ -
Van Straalen JW, Kearsley-Fleet L, Klotsche J, De Roock S, Minden K, Heiligenhaus A, et al; Paediatric Rheumatology International Trials Organisation (PRINTO), UK CAPS study and German ICON study.
Development and external validation of a model predicting new-onset chronic uveitis at different disease durations in juvenile idiopathic arthritis
Arthritis Rheumatol. 2022 Aug 23. doi: 10.1002/art.42329.
https://pubmed.ncbi.nlm.nih.gov/36054539/ -
McCracken C, Shantha JG, Yeh S, Jenkins K, Rouster-Stevens KA, Lambert SR, Prahalad S, Drews-Botsch C, Angeles-Han ST.
Relapse and Remission in Children With Chronic Noninfectious Uveitis Treated With Methotrexate
J Rheumatol. 2022 Aug 15:jrheum.220007. doi: 10.3899/jrheum.220007.
https://pubmed.ncbi.nlm.nih.gov/35970521/ -
Gaggiano C, Berlengiero V, Vitale A, Tarsia M, Grosso S, Tosi GM, Ricci F, Sota J, Caggiano V, Frediani B, Cantarini L, Cattalini M, Fabiani C.
The Role of Biologic Agents in the Management of Pediatric-Onset Noninfectious Posterior Scleritis
Ocul Immunol Inflamm. 2022 Aug 5:1-7. doi: 10.1080/09273948.2022.2106577.
https://pubmed.ncbi.nlm.nih.gov/35930360/ -
Paroli MP, Cappiello D, Staccini D, Caccavale R, Paroli M.
Tubulointerstitial Nephritis and Uveitis Syndrome (TINU): A Case Series in a Tertiary Care Uveitis Setting.
J Clin Med. 2022 Aug 25;11(17):4995. doi: 10.3390/jcm11174995.
https://pubmed.ncbi.nlm.nih.gov/36078924/
JULIO 2022
-
Skarin A, Berthold E, Rauer O, Bengtsson-Stigmar E.
Uveitis associated with juvenile arthritis: a continued cohort study 40 years after uveitis onset.
Pediatr Rheumatol Online J. 2022 Jul 8;20(1):47. doi: 10.1186/s12969-022-00704-8. PMID: 35804416; PMCID: PMC9264563.
https://pubmed.ncbi.nlm.nih.gov/35804416/ -
Utz VM, Angeles-Han ST, Mwase N, Cassedy A, Hennard T, Lovell DJ, et al.
Alternative Biologic Therapy in Children Failing Conventional TNFα Inhibitors for Refractory, Non-Infectious, Chronic Anterior Uveitis.
Am J Ophthalmol. 2022 Jul 18:S0002-9394(22)00264-1. doi: 10.1016/j.ajo.2022.06.024. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35863492/ -
Alnahdi MA, Alkharashi M.
Ocular manifestations of COVID-19 in the pediatric age group.
Eur J Ophthalmol. 2022 Jul 27:11206721221116210. doi: 10.1177/11206721221116210. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35898182/
JUNIO 2022
-
Li B, Yang L, Bai F, Tong B, Liu X.
Indications and effects of biological agents in the treatment of noninfectious uveitis.
Immunotherapy. 2022 Jun 13. doi: 10.2217/imt-2021-0303. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35695019/ -
Huynh E, Elhusseiny AM, Nihalani BR.
Paediatric anterior uveitis management in the USA: a single-centre, 10-year retrospective chart review exploring the efficacy and safety of systemic immunomodulatory therapy.
Eye (Lond). 2022 Jun 1. doi: 10.1038/s41433-022-02121-3. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35650322/
MAYO 2022
-
Foeldvari I, Maccora I, Petrushkin H, Rahman N, Anton J, de Boer J, Calzada-Hernández J, et al.
New and updated recommendations for the treatment of juvenile idiopathic arthritis associated uveitis and idiopathic chronic anterior uveitis.
Arthritis Care Res (Hoboken). 2022 May 31. doi: 10.1002/acr.24963. Epub ahead of print. PMID: 35638697.
https://pubmed.ncbi.nlm.nih.gov/35638697/ -
Kouwenberg CV, Wennink RAW, Shahabi M, Bozkir I, Ayuso VK, de Boer JH.
Clinical Course and Outcome in Pediatric Idiopathic Chronic Anterior Uveitis.
Am J Ophthalmol. 2022 May 2;241:198-205. doi: 10.1016/j.ajo.2022.04.015. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35513031/
ABRIL 2022
-
Maccora I, Abu Rumeileh S, Curci F, de Libero C, Marrani E, Mastrolia MV, Pagnini I, Simonini.
Tocilizumab and Abatacept for the Treatment of Childhood Chronic Uveitis: A Monocentric Comparison Experience.
G.Front Pediatr. 2022 Apr 12;10:851453. doi: 10.3389/fped.2022.851453. eCollection 2022
https://pubmed.ncbi.nlm.nih.gov/35498797/ -
Paroli MP, Abbouda A, Albanese G, Accorinti M, Falcione A, Spadea L, Paroli M.
Persistence of Juvenile Idiopathic Arthritis-Associated Uveitis in Adulthood: A Retrospective Study.
J Clin Med. 2022 Apr 28;11(9):2471. doi: 10.3390/jcm11092471.
https://pubmed.ncbi.nlm.nih.gov/35566597/
MARZO 2022
-
Hwang DK, Hung JH, Chang YC, Chen CL, Chen SN, Cheng CK, et al.
Step-wise diagnostic approach for patients with uveitis - Experts consensus in Taiwan.
J Microbiol Immunol Infect. 2022 Mar 18:S1684-1182(22)00029-9. doi: 10.1016/j.jmii.2022.02.003. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35361552/ -
Eurelings LEM, Missotten TOAR, van Velthoven MEJ, van DaeLe PLA, van Laar JAM, van Hagen PM, Thiadens AAHJ, Rombach SM.
Long-term follow-up of patients with uveitis treated with adalimumab: response rates and reasons for discontinuation of therapy.
Am J Ophthalmol. 2022 Mar 18:S0002-9394(22)00108-8. doi: 10.1016/j.ajo.2022.03.017. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35314190/ -
Osswald D, Rameau AC, Terzic J, Sordet C, Bourcier T, Sauer A.
Risk Factors Leading to Anti-TNF Alpha Therapies in Pediatric Severe Uveitis.
Front Pediatr. 2022 Mar 4;10:802977. doi: 10.3389/fped.2022.802977.
https://pubmed.ncbi.nlm.nih.gov/35311049/ -
Zhong Z, Ding J, Su G, Liao W, Gao Y, Zhu Y, Deng Y, Li F, Du L, Gao Y, Yang P.
Genetic and Clinical Features of Blau Syndrome among Chinese Patients with Uveitis.
Ophthalmology. 2022 Mar 18:S0161-6420(22)00209-3. doi: 10.1016/j.ophtha.2022.03.014. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35314268/
FEBRERO 2022
-
Maalouf G, Andrillon A, Leclercq M, Sève P, Bielefeld P, Gueudry J, Sené T, Titah C, Moulinet T, Rouvière B, Sène D, Desbois AC, Domont F, Touhami S, Thibault T, Chamieh CE, Cacoub P, Kodjikian L, Biard L, Bodaghi B, Saadoun D.
Lower relapses rate with infliximab versus adalimumab in sight threatening uveitis: a multicenter study of 330 patients.
Am J Ophthalmol. 2022 Feb 13:S0002-9394(22)00049-6. doi: 10.1016/j.ajo.2022.02.002.
https://pubmed.ncbi.nlm.nih.gov/35172172/ -
Tarsia M, Gaggiano C, Gessaroli E, Grosso S, Tosi GM, Frediani B, Cantarini L, Fabiani C.
Pediatric Scleritis: An Update.
Ocul Immunol Inflamm. 2022 Feb 28:1-10. doi: 10.1080/09273948.2021.2023582.
https://pubmed.ncbi.nlm.nih.gov/35226583/ -
Gaggiano C, Tarsia M, Tosi GM, Grosso S, Frediani B, Cantarini L, Fabiani C.
Adalimumab for refractory idiopathic scleritis in children.
Clin Exp Rheumatol. 2022 Feb 1. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35238748/
ENERO 2022
-
Walscheid K, Rothaus K, Niewerth M, Klotsche J, Minden K, Heiligenhaus A.
Occurrence and risk factors of uveitis in juvenile psoriatic arthritis: Data from a population-based nationwide study in Germany.
J Rheumatol. 2022 Jan 15:jrheum.210755. doi: 10.3899/jrheum.210755.
https://pubmed.ncbi.nlm.nih.gov/35034000/ -
Samalia P, Sims J, Deva N.
Idiopathic Retinal Vasculitis, Aneurysms and Neuroretinitis: Clinical Improvement with Infliximab.
Ocul Immunol Inflamm. 2022 Jan 26:1-8. doi: 10.1080/09273948.2022.2027466.
https://pubmed.ncbi.nlm.nih.gov/35081005/ -
Casa FD, Vitale A, Guerriero S, Sota J, Cimaz R, Ragab G, et al.
Development and Implementation of the AIDA International Registry for Patients with Non-Infectious Uveitis.
Ophthalmol Ther. 2022 Jan 31. doi: 10.1007/s40123-022-00459-1.
https://pubmed.ncbi.nlm.nih.gov/35099782/
DICIEMBRE 2021
-
Wen J, Hu H, Chen M, Yang H, Zhao Y, Liu Y.
Role of Janus Kinase (JAK) Inhibitor in Autoimmune Ocular Inflammation: A Systematic Review.
J Immunol Res. 2021 Dec 20;2021:2324400. doi: 10.1155/2021/2324400. eCollection 2021.
https://pubmed.ncbi.nlm.nih.gov/34966823/ -
Diala FJ, McCarthy K, Chen JL, Tsui E.
Multimodal imaging in pediatric uveitis.
Ther Adv Ophthalmol. 2021 Dec 6;13:25158414211059244. doi: 10.1177/25158414211059244. eCollection Jan-Dec 2021.
https://pubmed.ncbi.nlm.nih.gov/34901748/ -
Chevalier A, Duflos C, Clave S, Boyer O, Hogan J, Lahoche A et al.
Renal Prognosis in Children with Tubulointerstitial Nephritis and Uveitis Syndrome.
Kidney Int Rep. 2021 Oct 7;6(12):3045-3053. doi: 10.1016/j.ekir.2021.09.017. eCollection 2021 Dec.
https://pubmed.ncbi.nlm.nih.gov/34901573/
NOVIEMBRE 2021
-
AlBloushi AF, Solebo AL, Gokhale E, Al-Hayouti H, Ajamil-Rodanes S, Petrushkin H.
Long Term Outcomes of Pediatric Idiopathic Intermediate Uveitis: Outcomes of Pediatric Intermediate Uveitis.
Am J Ophthalmol. 2021 Nov 12:S0002-9394(21)00584-5. doi: 10.1016/j.ajo.2021.11.003
https://pubmed.ncbi.nlm.nih.gov/34780797/ -
Chang MH, Shantha JG, Fondriest JJ, Lo MS, Angeles-Han ST.
Uveitis in Children and Adolescents.
Rheum Dis Clin North Am. 2021 Nov;47(4):619-641. doi: 10.1016/j.rdc.2021.07.005.
https://pubmed.ncbi.nlm.nih.gov/34635295/ -
Maccora I, Marrani E, Mastrolia MV, Abu-Rumeileh S, Maniscalco V, Fusco E, Barbati F, Pagnini I, Simonini G.
Ocular involvement in monogenic autoinflammatory disease.
Autoimmun Rev. 2021 Nov;20(11):102944. doi: 10.1016/j.autrev.2021.102944.
https://pubmed.ncbi.nlm.nih.gov/34509650/
OCTUBRE 2021
-
Alafaleq M, Freund R, Penet MA, Fardeau C, Isnard-Bagnis C, Tezenas du Montcel S, et al.
Ciclosporin A in bilateral auto-immune chronic posterior uveitis associated with macular oedema: a Long-term Observational Safety and Efficacy Study.
Eye (Lond). 2021 Oct 30. doi: 10.1038/s41433-021-01829-y. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34718340/ -
Seepongphun U, Sittivarakul W, Dangboon W, Chotipanvithayakul R.
The Pattern of Uveitis in a Pediatric Population at a Tertiary Center in Thailand
Ocul Immunol Inflamm. 2021 Oct 22:1-9. doi: 10.1080/09273948.2021.1980814. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34686121/ -
Ramanan AV, Guly CM, Keller SY, Schlichting DE, de Bono S, Liao R, Quartier P.
Clinical effectiveness and safety of baricitinib for the treatment of juvenile idiopathic arthritis-associated uveitis or chronic anterior antinuclear antibody-positive uveitis: study protocol for an open-label, adalimumab active-controlled phase 3 clinical trial (JUVE-BRIGHT).
Trials. 2021 Oct 9;22(1):689.doi: 10.1186/s13063-021-05651-5.
https://pubmed.ncbi.nlm.nih.gov/34627340/ -
Cooper AM, Flanagan ER, Ronis T, Goldberg B, Sherman AK, Smith C, Holland GN; CARRA Uveitis Workgroup.
Knowledge about juvenile idiopathic arthritis-associated uveitis: more frequent reminders are associated with higher patient and family uveitis knowledge.
Pediatr Rheumatol Online J. 2021 Oct 2;19(1):149. doi: 10.1186/s12969-021-00639-6.
https://pubmed.ncbi.nlm.nih.gov/34600529/
SEPTIEMBRE 2021
-
Molimard J, Pajot C, Olle P, Belot A, Quartier P, Uettwiller F, Couret C, Coste V, Costet C, Bodaghi B, Dureau P, Bailhache M, Pillet P.
Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practice.
Pediatr Rheumatol Online J. 2021 Sep 3;19(1):139. doi: 10.1186/s12969-021-00626-x.
https://pubmed.ncbi.nlm.nih.gov/34479590/ -
Tirelli F, Shafer BM, Davidson SL, Lerman MA.
Immunomodulation and TNF-alpha inhibition for tubulointerstitial nephritis and uveitis syndrome: a case series.
J AAPOS. 2021 Sep 29:S1091-8531(21)00536-X. doi: 10.1016/j.jaapos.2021.03.017. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34600106/ -
Xiong A, Liu D, Chen H, Yang G, Xiong C, Shuai Y, He L, Guo Z, Zhang L, Yang Y, Cui B, Shuai S.
The Efficacy and Safety of Infliximab in Refractory Noninfectious Uveitis: A Meta-Analysis of Observational Studies.
Front Pharmacol. 2021 Sep 16;12:620340. doi: 10.3389/fphar.2021.620340. eCollection 2021.
https://pubmed.ncbi.nlm.nih.gov/34603013/ -
Kouwenberg CV, Koopman-Kalinina Ayuso V, de Boer JH.
Clinical benefits and potential risks of adalimumab in non-JIA chronic paediatric uveitis.
Acta Ophthalmol. 2021 Sep 16. doi: 10.1111/aos.15012. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34532967/ -
Norcia LF, Kiappe OP, Jorge EC.
Biological Therapy in Noninfectious Pediatric Uveitis: A Systematic Review.
Clin Ophthalmol. 2021 Sep 7;15:3765-3776. doi: 10.2147/OPTH.S322445. eCollection 2021.
https://pubmed.ncbi.nlm.nih.gov/34522080/
AGOSTO 2021
-
Sota J, Gentileschi S, Perfetti MO, Frediani B, Tosi GM, Cantarini L, Fabiani C.
Role of Adalimumab Biosimilar in the Treatment of Non-Anterior Uveitis Associated with Behcet's Syndrome.
Ophthalmol Ther. 2021 Aug 30. doi: 10.1007/s40123-021-00387-6. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34458968/ -
Lanz S, Seidel G, Skrabl-Baumgartner A
Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab.
Pediatr Rheumatol Online J. 2021 Aug 21;19(1):132. doi: 10.1186/s12969-021-00630-1.
https://pubmed.ncbi.nlm.nih.gov/34419092/
JULIO 2021
-
Sözeri B, Kardeş E, Salı E, Çakır D, Demir F.
Drug survival of the infliximab biosimilar (CT-P13) in paediatric patients with non-infectious uveitis.
Clin Exp Rheumatol. 2021 Jul-Aug;39(4):907-912. Epub 2021 Feb 9. PMID: 33635217.
https://pubmed.ncbi.nlm.nih.gov/33635217/ -
Wennink RAW, de Boer JH, Hiddingh S, Haasnoot AJW, Kalinina Ayuso V, de Hoop T, van Setten J, Spierings E, Kuiper JJW.
Next-Generation HLA Sequence Analysis Uncovers Shared Risk Alleles Between Clinically Distinct Forms of Childhood Uveitis.
Invest Ophthalmol Vis Sci. 2021 Jul 1;62(9):19. doi: 10.1167/iovs.62.9.19.
https://pubmed.ncbi.nlm.nih.gov/34254975/ -
Heaney A, McLoone E, Williams M, Silvestri G, Courtney AE, O'Rourke D, McAvoy CE.
Tubulointerstitial nephritis and uveitis in Northern Ireland.
Eye (Lond). 2021 Jul 29. doi: 10.1038/s41433-021-01677-w. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34326494/
JUNIO 2021
-
Joanne Thomas, Sanjana Kuthyar, Jessica G Shantha, Sheila T Angeles-Han, Steven Yeh.
Update on biologic therapies for juvenile idiopathic arthritis-associated uveítis.
Ann Eye Sci. 2021 Jun;6:19. doi: 10.21037/aes-2019-dmu-10. Epub 2021 Jun 15.
https://pubmed.ncbi.nlm.nih.gov/34131629/ -
Elena Bolletta, Marco Coassin, Danilo Iannetta et al.
Cataract Surgery with Intraocular Lens Implantation in Juvenile Idiopathic Arthritis-Associated Uveitis: Outcomes in the Era of Biological Therapy.
J Clin Med. 2021 May 31;10(11):2437. doi: 10.3390/jcm10112437.
https://pubmed.ncbi.nlm.nih.gov/34072679/ -
Quartier P.
Juvenile Idiopathic Arthritis-Associated Chronic Uveitis: Recent Therapeutic Approaches.
J Clin Med. 2021 Jun 30;10(13):2934. doi: 10.3390/jcm10132934.
https://pubmed.ncbi.nlm.nih.gov/34208973/
MAYO 2021
-
Bolletta E, Coassin M, Iannetta D, et al.
Cataract Surgery with Intraocular Lens Implantation in Juvenile Idiopathic Arthritis-Associated Uveitis: Outcomes in the Era of Biological Therapy.
J Clin Med. 2021;10(11):2437. Published 2021 May 31. doi:10.3390/jcm10112437
https://pubmed.ncbi.nlm.nih.gov/34072679/
ABRIL 2021
-
Shin Y, Kang JM, Lee J, Lee CS, Lee SC, Ahn JG.
Epidemiology of pediatric uveitis and associated systemic diseases.
Pediatr Rheumatol Online J. 2021 Apr 1;19(1):48.
https://pubmed.ncbi.nlm.nih.gov/33794945/ -
Wong Chung JERE, Engin Ö, Wolfs TFW, Renson TJC, de Boer JH.
Anterior uveitis in paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2.
Lancet. 2021 Apr 3;397(10281):e10. doi: 10.1016/S0140-6736(21)00579-1
https://pubmed.ncbi.nlm.nih.gov/33812491/
MARZO 2021
-
Papasavvas I, Herbort CP Jr.
Granulomatous Features in Juvenile Idiopathic Arthritis-Associated Uveitis is Not a Rare Occurrence.
Clin Ophthalmol. 2021 Mar 8;15:1055-1059. doi: 10.2147/OPTH.S299436.
https://pubmed.ncbi.nlm.nih.gov/33727787/ -
Miserocchi E, Giuffre C, Caporali R, Favalli EG.
Secukinumab in HLA-B27 associated uveitis.
Clin Exp Ophthalmol. 2021 Mar 20. doi: 10.1111/ceo.13922. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/33742762/ -
Sota J, Gentileschi S, Vitale A, Gaggiano C, De Bartolo G, Bianco MT, et al.
Effectiveness of SB5, an Adalimumab Biosimilar, in Patients With Noninfectious Uveitis: A Real-Life Monocentric Experience.
Asia Pac J Ophthalmol (Phila). 2021 Mar 19. doi: 10.1097/APO.0000000000000380. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/33756492/ -
Li Y, Mao X, Tang X, Mao H.
Efficacy and Safety of Anti-TNFalpha Therapy for Uveitis Associated with Juvenile Idiopathic Arthritis: A Systematic Review and Meta-Analysis.
Rheumatol Ther. 2021 Mar 15. doi: 10.1007/s40744-021-00296-x.
https://pubmed.ncbi.nlm.nih.gov/33721267/ -
Nguyen AH, Mekonnen B, Kim E, Acharya NR.
Clinical outcomes of pediatric macular edema associated with non-infectious uveitis.
J Ophthalmic Inflamm Infect. 2021 Mar 15;11(1):8. doi: 10.1186/s12348-021-00236-4
https://pubmed.ncbi.nlm.nih.gov/33718975/
FEBRERO 2021
-
Esen E, Sizmaz S, Balci S, Ekinci RMK, Demircan N.
Clinical features of childhood uveitis at a tertiary referral center in Southern Turkey.
Int Ophthalmol. 2021 Feb 24. doi: 10.1007/s10792-021-01764-7.
https://pubmed.ncbi.nlm.nih.gov/33624176/ -
Sözeri B, Kardeş E, Salı E, Çakır D, Demir F.
Drug survival of the infliximab biosimilar (CT-P13) in paediatric patients with non-infectious uveitis.
Clin Exp Rheumatol. 2021 Feb 9.
https://pubmed.ncbi.nlm.nih.gov/33635217/ -
Sobolewska B, Baglivo E, Edwards AO, Kramer M, Miserocchi E, Palestine AG, Schwab IR, Zamir E, Doycheva D, Zierhut M.
Drug-induced Sarcoid Uveitis with Biologics.
Ocul Immunol Inflamm. 2021 Feb 17:1-8. doi: 10.1080/09273948.2020.1850799.
https://pubmed.ncbi.nlm.nih.gov/33596386/ -
Ansari AS, Amir Z, Williams GS.
Bilateral 0.19 mg Fluocinolone Acetonide Intravitreal Implant in the Successful Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis and Secondary Macular Oedema: A Case Report and Review of Intravitreal Therapies.
Ophthalmol Ther. 2021 Mar;10(1):193-200. doi: 10.1007/s40123-020-00328-9. Epub 2021 Jan 19.
https://pubmed.ncbi.nlm.nih.gov/33464558/ -
Maccora I, Fusco E, Marrani E, Ramanan AV, Simonini G.
Changing evidence over time: updated meta-analysis regarding anti-TNF efficacy in childhood chronic uveitis.
Rheumatology (Oxford). 2021 Feb 1;60(2):568-587. doi: 10.1093/rheumatology/keaa595.
https://pubmed.ncbi.nlm.nih.gov/33219694/ -
Akbarali S, Rahi JS, Dick AD, Parkash K, Etherton K, Edelsten C, Liu X, Solebo AL.
Imaging-Based Uveitis Surveillance in Juvenile Idiopathic Arthritis: Feasibility, Acceptability, and Diagnostic Performance.
Arthritis Rheumatol. 2021 Feb;73(2):330-335. doi: 10.1002/art.41530. Epub 2020 Dec 24.
https://pubmed.ncbi.nlm.nih.gov/32976696/
-
Smith JR, Matthews JM, Conrad D, Hall AJ, Niederer RL, Singh-Grewal D, Tay-Kearney ML, Wells JM, Zagora SL; Australian and New Zealand Juvenile Idiopathic Arthritis-Uveitis Working Group, McCluskey PJ.
Recommendations for the management of childhood juvenile idiopathic arthritis-type chronic anterior uveitis.
Clin Exp Ophthalmol. 2021 Jan 10. doi: 10.1111/ceo.13856. Epub ahead of print. PMID: 33426782.
https://pubmed.ncbi.nlm.nih.gov/33426782/ -
Wakefield D, Clarke D, McCluskey P.
Recent Developments in HLA B27 Anterior Uveitis.
Front Immunol. 2021 Jan 5;11:608134. doi: 10.3389/fimmu.2020.608134. PMID: 33469457; PMCID: PMC7813675.
https://pubmed.ncbi.nlm.nih.gov/33469457/
DICIEMBRE 2020
-
van Straalen JW, Giancane G, Amazrhar Y, Tzaribachev N, Lazar C, Uziel Y, Telcharova-Mihaylovska A, Len CA, Miniaci A, Boteanu AL, Filocamo G, Mastri MV, Arkachaisri T, Magnolia MG, Hoppenreijs E, de Roock S, Wulffraat NM, Ruperto N, Swart JF.
A clinical prediction model for estimating the risk of developing uveitis in patients with juvenile idiopathic arthritis.
Rheumatology (Oxford). 2020 Dec 4:keaa733. doi: 10.1093/rheumatology/keaa733
https://pubmed.ncbi.nlm.nih.gov/33274366/ -
Tripathy K, Ying H, Maldonado Cerda A, Filipowicz A, Kaya M, Seymen Z, Anesi SD, Chang PY, Foster CS.
Widefield Fundus Fluorescein Angiography Features of Uveitis Associated with Juvenile Idiopathic Arthritis.
Ocul Immunol Inflamm. 2020 Dec 2:1-10
https://pubmed.ncbi.nlm.nih.gov/33264037/ -
Petty RE, Zheng Q.
Uveitis in juvenile idiopathic arthritis.
World J Pediatr. 2020 Dec;16(6):562-565
https://pubmed.ncbi.nlm.nih.gov/31965444/
NOVIEMBRE 2020
- Rahman N, Petrushkin H, Solebo AL.
Paediatric autoimmune and autoinflammatory conditions associated with uveitis.
Ther Adv Ophthalmol. 2020 Nov 2;12:2515841420966451
https://pubmed.ncbi.nlm.nih.gov/33225212/ - Maccora I, Fusco E, Marrani E, Ramanan AV, Simonini G.
Changing evidence over time: updated meta-analysis regarding anti-TNF efficacy in childhood chronic uveitis.
Rheumatology (Oxford). 2020 Nov 21:keaa595. doi: 10.1093/rheumatology/keaa595
https://pubmed.ncbi.nlm.nih.gov/33219694/ - Koay SY, Johnson M, Xing W, Foot B, MacEwen C, Dahlmann-Noor A, Thomas D.
Childhood uveitis not associated with juvenile idiopathic arthritis: a national survey of incidence, management and visual outcomes.
Eye (Lond). 2020 Nov 16. DOI:10.1038/s41433-020-01267-2
https://pubmed.ncbi.nlm.nih.gov/33199865/
-
Cassedy A, Altaye M, Andringa J, Cooper AM, Drews-Botsch C, Engelhard G Jr, Hennard T, Holland GN, Jenkins K, Lambert SR, Lipscomb J, McCracken C, McCurdy DK, McDonald J, Mwase N, Prahalad S, Stahl E, Miraldi Utz V, Walker AA, Yeh S, Angeles-Han ST.
Assessing the validity and reliability of the Effects of Youngsters' Eyesight on Quality of Life (EYE-Q) questionnaire among children with uveitis.
Arthritis Care Res (Hoboken). 2020 Oct 21. doi: 10.1002/acr.24491. Online ahead of print
https://pubmed.ncbi.nlm.nih.gov/33085849/
SEPTIEMBRE 2020
-
Akbarali S, Rahi JS, Dick AD, Parkash K, Etherton K, Edelsten C, Liu X, Solebo AL.
Imaging based uveitis surveillance in juvenile idiopathic arthritis: feasibility, acceptability and diagnostic performance.
Arthritis Rheumatol. 2020 Sep 25. doi: 10.1002/art.41530. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32976696/ -
Marino A, Weiss PF, Brandon TG, Lerman MA.
Juvenile Spondyloarthritis: focus on uveitis
Pediatr Rheumatol Online J. 2020 Sep 10;18(1):70. doi: 10.1186/s12969-020-00463-4
https://pubmed.ncbi.nlm.nih.gov/32912296/ -
Miserocchi E, Giuffrè C, Modorati GM, Cimaz R.
Management of Juvenile Idiopathic Arthritis-associated Uveitis during the COVID-19 Pandemic in a Pediatric Referral Center in Lombardy
Ocul Immunol Inflamm. 2020 Sep 25:1-3. doi: 10.1080/09273948.2020.1800752. Online ahead of print
https://pubmed.ncbi.nlm.nih.gov/32976038/ -
Takase H, Acharya NR, Babu K, Bodaghi B, Khairallah M, McCluskey PJ, Tesavibul N, Thorne JE, Tugal-Tutkun I, Yamamoto JH, Rao NA, Smith JR, Mochizuki M; 7th IWOS Study Group.
Recommendations for the management of ocular sarcoidosis from the International Workshop on Ocular Sarcoidosis.
Br J Ophthalmol. 2020 Sep 15:bjophthalmol-2020-317354. doi: 10.1136/bjophthalmol-2020-317354. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32933934/ -
Rosenbaum JT, Harrington CA, Searles RP, Fei SS, Zaki A, Arepalli S, Paley MA, Hassman LM, Vitale AT, Conrady CD, Keath P, Mitchell C, Watson L, Planck SR, Martin TM, Choi D.
Revising the diagnosis of idiopathic uveitis by peripheral blood transcriptomics.
Am J Ophthalmol. 2020 Sep 14:S0002-9394(20)30505-5. doi: 10.1016/j.ajo.2020.09.012. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32941857/ -
Sadhu S, Dutta Majumder P, Biswas J.
Biological therapy in refractory cases of uveitis and scleritis: An analysis of 18 cases from a tertiary eye care center from South India.
Indian J Ophthalmol. 2020 Sep;68(9):1929-1933. doi: 10.4103/ijo.IJO_966_20.
https://pubmed.ncbi.nlm.nih.gov/32823417/
AGOSTO 2020
-
Maccora I, Sen ES, Ramanan AV.
Update on noninfectious uveitis in children and its treatment
Curr Opin Rheumatol . 2020 Sep;32(5):395-402. doi:
10.1097/BOR.0000000000000723.
https://pubmed.ncbi.nlm.nih.gov/32675714/ -
Rypdal V, Glerup M, Songstad NT, Bertelsen G, Christoffersen T, Arnstad ED, Aalto K, Berntson L, Fasth A, Herlin T, Ekelund M, Peltoniemi S, Toftedal P, Nielsen S, Leinonen S, Bangsgaard R, Nielsen R, Rygg M, Nordal E; Nordic Study Group of Pediatric Rheumatology (NoSPeR).
Uveitis in Juvenile Idiopathic Arthritis: 18-year Outcome in the Population-based Nordic Cohort Study.
Ophthalmology. 2020 Aug 28:S0161-6420(20)30842-3. doi: 10.1016/j.ophtha.2020.08.024.
https://pubmed.ncbi.nlm.nih.gov/32866542/ -
Hassan WA, Medhat BM, Youssef MM, Farag Y, Mostafa N, Alnaggar AR, Behiry ME, Abdel Noor RA, Allam RSHM.
Characteristics, evolution, and outcome of patients with non-infectious uveitis referred for rheumatologic assessment and management: an Egyptian multicenter retrospective study.
Clin Rheumatol. 2020 Sep 2. doi: 10.1007/s10067-020-05362-3.
https://pubmed.ncbi.nlm.nih.gov/32876781/ -
Choe S, Heo JW, Oh BL.
Quiescence and Subsequent Anterior Chamber Inflammation in Adalimumab-treated Pediatric Noninfectious Uveitis
Korean J Ophthalmol. 2020 Aug;34(4):274-280. doi: 10.3341/kjo.2020.0005.
https://pubmed.ncbi.nlm.nih.gov/32783419/ -
Turk M, Hayworth J, Nevskaya T, Pope J.
The frequency of uveitis in patients with adult versus childhood spondyloarthritis.
RMD Open. 2020 Aug;6(2):e001196. doi: 10.1136/rmdopen-2020-001196.PMID: 32868451
https://pubmed.ncbi.nlm.nih.gov/32868451/ -
Orès R, Terrada C, Errera MH, Thorne JE, Doukhan R, Cassoux N, Penaud B, LeHoang P, Quartier PM, Bodaghi B.
Laser Flare Photometry: A Useful Tool for Monitoring Patients with Juvenile Idiopathic Arthritis-associated Uveitis.
Ocul Immunol Inflamm. 2020 Aug 24:1-11. doi: 10.1080/09273948.2020.1792511.
https://pubmed.ncbi.nlm.nih.gov/32835572/
JULIO 2020
-
Maccora I, Sen ES, Ramanan AV.
Update on noninfectious uveitis in children and its treatment.
Curr Opin Rheumatol. 2020 Jul 15. doi: 10.1097/BOR.0000000000000723. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32675714/
JUNIO 2020
-
Siiskonen M, Hirn I, Pesälä R, Hautala T, Ohtonen P, Hautala N.
Prevalence, incidence and epidemiology of childhood uveitis.
Acta Ophthalmol. 2020 Jun 26. doi: 10.1111/aos.14535. PMID: 32588987
https://pubmed.ncbi.nlm.nih.gov/32588987/ -
Fung SSM, El Hamouly A, Sami H, Jiandani D, Williams S, Tehrani N, Mireskandari K, Ali A.
Corneal endothelium in paediatric patients with uveitis: a prospective longitudinal study.
Br J Ophthalmol. 2020 Jun 10:bjophthalmol-2020-316120.
https://pubmed.ncbi.nlm.nih.gov/32522794/ -
Silvestri E, Bitossi A, Bettiol A, Emmi G, Urban ML, Mattioli I, Di Scala G, Bacherini D, Lopalco G, Venerito V, Iannone F, Vitale A, Tosi GM, Rizzo S, Fabiani C, Cantarini L, Virgili G, Vannozzi L, Prisco D.
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet's syndrome.
Inflammopharmacology. 2020 Jun;28(3):711-718. doi: 10.1007/s10787-020-00697-4.
https://pubmed.ncbi.nlm.nih.gov/32157555/ -
Sobrin L, Pistilli M, Dreger K, Kothari S, Khachatryan N, Artornsombudh P, Pujari SS, Foster CS, Jabs DA, Nussenblatt RB, Rosenbaum JT, Levy-Clarke GA, Sen HN, Suhler EB, Thorne JE, Bhatt NP, Kempen JH; Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Research Group.
Factors Predictive of Remission of Chronic Anterior Uveitis.
Ophthalmology. 2020 Jun;127(6):826-834. doi: 10.1016/j.ophtha.2019.11.020.
https://pubmed.ncbi.nlm.nih.gov/31932091/ -
Çakar Özdal P.
Behçet's Uveitis: Current Diagnostic and Therapeutic Approach.
Turk J Ophthalmol. 2020 Jun 27;50(3):169-182. doi: 10.4274/tjo.galenos.2019.60308
https://pubmed.ncbi.nlm.nih.gov/32631005/
MAYO 2020
- Stewart DJ, Sekar T, Tullus K.
A rare case of tubulointerstitial nephritis and uveitis (TINU) syndrome: Questions.
Pediatr Nephrol. 2020 May 21.
https://doi.org/10.1007/s00467-020-04582-8 - Leinonen S, Kotaniemi KM, Kivelä TT, Krootila K
Results 5 to 10 years after cataract surgery with primary IOL implantation in juvenile idiopathic arthritis-related uveitis.
J Cataract Refract Surg. 2020 Apr 24. doi: 10.1097/j.jcrs.0000000000000222. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32341296 - Navarrete A, Koriat A, Amer R.
Implications of pars planitis-associated cystoid macular edema on visual outcome and management in children
Graefes Arch Clin Exp Ophthalmol. 2020 Apr 28. doi: 10.1007/s00417-020-04696-7. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32346784
MARZO 2020
- Miserocchi E, Giuffrè C, Cornalba M, Pontikaki I, Cimaz R.
JAK inhibitors in refractory juvenile idiopathic arthritis-associated uveitis.
Clin Rheumatol. 2020 Mar;39(3):847-851.
https://www.ncbi.nlm.nih.gov/pubmed/31897953 - Carpentier SJ, Jung JL, Patnaik JL, Pecen PE, Palestine AG.
A Cross-Sectional Online Survey Identifies Subspecialty Differences in the Management of Pediatric Cataracts Associated with Uveitis.
Ophthalmol Ther. 2020 Mar 10. doi: 10.1007/s40123-020-00245-x. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32157612 - Walscheid K, Glandorf K, Rothaus K, Niewerth M, Klotsche J, Minden K, Heiligenhaus A.
Enthesitis-related arthritis: prevalence and complications of associated uveitis in children and adolescents from a population-based nation-wide study in Germany.
J Rheumatol. 2020 Mar 15. pii: jrheum.191085. doi: 10.3899/jrheum.191085. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32173656 - Silvestri E, Bitossi A, Bettiol A, Emmi G, Urban ML, Mattioli I, Di Scala G, Bacherini D, Lopalco G, Venerito V, Iannone F, Vitale A, Tosi GM, Rizzo S, Fabiani C, Cantarini L, Virgili G, Vannozzi L, Prisco D
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet's syndrome.
Inflammopharmacology. 2020 Mar 10. doi: 10.1007/s10787-020-00697-4. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32157555
FEBRERO 2020
- Schnabel A, Unger E, Brück N, Berner R, Range U, Holl-Wieden A, Morbach H, Leszczynska A, Bau V, Hedrich CM.
High-dose intravenous methylprednisolone in juvenile non-infectious uveitis: A retrospective analysis.
Clin Immunol. 2020 Feb;211:108327. doi: 10.1016/j.clim.2019.108327. Epub 2019 Dec 18.
https://www.ncbi.nlm.nih.gov/pubmed/31863906 - Walscheid K, Klotsche J, Tappeiner C, Niewerth M, Foell D, Minden K, Heiligenhaus A.
Adherence to ophthalmological screening recommendations and course of uveitis in children with juvenile idiopathic arthritis: data from the Inception Cohort of Newly diagnosed patients with JIA (ICON-JIA) study.
Clin Exp Rheumatol. 2020 Feb 19.
https://www.ncbi.nlm.nih.gov/pubmed/32105591 - Wennink RAW, Ayuso VK, de Vries LA, Vastert SJ, de Boer JH.
Tocilizumab as an Effective Treatment Option in Children with Refractory Intermediate and Panuveitis.
Ocul Immunol Inflamm. 2020 Feb 14:1-5. doi: 10.1080/09273948.2020.1712431.
https://www.ncbi.nlm.nih.gov/pubmed/32058831 - Jari M, Shiari R, Salehpour O, Rahmani K.
Epidemiological and advanced therapeutic approaches to treatment of uveitis in pediatric rheumatic diseases: a systematic review and meta-analysis.
Orphanet J Rare Dis. 2020 Feb 4;15(1):41. doi: 10.1186/s13023-020-1324-x.
https://www.ncbi.nlm.nih.gov/pubmed/32019589 - Gaggiano C, Rigante D, Tosi GM, Vitale A, Frediani B, Grosso S, Fabiani C, Cantarini L.
Treating juvenile idiopathic arthritis (JIA)-related uveitis beyond TNF-α inhibition: a narrative review.
Clin Rheumatol. 2020 Feb;39(2):327-337. doi: 10.1007/s10067-019-04763-3. Epub 2019 Dec 10.
https://www.ncbi.nlm.nih.gov/pubmed/31823144 - Sestan M, Grguric D, Sedmak M, Frkovic M, Kifer N, Grubic M, Peric S, Vukojevic N, Potocki K, Jelusic M.
Quality of life in children suffering from juvenile idiopathic arthritis-associated uveitis.
Rheumatol Int. 2020 Feb 22. doi: 10.1007/s00296-020-04536-1.
https://www.ncbi.nlm.nih.gov/pubmed/32088753 - Abraham A, Saboo US, Ducca BL, Lawand AT, Ronconi C, Cao JH.
The Detection of Occult Retinal Vasculitis on Fluorescein Angiography in Pediatric Uveitis.
Ophthalmol Retina. 2020 Feb;4(2):198-203. doi: 10.1016/j.oret.2019.09.007. Epub 2019 Sep 20.
https://www.ncbi.nlm.nih.gov/pubmed/31708487
ENERO 2020
- Miserocchi E, Giuffrè C, Cornalba M, Pontikaki I, Cimaz R.
JAK inhibitors in refractory juvenile idiopathic arthritis-associated uveitis.
Clin Rheumatol. 2020 Jan 2. doi: 10.1007/s10067-019-04875-w. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/31897953
DICIEMBRE 2019
- Schnabel A, Unger E, Brück N, Berner R, Range U, Holl-Wieden A, Morbach H, Leszczynska A, Bau V, Hedrich CM.
High-dose intravenous methylprednisolone in juvenile non-infectious uveitis: A retrospective analysis.
Clin Immunol. 2019 Dec 18;211:108327.
https://www.ncbi.nlm.nih.gov/pubmed/31863906 - Sen ES, Ramanan AV.
Juvenile idiopathic arthritis-associated uveitis.
Clin Immunol. 2019 Dec 9;211:108322. doi: 10.1016/j.clim.2019.108322.
https://www.ncbi.nlm.nih.gov/pubmed/31830532 - Gaggiano C, Rigante D, Tosi GM, Vitale A, Frediani B, Grosso S, Fabiani C, Cantarini L.
Treating juvenile idiopathic arthritis (JIA)-related uveitis beyond TNF-α inhibition: a narrative review.
Clin Rheumatol. 2019 Dec 10. doi: 10.1007/s10067-019-04763-3
https://www.ncbi.nlm.nih.gov/pubmed/31823144 - Miserocchi E, Giuffrè C, Cicinelli MV, Marchese A, Gattinara M, Modorati G, Bandello F.
Oral phospholipidic curcumin in juvenile idiopathic arthritis-associated uveitis.
Eur J Ophthalmol. 2019 Dec 4:1120672119892804. doi: 10.1177/1120672119892804.
https://www.ncbi.nlm.nih.gov/pubmed/31801359 - Miyazawa H, Fujita Y, Muramatsu K, Iwata H, Nomura T, Namba K, Hoshina D, Shimizu H.
Refractory juvenile psoriatic uveitis without arthritis: a literature review.
J Eur Acad Dermatol Venereol. 2019 Dec 2. doi: 10.1111/jdv.16127
https://www.ncbi.nlm.nih.gov/pubmed/31793073
OCTUBRE 2019
- Adán A, Moll-Udina A, Ramirez J, Llorenç V.
Subcutaneous Tocilizumab for Cystoid Macular Edema Secondary to Juvenile Idiopathic Arthritis (JIA)-associated Uveitis: A Case Report.
Ocul Immunol Inflamm. 2019 Oct 7:1-3. doi: 10.1080/09273948.2019.1644350. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31589540 - Foeldvari I, Klotsche J, Simonini G, Edelsten C, Angeles-Han ST, Bangsgaard R, de Boer J, Brumm G, Torrent RB, Constantin T, DeLibero C, Diaz J, Gerloni VM, Guedes M, Heiligenhaus A, Kotaniemi K, Leinonen S, Minden K, Miranda V, Miserocchi E, Nielsen S, Niewerth M, Pontikaki I, de Vicuna CG, Zilhao C, Yeh S, Anton J
Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC)
Pediatr Rheumatol Online J. 2019 Oct 1;17(1):66. doi: 10.1186/s12969-019-0345-2.
https://www.ncbi.nlm.nih.gov/pubmed/31575380 - Davies R, Cock D, Kearsley-Fleet L, Southwood T, Baildam E, Beresford MW, Foster HE, Thomson W, Ramanan A, Hyrich KL; British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study (BSPAR-ETN) and the Biologics for Children with Rheumatic Diseases (BCRD) study.
The risk of uveitis in patients with JIA receiving etanercept: the challenges of analysing real-world data
Rheumatology (Oxford). 2019 Oct 12. pii: kez449. doi: 10.1093/rheumatology/kez449. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31605484 - Cheung CSY, Mireskandari K, Ali A, Silverman E, Tehrani N.
Earlier use of systemic immunosuppression is associated with fewer ophthalmic surgeries in paediatric non-infectious uveitis
Br J Ophthalmol. 2019 Oct 11. pii: bjophthalmol-2019-314875. doi: 10.1136/bjophthalmol-2019-314875. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31604701
AGOSTO 2019
- Busch M, Wefelmeyer KL, Walscheid K, Rothaus K, Bauer D, Deeg CA, Degroote RL,
Identification of Ocular Autoantigens Associated With Juvenile Idiopathic Arthritis-Associated Uveitis.
Ackermann D, König S, Thanos S, Kasper M, Heiligenhaus A.
Front Immunol. 2019 Aug 6;10:1793.
https://www.ncbi.nlm.nih.gov/pubmed/31447836 - Reiff A.
Clinical Presentation, Management and Long Term Outcome of Pars Planitis (PP), Panuveitis (PU) and Vogt-Koyanagi-Harada disease (VKH) in Children and Adolescents.
Arthritis Care Res (Hoboken). 2019 Aug 23.
https://www.ncbi.nlm.nih.gov/pubmed/31444859
JULIO 2019
- Bauermann P, Heiligenhaus A, Heinz C.
Effect of Janus Kinase Inhibitor Treatment on Anterior Uveitis and Associated Macular Edema in an Adult Patient with Juvenile Idiopathic Arthritis.
Ocul Immunol Inflamm. 2019 Jul 3:1-3. doi: 10.1080/09273948.2019.1605453. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31268748 - Mastrangelo G, Foeldvari I, Anton J, Simonini G.
Defining outcome measures in juvenile idiopathic arthritis associated uveitis by a systematic review analysis: do we need a consensus?
Pediatr Rheumatol Online J. 2019 Jul 11;17(1):40.
https://www.ncbi.nlm.nih.gov/pubmed/31296236
JUNIO 2019
- Marino A, Weiss PF, Davidson SL, Lerman MA.
Symptoms in noninfectious uveitis in a pediatric cohort: initial presentation versus recurrences.
J AAPOS. 2019 Jun 26. pii: S1091-8531(19)30146-6
https://www.ncbi.nlm.nih.gov/pubmed/31254672 - Hayworth JL, Turk MA, Nevskaya T, Pope JE.
The frequency of uveitis in patients with juvenile inflammatory rheumatic diseases.
Joint Bone Spine. 2019 Jun 14. pii: S1297-319X(19)30092-2. doi: 10.1016/j.jbspin.2019.06.001
https://www.ncbi.nlm.nih.gov/pubmed/31207292 - Horton S, Jones AP, Guly CM, Hardwick B, Beresford MW, Lee RWJ, Dick AD, Ramanan AV.
Adalimumab in juvenile-idiopathic arthritis-associated uveitis (JIA-U): 5-year follow-up of the Bristol participants of the SYCAMORE trial.
Am J Ophthalmol. 2019 Jun 12. pii: S0002-9394(19)30274-0. doi: 10.1016/j.ajo.2019.06.007. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31201796
ABRIL 2019
- Alba-Linero C, Sala-Puigdollers A, Romero B, Llorenç V, Adan A, Zarranz-Ventura J.
Long-Term Intravitreal Dexamethasone Implant Outcomes in Uveitis.
Ocul Immunol Inflamm. 2019 Apr 17:1-10. doi: 10.1080/09273948.2019.1578380. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30994370 - Angeles-Han ST, Ringold S, Beukelman T, Lovell D, Cuello CA, Becker ML, Colbert RA, Feldman BM, Holland GN, Ferguson PJ, Gewanter H, Guzman J, Horonjeff J, Nigrovic PA, Ombrello MJ, Passo MH, Stoll ML, Rabinovich CE, Sen HN, Schneider R, Halyabar O, Hays K, Shah AA, Sullivan N, Szymanski AM, Turgunbaev M, Turner A, Reston J.
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis.
Arthritis Care Res (Hoboken). 2019 Apr 25. doi: 10.1002/acr.23871
https://www.ncbi.nlm.nih.gov/pubmed/31021540 - Ramanan AV, Dick AD, Jones AP, Hughes DA, McKay A, Rosala-Hallas A, Williamson PR, Hardwick B, Hickey H, Rainford N, Hickey G, Kolamunnage-Dona R, Culeddu G, Plumpton C, Wood E, Compeyrot-Lacassagne S, Woo P, Edelsten C, Beresford MW.
Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT
Health Technol Assess. 2019 Apr;23(15):1-140. doi: 10.3310/hta23150.
https://www.ncbi.nlm.nih.gov/pubmed/31033434 - Tosi GM, Sota J, Vitale A, Rigante D, Emmi G, Lopalco G, Guerriero S, Orlando I, Iannone F, Frediani B, Angotti R, Messina M, Galeazzi M, Vannozzi L, Cantarini L, Fabiani C.
Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis.
Clin Exp Rheumatol. 2019 Apr 3. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30943133
MARZO 2019
- Haasnoot AJW, Kuiper JJW, de Boer JH.
Predicting uveitis in juvenile idiopathic arthritis: from biomarkers to clinical practice.
Expert Rev Clin Immunol. 2019 Mar 15:1-10. doi: 10.1080/1744666X.2019.1593139. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30874452 - Touhami S, Diwo E, Sève P, Trad S, Bielefeld P, Sène D, Abad S, Brézin A, Quartier P, Koné Paut I, Weber M, Chiquet C, Errera MH, Sellam J, Cacoub P, Kaplanski G, Kodjikian L, Bodaghi B, Saadoun D.
Expert opinion on the use of biological therapy in non-infectious uveitis.
Expert Opin Biol Ther. 2019 Mar 19:1-14. doi: 10.1080/14712598.2019.1595578. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30888881 - Wildschütz L, Ackermann D, Witten A, Kasper M, Busch M, Glander S, Melkonyan H, Walscheid K, Tappeiner C, Thanos S, Barysenka A, Koch J, Heinz C, Laffer B, Bauer D, Stoll M, König S, Heiligenhaus A.
Transcriptomic and proteomic analysis of iris tissue and aqueous humor in juvenile idiopathic arthritis-associated uveitis.
J Autoimmun. 2019 Mar 15. pii: S0896-8411(19)30038-1. doi: 10.1016/j.jaut.2019.03.004. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30885419 - DeSouza PJ, Shah R.
Characterization of Blau syndrome panuveitis with wide-field fluorescein angiography.
Am J Ophthalmol Case Rep. 2019 Mar 29;14:92-94. doi: 10.1016/j.ajoc.2019.03.006.
https://www.ncbi.nlm.nih.gov/pubmed/30989150 - Oh LJ, Nguyen CL, Phan K, Wong E, Zagora S, Singh-Grewal D, Chaitow J, Grigg JR, McCluskey P.
Changing biological disease modifying treatment for paediatric uveitis in the real world.
Clin Exp Ophthalmol. 2019 Mar 4. doi: 10.1111/ceo.13494. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30834650
FEBRERO 2019
- Dipasquale V, Atteritano M, Fresta J, Castagna I, Conti G.
Tocilizumab for refractory uveitis associated with juvenile idiopathic arthritis: A report of two cases.
J Clin Pharm Ther. 2019 Feb 27. doi: 10.1111/jcpt.12821. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30815892 - Wu S, Zhong L, Sun Z, Zhu T, Song H, Sui R.
Ocular Features in Chinese Patients with Blau Syndrome.
Ocul Immunol Inflamm. 2019 Feb 26:1-7. doi: 10.1080/09273948.2019.1569239. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30806112 - Eiger-Moscovich M, Tomkins-Netzer O, Amer R, Habot-Wilner Z, Kasb A, Friling R, Kramer M.
Visual and Clinical Outcome of Macular Edema Complicating Pediatric Noninfectious Uveitis.
Am J Ophthalmol. 2019 Feb 14. pii: S0002-9394(19)30063-7. doi: 10.1016/j.ajo.2019.02.011. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30772346
ENERO 2019
- Vegas-Revenga N, Calvo-Río V, Mesquida M, Adán A, Hernández MV, Beltrán E, Pascual EV, Díaz-Valle D, Cordovés GD, Hernandez-Garfella M, Martínez-Costa L, Calvo I, Atanes A, Linares LF, Modesto C, González-Vela C, Demetrio-Pablo R, Aurrecoechea E, Cordero M, Domínguez-Casas LC, Atienza-Mateo B, Martín-Varillas JL, Loricera J, Palmou-Fontana N, Hernández JL, González-Gay MA, Blanco R.
Anti-il6-r tocilizumab in refractory and non-infectious uveitic cystoid macular edema. Multicenter study of 25 patients.
Am J Ophthalmol. 2019 Jan 17. pii: S0002-9394(19)30003-0. doi: 10.1016/j.ajo.2018.12.019. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30660771
DICIEMBRE 2018
- Heiligenhaus A, Minden K, Tappeiner C, Baus H, Bertram B, Deuter C, Foeldvari I, Föll D, Frosch M, Ganser G, Gaubitz M, Günther A, Heinz C, Horneff G, Huemer C, Kopp I, Lommatzsch C, Lutz T, Michels H, Neß T, Neudorf U, Pleyer U, Schneider M, Schulze-Koops H, Thurau S, Zierhut M, Lehmann HW.
Update of the evidence based, interdisciplinary guideline for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis.
Semin Arthritis Rheum. 2018 Dec 4. pii: S0049-0172(18)30462-1. doi: 10.1016/j.semarthrit.2018.11.004. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30595409 - Heiligenhaus A, Klotsche J, Tappeiner C, Sengler C, Niewerth M, Liedmann I, Hoeft S, Walscheid K, Lavric M, Foell D, Minden K.
Predictive factors and biomarkers for the 2-year outcome of uveitis in juvenile idiopathic arthritis: data from the Inception Cohort of Newly diagnosed patients with Juvenile Idiopathic Arthritis (ICON-JIA) study.
Rheumatology (Oxford). 2018 Dec 26. doi: 10.1093/rheumatology/key406. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30590748
NOVIEMBRE 2018
- Ito T, Hoshina T, Mizuki K, Fukuda 1, Ishibashi S, Kusuhara K
A pediatric case with parvovirus B19-associated uveitis without autoantibody formation.
Nagoya J Med Sci. 2018 Nov;80(4):611-614. doi: 10.18999/nagjms.80.4.611
https://www.ncbi.nlm.nih.gov/pubmed/30587876 - McCracken C, Yeh S, Jenkins K, Travers C, Stryker D, Tommasello S, Rouster-Stevens KA, Lambert SR, Prahalad S, Drews-Botsch C, Angeles-Han ST
Timing of infliximab and adalimumab initiation despite methotrexate in children with chronic non-infectious anterior uveitis.
Eye (Lond). 2018 Nov 28. doi: 10.1038/s41433-018-0283-0. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30487588
OCTUBRE 2018
- Hughes DA, Culeddu G, Plumpton C, Wood E, Dick AD, Jones AP, McKay A, Williamson PR, Compeyrot Lacassagne S, Hardwick B, Hickey H, Woo P, Beresford MW, Ramanan AV.
Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with Juvenile Idiopathic Arthritis
Ophthalmology. 2018 Oct 15. pii: S0161-6420(18)31146-1. doi: 10.1016/j.ophtha.2018.09.043. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30336181 - Lee JJY, Duffy CM, Guzman J, Oen K, Barrowman N, Rosenberg AM, Shiff NJ, Boire G, Stringer E, Spiegel L, Morishita KA, Lang B, Reddy D, Huber AM, Cabral DA, Feldman BM, Yeung RSM, Tucker LB, Watanabe Duffy K; ReACCh-Out Investigators.
Prospective Determination of the Incidence and Risk Factors of New-Onset Uveitis in Juvenile Idiopathic Arthritis: The Research in Arthritis in Canadian Children Emphasizing Outcomes Cohort.
Arthritis Care Res (Hoboken). 2018 Oct 15. doi: 10.1002/acr.23783. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30320957 - Hissink Muller P, Brinkman DMC, Schonenberg-Meinema D, van den Bosch WB, Koopman-Keemink Y, Brederije ICJ, Bekkering PW, Kuijpers TW, Van Rossum M, van Suijlekom-Smit LW, van den Berg JM, Boehringer S, Allaart CF, Ten Cate R.
Treat to target (drug-free) inactive disease in DMARD-naive juvenile idiopathic arthritis: 24-month clinical outcomes of a three-armed randomised trial
Ann Rheum Dis. 2018 Oct 11. pii: annrheumdis-2018-213902. doi: 10.1136/annrheumdis-2018-213902. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30309970 - Wieringa WG, Armbrust W, Legger GE, Los LI.
Efficacy of High-Dose Methotrexate in Pediatric Non-Infectious Uveitis
Ocul Immunol Inflamm. 2018 Oct 22:1-9. doi: 10.1080/09273948.2018.1529800. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30346845
SEPTIEMBRE 2018
- Zygmunt A, Lipińska J, Biernacka-Zielińska M, Lipiec E, Niwald A, Smolewska E
Comparison of uveitis in the course of juvenile idiopathic arthritis with isolated uveitis in children - own experiences.
Reumatologia. 2018;56(3):149-154.
https://www.ncbi.nlm.nih.gov/pubmed/30042602 - Ruiz-Medrano J, Díaz-Valle D, Cuiña R, Gegúndez JA, Chhablani J, Majumder PD, Gutierrez-Bonet R.
The role of tocilizumab in the treatment of inflammatory diseases of the eye and orbit: A useful alternative.
J Fr Ophtalmol. 2018 Sep 11. pii: S0181-5512(18)30282-1. doi: 10.1016/j.jfo.2018.02.006. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30217605 - Multicenter Uveitis Steroid Treatment Trial Research Group; Writing Committee:, Thorne JE, Sugar EA, Holbrook JT, Burke AE, Altaweel MM, Vitale AT, Acharya NR, Kempen JH, Jabs DA.
Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema: The PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) Trial.
Ophthalmology. 2018 Sep 20. pii: S0161-6420(18)31133-3. doi: 10.1016/j.ophtha.2018.08.021. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30269924 - Kulik U, Wiklund A, Kugelberg M, Lundvall A.
Long-term results after primary intraocular lens implantation in children with juvenile idiopathic arthritis-associated uveitis.
Eur J Ophthalmol. 2018 Sep 12:1120672118799623. doi: 10.1177/1120672118799623. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30207174 - Baghdasaryan E, Tepelus TC, Marion KM, Huang J, Huang P, Sadda SR, Lee OL.
Analysis of ocular inflammation in anterior chamber-involving uveitis using swept-source anterior segment OCT.
Int Ophthalmol. 2018 Sep 20. doi: 10.1007/s10792-018-1005-0. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30238391 - Ma S, Rogers SL, Hall AJ, Hodgson L, Brennan J, Stawell R, Lim LL.
Sarcoidosis related uveitis: Clinical presentations, disease course and rates of systemic disease progression after uveitis diagnosis.
Am J Ophthalmol. 2018 Sep 20. pii: S0002-9394(18)30532-4. doi: 10.1016/j.ajo.2018.09.013. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30243930 - Curragh DS, McAvoy CE, Rooney M, McLoone E.
Post-streptococcal uveitis syndrome in a Caucasian population: a case series.
Eye (Lond). 2018 Sep 18. doi: 10.1038/s41433-018-0214-0. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30228367 - Richard Colmant G, Kodjikian L, De Parisot De Bernecourt A, Guillaud M, Gerfaud-Valentin M, Denis P, Broussolle C, Jamilloux Y, Sève P.
Uveitis of Unknown Etiology: Clinical and Outcome features. A Retrospective Analysis of 355 Patients.
Ocul Immunol Inflamm. 2018 Sep 20:1-8. doi: 10.1080/09273948.2018.1522356. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30234412 - Agrawal R, Gunasekeran DV, Agarwal A, Carreño E, Aggarwal K, Gupta B, et al.
The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Description of the Spectrum of Choroidal Involvement in 245 Patients with Tubercular Uveitis.
Ocul Immunol Inflamm. 2018 Aug 29:1-11. doi: 10.1080/09273948.2018.1489061. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30156979 - Teixeira-Lopes F, Alfarroba S, Dinis A, Gomes MC, Tavares A.
Ocular tuberculosis - A closer look to an increasing reality.
Pulmonology. 2018 Sep - Oct;24(5):289-293
https://www.ncbi.nlm.nih.gov/pubmed/30293580
AGOSTO 2018
- Abd El Latif E MD, Fayez Goubran W MD, El Gemai EEDM MD, Habib AE MD, Abdelbaki AM MD, Ammar H MD, Seleet M MD.
Pattern of Childhood Uveitis in Egypt.
Ocul Immunol Inflamm. 2018 Aug 27:1-7. doi: 10.1080/09273948.2018.1502325. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30148647 - Cann M, Ramanan AV, Crawford A, Dick AD, Clarke SLN, Rashed F, Guly CM.
Outcomes of non-infectious Paediatric uveitis in the era of biologic therapy.
Pediatr Rheumatol Online J. 2018 Aug 6;16(1):51. doi: 10.1186/s12969-018-0266-5.
https://www.ncbi.nlm.nih.gov/pubmed/30081917 - Cecchin V, Zannin ME, Ferrari D, Pontikaki I, Miserocchi E, Paroli MP, Bracaglia C, Marafon DP, Pastore S, Parentin F, Simonini G, De Libero C, Falcini F, Petaccia A, Filocamo G, De Marco R, La Torre F, Guerriero S, Martino S, Comacchio F, Muratore V, Martini G, Vittadello F, Zulian F.
Longterm Safety and Efficacy of Adalimumab and Infliximab for Uveitis Associated with Juvenile Idiopathic Arthritis.
J Rheumatol. 2018 Aug;45(8):1167-1172. doi: 10.3899/jrheum.171006. Epub 2018 Apr 15.
https://www.ncbi.nlm.nih.gov/pubmed/29657140 - Constantin T, Foeldvari I, Anton J, de Boer J, Czitrom-Guillaume S, Edelsten C, Gepstein R, Heiligenhaus A, Pilkington CA, Simonini G, Uziel Y, Vastert SJ, Wulffraat NM, Haasnoot AM, Walscheid K, Pálinkás A, Pattani R, Györgyi Z, Kozma R, Boom V, Ponyi A, Ravelli A, Ramanan AV.
Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative.
Ann Rheum Dis. 2018 Aug;77(8):1107-1117. doi: 10.1136/annrheumdis-2018-213131. Epub 2018 Mar 28.
https://www.ncbi.nlm.nih.gov/pubmed/29592918 - Palmou-Fontana N, Calvo-Río V, Martín-Varillas JL, Fernández-Díaz C, Mesquida M,Adán A, Hernández MV, Cordero-Coma M, Maiz Alonso O, Díaz-Valle D, Fernández-Cid C, Ruiz-Moreno O, Hernández JL, González-Gay MA, Blanco R.
Golimumab in refractory uveitis associated to juvenile idiopathic arthritis: multicentre study of 7 cases and literature review.
Clin Exp Rheumatol. 2018 Jul-Aug;36(4):652-657. Epub 2017 Dec 15.
https://www.ncbi.nlm.nih.gov/pubmed/29303704
JULIO 2018
- Quartier P, Baptiste A, Despert V, Allain-Launay E, Koné-Paut I, Belot A, Kodjikian L, Monnet D, Weber M, Elie C, Bodaghi B, ADJUVITEStudy Group.
ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis.
Ann Rheum Dis. 2018 Jul;77(7):1003-1011. doi: 10.1136/annrheumdis-2017-212089. Epub 2017 Dec 23.
https://www.ncbi.nlm.nih.gov/pubmed/29275333 - Cann M, Ramanan AV, Crawford A, Dick AD, Clarke SLN, Rashed F, Guly CM.
Outcomes of non-infectious Paediatric uveitis in the era of biologic therapy.
Pediatr Rheumatol Online J. 2018 Aug 6;16(1):51. doi: 10.1186/s12969-018-0266-5.
https://www.ncbi.nlm.nih.gov/pubmed/30081917 - Palmou-Fontana N, Calvo-Río V, Martín-Varillas JL, Fernández-Díaz C, Mesquida M, Adán A, Hernández MV, Cordero-Coma M, Maiz Alonso O, Díaz-Valle D, Fernández-Cid C, Ruiz-Moreno O, Hernández JL, González-Gay MA, Blanco R.
Golimumab in refractory uveitis associated to juvenile idiopathic arthritis: multicentre study of 7 cases and literature review.
Clin Exp Rheumatol. 2018 Jul-Aug;36(4):652-657. Epub 2017 Dec 15.
https://www.ncbi.nlm.nih.gov/pubmed/29303704
JUNIO 2018
- Souto FMS, Giampietro BV, Takiuti JT, Campos LMA, Hirata CE, Yamamoto JH.
Clinical features of paediatric uveitis at a tertiary referral centre in São Paulo, SP, Brazil.
Br J Ophthalmol. 2018 Jun 15. pii: bjophthalmol-2018-312313. doi: 10.1136/bjophthalmol-2018-312313
https://www.ncbi.nlm.nih.gov/pubmed/29907630 - Fabiani C, Vitale A, Rigante D, Emmi G, Lopalco G, Sota J, Vannozzi L, di Scala G, Guerriero S, Orlando I, Franceschini R, Capozzoli M, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L.
Predictors of sustained clinical response in patients with Behçet's disease-related uveitis treated with infliximab and adalimumab.
Clin Rheumatol. 2018 Jun;37(6):1715-1720. doi: 10.1007/s10067-018-4092-4
https://www.ncbi.nlm.nih.gov/pubmed/29671190
MAYO 2018
- Atienza-Mateo B, Calvo-Río V, Beltrán E, Martínez-Costa L, Valls-Pascual E, Hernández-Garfella M, Atanes A, Cordero-Coma M, Miquel Nolla J, Carrasco-Cubero C, Loricera J, González-Vela MC, Vegas-Revenga N, Fernández-Díaz C, Demetrio-Pablo R, Domínguez-Casas LC, Luis Martín-Varillas J, Palmou-Fontana N, Hernández JL, González-Gay MÁ, Blanco R.
Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behçet's disease: multicentre retrospective study.
Rheumatology (Oxford). 2018 May 1;57(5):856-864. doi:10.1093/rheumatology/kex480.
https://www.ncbi.nlm.nih.gov/pubmed/29471416 - Angeles-Han ST, Lo MS, Henderson LA, Lerman MA, Abramson L, Cooper AM, Parsa MF, Zemel LS, Ronis T, Beukelman T, Cox E, Sen HN, Holland GN, Brunner HI, Lasky A, Rabinovich CE; Juvenile Idiopathic Arthritis Disease-Specific Uveitis Subcommittee of Childhood Arthritis Rheumatology Research Alliance.
Childhood Arthritis and Rheumatology Research Alliance consensus treatment plans for juvenile idiopathic arthritis-associated and idiopathic chronic anterior uveitis.
Arthritis Care Res (Hoboken). 2018 May 28. doi: 10.1002/acr.23610. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29806733 - Rosenbaum JT, Dick AD.
The Eyes Have It: A Rheumatologist's View of Uveitis.
Arthritis Rheumatol. 2018 May 23. doi: 10.1002/art.40568. [Epub ahead of print] Review.
https://www.ncbi.nlm.nih.gov/pubmed/29790291 - Walscheid K, Neekamp L, Heiligenhaus A, Weinhage T, Heinz C, Foell D.
Increased Circulating Proinflammatory T Lymphocytes in Children with Different Forms of Anterior Uveitis: Results from a Pilot Study.
Ocul Immunol Inflamm. 2018 May 17:1-10. doi: 10.1080/09273948.2018.1467464. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29771573
ABRIL 2018
- Bauer D, Kasper M, Walscheid K, Koch JM, Müther PS, Kirchhof B, Heiligenhaus A, Heinz C.
Multiplex Cytokine Analysis of Aqueous Humor in Juvenile Idiopathic Arthritis-AssociatedAnterior Uveitis With or Without Secondary Glaucoma.
Front Immunol. 2018 Apr 5;9:708. doi: 10.3389/fimmu.2018.00708. eCollection 2018.
https://www.ncbi.nlm.nih.gov/pubmed/29675026 - Cecchin V, Zannin ME, Ferrari D, Pontikaki I, Miserocchi E, Paroli MP, Bracaglia C, Marafon DP, Pastore S, Parentin F, Simonini G, De Libero C, Falcini F, Petaccia A, Filocamo G, De Marco R, La Torre F, Guerriero S, Martino S, Comacchio F, Muratore V, Martini G, Vittadello F, Zulian F.
Longterm Safety and Efficacy of Adalimumab and Infliximab for Uveitis Associated with Juvenile Idiopathic Arthritis.
J Rheumatol. 2018 Apr 15. pii: jrheum.171006. doi: 10.3899/jrheum.171006. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29657140 - Leinonen S, Immonen I, Kotaniemi K.
Fluocinolone acetonide intravitreal implant (Retisert® ) in the treatment of sight threatening macular oedema of juvenile idiopathic arthritis-related uveitis.
Acta Ophthalmol. 2018 Apr 14. doi: 10.1111/aos.13744. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/29655222 - Deitch I, Amer R, Tomkins-Netzer O, Habot-Wilner Z, Friling R, Neumann R, Kramer M.
The effect of anti-tumor necrosis factor alpha agents on the outcome in pediatric uveitis of diverse etiologies.
Graefes Arch Clin Exp Ophthalmol. 2018 Apr;256(4):801-808. doi: 10.1007/s00417-018-3928-6. Epub 2018 Feb 18.
https://www.ncbi.nlm.nih.gov/pubmed/29455252 - Fabiani C, Vitale A, Emmi G, Bitossi A, Lopalco G, Sota J, Guerriero S, Orlando I, Capozzoli M, Fusco F, Rana F, Iannone F, Frediani B, Galeazzi M, Vannozzi L, Tosi GM, Cantarini L.
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis.
Clin Rheumatol. 2018 Apr 3. doi: 10.1007/s10067-018-4069-3. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29611087
MARZO 2018
- Constantin T, Foeldvari I, Anton J, de Boer J, Czitrom-Guillaume S, Edelsten C, Gepstein R, Heiligenhaus A, Pilkington CA, Simonini G, Uziel Y, Vastert SJ, Wulffraat NM, Haasnoot AM, Walscheid K, Pálinkás A, Pattani R, Györgyi Z, Kozma R, Boom V, Ponyi A, Ravelli A, Ramanan AV.
Consensus-based recommendations for the management of uveitis associated with juvenileidiopathic arthritis: the SHARE initiative.
Ann Rheum Dis. 2018 Mar 28. pii: annrheumdis-2018-213131. doi: 10.1136/annrheumdis-2018-213131. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29592918 - Haasnoot AJW, Schilham MW, Kamphuis S, Hissink Muller PCE, Heiligenhaus A, Foell D, Minden K, Ophoff RA, Radstake TRDJ, Den Hollander AI, Reinards THCM, Hiddingh S, Schalij-Delfos NE, Hoppenreijs EPAH, van Rossum MAJ, Wouters C, Saurenmann RK, van den Berg JM, Wulffraat NM, Ten Cate R, de Boer JH, Pulit SL, Kuiper JJW.
An amino acid motif in HLA-DRβ1 distinguishes patients with uveitis in juvenile idiopathic arthritis.
Arthritis Rheumatol. 2018 Mar 7. doi: 10.1002/art.40484. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29513936 - Acharya NR, Patel S, Homayounfar G, Enanoria WTA, Shakoor A, Chakrabarti A, Goldstein DA.
Relapse of Juvenile Idiopathic Arthritis-Associated Uveitis after Discontinuation of Immunomodulatory Therapy.
Ocul Immunol Inflamm. 2018 Feb 16:1-7. doi: 10.1080/09273948.2018.1424341. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/29451845 - Ramanan AV, Guly C.
Adalimumab for childhood onset uveitis.
Ann Rheum Dis. 2018 Feb 28. pii: annrheumdis-2017-212767. doi: 10.1136/annrheumdis-2017-212767. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29490981 - Dawson V, Dao D, Leu M, Egense Mgc A, Jinadu L, Malone L, Alexander J.
Tubulointerstitial nephritis and uveitis (TINU) with granulomatosis: a novel report of simultaneous TINU and sarcoidosis in a pediatric patient.
J AAPOS. 2018 Mar 31. pii: S1091-8531(17)31040-6. doi: 10.1016/j.jaapos.2018.02.004. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/29614344 - Martín-Varillas JL, Calvo-Río V, Beltrán E, Sánchez-Bursón J, Mesquida M, Adán A, Hernandez MV, Garfella MH, Pascual EV, Martínez-Costa L, Sellas-Fernández A, Cordero-Coma M, Díaz-Llopis M, et al.
Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease.
Ophthalmology. 2018 Mar 27. pii: S0161-6420(17)33390-0. doi: 10.1016/j.ophtha.2018.02.020. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29602570
FEBRERO 2018
- Acharya NR, Patel S, Homayounfar G, Enanoria WTA, Shakoor A, Chakrabarti A, Goldstein DA.
Relapse of Juvenile Idiopathic Arthritis-Associated Uveitis after Discontinuation of Immunomodulatory Therapy
Ocul Immunol Inflamm. 2018 Feb 16:1-7. doi: 10.1080/09273948.2018.1424341
https://www.ncbi.nlm.nih.gov/pubmed/29451845
ENERO 2018
-
Ferrara M, Eggenschwiler L, Stephenson A, Montieth A, Nakhoul N, Araùjo-Miranda R, Foster CS.
The Challenge of Pediatric Uveitis: Tertiary Referral Center Experience in the United States.
Ocul Immunol Inflamm. 2018 Jan 15:1-8. doi: 10.1080/09273948.2017.1420202. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29333911
DICIEMBRE 2017
- Quartier P, Baptiste A, Despert V, Allain-Launay E, Koné-Paut I, Belot A, Kodjikian L, Monnet D, Weber M, Elie C, Bodaghi B; ADJUVITE Study Group.
ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis.
Ann Rheum Dis. 2017 Dec 23. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29275333 -
Leinonen ST, Aalto K, Kotaniemi KM, Kivelä TT.
Anti-adalimumab antibodies in juvenile idiopathic arthritis-related uveitis.
Clin Exp Rheumatol. 2017 Nov-Dec;35(6):1043-1046.
https://www.ncbi.nlm.nih.gov/pubmed/29148422 - Haasnoot AJW, Sint Jago NFM, Tekstra J, de Boer JH.
Impact of Uveitis on Quality of Life in Adult Patients With Juvenile Idiopathic Arthritis.
Arthritis Care Res (Hoboken). 2017 Dec;69(12):1895-1902.
https://www.ncbi.nlm.nih.gov/pubmed/28217950 - Palmou-Fontana N, Calvo-Río V, Martín-Varillas JL, Fernández-Díaz C, Mesquida M, Adán A, Hernández MV, Cordero-Coma M, Maiz Alonso O, Díaz-Valle D, Fernández-Cid C, Ruiz-Moreno O, Hernández JL, González-Gay MA, Blanco R.
Golimumab in refractory uveitis associated to juvenile idiopathic arthritis: multicentre study of 7 cases and literature review.
Clin Exp Rheumatol. 2017 Dec 15. [Epub ahead of print] Review.
https://www.ncbi.nlm.nih.gov/pubmed/29303704 - Borrego-Sanz L, Abásolo L, López-Abad C, Fernández-Gutiérrez B, García-Feijoo J, Diaz-Valle D, Pato E, Rodriguez-Rodriguez L.
Disease Remission in Children and Adolescents with Intermediate Uveitis: A Survival Analysis.
Ophthalmologica. 2017 Dec 14. doi: 10.1159/000485262. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29241207
NOVIEMBRE 2017
- Fabiani C, Sota J, Vitale A, Emmi G, Vannozzi L, Bacherini D, Lopalco G, Guerriero S, Venerito V, Orlando I, Franceschini R, Fusco F, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L.
Ten-Year Retention Rate of Infliximab in Patients with Behçet's Disease-Related Uveitis.
Ocul Immunol Inflamm. 2017 Nov 3
https://www.ncbi.nlm.nih.gov/pubmed/29099660 - Papadopoulou M, Zetterberg M, Oskarsdottir S, Andersson Grönlund M.
Assessment of the outcome of ophthalmological screening for uveitis in a cohort of Swedish children with juvenile idiopathic arthritis.
Acta Ophthalmol. 2017 Nov;95(7):741-747
https://www.ncbi.nlm.nih.gov/pubmed/28205413 - Salek SS, Pradeep A, Guly C, Ramanan AV, Rosenbaum JT.
Uveitis and Juvenile Psoriatic Arthritis or Psoriasis.
Am J Ophthalmol. 2017 Oct 31
https://www.ncbi.nlm.nih.gov/pubmed/29101009 - Leinonen ST, Aalto K, Kotaniemi KM, Kivelä TT.
Anti-adalimumab antibodies in juvenile idiopathic arthritis-related uveitis.
Clin Exp Rheumatol. 2017 Nov 14
https://www.ncbi.nlm.nih.gov/pubmed/29148422
OCTUBRE 2017
- Kolomeyer AM, Crane ES, Tu Y, Liu D, Chu DS.
Adult patients with uveitis associated with juvenile idiopathic arthritis: a retrospective review.
Can J Ophthalmol. 2017 Oct;52(5):458-462. doi: 10.1016/j.jcjo.2017.01.011.
https://www.ncbi.nlm.nih.gov/pubmed/28985804 - Fabiani C, Sota J, Rigante D, Vitale A, Emmi G, Vannozzi L, Franceschini R, Bacherini D, Frediani B, Galeazzi M, Tosi GM, Cantarini L.
Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet's Disease.
Ocul Immunol Inflamm. 2017 Oct 5:1-6. doi: 10.1080/09273948.2017.1351573.
https://www.ncbi.nlm.nih.gov/pubmed/28981395
SEPTIEMBRE 2017
- Sarens IL, Casteels I, Anton J, Bader-Meunier B, Brissaud P, Chédeville G, Cimaz R, Dick AD, Espada G, Fernandez-Martin J, Guly CM, Hachulla E, Harjacek M, Khubchandani R, Mackensen F, Merino R, Modesto C, Naranjo A, Oliveira-Knupp S, Özen S, Pajot C, Ramanan AV, Russo R, Susic G, Thatayatikom A, Thomée C, Vastert S, Bertin J, Arostegui JI, Rose CD, Wouters CH.
Blau Syndrome-Associated Uveitis: Preliminary Results From an International Prospective Interventional Case Series.
Am J Ophthalmol. 2017 Sep 6. pii: S0002-9394(17)30371-9. doi: 10.1016/j.ajo.2017.08.017. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/28887115 - Crowell EL, Bahr AK, Adesina OO, Kamdar AA, Kumar KS, Goldberg A.
Orbital Inflammatory Syndrome and Anterior Uveitis: A Case Series.
Ocul Immunol Inflamm. 2017 Sep 29:1-6. doi: 10.1080/09273948.2017.1349156. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/28961042
AGOSTO 2017
- Takkar B, Venkatesh P, Gaur N, Garg SP, Vohra R, Ghose S.
Patterns of uveitis in children at the apex institute for eye care in India: analysis and review of literature.
Int Ophthalmol. 2017 Aug 31. doi: 10.1007/s10792-017-0700-6. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/28861733 - Peng S, Sun X, Sun M.
Adalimumab for Uveitis in Juvenile Idiopathic Arthritis.
N Engl J Med. 2017 Aug 24;377(8):789. doi: 10.1056/NEJMc1708646.
https://www.ncbi.nlm.nih.gov/pubmed/28836421 - Nordal E, Rypdal V, Christoffersen T, Aalto K, Berntson L, Fasth A, Herlin T, Nielsen S, Peltoniemi S, Straume B, Zak M, Rygg M; Nordic Study Group of Pediatric Rheumatology (NoSPeR).
Incidence and predictors of Uveitis in juvenile idiopathic arthritis in a Nordic long-term cohort study.
Pediatr Rheumatol Online J. 2017 Aug 18;15(1):66. doi: 10.1186/s12969-017-0195-8.
https://www.ncbi.nlm.nih.gov/pubmed/28821293 - Sen ES, Morgan MJ, MacLeod R, Strike H, Hinchcliffe A, Dick AD, Muthusamy B, Ramanan AV.
Cross sectional, qualitative thematic analysis of patient perspectives of disease impact in juvenile idiopathic arthritis-associated uveitis.
Pediatr Rheumatol Online J. 2017 Aug 4;15(1):58. doi: 10.1186/s12969-017-0189-6.
https://www.ncbi.nlm.nih.gov/pubmed/28778202
JULIO 2017
- Sardar E, Dusser P, Rousseau A, Bodaghi B, Labetoulle M, Koné-Paut I.
Retrospective Study Evaluating Treatment Decisions and Outcomes of Childhood Uveitis Not Associated with Juvenile Idiopathic Arthritis.
J Pediatr. 2017 Jul;186:131-137.e1. doi: 10.1016/j.jpeds.2017.03.052. Epub 2017 Apr 27.
https://www.ncbi.nlm.nih.gov/pubmed/28457525 - Sota J, Rigante D, Lopalco G, Frediani B, Franceschini R, Galeazzi M, Iannone F, Tosi GM, Fabiani C, Cantarini L.
Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review.
Rheumatol Int. 2017 Jul 27. doi: 10.1007/s00296-017-3775-5. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/28752230
JUNIO 2017
- Rosenbaum JT.
New developments in uveitis associated with HLA B27.
Curr Opin Rheumatol. 2017 Jul;29(4):298-303.
https://www.ncbi.nlm.nih.gov/pubmed/28376061 - Simonini G, Bracaglia C, Cattalini M, Taddio A, Brambilla A, De Libero C, Pires Marafon D, Caputo R, Cimaz R.
Predictors of Relapse after Discontinuing Systemic Treatment in Childhood Autoimmune Chronic Uveitis.
J Rheumatol. 2017 Jun;44(6):822-826.
https://www.ncbi.nlm.nih.gov/pubmed/28365583 - Muñoz-Gallego A, Barral E, Enríquez E, Tejada P, Barceló A, de Inocencio J.
Adalimumab for the treatment of refractory noninfectious paediatric uveitis.
Int Ophthalmol. 2017 Jun;37(3):719-725.
https://www.ncbi.nlm.nih.gov/pubmed/27432171
MAYO 2017
- Lopalco G, Fabiani C, Sota J, Lucherini OM, Tosi GM, Frediani B, Iannone F, Galeazzi M, Franceschini R, Rigante D, Cantarini L.
IL-6 blockade in the management of non-infectious uveitis.
Clin Rheumatol. 2017 May 20. [Epub ahead of print]
ABRIL 2017
- Berker N, Sen E, Elgin U, Atilgan CU, Dursun E, Yilmazbas P.
Analysis of clinical features and visual outcomes of pars planitis
Int Ophthalmol. 2017 Apr 7. doi: 10.1007/s10792-017-0526-2. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28389773
MARZO 2017
- Simonini G, Bracaglia C, Cattalini M, Taddio A, Brambilla A, De Libero C, Pires Marafon D, Caputo R, Cimaz R.
Predictors of Relapse after Discontinuing Systemic Treatment in Childhood Autoimmune Chronic Uveitis.
J Rheumatol. 2017 Apr 1. pii: jrheum.161336. doi: 10.3899/jrheum.161336. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/28365583 - Rosenbaum JT.
New developments in uveitis associated with HLA B27.
Curr Opin Rheumatol. 2017 Apr 3. doi: 10.1097/BOR.0000000000000403. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/28376061
FEBRERO 2017
- Haasnoot AJ, Sint Jago NF, Tekstra J, de Boer JH1.
Impact of uveitis on Quality of Life in Adult patients with Juvenile Idiopathic Arthritis.
Arthritis Care Res (Hoboken). 2017 Feb 19. doi: 10.1002/acr.23224. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28217950 - Papadopoulou M, Zetterberg M,, Oskarsdottir S, Andersson Grönlund M.
Assessment of the outcome of ophthalmological screening for uveitis in a cohort of Swedish children with juvenile idiopathic arthritis.
Acta Ophthalmol. 2017 Feb 15. doi: 10.1111/aos.13388. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28205413 - Quesada-Masachs E, Caballero CM.
Subcutaneous Tocilizumab May Be Less Effective than Intravenous Tocilizumab in the Treatment of Juvenile Idiopathic Arthritis-associated Uveitis.
J Rheumatol. 2017 Feb;44(2):260-261. doi: 10.3899/jrheum.160908.
https://www.ncbi.nlm.nih.gov/pubmed/28148759 - Kahwage PP, Ferriani MP, Furtado JM, de Carvalho LM, Pileggi GS, Gomes FH, Terreri MT, Magalhães CS, Pereira RM, Sacchetti SB, Marini R, Bonfá E, Silva CA, Ferriani VP.
Uveitis in childhood-onset systemic lupus erythematosus patients: a multicenter survey.
Clin Rheumatol. 2017 Mar;36(3):547-553. doi: 10.1007/s10067-016-3534-0. Epub 2017 Jan 9.
https://www.ncbi.nlm.nih.gov/pubmed/28070763
ENERO 2017
- LaMattina KC, Goldstein DA.
Adalimumab for the treatment of uveitis.
Expert Rev Clin Immunol. 2017 Mar;13(3):181-188. doi: 10.1080/1744666X.2017.1288097.
https://www.ncbi.nlm.nih.gov/pubmed/28140700
DICIEMBRE 2016
- Tappeiner C, Mesquida M, Adán A, Anton J, Ramanan AV, Carreno E, Mackensen F, Kotaniemi K, de Boer JH, Bou R, de Vicuña CG, Heiligenhaus A.
Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis.
J Rheumatol. 2016 Dec;43(12):2183-2188.
https://www.ncbi.nlm.nih.gov/pubmed/27633821
NOVIEMBRE 2016
- Pato E, Martin-Martinez MA, Castelló A, Méndez-Fernandez R, Muñoz-Fernández S, Cordero-Coma M, Martinez-Costa L, Valls E, Reyes M, Francisco F, Esteban M, Fonollosa A, Sanchez-Alonso F, Fernández-Espartero C, Diaz-Valle T, Carrasco JM, Beltran-Catalán E, Hernández-Garfella M, Hernández MV, Pelegrin L, Blanco R, Diaz-Valle D.
Development of an activity disease score in patients with uveitis (UVEDAI).
Rheumatol Int. 2016 Nov 4.
https://www.ncbi.nlm.nih.gov/pubmed/27815703 - Birolo C, Zannin ME, Arsenyeva S, Cimaz R, Miserocchi E, Dubko M, Deslandre CJ, Falcini F, Alessio M, La Torre F, Denisova E, Martini G, Nikishina I, Zulian F.
Comparable Efficacy of Abatacept Used as First-line or Second-line Biological Agent for Severe Juvenile Idiopathic Arthritis-related Uveitis.
J Rheumatol. 2016 Nov;43(11):2068-2073.
https://www.ncbi.nlm.nih.gov/pubmed/27633826
SEPTIEMBRE 2016
- Breitbach M, Tappeiner C, Böhm MR, Zurek-Imhoff B, Heinz C, Thanos S, Ganser G, Heiligenhaus A.
Discontinuation of long-term adalimumab treatment in patients with juvenile idiopathic arthritis-associated uveitis.
Graefes Arch Clin Exp Ophthalmol. 2016 Sep 30.
https://www.ncbi.nlm.nih.gov/pubmed/27687987 - Balevic SJ, Rabinovich CE.
Drug Des Devel Ther. 2016 Sep 19;10:2997-3003.
Profile of adalimumab and its potential in the treatment of uveitis.
https://www.ncbi.nlm.nih.gov/pubmed/27698552 - Haasnoot AJ, Vernie LA, Rothova A, V D Doe P, Los LI, Schalij-Delfos NE, de Boer JH.
Impact of Juvenile Idiopathic Arthritis Associated Uveitis in Early Adulthood.
PLoS One. 2016 Oct 10;11(10):e0164312.
https://www.ncbi.nlm.nih.gov/pubmed/27723840 - Calvo-Río V, Santos-Gómez M, Calvo I, González-Fernández MI, López Montesinos B, Mesquida M, Adán A, Victoria Hernández M, Maíz O, Atanes A, Bravo B, Modesto C, Díaz-Cordovés G, Palmou-Fontana N, Loricera J, González-Vela MC, Demetrio-Pablo R, Hernández JL, González-Gay MA, Blanco R.
Anti-IL6-R Tocilizumab for Severe Juvenile Idiopathic Arthritis-Associated Uveitis Refractory to anti-TNF therapy. A multicenter study of 25 patients.
Arthritis Rheumatol. 2016 Oct 1.
https://www.ncbi.nlm.nih.gov/pubmed/27696756 - Böhm MR, Tappeiner C, Breitbach MA, Zurek-Imhoff B, Heinz C, Heiligenhaus A.
Ocular hypotony in patients with juvenile idiopathic arthritis - associated uveitis.
Am J Ophthalmol. 2016 Sep 21.
https://www.ncbi.nlm.nih.gov/pubmed/27664701 - Tappeiner C, Mesquida M, Adán A, Anton J, Ramanan AV, Carreno E, Mackensen F, Kotaniemi K, de Boer JH, Bou R, de Vicuña CG, Heiligenhaus A.
Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis.
J Rheumatol. 2016 Sep 15.
https://www.ncbi.nlm.nih.gov/pubmed/27633821 - Moradi A, Stroh IG, Reddy AK, Hornbeak DM, Leung TG, Burkholder BM, Thorne JE.
Risk of Hypotony in Juvenile Idiopathic Arthritis-Associated Uveitis.
Am J Ophthalmol. 2016 Sep;169:113-24.
https://www.ncbi.nlm.nih.gov/pubmed/27345732
AGOSTO 2016
- Tappeiner C, Mesquida M, Adán A, Anton J, Ramanan AV, Carreno E, Mackensen F, Kotaniemi K, de Boer JH, Bou R, de Vicuña CG, Heiligenhaus A.
Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis.
J Rheumatol. 2016 Sep 15. pii: jrheum.160231. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27633821 - Birolo C, Zannin ME, Arsenyeva S, Cimaz R, Miserocchi E, Dubko M, Deslandre CJ, Falcini F, Alessio M, La Torre F, Denisova E, Martini G, Nikishina I, Zulian F.
Comparable Efficacy of Abatacept Used as First-line or Second-line Biological Agent for Severe Juvenile Idiopathic Arthritis-related Uveitis.
J Rheumatol. 2016 Sep 15. pii: jrheum.151389. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/27633826 - Guindolet D, Dureau P, Terrada C, Edelson C, Barjol A, Caputo G, LeHoang P, Bodaghi B.
Cataract Surgery with Primary Lens Implantation in Children with Chronic Uveitis.
Ocul Immunol Inflamm. 2016 Sep 6:1-7. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27599095 - Paovic J, Paovic P, Sredovic V, Jovanovic S
Clinical Manifestations, Complications and Treatment of Ocular Sarcoidosis: Correlation between Visual Efficiency and Macular Edema as Seen on Optical Coherence Tomography.
Semin Ophthalmol. 2016 Sep 14:1-8. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/27628176
JULIO 2016
- Haasnoot AM, Kuiper JJ, Hiddingh S, Schellekens PA, de Jager W, Imhof SM, Radstake TR, de Boer JH.
Ocular Fluid Analysis in Children Reveals Interleukin-29/Interferon-λ1 as a Biomarker for Juvenile Idiopathic Arthritis-Associated Uveitis.
Arthritis Rheumatol. 2016 Jul;68(7):1769-79. doi: 10.1002/art.39621.
http://www.ncbi.nlm.nih.gov/pubmed/26866822 - Muñoz-Gallego A, Barral E, Enríquez E, Tejada P, Barceló A, de Inocencio J
Adalimumab for the treatment of refractory noninfectious paediatric uveitis.
Int Ophthalmol. 2016 Jul 18. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27432171 - Kostik MM, Gaidar EV, Hynnes AY, Dubko MF, Masalova VV, Snegireva LS, Chikova IA, Isupova EA, Nikitina TN, Serogodskaya ED, Kalashnikova OV, Ravelli A, Chasnyk VG.
Methotrexate treatment may prevent uveitis onset in patients with juvenile idiopathic arthritis: experiences and subgroup analysis in a cohort with frequent methotrexate use.
Clin Exp Rheumatol. 2016 Jul-Aug;34(4):714-8. Epub 2016 Jun 22.
http://www.ncbi.nlm.nih.gov/pubmed/27385618
JUNIO 2016
- García Munitis P, Ves Losada JE, Mata E.
Uveitis: when the referral is to the pediatrician.
Arch Argent Pediatr. 2016 Jun 1;114(3):272-6. doi: 10.5546/aap.2016.272.
http://www.ncbi.nlm.nih.gov/pubmed/27164341
MAYO 2016
- Couto C, Frick MM, LaMattina K, Schlaen A, Khoury M, Lopez MM, et al.
Chronic Anterior Uveitis in Children.
Ocul Immunol Inflamm. 2016 May 18:1-5. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27191963
ABRIL 2016
- Clarke SL, Sen ES, Ramanan AV.
Juvenile idiopathic arthritis-associated uveitis.
Pediatr Rheumatol Online J. 2016 Apr 27;14(1):27. doi: 10.1186/s12969-016-0088-2. Review.
http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27121190 - Oray M, Khachatryan N, Ebrahimiadib N, Abu Samra K, Lee S, Foster CS.
Ocular morbidities of juvenile idiopathic arthritis-associated uveitis in adulthood: results from a tertiary center study.
Graefes Arch Clin Exp Ophthalmol. 2016 Apr 15. [Epub ahead of print] http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27084082 - Castiblanco C, Meese H, Foster CS.
Treatment of pediatric uveitis with adalimumab: the MERSI experience.
J AAPOS. 2016 Apr;20(2):145-7. doi: 10.1016/j.jaapos.2015.12.006.
http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27079596
MARZO 2016
- Vallet H, Seve P, Biard L, Baptiste Fraison J, Bielefeld P, Perard L, et al; french uveitis network.
Infliximab versus adalimumab in the treatment of refractory inflammatory uveitis: Multicenter study from the french uveitis network.
Arthritis Rheumatol. 2016 Mar 25. doi: 10.1002/art.39667. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27015607 - Silpa-Archa S, Oray M, Preble JM, Foster CS.
Outcome of tocilizumab treatment in refractory ocular inflammatory diseases.
Acta Ophthalmol. 2016 Mar 24. doi: 10.1111/aos.13015. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27010181 - Stroh IG, Moradi A, Burkholder BM, Hornbeak DM, Leung TG, Thorne JE.
Occurrence of and Risk Factors for Ocular Hypertension and Secondary Glaucoma inJuvenile Idiopathic Arthritis-associated Uveitis.
Ocul Immunol Inflamm. 2016 Mar 22:1-10. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27003850 - Verhagen FH, Brouwer AH, Kuiper JJ, Ossewaarde-van Norel J, Ten Dam-van Loon NH, de Boer JH.
Potential Predictors of Poor Visual Outcome in Human Leukocyte Antigen-B27-Associated Uveitis.
Am J Ophthalmol. 2016 Mar 3. pii: S0002-9394(16)30074-5. doi: 10.1016/j.ajo.2016.02.024. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26940162 - Yeo TH, Ilangovan S, Keane PA, Pavesio C, Agrawal R.
Discrepancies in assessing anterior chamber activity among uveitis specialists.
Jpn J Ophthalmol. 2016 Mar 28. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/27020454 - Rosenbaum JT, Lin P, Asquith M.
Does the Microbiome Cause B27-related Acute Anterior Uveitis?
Ocul Immunol Inflamm. 2016 Mar 22:1-5. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27002532 - Phatak S, Lowder C, Pavesio C.
Controversies in intraocular lens implantation in pediatric uveitis.
J Ophthalmic Inflamm Infect. 2016 Dec;6(1):12. doi: 10.1186/s12348-016-0079-
http://www.ncbi.nlm.nih.gov/pubmed/27009616 - Abásolo L, Prieto-García Á, Díaz-Valle D, Benítez-Del-Castillo JM, Pato E, García-Feijoo J, Fernández-Gutiérrez B, Rodriguez-Rodriguez L
Influence of baseline demographic and clinical characteristics in the visual outcome of intermediate uveitis: a survival analysis.
Br J Ophthalmol. 2016 Mar 30. pii: bjophthalmol-2015-307774. doi: 10.1136/bjophthalmol-2015-307774. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27030281 - Lavezzo MM, Sakata VM, Morita C, Rodriguez EE, Abdallah SF, da Silva FT, Hirata CE, Yamamoto JH.
Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes.
Orphanet J Rare Dis. 2016 Mar 24;11(1):29. doi: 10.1186/s13023-016-0412-4.
http://www.ncbi.nlm.nih.gov/pubmed/27008848 - Nobre-Cardoso J, Champion E, Darugar A, Fel A, Lehoang P, Bodaghi B.
Treatment of Non-infectious Uveitic Macular Edema with the Intravitreal Dexamethasone Implant.
Ocul Immunol Inflamm. 2016 Mar 22:1-8. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27003221
FEBRERO 2016
- Henderson LA, Zurakowski D, Angeles-Han ST, Lasky A, Rabinovich CE, Lo MS; CARRA Registry Investigators.
Medication use in juvenile uveitis patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance Registry.
Pediatr Rheumatol Online J. 2016 Feb 16;14(1):9. doi: 10.1186/s12969-016-0069-5.
http://www.ncbi.nlm.nih.gov/pubmed/26879972 - Kolomeyer AM, Tu Y, Miserocchi E, Ranjan M, Davidow A, Chu DS.
Chronic Non-infectious Uveitis in Patients with Juvenile Idiopathic Arthritis.
Ocul Immunol Inflamm. 2016 Feb 22:1-9. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26902465 - Haasnoot AJ, Kuiper JJ, Hiddingh S, Schellekens PA, de Jager W2, Imhof SM, Radstake TR, de Boer JH.
Ocular fluid analysis in children reveals interleukin-29/interferon-λ1 as a biomarker for juvenile idiopathic arthritis associated uveitis.
Arthritis Rheumatol. 2016 Feb 11. doi: 10.1002/art.39621. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26866822 - Amin RM, Miserocchi E, Thorne JE, Hornbeak D, Jabs DA, Zierhut M.
Treatment Options for Juvenile Idiopathic Arthritis (JIA) Associated Uveitis.
Ocul Immunol Inflamm. 2016 Feb;24(1):81-90. doi: 10.3109/09273948.2015.1077976. Epub 2015 Dec 11.
http://www.ncbi.nlm.nih.gov/pubmed/26652068 - Grixti A, Hagan R, Nayak H, Chandna A.
Multifocal choroiditis with panuveitis in an 8-year-old boy with long standing idiopathic acute anterior uveitis.
Eur J Ophthalmol. 2016 Feb 29:0. doi: 10.5301/ejo.5000772. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26951535
ENERO 2016
- Tappeiner C, Schenck S, Niewerth M, Heiligenhaus A, Minden K, Klotsche J.
Impact of Antiinflammatory Treatment on the Onset of Uveitis in Juvenile Idiopathic Arthritis: Longitudinal Analysis From a Nationwide Pediatric Rheumatology Database.
Arthritis Care Res (Hoboken). 2016 Jan;68(1):46-54. doi: 10.1002/acr.22649.
http://onlinelibrary.wiley.com/doi/10.1002/acr.22649/abstract
DICIEMBRE 2015
- Tappeiner C, Klotsche J, Schenck S, Niewerth M, Minden K, Heiligenhaus A.
Temporal change in prevalence and complications of uveitis associated with juvenile idiopathic arthritis:data from a cross-sectional analysis of a prospective nationwide study.
Clin Exp Rheumatol. 2015 Nov-Dec;33(6):936-44.
http://www.ncbi.nlm.nih.gov/pubmed/26517055
NOVIEMBRE 2015
- Sheila T. Angeles-Han, Steven Yeh, Courtney McCracken, Kirsten Jenkins, Daneka Stryker, Erica Myoung, Larry B. Vogler, Kelly Rouster-Stevens, Scott R. Lambert, Melanie J. Harrison, Sampath Prahalad and Carolyn Drews-Botsch
Using the Effects of Youngsters’ Eyesight on Quality of Life Questionnaire to Measure Visual Outcomes in Children With Uveitis (pages 1513–1520)
Arthritis Care & Research DOI: 10.1002/acr.22627
Abstract - Ivan Foeldvari, Ingrid Becker and Gerd Horneff
Uveitis Events During Adalimumab, Etanercept, and Methotrexate Therapy in Juvenile Idiopathic Arthritis: Data From the Biologics in Pediatric Rheumatology Registry (pages 1529–1535)
Arthritis Care & Research
DOI: 10.1002/acr.22613
Abstract
OCTUBRE 2015
- Haroon M, O'Rourke M, Ramasamy P, Murphy CC, FitzGerald O.
A novel evidence-based detection of undiagnosed spondyloarthritis in patients presenting with acute anterior uveitis: the DUET (Dublin Uveitis Evaluation Tool)
Ann Rheum Dis 2015;74:1990-5.
http://ard.bmj.com/content/74/11/1990.abstract - Gupta A, Ramanan AV
Uveitis in Children: Diagnosis and Management.
Indian J Pediatr. 2015 Sep 30. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/26420255 - Angeles-Han ST, McCracken C, Yeh S, Jang SR, Jenkins K, Cope S, Bohnsack J, Hersh A, Thompson SD, Prahalad S
HLA Associations in a Cohort of Children With Juvenile Idiopathic Arthritis With and Without Uveitis
Invest Ophthalmol Vis Sci. 2015 Sep 1;56(10):6043-8. doi: 10.1167/iovs.15-17168.
http://www.ncbi.nlm.nih.gov/pubmed/26393471
SEPTIEMBRE 2015
- Simonini G, Cimaz R, Jones GT, Macfarlane GJ.
Non-anti-TNF biologic modifier drugs in non-infectious refractory chronic uveitis: The current evidence from a systematic review.
Semin Arthritis Rheum. 2015 Oct;45(2):238-50. doi: 10.1016/j.semarthrit.2015.05.006
http://www.ncbi.nlm.nih.gov/pubmed/26164255 - Miserocchi E, Modorati G, Berchicci L, Pontikaki I, Meroni P, Gerloni V.
Long-term treatment with rituximab in severe juvenile idiopathic arthritis-associated uveitis.
Br J Ophthalmol. 2015 Sep 22. pii: bjophthalmol-2015-306790. doi: 10.1136/bjophthalmol-2015-306790. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26396026
AGOSTO 2015
- Angeles-Han ST, McCracken C, Yeh S, Jenkins K, Stryker D, Travers C, Rouster-Stevens K, Vogler LB, Lambert SR, Drews-Botsch C, Prahalad S.
The Association of Race with Childhood Uveitis.
Am J Ophthalmol. 2015 Aug 6. pii:S0002-9394(15)00463-8. doi: 10.1016/j.ajo.2015.08.002. EPUB ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/26255577 - Liang F, Terrada C, Ducos de Lahitte G, Quartier P, Lehoang P, Thorne JE, Bodaghi B.
Foveal Serous Retinal Detachment in Juvenile Idiopathic Arthritis-associated Uveitis.
Ocul Immunol Inflamm. 2015 Aug 19:1-6. EPUB ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/26171661 - Marrani E, Paganelli V, de Libero C, Cimaz R, Simonini G.
Long-term efficacy of abatacept in pediatric patients with idiopathic uveitis: a case series.
Graefes Arch Clin Exp Ophthalmol. 2015 Aug 27. EPUB ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/26311261
JULIO 2015
- Tappeiner C, Schenck S, Niewerth M, Heiligenhaus A, Minden K, Klotsche J
Impact of anti-inflammatory treatment on the onset of uveitis in juvenile idiopathic arthritis: Longitudinal analysis from a nation-wide paediatric rheumatological database.
Arthritis Care Res (Hoboken). 2015 Jul 20. doi: 10.1002/acr.22649. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26212111
JUNIO 2015
- de Groot-Mijnes JD, Dekkers J, de Visser L, Rothova A, van Loon AM, de Boer JH.
Antibody Production against B19 Virus in Ocular Fluid of JIA-Associated Uveitis Patients.
Ophthalmology. 2015 Jun;122(6):1270-1272.e1. doi: 10.1016/j.ophtha.2015.01.006.
http://www.ncbi.nlm.nih.gov/pubmed/25704320 - Rosenbaum JT.
Uveitis in spondyloarthritis including psoriatic arthritis, ankylosing spondylitis, and inflammatory bowel disease.
Clin Rheumatol. 2015 Jun;34(6):999-1002. doi: 10.1007/s10067-015-2960-8.
http://www.ncbi.nlm.nih.gov/pubmed/25953065 - Angeles-Han ST, McCracken C, Yeh S, Jenkins K, Stryker D, Rouster-Stevens K, Vogler LB, Lambert SR et al.
Characteristics of a cohort of children with Juvenile Idiopathic Arthritis and JIA-associated Uveitis
Pediatr Rheumatol Online J. 2015 Jun 2;13:19. doi: 10.1186/s12969-015-0018-8.
http://www.ncbi.nlm.nih.gov/pubmed/26031738 - Sen ES, Dick AD, Ramanan AV.
Uveitis associated with juvenile idiopathic arthritis.
Nat Rev Rheumatol. 2015 Jun;11(6):338-348. doi: 10.1038/nrrheum.2015.20.
http://www.ncbi.nlm.nih.gov/pubmed/25825278
MAYO 2015
- Alejandro Rodríguez-García
Importancia de la evaluación oftalmológica en pacientes con artritis idiopática juvenil
Reumatol Clin.2015;11:133-8 - Vol. 11 Núm.03 DOI: 10.1016/j.reuma.2014.08.003
http://www.reumatologiaclinica.org/es/importancia-evaluacion-oftalmologica-pacientes-con/articulo/90411536/ - Rosa Bou, Alfredo Adán, Fátima Borrás, Beatriz Bravo, Inmaculada Calvo, Jaime De Inocencio, Jesús Díaz, Julia Escudero, Alex Fonollosa, Carmen García de Vicuña, Victoria Hernández, Rosa Merino, Jesús Peralta, María-Jesús Rúa, Pilar Tejada and Jordi Antón
Clinical management algorithm of uveitis associated with juvenile idiopathic arthritis: interdisciplinary panel consensus
Rheumatology International. Clinical and Experimental Investigations 2015
35:3231 DOI: 10.1007/s00296-015-3231-3
http://link.springer.com/article/10.1007/s00296-015-3231-3/fulltext.html
ABRIL 2015
- Klotsche J, Niewerth M, Haas JP, Huppertz HI, Zink A, Horneff G, Minden K.
Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA).
Ann Rheum Dis. 2015 Apr 29. pii: annrheumdis-2014-206747. doi: 10.1136/annrheumdis-annrheumdis-2014-206747. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25926155 - Lerman MA, Rabinovich CE.
The Future Is Now: Biologics for Non-Infectious Pediatric Anterior Uveitis.
Paediatr Drugs. 2015 Apr 17. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25893479
MARZO 2015
- Sen ES, Dick AD, Ramanan AV.
Uveitis associated with juvenile idiopathic arthritis.
Nat Rev Rheumatol. 2015 Mar 31. doi: 10.1038/nrrheum.2015.20. [Epub ahead of print] Review.
http://www.ncbi.nlm.nih.gov/pubmed/25825278
FEBRERO 2015
- Heiligenhaus, A; Minden, K; Föll, D; Pleyer, U
Uveitis in juvenile idiopathic arthritis.
Dtsch Arztebl Int. 2015 Feb 6;112(6):92-100.
http://www.ncbi.nlm.nih.gov/pubmed/25721436 - Bou R, Adán A, Borrás F, Bravo B, Calvo I, De Inocencio J, Díaz J, Escudero J, Fonollosa A, de Vicuña CG, Hernández V, Merino R, Peralta J, Rúa MJ, Tejada P, Antón J.
Clinical management algorithm of uveitis associated with juvenile idiopathic arthritis: interdisciplinary panel consensus.
Rheumatol Int. 2015 Feb 6.
http://www.ncbi.nlm.nih.gov/pubmed/25656443 - Tappeiner C, Miserocchi E, Bodaghi B, Kotaniemi K, Mackensen F, Gerloni V, Quartier P, Lutz T, Heiligenhaus A.
Abatacept in the Treatment of Severe, Longstanding, and Refractory Uveitis Associated with Juvenile Idiopathic Arthritis.
J Rheumatol. 2015 Feb 1.
http://www.ncbi.nlm.nih.gov/pubmed/25641892 - Haasnoot AJ, van Tent-Hoeve M, Wulffraat NM, Schalij-Delfos NE, Los LI, Armbrust W, Zuithoff NP, de Boer JH.
Erythrocyte sedimentation rate as baseline predictor for the development of uveitis in children with juvenile idiopathic arthritis.
Am J Ophthalmol. 2015 Feb;159(2):372-7.
http://www.ncbi.nlm.nih.gov/pubmed/25447121
ENERO 2015
- Christoph Tappeiner, Elisabetta Miserocchi, Bahram Bodaghi, Kaisu Kotaniemi, Friederike Mackensen, Valeria Gerloni, Pierre Quartier, Thomas Lutz and Arnd Heiligenhaus
Abatacept in the Treatment of Severe, Longstanding, and Refractory Uveitis Associated with Juvenile Idiopathic Arthritis
J Rheumatol published online before print February 1, 2015,doi:10.3899/jrheum.140410
http://www.jrheum.org/content/early/2015/01/27/jrheum.140410.abstract
DICIEMBRE 2014
- Rodríguez-García A.
Importancia de la evaluación oftalmológica en pacientes con artritis idiopática juvenil.
Reumatol Clin. 2014 Dec 2. pii: S1699-258X(14)00169-7. doi: 10.1016/j.reuma.2014.08.003. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25488285
NOVIEMBRE 2014
- Hettinga YM, Verhagen FH, van Genderen M, de Boer JH.
Characteristics of childhood uveitis leading to visual impairment and blindness in the Netherlands.
Acta Ophthalmol. 2014 Dec;92(8):798-804.
http://www.ncbi.nlm.nih.gov/pubmed/?term=24975684
OCTUBRE 2014
- Langner-Wegscheider BJ, de Smet MD
Surgical Management of Severe Complications Arising from Uveitis in Juvenile Idiopathic Arthritis
Ophthalmologica. 2014 Oct 18. [Epub ahead of print]
SEPTIEMBRE 2014
- Kalinina Ayuso V, Makhotkina N, van Tent-Hoeve M, de Groot-Mijnes JD, Wulffraat NM, Rothova A, de Boer JH.
Pathogenesis of juvenile idiopathic arthritis associated uveitis: the known and unknown.
Surv Ophthalmol. 2014 September - October;59(5):517-531.
http://www.ncbi.nlm.nih.gov/pubmed/25130893
AGOSTO 2014
- Foeldvari I.
Ocular Involvement in Juvenile Idiopathic Arthritis: Classification and Treatment.
Clin Rev Allergy Immunol. 2014 Aug 1. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/25081063 - Bou R1, Iglesias E, Antón J.
Treatment of uveitis associated with juvenile idiopathic arthritis.
Curr Rheumatol Rep. 2014 Aug; 16(8):437. doi: 10.1007/s11926-014-0437-4.
http://www.ncbi.nlm.nih.gov/pubmed/24938442
JULIO 2014
- Interlandi E, Leccese P, Olivieri I, Latanza L.
Adalimumab for treatment of severe Behçet's uveitis: a retrospective long-term follow-up study.
Clin Exp Rheumatol. 2014 Jul 8. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/25005224 - Vastert SJ1, Bhat P, Goldstein DA.
Pathophysiology of JIA-associated Uveitis.
Ocul Immunol Inflamm. 2014 Jul 2:1-10.
http://www.ncbi.nlm.nih.gov/pubmed/24988139 - Simonini G1, Katie D, Cimaz R, Macfarlane GJ, Jones GT.
Current Evidence of Anti-TNFα treatment efficacy in childhood chronic uveitis: A systematic review and meta-analysis approach of individual drugs.
Arthritis Care Res (Hoboken). 2014 July;66(7):1073-84 doi: 10.1002/acr.22214.
http://www.ncbi.nlm.nih.gov/pubmed/24740981 - Calandra S1, Gallo MC1, Consolaro A1, Pistorio A1, Lattanzi B1, Bovis F1, Muratore V1, De Marco R1, Martini A1, Ravelli A2.
Female sex and oligoarthritis category are not risk factors for uveitis in italian children with juvenile idiopathic arthritis.
J Rheumatol. 2014 Jul;41(7):1416-25. doi: 10.3899/jrheum.131494. Epub 2014 Jun 15.
http://www.ncbi.nlm.nih.gov/pubmed/24931957
JUNIO 2014
- Wong MM, Anninger W.
The Pediatric Red Eye.
Pediatr Clin North Am. 2014 Jun;61(3):591-606
http://www.ncbi.nlm.nih.gov/pubmed/24852155
MAYO 2014
- Totan Y, Güler E, Guragaç FB, Dervisogullari MS, Tenlik A, Hepsen IF.
Cystoid macular edema associated with juvenile idiopathic arthritis resolved by a dexamethasone intravitreal implant.
J Pediatr Ophthalmol Strabismus. 2014 May 6;51:e25-8. doi: 10.3928/01913913-20140429-01.
http://www.ncbi.nlm.nih.gov/pubmed/24811080
ABRIL 2014
- Emmi G, Silvestri E, Ciucciarelli L, Squatrito D, Emmi L.
Anti-IL1 blocking agents in drug-resistant Behçet's syndrome: our little case series.
Clin Exp Rheumatol. 2014 Apr 7. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24709082
FEBRERO 2014
- Pasadhika S, Rosenbaum JT.
Update on the use of systemic biologic agents in the treatment of noninfectious uveitis.
Biologics. 2014 Feb 15;8:67-81.
http://www.ncbi.nlm.nih.gov/pubmed/24600203 - Tugal-Tutkun 1, Quartier P, Bodaghi B.
Disease of the Year: Juvenile Idiopathic Arthritis-associated Uveitis-Classification and Diagnostic Approach.
Ocul Immunol Inflamm. 2014 Feb;22(1):56-63. doi: 10.3109/09273948.2013.871565. Epub 2014 Jan 10.
http://www.ncbi.nlm.nih.gov/pubmed/24410427 - Pålsson S, Nyström A, Sjödell L, Jakobsson G, Byhr E, Andersson Grönlund M, Zetterberg M.
Combined Phacoemulsification, Primary Intraocular Lens Implantation, and Pars Plana Vitrectomy in Children with Uveitis.
Ocul Immunol Inflamm. 2014 Feb 24. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24564567 - Angeles-Han ST, Yeh S, Vogler LB.
Updates on the risk markers and outcomes of severe juvenile idiopathic arthritis-associated uveitis.
Int J Clin Rheumtol. 2013 Feb 1;8(1). doi: 10.2217/ijr.12.83.
http://www.ncbi.nlm.nih.gov/pubmed/24187594
ENERO 2014
- de Boer J, Steijaert A, van den Bor R, Stellato R, Ossewaarde-van Norel J.
Development of Macular Edema and Impact on Visual Acuity in Uveitis Associated with Juvenile Idiopathic Arthritis.
Ocul Immunol Inflamm. 2014 Jan 10. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24410459
DICIEMBRE 2013
- Levy-Clarke G, Jabs DA, Read RW, Rosenbaum JT, Vitale A, Van Gelder RN.
Expert Panel Recommendations for the Use of Anti-Tumor Necrosis Factor Biologic Agents in Patients with Ocular Inflammatory Disorders.
Ophthalmology. 2013 Dec 17. pii: S0161-6420(13)00893-2. doi: 10.1016/j.ophtha.2013.09.048. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24359625 - Kotaniemi K, Sihto-Kauppi K, Salomaa P, Säilä H, Ristolainen L, Kauppi M.
The frequency and outcome of uveitis in patients with newly diagnosed juvenile idiopathic arthritis in two 4-year cohorts from 1990-1993 and 2000-2003.
Clin Exp Rheumatol. 2013 Dec 16. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24351424 - Artornsombudh P, Pistilli M, Foster CS, Pujari SS, Gangaputra SS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Kempen JH.
Factors Predictive of Remission of New-Onset Anterior Uveitis.
Ophthalmology. 2013 Dec 14. pii: S0161-6420(13)00886-5. doi: 10.1016/j.ophtha.2013.09.041. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24342020 - Angeles-Han ST, Pelajo CF, Vogler LB, Rouster-Stevens K, Kennedy C, Ponder L, McCracken C, Lopez-Benitez J, Drews-Botsch C, Prahalad S; CARRA Registry Investigators.
Risk Markers of Juvenile Idiopathic Arthritis-associated Uveitis in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry.
J Rheumatol. 2013 Dec;40(12):2088-96. doi: 10.3899/jrheum.130302. Epub 2013 Nov 1.
http://www.ncbi.nlm.nih.gov/pubmed/24187099
OCTUBRE 2013
- Hu-Torres S, Foster CS.
Disease of the Year: Juvenile Idiopathic Arthritis-Differential Diagnosis.
Ocul Immunol Inflamm.2013 Oct 9. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/24107146
AGOSTO 2013
-
Lerman MA, Burnham JM, Chang PY, Daniel E, Foster CS, Hennessy S, Jabs DA, Joffe MM, Oktay Kaçmaz R, Levy-Clarke GA, Mills MD, Nussenblatt RB,Rosenbaum JT, Suhler EB, Thorne JE, Kempen JH.Response of Pediatric Uveitis to Tumor Necrosis Factor-a Inhibitors.J Rheumatol. 2013 Aug;40(8):1394-1403.
JUNIO 2013
- Zierhut M, Heiligenhaus A, deBoer J, Cunningham ET, Tugal-Tutkun I.
Controversies in juvenile idiopathic arthritis-associated uveitis.
Ocul Immunol Inflamm. 2013 Jun;21(3):167-79. doi: 10.3109/09273948.2013.800561.
http://www.ncbi.nlm.nih.gov/pubmed/23713826
MAYO 2013
- Papadopoulou C, Kostik M, Böhm M, Nieto-Gonzalez JC, Gonzalez-Fernandez MI, Pistorio A, Martini A, Ravelli A.
Methotrexate Therapy May Prevent the Onset of Uveitis in Juvenile Idiopathic Arthritis.
J Pediatr 2013 May 9. pii: S0022-3476(13)00323-5. doi: 10.1016/j.jpeds.2013.03.047. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/23664559 - Simonini G, Paudyal P, Jones GT, Cimaz R,Macfarlane GJ.
Current evidence of methotrexate efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach.
Rheumatology 2013 May; 52:825-31.
http://www.ncbi.nlm.nih.gov/pubmed/22879466 - Sakai T, Watanabe H, Kuroyanagi K, Akiyama G, Okano K, Kohno H, Tsuneoka H.
Health- and vision-related quality of life in patients receiving infliximab therapy for Behcet uveitis.
Br J Ophthalmol. 2013; 97:338-42.
http://www.ncbi.nlm.nih.gov/pubmed/23314623
ENERO 2013
-
Zannin ME, Birolo C, Gerloni VM, Miserocchi E, et al.Safety and Efficacy of Infliximab and Adalimumab for Refractory Uveitis in Juvenile Idiopathic Arthritis: 1-year Followup Data from the Italian Registry.J Rheumatol. 2013 Jan;40(1):74-9. doi: 10.3899/jrheum.120583.
OCTUBRE 2012
- Gregory AC 2nd,Kempen JH,Daniel E et al.
Risk Factors for Loss of Visual Acuity among Patients with Uveitis Associated with Juvenile Idiopathic Arthritis: The Systemic Immunosuppressive Therapy for Eye Diseases Study.
Ophthalmology.2012 Oct 11. pii: S0161-6420(12)00687-2. doi: 10.1016/j.ophtha.2012.07.052. [Epub ahead of print].
http://www.ncbi.nlm.nih.gov/pubmed/23062650
SEPTIEMBRE 2012
- Heiligenhaus A, Foeldvari I, Edelsten C, Smith JR, Saurenmann RK, Bodaghi B, de Boer J, Graham E, Anton J, Kotaniemi K, Mackensen F, Minden K, Nielsen S, Rabinovich EC, Ramanan AV, Strand V; Multinational Interdisciplinary Working Group for Uveitis in Childhood.
Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: a consensus effort from the multinational interdisciplinary working group for uveitis in childhood.
Arthritis Care Res (Hoboken). 2012 Sep;64(9):1365-72. doi: 10.1002/acr.21674.
http://www.ncbi.nlm.nih.gov/pubmed/22438273
JUNIO 2012
- Tappeiner C, Heinz C, Ganser G, Heiligenhaus A
Is tocilizumab an effective option for treatment of refractory uveitis associated with juvenile idiopathic arthritis?
J Rheumatol. 2012 Jun;39(6):1294-5
http://www.ncbi.nlm.nih.gov/pubmed/22661419
Última actualización: 15 abril 2026
MARZO 2026
-
de Rosas EC, Wang JC, Zigler CK, Torok KS.
Methotrexate and Mycophenolate Mofetil and Clinical Response in Juvenile Localized Scleroderma.
JAMA Dermatol. 2026 Mar 1;162(3):271-278. doi: 10.1001/jamadermatol.2025.5662.
https://pubmed.ncbi.nlm.nih.gov/41604178/ -
Qi X, Chen X, Dai X, Xie X, Liu H, Zhao Z.
A retrospective analysis of clinical characteristics of systemic sclerosis-associated interstitial lung disease.
Medicine (Baltimore). 2026 Mar 6;105(10):e47876. doi: 10.1097/MD.0000000000047876.
https://pubmed.ncbi.nlm.nih.gov/41790634/ -
Ross L, Burns AT, La Gerche A, Hansen D, Coghlan JG, Stevens W, et al; and the SCTC Cardiac Working Group.
Scleroderma clinical trials consortium classification criteria for systemic sclerosis heart involvement.
çRheumatology (Oxford). 2026 Mar 5;65(3):keag109. doi: 10.1093/rheumatology/keag109.
https://pubmed.ncbi.nlm.nih.gov/41758916/ -
Perazzi M, Croce E, Macrì G, Pedrazzoli RZ, Sola D, Patrucco F, et al.
Evaluation of non-invasive techniques for the diagnosis of pulmonary complications in systemic sclerosis and scleroderma-like overlap syndromes: role of lung ultrasound
J Autoimmun. 2026 Mar;159:103537. doi: 10.1016/j.jaut.2026.103537.
https://pubmed.ncbi.nlm.nih.gov/41764846/ -
Gkouvi A, Liapis NM, Zafiriou E, Bogdanos DP, Katsiari CG, Simopoulou T.
Hyaluronic acid fillers in systemic sclerosis and localized scleroderma: A systematic review.
Autoimmun Rev. 2026 Mar;25(3):104009. doi: 10.1016/j.autrev.2026.104009.
https://pubmed.ncbi.nlm.nih.gov/41730404/ -
Campochiaro C, Maltez N, Suliman Y, Alunno A, Alcacer-Pitarch B, Allanore Y, et al.
Points to consider for reporting digital ulcers in systemic sclerosis interventional studies: An initiative from the world Scleroderma Foundation digital ulcer ad hoc committee.
Autoimmun Rev. 2026 Mar;25(3):104010. doi: 10.1016/j.autrev.2026.104010.
https://pubmed.ncbi.nlm.nih.gov/41740914/ -
Alqahtani S, Cacace F, Bauchat A, DePriest BP, Driscoll TA, Bonfim C,et al
Autologous stem cell transplant for severe, progressive juvenile systemic sclerosis.
Stem Cells Transl Med. 2026 Mar 23;15(4):szag005. doi: 10.1093/stcltm/szag005.
https://pubmed.ncbi.nlm.nih.gov/41866801/
FEBRERO 2026
-
Foeldvari I, Pain CE.
Juvenile systemic sclerosis.
Best Pract Res Clin Rheumatol. 2026 Feb 3:102116.
https://pubmed.ncbi.nlm.nih.gov/41638996/
ENERO 2026
- Murarasu A, Beaudeau L, Le Guern V, Guettrot-Imbert G, Cazalets C, Durant C, et al.
Fetal and maternal outcome in the pregnancies of patients with systemic sclerosis and very early diagnosis of systemic sclerosis in France: a prospective study.
Lancet Rheumatol. 2026 Jan;8(1):e33-e41
https://pubmed.ncbi.nlm.nih.gov/41173018/
OCTUBRE 2025
-
Mattson J, Bao H, Flack M, Coeytaux K.
Incidence and prevalence of juvenile SSc in the United States: An analysis by age group.
J Scleroderma Relat Disord. 2025 Oct 16:23971983251370871.
https://pubmed.ncbi.nlm.nih.gov/41112957/ -
Chevalier K, Thoreau B, Michel M, Godeau B, Agard C, Papo T, et al.
Unravelling IPAF, VEDOSS and connective tissue diseases classifications through the mixed connective tissue disease spectrum.Ç
RMD Open. 2025 Oct 23;11(4):e006145.
https://pubmed.ncbi.nlm.nih.gov/41130746/
SEPTIEMBRE 2025
-
Ansari MS, Vahabi SM, Memari H, Hosseini F, Bahramian S, Etesami I.
Use of the oral Janus kinase inhibitor tofacitinib in the treatment of morphea: A retrospective study.
J Am Acad Dermatol. 2025 Sep;93(3):769-771. doi: 10.1016/j.jaad.2025.05.1377.
https://pubmed.ncbi.nlm.nih.gov/40374119/ -
Antoniou KM, Distler O, Gheorghiu AM, Moor CC, Vikse J, Bizymi N, et al.
ERS/EULAR clinical practice guidelines for connective tissue diseases associated interstitial lung disease.
Ann Rheum Dis. 2025 Sep 3:S0003-4967(25)04320-1. doi: 10.1016/j.ard.2025.08.021. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40912974/ -
Krickau T, Woelfle J, Beck M, Kuwert T, Schmidkonz C, Engel K, Atzinger A.
Diagnosing Organ Involvement in Juvenile Systemic Sclerosis with (68)Ga-FAPI-46 PET/CT.
J Nucl Med Technol. 2025 Sep 5;53(3):248-251. doi: 10.2967/jnmt.125.269645.
https://pubmed.ncbi.nlm.nih.gov/40555509/ -
Stefancic S, Robinson A, Havrilla HJ, Sood V, Torok KS.
Gastrointestinal Impact and Tool Performance in Juvenile Systemic Sclerosis Using the UCLA GIT 2.0 Assessment.
Arthritis Care Res (Hoboken). 2025 Sep 1. doi: 10.1002/acr.25643. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40888178/ - Hudson M, Pauling JD, Rodriguez-Reyna TS, Paik JJ, Shah AA, Frech TM, et al.
Criteria for defining and dating onset of organ system involvement in systemic sclerosis.
J Scleroderma Relat Disord. 2025 Sep 23:23971983251374385. doi: 10.1177/23971983251374385. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/41019155/ -
Batani V, Palmisano A, Campochiaro C, Vignale D, Bruno E, Peretto G, et al.
The complex diagnosis of primary heart involvement in systemic sclerosis: red flags to drive the choice of cardiac magnetic resonance.
Rheumatology (Oxford). 2025 Sep 1;64(9):5004-5013. doi: 10.1093/rheumatology/keaf234.
https://pubmed.ncbi.nlm.nih.gov/40353849/
JULIO 2025
-
Eldib A, Aldhmour M, Feistritzer C, Bayraktutar BN, Gagrani M, Pihlblad MSet al.
Ophthalmic findings in pediatric patients with craniofacial scleroderma.
J AAPOS. 2025 Jul 24:104269. doi: 10.1016/j.jaapos.2025.104269. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40712919/
JUNIO 2025
-
Egeli BH, Dallas J, Reusch DB, Shaw KS, Gellis S, Sundel R, Son MB, Vleugels RA, Dedeoglu F.
Juvenile localized scleroderma: a large retrospective cohort study from a tertiary care center.
Pediatr Rheumatol Online J. 2025 Jun 6;23(1):63. doi: 10.1186/s12969-025-01116-0.
https://pubmed.ncbi.nlm.nih.gov/40481578/ -
Liguoro I, Simonini G, Martini G.
The burden of extracutaneous manifestations in juvenile localized scleroderma: A literature review.
Autoimmun Rev. 2025 Jun 24;24(7):103812. doi: 10.1016/j.autrev.2025.103812. Epub 2025 Apr 4.
https://pubmed.ncbi.nlm.nih.gov/40189033/ -
Ohta R, Horinishi Y, Sano C, Ichinose K.
Efficacy of Mycophenolate Mofetil in Treating Skin Fibrosis in Systemic Sclerosis: A Systematic Review and Meta-Analysis.
J Clin Med. 2025 Jun 12;14(12):4187. doi: 10.3390/jcm14124187.
https://pubmed.ncbi.nlm.nih.gov/40565931/ -
Bjørkekjær HJ, Bruni C, Broch K, Brunborg C, Carreira PE, Airò P et al.
A comparative analysis of risk stratification tools in SSc-associated pulmonary arterial hypertension: a EUSTAR analysis.
Rheumatology (Oxford). 2025 Jun 1;64(6):3643-3656. doi: 10.1093/rheumatology/keaf053.
https://pubmed.ncbi.nlm.nih.gov/39878955/ -
Ezquerra-Durán A, Alcala-Gonzalez LG, Guillen-Del-Castillo A, Simeón-Aznar CP, Barba E, Malagelada C, Hughes M, McMahan ZH.
The role of prokinetics in managing gastrointestinal involvement in SSc: a systematic literature review.
Rheumatology (Oxford). 2025 Jun 1;64(6):3266-3279. doi: 10.1093/rheumatology/keaf064.
https://pubmed.ncbi.nlm.nih.gov/39909554/ -
Hoekstra EM, Liem SIE, Boonstra M, Fehres CM, Schoones JW, Huizinga TWJ, de Vries-Bouwstra JK.
The prognostic power of anti-topoisomerase I and anti-centromere antibodies in systemic sclerosis - A systematic review of the literature.
Semin Arthritis Rheum. 2025 Jun;72:152667. doi: 10.1016/j.semarthrit.2025.152667. Epub 2025 Feb 22.
https://pubmed.ncbi.nlm.nih.gov/40037059/ -
Macklin M, Bauer Ventura I, Khanna D.
Therapeutic Choices in Systemic Sclerosis-Associated Interstitial Lung Disease, a Survey of 2 International Research Groups.
J Clin Rheumatol. 2025 Jun 10. doi: 10.1097/RHU.0000000000002249. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40489954/ -
Ross RL, Caballero-Ruiz B, Clarke EL, Kakkar V, Wasson CW, Mulipa P et al.
Biological hallmarks of systemic sclerosis are present in the skin and serum of patients with Very Early Diagnosis of Systemic Sclerosis (VEDOSS).
Rheumatology (Oxford). 2025 Jun 1;64(6):3606-3617. doi: 10.1093/rheumatology/keae698.
https://pubmed.ncbi.nlm.nih.gov/39700423/ -
Ingrid E, Bavanendrakumar M, Oon S, Perera W, Day J, Ross L.
Imaging findings of scleroderma-associated myopathy: A systematic literature review.
Semin Arthritis Rheum. 2025 Jun;72:152672. doi: 10.1016/j.semarthrit.2025.152672. Epub 2025 Feb 23.
https://pubmed.ncbi.nlm.nih.gov/40037060/ -
Iancau A, Attia S, Sarlashkar P, Cepica T, Duarte Silva F, Eajazi A, Xi Y, Jacobe H, Chhabra A.
Localized scleroderma: multiparametric MRI with diffusion-weighted imaging and gadolinium-based perfusion imaging for assessing disease activity.
Skeletal Radiol. 2025 Jun 6. doi: 10.1007/s00256-025-04967-6. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40478368/
MARZO 2025
-
Liguoro I, Simonini G, Martini G.
The burden of extracutaneous manifestations in juvenile localized scleroderma: A literature review
Autoimmun Rev. 2025 Apr 4;24(7):103812. doi: 10.1016/j.autrev.2025.103812. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40189033/
MARZO 2025
-
Hamaguchi Y, Ueda-Hayakawa I, Kaneko U, Shimizu M, Miyamae T, Ishikawa H, et al; Ministry of Health, Labour and Welfare's Localized Scleroderma Research Group.
Nationwide epidemiological and clinical survey of juvenile-onset morphea in Japan.
J Dermatol. 2025 Mar 5. doi: 10.1111/1346-8138.17684. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40040588/ -
Torres Villarreal MC, Cajas Santana LJ.
Prevalence and risk factors of interstitial lung disease in early systemic sclerosis and systemic sclerosis sine scleroderma: a cross-sectional study.
ARP Rheumatol. 2025 Jan-Mar;4(1):5-12.
https://pubmed.ncbi.nlm.nih.gov/40170470/ -
Boleto G, Campochiaro C, Distler O, Balanescu A, Launay D, Bergmann C, et al.
Interstitial lung disease in anti-U1RNP systemic sclerosis patients: A European Scleroderma Trials and Research analysis.
J Scleroderma Relat Disord. 2025 Mar 19:23971983251324827. doi: 10.1177/23971983251324827. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40124983/ -
Hua VK, Chang J, Laxer RM, Broderick L.
Disabling pansclerotic morphoea: a century of discovery.
Br J Dermatol. 2025 Mar 18;192(4):585-596. doi: 10.1093/bjd/ljae443.
https://pubmed.ncbi.nlm.nih.gov/39520387/ -
Bellando-Randone S, Wilhalme H, Bruni C, Czirjak L, Distler O, Allanore Y, et al; and the EUSTAR collaborators.
The effect of hydroxychloroquine on activities of daily living and hand function in systemic sclerosis: results from an analysis of the EUSTAR cohort.
Arthritis Res Ther. 2025 Mar 27;27(1):66. doi: 10.1186/s13075-025-03476-0.
https://pubmed.ncbi.nlm.nih.gov/40148996/ -
Yu JM, VanBuren JM, Child A, Alvey JS, Mandl LA, Pinheiro LC, et al.
Psychometric Evaluation of the Scleroderma Skin Questionnaire: A Novel Patient-Reported Outcome for Skin Disease in Patients With Systemic Sclerosis
J Rheumatol. 2025 Mar 1;52(3):263-269. doi: 10.3899/jrheum.2024-0736.
https://pubmed.ncbi.nlm.nih.gov/39814444/ -
Tanaka Y.
Is mixed connective tissue disease (MCTD) a subtype of systemic sclerosis?
Semin Arthritis Rheum. 2025 Mar 1:152678. doi: 10.1016/j.semarthrit.2025.152678. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40024856/
FEBRERO 2025
-
Jacquel L, Bechara R, Terzic J, Rameau AC, Chatelus E, Rossi-Semerano L, et al; SOFREMIP.
An updated overview of Juvenile systemic sclerosis in a French cohort.
Pediatr Rheumatol Online J. 2025 Feb 8;23(1):13.
https://pubmed.ncbi.nlm.nih.gov/39923051/ -
Ingrid E, Bavanendrakumar M, Oon S, Perera W, Day J, Ross L.
Imaging findings of scleroderma-associated myopathy: A systematic literature review.
Semin Arthritis Rheum. 2025 Feb 23;72:152672. doi: 10.1016/j.semarthrit.2025.152672. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40037060/ -
Martínez-Urbistondo M, González-Guzmán A, Fernández-Guitián R, Blanco-Valencia XP, Esteban-Sampedro J, Martín-Portugués M, et al.
Neoplasm related mortality risk in Systemic Sclerosis: a nationwide study.
BMC Rheumatol. 2025 Feb 27;9(1):27. doi: 10.1186/s41927-025-00477-z.
https://pubmed.ncbi.nlm.nih.gov/40011972/
ENERO 2025
-
Sener S, Batu ED.
Use of biologic drug in the treatment of localized scleroderma and systemic sclerosis in children: A scoping review.
Semin Arthritis Rheum. 2025 Jan 29;71:152634. doi: 10.1016/j.semarthrit.2025.152634. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39938346/ -
Bacich D, Tessari C, Andreis M, Geatti V, Cattapan I, Pradegan N, et al.
Heart transplantation in juvenile-onset systemic sclerosis with primary cardiac involvement: report of two cases and comprehensive literature review.
Curr Probl Cardiol. 2025 Jan;50(1):102891. doi: 10.1016/j.cpcardiol.2024.102891.
https://pubmed.ncbi.nlm.nih.gov/39486240/
DICIEMBRE 2024
-
Wang F, Li C, Li X, Li S, Jia Y.
Autoantibodies in systemic sclerosis overlap syndrome and their correlation with organ damage and survival.
Ann Med. 2024 Dec;56(1):2407526. doi: 10.1080/07853890.2024.2407526. Epub 2024 Sep 30.
https://pubmed.ncbi.nlm.nih.gov/39348269/ -
Odell ID.
Genetic and Molecular Drivers of Scleroderma Pathogenesis.
Clin Dermatol. 2024 Dec 13:S0738-081X(24)00272-4. doi: 10.1016/j.clindermatol.2024.12.007. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39675445/ -
Hughes M, Sylvestre Y, Manning J, Wragg E, Mandzuk M, Samaranayaka M et al.
Longitudinal trajectories of the Scleroderma Health Assessment Questionnaire (SHAQ) visual analogue scales: a retrospective cohort study.
Rheumatology (Oxford). 2024 Dec 6:keae667. doi: 10.1093/rheumatology/keae667. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39657244/ -
Yamamoto M, Nakajima K, Matsuda M, Takahashi A, Nakai K.
Benefits of the Topical JAK Inhibitor Delgocitinib in a Patient With Pediatric Localized Scleroderma.
Pediatr Dermatol. 2024 Dec 10. doi: 10.1111/pde.15844. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39659052/
NOVIEMBRE 2024
-
Auth J, Müller F, Völkl S, Bayerl N, Distler JHW, Tur C, et al.
CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case series.
Lancet Rheumatol. 2024 Nov 11:S2665-9913(24)00282-0. doi: 10.1016/S2665-9913(24)00282-0. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39542003/ -
Di Pasquale G, Caione N, Di Berardino A, Di Donato G.
Pulmonary manifestations of juvenile vs. adult systemic sclerosis: insights into pathophysiological and clinical features.
Pediatr Pulmonol. 2024 Nov 15. doi: 10.1002/ppul.27347.
https://pubmed.ncbi.nlm.nih.gov/39545645/ -
Foeldvari I, Branton S, Li SC, Rosser FJ, Torok KS.
What are Juvenile-onset systemic sclerosis providers thoughts, experiences, and reasons for autologous stem cell transplant? Result of a multinational survey.
J Scleroderma Relat Disord. 2024 Nov 8:23971983241293297. doi: 10.1177/23971983241293297. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39544894/ -
Hua VK, Chang J, Laxer RM, Broderick L.
Disabling Pansclerotic Morphea: A century of discovery.
Br J Dermatol. 2024 Nov 9:ljae443. doi: 10.1093/bjd/ljae443. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39520387/
OCTUBRE 2024
-
Metko D, Mehta S, Geng R, Mufti A, Yeung J.
Tocilizumab for the Treatment of Refractory Morphea: A Systematic Review.
J Cutan Med Surg. 2024 Oct 25:12034754241291045. doi: 10.1177/12034754241291045. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39450622/
SEPTIEMBRE 2024
-
Branton SA, Stubbs LA, Havrilla HJ, Torok KS.
National Registry for Childhood Onset Scleroderma I: Insights from the first 341 juvenile localized scleroderma patients.
J Scleroderma Relat Disord. 2024 Sep 23:23971983241272460. doi: 10.1177/23971983241272460. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39544906/ -
Denton CP, De Lorenzis E, Roblin E, Goldman N, Alcacer-Pitarch B, Blamont E, et al.
The 2024 British Society for Rheumatology guideline for management of systemic sclerosis.
Rheumatology (Oxford). 2024 Sep 11:keae394. doi: 10.1093/rheumatology/keae394. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39255973/ -
Pain CE, Torok KS.
Challenges and complications in juvenile localized scleroderma: A practical approach.
Best Pract Res Clin Rheumatol. 2024 Sep;38(3):101987. doi: 10.1016/j.berh.2024.101987
https://pubmed.ncbi.nlm.nih.gov/39294014/ -
Schonenberg-Meinema D, Cutolo M, Smith V.
Capillaroscopy in the daily clinic of the pediatric rheumatologist.
Best Pract Res Clin Rheumatol. 2024 Sep;38(3):101978. doi: 10.1016/j.berh.2024.101978.
https://pubmed.ncbi.nlm.nih.gov/39034217/
JULIO 2024
-
Xanthouli P, Uesbeck P, Lorenz HM, Blank N, Eichstaedt CA, Harutyunova S et al.
Effect of ambrisentan in patients with systemic sclerosis and mild pulmonary arterial hypertension: long-term follow-up data from EDITA study.
Arthritis Res Ther. 2024 Jul 18;26(1):136. doi: 10.1186/s13075-024-03363-0.
https://pubmed.ncbi.nlm.nih.gov/39026360/ -
Fairley JL, O'Rourke R, Puranik R, Nikpour M.
Cardiac magnetic resonance imaging in systemic sclerosis: Heart involvement in high-resolution.
Rheumatol Immunol Res. 2024 Jul 15;5(2):83-92. doi: 10.1515/rir-2024-0011.
https://pubmed.ncbi.nlm.nih.gov/39015845/ -
Di Donato S, Huang S, Pauling JD, Del Galdo F, Sabbagh M, Khanna D, Hughes M.
Clinically relevant differences between primary Raynaud's phenomenon and secondary to connective tissue disease.
Semin Arthritis Rheum. 2024 Jul 18;68:152521. doi: 10.1016/j.semarthrit.2024.152521. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39089171/ -
De Lorenzis E, Del Galdo F, Natalello G, Varone F, Di Donato S, Verardi L, et al.
Concordance and Prognostic Relevance of Different Definitions of Systemic Sclerosis Interstitial Lung Disease Progression.
Am J Respir Crit Care Med. 2024 Jul 30. doi: 10.1164/rccm.202311-2153OC. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39078207/
JUNIO 2024
-
Rijal H, Bouadi N, Piguet V, Mukovozov I.
Treatment Outcomes of Scleroderma With Janus Kinase Inhibitors: A Systematic Review.
J Cutan Med Surg. 2024 Jun 10. doi: 10.1177/12034754241260021. Epub ahead of print
https://pubmed.ncbi.nlm.nih.gov/38859662/ -
Chevalier K, Chassagnon G, Leonard-Louis S, Cohen P, Dunogue B, Regent A, et al.
Anti-U1RNP antibodies are associated with a distinct clinical phenotype and a worse survival in patients with systemic sclerosis.
J Autoimmun. 2024 Jun;146:103220. doi: 10.1016/j.jaut.2024.103220.
https://pubmed.ncbi.nlm.nih.gov/38642508/ -
Mismetti V, Si-Mohamed S, Cottin V.
Interstitial Lung Disease Associated with Systemic Sclerosis.
Semin Respir Crit Care Med. 2024 Jun;45(3):342-364. doi: 10.1055/s-0044-1786698.
https://pubmed.ncbi.nlm.nih.gov/38714203/ -
Avanoglu-Guler A, Campochiaro C, De Luca G, Hughes M, Tufan A, Green L, et al.
Calcinosis in systemic sclerosis: An update on pathogenesis, related complications, and management: A heavy burden still waiting to be lifted off patients' hands.
Semin Arthritis Rheum. 2024 Jun;66:152431. doi: 10.1016/j.semarthrit.2024.152431.
https://pubmed.ncbi.nlm.nih.gov/38537324/ -
Koczanowski S, Morrisroe K, Fairley J, Nikpour M, Oon S, Brown Z.
Role of intravenous immunoglobulins in systemic sclerosis (SSc): A systematic literature review.
Semin Arthritis Rheum. 2024 Jun 22. doi: 10.1016/j.semarthrit.2024.152471. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/38954999/ -
Matsuda KM, Sugimoto E, Ako Y, Kitamura M, Miyahara M, Kotani H, et al.
Reliability, validity, and sensitivity of the Japanese version of the University of California Los Angeles scleroderma clinical trial consortium gastrointestinal tract instrument: Application to efficacy
assessment of intravenous immunoglobulin administration.
J Dermatol. 2024 Jun;51(6):741-751. doi: 10.1111/1346-8138.17202.
https://pubmed.ncbi.nlm.nih.gov/38558171/
-
Tirelli F, Zanatta E, Moccaldi B, Binda M, Martini G, Giraudo C, et al.
Systemic sclerosis sine scleroderma in children is more aggressive than in adults.
Rheumatology (Oxford). 2024 May 22:keae304. doi: 10.1093/rheumatology/keae304.
https://pubmed.ncbi.nlm.nih.gov/38775723/ -
Türkmen Ş, Pirim G, Sözeri B.
Ultrasonographic Evaluation of Juvenile Localized Scleroderma: Enhancing Objectivity in Diagnosis and Management.
Curr Med Imaging. 2024 May 24. doi: 10.2174/0115734056299155240516102231.
https://pubmed.ncbi.nlm.nih.gov/38798225/
ABRIL 2024
-
Kose H, Simsek A, Kizmaz MA, Bozkurt T, Ozturk F, Cekic S, et al.
Interferons Dominate Damage and Activity in Juvenile Scleroderma.
Mod Rheumatol. 2024 Apr 6:roae032. doi: 10.1093/mr/roae032. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/38581664/
MARZO 2024
-
Knobler R, Geroldinger-Simić M, Kreuter A, Hunzelmann N, Moinzadeh P, Rongioletti F, et al.
Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromes.
J Eur Acad Dermatol Venereol. 2024 Mar 8. doi: 10.1111/jdv.19912. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/38456584/ -
Kreuter A, Moinzadeh P, Kinberger M, Horneff G, Worm M, Werner RN, et al.
S2k guideline: Diagnosis and therapy of localized scleroderma.
J Dtsch Dermatol Ges. 2024 Mar 1. doi: 10.1111/ddg.15328. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/38426689/ -
Morrisroe K, Hansen D, Stevens W, Ross L, Sahhar J, Ngian GS, et al.
Predictors and prognosis of pulmonary hypertension complicating interstitial lung disease in systemic sclerosis.
Rheumatology (Oxford). 2024 Mar 12:keae166. doi: 10.1093/rheumatology/keae166. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/38471118/ -
Erdogan M, Kilickiran Avci B, Ebren C, Ersoy Y, Ongen Z, Ongen G, et al.
Screening for pulmonary arterial hypertension in patients with systemic sclerosis in the era of new pulmonary arterial hypertension definitions.
Clin Exp Rheumatol. 2024 Mar 15. doi: 10.55563/clinexprheumatol/gzo4r2. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/38489342/ -
Channick R, Chin KM, McLaughlin VV, Lammi MR, Zamanian RT, Turricchia S,
Macitentan in Pulmonary Arterial Hypertension Associated with Connective Tissue Disease (CTD-PAH): Real-World Evidence from the Combined OPUS/OrPHeUS Dataset.
Cardiol Ther. 2024 Mar 7. doi: 10.1007/s40119-024-00361-w. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/38451426/ -
Thammaroj P, Chowchuen P, Foocharoen C.
Clinical course and factors associated with progressive acro-osteolysis in early systemic sclerosis: a retrospective cohort study.
Sci Rep. 2024 Mar 1;14(1):5129. doi: 10.1038/s41598-024-55877-x.
https://pubmed.ncbi.nlm.nih.gov/38429484/
FEBRERO 2024
-
Stubbs LA, Ogunbona O, Beil E, Szafron V, Adesina A, Anvari S, Lai J, Ramirez A, Ditzler MG, DeGuzman M.
Juvenile eosinophilic fasciitis: a single center case series.
Pediatr Rheumatol Online J. 2024 Feb 24;22(1):29. doi: 10.1186/s12969-024-00960-w.
https://pubmed.ncbi.nlm.nih.gov/38395889/
ENERO 2024
-
Terminiello A, Marrani E, Pagnini I, Maccora I, Maniscalco V, Rumeileh SA, Mastrolia MV, Simonini G.
Childhood mixed connective tissue disease at disease onset: Evidence from a systematic review.
Autoimmun Rev. 2024 Jan 6;23(4):103513. doi: 10.1016/j.autrev.2023.103513. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/38191065/ -
Akbaş A, Kılınç F, Hayran Y.
A Comparison of Clinical, Demographic and Treatment Characteristics of Pediatric-Onset and Adult-Onset Patients Diagnosed With Localized Scleroderma.
Dermatol Pract Concept. 2024 Jan 1;14(1):e2024023. doi: 10.5826/dpc.1401a23.
https://pubmed.ncbi.nlm.nih.gov/38364378/ -
Tornling G, Edenius C, Pauling JD, Denton CP, Olsson A, Kowalski J, et al.
A phase 2 trial investigating the efficacy and safety of the mPGES-1 inhibitor vipoglanstat in systemic sclerosis-related Raynaud's.
Rheumatology (Oxford). 2024 Jan 30:keae049. doi: 10.1093/rheumatology/keae049. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/38291895/ -
Herrick AL, Orozco G.
Raynaud phenomenon: from GWAS to drug repurposing.
Nat Rev Rheumatol. 2024 Jan 16. doi: 10.1038/s41584-024-01076-x. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/38228855/
DICIEMBRE 2023
-
Foeldvari I, Torok KS, Antón J, Blakley M, Constantin T, Cutolo M, et al.
Best clinical practice in the treatment of juvenile systemic sclerosis: expert panel guidance - the result of the International Hamburg Consensus Meeting December 2022.
Expert Rev Clin Immunol. 2023 Dec 27:1-18. doi: 10.1080/1744666X.2023.2298354. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/38149621/ -
Foeldvari I, Torok KS, Anton J, Blakley M, Constantin T, Curran M, et al.
Proposed Response Parameters for Twelve-Month Drug Trial in Juvenile Systemic Sclerosis: Results of the Hamburg International Consensus Meetings.
Arthritis Care Res (Hoboken). 2023 Dec;75(12):2453-2462. doi: 10.1002/acr.25171.
https://pubmed.ncbi.nlm.nih.gov/37332054/
NOVIEMBRE 2023
-
Bhat A.
Juvenile Scleroderma.
Indian J Pediatr. 2023 Nov 15. doi: 10.1007/s12098-023-04894-1.
https://pubmed.ncbi.nlm.nih.gov/37966656/
OCTUBRE 2023
-
Tirelli F, Giraudo C, Soliani M, Calabrese F, Martini G, Gisondi P, Meneghel A, Zulian F.
Connective tissue nevus misdiagnosed as juvenile localized scleroderma
Pediatr Rheumatol Online J. 2023 Oct 17;21(1):125. doi: 10.1186/s12969-023-00913-9.
https://pubmed.ncbi.nlm.nih.gov/37848914/
SEPTIEMBRE 2023
-
Sanchez-Espino LF, Luca N, Pope E, Laxer RM, Knight AM, Sibbald C.
Systematic review of health-related quality of life impact in juvenile localized scleroderma: Health-related quality of life in juvenile localized scleroderma.
Arthritis Care Res (Hoboken). 2023 Sep 26. doi: 10.1002/acr.25243. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37750181/ -
Bass RD, Moore DF, Steen VD.
Prevalence and Characteristics of Systemic Sclerosis Patients Fulfilling the 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus.
Arthritis Care Res (Hoboken). 2023 Sep 10. doi: 10.1002/acr.25235. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37691427/ -
Campochiaro C, Allanore Y, Braun-Moscovici Y, Matucci-Cerinic M, Balbir-Gurman A.
Is cyclophosphamide still the gold standard in early severe rapidly progressive systemic sclerosis?
Autoimmun Rev. 2023 Sep 9:103439. doi: 10.1016/j.autrev.2023.103439. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37690478/ -
Tandaipan J, Guillén-Del-Castillo A, Simeón-Aznar CP, Carreira PE, De la Puente C, Narváez J, et al.
Immunoglobulins in systemic sclerosis management. A large multicenter experience.
Autoimmun Rev. 2023 Sep 12;22(11):103441. doi: 10.1016/j.autrev.2023.103441. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37708984/ -
Di Battista M, Wasson CW, Alcacer-Pitarch B, Del Galdo F.
Autonomic dysfunction in systemic sclerosis: A scoping review.
Semin Arthritis Rheum. 2023 Sep 26;63:152268. doi: 10.1016/j.semarthrit.2023.152268. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37776665/ -
Joly-Chevrier M, Gélinas A, Ghazal S, Moussa S, McCuaig CC, Piram M, et al.
Morphea, Eosinophilic Fasciitis and Cancer: A Scoping Review.
Cancers (Basel). 2023 Sep 7;15(18):4450. doi: 10.3390/cancers15184450.
https://pubmed.ncbi.nlm.nih.gov/37760419/
AGOSTO 2023
-
Pain CE, Murray A, Dinsdale G, Marsden A, Manning J, Riley P, Leone V, Amin T, Zulian F, Herrick AL.
Non-invasive imaging and clinical skin scores in juvenile localised scleroderma.
Rheumatology (Oxford). 2023 Aug 2:kead380. doi: 10.1093/rheumatology/kead380. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37531286/ -
De Angelis R, Riccieri V, Cipolletta E, Del Papa N, Ingegnoli F, Bosello S, et al.
Significant nailfold capillary loss and late capillaroscopic pattern are associated with pulmonary arterial hypertension in systemic sclerosis.
Rheumatology (Oxford). 2023 Aug 25:kead445. doi: 10.1093/rheumatology/kead445. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37624917/
MAYO 2023
-
Chen HW, Walker AM, Stein AB, Chen SL, Schollaert-Fitch KL, Torok KS, Jacobe HT.
Clinical characteristics associated with musculoskeletal extracutaneous manifestations in pediatric and adult morphea: a prospective, cohort study.
J Invest Dermatol. 2023 May 2:S0022-202X(23)02042-0. doi: 10.1016/j.jid.2023.04.010. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37142185/ -
Wang S, Berry CT, Treat JR, Jen M.
Morphea after initiation of dupilumab in two pediatric atopic dermatitis patients.
Pediatr Dermatol. 2023 May-Jun;40(3):540-543. doi: 10.1111/pde.15200. Epub 2022 Nov 22.
https://pubmed.ncbi.nlm.nih.gov/37212737/
ABRIL 2023
-
Stubbs LA, Ferry AM, Guffey D, Loccke C, Wade EM, Pour P, Ardalan K, Chira P, Ganske IM, Glaser D, Higgins G, Luca N, Moore KF, Sivaraman V, Stewart K, Vasquez-Canizares N, Hunt RD, Maricevich RS, Torok KS, Li SC; Childhood Arthritis, Rheumatology Research Alliance (CARRA) Scleroderma Workgroup.
Barriers to care in juvenile localized and systemic scleroderma: an exploratory survey study of caregivers' perspectives
Pediatr Rheumatol Online J. 2023 Apr 25;21(1):39. doi: 10.1186/s12969-023-00819-6.
https://pubmed.ncbi.nlm.nih.gov/37098622/
MARZO 2023
-
Mulcaire-Jones E, Low AHL, Domsic R, Whitfield ML, Khanna D.
Advances in biological and targeted therapies for systemic sclerosis.
Expert Opin Biol Ther. 2023 Mar 25. doi: 10.1080/14712598.2023.2196009. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36964674/ -
Makol A, Nagaraja V, Amadi C, Pugashetti JV, Caoili E, Khanna D.
Recent innovations in the screening and diagnosis of systemic sclerosis-associated interstitial lung disease.
Expert Rev Clin Immunol. 2023 Mar 31. doi: 10.1080/1744666X.2023.2198212. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36999788/ -
Ciaffi J, Liem SIE, van Leeuwen NM, Allaart CF, Huizinga TWJ, de Vries-Bouwstra JK.
Comment on: Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR database.
Rheumatology (Oxford). 2023 Mar 21:kead120. doi: 10.1093/rheumatology/kead120. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36943357/ -
De Angelis R, Ferri C, Giuggioli D, Bajocchi G, Dagna L, Bellando-Randone S, et al; SPRING-SIR (Systemic Sclerosis PRogression INvestiGation group of the Italian Society of Rheumatology).
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society
or Rheumatology.
RMD Open. 2023 Mar;9(1):e002890. doi: 10.1136/rmdopen-2022-002890.
https://pubmed.ncbi.nlm.nih.gov/36868782/ -
Fukasawa T, Yoshizaki A, Ebata S, Fukayama M, Kuzumi A, Norimatsu Y, et al.
Interleukin-17 pathway inhibition with brodalumab in early systemic sclerosis: analysis of a single-arm, open-label, phase 1 trial.
J Am Acad Dermatol. 2023 Mar 28:S0190-9622(23)00516-9. doi: 10.1016/j.jaad.2023.02.061. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36997069/
FEBRERO 2023
-
Lagziel T, Kawaji Q, Hultman CS.
Incisional Release and Fat Grafting for the Surgical Management of Perioral Fibrosis in Scleroderma: A Technical Report and Institutional Review
Ann Plast Surg. 2023 Feb 4. doi: 10.1097/SAP.0000000000003475. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36943019/ -
Kardum Ž, Milas-Ahić J, Šahinović I, Masle AM, Uršić D, Kos M.
Serum levels of interleukin 17 and 22 in patients with systemic sclerosis: a single-center cross-sectional study.
Rheumatol Int. 2023 Feb;43(2):345-354. doi: 10.1007/s00296-022-05250-w.
https://pubmed.ncbi.nlm.nih.gov/36416900/
ENERO 2023
-
Giannini M, Ellezam B, Leclair V, Lefebvre F, Troyanov Y, Hudson M, et al.
Scleromyositis: A distinct novel entity within the systemic sclerosis and autoimmune myositis spectrum. Implications for care and pathogenesis.
Front Immunol. 2023 Jan 26;13:974078. doi: 10.3389/fimmu.2022.974078.
https://pubmed.ncbi.nlm.nih.gov/36776390/ -
Mazilu D, Boltașiu Tătaru LA, Mardale DA, Bijă MS, Ismail S, Zanfir V, et al
Eosinophilic Fasciitis: Current and Remaining Challenges.
Int J Mol Sci. 2023 Jan 19;24(3):1982. doi: 10.3390/ijms24031982.
https://pubmed.ncbi.nlm.nih.gov/36768300/
JULIO 2022
-
Garaiman A, Steigmiller K, Gebhard C, Mihai C, Dobrota R, Bruni C, et al; EUSTAR Collaborators
Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC model.
Rheumatology (Oxford). 2022 Jul 29:keac405. doi: 10.1093/rheumatology/keac405. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35904554/ -
Vigneron C, Pène F, Charpentier J, Mouthon L, Chaigne B.
Scleroderma cardiac crisis: A-life-threatening but reversible complication of systemic sclerosis.
Autoimmun Rev. 2022 Jul 31;21(10):103162. doi: 10.1016/j.autrev.2022.103162. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35921989/ -
Santiago T, Santos EJF, Ruaro B, Lepri G, Green L, Wildt M, et al.
Recommendations for the execution and reporting of skin ultrasound in systemic sclerosis: an international collaboration under the WSF skin ultrasound group.
RMD Open. 2022 Jul;8(2):e002371. doi: 10.1136/rmdopen-2022-002371.
https://pubmed.ncbi.nlm.nih.gov/35850975/ -
Ferri C, De Angelis R, Giuggioli D, Bajocchi G, Dagna L, Zanframundo G, et al. SPRING-SIR (Systemic Sclerosis PRogression INvestiGation group of the Italian Society of Rheumatology).
Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature.
Autoimmun Rev. 2022 Jul 28;21(10):103159. doi: 10.1016/j.autrev.2022.103159. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35908642/
MAYO 2022
-
Cai R, Yi Z, Li T, Mu R.
Botulinum toxin in the treatment of Raynaud phenomenon in patients with systemic sclerosis: a systemic review.
Chin Med J (Engl). 2022 May 5;135(9):1133-1134. doi: 10.1097/CM9.0000000000001903.
https://pubmed.ncbi.nlm.nih.gov/35773968/ -
Hofmann NN, Ambühl RA, Jordan S, Distler O.
Calcineurin inhibitors in systemic sclerosis - a systematic literature review.
Ther Adv Musculoskelet Dis. 2022 May 19;14:1759720X221092374. doi: 10.1177/1759720X221092374.
https://pubmed.ncbi.nlm.nih.gov/35619877/ - Kreuter M, Hoffmann-Vold AM, Matucci-Cerinic M, Saketkoo LA, Highland KB, Wilson H, Alves M, et al.
Impact of lung function and baseline clinical characteristics on patient-reported outcome measures in systemic sclerosis-associated interstitial lung disease.
Rheumatology (Oxford). 2022 May 31:keac325. doi: 10.1093/rheumatology/keac325. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35640959/
MARZO 2022
-
Foocharoen C, Tonsawan P, Pongkulkiat P, Anutrakulchai S, Mahakkanukrauh A, Suwannaroj S.
Management Review of Scleroderma Renal Crisis: An Update with Practical pointers.
Mod Rheumatol. 2022 Mar 29:roac028. doi: 10.1093/mr/roac028. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35349704/ -
Isomura Y, Shirai Y, Kuwana M.
Clinical worsening following discontinuation of tocilizumab in diffuse cutaneous systemic sclerosis: a single-centre experience in Japan.
Rheumatology (Oxford). 2022 Mar 8:keac136. doi: 10.1093/rheumatology/keac136. Online ahead of print
https://pubmed.ncbi.nlm.nih.gov/35258561/ -
McGaugh S, Kallis P, De Benedetto A, Thomas RM.
Janus kinase inhibitors for treatment of morphea and systemic sclerosis: A literature review.
Dermatol Ther. 2022 Mar 12:e15437. doi: 10.1111/dth.15437. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35278019/ -
Scofield RH, Lewis VM, Cavitt J, Kurien BT, Assassi S, Martin J, et al.
47XXY and 47XXX in Scleroderma and Myositis.
ACR Open Rheumatol. 2022 Mar 29. doi: 10.1002/acr2.11413. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35352506/ -
Bartosz M, Tworek M, Łapczyńska E, Tekielak A, Kochanowska J, Polak K, Bergler-Czop B.
Utility of phototherapy in patients with systemic sclerosis: systematic review.
Dermatol Ther. 2022 Mar 31:e15478. doi: 10.1111/dth.15478. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35357072/ -
Cui J, Jin L, Ding M, He J, Yang L, Cui S, Wang X, Ma J, Liu A.
Efficacy and safety of mesenchymal stem cells in the treatment of systemic sclerosis: a systematic review and meta-analysis.
Stem Cell Res Ther. 2022 Mar 21;13(1):118. doi: 10.1186/s13287-022-02786-3.
https://pubmed.ncbi.nlm.nih.gov/35313985/ -
Zanatta E, Huscher D, Ortolan A, Avouac J, Airò P, Balbir-Gurman A, et al; EUSTAR collaborators.
Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from EUSTAR cohort.
Rheumatology (Oxford). 2022 Mar 28:keac188. doi: 10.1093/rheumatology/keac188. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35348643/ -
Xiong A, Liu Q, Zhong J, Cao Y, Xiang Q, Hu Z, Zhou S, Song Z, Chen H, Zhang Y, Cui H, Shuai S.
Increased risk of mortality in systemic sclerosis-associated pulmonary hypertension: a systemic review and meta-analysis.
Adv Rheumatol. 2022 Mar 30;62(1):10. doi: 10.1186/s42358-022-00239-2.
https://pubmed.ncbi.nlm.nih.gov/35354494/ -
Bruni C, Heidenreich S, Duenas A, Hoffmann-Vold AM, Gabrielli A, Allanore Y, et al.
Patient preferences for the treatment of systemic sclerosis-associated interstitial lung disease: a discrete choice experiment.
Rheumatology (Oxford). 2022 Mar 3:keac126. doi: 10.1093/rheumatology/keac126. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35238334/ -
Kuwana M, Saito A, Sakamoto W, Raabe C, Saito K.
Incidence Rate and Prevalence of Systemic Sclerosis and Systemic Sclerosis-Associated Interstitial Lung Disease in Japan: Analysis Using Japanese Claims Databases.
Adv Ther. 2022 Mar 22. doi: 10.1007/s12325-022-02078-5. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35316503/
FEBRERO 2022
-
Castelino FV, VanBuren JM, Startup E, Assassi S, Bernstein EJ, Chung L, Correia C, Evnin LB, Frech TM, Gordon JK, Hant FN, Hummers LK, Khanna D, Sandorfi N, Shah AA, Shanmugam VK, Steen V.
Baseline characteristics of systemic sclerosis patients with restrictive lung disease in a multi-center US-based longitudinal registry.
Int J Rheum Dis. 2022 Feb;25(2):163-174. doi: 10.1111/1756-185X.14253.
https://pubmed.ncbi.nlm.nih.gov/34841681/
ENERO 2022
-
Furusawa A, Wakiguchi H, Okazaki F, Korenaga Y, Azuma Y, Yasudo H, Hasegawa S.
Successful treatment of children with juvenile systemic sclerosis using mycophenolate mofetil after methylprednisolone pulse therapy: A 3-year follow-up.
Int J Rheum Dis. 2022 Jan;25(1):95-96. doi: 10.1111/1756-185X.14260.
https://pubmed.ncbi.nlm.nih.gov/34866347/ -
Szczepanik-Kułak P, Michalak-Stoma A, Krasowska D.
Usefulness of Dermoscopy in Localized Scleroderma (LoS, Morphea) Diagnosis and Assessment-Monocentric Cross-Sectional Study.
J Clin Med. 2022 Jan 30;11(3):764. doi: 10.3390/jcm11030764.
https://pubmed.ncbi.nlm.nih.gov/35160216/
DICIEMBRE 2021
-
Wenzel D, Haddadi NS, Afshari K, Richmond JM, Rashighi M.
Upcoming treatments for morphea.
Immun Inflamm Dis. 2021 Dec;9(4):1101-1145. doi: 10.1002/iid3.475. Epub 2021 Jul 17.
https://pubmed.ncbi.nlm.nih.gov/34272836/ -
Li SC, Higgins GC, Chen M, Torok KS, Rabinovich CE et al.
Extracutaneous involvement is common and associated with prolonged disease activity and greater impact in juvenile localized scleroderma.
Rheumatology (Oxford). 2021 Dec 1;60(12):5724-5733. doi: 10.1093/rheumatology/keab238.
https://pubmed.ncbi.nlm.nih.gov/33711155/
NOVIEMBRE 2021
-
Becker MO, Dobrota R, Garaiman A, Debelak R, Fligelstone K, Tyrrell Kennedy A et al.
Development and validation of a patient-reported outcome measure for systemic sclerosis: the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaire.
Ann Rheum Dis. 2021 Nov 25:annrheumdis-2021-220702. doi: 10.1136/annrheumdis-2021-220702. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34824049/ -
Castelino FV, VanBuren JM, Startup E, Assassi S, Bernstein EJ, Chung L et al.
Baseline characteristics of systemic sclerosis patients with restrictive lung disease in a multi-center US-based longitudinal registry.
Int J Rheum Dis. 2021 Nov 28. doi: 10.1111/1756-185X.14253. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34841681/ -
Diaconu AD, Ostafie I, Ceasovschih A, Șorodoc V, Lionte C, Ancuța C, Șorodoc L.
Role of Vitamin D in Systemic Sclerosis: A Systematic Literature Review.
J Immunol Res. 2021 Nov 29;2021:9782994. doi: 10.1155/2021/9782994.
https://pubmed.ncbi.nlm.nih.gov/34881335/
OCTUBRE 2021
-
Vonk MC, Smith V, Sfikakis PP, Cutolo M, Del Galdo F, Seibold JR.
Pharmacological treatments for SSc-ILD: Systematic review and critical appraisal of the evidence.
Autoimmun Rev. 2021 Oct 27:102978. doi: 10.1016/j.autrev.2021.102978. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34718159/ -
Chung MP, Valenzuela A, Li S, Catanese B, Stevens K, Fiorentino D, Strand V, Chung L.
A Pilot Study to Evaluate the Safety and Efficacy of Treprostinil in the Treatment of Calcinosis in Systemic Sclerosis.
Rheumatology (Oxford). 2021 Oct 29:keab810. doi: 10.1093/rheumatology/keab810. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34718447/ -
Zulian F, Lanzoni G, Castaldi B, Meneghel A, Tirelli F, Zanatta E, Martini G.
Systemic sclerosis sine scleroderma in children.
Rheumatology (Oxford). 2021 Oct 4:keab738. doi: 10.1093/rheumatology/keab738. Online ahead of print
https://pubmed.ncbi.nlm.nih.gov/34605913/
SEPTIEMBRE 2021
-
Ulc E, Rudnicka L, Waśkiel-Burnat A, Warszawik-Hendzel O, Niemczyk A, Olszewska M.
Therapeutic and Reconstructive Management Options in Scleroderma (Morphea) en Coup de Sabre in Children and Adults. A Systematic Literature Review.
J Clin Med. 2021 Sep 29;10(19):4517. doi: 10.3390/jcm10194517.
https://pubmed.ncbi.nlm.nih.gov/34640533/ -
Kondoh Y, Makino S, Ogura T, Suda T, Tomioka H, Amano H, et al; joint committee of Japanese Respiratory Society and Japan College of Rheumatology.
2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease
Respir Investig. 2021 Sep 30:S2212-5345(21)00082-4. doi: 10.1016/j.resinv.2021.04.011. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34602377/ -
Zhang Y, Qin D, Li Q, Yang X, Luo Q, Wang H.
Diagnostic value of cardiac natriuretic peptide on pulmonary hypertension in systemic sclerosis: a systematic review and meta-analysis.
Joint Bone Spine. 2021 Sep 30:105287. doi: 10.1016/j.jbspin.2021.105287. Online ahead of print
https://pubmed.ncbi.nlm.nih.gov/34601113/
AGOSTO 2021
-
Hixon AM, Christensen E, Hamilton R, Drees C.
Epilepsy in Parry-Romberg syndrome and linear scleroderma en coup de sabre: Case series and systematic review including 140 patients.
Epilepsy Behav. 2021 Aug;121(Pt A):108068. doi: 10.1016/j.yebeh.2021.108068.
https://pubmed.ncbi.nlm.nih.gov/34052630/ -
Shenavandeh S S, Ajri M, Hamidi S.
Causes of Raynaud's phenomenon and the predictive laboratory and capillaroscopy features for the evolution to a definite connective tissue disease.
Rheumatology (Oxford). 2021 Aug 31:keab668. doi: 10.1093/rheumatology/keab668. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34463711/ -
Flavahan NA.
New mechanism-based approaches to treating and evaluating the vasculopathy of scleroderma.
Curr Opin Rheumatol. 2021 Aug 16. doi: 10.1097/BOR.0000000000000830. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34402454/ -
Sibeoni J, Dunogué B, Dupont A, Haiddar D, Benmostefa N, Falissard B, Mouthon L, Révah-Levy A, Verneuil L.
Development and validation of a Patient-Reported Outcome in systemic sclerosis: the Hand scleroDerma lived Experience Scale (HAnDE Scale).
Br J Dermatol. 2021 Aug 6. doi: 10.1111/bjd.20688. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34355380/
JULIO 2021
-
Baumberger R, Jordan S, Distler O, Baschung Pfister P, Maurer B.
Diagnostic measures for patients with systemic sclerosis-associated myopathy.
Clin Exp Rheumatol. 2021 Jul-Aug;39 Suppl 131(4):85-93. Epub 2021 Jul 15.
https://pubmed.ncbi.nlm.nih.gov/34323680/ -
Verardi L, Calandriello L, De Lorenzis E, Natalello G, Gigante L, Cicchetti G, Larici AR, Gremese E, D'Agostino MA, Bosello SL.
An unusual lung involvement in scleroderma: lipoid pneumonia.
Clin Exp Rheumatol. 2021 Jul-Aug;39 Suppl 131(4):161-162.
https://pubmed.ncbi.nlm.nih.gov/34323683/
MAYO 2021
-
Hurtubise R, Hudson M, Gyger G, Wang M, Steele RJ, Baron M; Canadian Scleroderma Research Group (CSRG), Hoa S.
Association between gastroprotective agents and risk of incident interstitial lung disease in systemic sclerosis.
Respir Med. 2021 May 27;185:106482. doi: 10.1016/j.rmed.2021.106482. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34089970/ -
Foeldvari I, Torok KS.
Review for best practice in clinical rheumatology juvenile systemic sclerosis - Updates and practice points.
Best Pract Res Clin Rheumatol. 2021 Apr 22:101688. doi: 10.1016/j.berh.2021.101688
https://pubmed.ncbi.nlm.nih.gov/33896752/
ABRIL 2021
-
Foeldvari I, Torok KS.
Review for best practice in clinical rheumatology juvenile systemic sclerosis - Updates and practice points.
Best Pract Res Clin Rheumatol. 2021 Apr 22:101688. doi: 10.1016/j.berh.2021.101688
https://pubmed.ncbi.nlm.nih.gov/33896752/ -
Weibel L.
Diagnosis and management of morphoea in children: an overview.
Clin Exp Dermatol. 2021 Apr;46(3):487-494.
https://pubmed.ncbi.nlm.nih.gov/33751628/ -
Acosta-Herrera M, Kerick M, Lopéz-Isac E, Assassi S, Beretta L, Simeón-Aznar CP, et al.
Comprehensive analysis of the major histocompatibility complex in systemic sclerosis identifies differential HLA associations by clinical and serological subtypes.
Ann Rheum Dis. 2021 Apr 1:annrheumdis-2021-219884. doi: 10.1136/annrheumdis-2021-219884. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34096881/
MARZO 2021
-
Foeldvari I, Klotsche J, Kasapcopur O, Adrovic A, Terreri MT, Sakamoto AP, et al.
Differences sustained between diffuse and limited forms of juvenile systemic sclerosis in expanded international cohort. www.juvenile-scleroderma.com.
Arthritis Care Res (Hoboken). 2021 Mar 30. doi: 10.1002/acr.24609. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/33787070/ -
Knights H, Minas E, Khan F, Shaw L, Al Obaidi M, Mankad K, Eleftheriou D.
Magnetic resonance imaging findings in children with Parry-Romberg syndrome and en coup de sabre.
Pediatr Rheumatol Online J. 2021 Mar 23;19(1):42.
https://pubmed.ncbi.nlm.nih.gov/33757522/ -
Cerejeira D, Bonito F, António AM, Cunha H.
Segmental stiff skin syndrome (SSS): Clinical case and a brief review.
Australas J Dermatol. 2021 Mar 26. doi: 10.1111/ajd.13589. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/33769553/ -
Aringer M, Riemekasten G.
Relevance of immunomodulatory therapy for interstitial lung disease in systemic sclerosis.
Best Pract Res Clin Rheumatol. 2021 Mar 18:101672. doi: 10.1016/j.berh.2021.101672. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/33745826/ -
Gigante A, Hoffmann-Vold AM, Fegatelli DA, Gabrielli A, Leodori G, Coleiro B, De Santis M, et al.
Estimated glomerular filtration rate is a marker of mortality in the European Scleroderma Trials and Research Group (EUSTAR) database.
Rheumatology (Oxford). 2021 Mar 26:keab302. doi: 10.1093/rheumatology/keab302. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/33769468/ -
Young A, Moles VM, Jaafar S, Visovatti S, Huang S, Vummidi D, Nagaraja V, McLaughlin V, Khanna D.
Performance of the DETECT Algorithm for Pulmonary Hypertension Screening in a Systemic Sclerosis Cohort.
Arthritis Rheumatol. 2021 Mar 24. doi: 10.1002/art.41732. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/33760392
FEBRERO 2021
-
Li SC, O'Neil KM, Higgins GC.
Morbidity and Disability in Juvenile Localized Scleroderma: The Case for Early Recognition and Systemic Immunosuppressive Treatment.
J Pediatr. 2021 Feb 3:S0022-3476(21)00102-5. doi: 10.1016/j.jpeds.2021.01.068.
https://pubmed.ncbi.nlm.nih.gov/33548257/
-
Adrovic A, Yildiz M, Haslak F, Koker O, Aliyeva A, Sahin S, Barut K, Kasapcopur O.
Tocilizumab therapy in juvenile systemic sclerosis: a retrospective single centre pilot study.
Rheumatol Int. 2021 Jan;41(1):121-128. doi: 10.1007/s00296-020-04732-z. Epub 2020 Oct 27. PMID: 33108799.
https://pubmed.ncbi.nlm.nih.gov/33108799/
DICIEMBRE 2020
-
Zulian F, Dal Pozzolo R, Meneghel A, Castaldi B, Marcolongo R, Caforio ALP, Martini G.
Rituximab for rapidly progressive juvenile systemic sclerosis.
Rheumatology (Oxford). 2020 Dec 1;59(12):3793-3797
https://pubmed.ncbi.nlm.nih.gov/32442284/ -
Norikawa N, Kumekawa M, Yamamoto T.
Juvenile temporal arteritis with eosinophilia associated with limited systemic sclerosis.
Int J Dermatol. 2020 Dec;59(12):e475-e476
https://pubmed.ncbi.nlm.nih.gov/32857414/
NOVIEMBRE 2020
-
VFoeldvari I, Culpo R, Sperotto F, Anton J, Avcin T, Baildam E, Boros C, Chaitow J, Constantin T, Kasapcopur O, Knupp Feitosa de Oliveira S, Pilkington C, Toplak N, van Royen A, Saad Magalhaes C, Vastert SJ, Wulffraat N, Zulian F.
Consensus-based recommendations for the management of juvenile systemic sclerosis.
Rheumatology (Oxford). 2020 Nov 4. doi: 10.1093/rheumatology/keaa584.
https://pubmed.ncbi.nlm.nih.gov/33147624/ - Foeldvari I, Klotsche J, Hinrichs B, Helmus N, Kasapcopur O, Adrovic A, Sztajnbok F, Terreri MT, Anton J, Smith V, Katsicas M, Kostik M, Vasquez-Canizares N, Avcin T, Feldman B, Janarthanan M, Santos MJ, Sawhney S, Schonenberg-Meinema D, Sifuentes-Giraldo WA, Alexeeva E, Appenzeller S, Battagliotti C, Berntson L, Bica B, Costa Reis P, Eleftheriou D, Kallinich T, Lehman T, Marrani E, Minden K, Nielsen S, Nuruzzaman F, Patwardhan A, Khubchandani R, Stanevicha V, Uziel Y, Torok KS.
Under detection of interstitial lung disease in juvenile systemic sclerosis (jSSc).
Arthritis Care Res (Hoboken). 2020 Nov 3. doi: 10.1002/acr.24499
https://pubmed.ncbi.nlm.nih.gov/33141441/
OCTUBRE 2020
-
Virdi A, Patrizi A, Cambiaghi S, Diociaiuti A, El Hachem M, Schena D, Bassi A, Bonamonte D, Brazzelli V, Belloni Fortina A, Pepe P, Di Lernia V, Neri I.
A retrospective study on clinical subtypes and management of morphea in 10 Italian Dermatological Units.
G Ital Dermatol Venereol. 2020 Oct 16. doi: 10.23736/S0392-0488.20.06632-8. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/33070566/
SEPTIEMBRE 2020
-
Martini G, Saggioro L, Culpo R, Vittadello F, Meneghel A, Zulian F.
Mycophenolate mofetil for methotrexate-resistant juvenile localized scleroderma.
Rheumatology (Oxford). 2020 Sep 25:keaa392. doi: 10.1093/rheumatology/keaa392. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32978631/ -
Allanore Y, Wung P, Soubrane C, Esperet C, Marrache F, Bejuit R, Lahmar A, Khanna D, Denton CP; Investigators.
A randomised, double-blind, placebo-controlled, 24-week, phase II, proof-of-concept study of romilkimab (SAR156597) in early diffuse cutaneous systemic sclerosis
Ann Rheum Dis. 2020 Sep 22:annrheumdis-2020-218447. doi: 10.1136/annrheumdis-2020-218447. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32963047/ -
Fan Y, Bender S, Shi W, Zoz D.
Incidence and prevalence of systemic sclerosis and systemic sclerosis with interstitial lung disease in the United States.
J Manag Care Spec Pharm. 2020 Sep 30:1-9. doi: 10.18553/jmcp.2020.20136. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32996805/ -
Riccardi A, Marcoccia A, Borgia A, Guastafierro T, Bondanini F, Fasano S, Irace R, Messiniti V, Sanduzzi A, Bocchino M, Ciani A, D'Alto M, Argiento P, De Matteis GM, Spanò A, Valentini G.
Undifferentiated connective tissue disease at risk of systemic sclerosis: A weighted score to identify patients who will evolve.
Autoimmun Rev. 2019 Sep;18(9):102358. doi: 10.1016/j.autrev.2019.102358.
https://pubmed.ncbi.nlm.nih.gov/31323358/ -
Hoffmann-Vold AM, Allanore Y, Alves M, Brunborg C, Airó P, Ananieva LP, Czirják L, Guiducci S, Hachulla E, Li M, Mihai C, Riemekasten G, Sfikakis PP, Kowal-Bielecka O, Riccardi A, Distler O.
Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database.
Ann Rheum Dis. 2020 Sep 28:annrheumdis-2020-217455. doi: 10.1136/annrheumdis-2020-217455. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32988845/ -
Ciaffi J, van Leeuwen NM, Boonstra M, Kroft LJM, Schouffoer AA, Ninaber MK, Huizinga TWJ, de Vries-Bouwstra JK.
Evolution of interstitial lung disease one year after hematopoietic stem cell transplantation or cyclophosphamide for systemic sclerosis.
Arthritis Care Res (Hoboken). 2020 Sep 22. doi: 10.1002/acr.24451. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32961038/ -
Denton CP, Laird B, Moros L, Luna Flores JL.
Things left unsaid: important topics that are not discussed between patients with systemic sclerosis, their carers and their healthcare professionals-a discourse analysis.
Clin Rheumatol. 2020 Sep 11. doi: 10.1007/s10067-020-05371-2. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32915347/ -
Fallet B, Walker UA.
Current immunosuppressive and antifibrotic therapies of systemic sclerosis and emerging therapeutic strategies.
Expert Rev Clin Pharmacol. 2020 Oct 2. doi: 10.1080/17512433.2020.1832466.
https://pubmed.ncbi.nlm.nih.gov/33008265/ -
Yin H, Li R, Lu L, Yan Q.
Understanding Fibrosis in Systemic Sclerosis: Novel and Emerging Treatment Approaches.
Curr Rheumatol Rep. 2020 Sep 21;22(11):77. doi: 10.1007/s11926-020-00953-0.
https://pubmed.ncbi.nlm.nih.gov/32959073/ -
Jensen B, James R, Hong Y, Omoyinmi E, Pilkington C, Sebire NJ, Howell KJ, Brogan PA, Eleftheriou D.
A case of Myhre syndrome mimicking juvenile scleroderma
Pediatr Rheumatol Online J. 2020 Sep 11;18(1):72. doi: 10.1186/s12969-020-00466-1
https: //pubmed.ncbi.nlm.nih.gov/32917212/
AGOSTO 2020
-
Kaushik, A, Mahajan R, De, Handa S.
Paediatric morphoea: a holistic review. Part 1: epidemiology, aetiopathogenesis and clinical classification.
Clin Exp Dermatol. 2020 Aug;45(6):673-678. doi: 10.1111/ced.14234. Epub 2020 May 30
https://pubmed.ncbi.nlm.nih.gov/32472964/ -
Kaushik, A, Mahajan R, De, Handa S.
Paediatric morphoea: a holistic review. Part 2: diagnosis, measures of disease activity, management and natural history
Clin Exp Dermatol. 2020 Aug;45(6):679-684. doi: 10.1111/ced.14236.
https://pubmed.ncbi.nlm.nih.gov/32449205/ - Dag A, Tarakci E, Adrovic A, Kasapcopur O.
Effects of Sense and Functionality Changes in the Hands on Activity and Participation in Patients with Juvenile Scleroderma.
Mod Rheumatol.2020 Aug 28;1-25. doi: 10.1080/14397595.2020.1816612.
https://pubmed.ncbi.nlm.nih.gov/32857628/
JUNIO 2020
-
Francesco Zulian, Francesca Tirelli
Treatment in Juvenile Scleroderma
Curr Rheumatol Rep. 2020 Jun 26;22(8):45. doi: 10.1007/s11926-020-00910-x.
https://pubmed.ncbi.nlm.nih.gov/32591919/ -
Plachouri KM, Gkentzi D, Ravazoula P, Melachrinou M, Georgiou S.
Pediatrician's Alert: Misdiagnosis of Mixed Localized Scleroderma in a Child.
Pediatr Int. 2020 Jun;62(6):759-761. doi: 10.1111/ped.14170.
https://pubmed.ncbi.nlm.nih.gov/32578362/ -
Civieri G, Castaldi B, Martini G, Meneghel A, Milanesi O, Zulian F.
Early detection of ventricular dysfunction in juvenile systemic sclerosis by speckle tracking echocardiography.
Rheumatology (Oxford). 2020 Jun 23:keaa208. doi: 10.1093/rheumatology/keaa208.
https://pubmed.ncbi.nlm.nih.gov/32572491/
MAYO 2020
- Fadanelli G, Agazzi A, Vittadello F, Meneghel A, Zulian F, Martini G.
Methotrexate in Linear Scleroderma: long-term efficacy in 50 children from a single Pediatric Rheumatology Centre.
Arthritis Care Res (Hoboken). 2020 May 20.
https://doi.org/10.1002/acr.24260 - Zloof Y, Schonfeld T, Dagan T, Amarilyo G, Braun M, Hashkes P, Harel L.
Systemic Sclerosis Sine Scleroderma With Pulmonary Arterial Hypertension in a 3-Year-Old Girl.
Pediatrics. 2020 May;145(5):e20192504.
https://doi.org/10.1542/peds.2019-2504 - Zulian F, Dal Pozzolo R, Meneghel A, Castaldi B, Marcolongo R, Caforio ALP, Martini G.
Rituximab for rapidly progressive juvenile systemic sclerosis.
Rheumatology (Oxford). 2020 May 23:keaa193.
https://doi.org/10.1093/rheumatology/keaa193 - Abbas LF, O'Brien JC, Goldman S, Pezeshk P, Chalian M, Chhabra A, Jacobe HT.
A Cross-sectional Comparison of Magnetic Resonance Imaging Findings and Clinical Assessment in Patients With Morphea.
JAMA Dermatol. 2020 Apr 1:e200036. doi: 10.1001/jamadermatol.2020.0036. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32236514 - O'Brien JC, Nymeyer H, Green A, Jacobe HT.
Changes in Disease Activity and Damage Over Time in Patients With Morphea.
JAMA Dermatol. 2020 Apr 1:e200034. doi: 10.1001/jamadermatol.2020.0034. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32236501 - Arthur M, Fett NM, Latour E, Jacobe H, Kunzler E, Florez-Pollack S, Houser J, Sharma S, Prasad S, Femia A, Stern MJ, Pappas-Taffer LK, Gaffney R, Fernandez AP, Knabel D, Cardones AR, Leung N, Laumann A, Yu JM, Zhao J, Vleugels RA, Tkachenko E, Lo K.
Evaluation of the Effectiveness and Tolerability of Mycophenolate Mofetil and Mycophenolic Acid for the Treatment of Morphea.
JAMA Dermatol. 2020 Apr 1:e200035. doi: 10.1001/jamadermatol.2020.0035. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32236497
MARZO 2020
- Rubio-Rivas M, Corbella X, Guillén-Del-Castillo A, Tolosa Vilella C, Colunga Argüelles D, Argibay A et al. for the RESCLE investigators, Autoimmune Diseases Study Group (GEAS)
Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation.
Autoimmun Rev. 2020 Mar 17:102507. doi: 10.1016/j.autrev.2020.102507. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32194200 - Enevoldsen FC, Sahana J, Wehland M, Grimm D, Infanger M, Krüger M.
Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy.
J Clin Med. 2020 Mar 18;9(3). pii: E824. doi: 10.3390/jcm9030824.
https://www.ncbi.nlm.nih.gov/pubmed/32197449 - Tang R, Yu J, Shi Y, Zou P, Zeng Z, Tang B, Wang Y, Ling G, Luo M, Xiao R.
Safety and efficacy of Rituximab in systemic sclerosis: A systematic review and meta-analysis.
Int Immunopharmacol. 2020 Mar 11;83:106389. doi: 10.1016/j.intimp.2020.106389. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32172205 - Chung MP, Chung L.
Drugs in phase I and phase II clinical trials for systemic sclerosis.
Expert Opin Investig Drugs. 2020 Mar 25:1-14. doi: 10.1080/13543784.2020.1743973. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32178544 - Flores Quispe SKJ, Cavaliere A, Weber M, Stramare R, Zuliani M, Quaia E, Zulian F, Giraudo C.
Sarcopenia in juvenile localized scleroderma: new insights on deep involvement.
Eur Radiol. 2020 Mar 6. doi: 10.1007/s00330-020-06764-2. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32144460 - Mecoli CA, Shah AA, Boin F, Wigley FM, Hummers LK.
The Utility of Plasma Vascular Biomarkers in Systemic Sclerosis: A Prospective Longitudinal Analysis.
Arthritis Rheumatol. 2020 Mar 21. doi: 10.1002/art.41265. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32200572 - Bellando-Randone S, Matucci-Cerinic M.
The race against time to disclose lung inflammation in interstitial lung disease In systemic sclerosis: is PET scan the winning solution?
Rheumatology (Oxford). 2020 Mar 11. pii: keaa077. doi: 10.1093/rheumatology/keaa077. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/32159796 - Ufuk F, Demirci M, Altinisik G.
Quantitative computed tomography assessment for systemic sclerosis-related interstitial lung disease: comparison of different methods.
Eur Radiol. 2020 Mar 19. doi: 10.1007/s00330-020-06772-2. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32193641 - Orteu CH, Ong VH, Denton CP.
Scleroderma mimics - Clinical features and management.
Best Pract Res Clin Rheumatol. 2020 Mar 5:101489. doi: 10.1016/j.berh.2020.101489. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32147386 - Cheema TJ, Young M, Rabold E, Barbieri AN, Baldwin N, Steen VD.
Patient and Physician Perspectives on Systemic Sclerosis-Associated Interstitial Lung Disease.
Clin Med Insights Circ Respir Pulm Med. 2020 Mar 18;14:1179548420913281.
https://www.ncbi.nlm.nih.gov/pubmed/32214863 - Chung MP, Dontsi M, Postlethwaite D, Kesh S, Simard JF, Fiorentino D, Zaba LC, Chung L.
Increased Mortality in Asians With Systemic Sclerosis in Northern California.
ACR Open Rheumatol. 2020 Mar 21. doi: 10.1002/acr2.11126. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32198914 - Biney I, Dudney T, Goldman M, Carder L, Schriver E.
Successful Use of Hyperbaric Oxygen as Adjunctive Therapy for a Nonhealing Venous Ulcer in a Patient with Systemic Sclerosis and Pulmonary Arterial Hypertension: A Case Report and Review of the Literature.
Case Rep Pulmonol. 2020 Feb 24;2020:4750375. doi: 10.1155/2020/4750375.
https://www.ncbi.nlm.nih.gov/pubmed/32181042
FEBRERO 2020
- Weibel L, Theiler M, Howell KJ, Denton CP, Waelchli R, Atherton D, Woo P, Harper JI.
Prospective evaluation of treatment response and disease reversibility of paediatric localized scleroderma (morphoea) to steroids and methotrexate using multi-modal imaging.
J Eur Acad Dermatol Venereol. 2020 Feb 20. doi: 10.1111/jdv.16308.
https://www.ncbi.nlm.nih.gov/pubmed/32080907 - Li SC, Zheng RJ.
Overview of Juvenile localized scleroderma and its management.
World J Pediatr. 2020 Feb;16(1):5-18. doi: 10.1007/s12519-019-00320-9. Epub 2019 Nov 30.
https://www.ncbi.nlm.nih.gov/pubmed/31786801 - Wu EY, Li SC, Torok KS, Virkud YV, Fuhlbrigge RC, Rabinovich CE; Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry Investigators.
Baseline Description of the Juvenile Localized Scleroderma Subgroup From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry.
ACR Open Rheumatol. 2019 Apr 10;1(2):119-124. doi: 10.1002/acr2.1019.
https://www.ncbi.nlm.nih.gov/pubmed/31777788
ENERO 2020
- Do N, Ringold S, Sullivan E, Brandling-Bennett H.
A retrospective study: Impact of consensus treatment plans on systemic therapy of pediatric morphea.
Pediatr Dermatol. 2020 Jan 22. doi: 10.1111/pde.14074. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/31967352
DICIEMBRE 2019
- Reiff D, Crayne CB, Mannion ML, Cron RQ.
Characteristics of coexisting localized scleroderma and inflammatory arthritis.
Eur J Rheumatol. 2019 Dec 3:1-5.
https://www.ncbi.nlm.nih.gov/pubmed/31804172
OCTUBRE 2019
- Li SC, Torok KS, Rabinovich CE, Dedeoglu F, Becker ML, Ferguson PJ et al; CARRA Registry Investigators
Initial Results from a Pilot Comparative Effectiveness Study of Three Methotrexate-Based Consensus Treatment Plans for Juvenile Localized Scleroderma
J Rheumatol. 2019 Oct 15. pii: jrheum.190311. doi: 10.3899/jrheum.190311. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31615917 - Foeldvari I.
Update on the Systemic Treatment of Pediatric Localized Scleroderma
Paediatr Drugs. 2019 Oct 31. doi: 10.1007/s40272-019-00363-5. [Epub ahead of print] Review.
https://www.ncbi.nlm.nih.gov/pubmed/31667717
SEPTIEMBRE 2019
- Hoa S, Bernatsky S, Steele RJ, Baron M, Hudson M.
Association between immunosuppressive therapy and course of mild interstitial lung disease in systemic sclerosis.
Rheumatology (Oxford). 2019 Sep 19. pii: kez407. doi: 10.1093/rheumatology/kez407. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/31535689
- Zigler CK, Ardalan K, Lane S, Schollaert KL, Torok KS.
A novel patient-reported outcome for paediatric localized scleroderma: A qualitative assessment of content validity.
Br J Dermatol. 2019 Sep 9. doi: 10.1111/bjd.18512. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/31498874
- Barrat FJ, Lu TT.
Role of type I interferons and innate immunity in systemic sclerosis: unbalanced activities on distinct cell types?
Curr Opin Rheumatol. 2019 Aug 20. doi: 10.1097/BOR.0000000000000659.
https://www.ncbi.nlm.nih.gov/pubmed/31436583
AGOSTO 2019
- Barrat FJ, Lu TT.
Role of type I interferons and innate immunity in systemic sclerosis: unbalanced activities on distinct cell types?
Curr Opin Rheumatol. 2019 Aug 20. doi: 10.1097/BOR.0000000000000659.
https://www.ncbi.nlm.nih.gov/pubmed/31436583
JULIO 2019
- Li SC, Fuhlbrigge RC, Laxer RM, Pope E, Ibarra MF, Stewart K, et al.Developing comparative effectiveness studies for a rare, understudied pediatric disease: lessons learned from the CARRA juvenile localized scleroderma consensus treatment plan pilot study.
Pediatr Rheumatol Online J. 2019 Jul 15;17(1):43.
https://www.ncbi.nlm.nih.gov/pubmed/31307476 - Elhai M, Boubaya M, Distler O, Smith V, Matucci-Cerinic M, Alegre Sancho JJ et al.
Outcomes of patients with systemic sclerosis treated with Rituximab in contemporary practice: a prospective cohort study.
Ann Rheum Dis. 2019 Jul;78(7):979-987.
https://ard.bmj.com/content/78/7/979 - Khanna D, Spino C, Johnson S, Chung L, Whitfield M, Denton CP et al.
Abatacept in Early Diffuse Cutaneous Systemic Sclerosis - Results of a Phase 2 Investigator-Initiated, Multicenter, Double-Blind Randomized Placebo-Controlled Trial.
Arthritis Rheumatol. 2019 Jul 24. doi: 10.1002/art.41055. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31342624 - Gordon SM, Hughes JB, Nee R, Stitt RS, Bailey WT, Little DJ, Edison JD, Olson SW.
Systemic sclerosis medications and risk of scleroderma renal crisis.
BMC Nephrol. 2019 Jul 25;20(1):279.
https://www.ncbi.nlm.nih.gov/pubmed/31345158 - Albuquerque JV, Andriolo BN, Vasconcellos MR, Civile VT, Lyddiatt A, Trevisani VF.
Interventions for morphea.
Cochrane Database Syst Rev. 2019 Jul 16;7:CD005027. doi: 10.1002/14651858.CD005027.pub5. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31309547 - Sattar B, Chokshi RV.
Colonic and Anorectal Manifestations of Systemic Sclerosis.
Curr Gastroenterol Rep. 2019 Jul 8;21(7):33.
https://www.ncbi.nlm.nih.gov/pubmed/31281951
JUNIO 2019
- Becker M, Graf N, Sauter R, Allanore Y, Curram J, Denton CP et al.
Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis.
Ann Rheum Dis. 2019 Jun 21. pii: annrheumdis-2019-215145. doi: 10.1136/annrheumdis-2019-215145. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/31227488
ABRIL 2019
- Mertens JS, de Jong EMGJ, van den Hoogen LL, Wienke J, Thurlings RM, Seyger MMB, Hoppenreijs EPAH, Wijngaarde CA, van Vlijmen-Willems IMJJ, van den Bogaard E, Giovannone B, van Wijk F, van Royen-Kerkhof A, Marut W, Radstake TRD.
The identification of CCL18 as biomarker of disease activity in localized scleroderma
J Autoimmun. 2019 Apr 18. pii: S0896-8411(19)30091-5. doi: 10.1016/j.jaut.2019.04.008. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31006523 - Kunzler E, Florez-Pollack S, Teske N, O'Brien J, Prasad S, Jacobe H.
Linear morphea: Clinical characteristics, disease course, and treatment of the Morphea in Adults and Children cohort.
J Am Acad Dermatol. 2019 Apr 17. pii: S0190-9622(19)30157-4. doi: 10.1016/j.jaad.2019.01.050. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31005342 - Hennocq Q, Facchini A, Kverneland B, Bodemer C, Picard A, Khonsari RH.
Craniofacial bone atrophy in Parry Romberg syndrome demonstrated using a Bayesian hierarchical model.
J Craniomaxillofac Surg. 2019 Apr 8. pii: S1010-5182(18)31161-2. doi: 10.1016/j.jcms.2019.03.032. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31030853
MARZO 2019
- Soh HJ, Samuel C, Heaton V, Renton WD, Cox A, Munro J.
Challenges in the diagnosis and treatment of disabling pansclerotic morphea of childhood: case-based review.
Rheumatol Int. 2019 Mar 5. doi: 10.1007/s00296-019-04269-w. [Epub ahead of print].
https://www.ncbi.nlm.nih.gov/pubmed/30838436 - Ferdowsi N, Huq M, Stevens W, Hudson M, Wang M, Tay T, Burchell JL, Mancuso S, Rabusa C, Sundararajan V, Prior D, Proudman SM, Baron M, Nikpour M; Scleroderma Clinical Trials Consortium Damage Index Working Group, The Australian Scleroderma Interest Group, Canadian Scleroderma Research Group.
Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis.
Ann Rheum Dis. 2019 Mar 30. pii: annrheumdis-2018-214764. doi: 10.1136/annrheumdis-2018-214764. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30928903 - Horimoto AMC, de Souza AS, Rodrigues SH, Kayser C.
Risk of digital ulcers occurrence in systemic sclerosis: a cross-sectional study.
Adv Rheumatol. 2019 Mar 28;59(1):14.
https://www.ncbi.nlm.nih.gov/pubmed/30922404
FEBRERO 2019
- Skagen K, Hetlevik SO, Zamani M, Lilleby V, Skjelland M.
Preclinical Carotid Atherosclerosis in Patients With Juvenile-Onset Mixed Connective Tissue Disease.
J Stroke Cerebrovasc Dis. 2019 Feb 13. pii: S1052-3057(19)30036-9. doi: 10.1016/j.jstrokecerebrovasdis.2019.01.027.
https://www.ncbi.nlm.nih.gov/pubmed/30772156
ENERO 2019
- Hetlevik SO, Flatø B, Aaløkken TM, Lund MB, Reiseter S, Mynarek GK, Nordal E, Rygg M, Lilleby V.
Pulmonary Manifestations and Progression of Lung Disease in Juvenile-onset Mixed Connective Tissue Disease.
J Rheumatol. 2019 Jan;46(1):93-100. doi: 10.3899/jrheum.180019. Epub 2018 Aug 1.
https://www.ncbi.nlm.nih.gov/pubmed/30068767
DICIEMBRE 2018
- Lythgoe H, Almeida B, Bennett J, Bhat C, Bilkhu A, Brennan M, Deepak S, Dawson P, Eleftheriou D, Harrison K, Hawley D, Heaf E, Leone V, Long E, Maltby S, McErlane F, Rafiq N, Ramanan AV, Riley P, Rangaraj S, Varnier G, Wilkinson N, Pain CE.
Multi-centre national audit of juvenile localised scleroderma: describing current UK practice in disease assessment and management.
Pediatr Rheumatol Online J. 2018 Dec 18;16(1):80. doi: 10.1186/s12969-018-0295-0.
https://www.ncbi.nlm.nih.gov/pubmed/30563543
NOVIEMBRE 2018
- Li X, Qian YQ, Liu N, Mu R, Zuo Y, Wang GC, Jia Y, Li ZG
Survival rate, causes of death, and risk factors in systemic sclerosis: a large cohort study.
Clin Rheumatol. 2018 Nov;37(11):3051-3056. doi: 10.1007/s10067-018-4291-z.
https://www.ncbi.nlm.nih.gov/pubmed/30225558
OCTUBRE 2018
- Ambartsumyan L, Zheng HB, Iyer RS, Soares J, Henstorf G, Stevens AM.
Relationship between esophageal abnormalities on fluoroscopic esophagram and pulmonary function testing in juvenile systemic sclerosis
Arthritis Care Res (Hoboken). 2018 Oct 8. doi: 10.1002/acr.23778. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30295423 - Boozalis E, Shah AA, Wigley F, Kang S, Kwatra SG.
Morphea and systemic sclerosis are associated with an increased risk of melanoma and non-melanoma skin cancer
J Am Acad Dermatol. 2018 Oct 20. pii: S0190-9622(18)32755-5. doi: 10.1016/j.jaad.2018.10.022. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30352282 - Kurzinski K, Zigler CK, Torok KS.
Prediction of Disease Relapse in a Cohort of Juvenile Localized Scleroderma Patients
Br J Dermatol. 2018 Oct 13. doi: 10.1111/bjd.17312. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30315656
SEPTIEMBRE 2018
- Zanatta E, Polito P, Favaro M, Larosa M, Marson P, Cozzi F, Doria A.
Therapy of scleroderma renal crisis: State of the art.
Autoimmun Rev. 2018 Sep;17(9):882-889.
https://www.ncbi.nlm.nih.gov/pubmed/30005860 - Ram Poudel D, George M, Dhital R, Karmacharya P, Sandorfi N, Derk CT.
Mortality, length of stay and cost of hospitalization among patients with systemic sclerosis: results from the National Inpatient Sample.
Rheumatology (Oxford). 2018 Sep 1;57(9):1611-1622.
https://www.ncbi.nlm.nih.gov/pubmed/29868788 - Dougherty DH, Kwakkenbos L, Carrier ME, Salazar G, Assassi S, Baron M, Bartlett SJ, Furst DE, Gottesman K, van den Hoogen F, Malcarne VL, Mouthon L, Nielson WR, Poiraudeau S, Sauvé M, Boire G, Bruns A, Chung L, Denton C, Dunne JV, Fortin P, Frech T, Gill A, Gordon J, Herrick AL, Hinchcliff M, Hudson M, Johnson SR, Jones N, Kafaja S, Larché M, Manning J, Pope J, Spiera R, Steen V, Sutton E, Thorne C, Wilcox P, Thombs BD, Mayes MD; SPIN Investigators
The Scleroderma Patient-Centered Intervention Network Cohort: baseline clinical features and comparison with other large scleroderma cohorts.
Rheumatology (Oxford). 2018 Sep 1;57(9):1623-1631
https://www.ncbi.nlm.nih.gov/pubmed/29868924
AGOSTO 2018
- Li SC.
Scleroderma in Children and Adolescents: Localized Scleroderma and Systemic Sclerosis.
Pediatr Clin North Am. 2018 Aug;65(4):757-781. doi: 10.1016/j.pcl.2018.04.002.
https://www.ncbi.nlm.nih.gov/pubmed/30031497
JULIO 2018
- Maloney E, Menashe SJ, Iyer RS, Ringold S, Chakraborty AK, Ishak GE.
The central nervous system manifestations of localized craniofacial scleroderma: a study of 10 cases and literature review.
Pediatr Radiol. 2018 Jul 3. doi: 10.1007/s00247-018-4177-x. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29971479 - Kashem SW, Correll CK, Vehe RK, Hobday PM, Binstadt BA, Maguiness SM.
Inflammatory arthritis in pediatric patients with morphea.
J Am Acad Dermatol. 2018 Jul;79(1):47-51.e2. doi: 10.1016/j.jaad.2018.03.005. Epub 2018 Mar 10.
https://www.ncbi.nlm.nih.gov/pubmed/29535035
JUNIO 2018
- Siddiqui F, Kumar M.
A 13-year-old girl with a linear dark patch on her forehead: A case of scleroderma en coup de sabre in a child with skin of color presenting with a bruise-like appearance.
JAAD Case Rep. 2018 Apr 30;4(5):418-420. doi: 10.1016/j.jdcr.2017.08.018. eCollection 2018 Jun
https://www.ncbi.nlm.nih.gov/pubmed/29984268 - Agazzi A, Fadanelli G, Vittadello F, Zulian F, Martini G.
Reliability of LoSCAT score for activity and tissue damage assessment in a large cohort of patients with Juvenile Localized Scleroderma.
Pediatr Rheumatol Online J. 2018 Jun 18;16(1):37. doi: 10.1186/s12969-018-0254-9
https://www.ncbi.nlm.nih.gov/pubmed/29914516
MAYO 2018
- Denton CP, Ong VH, Xu S, Chen-Harris H, Modrusan Z, Lafyatis R, Khanna D, Jahreis A, Siegel J, Sornasse T.
Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis.
Ann Rheum Dis. 2018 May 31. pii: annrheumdis-2018-213031. doi: 10.1136/annrheumdis-2018-213031. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/29853453 - Martini G, Fadanelli G, Agazzi A, Vittadello F, Meneghel A, Zulian F.
Disease course and long-term outcome of juvenile localized scleroderma: Experience from a single pediatric rheumatology Centre and literature review.
Autoimmun Rev. 2018 May 3. pii: S1568-9972(18)30113-7. doi: 10.1016/j.autrev.2018.02.004. [Epub ahead of print] Review.
https://www.ncbi.nlm.nih.gov/pubmed/29729451 - Constantin T, Foeldvari I, Pain CE, Pálinkás A, Höger P, Moll M, Nemkova D, Weibel L, Laczkovszki M, Clements P, Torok KS.
Development of minimum standards of care for juvenile localized scleroderma.
Eur J Pediatr. 2018 May 4. doi: 10.1007/s00431-018-3144-8. [Epub ahead of print] Review.
https://www.ncbi.nlm.nih.gov/pubmed/29728839
ABRIL 2018
-
Adrovic A, Sahin S, Barut K, Kasapcopur O.
JUVENILE SCLERODERMA-what has changed in the meantime?
Curr Rheumatol Rev. 2018 Apr 22. doi: 10.2174/1573397114666180423105056. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29692255
MARZO 2018
- Fernández-Codina A, Fernández-Fernández J, Fernández-Pantiga A; en nombre del grupo vii de trabajo de final de master en Manejo Clínico de Enfermedades Autoinmunes Sistémicas de la Sociedad Española de Medicina Interna.
Utilización de Tocilizumab en la esclerosis sistémica: breve revisión de la literatura.
Rev Clin Esp. 2018 Mar 27. pii: S0014-2565(18)30063-8. doi: 10.1016/j.rce.2018.02.011. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29602447 - Kashem SW, Correll CK, Vehe RK, Hobday PM, Binstadt BA, Maguiness SM.
Inflammatory arthritis in pediatric patients with morphea.
J Am Acad Dermatol. 2018 Mar 10. pii: S0190-9622(18)30365-7. doi: 10.1016/j.jaad.2018.03.005. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29535035 - Saigusa R, Asano Y, Yamashita T, Takahashi T, Nakamura K, Miura S, Ichimura Y, Toyama T, Taniguchi T, Sumida H, Tamaki Z, Miyazaki M, Yoshizaki A, Sato S.
Systemic sclerosis complicated with localized scleroderma-like lesions induced by Köbner phenomenon.
J Dermatol Sci. 2018 Mar;89(3):282-289.
https://www.ncbi.nlm.nih.gov/pubmed/29279288
FEBRERO 2018
- Stevens BE, Torok KS, Li SC, Hershey N, Curran M, Higgins GC, Moore KF, Rabinovich CE, Dodson S, Stevens AM; CARRA Registry Investigators; Childhood Arthritis Rheumatology Research Alliance Stanford CA.
Arthritis Care Res (Hoboken). 2018 Feb 18. doi: 10.1002/acr.23547. [Epub ahead of print]
Clinical characteristics and factors associated with disability and impaired quality of life in children with juvenile systemic sclerosis
https://www-ncbi-nlm-nih-gov/pubmed/29457372
DICIEMBRE 2017
- Seibold JR, Wigley FM.
Editorial: Clinical Trials in Raynaud's Phenomenon: A Spoonful of Sugar (Pill) Makes the Medicine Go Down (in Flames).
Arthritis Rheumatol. 2017 Dec;69(12):2256-2258. doi: 10.1002/art.40307. Epub 2017 Nov 10.
https://www.ncbi.nlm.nih.gov/pubmed/28859256 - Cossu M, van Bon L, Preti C, Rossato M, Beretta L, Radstake TRDJ.
Earliest Phase of Systemic Sclerosis Typified by Increased Levels of Inflammatory Proteins in the Serum.
Arthritis Rheumatol. 2017 Dec;69(12):2359-2369.
https://www.ncbi.nlm.nih.gov/pubmed/28859262 - Denton CP, Hachulla É, Riemekasten G, Schwarting A, Frenoux JM, Frey A, Le Brun FO, Herrick AL; Raynaud Study Investigators.
Efficacy and Safety of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis: A Randomized, Placebo-Controlled, Phase II Study.
Arthritis Rheumatol. 2017 Dec;69(12):2370-2379.
https://www.ncbi.nlm.nih.gov/pubmed/29193819 - Gordon JK, Martyanov V, Franks JM, Bernstein EJ, Szymonifka J, Magro C, Wildman HF, Wood TA, Whitfield ML, Spiera RF.
Belimumab for the Treatment of Early Diffuse Systemic Sclerosis: Results of a Randomized, Double-Blind, Placebo-Controlled, Pilot Trial.
Arthritis Rheumatol. 2017 Oct 26. doi: 10.1002/art.40358. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29073351
NOVIEMBRE 2017
- Mullin CJ, Mathai SC.
New insights into the recognition, classification and management of systemic sclerosis-associated pulmonary hypertension.
Curr Opin Rheumatol. 2017 Nov;29(6):561-567
https://www.ncbi.nlm.nih.gov/pubmed/28817465 - Rangarajan V, Matiasz R, Freed BH.
Cardiac complications of systemic sclerosis and management: recent progress.
Curr Opin Rheumatol. 2017 Nov;29(6):574-584
https://www.ncbi.nlm.nih.gov/pubmed/28957839 - Johnson SR.
Progress in the clinical classification of systemic sclerosis.
Curr Opin Rheumatol. 2017 Nov;29(6):568-573
https://www.ncbi.nlm.nih.gov/pubmed/28961157
OCTUBRE 2017
- Merlin E, Breton S, Fraitag S, Stéphan JL, Wouters C, Bodemer C, Bader-Meunier B.
Fibrous Arthropathy Associated With Morphea: A New Cause of Diffuse Acquired Joint Contractures.
Pediatrics. 2017 Oct;140(4). pii: e20161899. doi: 10.1542/peds.2016-1899.
https://www.ncbi.nlm.nih.gov/pubmed/28954874 - Johnson SR, Soowamber ML, Fransen J, Khanna D, Van Den Hoogen F, Baron M, et al.
There is a need for new systemic sclerosis subset criteria. A content analytic approach.
Scand J Rheumatol. 2017 Oct 9:1-9. doi: 10.1080/03009742.2017.1299793
https://www.ncbi.nlm.nih.gov/pubmed/28990485 - Barsotti S, Bruni C, Orlandi M, Della Rossa A, Marasco E, Codullo V, Guiducci S.
One year in review 2017: systemic sclerosis
Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):3-20. Epub 2017 Sep 29. Review.
https://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/29035173 - Lythgoe H, Baildam E, Beresford MW, Cleary G, McCann LJ, Pain CE.
Tocilizumab as a potential therapeutic option for children with severe, refractory juvenile localized scleroderma
Rheumatology (Oxford). 2017 Oct 25. doi: 10.1093/rheumatology/kex382. [Epub ahead of print]
https://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/29077971
SEPTIEMBRE 2017
- Martini G, Campus S, Bernd R, Boscarol G, Meneghel A, Zulian F.
Tocilizumab in two children with pansclerotic morphoea: a hopeful therapy for refractory cases?
Clin Exp Rheumatol. 2017 Sep 29. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/28980909 - Knobler R, Moinzadeh P, Hunzelmann N, Kreuter A, Cozzio A, Mouthon L, Cutolo M, Rongioletti F,et al.
European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes.
J Eur Acad Dermatol Venereol. 2017 Sep;31(9):1401-1424.
https://www.ncbi.nlm.nih.gov/pubmed/28792092 - Kumánovics G, Péntek M, Bae S, Opris D, Khanna D, Furst DE, Czirják L.
Assessment of skin involvement in systemic sclerosis.
Rheumatology (Oxford). 2017 Sep 1;56(suppl_5):v53-v66. doi: 10.1093/rheumatology/kex202
https://www.ncbi.nlm.nih.gov/pubmed/28992173 - Mertens JS, Thurlings RM, Kievit W, Seyger MMB, Radstake TRD, de Jong EMGJ.
Long-term outcome of eosinophilic fasciitis: A cross-sectional evaluation of 35 patients.
J Am Acad Dermatol. 2017 Sep;77(3):512-517.e5. doi: 10.1016/j.jaad.2017.05.018.
https://www.ncbi.nlm.nih.gov/pubmed/28734566 - Iniesta Arandia N, Simeón-Aznar CP, Guillén Del Castillo A, Colunga Argüelles D, Rubio-Rivas M, Trapiella Martínez L, et al.
Influence of antibody profile in clinical features and prognosis in a cohort of Spanish patients with systemic sclerosis.
Clin Exp Rheumatol. 2017 Sep 21. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/28980912 - Freire M, Rivera A, Sopeña B, Tolosa Vilella C, Guillén-Del Castillo A, Colunga Argüelles D, et al.
Clinical and epidemiological differences between men and women with systemic sclerosis: a study in a Spanish systemic sclerosis cohort and literature review.
Clin Exp Rheumatol. 2017 Sep 18. [Epub ahead of print] Review.
https://www.ncbi.nlm.nih.gov/pubmed/28980905 - Dedeoglu R, Adroviç A, Oztunç F, Sahin S, Barut K, Kasapcopur O.
New Insights into Cardiac Involvement in Juvenile Scleroderma: A Three-Dimensional Echocardiographic Assessment Unveils Subclinical Ventricle Dysfunction.
Pediatr Cardiol. 2017 Sep 14. doi: 10.1007/s00246-017-1714-6. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/28913656
AGOSTO 2017
- Ardalan K, Zigler CK, Torok KS.
Predictors of Longitudinal Quality of Life in Juvenile Localized Scleroderma.
Arthritis Care Res (Hoboken). 2017 Jul;69(7):1082-1087. doi: 10.1002/acr.23101. Epub 2017 Jun 7.
https://www.ncbi.nlm.nih.gov/pubmed/27696700
JULIO 2017
- Ardalan K, Zigler CK, Torok KS.
Predictors of Longitudinal Quality of Life in Juvenile Localized Scleroderma.
Arthritis Care Res (Hoboken). 2017 Jul;69(7):1082-1087. doi: 10.1002/acr.23101. Epub 2017 Jun 7.
https://www.ncbi.nlm.nih.gov/pubmed/27696700
JUNIO 2017
- Li T, Liu Y, Xu H.
Successful treatment of infliximab in a patient with scleroderma: a case report.
Medicine (Baltimore). 2017 Jun;96(22):e6737.
https://www.ncbi.nlm.nih.gov/pubmed/28562527 - Bissell LA, Md Yusof MY, Buch MH.
Primary myocardial disease in scleroderma-a comprehensive review of the literature to inform the UK Systemic Sclerosis Study Group cardiac working group.
Rheumatology (Oxford). 2017 Jun 1;56(6):882-895
https://www.ncbi.nlm.nih.gov/pubmed/27940590 - Giacomelli R, Liakouli V, Berardicurti O, Ruscitti P, Di Benedetto P, Carubbi F, Guggino G, Di Bartolomeo S, Ciccia F, Triolo G, Cipriani P.
Interstitial lung disease in systemic sclerosis: current and future treatment.
Rheumatol Int. 2017 Jun;37(6):853-863.
https://www.ncbi.nlm.nih.gov/pubmed/28063071 - Pellar RE, Pope JE.
Evidence-based management of systemic sclerosis: Navigating recommendations and guidelines.
Semin Arthritis Rheum. 2017 Jun;46(6):767-774
https://www.ncbi.nlm.nih.gov/pubmed/28088339
MAYO 2017
- Tsou PS, Sawalha AH.
Unfolding the pathogenesis of scleroderma through genomics and epigenomics.
J Autoimmun. 2017 May 16. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/28526340
ABRIL 2017
- Denton CP, Khanna D.
Systemic sclerosis
Lancet. 2017 Apr 13. pii: S0140-6736(17)30933-9. doi: 10.1016/S0140-6736(17)30933-9. [Epub ahead of print] Review.
https://www.ncbi.nlm.nih.gov/pubmed/28413064
MARZO 2017
- Volkmann ER, Tashkin DP, Li N, Roth MD, Khanna D, Hoffmann-Vold AM, Kim G, Goldin J, Clements PJ, Furst DE, Elashoff RM.
Mycophenolate versus Placebo for Systemic Sclerosis-Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II.
Arthritis Rheumatol. 2017 Apr 4. doi: 10.1002/art.40114.
https://www.ncbi.nlm.nih.gov/pubmed/28376288 - Boulos D, Ngian GS, Rajadurai A, Elford K, Stevens W, Proudman S, Owen C, Roddy J, Nikpour M, Youssef P, Hill C, Sahhar J.
Long-term efficacy and tolerability of mycophenolate mofetil therapy in diffuse scleroderma skin disease.
Int J Rheum Dis. 2017 Mar 24. doi: 10.1111/1756-185X.13035.
https://www.ncbi.nlm.nih.gov/pubmed/28337853 - Nevskaya T, Baron M, Pope JE; Canadian Scleroderma Research Group.
Predictive value of European Scleroderma Group Activity Index in an early scleroderma cohort.
Rheumatology (Oxford). 2017 Mar 17. doi: 10.1093/rheumatology/kex015.
https://www.ncbi.nlm.nih.gov/pubmed/28340090
FEBRERO 2017
- McCann LJ, Pain CE.
A Practical Approach to Juvenile Dermatomyositis and Juvenile Scleroderma.
Indian J Pediatr. 2016 Feb;83(2):163-71.
https://www.ncbi.nlm.nih.gov/pubmed/26489640
ENERO 2017
- Eutsler EP, Horton DB, Epelman M, Finkel T, Averill LW.
Musculoskeletal MRI findings of juvenile localized scleroderma.
Pediatr Radiol. 2017 Jan 14. doi: 10.1007/s00247-016-3765-x. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/28091699 - Garcia-Romero MT, Randhawa HK, Laxer R, Pope E.
The role of local temperature and other clinical characteristics of localized scleroderma as markers of disease activity.
Int J Dermatol. 2017 Jan;56(1):63-67. doi: 10.1111/ijd.13452.
https://www.ncbi.nlm.nih.gov/pubmed/27943304 - Hetlevik SO, Flatø B, Rygg M, Nordal EB, Brunborg C, Hetland H, Lilleby V.
Long-term outcome in juvenile-onset mixed connective tissue disease: a nationwide Norwegian study.
Ann Rheum Dis. 2017 Jan;76(1):159-165. doi: 10.1136/annrheumdis-2016-209522. Epub 2016 Jun 9.
https://www.ncbi.nlm.nih.gov/pubmed/27283334
DICIEMBRE 2016
- Valentini G, Iudici M, Walker UA, Jaeger VK, Baron M, Carreira P, Czirják L, Denton CP, Distler O, Hachulla E, Herrick AL, Kowal-Bielecka O, Pope J, Müller-Ladner U, Riemekasten G, Avouac J, Frerix M, Jordan S, Minier T, Siegert E, Ong VH, Vettori S, Allanore Y.
The European Scleroderma Trials and Research group (EUSTAR) task forcé for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index.
Ann Rheum Dis. 2017 Jan;76(1):270-276.
https://www.ncbi.nlm.nih.gov/pubmed/27621285
NOVIEMBRE 2016
- Silva M, Ribeiro R, Oliveira J.
Pseudoainhum in Systemic Sclerosis.
J Rheumatol. 2016 Nov;43(11):2076.
https://www.ncbi.nlm.nih.gov/pubmed/27803345 - Stevens AM, Kanaan SB, Torok KS, Medsger TA, Mayes MD, Reveille JD, Klein-Gitelman M, Reed AM, Lee T, Li SC, Henstorf G, Luu C, Aydelotte T, Lee Nelson J.
HLA-DRB1, DQA1, and DQB1 in Juvenile-Onset Systemic Sclerosis.
Arthritis Rheumatol. 2016 Nov;68(11):2772-2777.
https://www.ncbi.nlm.nih.gov/pubmed/27214100 - Trombetta AC, Pizzorni C, Ruaro B, Paolino S, Sulli A, Smith V, Cutolo M.
Effects of Longterm Treatment with Bosentan and Iloprost on Nailfold Absolute Capillary Number, Fingertip Blood Perfusion, and Clinical Status in Systemic Sclerosis.
J Rheumatol. 2016 Nov;43(11):2033-2041.
https://www.ncbi.nlm.nih.gov/pubmed/27744392
OCTUBRE 2016
- Pain CE, Constantin T, Toplak N, Moll M, Iking-Konert C, Piotto DP, Aktay Ayaz N, Nemcova D, Hoeger PH, Cutolo M, Smith V, Foeldvari I; Paediatric Rheumatology European Society (PRES) Juvenile Scleroderma Working Group.
Raynaud's syndrome in children: systematic review and development of recommendations for assessment and monitoring
Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):200-206.
https://www.ncbi.nlm.nih.gov/pubmed/27494080 - Zulian F, Balzarin M, Birolo C.
Recent advances in the management of juvenile systemic sclerosis
Expert Rev Clin Immunol. 2016 Oct 3
https://www.ncbi.nlm.nih.gov/pubmed/27690679
SEPTIEMBRE 2016
- Cabrera N, Duquesne A, Desjonquères M, Larbre JP, Lega JC, Fabien N, Belot A.
Tocilizumab in the treatment of mixed connective tissue disease and overlap syndrome in children.
RMD Open. 2016 Sep 15;2(2):e000271.
https://www.ncbi.nlm.nih.gov/pubmed/27738519 - Valões CC, Novak GV, Brunelli JB, Kozu KT, Toma RK, Silva CA.
Esophageal abnormalities in juvenile localized scleroderma: is it associated with other extracutaneous manifestations?
Rev Bras Reumatol. 2016 Sep 17.
https://www.ncbi.nlm.nih.gov/pubmed/27693175
AGOSTO 2016
- Woodworth TG, Suliman YA, Furst DE, Clements P.
Scleroderma renal crisis and renal involvement in systemic sclerosis.
Nat Rev Nephrol. 2016 Sep 19. doi: 10.1038/nrneph.2016.124. [Epub ahead of print].
http://www.ncbi.nlm.nih.gov/pubmed/27641135 - Valentini G, Iudici M, Walker UA, Jaeger VK, Baron M, Carreira P, Czirják L, Denton CP, Distler O, Hachulla E, Herrick AL, Kowal-Bielecka O, Pope J, Müller-Ladner U, Riemekasten G, Avouac J, Frerix M, Jordan S, Minier T, Siegert E, Ong VH, Vettori S, Allanore Y.
The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index.
Ann Rheum Dis. 2016 Sep 12. pii: annrheumdis-2016-209768. doi: 10.1136/annrheumdis-2016-209768. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/27621285 - Distler JH, Feghali-Bostwick C, Soare A, Asano Y, Distler O, Abraham DJ.
Frontiers of antifibrotic therapy in systemic sclerosis.
Arthritis Rheumatol. 2016 Sep 16. doi: 10.1002/art.39865. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/27636741 - Crowell MD, Umar SB, Griffing WL, DiBaise JK, Lacy BE, Vela MF.
Esophageal Motor Abnormalities in Patients with Scleroderma: Heterogeneity, Risk Factors, and Effects on Quality of Life.
Clin Gastroenterol Hepatol. 2016 Sep 6. pii: S1542-3565(16)30615-2. doi: 10.1016/j.cgh.2016.08.034. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/27613260 - Baron M, Pope J, Robinson D, Jones N, Khalidi N, Docherty P, Kaminska E, Masetto A, Sutton E, Mathieu JP, Ligier S, Grodzicky T, LeClercq S, Thorne C, Gyger G, Smith D, Fortin PR, Larché M, Abu-Hakima M, Rodriguez-Reyna TS, Cabral-Castaneda AR, Fritzler MJ, Wang M, Hudson M.
Calcinosis is associated with digital ischaemia in systemic sclerosis-a longitudinal study.
Rheumatology (Oxford). 2016 Sep 4. pii: kew313. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27593964 - Fotis L, Baszis KW, White AJ, French AR.
Four Cases of Anti-PM/Scl Antibody-positive Juvenile Overlap Syndrome with Features of Myositis and Systemic Sclerosis.
J Rheumatol. 2016 Sep;43(9):1768-9.
http://www.ncbi.nlm.nih.gov/pubmed/27587018 - Sakkas LI.
Spotlight on tocilizumab and its potential in the treatment of systemic sclerosis.
Drug Des Devel Ther. 2016 Aug 29;10:2723-8.
http://www.ncbi.nlm.nih.gov/pubmed/27621593 - Ando K, Nakashita T, Kaneko N, Takahashi K, Motojima S.
Associations between peripheral blood eosinophil counts in patients with systemic sclerosis and disease severity.
Springerplus. 2016 Aug 23;5(1):1401.
http://www.ncbi.nlm.nih.gov/pubmed/27610320
JUNIO 2016
- Sanges S, Desauw C, de Groote P, Fertin M, Lamblin N, Bervar JF, Hatron PY, Hachulla E, Launay D.
Tolerance of bevacizumab therapy in systemic sclerosis-associated pulmonary arterial hypertension: A case report.
Rev Med Interne. 2016 Jun 28. pii: S0248-8663(16)30410-6. doi: 10.1016/j.revmed.2016.05.020
http://www.ncbi.nlm.nih.gov/pubmed/27370897
MAYO 2016
- Linnemann B, Erbe M.
Raynaud's phenomenon and digital ischaemia - pharmacologic approach and alternative treatment options.
Vasa. 2016 May;45(3):201-212. doi: 10.1024/0301-1526/a000526
http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27129065
ABRIL 2016
- Hughes M, Herrick AL.
Digital ulcers in systemic sclerosis
Rheumatology (Oxford). 2016 Apr 19. pii: kew047. [Epub ahead of print] http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27094599 - Tarp S, Amarilyo G, Foeldvari I, Christensen R, Woo JM, Cohen N, Pope TD, Furst DE.
Efficacy and safety of biological agents for systemic juvenile idiopathic arthritis: a systematic review and meta-analysis of randomized trials.
Rheumatology (Oxford). 2016 Apr;55(4):669-79. doi: 10.1093/rheumatology/kev382. Epub 2015 Nov 30
http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/26628580 - Linnemann B, Erbe M.
Raynaud's phenomenon and digital ischaemia - pharmacologic approach and alternative treatment options
Vasa. 2016 May;45(3):201-212.
http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27129065
MARZO 2016
- Dobrota R, Maurer B, Graf N, Jordan S, Mihai C, Kowal-Bielecka O, Allanore Y, Distler O; EUSTAR coauthors.
Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: a EUSTAR analysis.
Ann Rheum Dis. 2016 Mar 25. pii: annrheumdis-2015-208024. doi: 10.1136/annrheumdis-2015-208024. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27016052 - Ligon C, Hummers LK.
Biomarkers in Scleroderma: Progressing from Association to Clinical Utility.
Curr Rheumatol Rep. 2016 Mar;18(3):17. doi: 10.1007/s11926-016-0565-0.
http://www.ncbi.nlm.nih.gov/pubmed/26970773 - Gigante A, Barbano B, Barilaro G, Quarta S, Gasperini ML, Di Mario F, Romaniello A, Amoroso A, Cianci R, Rosato E.
Serum uric acid as a marker of microvascular damage in systemic sclerosis patients.
Microvasc Res. 2016 Mar 18. pii: S0026-2862(16)30021-8. doi: 10.1016/j.mvr.2016.03.007. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27003713
FEBRERO 2016
- Hashkes PJ.
50 Years Ago in TheJournal of Pediatrics: Scleroderma in Childhood.
J Pediatr. 2016 Feb;169:35. doi: 10.1016/j.jpeds.2015.07.062.
http://www.ncbi.nlm.nih.gov/pubmed/26810099
NOVIEMBRE 2015
- Stella Aslibekyan, Vincent A. Laufer, Donna K. Arnett and S. Louis Bridges
A novel genetic association with systemic sclerosis: The utility of whole exome sequencing in autoimmune disease
Arthritis & Rheumatology. DOI: 10.1002/art.39451
Abstract - Athanasios Mavropoulos, Theodora Simopoulou, Areti Varna, Christos Liaskos, Christina Katsiari, Dimitrios P. Bogdanos and Lazaros I. Sakkas
B regulatory cells are decreased and functionally impaired in patients with systemic sclerosis
Arthritis & Rheumatology DOI: 10.1002/art.39437
Abstract - Alexandre TJ Maria, Karine Toupet, Claire Bony, Nelly Pirot, Marie-Catherine Vozenin, Benoît Petit, Pascal Roger, Frédéric Batteux, Alain Le Quellec, Christian Jorgensen, Danièle Noël and Philippe Guilpain
Anti-fibrotic, anti-oxidant and immunomodulatory effects of mesenchymal stem cells in HOCl-induced systemic sclerosis
Arthritis & Rheumatology. DOI: 10.1002/art.39477
Abstract - Ramos, Paula S; Silver, Richard M; Feghali-Bostwick, Carol A
Genetics of systemic sclerosis: recent advances
Current Opinion in Rheumatology:
November 2015 - Volume 27 - Issue 6 - p 521–529
doi: 10.1097/BOR.0000000000000214 - Lara Bossini-Castillo, , Elena López-Isac, Javier Martín
Immunogenetics of systemic sclerosis: Defining heritability, functional variants and shared-autoimmunity pathways
Journal of Autoimmunity
Volume 64, November 2015, Pages 53–65
OCTUBRE 2015
- Hughes M, Ong VH, Anderson ME, Hall F, Moinzadeh P, Griffiths B, Baildam E, Denton CP, Herrick AL
Consensus best practice pathway of the UK Scleroderma Study Group: digital vasculopathy in systemic sclerosis.
Rheumatology (Oxford). 2015 Nov;54(11):2015-24. doi: 10.1093/rheumatology/kev201.
http://www.ncbi.nlm.nih.gov/pubmed/26116156
SEPTIEMBRE 2015
- Simeón-Aznar CP, Fonollosa-Plá V, Tolosa-Vilella C, Espinosa-Garriga G, Campillo-Grau M, Ramos-Casals M, García-Hernández FJ, Castillo-Palma MJ, Sánchez-Román J, Callejas-Rubio JL, Ortego-Centeno N, Egurbide-Arberas MV, Trapiellla-Martínez L, Caminal-Montero L, Sáez-Comet L, Velilla-Marco J, Camps-García MT, de Ramón-Garrido E, Esteban-Marcos EM, Pallarés-Ferreres L, Navarrete-Navarrete N, Vargas-Hitos JA, Torre RG, Salvador-Cervello G, Rios-Blanco JJ, Vilardell-Tarrés M; Spanish Scleroderma Study Group (SSSG), Autoimmune Diseases Study Group (GEAS), Spanish Society of Internal Medicine (SEMI).
Registry of the Spanish Network for Systemic Sclerosis: Survival, Prognostic Factors, and Causes of Death.
Medicine (Baltimore). 2015 Oct;94(43):e1728.
http://www.ncbi.nlm.nih.gov/pubmed/26512564 - Avouac J, Riemekasten G, Meune C, Ruiz B, Kahan A, Allanore Y.
Autoantibodies against Endothelin 1 Type A Receptor Are Strong Predictors of Digital Ulcers in Systemic Sclerosis
J Rheumatol October 2015;42(10):1801-7; doi:10.3899/jrheum.150061
http://www.jrheum.org/content/42/10/1801.abstract
AGOSTO 2015
- Torok KS, Kurzinski K, Kelsey C, Yabes J, Magee K, Vallejo AN, Medsger T Jr, Feghali-Bostwick CA.
Peripheral blood cytokine and chemokine profiles in juvenile localized scleroderma: T-helper cell-associated cytokine profiles.
Semin Arthritis Rheum. 2015 Jun 17. pii:S0049-0172(15)00144-4.doi:10.1016/j.semarthrit.2015.06.006. EPUB ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/26254121 - Poff S, Li SC, Kelsey CE, Foeldvari I, Torok KS.
Durometry as an Outcome Measure in Juvenile Localized Scleroderma.
Br J Dermatol. 2015 Aug 24. doi:10.1111/bjd.14103. EPUB ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/26302039 - Ingegnoli F, Boracchi P, Gualtierotti R, Smith V, Cutolo M, Foeldvari I; EUSTAR co-authors.
A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study.
Microvasc Res. 2015 Aug 4;102:19-24. doi:10.1016/j.mvr.2015.07.007. EPUB ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26254260
JUNIO 2015
- Hughes M, Ong VH, Anderson ME, Hall F, Moinzadeh P, Griffiths B, Baildam E, Denton CP, Herrick AL.
Consensus best practice pathway of the UK Systemic Sclerosis Study Group: digital vasculopathy in systemic sclerosis.
Rheumatology (Oxford). 2015 Jun 26. pii: kev201. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26116156
MAYO 2015
- Eric Hachulla, Pierre-Yves Hatron, Patrick Carpentier, Christian Agard, Emmanuel Chatelus, Patrick Jego, et al, on behalf of the SEDUCE study group.
Efficacy of sildenafil on ischaemic digital ulcer healing in systemic sclerosis: the placebo-controlled SEDUCE study.
Ann Rheum Dis doi:10.1136/annrheumdis-2014-207001 [Published on line: 20 may 2015] http://ard.bmj.com/content/early/2015/05/20/annrheumdis-2014-207001.abstract - Britta Maurer, Nicole Graf, Beat A Michel, Ulf Müller-Ladner, László Czirják, Christopher P Denton, et al, EUSTAR co-authors
Extended report: Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database
Ann Rheum Dis 2015;74:1124-1131 doi:10.1136/annrheumdis-2014-205226
http://ard.bmj.com/content/74/6/1124.abstract - Suzana Jordan, Jörg H W Distler, Britta Maurer, Dörte Huscher, Jacob M van Laar, Yannick Allanore, et al on behalf of the EUSTAR Rituximab study group
Extended report: Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group.
Ann Rheum Dis 2015;74:1188-1194 doi:10.1136/annrheumdis-2013-204522
http://ard.bmj.com/content/74/6/1188.abstract - Young, Amber; Khanna, Dinesh
Systemic sclerosis: a systematic review on therapeutic management from 2011 to 2014
Current Opinion in Rheumatology, May 2015, Vol 27, Issue 3
http://journals.lww.com/co-rheumatology/Abstract/2015/05000/Systemic_sclerosis___a_systematic_review_on.6.aspx - Fiona M. McQueen and Kamal Solanki
Rituximab in diffuse cutaneous systemic sclerosis: should we be using it today?
Rheumatology (2015) 54 (5): 757-767 doi:10.1093/rheumatology/keu463
http://rheumatology.oxfordjournals.org/content/54/5/757.full
ABRIL 2015
- Tolkachjov SN, Patel NG, Tollefson MM.
Progressive hemifacial atrophy: a review.
Orphanet J Rare Dis. 2015 Apr 1;10(1):39. doi: 10.1186/s13023-015-0250-9.
http://www.ncbi.nlm.nih.gov/pubmed/25881068
Acceso directo: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391548/
MARZO 2015
- Mertens JS, Seyger MM, Kievit W, Hoppenreijs EP, Jansen TL, van de Kerkhof PC, Radstake TR, de Jong EM.
Disease recurrence in localized scleroderma: a retrospective analysis of 344 patients with paediatric- or adult-onset disease.
Br J Dermatol. 2015 Mar;172(3):722-8. doi: 10.1111/bjd.13514
http://www.ncbi.nlm.nih.gov/pubmed/25381928 - Young A, Khanna D.
Systemic sclerosis: a systematic review on therapeutic management from 2011 to 2014.
Curr Opin Rheumatol. 2015 May;27(3):241-8. doi: 10.1097/BOR
http://www.ncbi.nlm.nih.gov/pubmed/25775190 - Moinzadeh P, Aberer E, Ahmadi-Simab K, Blank N, Distler JHW, Fierlbeck G et al
Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis
Ann Rheum Dis 2015;74:730-737. doi:10.1136/annrheumdis-2013-204487
http://ard.bmj.com/content/74/4/730.full.pdf+html - Wu CY, Asano Y, Taniguchi T, Sato S, Yu HS.
Serum heparanase levels: A protective marker against digital ulcers in patients with systemic sclerosis.
J Dermatol. 2015 Mar 21. doi: 10.1111/1346-8138.12842. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/25808574 - Foeldvari I.
Update on juvenile systemic sclerosis
Curr Rheumatol Rep. 2015 Mar;17(3):491. doi: 10.1007/s11926-014-0491-y.
http://www.ncbi.nlm.nih.gov/pubmed/25761925 - Hughes M, Snapir A, Wilkinson J, Snapir D, Wigley FM, Herrick AL.
Prediction and impact of attacks of Raynaud's phenomenon, as judged by patient perception.
Rheumatology (Oxford). 2015 Mar 9. pii: kev002. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/25752312 - Hughes M, Moore T, O'Leary N, Tracey A, Ennis H, Dinsdale G, Murray A, Roberts C, Herrick AL.
A study comparing videocapillaroscopy and dermoscopy in the assessment of nailfold capillaries in patients with systemic sclerosis-spectrum disorders.
Rheumatology (Oxford). 2015 Mar 6. pii: keu533. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/25749623
DICIEMBRE 2014
- Gerhold K, Becker MO.
Nailfold capillaroscopy in juvenile rheumatic diseases: known measures, patterns and indications.
Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-183-8.
http://www.ncbi.nlm.nih.gov/pubmed/24960119
NOVIEMBRE 2014
- Falcini F, Rigante D, Candelli M, Martini G, Corona F, Petaccia A, La Torre F, Raffaele CG, Matucci Cerinic M.
Anti-nuclear antibodies as predictor of outcome in a multi-center cohort of Italian children and adolescents with Raynaud's phenomenon.
Clin Rheumatol. 2014 Nov 28. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/?term=25428518 - Polcari I, Moon A, Mathes EF, Gilmore ES, Paller AS.
Headaches as a Presenting Symptom of Linear Morphea en Coup de Sabre.
Pediatrics. 2014 Nov 17. pii: peds.2014-0019. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/?term=25404727 - Mertens JS, Seyger MM, Kievit W, Hoppenreijs EP, Jansen TL, van de Kerkhof PC, Radstake TR, de Jong EM.
Disease recurrence in localized scleroderma: a retrospective analysis of 344 patients with pediatric or adult-onset disease.
Br J Dermatol. 2014 Nov 7 [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/?term=25381928 - Condie D, Grabell D, Jacobe H.
Comparison of outcomes in adults with pediatric-onset morphea and those with adult-onset morphea: a cross-sectional study from the morphea in adults and children cohort.
Arthritis Rheumatol. 2014 Dec;66(12):3496-504.
http://www.ncbi.nlm.nih.gov/pubmed/?term=25156342 - Taniguchi T, Asano Y, Tamaki Z, Akamata K, Aozasa N, Noda S, Takahashi T, Ichimura Y, Toyama T, Sugita M, Sumida H, Kuwano Y, Miyazaki M, Yanaba K, Sato S.
Histological features of localized scleroderma 'en coup de sabre': a study of 16 cases.
J Eur Acad Dermatol Venereol. 2014 Dec;28(12):1805-10.
http://www.ncbi.nlm.nih.gov/pubmed/?term=24118540 - Jackson CT, Maibach HI.
Localized scleroderma variants: pharmacologic implications.
J Dermatolog Treat. 2014 Dec;25(6):529-31.
http://www.ncbi.nlm.nih.gov/pubmed/?term=22905721
OCTUBRE 2014
- Hong BY1, Giang R, Mbuagbaw L, Larche M, Thabane L
Factors associated with development of gastrointestinal problems in patients with scleroderma: a protocol for a systematic review.
Syst Rev. 2014 Oct 13;3(1):115. doi: 10.1186/2046-4053-3-115.
http://www.ncbi.nlm.nih.gov/pubmed/25312976 - Hoffmann-Vold AM, Gunnarsson R, Garen T, Midtvedt O, Molberg O.
Performance of the 2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis (SSc) in Large, Well-defined Cohorts of SSc and Mixed Connective Tissue Disease.
J Rheumatol. 2014 Oct 1. pii: jrheum.140047. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/25274890
SEPTIEMBRE 2014
- Jacobe H, Ahn C, Arnett F, Reveille JD.
Major histocompatibility complex (MHC) class I and II alleles which confer susceptibility or protection in the Morphea in Adults and Children (MAC) cohort.
Arthritis Rheumatol. 2014 Sep 15. doi: 10.1002/art.38814. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/25223600
AGOSTO 2014
- van Bon L1, Cossu M1, Loof A2, Gohar F3, Wittkowski H3, Vonk M4, Roth J5, van den Berg W4, van Heerde W2, Broen JC6, Radstake TR6.
Proteomic analysis of plasma identifies the Toll-like receptor agonists S100A8/A9 as a novel possible marker forsystemic sclerosis phenotype.
Ann Rheum Dis. 2014 Aug;73(8):1585-9. doi: 10.1136/annrheumdis-2013-205013. Epub 2014 Apr 9.
http://www.ncbi.nlm.nih.gov/pubmed/24718960
JULIO 2014
- Launay D, Savale L, Berezne A, Le Pavec J, Hachulla E, Mouthon L, Sitbon O, Lambert B, Gaudric M, Jais X, Stephan F, Hatron PY, Lamblin N, Vignaux O, Cottin V, Farge D, Wallaert B, Guillevin L, Simonneau G, Mercier O, Fadel E, Dartevelle P, Humbert M, Mussot S; On behalf of the Working Group on Heart/Lung transplantation in systemic sclerosis of the French Network on Pulmonary Hypertension.
Lung and heart-lung transplantation for systemic sclerosis patients. A monocentric experience of 13 patients, review of the literature and position paper of a multidisciplinary Working Group.
Presse Med. 2014 Jul 11. pii: S0755-4982(14)00311-X. doi: 10.1016/j.lpm.2014.01.020.
http://www.ncbi.nlm.nih.gov/pubmed/25027464 - Saad Magalhães C, Fernandes Tde A, Fernandes TD, Resende LA.
A cross-sectional electromyography assessment in linear sclerodermapatients.
Pediatr Rheumatol Online J. 2014 Jul 12;12:27.
http://www.ncbi.nlm.nih.gov/pubmed/25053924
JUNIO 2014
- Schicchi N, Valeri G, Moroncini G, Agliata G, Salvolini L, Gabrielli A, Giovagnoni A.
Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance.
Radiol Med. 2014 Jun 7. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24907065 - Webber M, Natarajan A, Schreiber B, Sanjay P, Schwaiger J, Handler C, Coghlan G.
136 Cardiac involvement in systemic sclerosis: strengths and limitations of cardiac magnetic resonance imaging.
Heart. 2014 Jun;100 Suppl 3:A80. doi: 10.1136/heartjnl-2014-306118.136.
http://www.ncbi.nlm.nih.gov/pubmed/24922935
MAYO 2014
-
Yilmaz N, Can M, Kocakaya D, Karakurt S, Yavuz S.Two-year experience with mycophenolate mofetil in patients with scleroderma lung disease: a case series.Int J Rheum Dis. 2014 May 26. doi: 10.1111/1756-185X.12399. [Epub ahead of print]
- Hawley DP1, Pain CE2, Baildam EM2, Murphy R2, Taylor AE2, Foster HE3.
United Kingdom survey of current management of juvenile localized scleroderma.
Rheumatology (Oxford). 2014 May 21. pii: keu212. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/24850875
MARZO 2014
- Hatta Y1, Hasegawa M, Matsushita T, Hamaguchi Y, Fujimoto M, Takehara K.
The clinical characteristics of juvenile-onset systemic sclerosis in Japanese patients.
Mod Rheumatol. 2014 Mar;24(2):377-9. doi: 10.3109/14397595.2013.854073.
http://www.ncbi.nlm.nih.gov/pubmed/24593219
ENERO 2014
- Jordan S, Distler JH, Maurer B, Huscher D, van Laar JM, Allanore Y, Distler O; on behalf of the EUSTAR Rituximab study group.
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group.
Ann Rheum Dis. 2014 Jan 17. doi: 10.1136/annrheumdis-2013-204522. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24442885
DICIEMBRE 2013
- Khanna D, Gladue H, Channick R et al.
Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension.
Arthritis Rheum. 2013 Dec;65(12):3194-201. doi: 10.1002/art.38172
http://www.ncbi.nlm.nih.gov/pubmed/24022584
NOVIEMBRE 2013
- van den Hoogen F, Khanna D, Fransen J, Johnson SR et al.
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.
Arthritis Rheum. 2013 Nov;65(11):2737-47. doi: 10.1002/art.38098.
http://www.ncbi.nlm.nih.gov/pubmed/24122180
OCTUBRE 2013
- Cutolo M, Smith V.
State of the art on nailfold capillaroscopy: a reliable diagnostic tool and putative biomarker in rheumatology?
Rheumatology 2013;52:1933-40. doi:10.1093/rheumatology/ket153
http://rheumatology.oxfordjournals.org/content/52/11/1933.abstract
SEPTIEMBRE 2013
-
Ingegnoli F, Herrick AL.Nailfold Capillaroscopy in PediatricsArthritis Care Res 2013 Sep; 65(9):1393-1400.
-
Tingey T, Shu J, Smuczek J, Pope J.Meta-Analysis of Healing and Prevention of Digital Ulcers in Systemic SclerosisArthritis Care Res 2013 Sep; 65(9):1460-71.
-
Lefèvre G, Luc Dauchet L, Hachulla E, Montani D, Sobanski V, Lambert M, Hatron PY, Humbert M, Launay D.Survival and Prognostic Factors in Systemic Sclerosis–Associated Pulmonary Hypertension: A Systematic Review and Meta-AnalysisArthritis Rheum 2013 Sep;65(9):2412-23.
AGOSTO 2013
-
Gladue H, Steen V, Allanore Y, Saggar R, Saggar R, Maranian P, Berrocal VJ, Avouac J, Meune C, Trivedi M, Khanna D.Combination of Echocardiographic and Pulmonary Function Test Measures Improves Sensitivity for Diagnosis of Systemic Sclerosis-associated Pulmonary Arterial Hypertension: Analysis of 2 Cohorts.J Rheumatol. 2013 Aug 15. [Epub ahead of print]
ABRIL 2013
- Browning JC.
Pediatric morphea.
Dermatol Clin. 2013 Apr;31:229-37. doi: 10.1016/j.det.2012.12.002. Epub 2013 Feb 1.
http://www.ncbi.nlm.nih.gov/pubmed/23557652 - Hatta Y, Hasegawa M, Matsushita T, Hamaguchi Y, Fujimoto M, Takehara K.
The clinical characteristics of juvenile-onset systemic sclerosis in Japanese patients.
Mod Rheumatol 2013 Apr 27. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/23624940
ENERO 2013
- Bonifazi M, Tramacere I, Pomponio G, Gabrielli B, Avvedimento EV, La Vecchia C, Negri E, Gabrielli A.
Systemic sclerosis (scleroderma) and cancer risk: systematic review and meta-analysis of observational studies.
Rheumatology (Oxford) 2013 Jan;52(1):143-54. doi: 10.1093/rheumatology/kes303. Epub 2012 Nov 22.
http://www.ncbi.nlm.nih.gov/pubmed/23175568 - Schanz S, Henes J, Ulmer A, Kötter I, Fierlbeck G, Claussen CD, Horger M.
Magnetic resonance imaging findings in patients with systemic scleroderma and musculoskeletal symptoms.
Eur Radiol 2013 Jan;23(1):212-21. doi: 10.1007/s00330-012-2584-1.
http://www.ncbi.nlm.nih.gov/pubmed/22843057
DICIEMBRE 2012
- La Torre F, Giorgia Martini G, Russo R, Katsicas MM, Corona F, Calcagno G, Falcini F, Vittadello F, Zulian F.
A preliminary disease severity score for juvenile systemic sclerosis.
Arthritis Rheum 2012 Dec; 64(12):4143-50. DOI: 10.1002/art.34652.
http://onlinelibrary.wiley.com/doi/10.1002/art.34652/abstract
SEPTIEMBRE 2012
- Caron M, Hudson M, Baron M, Nessim S, Steele R; Canadian Scleroderma Research Group.
Longitudinal study of renal function in systemic sclerosis.
J Rheumatol 2012 Sep;39(9):1829-34. doi: 10.3899/jrheum.111417
http://www.ncbi.nlm.nih.gov/pubmed/22859351
AGOSTO 2012
- Li SC,Torok KS, Pope E, Dedeoglu F, Hong S, Jacobe HT, Rabinovich CE, Laxer RM, Higgins GC, Ferguson PJ, Lasky A, Baszis K, Becker M, Campillo S,Cartwright V, Cidon M, Inman CJ, Jerath R, O'Neil KM, Vora S, Zeft A, Wallace CA, Ilowite NT, Fuhlbrigge RC; Childhood Arthritis and Rheumatology Research Alliance (CARRA) Localized Scleroderma Workgroup.
Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma.
Arthritis Care Res (Hoboken) 2012 Aug;64(8):1175-85. doi: 10.1002/acr.21687.
http://www.ncbi.nlm.nih.gov/pubmed/22505322
Última actualización: 5 marzo 2026
ENERO 2026
- De Souza R, Rutstein B, Schletzbaum-Bowler M, Singer N, Kohlheim M, Del Gaizo V, et al.
Variability in vaccination practices in children with rheumatic diseases: results of a childhood arthritis and rheumatology research alliance (CARRA)-wide survey.
Pediatr Rheumatol Online J. 2026 Jan 31.
https://pubmed.ncbi.nlm.nih.gov/41620617/
DICIEMBRE 2025
- Ohnishi T, Wakiguchi H, Ishimori S, Itoh N, Yashiro M, Yamazaki S et al.
Vaccination in paediatric, adolescent, and transitional-age rheumatic diseases: a systematic review
Mod Rheumatol. 2025 Dec 22;36(1):97–112
https://pubmed.ncbi.nlm.nih.gov/40709824/
OCTUBRE 2025
-
Brugha R, Kirkham A, Bate J, Burke GAA, Hughes A, Magwaro S, et al; OCTAVE-Minor Collaborative Groupˆ.
SARS-CoV-2-Specific Immune Responses to Vaccination in Children and Adolescents with Suppressed Immune Systems: A Prospective, Observational Study.
J Pediatr. 2025 Oct 23:114873
https://pubmed.ncbi.nlm.nih.gov/41139014/ -
Maritsi D, Alpert N, Bizjak M, Ziv A, et al.; PReS Vaccination Working Party.
Influenza vaccine uptake in juvenile idiopathic arthritis during the COVID-19 pandemic: a multicentre cross-sectional study by PRES vaccination working party.
Pediatr Rheumatol Online J. 2025 Oct 15;23(1):103.
https://pubmed.ncbi.nlm.nih.gov/41094677/
SEPTIEMBRE 2025
-
Tsai MC, Chen HH, Wu WY, Huang YC, Hsu CY, Fu LS.
Risk of Juvenile Idiopathic Arthritis Following HPV9 Vaccination: A Retrospective Cohort Study Before and During the COVID-19 Pandemic
Mayo Clin Proc Innov Qual Outcomes. 2025 Sep 9;9(5):100647. doi: 10.1016/j.mayocpiqo.2025.100647.
https://pubmed.ncbi.nlm.nih.gov/40988655/
JULIO 2025
-
Ohnishi T, Wakiguchi H, Ishimori S, Itoh N, Yashiro M, Yamazaki S, et al.
Vaccination in paediatric, adolescent, and transitional-age rheumatic diseases: A systematic review.
Mod Rheumatol. 2025 Jul 25:roaf069. doi: 10.1093/mr/roaf069. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/40709824/
ABRIL 2025
-
Gyori A, Nagy A, Ottoffy G, Decsi T, Simon D, Berki T, Dergez T, Kuti D, Mosdosi B.
Influenza vaccination in patients with juvenile idiopathic arthritis under different treatments: safety and immune response
Pediatr Rheumatol Online J. 2025 Apr 25;23(1):43. doi: 10.1186/s12969-025-01099-y.
https://pubmed.ncbi.nlm.nih.gov/40281592/
MARZO 2025
-
Nepesov MI, Gür GU, Yamanel RGS, Çakan M.
Hepatitis B vaccine and juvenile idiopathic arthritis: comparison of the seropositivity rates with healthy children at the time of diagnosis and booster dose response under treatment.
Clin Rheumatol. 2025 Mar;44(3):1299-1305. doi: 10.1007/s10067-025-07313-2.
https://pubmed.ncbi.nlm.nih.gov/39808236/ -
Patel NJ, Srivatsan S, Kowalski EN, King A, Wang X, Vanni KM, et al.
Patients with systemic autoimmune rheumatic diseases remain at risk for hospitalisation for COVID-19 infection in the Omicron era (2022-2024): a retrospective cohort study.
RMD Open. 2025 Mar 5;11(1):e005114. doi: 10.1136/rmdopen-2024-005114.
https://pubmed.ncbi.nlm.nih.gov/40044572/
FEBRERO 2025
-
Alexeeva E, Dvoryakovskaya T, Fetisova A, Kriulin I, Krekhova E, Kabanova A, Labinov V, Labinova E, Kostik M.
The Efficacy and Safety of Simultaneous Vaccination with Polysaccharide Conjugate Vaccines Against Pneumococcal (13-Valent Vaccine) and Haemophilus influenzae Type b Infections in Children with Juvenile Idiopathic Arthritis Without Systemic Manifestations: A Prospective Cohort Study.
Vaccines (Basel). 2025 Feb 12;13(2):177.
https://pubmed.ncbi.nlm.nih.gov/40006724/
ENERO 2025
-
Nepesov MI, Gür GU, Yamanel RGS, Çakan M.
Hepatitis B vaccine and juvenile idiopathic arthritis: comparison of the seropositivity rates with healthy children at the time of diagnosis and booster dose response under treatment.
Clin Rheumatol. 2025 Jan 14. doi: 10.1007/s10067-025-07313-2. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39808236/
NOVIEMBRE 2024
-
Ørbo HS, de Matos Kasahara T, Wolf AS, Bjørlykke KH, Sexton J, Jyssum I, et al.
Humoral and cellular responses to a fifth bivalent SARS-CoV-2 vaccine dose in patients with immune-mediated inflammatory diseases on tumour necrosis factor inhibitors: a prospective cohort study
Lancet Reg Health Eur. 2024 Nov 15;48:101121. doi: 10.1016/j.lanepe.2024.101121.
https://pubmed.ncbi.nlm.nih.gov/39624496/ -
Meier-Stephenson V, Hawkes MT, Burton C, Calcutt A, Davis C, Dooley J, Good M, et al.
A phase 1 randomized controlled trial of a peptide-based group A streptococcal vaccine in healthy volunteers.
Trials. 2024 Nov 19;25(1):781. doi: 10.1186/s13063-024-08634-4.
https://pubmed.ncbi.nlm.nih.gov/39563457/
SEPTIEMBRE 2024
-
Tsyruk O, Kaplan GG, Fortin PR, Hitchon CA, Chandran V, Larché MJ, et al. On Behalf Of The Succeed Investigative Team.
How Safe Are COVID-19 Vaccines in Individuals with Immune-Mediated Inflammatory Diseases? The SUCCEED Study.
Vaccines (Basel). 2024 Sep 8;12(9):1027. doi: 10.3390/vaccines12091027.
https://pubmed.ncbi.nlm.nih.gov/39340057/ -
Wolf AS, Bjørlykke KH, Ørbo HS, Bhandari S, Solum G, Kjønstad IF, et al.
T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients on TNF inhibitor treatment: a prospective cohort study.
EBioMedicine. 2024 Sep 10;108:105317. doi: 10.1016/j.ebiom.2024.105317. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39260039/
AGOSTO 2024
-
Maritsi D, Dasoula F, Ziv A, Bizjak M, Balažiová B, Matošević M, et al.
Influenza vaccine uptake in juvenile idiopathic arthritis: a multi-centre cross-sectional study.
Eur J Pediatr. 2024 Jul;183(7):2937-2944. doi: 10.1007/s00431-024-05552-0. Epub 2024 Apr 15.
https://pubmed.ncbi.nlm.nih.gov/38619568/
JULIO 2024
-
Maritsi D, Dasoula F, Ziv A, Bizjak M, Balažiová B, Matošević M, et al.
Influenza vaccine uptake in juvenile idiopathic arthritis: a multi-centre cross-sectional study.
Eur J Pediatr. 2024 Jul;183(7):2937-2944. doi: 10.1007/s00431-024-05552-0. Epub 2024 Apr 15.
https://pubmed.ncbi.nlm.nih.gov/38619568/ -
Eviatar T, Pappo A, Freund T, Friedlander Y, Elkayam O, Hagin D, Heshin-Bekenstein M.
Cellular immune response to the anti-SARS-CoV-2 BNT162b2 mRNA vaccine in pediatric autoimmune inflammatory rheumatic disease patients and controls.
Clin Exp Immunol. 2024 Jul 12;217(2):167-172. doi: 10.1093/cei/uxae044.
https://pubmed.ncbi.nlm.nih.gov/38767466/ -
Savšek TŠ, Avramovič MZ, Avčin T, Korva M, Avšič-Županc T, Toplak N.
Serological response after COVID-19 infection compared to vaccination against COVID-19 in children with autoimmune rheumatic diseases.
Pediatr Rheumatol Online J. 2024 Jul 25;22(1):68. doi: 10.1186/s12969-024-01003-0.
https://pubmed.ncbi.nlm.nih.gov/39054538/
MAYO 2024
-
Farisogullari B, Lawson-Tovey S, Hyrich KL, Gossec L, Carmona L, Strangfeld A, et al; EULAR COVAX Registry.
Factors associated with disease flare following SARS-CoV-2 vaccination in people with inflammatory rheumatic and musculoskeletal diseases: results from the physician-reported EULAR Coronavirus Vaccine (COVAX) Registry.
Ann Rheum Dis. 2024 May 30:ard-2024-225869. doi: 10.1136/ard-2024-225869.
https://pubmed.ncbi.nlm.nih.gov/38816065/
MARZO 2024
-
Kopsidas I, Mentesidou L, Syggelou A, Papadimitriou M, Matsas M, Kossiva L, Maritsi DN.
Measles-specific antibodies loss after a single dose of MMR vaccine in children with oligo-articular JIA on methotrexate treatment: a single-center case-controlled study.
Rheumatol Int. 2024 Mar 18. doi: 10.1007/s00296-024-05563-y. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/38498151/ -
Frodlund M, Nived P, Chatzidionysiou K, Södergren A, Klingberg E, Hansson M, et al.
The serological immunogenicity of the third and fourth doses of COVID-19 vaccine in patients with inflammatory rheumatic diseases on different biologic or targeted DMARDs: a Swedish nationwide study (COVID-19-REUMA).
Microbiol Spectr. 2024 Mar 5:e0298123. doi: 10.1128/spectrum.02981-23. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/38441463/
FEBRERO 2024
-
Hamad Saied M, van Straalen JW, de Roock S, Verduyn Lunel FM, de Wit J, de Rond LGH, Van Nieuwenhove E, Vastert BJ, van Montfrans JM, van Royen-Kerkhof A, de Joode-Smink GCJ, Swart JF, Wulffraat NM, Jansen MHA.
Humoral and cellular immunogenicity, effectiveness and safety of COVID-19 mRNA vaccination in patients with pediatric rheumatic diseases: A prospective cohort study.
Vaccine. 2024 Feb 15;42(5):1145-1153. doi: 10.1016/j.vaccine.2024.01.047.
https://pubmed.ncbi.nlm.nih.gov/38262809/
ENERO 2024
-
Hamad Saied M, van Straalen JW, de Roock S, Verduyn Lunel FM, de Wit J, de Rond LGH, et al.
Humoral and cellular immunogenicity, effectiveness and safety of COVID-19 mRNA vaccination in patients with pediatric rheumatic diseases: A prospective cohort study.
Vaccine. 2024 Jan 22:S0264-410X(24)00059-8. doi: 10.1016/j.vaccine.2024.01.047. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/38262809/
DICIEMBRE 2023
-
Geck L, Tascilar K, Simon D, Kleyer A, Schett G, Rech J.
Anti-Interleukin-1 Therapy Does Not Affect the Response to SARS-CoV-2 Vaccination and Infection in Patients with Systemic Autoinflammatory Diseases.
J Clin Med. 2023 Dec 8;12(24):7587. doi: 10.3390/jcm12247587.
https://pubmed.ncbi.nlm.nih.gov/38137656/
NOVIEMBRE 2023
-
Sharanya P, Kota VR.
Vaccination of Pediatric Patients With Autoimmune Inflammatory Rheumatic Diseases - EULAR/PRES Updated Recommendations, 2021.
Indian Pediatr. 2023 Nov 15;60(11):947-950.
https://pubmed.ncbi.nlm.nih.gov/37950473/ -
Akgün Ö, Demirkan FG, Kavrul Kayaalp G, Erdemir M, Akay N, Çakmak F, Önel M, Keskindemirci G, Eker Ömeroğlu R, Gökçay EG, Aktay Ayaz N.
Vaccination coverage of children with rheumatic diseases compared with healthy controls: a retrospective case-control study.
Postgrad Med. 2023 Nov 24. doi: 10.1080/00325481.2023.2287988.
https://pubmed.ncbi.nlm.nih.gov/37997766/
SEPTIEMBRE 2023
-
Wroński J, Ciechomska M, Kuca-Warnawin E.
Impact of methotrexate treatment on vaccines immunogenicity in adult rheumatological patients - Lessons learned from the COVID-19 pandemic.
Biomed Pharmacother. 2023 Sep;165:115254. doi: 10.1016/j.biopha.2023.115254.
https://pubmed.ncbi.nlm.nih.gov/37542854/ -
Alnaimat F, Sweis JJG, Jansz J, Modi Z, Prasad S, AbuHelal A, Vagts C, et al.
Vaccination in the Era of Immunosuppression.
Vaccines (Basel). 2023 Sep 1;11(9):1446. doi: 10.3390/vaccines11091446.
https://pubmed.ncbi.nlm.nih.gov/37766123/ -
Doskaliuk B, Ravichandran N, Sen P, Day J, Joshi M, Nune A, et al; COVAD study group; Chinoy H, Agarwal V, Aggarwal R, Gupta L.
Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study.
Rheumatol Int. 2023 Sep;43(9):1651-1664. doi: 10.1007/s00296-023-05345-y.
https://pubmed.ncbi.nlm.nih.gov/37351634/ -
Wang J, Ma C, Li M, Gao X, Wu H, Dong W, Wei L.
Streptococcus pyogenes: Pathogenesis and the Current Status of Vaccines.
Vaccines (Basel). 2023 Sep 21;11(9):1510. doi: 10.3390/vaccines11091510.
https://pubmed.ncbi.nlm.nih.gov/37766186/
AGOSTO 2023
-
Hamad Saied M, van Straalen JW, de Roock S, de Joode-Smink GCJ, Verduyn Lunel FM, Swart JF, Wulffraat NM, Jansen MHA.
Long-term immunoprotection after live attenuated measles-mumps-rubella booster vaccination in children with juvenile idiopathic arthritis.
Vaccine. 2023 Aug 23;41(37):5477-5482. doi: 10.1016/j.vaccine.2023.07.052. Epub 2023 Jul 27.
https://pubmed.ncbi.nlm.nih.gov/37516575/
JULIO 2023
-
Hamad Saied M, van Straalen JW, de Roock S, de Joode-Smink GCJ, Verduyn Lunel FM, Swart JF, Wulffraat NM, Jansen MHA.
Long-term immunoprotection after live attenuated measles-mumps-rubella booster vaccination in children with juvenile idiopathic arthritis.
Vaccine. 2023 Aug 23;41(37):5477-5482. doi: 10.1016/j.vaccine.2023.07.052. Epub 2023 Jul 27.
https://pubmed.ncbi.nlm.nih.gov/37516575/ -
Bindoli S, Baggio C, Galozzi P, Vesentini F, Doria A, Cosma C, Padoan A, Sfriso P.
Autoinflammatory Diseases and COVID-19 Vaccination: Analysis of SARS-CoV-2 Anti-S-RBD IgG Levels in a Cohort of Patients Receiving IL-1 Inhibitors.
J Clin Med. 2023 Jul 18;12(14):4741. doi: 10.3390/jcm12144741.
https://pubmed.ncbi.nlm.nih.gov/37510856/ -
Ohm M, van Straalen JW, de Joode-Smink G, van Montfrans J, Bartels M, van Wildenbeest JG et al.
Meningococcal ACWY conjugate vaccine immunogenicity in adolescents with primary or secondary immune deficiencies, a prospective observational cohort study.
Pediatr Rheumatol Online J. 2023 Jul 20;21(1):73. doi: 10.1186/s12969-023-00846-3.
https://pubmed.ncbi.nlm.nih.gov/37475057/
JUNIO 2023
-
Šinkovec Savšek T, Zajc Avramovič M, Avčin T, Korva M, Avšič Županc T, Toplak N.
Disease relapse rate in children with autoimmune rheumatic diseases after COVID-19 infection and vaccination.
Pediatr Rheumatol Online J. 2023 May 19;21(1):46. doi: 10.1186/s12969-023-00829-4.
https://pubmed.ncbi.nlm.nih.gov/37208721/ -
Ohm M, van Straalen JW, Zijlstra M, de Joode-Smink G, Jasmijn Sellies A, Swart JF, et al.
Meningococcal ACWY conjugate vaccine immunogenicity and safety in adolescents with juvenile idiopathic arthritis and inflammatory bowel disease: A prospective observational cohort study.
Vaccine. 2023 May 15:S0264-410X(23)00480-2. doi: 10.1016/j.vaccine.2023.04.056. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37198018/ - Luo X, Tao J, Pang M, Zhang Z, Tang X.
Knowledge and practices of vaccination for children with rheumatic diseases: A single-center study in China.
Hum Vaccin Immunother. 2023 May 21:2215108. doi: 10.1080/21645515.2023.2215108. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37211623/
MARZO 2023
-
Gottschalk MN, Heiland M, Nahles S, Preissner R, Petri WA, Wendy S, Preissner S.
Increased incidence of adult-onset Still's disease in association with COVID-19 vaccination and SARS-CoV-2 infection.
Orphanet J Rare Dis. 2023 Mar 10;18(1):50. doi: 10.1186/s13023-023-02651-3.
https://pubmed.ncbi.nlm.nih.gov/36899416/ -
Álvaro-Gracia JM, Sanchez-Piedra C, Culqui D, Rosello R, Garcia-Dorta A, Campos C, et al.
Effects of COVID-19 vaccination on disease activity in patients with rheumatoid arthritis and psoriatic arthritis on targeted therapy in the COVIDSER study.
RMD Open. 2023 Mar;9(1):e002936. doi: 10.1136/rmdopen-2022-002936.
https://pubmed.ncbi.nlm.nih.gov/36927849/ -
Tunitsky-Lifshitz Y, Maoz-Segal R, Niznik S, Shavit R, Haj Yahia S, Langevitz P, Agmon-Levin N.
The third dose of BNT162b2 COVID-19 vaccine is efficacious and safe for systemic lupus erythematosus patients receiving belimumab.
Lupus. 2023 Mar 23:9612033231164262. doi: 10.1177/09612033231164262. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36952594/ -
An Z, Zhou X, Li Y, Jaquith J, McCarthy-Fruin K, Sletten J, et al.
Immune responses and disease biomarker long-term changes following COVID-19 mRNA vaccination in a cohort of rheumatic disease patients.
medRxiv. 2023 Mar 27:2023.03.22.23287597. doi: 10.1101/2023.03.22.23287597.
https://pubmed.ncbi.nlm.nih.gov/36993236/ -
Naveen R, Thakare DR, Kuwana M, Pauling JD, Day J, Joshi M, et al; COVAD Study Group; Aggarwal R, Gupta L, Agarwal V, Makol A.
Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey.
Rheumatol Int. 2023 Mar 31:1-11. doi: 10.1007/s00296-023-05310-9. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37000295/
FEBRERO 2023
-
Ziv A, Heshin-Bekenstein M, Haviv R, Kivity S, Netzer D, Yaron S, Schur Y, Egert T, Egert Y, Sela Y, Hashkes PJ, Uziel Y.
Effectiveness of the BNT162b2 mRNA COVID-19 vaccine among adolescents with juvenile-onset inflammatory rheumatic diseases.
Rheumatology (Oxford). 2023 Feb 23;62(SI2):SI145-SI151. doi: 10.1093/rheumatology/keac408.
https://pubmed.ncbi.nlm.nih.gov/35920789/ -
Seo P, Winthrop K, Sawalha AH, Choi S, Park HA, Hwang W, Lee EB, Park JK.
Physician Perspectives on Vaccination in Patients With Autoimmune Inflammatory Rheumatic Diseases: An International Survey.
J Rheumatol. 2023 Feb;50(2):246-251. doi: 10.3899/jrheum.220135.
https://pubmed.ncbi.nlm.nih.gov/36319001/
ENERO 2023
-
Massaro MG, Caldarelli M, Franza L, Candelli M, Gasbarrini A, Gambassi G, Cianci R, Rigante D.
Current Evidence on Vaccinations in Pediatric and Adult Patients with Systemic Autoinflammatory Diseases.
Vaccines (Basel). 2023 Jan 10;11(1):151. doi: 10.3390/vaccines11010151.
https://pubmed.ncbi.nlm.nih.gov/36679996/ - Chighizola CB, Suardi I, Carrea G, Argolini L, Gattinara M, Marino A, Pontikaki I, Caporali R, Gerosa M.
Anti-SARS-CoV-2 vaccination in adolescent and adult patients with juvenile onset systemic lupus erythematosus: tolerability and impact on disease activity.
Rheumatology (Oxford). 2023 Jan 25:kead047. doi: 10.1093/rheumatology/kead047. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36702464/
- van Dam KPJ, Wieske L, Stalman EW, Kummer LYL, Roosen J, van Kempen ZLE, et al ; T2B! Immunity against SARS-CoV-2 study group.
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations.
J Autoimmun. 2023 Jan 2;135:102984. doi: 10.1016/j.jaut.2022.102984. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36621174/
- Yeo JG, Teh KL, Ni Chia W, Book YX, Hoh SF, Gao X, et al.
COVID-19 mRNA vaccine immunogenicity decay and breakthrough illness in adolescents and young adults with childhood-onset rheumatic diseases.
Rheumatology (Oxford). 2023 Jan 20:kead031. doi: 10.1093/rheumatology/kead031. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36661304/
AGOSTO 2022
-
Udaondo C, Cámara C, Miguel Berenguel L, Alcobendas Rueda R, Muñoz Gómez C, Millán Longo C, Díaz-Delgado B, Falces-Romero I, Díaz Almirón M, Ochando J, Méndez-Echevarría A, Remesal Camba A, Calvo C.
Humoral and cellular immune response to mRNA SARS-CoV-2 BNT162b2 vaccine in adolescents with rheumatic diseases
Pediatr Rheumatol Online J. 2022 Aug 13;20(1):64. doi: 10.1186/s12969-022-00724-4.
https://pubmed.ncbi.nlm.nih.gov/35964130/ -
Ohnishi Y, Okada S, Kawakami-Miyake A, Furuta T, Fukano R, Yasudo H, Shimokawa M, Hasegawa S.
Safety and Feasibility of Infliximab Therapy in Children With Kawasaki Disease Who Received Live Vaccinations
Pediatr Infect Dis J. 2022 Sep 1;41(9):e388-e392. doi: 10.1097/INF.0000000000003611. Epub 2022 Jul 27.
https://pubmed.ncbi.nlm.nih.gov/35895884/ -
Ziv A, Heshin-Bekenstein M, Haviv R, Kivity S, Netzer D, Yaron S, Schur Y, Egert T, Egert Y, Sela Y, Hashkes PJ, Uziel Y.
Effectiveness of the BNT162b2 mRNA COVID-19 Vaccine among Adolescents with Juvenile-onset Inflammatory Rheumatic Diseases
Rheumatology (Oxford). 2022 Aug 3:keac408. doi: 10.1093/rheumatology/keac408.
https://pubmed.ncbi.nlm.nih.gov/35920789/ -
Sen ES, Julandani D, Ramanan AV.
SARS-CoV-2 vaccinations in children and adolescents with rheumatic diseases
Rheumatology (Oxford). 2022 Aug 2:keac431. doi: 10.1093/rheumatology/keac431.
https://pubmed.ncbi.nlm.nih.gov/35916712/ -
Balažiová B, Kuková Z, Mišíková D, Novosedlíková K, Dallos T.
Real-life vaccination coverage in Slovak children with rheumatic diseases.
Front Pediatr. 2022 Aug 12;10:956136. doi: 10.3389/fped.2022.956136.
https://pubmed.ncbi.nlm.nih.gov/36034574/
JULIO 2022
-
Jansen MH, Rondaan C, Legger G, Minden K, Uziel Y, Toplak N, Maritsi D, van den Berg M, Berbers G, Bruijning P, Egert Y, Normand C, Bijl M, Foster H, Kone-Paut I, Wouters C, Ravelli A, Elkayam O, Wulffraat NM, Heijstek MW.
Efficacy, Immunogenicity and Safety of Vaccination in Pediatric Patients With Autoimmune Inflammatory Rheumatic Diseases (pedAIIRD): A Systematic Literature Review for the 2021 Update of the EULAR/PRES Recommendations.
Front Pediatr. 2022 Jul 6;10:910026. doi: 10.3389/fped.2022.910026.
https://pubmed.ncbi.nlm.nih.gov/35874582/ -
Lawson-Tovey S, Machado PM, Strangfeld A, Mateus E, Gossec L, Carmona L, et al; ; EULAR COVAX..
SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry.
RMD Open. 2022 Jul;8(2):e002322. doi: 10.1136/rmdopen-2022-002322.
https://pubmed.ncbi.nlm.nih.gov/35908834/ -
Gil-Vila A, Naveen R, Selva-O'Callaghan A, Sen P, Nune A, Gaur PS, et al; COVAD Study Group.
COVID-19 Vaccination In Autoimmune Diseases (COVAD) Study: Vaccine Safety In Idiopathic Inflammatory Myopathies.
Muscle Nerve. 2022 Jul 23:10.1002/mus.27681. doi: 10.1002/mus.27681. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35869701/
JUNIO 2022
-
Jansen MHA, Rondaan C, Legger GE, Minden K, Uziel Y, Toplak N, Maritsi D et al.
EULAR/PRES recommendations for vaccination of paediatric patients with autoimmune inflammatory rheumatic diseases: Update 2021.
Ann Rheum Dis. 2022 Jun 20:annrheumdis-2022-222574. doi: 10.1136/annrheumdis-2022-222574. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35725297/ -
Abhishek A, Boyton RJ, Peckham N, McKnight Á, Coates LC, Bluett J et al.
Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial.
Lancet Respir Med. 2022 Jun 27:S2213-2600(22)00186-2. doi: 10.1016/S2213-2600(22)00186-2. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35772416/ -
Rider LG, Parks CG, Wilkerson J, Schiffenbauer AI, Kwok RK, Noroozi Farhadi et al.
Baseline factors associated with self-reported disease flares following COVID-19 vaccination among adults with systemic rheumatic disease: results from the COVID-19 global rheumatology alliance vaccine survey.
Rheumatology (Oxford). 2022 Jun 28;61(SI2):SI143-SI150. doi:10.1093/rheumatology/keac249.
https://pubmed.ncbi.nlm.nih.gov/35460240/
MAYO 2022
-
Aikawa NE, Kupa LVK, Silva CA, Saad CGS, Pasoto SG, Yuki EFN, et al.
Strong response after 4th dose of mRNA COVID-19 vaccine in autoimmune rheumatic diseases patients with poor response to inactivated vaccine.
Rheumatology (Oxford). 2022 May 26:keac301. doi: 10.1093/rheumatology/keac301. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35639644/ -
Assawasaksakul T, Lertussavavivat T, Sathitratanacheewin S, Oudomying N, Connolly CM, Frey S, Chiang TP, Teles M, Alejo JL, Albayda J,
Safety of third-dose SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal disease.
Rheumatology (Oxford). 2022 May 18:keac298. doi: 10.1093/rheumatology/keac298. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35583259/ -
De Santis M, Motta F, Isailovic N, Clementi M, Criscuolo E, Clementi N, et al.
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases.
Vaccines (Basel). 2022 May 18;10(5):801. doi: 10.3390/vaccines10050801.
https://pubmed.ncbi.nlm.nih.gov/35632557/ -
Vichaiwattana P, Wanlapakorn N, et al.
Comparison of Immunogenicity and Safety of Inactivated, Adenovirus-Vectored, and Heterologous Adenovirus-Vectored/mRNA Vaccines in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: A Prospective Cohort Study.
Vaccines (Basel). 2022 May 26;10(6):853. doi: 10.3390/vaccines10060853.
https://pubmed.ncbi.nlm.nih.gov/35746461/
MARZO 2022
-
Cuadros EN, Calzada-Hernández J, Clemente D, Martín SG, Silveira LF, Lirola-Cruz MJ, Tagarro A, Lovillo MC, Rueda RMA, López AL, Aritziturri MS, Calvo C.
Position statement of the Spanish Society of Pediatric Rheumatology on infection screening, prophylaxis, and vaccination of pediatric patients with rheumatic diseases and immunosuppressive therapies: Part 1 (screening).
Eur J Pediatr. 2022 Mar 8. doi: 10.1007/s00431-022-04418-7. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35258699/ -
Fragoulis GE, Karamanakos A, Arida A, Bournia VK, Evangelatos G, Fanouriakis A, Fragiadaki K, Kravvariti E, Laskari K, Panopoulos S, Papazoglou N, Pappa M, Tektonidou MGG, Sfikakis PP.
Clinical outcomes of breakthrough COVID-19 after booster vaccination in patients with systemic rheumatic diseases.
RMD Open. 2022 Mar;8(1):e002279. doi: 10.1136/rmdopen-2022-002279.
https://pubmed.ncbi.nlm.nih.gov/35246472/ -
Aikawa NE, Kupa LVK, Medeiros-Ribeiro AC, Saad CGS, Yuki EFN, Pasoto SG, et al.
Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases.
Ann Rheum Dis. 2022 Mar 11:annrheumdis-2021-222096. doi: 10.1136/annrheumdis-2021-222096. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35277389/ -
Mori S, Ueki Y, Ishiwada N.
Impact of Janus Kinase Inhibitors on Antibody Response to 13-Valent Pneumococcal Conjugate Vaccine in Patients with Rheumatoid Arthritis.
Mod Rheumatol. 2022 Mar 26:roac029. doi: 10.1093/mr/roac029. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35348759/ -
Troldborg A, Thomsen MK, Bartels LE, Andersen JB, Vils SR, Mistegaard CE, et al.
Time Since Rituximab Treatment Is Essential for Developing a Humoral Response to COVID-19 mRNA Vaccines in Patients With Rheumatic Diseases.
J Rheumatol. 2022 Mar 1:jrheum.211152. doi: 10.3899/jrheum.211152. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35232803/
FEBRERO 2022
-
Heshin-Bekenstein M, Ziv A, Toplak N, Hagin D, Kadishevich D, Butbul YA, Saiag E, Kaufman A, Shefer G, Sharon O, Pel S, Elkayam O, Uziel Y.
Safety and immunogenicity of BNT162b2 mRNA COVID-19 vaccine in adolescents with rheumatic diseases treated with immunomodulatory medications.
Rheumatology (Oxford). 2022 Feb 18:keac103. doi: 10.1093/rheumatology/keac103.
https://pubmed.ncbi.nlm.nih.gov/35179569/
ENERO 2022
-
Atagündüz P, Keser G, Soy M.
Interleukin-1 Inhibitors and Vaccination Including COVID-19 in Inflammatory Rheumatic Diseases: A Nonsystematic Review.
Front Immunol. 2022 Jan 27;12:734279. doi: 10.3389/fimmu.2021.734279.
https://pubmed.ncbi.nlm.nih.gov/35154066/ -
Marty PK, Van Keulen VP, Erskine CL, Shah M, Hummel A, Stachowitz M, Fatis S, Granger D, Block MS, Duarte-García A, Warrington KJ, Theel ES, Zhou X, Zeng H, Specks U, Escalante P, Peikert T.
Antigen Specific Humoral and Cellular Immunity Following SARS-CoV-2 Vaccination in ANCA-Associated Vasculitis Patients Receiving B-Cell Depleting Therapy.
Front Immunol. 2022 Jan 28;13:834981. doi: 10.3389/fimmu.2022.834981.
https://pubmed.ncbi.nlm.nih.gov/35154159/
DICIEMBRE 2021
-
Keller M, Pittet LF, Zimmermann P.
Immunogenicity and safety of routine vaccines in children and adolescents with rheumatic diseases on immunosuppressive treatment - a systematic review.
Eur J Pediatr. 2021 Dec 22;1-34. doi: 10.1007/s00431-021-04283-w. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34936010/ -
Degrava Sampaio-Barros P, Medeiros-Ribeiro AC, Luppino-Assad AP, Miossi R, Carriço da Silva H et al.
SARS-CoV-2 vaccine in patients with systemic sclerosis: Impact of disease subtype and therapy.
Rheumatology (Oxford). 2021 Dec 11;keab886. doi: 10.1093/rheumatology/keab886. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34894235/ -
Tzioufas AG, Bakasis AD, Goules AV, Bitzogli K et al.
A prospective multicenter study assessing humoral immunogenicity and safety of the mRNA SARS-CoV-2 vaccines in Greek patients with systemic autoimmune and autoinflammatory rheumatic diseases.
J Autoimmun. 2021 Dec;125:102743. doi: 10.1016/j.jaut.2021.102743. Epub 2021 Oct 28.
https://pubmed.ncbi.nlm.nih.gov/34757289/
NOVIEMBRE 2021
-
Dimopoulou D, Vartzelis G, Dasoula F, Tsolia M, Maritsi D.
Immunogenicity of the COVID-19 mRNA vaccine in adolescents with juvenile idiopathic arthritis on treatment with TNF inhibitors.
Ann Rheum Dis. 2021 Nov 29:annrheumdis-2021-221607. doi: 10.1136/annrheumdis-2021-221607. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34844930/
AGOSTO 2021
-
Chiang TP, Connolly CM, Ruddy JA, Boyarsky BJ, Alejo JL, Werbel WA, Massie A, Christopher-Stine L, Garonzik-Wang J, Segev DL, Paik JJ.
Antibody response to the Janssen/Johnson & Johnson SARS-CoV-2 vaccine in patients with rheumatic and musculoskeletal diseases.
Ann Rheum Dis. 2021 Aug 24:annrheumdis-2021-221145. doi: 10.1136/annrheumdis-2021-221145. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34429320/ -
Boekel L, Steenhuis M, Hooijberg F, Besten YR, van Kempen ZLE, Kummer LY, et al.
Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies.
Lancet Rheumatol. 2021 Aug 6. doi: 10.1016/S2665-9913(21)00222-8. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34396154/ -
Prendecki M, Clarke C, Edwards H, McIntyre S, Mortimer P, Gleeson S, et al.
Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression.
Ann Rheum Dis. 2021 Aug 6:annrheumdis-2021-220626. doi: 10.1136/annrheumdis-2021-220626. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34362747/ -
Wong PKK, Lahiri M, Lye DC, Johnson D, Charles PGP.
A vaccination update for rheumatologists-SARS-CoV-2, influenza and herpes zoster.
Int J Rheum Dis. 2021 Aug;24(8):979-983. doi: 10.1111/1756-185X.14179.
https://pubmed.ncbi.nlm.nih.gov/34350721/
JULIO 2021
-
Rollet-Cohen V, Mirete J, Dingulu G, Hofer F, Hofer M, Woerner A, Dommergues MA, Hentgen V.
Suboptimal vaccination coverage of recommended vaccines among French children with recurrent autoinflammatory fever syndromes: a study from the Juvenile Inflammatory Rheumatism cohort.
Clin Rheumatol. 2021 Jul;40(7):2855-2864. doi: 10.1007/s10067-020-05553-y. Epub 2021 Jan 13. PMID: 33439385.
https://pubmed.ncbi.nlm.nih.gov/33439385/
JUNIO 2021
-
Jeffrey R Curtis, Sindhu R Johnson, Donald D Anthony et al.
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 2
Arthritis Rheumatol. 2021 Jun 15. doi: 10.1002/art.41877. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34128356/ -
Amelia Santosa, Chuanhui Xu, Thaschawee Arkachaisri et al.
Recommendations for COVID-19 vaccination in people with rheumatic disease: Developed by the Singapore Chapter of Rheumatologists
Int J Rheum Dis. 2021 Jun;24(6):746-757. doi: 10.1111/1756-185X.14107. Epub 2021 May 10
https://pubmed.ncbi.nlm.nih.gov/33973379/ -
Victoria Furer, Tali Eviatar, Devy Zisman et al.
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study.
Ann Rheum Dis. 2021 Jun 14;annrheumdis-2021-220647. doi: 10.1136/annrheumdis-2021-220647. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34127481/ -
Yolanda Braun-Moscovici, Marielle Kaplan, Maya Braun et al.
Disease activity and humoral response in patients with inflammatory rheumatic diseases after two doses of the Pfizer mRNA vaccine against SARS-CoV-2.
Ann Rheum Dis. 2021 Jun 18;annrheumdis-2021-220503. doi: 10.1136/annrheumdis-2021-220503. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34074678/
MAYO 2021
-
Hazlewood GS, Pardo Pardo J, Barnabe C, Schieir O, Barber CEH, Bernatsky S, Colmegna I, Hitchon C, Loeb M, Mertz D, Proulx L, Richards DP, Scuccimarri R, Tugwell P, Schünemann HJ, Mirza RD, Zhou AL, Nikolic RPA, Thomas M, Chase H, Ejaredar M, Nieuwlaat R.
Canadian Rheumatology Association Recommendation for the Use of COVID-19 Vaccination for Patients With Autoimmune Rheumatic Diseases.
J Rheumatol. 2021 May 15:jrheum.210288. doi:10.3899/jrheum.210288
https://pubmed.ncbi.nlm.nih.gov/33993119/
MARZO 2021
-
Curtis JR, Johnson SR, Anthony DD, Arasaratnam RJ, Baden LR, Bass AR, et al.
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients with Rheumatic and Musculoskeletal Diseases - Version 1.
Arthritis Rheumatol. 2021 Mar 17. doi: 10.1002/art.41734. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/33728796/ -
Arnold J, Winthrop K, Emery P.
COVID-19 vaccination and antirheumatic therapy.
Rheumatology (Oxford). 2021 Mar 12:keab223. doi: 10.1093/rheumatology/keab223. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/33710296/ -
Park JK, Lee EB, Shin K, Sung YK, Kim TH, Kwon SR, et al; Korean College of Rheumatology Task Force for COVID-19 Vaccine Guidance for Patients with Autoimmune.
COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases: Clinical Guidance of the Korean College of Rheumatology.
J Korean Med Sci. 2021 Mar 29;36(12):e95. doi: 10.3346/jkms.2021.36.e95.
https://pubmed.ncbi.nlm.nih.gov/33783147/ -
Soy M, Keser G, Atagunduz P, Mutlu MY, Gunduz A, Koybaşi G, Bes C.
A practical approach for vaccinations including COVID-19 in autoimmune/autoinflammatory rheumatic diseases: a non-systematic review.
Clin Rheumatol. 2021 Mar 22:1-13. doi: 10.1007/s10067-021-05700-z. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/33751280/ -
Jensen L, Nielsen S, Christensen AE, Pedersen FK, Trebbien R, Kølsen Fischer T, et al.
Response to influenza vaccination in immunocompromised children with rheumatic disease: a prospective cohort study.
Pediatr Rheumatol Online J. 2021 Mar 12;19(1):26. doi: 10.1186/s12969-021-00518-0.
https://pubmed.ncbi.nlm.nih.gov/33712043/ -
Constantinou CA, Ziogas DC, Venetsanopoulou A, Gamaletsou MN, Koutsogeorgopoulou L, Barbouni A, Tzioufas AG, Sipsas NV.
A clinical audit of pneumococcal vaccination among patients with autoimmune rheumatic diseases living in Greece: The power of awareness.
Vaccine. 2021 Mar 12;39(11):1593-1597. doi: 10.1016/j.vaccine.2021.02.009.
https://pubmed.ncbi.nlm.nih.gov/33610375/
FEBRERO 2021
-
Peracchi OA, Nicácio AAM, Yamada J, Len CA, Moraes-Pinto MI, Terreri MT.
Adequate tetanus but poor diphtheria and pertussis response to a Tdap booster in adolescents with juvenile systemic lupus erythematosus.
Lupus. 2021 Feb;30(2):299-306. doi: 10.1177/0961203320973263.
https://pubmed.ncbi.nlm.nih.gov/33197362/ -
Nicácio AAMF, Peracchi OAB, Yamada J, Fraga MM, Vitalle MS, de Moraes-Pinto MI, Terreri MT.
Tdap booster to adolescents with juvenile idiopathic arthritis on and off anti-TNF agents is safe and immunogenic.
Vaccine. 2021 Feb 12;39(7):1165-1172. doi: 10.1016/j.vaccine.2020.12.071. Epub 2021 Jan 19.
https://pubmed.ncbi.nlm.nih.gov/33478788/ -
Beesley RP, Costello W, Angevare SP, Wouters C, Wulffraat N, Uzie Y.
Survey of adult and paediatric rheumatology patients suggests information about COVID-19 vaccination will aid uptake.
Rheumatology (Oxford). 2021 Feb 16:keab169. doi: 10.1093/rheumatology/keab169.
https://pubmed.ncbi.nlm.nih.gov/33590835/
-
Tse HN, Borrow R, Arkwright PD.
Immune Response and Safety of Viral Vaccines in Children with Autoimmune Diseases on Immune Modulatory Drug Therapy.
Expert Rev Vaccines. 2021 Jan 28:1-13. doi: 10.1080/14760584.2021.1875825. Epub ahead of print. PMID: 33507119.
https://pubmed.ncbi.nlm.nih.gov/33507119/
DICIEMBRE 2020
-
Grein IHR, Pinto NBF, Groot N, Martins CB, Lobo A, Aikawa NE, Barbosa C, Terreri MT, da Fraga ACM, de Oliveira SKF, Sztajnbok F, Paim Marques LB, Islabão AG, Appenzeller S, Bica B, de Oliveira Sato J, Magalhães CS, Ferriani V, Pasmans H, Schepp R, van der Klis F, de Roock S, Wulffraat N, Pileggi GS.
Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in patients with juvenile dermatomyositis: a real-world multicentre study.
Pediatr Rheumatol Online J. 2020 Nov 11;18(1):87.
https://pubmed.ncbi.nlm.nih.gov/33176806/ -
Peracchi OA, Nicácio AAM, Yamada J, Len CA, Moraes-Pinto MI, Terreri MT.
Adequate tetanus but poor diphtheria and pertussis response to a Tdap booster in adolescents with juvenile systemic lupus erythematosus.
Lupus. 2020 Nov 16:961203320973263. doi: 10.1177/0961203320973263
https://pubmed.ncbi.nlm.nih.gov/33197362/
SEPTIEMBRE 2020
-
Ben Nessib D, Fazaa A, Miladi S, Sellami M, Ouenniche K, Souabni L, Kassab S, Chekili S, Ben Abdelghani K, Laatar A.
Do immunosuppressive agents hamper the vaccination response in patients with rheumatic diseases? A review of the literature.
Therapie. 2020 Sep 3:S0040-5957(20)30148-7. doi: 10.1016/j.therap.2020.08.002. Online ahead of print
https://pubmed.ncbi.nlm.nih.gov/32951867/ -
Figueroa-Parra G, Esquivel-Valerio JA, Santoyo-Fexas L, Moreno-Salinas A, Gamboa-Alonso CM, De Leon-Ibarra AL, Galarza-Delgado DA.
Knowledge and attitudes about influenza vaccination in rheumatic diseases patients.
Hum Vaccin Immunother. 2020 Sep 29:1-6. doi: 10.1080/21645515.2020.1816108. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32991221/ -
Bühler S, Jaeger VK, Eperon G, Furrer H, Fux CA, Jansen S, et al.
Safety and immunogenicity of a primary yellow fever vaccination under low-dose methotrexate therapy-a prospective multi-centre pilot study1.
J Travel Med. 2020 Sep 26;27(6):taaa126. doi: 10.1093/jtm/taaa126.
https://pubmed.ncbi.nlm.nih.gov/32729905/
AGOSTO 2020
-
Alfayadh NM, Gowdie PJ, Akikusa JD, Easton ML, Buttery JP.
Vaccinations Do Not Increase Arthritis Flares in Juvenile Idiopathic Arthritis: A Study of the Relationship between Routine Childhood Vaccinations on the Australian Immunisation Schedule and Arthritis Activity in Children with Juvenile Idiopathic Arthritis.
Int J Rheumatol. 2020 Aug 4;2020:1078914. doi: 10.1155/2020/1078914.
https://pubmed.ncbi.nlm.nih.gov/32831849/ -
Welzel T, Wörner A, Heininger U.Z.
Travel vaccinations in rheumatic diseases : Specific considerations in children and adults.
Rheumatol. 2020 Aug 26. doi: 10.1007/s00393-020-00852-w.
https://pubmed.ncbi.nlm.nih.gov/32845394/
JULIO 2020
-
Rotstein Grein IH, Pinto NF, Lobo A, Groot N, Sztajnbok F, da Silva CAA, Paim Marques LB, Appenzeller S, Islabão AG, Magalhães CS, de Almeida RG, Bica B, Fraga M, da Fraga ACM, Dos Santos MC, Robazzi T, Terreri MTR, Bandeira M, Pasmans H, Schepp R, van der Klis F, de Roock S, Wulffraat N, Pileggi G.
Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in patients with childhood systemic lupus erythematosus: a real-world interventional multi-centre study.
Lupus. 2020 Jul;29(8):934-942. doi: 10.1177/0961203320928406. Epub 2020 Jun 5.
https://pubmed.ncbi.nlm.nih.gov/32501172/
MAYO 2020
- Toplak N, Uziel Y.
Vaccination for Children on Biologics.
Curr Rheumatol Rep. 2020 May 20;22(7):26.
https://doi.org/10.1007/s11926-020-00905-8
MARZO 2020
- Nakafero G, Grainge MJ, Myles PR, Mallen CD, Zhang W, Doherty M, Nguyen-Van-Tam JS, Abhishek A.
Effectiveness of inactivated influenza vaccine in autoimmune rheumatic diseases treated with disease-modifying anti-rheumatic drugs.
Rheumatology (Oxford). 2020 Mar 11. pii: keaa078. doi: 10.1093/rheumatology/keaa078. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32160295
FEBRERO 2020
- Bizjak M, Blazina Š, Zajc Avramovic M, Markelj G, Avcin T, Toplak N.
Vaccination coverage in children with rheumatic diseases.
Clin Exp Rheumatol. 2020 Jan-Feb;38(1):164-170. Epub 2019 Oct 2.
https://www.ncbi.nlm.nih.gov/pubmed/31577215 - Brunner HI, Tzaribachev N, Cornejo GV, Joos R, Gervais E, Cimaz R, Calvo Penadés I, Cuttica R, Lutz T, Quartier P, Gandhi Y, Nys M, Wong R, Martini A, Lovell DJ, Ruperto N; Pediatric Rheumatology Collaborative Study Group and the Paediatric Rheumatology International Trials Organisation.
Maintenance of antibody response to diphtheria/tetanus vaccine in patients aged 2-5?years with polyarticular-course juvenile idiopathic arthritis receiving subcutaneous abatacept.
Pediatr Rheumatol Online J. 2020 Feb 22;18(1):19. doi: 10.1186/s12969-020-0410-x.
https://www.ncbi.nlm.nih.gov/pubmed/32087715
ENERO 2020
- Uziel Y, Moshe V, Onozo B, Kulcsár A, Tróbert-Sipos D, Akikusa JD, Salviato Pileggi G, Maritsi D, Kasapcopur O, Rodrigues M, Smerla R, Rigante D, Makay B, Atsali E, Wulffraat N, Toplak N; PReS working party of Vaccination Study Group.
Live attenuated MMR/V booster vaccines in children with rheumatic diseases on immunosuppressive therapy are safe: Multicenter, retrospective data collection.
Vaccine. 2020 Jan 24. pii: S0264-410X(20)30052-9. doi: 10.1016/j.vaccine.2020.01.037. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31987692
JULIO 2019
- Qendro T, de la Torre ML, Panopalis P, Hazel E, Ward BJ, Colmegna I, Hudson M.
Suboptimal immunization coverage among Canadian rheumatology patients in routine clinical care.
J Rheumatol. 2019 Jul 15. pii: jrheum.181376. doi: 10.3899/jrheum.181376. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/?term=31308211
MARZO 2018
- Speth F, Hinze CH, Andel S, Mertens T, Haas JP.
Varicella-zoster-virus vaccination in immunosuppressed children with rheumatic diseases using a pre-vaccination check list.
Pediatr Rheumatol Online J. 2018 Mar 2;16(1):15.
https://www.ncbi.nlm.nih.gov/pubmed/29499726 - Jeyaratnam J, Ter Haar NM, Lachmann HJ, Kasapcopur O, Ombrello AK, Rigante D, Dedeoglu F, Baris EH, Vastert SJ, Wulffraat NM, Frenkel J.
The safety of live-attenuated vaccines in patients using IL-1 or IL-6 blockade: an international survey.
Pediatr Rheumatol Online J. 2018 Mar 21;16(1):19. doi: 10.1186/s12969-018-0235-z.
https://www.ncbi.nlm.nih.gov/pubmed/29562920
